Variant and risk allele,P-value,P-value annotation,RAF,OR,Beta,CI,Mapped gene,Reported trait,Trait(s),Study accession,Location
rs17837210-<b>A</b>,9 x 10-6,,'-,1.8,'-,[1.39-2.33],FAM124A,Placental abruption,Abruptio Placentae,GCST005844,13:51281874
rs219551-<b>T</b>,6 x 10-6,,'-,1.64,'-,[1.33-2.04],NUTF2P8,Placental abruption,Abruptio Placentae,GCST005844,2:21317839
rs799758-<b>T</b>,8 x 10-6,,'-,1.47,'-,[1.24-1.74],GALNT13,Placental abruption,Abruptio Placentae,GCST005844,2:154405632
rs76258369-<b>T</b>,3 x 10-6,,'-,1.56,'-,[1.3-1.88],"LINC01019, IRX1",Placental abruption,Abruptio Placentae,GCST005844,5:3545433
rs30080-<b>?</b>,5 x 10-6,,'-,1.369863,'-,[1.2-1.59],DOCK2,Placental abruption,Abruptio Placentae,GCST005844,5:169846553
rs4867606-<b>A</b>,5 x 10-6,,'-,1.82,'-,[1.41-2.36],KCNIP1,Placental abruption,Abruptio Placentae,GCST005844,5:170497691
rs11995662-<b>?</b>,5 x 10-6,,'-,1.6393442,'-,[1.33-2.04],PDGFRL,Placental abruption,Abruptio Placentae,GCST005844,8:17641221
rs7094759-<b>?</b>,4 x 10-6,,'-,1.3513513,'-,[1.19-1.54],ADAM12,Placental abruption,Abruptio Placentae,GCST005844,10:126163537
rs2291228-<b>A</b>,8 x 10-6,,'-,0.729927,'-,[1.19-1.57],"DOCK2, INSYN2B",Placental abruption,Abruptio Placentae,GCST005844,5:169861728
rs34288836-<b>?</b>,4 x 10-6,,NR,2.52,'-,'-,"GALNT3, TTC21B",Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,2:165809595
rs113018921-<b>?</b>,8 x 10-6,,NR,2.82,'-,'-,MSI2,Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,17:57647536
rs11788387-<b>?</b>,6 x 10-7,,NR,2.96,'-,'-,RNA5SP287,Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,9:81855961
rs118112762-<b>?</b>,7 x 10-6,,NR,3.25,'-,'-,FNDC3A,Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,13:49071567
rs17766756-<b>?</b>,3 x 10-6,,NR,3.78,'-,'-,"NKAIN2, RNF217-AS1",Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,6:124704154
rs202013048-<b>?</b>,4 x 10-6,,NR,3.78,'-,'-,"MTHFD2P4, FSTL5",Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,4:162241645
rs61887835-<b>?</b>,7 x 10-6,,NR,4.7,'-,'-,LGR4,Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,11:27409619
rs117023642-<b>?</b>,4 x 10-7,,NR,5.85,'-,'-,LINC02153,Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,8:20981609
rs12765664-<b>?</b>,5 x 10-6,,NR,2.9411764,'-,'-,ADAMTS14,Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,10:70735022
rs7537459-<b>?</b>,5 x 10-6,,NR,2.7027025,'-,'-,"LINC01739, LINC00466",Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,1:63068264
rs2807820-<b>?</b>,7 x 10-6,,NR,1.9607843,'-,'-,'-,Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,14:28028365
rs642846-<b>?</b>,2 x 10-6,,NR,1.94,'-,'-,KSR2,Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,12:117674581
rs2616554-<b>?</b>,4 x 10-6,,NR,1.95,'-,'-,VGLL4,Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,3:11623075
rs4919105-<b>?</b>,2 x 10-6,,NR,2.02,'-,'-,UBTD1,Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,10:97520476
rs6590390-<b>?</b>,5 x 10-6,,NR,2.13,'-,'-,"RPS27P20, LINC01395",Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,11:129540086
rs4704916-<b>?</b>,8 x 10-6,,NR,2.13,'-,'-,'-,Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,5:158104961
rs201608472-<b>?</b>,2 x 10-6,,NR,2.15,'-,'-,SUCLG2,Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,3:67394450
rs7231406-<b>?</b>,6 x 10-6,,NR,2.3,'-,'-,FHOD3,Spontaneous preterm birth with premature rupture of membranes,"preterm premature rupture of the membranes, spontaneous preterm birth",GCST008180,18:36644496
rs10793451-<b>T</b>,2 x 10-6,,NR,7.14,'-,[2.71-18.81],ZNF485,Premature menopause in childhood cancer survivors,primary ovarian insufficiency,GCST005518,10:43608447
rs6759058-<b>A</b>,9 x 10-6,,NR,4.3,'-,[2.14-8.64],PRKCE,Premature menopause in childhood cancer survivors,primary ovarian insufficiency,GCST005518,2:45773347
rs10058075-<b>G</b>,4 x 10-6,,NR,11.64,'-,[3.18-42.63],"DAB2, C9",Premature menopause in childhood cancer survivors,primary ovarian insufficiency,GCST005518,5:39416192
rs4323056-<b>A</b>,4 x 10-7,,NR,6.87,'-,[2.86-16.52],NPY2R,Premature menopause in childhood cancer survivors,primary ovarian insufficiency,GCST005518,4:155136200
rs2880418-<b>G</b>,2 x 10-6,,NR,5.66,'-,[2.52-12.73],NPY2R,Premature menopause in childhood cancer survivors,primary ovarian insufficiency,GCST005518,4:155148727
rs4402990-<b>C</b>,8 x 10-6,,NR,4.19,'-,[2.10-8.37],NPY2R,Premature menopause in childhood cancer survivors,primary ovarian insufficiency,GCST005518,4:155187781
rs9999820-<b>G</b>,3 x 10-7,,NR,7.52,'-,[2.95-19.22],NPY2R,Premature menopause in childhood cancer survivors,primary ovarian insufficiency,GCST005518,4:155197173
rs3966085-<b>G</b>,6 x 10-6,,NR,28.89,'-,[3.10-269.69],"UGT2A3, UGT2B27P",Premature menopause in childhood cancer survivors,primary ovarian insufficiency,GCST005518,4:68964824
rs147451859-<b>G</b>,6 x 10-9,,0.07,1.74,'-,[NR],PPCDC,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,15:75039102
rs17587029-<b>G</b>,3 x 10-8,,0.05,1.84,'-,[NR],"CHCHD5, SLC20A1",Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,2:112624477
rs6488809-<b>T</b>,3 x 10-7,,0.06,1.74,'-,[NR],DERA,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,12:16001304
rs1410669-<b>G</b>,5 x 10-7,,0.07,1.71,'-,[NR],RNU4-66P,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,6:71740732
rs11096688-<b>T</b>,7 x 10-7,,0.1,1.45,'-,[NR],LINC02850,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,2:20885650
rs73419340-<b>A</b>,8 x 10-7,,0.06,0.49,'-,[NR],"VPS50, CALCR",Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,7:93388705
rs1189020-<b>T</b>,9 x 10-7,,0.06,1.61,'-,[NR],LINC02284,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,14:56410241
rs78264913-<b>C</b>,1 x 10-6,,0.05,1.53,'-,[NR],TMTC1,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,12:29733920
rs77569618-<b>A</b>,1 x 10-6,,0.09,1.48,'-,[NR],LINC02236,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,5:6784082
rs1119997-<b>G</b>,1 x 10-6,,0.46,1.3,'-,[NR],ADCY8,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,8:131109670
rs2300441-<b>A</b>,7 x 10-14,,0.3578,'-,0.4335 unit decrease,NR,FSHR,Follicle stimulating hormone levels in polycystic ovary syndrome,"polycystic ovary syndrome, follicle stimulating hormone measurement",GCST010263,2:48967370
rs140123771-<b>AT</b>,5 x 10-6,,0.2041,'-,0.3058 unit decrease,NR,FSHR,Follicle stimulating hormone levels in polycystic ovary syndrome,"polycystic ovary syndrome, follicle stimulating hormone measurement",GCST010263,2:49135229
rs7151257-<b>A</b>,8 x 10-6,,0.3538,'-,0.2607 unit decrease,NR,LINC00871,Follicle stimulating hormone levels in polycystic ovary syndrome,"polycystic ovary syndrome, follicle stimulating hormone measurement",GCST010263,14:46123550
rs11070169-<b>T</b>,9 x 10-6,,0.33,'-,0.2557 unit increase,NR,LINC02694,Follicle stimulating hormone levels in polycystic ovary syndrome,"polycystic ovary syndrome, follicle stimulating hormone measurement",GCST010263,15:39027810
rs3115229-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,"KIAA1109, RN7SL335P",Vaso-occlusive pain in sickle-cell anemia,"Sickle cell anemia, vaso-occlusive pain measurement",GCST004644,4:122088578
rs4234795-<b>G</b>,2 x 10-7,,0.94,'-,0.84 unit decrease,[0.55-1.13],SORCS2,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,4:7209075
rs9714060-<b>G</b>,7 x 10-7,,0.43,'-,0.39 unit decrease,[0.23-0.55],MUC4,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,3:195760605
rs146893001-<b>C</b>,1 x 10-6,,0.01,'-,2.04 unit decrease,[1.26-2.82],PTPN3,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,9:109419337
rs7216169-<b>T</b>,1 x 10-7,,0.22,'-,0.45 unit increase,[0.27-0.63],RABEP1,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,17:5316216
rs543023132-<b>G</b>,1 x 10-6,,0.02,'-,1.54 unit decrease,[0.95-2.13],RNU7-152P,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,6:155652652
rs144995469-<b>T</b>,1 x 10-6,,0.03,'-,1.15 unit decrease,[0.7-1.6],"TMEM260, OTX2",Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,14:56732364
rs74989317-<b>A</b>,2 x 10-6,,0.04,'-,0.99 unit decrease,[0.6-1.38],LINC00649,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,21:33923835
rs73108077-<b>C</b>,2 x 10-6,,0.06,'-,0.83 unit decrease,[0.5-1.16],"DEFB121, DEFB122",Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,20:31419056
rs114402357-<b>T</b>,2 x 10-6,,0.01,'-,2.03 unit increase,[1.25-2.81],LINC00424,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,13:21919496
rs77141833-<b>C</b>,2 x 10-6,,0.03,'-,1.12 unit decrease,[0.69-1.55],VSIG8,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,1:159855400
rs62015549-<b>T</b>,2 x 10-6,,0.01,'-,2.44 unit decrease,[1.48-3.4],THSD4,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,15:71379079
rs76513454-<b>C</b>,2 x 10-6,,0.01,'-,2.17 unit decrease,[1.33-3.01],SCYL3,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,1:218688227
rs139628543-<b>C</b>,2 x 10-6,,0.06,'-,0.75 unit increase,[0.46-1.04],KLHL30,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,2:238144404
rs59264502-<b>A</b>,2 x 10-6,,0.46,'-,0.37 unit increase,[0.21-0.53],RNA5SP38,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,13:106193924
rs147900370-<b>C</b>,2 x 10-6,,0.04,'-,0.92 unit decrease,[0.57-1.27],"TSHB, SYCP1",Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,1:115010304
rs1669539-<b>T</b>,1 x 10-6,,0.74,'-,1.52 mmHg increase,[0.89-2.15],ECRG4,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,2:105998818
rs3105491-<b>T</b>,2 x 10-6,,0.3,'-,1.52 mmHg increase,[0.89-2.15],SEPHS1P7,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,2:114223390
rs11568377-<b>A</b>,4 x 10-6,,0.17,'-,1.64 mmHg decrease,[0.95-2.33],ABCB11,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,2:168996710
rs826221-<b>A</b>,7 x 10-6,,0.93,'-,2.66 mmHg decrease,[1.50-3.82],THRB,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,3:24226945
rs10520528-<b>T</b>,2 x 10-6,,0.43,'-,1.3 mmHg increase,[0.77-1.83],TENM3,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,4:182339448
rs4869931-<b>A</b>,8 x 10-6,,0.47,'-,1.21 mmHg increase,[0.68-1.74],PLEKHG1,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,6:150688753
rs1442407-<b>T</b>,8 x 10-6,,0.1,'-,1.98 mmHg increase,[1.12-2.84],CSMD1,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,8:3234062
rs7045640-<b>A</b>,8 x 10-6,,0.76,'-,1.75 mmHg decrease,[0.99-2.51],CARM1P1,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,9:2978377
rs7952106-<b>G</b>,9 x 10-7,,0.23,'-,1.54 mmHg increase,[0.93-2.15],DRD2,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,11:113553836
rs11053548-<b>A</b>,5 x 10-6,,0.91,'-,2.12 mmHg increase,[1.22-3.02],CLEC12B,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,12:10018128
rs11692361-<b>?</b>,4 x 10-7,,NR,1.4388489,'-,[1.25-1.65],MEIS1,Endometriosis,endometriosis,GCST003819,2:66496567
rs10256972-<b>?</b>,3 x 10-6,,NR,1.29,'-,[1.162-1.433],C7orf50,Endometriosis,endometriosis,GCST003819,7:999367
rs4966038-<b>?</b>,2 x 10-9,,NR,1.378,'-,[1.242-1.529],IGF1R,Endometriosis,endometriosis,GCST003819,15:98903403
rs2276314-<b>?</b>,7 x 10-6,,NR,1.3140606,'-,[1.17-1.48],C18orf21,Endometriosis,endometriosis,GCST003819,18:35977503
rs12140361-<b>?</b>,3 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,7.098 unit increase,'-,SDHC,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,1:161352208
rs7566539-<b>?</b>,3 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,7.171 unit increase,'-,'-,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,2:122620366
rs9934640-<b>?</b>,5 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,8.074 unit increase,'-,RNA5SP431,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,16:79311795
rs9283636-<b>?</b>,5 x 10-7,"(adjusted for dose, GFR & AST)",NR,'-,3.049 unit increase,'-,'-,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,3:166315136
rs12165173-<b>?</b>,5 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,1.06 unit decrease,'-,'-,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,2:217010416
rs12412836-<b>?</b>,4 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,0.75 unit decrease,'-,COL13A1,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,10:69910197
rs12571637-<b>?</b>,7 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,1.59 unit decrease,'-,'-,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,10:85041429
rs17280534-<b>?</b>,6 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,1.49 unit decrease,'-,LINC02299,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,14:96778118
rs17635967-<b>?</b>,6 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,1.49 unit decrease,'-,RHEB,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,7:151487834
rs2202766-<b>?</b>,7 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,1.47 unit decrease,'-,'-,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,6:105789630
rs4313770-<b>?</b>,6 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,1.49 unit decrease,'-,RASGRP1,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,15:38490292
rs4692174-<b>?</b>,7 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,0.88 unit decrease,'-,LINC02261,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,4:27184810
rs5741804-<b>?</b>,9 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,1.49 unit decrease,'-,BPI,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,20:38323940
rs7102974-<b>?</b>,6 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,1.49 unit decrease,'-,TMEM258,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,11:61792563
rs7230264-<b>?</b>,9 x 10-7,"(adjusted for dose, GFR & AST)",NR,'-,0.65 unit decrease,'-,UBA52P9,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,18:27347470
rs7909167-<b>?</b>,6 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,1.49 unit decrease,'-,"GPN3P1, GPR158",Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,10:25602315
rs8187707-<b>?</b>,5 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,1.21 unit decrease,'-,ABCC2,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,10:99850776
rs9982086-<b>?</b>,9 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,1.06 unit decrease,'-,"MRPL39, JAM2",Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,21:25631797
rs9558996-<b>?</b>,5 x 10-6,,NR,'-,1.285 unit increase,'-,FAM155A,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,13:107290084
rs11130471-<b>?</b>,9 x 10-6,,NR,'-,1.641 unit decrease,'-,"LINC02030, WNT5A",Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,3:55376983
rs17806780-<b>?</b>,9 x 10-6,,NR,'-,1.484 unit increase,'-,ZNF827,Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,4:145811502
rs12516561-<b>?</b>,4 x 10-6,,NR,'-,1.671 unit increase,'-,"WNT8A, NME5",Carboplatin disposition in epthelial ovarian cancer,"Malignant epithelial tumor of ovary, response to carboplatin",GCST005351,5:138109311
rs9302891-<b>?</b>,7 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,6.616 unit increase,'-,ABCA10,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,17:69228706
rs2483519-<b>?</b>,2 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,2.729 unit increase,'-,ABLIM1,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,10:114642349
rs16969611-<b>?</b>,7 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,3.629 unit increase,'-,LINC00393,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,13:107030239
rs1574560-<b>?</b>,6 x 10-7,"(adjusted for dose, GFR & AST)",NR,'-,3.049 unit increase,'-,'-,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,3:166329716
rs2056859-<b>?</b>,2 x 10-6,,NR,'-,11.03 unit increase,'-,"LINC01629, RN7SKP17",Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,14:76937083
rs17741873-<b>?</b>,8 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,2.888 unit increase,'-,"PLAU, CAMK2G",Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,10:73894042
rs1851138-<b>?</b>,6 x 10-6,,NR,'-,6.833 unit increase,'-,ACTG1P22,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,2:57804114
rs1614627-<b>?</b>,6 x 10-7,,NR,'-,7.424 unit increase,'-,"CDA, PINK1",Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,1:20620263
rs9787692-<b>?</b>,7 x 10-7,"(adjusted for dose, GFR & AST)",NR,'-,3.672 unit increase,'-,"KRT8P37, CHCHD3P1",Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,10:8603200
rs4235212-<b>?</b>,6 x 10-6,,NR,'-,2.503 unit increase,'-,GLRA3,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,4:174644094
rs10510382-<b>?</b>,6 x 10-6,,NR,'-,3.033 unit increase,'-,LMCD1-AS1,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,3:7956266
rs9938946-<b>?</b>,3 x 10-6,,NR,'-,3.774 unit increase,'-,HS3ST4,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,16:25955783
rs8083427-<b>?</b>,3 x 10-6,,NR,'-,5.467 unit increase,'-,KCTD1,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,18:26521596
rs2505127-<b>?</b>,6 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,5.005 unit increase,'-,JCAD,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,10:30080931
rs17130142-<b>?</b>,2 x 10-7,,NR,'-,8.641 unit increase,'-,PKN2-AS1,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,1:87773925
rs17131753-<b>?</b>,7 x 10-6,,NR,'-,7.784 unit increase,'-,RN7SKP247,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,1:81208812
rs470903-<b>?</b>,3 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,5.453 unit increase,'-,MBP,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,18:77003313
rs11840576-<b>?</b>,2 x 10-6,,NR,'-,8.684 unit increase,'-,LINC00676,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,13:109657033
rs12425791-<b>?</b>,4 x 10-6,,NR,'-,2.026 unit increase,'-,"NINJ2-AS1, LINC02455",Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,12:674318
rs2205226-<b>?</b>,5 x 10-6,,NR,'-,4.956 unit increase,'-,NRXN3,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,14:79888998
rs7013285-<b>?</b>,3 x 10-6,"(adjusted for dose, GFR & AST)",NR,'-,3.067 unit increase,'-,OXR1,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,8:106314611
rs2758596-<b>?</b>,6 x 10-6,,NR,'-,4.844 unit increase,'-,"PMF1-BGLAP, PMF1",Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,1:156219495
rs17169015-<b>?</b>,5 x 10-6,,NR,'-,18.28 unit increase,'-,PTN,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,7:137259485
rs16838233-<b>?</b>,4 x 10-6,,NR,'-,5.346 unit increase,'-,LINC01756,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,1:29429306
rs17211649-<b>?</b>,2 x 10-6,,NR,'-,14.22 unit increase,'-,"EGILA, RNASE4, ANG",Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,14:20698124
rs2241111-<b>?</b>,6 x 10-6,,NR,'-,4.844 unit increase,'-,"SEMA4A, SLC25A44",Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,1:156193927
rs969348-<b>?</b>,6 x 10-6,,NR,'-,5.866 unit increase,'-,TMC3-AS1,Paclitaxel disposition in epithelial ovarian cancer,"Malignant epithelial tumor of ovary, response to paclitaxel",GCST005352,15:81554938
rs76169311-<b>A</b>,3 x 10-7,,0.1,'-,3.75 mIU/mL increase,[2.28-5.22],CRB1,Luteinizing hormone levels in polycystic ovary syndrome,"luteinizing hormone measurement, polycystic ovary syndrome",GCST005269,1:197372771
rs56949836-<b>T</b>,4 x 10-7,,0.06,'-,4.66 mIU/mL increase,[2.84-6.48],"OR7E31P, IL6RP1",Luteinizing hormone levels in polycystic ovary syndrome,"luteinizing hormone measurement, polycystic ovary syndrome",GCST005269,9:90167763
rs11031006-<b>A</b>,3 x 10-16,,0.2,'-,3.19 mIU/mL increase,[2.15-4.23],FSHB,Luteinizing hormone levels in polycystic ovary syndrome,"luteinizing hormone measurement, polycystic ovary syndrome",GCST005269,11:30204981
rs77667361-<b>T</b>,5 x 10-6,,0.04,'-,0.1 log10(mIU/mL) decrease,[-0.15600-0.23600],UBQLN4P2,Follicle stimulating hormone levels in polycystic ovary syndrome,"polycystic ovary syndrome, follicle stimulating hormone measurement",GCST005270,2:152959707
rs140485756-<b>C</b>,2 x 10-7,,0.03,'-,0.14 log10(mIU/mL) increase,[0.081-0.199],ADGRB3,Follicle stimulating hormone levels in polycystic ovary syndrome,"polycystic ovary syndrome, follicle stimulating hormone measurement",GCST005270,6:69410439
chr10:119956844-<b>TCA</b>,7 x 10-7,,0.02,'-,0.27 log10(mIU/mL) increase,[0.17-0.37],'-,Follicle stimulating hormone levels in polycystic ovary syndrome,"polycystic ovary syndrome, follicle stimulating hormone measurement",GCST005270,Mapping not available
rs112137861-<b>A</b>,3 x 10-7,,0.05,'-,0.08 log10(mIU/mL) increase,[0.041-0.119],SOX5,Follicle stimulating hormone levels in polycystic ovary syndrome,"polycystic ovary syndrome, follicle stimulating hormone measurement",GCST005270,12:23857104
chr10:65193342-<b>T</b>,2 x 10-7,,0.43,'-,0.07 log10 (nmol/L) decrease,[0.050-0.090],'-,Sex hormone-binding globulin levels in polycystic ovary syndrome,"polycystic ovary syndrome, sex hormone-binding globulin measurement",GCST005271,Mapping not available
rs181791462-<b>C</b>,5 x 10-6,,0.02,'-,33.08 ng/dL increase,[20.59-45.57],"ZNF438, LINC02664",Testosterone levels in polycystic ovary syndrome,"polycystic ovary syndrome, testosterone measurement",GCST005272,10:31088634
rs74585555-<b>A</b>,5 x 10-7,,0.07,'-,15.56 ng/dL increase,[9.82-21.30],ANKRD11P1,Testosterone levels in polycystic ovary syndrome,"polycystic ovary syndrome, testosterone measurement",GCST005272,2:81214976
rs706560-<b>G</b>,6 x 10-6,,0.02,'-,33.29 ng/dL increase,[21.82-44.76],DGKI,Testosterone levels in polycystic ovary syndrome,"polycystic ovary syndrome, testosterone measurement",GCST005272,7:137590308
rs146813585-<b>G</b>,3 x 10-6,,0.04,'-,22.27 ng/dL increase,[14.04-30.50],'-,Testosterone levels in polycystic ovary syndrome,"polycystic ovary syndrome, testosterone measurement",GCST005272,16:25557251
rs10986105-<b>T</b>,2 x 10-6,,0.05,1.69,'-,[1.3-2.2],DENND1A,Polycystic ovary syndrome,polycystic ovary syndrome,GCST005273,9:123787676
rs7574059-<b>C</b>,2 x 10-7,,0.58,1.19,'-,[1.06-1.34],ELOAP1,Polycystic ovary syndrome,polycystic ovary syndrome,GCST005273,2:123613428
rs804279-<b>A</b>,8 x 10-10,,0.26,1.35,'-,[1.18-1.54],"NEIL2, GATA4",Polycystic ovary syndrome,polycystic ovary syndrome,GCST005273,8:11766380
rs10993397-<b>C</b>,5 x 10-13,,0.56,1.37,'-,[1.22-1.54],AOPEP,Polycystic ovary syndrome,polycystic ovary syndrome,GCST005273,9:94917489
rs11031006-<b>A</b>,2 x 10-8,,0.15,1.41,'-,[1.21-1.65],FSHB,Polycystic ovary syndrome,polycystic ovary syndrome,GCST005273,11:30204981
rs1784692-<b>T</b>,1 x 10-6,,0.82,1.39,'-,[1.19-1.61],ZBTB16,Polycystic ovary syndrome,polycystic ovary syndrome,GCST005273,11:114078510
rs1355471-<b>A</b>,8 x 10-8,,0.49,1.15,'-,[1.02-1.29],CCDC91,Polycystic ovary syndrome,polycystic ovary syndrome,GCST005273,12:28568792
rs7563201-<b>G</b>,3 x 10-10,,0.54,1.13,'-,[1.09–1.17],THADA,Polycystic ovary syndrome,polycystic ovary syndrome,GCST003144,2:43334641
rs1351592-<b>G</b>,1 x 10-12,,0.17,1.18,'-,[1.13–1.23],ERBB4,Polycystic ovary syndrome,polycystic ovary syndrome,GCST003144,2:212529988
rs11225154-<b>A</b>,8 x 10-11,,0.09,1.22,'-,[1.15–1.29],YAP1,Polycystic ovary syndrome,polycystic ovary syndrome,GCST003144,11:102172509
rs11031006-<b>A</b>,1 x 10-9,,0.14,1.16,'-,[1.11–1.22],FSHB,Polycystic ovary syndrome,polycystic ovary syndrome,GCST003144,11:30204981
rs13164856-<b>T</b>,4 x 10-9,,0.73,1.13,'-,[1.09–1.18],"IRF1-AS1, IRF1",Polycystic ovary syndrome,polycystic ovary syndrome,GCST003144,5:132477512
rs1275468-<b>C</b>,2 x 10-8,,0.75,1.13,'-,[1.08–1.18],KRR1,Polycystic ovary syndrome,polycystic ovary syndrome,GCST003144,12:75541377
rs7312770-<b>C</b>,2 x 10-7,,0.47,1.1,'-,[1.06–1.15],"RPS26, ERBB3",Polycystic ovary syndrome,polycystic ovary syndrome,GCST003144,12:56073803
rs7218361-<b>A</b>,1 x 10-6,,0.04,1.25,'-,[1.14–1.37],"NEUROD2, CDK12",Polycystic ovary syndrome,polycystic ovary syndrome,GCST003144,17:39569151
rs10760321-<b>A</b>,1 x 10-6,,0.71,1.11,'-,[1.07–1.16],LHX2,Polycystic ovary syndrome,polycystic ovary syndrome,GCST003144,9:124101917
chr1:120172286-<b>T</b>,6 x 10-7,,0.0106,'-,0.9817 unit increase,[0.6-1.37],'-,Polycystic ovary syndrome,polycystic ovary syndrome,GCST010687,Mapping not available
chr10:96167706-<b>A</b>,1 x 10-6,,0.0068,'-,1.0969 unit increase,[0.65-1.54],'-,Polycystic ovary syndrome,polycystic ovary syndrome,GCST010687,Mapping not available
rs17186366-<b>C</b>,3 x 10-8,,0.084,1.37,'-,[1.23-1.54],LINC02529,Polycystic ovary syndrome,polycystic ovary syndrome,GCST010687,6:159477229
rs113168128-<b>A</b>,5 x 10-8,,0.021,1.72,'-,[1.42-2.10],ERBB4,Polycystic ovary syndrome,polycystic ovary syndrome,GCST010687,2:211427047
rs144248326-<b>C</b>,8 x 10-7,,0.0103,2.13,'-,[1.56-2.86],WWTR1,Polycystic ovary syndrome,polycystic ovary syndrome,GCST010687,3:149602086
rs1427407-<b>?</b>,4 x 10-53,,0.78,'-,0.3 unit decrease,[NR],'-,Fetal hemoglobin levels in sickle cell anemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST002687,Mapping not available
rs9494145-<b>?</b>,2 x 10-10,,0.05,'-,0.23 unit increase,[NR],"MYB, HBS1L",Fetal hemoglobin levels in sickle cell anemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST002687,6:135111414
rs3132461-<b>G</b>,2 x 10-13,,NR,1.358,'-,[NR],"PPIAP9, MICB",Cervical cancer,cervical carcinoma,GCST004833,6:31512891
rs4396968-<b>T</b>,1 x 10-6,,NR,1.26,'-,[NR],GABRB1,Cervical cancer,cervical carcinoma,GCST004833,4:47087167
rs2267681-<b>?</b>,2 x 10-6,,NR,1.1806375,'-,[NR],TBXAS1,Cervical cancer,cervical carcinoma,GCST004833,7:139841136
rs56804039-<b>?</b>,4 x 10-6,,NR,1.2091899,'-,[NR],RN7SL178P,Cervical cancer,cervical carcinoma,GCST004833,8:8523519
rs4738017-<b>G</b>,7 x 10-6,,NR,1.174,'-,[NR],"SULF1, SLCO5A1",Cervical cancer,cervical carcinoma,GCST004833,8:69663895
rs9532669-<b>A</b>,2 x 10-7,,NR,1.216,'-,[NR],"SUGT1P3, ELF1",Cervical cancer,cervical carcinoma,GCST004833,13:40927414
rs11637339-<b>C</b>,6 x 10-6,,NR,1.184,'-,[NR],"RPL7P5, LINC02244",Cervical cancer,cervical carcinoma,GCST004833,15:99451803
rs17087933-<b>?</b>,2 x 10-6,,NR,1.2787724,'-,[NR],'-,Cervical cancer,cervical carcinoma,GCST004833,18:73596115
rs2239704-<b>A</b>,6 x 10-9,,NR,1.23,'-,[NR],LTA,Cervical cancer,cervical carcinoma,GCST004833,6:31572364
rs9272143-<b>?</b>,5 x 10-15,,NR,1.3513513,'-,[NR],HLA-DQA1,Cervical cancer,cervical carcinoma,GCST004833,6:32633026
HLA-DQB1*602-<b>?</b>,4 x 10-12,,0.141,1.44,'-,[NR],'-,Cervical cancer,cervical carcinoma,GCST004833,Mapping not available
HLA-DQA1*0301-<b>?</b>,4 x 10-8,(conditional on HLA-DQB1*0602),0.224,'-,'-,'-,'-,Cervical cancer,cervical carcinoma,GCST004833,Mapping not available
HLA-B*15-<b>?</b>,2 x 10-9,,0.072,0.64,'-,[NR],'-,Cervical cancer,cervical carcinoma,GCST004833,Mapping not available
HAL-DRB1*13-<b>?</b>,1 x 10-9,,0.106,0.69,'-,[NR],'-,Cervical cancer,cervical carcinoma,GCST004833,Mapping not available
rs6547598-<b>A</b>,1 x 10-6,,0.93,1.35,'-,[NR],TCF7L1,Cervical cancer,cervical carcinoma,GCST007119,2:85219363
rs59661306-<b>G</b>,2 x 10-11,,0.15,1.2987013,'-,[NR],"LUCAT1, ADGRV1",Cervical cancer,cervical carcinoma,GCST007119,5:91087644
rs7457728-<b>C</b>,1 x 10-8,,0.39,1.19,'-,[NR],LINC01445,Cervical cancer,cervical carcinoma,GCST007119,7:54380269
rs115137622-<b>C</b>,9 x 10-9,,0.62,1.32,'-,[NR],HLA-DPA3,Cervical cancer,cervical carcinoma,GCST007119,6:33143124
rs8067378-<b>G</b>,3 x 10-6,,0.28,1.22,'-,[NR],"ZPBP2, GSDMB",Cervical cancer,cervical carcinoma,GCST007119,17:39895095
rs183652081-<b>A</b>,4 x 10-7,,NR,2.4900398,'-,NR,ARMH3,Cervical cancer,cervical carcinoma,GCST90011816,10:102040002
rs2856437-<b>A</b>,1 x 10-15,,0.063203,1.3032712,'-,NR,PBX2,Cervical cancer,cervical carcinoma,GCST90011816,6:32189587
rs3130218-<b>A</b>,5 x 10-9,,NR,1.16171,'-,NR,"HLA-DPB2, COL11A2P1",Cervical cancer,cervical carcinoma,GCST90011816,6:33110386
rs2242660-<b>G</b>,2 x 10-7,,NR,1.1015,'-,NR,PRRC2A,Cervical cancer,cervical carcinoma,GCST90011816,6:31629976
rs3131631-<b>G</b>,5 x 10-10,,NR,1.1332,'-,NR,"PPIAP9, MICB",Cervical cancer,cervical carcinoma,GCST90011816,6:31516906
rs10175462-<b>G</b>,8 x 10-14,,0.638323,1.1519,'-,NR,"PAX8-AS1, PAX8",Cervical cancer,cervical carcinoma,GCST90011816,2:113230915
rs9276435-<b>C</b>,2 x 10-10,,NR,1.1631,'-,NR,HLA-DQA2,Cervical cancer,cervical carcinoma,GCST90011816,6:32746090
rs2523496-<b>T</b>,4 x 10-25,,NR,1.2076,'-,NR,MICA,Cervical cancer,cervical carcinoma,GCST90011816,6:31409942
rs9272050-<b>G</b>,1 x 10-39,,NR,1.267,'-,NR,HLA-DQA1,Cervical cancer,cervical carcinoma,GCST90011816,6:32631294
rs114115115-<b>T</b>,6 x 10-13,,NR,1.3463,'-,NR,MUC22,Cervical cancer,cervical carcinoma,GCST90011816,6:31021915
rs116149201-<b>G</b>,3 x 10-9,,NR,3.5068,'-,NR,"HLA-DRB5, HLA-DRB9",Cervical cancer,cervical carcinoma,GCST90011816,6:32480953
rs12037376-<b>A</b>,9 x 10-17,,0.17,1.16,'-,1.12–1.19,WNT4,Endometriosis,endometriosis,GCST004549,1:22135618
rs11674184-<b>T</b>,3 x 10-17,,0.61,1.13,'-,1.10–1.15,GREB1,Endometriosis,endometriosis,GCST004549,2:11581409
rs6546324-<b>A</b>,3 x 10-8,,0.31,1.08,'-,1.05–1.11,LINC02831,Endometriosis,endometriosis,GCST004549,2:67629358
rs10167914-<b>G</b>,1 x 10-9,,0.3,1.12,'-,1.08–1.15,"IL1A, IL1B",Endometriosis,endometriosis,GCST004549,2:112805784
rs1903068-<b>A</b>,1 x 10-11,,0.68,1.11,'-,1.07–1.13,"RN7SL822P, KDR",Endometriosis,endometriosis,GCST004549,4:55142310
rs760794-<b>T</b>,2 x 10-10,,0.43,1.09,'-,1.06–1.12,LNC-LBCS,Endometriosis,endometriosis,GCST004549,6:19790329
rs12700667-<b>A</b>,9 x 10-10,,0.74,1.1,'-,1.07–1.13,MIR148A,Endometriosis,endometriosis,GCST004549,7:25862019
rs1537377-<b>C</b>,1 x 10-10,,0.4,1.09,'-,1.06–1.12,CDKN2B-AS1,Endometriosis,endometriosis,GCST004549,9:22169701
rs4762326-<b>T</b>,2 x 10-9,,0.47,1.08,'-,1.05–1.11,VEZT,Endometriosis,endometriosis,GCST004549,12:95275175
rs1971256-<b>C</b>,4 x 10-8,,0.2,1.09,'-,1.06–1.13,CCDC170,Endometriosis,endometriosis,GCST004549,6:151494876
rs71575922-<b>G</b>,2 x 10-8,,0.16,1.11,'-,1.07–1.15,SYNE1,Endometriosis,endometriosis,GCST004549,6:152232879
rs74485684-<b>T</b>,2 x 10-8,,0.84,1.11,'-,1.07–1.15,FSHB,Endometriosis,endometriosis,GCST004549,11:30220740
rs77294520-<b>C</b>,1 x 10-12,,0.147,1.16,'-,1.11-1.21,GREB1,Endometriosis,endometriosis,GCST004549,2:11520829
rs2206949-<b>T</b>,3 x 10-7,,0.262,1.1,'-,1.06-1.14,ESR1,Endometriosis,endometriosis,GCST004549,6:151716421
rs17803970-<b>A</b>,7 x 10-8,,0.92,1.15,'-,1.09-1.21,SYNE1,Endometriosis,endometriosis,GCST004549,6:152232583
rs10757272-<b>C</b>,3 x 10-7,,0.504,1.07,'-,1.04-1.10,CDKN2B-AS1,Endometriosis,endometriosis,GCST004549,9:22088261
rs1448792-<b>G</b>,2 x 10-7,,0.741,1.08,'-,1.05-1.12,LINC01239,Endometriosis,endometriosis,GCST004549,9:22641634
rs12037376-<b>A</b>,1 x 10-12,(EA),0.17,1.14,'-,1.10-1.19,WNT4,Endometriosis,endometriosis,GCST004549,1:22135618
rs10167914-<b>G</b>,5 x 10-8,(EA),0.3,1.11,'-,1.07-1.15,"IL1A, IL1B",Endometriosis,endometriosis,GCST004549,2:112805784
rs11674184-<b>T</b>,3 x 10-14,(EA),0.61,1.12,'-,1.09-1.15,GREB1,Endometriosis,endometriosis,GCST004549,2:11581409
rs6546324-<b>A</b>,3 x 10-7,(EA),0.31,1.08,'-,1.05-1.11,LINC02831,Endometriosis,endometriosis,GCST004549,2:67629358
rs77294520-<b>C</b>,1 x 10-12,(EA),0.147,1.16,'-,1.11-1.21,GREB1,Endometriosis,endometriosis,GCST004549,2:11520829
rs1903068-<b>A</b>,2 x 10-11,(EA),0.68,1.11,'-,1.07-1.14,"RN7SL822P, KDR",Endometriosis,endometriosis,GCST004549,4:55142310
rs17803970-<b>A</b>,1 x 10-7,(EA),0.92,1.15,'-,1.09-1.21,SYNE1,Endometriosis,endometriosis,GCST004549,6:152232583
rs1971256-<b>C</b>,1 x 10-7,(EA),0.2,1.1,'-,1.06-1.13,CCDC170,Endometriosis,endometriosis,GCST004549,6:151494876
rs71575922-<b>G</b>,2 x 10-8,(EA),0.16,1.11,'-,1.07-1.16,SYNE1,Endometriosis,endometriosis,GCST004549,6:152232879
rs760794-<b>T</b>,7 x 10-8,(EA),0.43,1.08,'-,1.05-1.11,LNC-LBCS,Endometriosis,endometriosis,GCST004549,6:19790329
rs12700667-<b>A</b>,2 x 10-8,(EA),0.74,1.09,'-,1.06-1.13,MIR148A,Endometriosis,endometriosis,GCST004549,7:25862019
rs10757272-<b>C</b>,6 x 10-6,(EA),0.504,1.06,'-,1.04-1.09,CDKN2B-AS1,Endometriosis,endometriosis,GCST004549,9:22088261
rs1448792-<b>G</b>,1 x 10-7,(EA),0.741,1.09,'-,1.05-1.12,LINC01239,Endometriosis,endometriosis,GCST004549,9:22641634
rs1537377-<b>C</b>,2 x 10-8,(EA),0.4,1.08,'-,1.05-1.11,CDKN2B-AS1,Endometriosis,endometriosis,GCST004549,9:22169701
rs74485684-<b>T</b>,3 x 10-8,(EA),0.84,1.11,'-,1.07-1.16,FSHB,Endometriosis,endometriosis,GCST004549,11:30220740
rs4762326-<b>T</b>,1 x 10-6,(EA),0.47,1.07,'-,1.04-1.10,VEZT,Endometriosis,endometriosis,GCST004549,12:95275175
rs12037376-<b>A</b>,2 x 10-6,(Japanese),0.58,1.28,'-,1.16-1.42,WNT4,Endometriosis,endometriosis,GCST004549,1:22135618
rs4762326-<b>G</b>,4 x 10-6,(Japanese),0.98,1.22,'-,1.12-1.33,VEZT,Endometriosis,endometriosis,GCST004549,12:95275175
rs8089784-<b>G</b>,9 x 10-6,(random effect),NR,1.1904762,'-,NR,BCL2,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,18:63261832
rs9486705-<b>C</b>,6 x 10-6,(random effect),NR,1.1111112,'-,NR,FHL5,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,6:96611055
rs56325297-<b>T</b>,8 x 10-7,(random effect),NR,1.1111112,'-,NR,DPP6,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,7:153851229
rs114323125-<b>C</b>,2 x 10-6,(random effect),NR,1.0869565,'-,NR,SNX16,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,8:81828713
rs59479500-<b>G</b>,6 x 10-6,(random effect),NR,1.0752687,'-,NR,SBF2,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,11:10011438
rs6488439-<b>A</b>,5 x 10-6,(random effect),NR,1.0752687,'-,NR,"LINC01252, ETV6",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,12:11621221
rs10859847-<b>G</b>,6 x 10-6,(random effect),NR,1.0752687,'-,NR,FGD6,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,12:95197757
rs112495680-<b>G</b>,5 x 10-6,(random effect),NR,1.0638298,'-,NR,"RPL35P2, SMIM29",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,6:34255321
rs2474725-<b>C</b>,6 x 10-6,(random effect),NR,1.0638298,'-,NR,NRP1,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,10:33195338
rs1445920-<b>C</b>,6 x 10-6,(random effect),NR,1.0526316,'-,NR,LINC02059,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,5:86798133
rs718737-<b>G</b>,5 x 10-6,(random effect),NR,1.0526316,'-,NR,"MTND4P6, ST7",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,7:117243537
rs12251016-<b>T</b>,5 x 10-7,(random effect),NR,1.0526316,'-,NR,MLLT10,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,10:21532989
rs35863760-<b>C</b>,8 x 10-6,(fixed effect),NR,1.0526316,'-,NR,RBFOX3,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,17:79538987
rs4346346-<b>A</b>,1 x 10-6,(random effect),NR,1.0416667,'-,NR,"LINC01931, MMADHC-DT",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,2:149813850
rs146462216-<b>G</b>,8 x 10-6,(fixed effect),NR,1.0416667,'-,NR,"NR3C1, RNU7-156P",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,5:143445440
rs4700924-<b>A</b>,3 x 10-6,(random effect),NR,1.0416667,'-,NR,"MAPK9, RASGEF1C",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,5:180218870
rs1873291-<b>T</b>,3 x 10-6,(random effect),NR,1.0416667,'-,NR,EYS,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,6:65634962
rs725964-<b>A</b>,9 x 10-6,(random effect),NR,1.0416667,'-,NR,ETV1,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,7:13948898
rs35698191-<b>A</b>,6 x 10-6,(random effect),NR,1.0416667,'-,NR,CDCA2,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,8:25464329
rs721839-<b>C</b>,5 x 10-6,(random effect),NR,1.0416667,'-,NR,MTND2P9,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,9:80602054
rs10795984-<b>A</b>,1 x 10-6,(random effect),NR,1.0416667,'-,NR,CAMK1D,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,10:12814058
rs7073342-<b>T</b>,8 x 10-6,(random effect),NR,1.0416667,'-,NR,ASCC1,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,10:72211079
rs12936464-<b>A</b>,2 x 10-6,(random effect),NR,1,'-,NR,POLR2A,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,17:7500623
rs13409739-<b>G</b>,8 x 10-6,(random effect),NR,1.04,'-,NR,ERBB4,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,2:211715459
rs162212-<b>A</b>,6 x 10-6,(random effect),NR,1.04,'-,NR,GRM7,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,3:7797790
rs7084339-<b>A</b>,7 x 10-6,(random effect),NR,1.04,'-,NR,"PLCE1, PLCE1-AS1",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,10:94283975
rs938875-<b>A</b>,4 x 10-6,(random effect),NR,1.04,'-,NR,MAP2K5,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,15:67660584
rs7544256-<b>A</b>,1 x 10-7,(random effect),NR,1.05,'-,NR,"NGF-AS1, TTC34",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,1:115281777
rs72809316-<b>A</b>,6 x 10-6,(random effect),NR,1.05,'-,NR,"LINC01484, LINC01485",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,5:173749476
rs2397690-<b>T</b>,8 x 10-6,(random effect),NR,1.05,'-,NR,MCHR2-AS1,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,6:99995415
rs17400865-<b>T</b>,3 x 10-6,(random effect),NR,1.06,'-,NR,LINC02163,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,5:104197628
rs17135931-<b>A</b>,6 x 10-8,(random effect),NR,1.06,'-,NR,EXOC2,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,6:625188
rs12714497-<b>G</b>,5 x 10-6,(random effect),NR,1.07,'-,NR,HNRNPA3P8,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,3:80259111
rs9645504-<b>C</b>,7 x 10-6,(random effect),NR,1.07,'-,NR,"COL13A1, RPL5P26",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,10:69800640
rs6549387-<b>T</b>,2 x 10-6,(random effect),NR,1.08,'-,NR,FOXP1,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,3:71382988
rs11031005-<b>T</b>,1 x 10-8,(random effect),NR,1.08,'-,NR,FSHB,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,11:30204809
rs11960401-<b>C</b>,9 x 10-6,(random effect),NR,1.09,'-,NR,WSPAR,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,5:133894264
rs4955263-<b>C</b>,9 x 10-6,(random effect),NR,1.12,'-,NR,"CMTM8, RPSAP11",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,3:32222872
rs13062850-<b>T</b>,7 x 10-6,(random effect),NR,1.12,'-,NR,"LPP-AS2, LINC01991",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,3:188071920
rs11836750-<b>G</b>,8 x 10-6,(random effect),NR,1.13,'-,NR,LINC02388,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,12:58711963
rs35722758-<b>G</b>,6 x 10-6,(random effect),NR,1.14,'-,NR,KIF18B,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,17:44927467
rs112796779-<b>A</b>,6 x 10-6,(random effect),NR,1.15,'-,NR,LRP1B,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,2:140549061
rs143943961-<b>C</b>,2 x 10-6,(random effect),NR,1.17,'-,NR,ROBO2,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,3:76492703
rs151257179-<b>G</b>,2 x 10-6,(random effect),NR,1.17,'-,NR,"LINC02644, ZNF438",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,10:30795527
rs79270576-<b>C</b>,2 x 10-6,(random effect),NR,1.18,'-,NR,'-,Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,1:5226867
rs3097165-<b>G</b>,4 x 10-6,(random effect),NR,1.18,'-,NR,"BNIP1, RPL7AP33",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,5:173165707
rs112332086-<b>T</b>,8 x 10-6,(fixed effect),NR,1.09,'-,[NR],"LINC01828, LINC01829",Endometriosis or migraine,"endometriosis, migraine disorder",GCST010178,2:67226594
rs13118306-<b>C</b>,4 x 10-8,,'-,'-,0.0231304 unit decrease,[0.015-0.031],CC2D2A,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,4:15476188
rs2134025-<b>A</b>,1 x 10-8,,'-,'-,0.0282905 unit increase,[0.019-0.038],LINC02503,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,4:104011140
rs12512642-<b>T</b>,5 x 10-8,,'-,'-,0.0274113 unit increase,[0.018-0.037],LINC02479,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,4:130288732
rs57273516-<b>A</b>,5 x 10-8,,'-,'-,0.0255575 unit increase,[0.016-0.035],"RNA5SP130, NICN1",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,3:49445641
rs13164188-<b>T</b>,9 x 10-9,,'-,'-,0.0242283 unit increase,[0.016-0.032],LINC02147,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,5:104578822
rs9835157-<b>A</b>,4 x 10-10,,'-,'-,0.0334667 unit increase,[0.023-0.044],IP6K1,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,3:49760336
rs6051080-<b>A</b>,1 x 10-7,(same direction),0.649,1.12,'-,[1.08-1.17],FAM182A,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,20:25995038
rs11085466-<b>G</b>,2 x 10-7,(same direction),0.782,1.15,'-,[1.09-1.22],ZNF429,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,19:21569009
rs17503919-<b>A</b>,2 x 10-7,(same direction),0.862,1.17,'-,[1.11-1.25],RNGTT,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,6:88856018
rs76225372-<b>A</b>,2 x 10-7,(same direction),0.912,1.21,'-,[1.13-1.31],MALRD1,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,10:19031157
rs7740797-<b>G</b>,2 x 10-7,(same direction),0.513,1.12,'-,[1.07-1.16],SCAF8,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,6:154800125
rs3181245-<b>C</b>,2 x 10-7,(same direction),0.514,1.12,'-,[1.07-1.16],TDP2,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,6:24651092
rs9901225-<b>T</b>,1 x 10-6,(same direction),0.55,1.11,'-,[1.06-1.16],RETREG3,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,17:42603793
rs2052678-<b>?</b>,1 x 10-7,(same direction),0.139,1.1627907,'-,[1.1-1.23],TMTC1,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,12:29680396
rs34462569-<b>G</b>,4 x 10-6,(opposite direction),0.934,1.22,'-,[1.12-1.33],"GALNT3, CSRNP3",Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,2:165696408
rs4727012-<b>C</b>,1 x 10-6,(opposite direction),0.891,1.18,'-,[1.10-1.26],"RNU6-650P, COX6B1P1",Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,7:149043401
rs112541862-<b>A</b>,4 x 10-6,(opposite direction),0.962,1.3,'-,[1.16-1.45],"AOPEP, FBP1",Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,9:94720876
rs606460-<b>G</b>,4 x 10-6,(opposite direction),0.725,1.11,'-,[1.06-1.17],"SERPINH1, GDPD5",Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,11:75537412
rs11607499-<b>T</b>,2 x 10-6,(opposite direction),0.954,1.27,'-,[1.15-1.40],MIR4300HG,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,11:82100187
rs12817211-<b>C</b>,3 x 10-6,(opposite direction),0.767,1.12,'-,[1.07-1.18],LIMA1,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,12:50185615
rs11150038-<b>G</b>,1 x 10-6,(opposite direction),0.944,1.27,'-,[1.15-1.39],CLEC3A,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,16:78042662
rs4816890-<b>?</b>,2 x 10-6,(opposite direction),0.363,1.1111112,'-,[1.06-1.16],MIR6130,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,21:23048180
rs10457678-<b>A</b>,4 x 10-7,(same direction),0.773,1.1,'-,[1.06-1.14],ECT2L,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,6:138801103
rs17035310-<b>C</b>,6 x 10-7,(same direction),0.876,1.13,'-,[1.08-1.18],TET2,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,4:105143597
rs3184504-<b>C</b>,8 x 10-9,(same direction),0.52,1.1,'-,[1.06-1.13],"SH2B3, ATXN2",Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,12:111446804
rs1512436-<b>?</b>,1 x 10-6,(same direction),0.447,1.0752687,'-,[1.05-1.11],'-,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,11:106436144
rs10217586-<b>?</b>,2 x 10-6,(same direction),0.461,1.0752687,'-,[1.04-1.11],CDKN2B-AS1,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,9:22121350
rs4853036-<b>?</b>,6 x 10-6,(same direction),0.264,1.0869565,'-,[1.05-1.12],GMCL1,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,2:69832692
rs4789378-<b>?</b>,9 x 10-6,(same direction),0.352,1.0752687,'-,[1.04-1.11],MGAT5B,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,17:76934284
rs12446552-<b>?</b>,3 x 10-6,(same direction),0.277,1.0869565,'-,[1.05-1.12],LITAF,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,16:11626210
rs4378954-<b>C</b>,4 x 10-7,(same direction),0.898,1.15,'-,[1.09-1.21],LSAMP,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,3:115931601
rs77922938-<b>?</b>,8 x 10-6,(opposite direction),0.047,1.1764705,'-,[1.1-1.27],'-,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,9:108297916
rs1952157-<b>C</b>,6 x 10-6,(opposite direction),0.69,1.08,'-,[1.05-1.12],NPAS3,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,14:33820232
rs76525880-<b>A</b>,7 x 10-6,(opposite direction),0.929,1.16,'-,[1.09-1.24],"HOXB1, HOXB2",Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,17:48536888
rs12970291-<b>T</b>,5 x 10-8,(opposite direction),0.965,1.27,'-,[1.16-1.38],TSHZ1,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,18:75305279
rs10899426-<b>?</b>,2 x 10-7,,NR,2.74,'-,'-,"KCTD14, INTS4",Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel,"progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004897,11:78008566
rs6256-<b>?</b>,1 x 10-6,,NR,1.93,'-,'-,PTH,Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel,"progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004897,11:13492506
rs10832063-<b>?</b>,5 x 10-6,,NR,1.8,'-,'-,"PTH, HMGN2P36",Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel,"progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004897,11:13553087
rs10500780-<b>?</b>,5 x 10-6,,NR,1.79,'-,'-,BTBD10,Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel,"progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004897,11:13401400
rs1564271-<b>?</b>,9 x 10-6,,NR,1.62,'-,'-,PDSS1,Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,10:26722183
rs10899426-<b>?</b>,9 x 10-6,,NR,2.29,'-,'-,"KCTD14, INTS4",Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,11:78008566
rs4618572-<b>?</b>,9 x 10-6,,NR,1.86,'-,'-,"FOXF2, RN7SL352P",Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,6:1492427
rs295315-<b>?</b>,8 x 10-7,,NR,1.82,'-,'-,"RASA2, LINC02618",Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,3:141643383
rs17693104-<b>?</b>,8 x 10-7,,NR,1.65,'-,'-,SH2D4B,Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,10:80608465
rs868767-<b>?</b>,2 x 10-6,,NR,2.12,'-,'-,"LINC02618, RASA2",Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,3:141658488
rs2050203-<b>?</b>,4 x 10-6,,NR,1.78,'-,'-,"GAPDHP53, SYNDIG1",Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,20:24451198
rs11621975-<b>?</b>,5 x 10-6,,NR,2.31,'-,'-,"DIO3, LINC02320",Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,14:101629499
rs17548007-<b>?</b>,5 x 10-6,,NR,1.86,'-,'-,ASCL1,Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,12:102981636
rs202280-<b>?</b>,6 x 10-6,,NR,2,'-,'-,FABP5,Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,8:81290982
rs739187-<b>T</b>,8 x 10-9,,0.27,1.23,'-,[1.16-1.30],"ELFN2, CYTH4",Uterine fibroids,uterine fibroid,GCST004779,22:37332213
rs55768811-<b>T</b>,3 x 10-7,,0.09,1.3157895,'-,[1.15-1.52],RN7SL553P,Uterine fibroids,uterine fibroid,GCST004779,3:5306910
rs6472827-<b>C</b>,4 x 10-7,,0.93,1.3157895,'-,[1.16-1.54],JPH1,Uterine fibroids,uterine fibroid,GCST004779,8:74207107
rs11987640-<b>G</b>,5 x 10-7,,0.8,1.2345679,'-,[1.12-1.37],CSMD1,Uterine fibroids,uterine fibroid,GCST004779,8:4584258
rs79024726-<b>T</b>,9 x 10-8,,0.813907,1.13,'-,[1.08-1.18],CSMD2,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,1:33832760
rs113998067-<b>C</b>,3 x 10-8,,0.042653,1.27,'-,[1.17-1.38],"GNL2, RSPO1",Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,1:37607755
rs819913-<b>C</b>,4 x 10-7,,0.016407,1.42,'-,[1.24-1.63],PLPPR4,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,1:99299799
rs7579014-<b>A</b>,6 x 10-7,,0.640718,1.1,'-,[1.06-1.14],BCL11A,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,2:60480759
rs148261157-<b>A</b>,5 x 10-6,,0.033009,1.25,'-,[1.14-1.38],"RN7SL361P, IFITM3P9",Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,2:60670444
rs2960422-<b>A</b>,6 x 10-7,,0.600616,1.1,'-,[1.06-1.14],PPARG,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,3:12293492
rs872267-<b>G</b>,9 x 10-6,,0.736735,1.09,'-,[1.05-1.14],EEFSEC,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,3:128169224
rs1740828-<b>G</b>,6 x 10-13,,0.522413,1.16,'-,[1.11-1.20],"BOLA2P3, CASC15",Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,6:21648854
rs6149499-<b>G</b>,6 x 10-7,,0.870856,1.16,'-,[1.09-1.23],"OR14J1, OR2U2P",Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,6:29288284
rs2747716-<b>A</b>,4 x 10-10,,0.573668,1.12,'-,[1.08-1.16],LINC02523,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,6:125687226
rs76165228-<b>A</b>,9 x 10-8,,0.140979,1.15,'-,[1.09-1.21],PPP1R14C,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,6:150198039
rs9639594-<b>A</b>,2 x 10-8,,0.206208,1.14,'-,[1.09-1.19],CPVL,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,7:29139570
rs4733613-<b>C</b>,1 x 10-13,,0.123746,1.21,'-,[1.15-1.28],"LINC00824, CCDC26",Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,8:128587032
rs1923357-<b>C</b>,6 x 10-7,,0.17755,1.12,'-,[1.07-1.17],PTPRD,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,9:10266786
rs1679014-<b>T</b>,4 x 10-6,,0.067996,1.17,'-,[1.09-1.25],CDKN2B-AS1,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,9:22207038
rs10835920-<b>T</b>,2 x 10-6,,0.380414,1.1,'-,[1.05-1.14],WT1-AS,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,11:32468118
rs117610694-<b>T</b>,6 x 10-7,,0.01153,1.47,'-,[1.26-1.71],FCHSD2,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,11:73070209
rs9668337-<b>A</b>,3 x 10-6,,0.735122,1.1,'-,[1.06-1.15],SSPN,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,12:26273405
rs1677893-<b>A</b>,1 x 10-6,,0.446362,1.09,'-,[1.05-1.13],NAV3,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,12:77944606
rs376674848-<b>CGT</b>,2 x 10-7,,0.607588,1.11,'-,[1.07-1.15],'-,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,12:84220726
rs3184504-<b>C</b>,6 x 10-9,,0.515767,1.11,'-,[1.07-1.15],"SH2B3, ATXN2",Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,12:111446804
rs10850382-<b>T</b>,2 x 10-7,,0.308258,1.11,'-,[1.07-1.15],TBX3,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,12:114776743
rs7981863-<b>C</b>,5 x 10-15,,0.715876,1.17,'-,[1.13-1.22],RNY1P8,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,13:73238004
rs937213-<b>C</b>,7 x 10-10,,0.421624,1.12,'-,[1.08-1.16],EIF2AK4,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,15:40029923
rs17601876-<b>G</b>,2 x 10-10,,0.479814,1.12,'-,[1.08-1.16],"CYP19A1, MIR4713HG",Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,15:51261712
rs1129506-<b>G</b>,1 x 10-7,,0.380334,1.11,'-,[1.07-1.15],"EVI2A, NF1",Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,17:31319014
rs11263761-<b>A</b>,3 x 10-14,,0.51711,1.15,'-,[1.11-1.19],HNF1B,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,17:37737784
rs882380-<b>A</b>,1 x 10-8,,0.612652,1.11,'-,[1.07-1.15],SKAP1,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,17:48216874
rs60856912-<b>T</b>,4 x 10-6,,0.161982,1.12,'-,[1.06-1.17],BPTF,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,17:67896227
rs561726060-<b>T</b>,8 x 10-6,,0.00709,1.68,'-,[1.34-2.12],GATA6,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,18:22263993
rs4607001-<b>T</b>,9 x 10-8,,0.201643,1.13,'-,[1.08-1.18],LINC00261,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,20:22467899
rs529138199-<b>C</b>,2 x 10-7,,0.06069,1.23,'-,[1.14-1.33],NCAM2,Endometrial cancer (endometrioid histology),endometrial carcinoma,GCST006465,21:21005810
rs370989584-<b>CT</b>,1 x 10-7,,0.010947,2.23,'-,[1.66-2.99],R3HDM2P1,Endometrial cancer (Non-endometrioid histology),endometrial carcinoma,GCST006466,4:133040031
rs4052756-<b>T</b>,5 x 10-7,,0.560757,1.27,'-,[1.15-1.39],ID4,Endometrial cancer (Non-endometrioid histology),endometrial carcinoma,GCST006466,6:19914263
rs117280150-<b>G</b>,2 x 10-7,,0.042504,1.66,'-,[1.37-2.02],SGCZ,Endometrial cancer (Non-endometrioid histology),endometrial carcinoma,GCST006466,8:14014030
rs142459060-<b>C</b>,6 x 10-7,,0.031749,1.73,'-,[1.40-2.15],EXT1,Endometrial cancer (Non-endometrioid histology),endometrial carcinoma,GCST006466,8:117816659
rs571866661-<b>C</b>,5 x 10-7,,0.88,1.2820514,'-,[1.16-1.43],"PAK1, TOMM20P1",Endometrial cancer (Non-endometrioid histology),endometrial carcinoma,GCST006466,11:77315297
rs145505949-<b>T</b>,3 x 10-7,,0.121543,1.38,'-,[1.22-1.57],LINC02451,Endometrial cancer (Non-endometrioid histology),endometrial carcinoma,GCST006466,12:42656220
rs12184995-<b>A</b>,7 x 10-7,,0.170204,1.31,'-,[1.18-1.46],LINC02331,Endometrial cancer (Non-endometrioid histology),endometrial carcinoma,GCST006466,14:53759970
rs79024726-<b>T</b>,5 x 10-8,,0.81,1.11,'-,[1.07-1.16],CSMD2,Endometrial cancer,endometrial carcinoma,GCST006464,1:33832760
rs113998067-<b>C</b>,4 x 10-8,,0.04,1.23,'-,[1.14-1.32],"GNL2, RSPO1",Endometrial cancer,endometrial carcinoma,GCST006464,1:37607755
rs11583244-<b>T</b>,8 x 10-7,,0.39,1.08,'-,[1.05-1.12],"RNU6-1304P, SRP9",Endometrial cancer,endometrial carcinoma,GCST006464,1:225764772
rs7579014-<b>A</b>,1 x 10-7,,0.64,1.09,'-,[1.06-1.12],BCL11A,Endometrial cancer,endometrial carcinoma,GCST006464,2:60480759
rs148261157-<b>A</b>,3 x 10-8,,0.03,1.26,'-,[1.16-1.36],"RN7SL361P, IFITM3P9",Endometrial cancer,endometrial carcinoma,GCST006464,2:60670444
rs2960422-<b>A</b>,5 x 10-7,,0.6,1.08,'-,[1.05-1.12],PPARG,Endometrial cancer,endometrial carcinoma,GCST006464,3:12293492
rs872267-<b>G</b>,1 x 10-6,,0.74,1.09,'-,[1.05-1.13],EEFSEC,Endometrial cancer,endometrial carcinoma,GCST006464,3:128169224
rs1740828-<b>G</b>,4 x 10-16,,0.52,1.15,'-,[1.11-1.19],"BOLA2P3, CASC15",Endometrial cancer,endometrial carcinoma,GCST006464,6:21648854
rs2747716-<b>A</b>,3 x 10-10,,0.57,1.1,'-,[1.07-1.14],LINC02523,Endometrial cancer,endometrial carcinoma,GCST006464,6:125687226
rs76165228-<b>A</b>,6 x 10-6,,0.14,1.11,'-,[1.06-1.16],PPP1R14C,Endometrial cancer,endometrial carcinoma,GCST006464,6:150198039
rs34670419-<b>G</b>,3 x 10-7,,0.96,1.25,'-,[1.15-1.36],ZKSCAN5,Endometrial cancer,endometrial carcinoma,GCST006464,7:99533211
rs35286446-<b>GAT</b>,3 x 10-9,,0.58,1.1,'-,[1.06-1.13],LINC00824,Endometrial cancer,endometrial carcinoma,GCST006464,8:128433618
rs4733613-<b>C</b>,8 x 10-14,,0.12,1.18,'-,[1.13-1.24],"LINC00824, CCDC26",Endometrial cancer,endometrial carcinoma,GCST006464,8:128587032
rs1679014-<b>T</b>,6 x 10-9,,0.07,1.18,'-,[1.12-1.25],CDKN2B-AS1,Endometrial cancer,endometrial carcinoma,GCST006464,9:22207038
rs10835920-<b>T</b>,1 x 10-8,,0.38,1.09,'-,[1.06-1.13],WT1-AS,Endometrial cancer,endometrial carcinoma,GCST006464,11:32468118
rs9668337-<b>A</b>,1 x 10-9,,0.74,1.11,'-,[1.08-1.15],SSPN,Endometrial cancer,endometrial carcinoma,GCST006464,12:26273405
rs1677893-<b>A</b>,3 x 10-7,,0.45,1.08,'-,[1.05-1.11],NAV3,Endometrial cancer,endometrial carcinoma,GCST006464,12:77944606
rs3184504-<b>C</b>,1 x 10-10,,0.52,1.1,'-,[1.07-1.14],"SH2B3, ATXN2",Endometrial cancer,endometrial carcinoma,GCST006464,12:111446804
rs10850382-<b>T</b>,3 x 10-9,,0.31,1.1,'-,[1.07-1.14],TBX3,Endometrial cancer,endometrial carcinoma,GCST006464,12:114776743
rs7981863-<b>C</b>,3 x 10-17,,0.72,1.16,'-,[1.12-1.20],RNY1P8,Endometrial cancer,endometrial carcinoma,GCST006464,13:73238004
rs937213-<b>C</b>,5 x 10-9,,0.42,1.09,'-,[1.06-1.13],EIF2AK4,Endometrial cancer,endometrial carcinoma,GCST006464,15:40029923
rs17601876-<b>G</b>,3 x 10-14,,0.48,1.12,'-,[1.09-1.16],"CYP19A1, MIR4713HG",Endometrial cancer,endometrial carcinoma,GCST006464,15:51261712
rs1129506-<b>G</b>,4 x 10-8,,0.38,1.1,'-,[1.06-1.13],"EVI2A, NF1",Endometrial cancer,endometrial carcinoma,GCST006464,17:31319014
rs11263761-<b>A</b>,3 x 10-20,,0.52,1.15,'-,[1.12-1.19],HNF1B,Endometrial cancer,endometrial carcinoma,GCST006464,17:37737784
rs882380-<b>A</b>,5 x 10-9,,0.61,1.1,'-,[1.06-1.13],SKAP1,Endometrial cancer,endometrial carcinoma,GCST006464,17:48216874
rs60856912-<b>T</b>,4 x 10-7,,0.16,1.11,'-,[1.06-1.15],BPTF,Endometrial cancer,endometrial carcinoma,GCST006464,17:67896227
rs561726060-<b>T</b>,5 x 10-7,,0.01,1.66,'-,[1.36-2.02],GATA6,Endometrial cancer,endometrial carcinoma,GCST006464,18:22263993
rs4607001-<b>T</b>,1 x 10-6,,0.2,1.1,'-,[1.06-1.14],LINC00261,Endometrial cancer,endometrial carcinoma,GCST006464,20:22467899
rs376296328-<b>?</b>,8 x 10-6,(serous_hg),NR,1.48,'-,'-,SPINK9,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:148321490
rs3867263-<b>?</b>,4 x 10-6,(serous_hg),NR,1.25,'-,'-,SERPINB11,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,18:63664376
rs40409-<b>?</b>,2 x 10-6,(clearcell),NR,1.57,'-,'-,PTPRG,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:61992237
rs4362851-<b>?</b>,2 x 10-6,(ser_lg_lmp),NR,1.81,'-,'-,RN7SL776P,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:167363437
rs4709698-<b>?</b>,3 x 10-6,(serous_hg),NR,1.24,'-,'-,PACRG,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:163301732
rs4918665-<b>?</b>,7 x 10-6,(serous),NR,1.24,'-,'-,RPS6P15,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,10:111552672
rs4936453-<b>?</b>,8 x 10-6,(clearcell),NR,1.54,'-,'-,POU2AF1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,11:111430057
rs56236040-<b>?</b>,4 x 10-6,(ser_lg_lmp),NR,6.6,'-,'-,CICP17,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:51423896
rs57960590-<b>?</b>,4 x 10-6,(serous),NR,1.61,'-,'-,CCDC170,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:151590844
rs58142303-<b>?</b>,7 x 10-6,(serous),NR,1.63,'-,'-,ADGRV1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:90981864
rs5932545-<b>?</b>,3 x 10-6,(endometrioid),NR,1.45,'-,'-,RPL32P35,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,X:128926215
rs59923016-<b>?</b>,1 x 10-6,(overall),NR,1.21,'-,'-,ZNF423,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,16:49765545
rs5993791-<b>?</b>,8 x 10-6,(clearcell),NR,3.94,'-,'-,SEPTIN5,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,22:19681497
rs60930737-<b>?</b>,2 x 10-6,(ser_lg_lmp),NR,2.09,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs6134303-<b>?</b>,8 x 10-7,(mucinous_all),NR,1.59,'-,'-,PGAM3P,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,20:11586401
rs61658193-<b>?</b>,9 x 10-6,(serous),NR,1.3,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,9:74295222
rs61974021-<b>?</b>,4 x 10-6,(ser_lg_lmp),NR,4.17,'-,'-,LINC02588,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,14:26740487
rs62397673-<b>?</b>,3 x 10-6,(endometrioid),NR,1.97,'-,'-,"FAM153A, OR1X5P",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:177806110
rs6461701-<b>?</b>,5 x 10-6,(clearcell),NR,1.6,'-,'-,CARD11,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:2916633
rs67729017-<b>?</b>,8 x 10-6,(mucinous_all),NR,2.53,'-,'-,SNTG1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,8:50701586
rs70959845-<b>?</b>,4 x 10-6,(overall),NR,1.22,'-,'-,"RN7SL361P, BCL11A",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:60572849
rs7172033-<b>?</b>,7 x 10-6,(lmp),NR,1.97,'-,'-,NMNAT1P5,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,15:59949310
rs71877790-<b>?</b>,5 x 10-6,(endometrioid),NR,1.56,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs7206411-<b>?</b>,2 x 10-7,(clearcell),NR,1.65,'-,'-,CMIP,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,16:81619883
rs72492309-<b>?</b>,2 x 10-6,(serous),NR,1.27,'-,'-,"HLA-DRB5, RNU1-61P",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:32541977
rs151224156-<b>?</b>,3 x 10-6,(overall),NR,1.43,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:57784687
rs169225-<b>?</b>,7 x 10-7,(serous_hg),NR,1.24,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,20:22393040
rs17057973-<b>?</b>,8 x 10-6,(ser_lg_lmp),NR,2.77,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:97730186
rs1728807-<b>?</b>,9 x 10-6,(serous),NR,1.23,'-,'-,"SLC6A1, SLC6A1-AS1",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:11007643
rs17808848-<b>?</b>,3 x 10-6,(ser_lg_lmp),NR,2.11,'-,'-,ARL2BPP6,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:175210799
rs1791890-<b>?</b>,3 x 10-7,(mucinous_all),NR,1.61,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,11:116120763
rs1800351-<b>?</b>,7 x 10-6,(lmp),NR,1.62,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs185335029-<b>?</b>,8 x 10-6,(overall),NR,1.18,'-,'-,LRRC3B,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:26787883
rs185652178-<b>?</b>,8 x 10-7,(serous_hg),NR,1.55,'-,'-,JAKMIP2-AS1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:147579243
rs199256-<b>?</b>,8 x 10-6,(mucinous_all),NR,1.52,'-,'-,LINC01277,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:143007986
rs200114742-<b>?</b>,8 x 10-6,(serous_hg),NR,1.25,'-,'-,LINC01085,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:14172253
rs200529678-<b>?</b>,5 x 10-6,(lmp),NR,2.59,'-,'-,"LINC01949, MIR4280HG",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:87170215
rs2119438-<b>?</b>,6 x 10-6,(ser_lg_lmp),NR,1.77,'-,'-,LINC02232,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:64932417
rs2371271-<b>?</b>,6 x 10-6,(endometrioid),NR,1.46,'-,'-,ERBB4,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:211451963
rs243172-<b>?</b>,4 x 10-6,(serous),NR,1.22,'-,'-,FOXN3,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,14:89546219
rs2829235-<b>?</b>,7 x 10-6,(overall),NR,1.18,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,21:24659554
rs28568660-<b>?</b>,2 x 10-6,(serous_hg),NR,1.28,'-,'-,OSBPL10,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:31878815
rs28734075-<b>?</b>,7 x 10-6,(clearcell),NR,3.22,'-,'-,"ADRA2C, OR7E163P",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:3824215
rs34097398-<b>?</b>,4 x 10-7,(ser_lg_lmp),NR,2.1,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,X:33452415
rs34344307-<b>?</b>,1 x 10-6,(endometrioid),NR,1.51,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,16:77008512
rs34350340-<b>?</b>,4 x 10-6,(clearcell),NR,1.87,'-,'-,UPF3B,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,X:119837616
rs34357515-<b>?</b>,1 x 10-6,(clearcell),NR,1.69,'-,'-,NCLN,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,19:3197622
rs34470775-<b>?</b>,8 x 10-6,(clearcell),NR,2.19,'-,'-,RN7SKP60,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:165518039
rs35941888-<b>?</b>,5 x 10-6,(lmp),NR,1.66,'-,'-,TTC28,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,22:28343530
rs3754464-<b>?</b>,2 x 10-6,(serous),NR,1.29,'-,'-,IFI16,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,1:159009146
rs987254-<b>?</b>,8 x 10-6,(lmp),NR,1.83,'-,'-,MECOM,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:169266197
rs72745575-<b>?</b>,2 x 10-6,(lmp),NR,2.07,'-,'-,"TLE1, GLIS3",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,9:81548365
rs73468194-<b>?</b>,8 x 10-6,(mucinous_all),NR,1.48,'-,'-,"FAM3C2P, PDCL2P1",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,X:23151499
rs74477043-<b>?</b>,7 x 10-6,(overall),NR,1.51,'-,'-,LINC02655,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,10:80653667
rs7455465-<b>?</b>,8 x 10-6,(lmp),NR,3.32,'-,'-,NPSR1-AS1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:34585100
rs74828133-<b>?</b>,6 x 10-6,(endometrioid),NR,1.53,'-,'-,PGM5P4-AS1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:113530775
rs74917072-<b>?</b>,5 x 10-7,(overall),NR,1.25,'-,'-,"UBE2F-SCLY, UBE2F",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:238022053
rs75157307-<b>?</b>,3 x 10-6,(serous_hg),NR,1.27,'-,'-,KCNS3,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:18193172
rs7559097-<b>?</b>,6 x 10-6,(mucinous_all),NR,1.61,'-,'-,"LINC02613, HNRNPLL",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:38517625
rs7644028-<b>?</b>,3 x 10-6,(clearcell),NR,1.57,'-,'-,MTND5P15,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:176972255
rs76731728-<b>?</b>,4 x 10-6,(endometrioid),NR,1.95,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,10:41850928
rs77122835-<b>?</b>,9 x 10-6,(overall),NR,1.29,'-,'-,LSAMP,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:116459821
rs78649302-<b>?</b>,3 x 10-6,(lmp),NR,1.86,'-,'-,DCUN1D2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,13:113481059
rs78720768-<b>?</b>,4 x 10-6,(lmp),NR,2.2,'-,'-,LINC00466,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,1:63315469
rs78950910-<b>?</b>,9 x 10-6,(lmp),NR,4.82,'-,'-,MTUS2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,13:29266071
rs79812184-<b>?</b>,7 x 10-6,(overall),NR,1.48,'-,'-,BRD8,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:138171416
rs79925169-<b>?</b>,5 x 10-6,(overall),NR,1.23,'-,'-,SEMA4D,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,9:89469330
rs80119973-<b>?</b>,2 x 10-6,(endometrioid),NR,3.03,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,8:13963095
rs8060270-<b>?</b>,3 x 10-6,(mucinous_all),NR,1.67,'-,'-,"LINC01568, ZFHX3",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,16:73418955
rs8069681-<b>?</b>,1 x 10-6,(lmp),NR,1.7,'-,'-,"SLC52A1, ZFP3-DT",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,17:5064847
rs845930-<b>?</b>,8 x 10-6,(overall),NR,1.18,'-,'-,TIAM1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,21:31347809
rs870274-<b>?</b>,7 x 10-6,(ser_lg_lmp),NR,1.7,'-,'-,TACC2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,10:122120548
rs9316411-<b>?</b>,2 x 10-6,(overall),NR,1.37,'-,'-,"PSME2P2, CYSLTR2",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,13:48747718
rs9382808-<b>?</b>,2 x 10-6,(clearcell),NR,1.82,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:60484461
rs9442387-<b>?</b>,8 x 10-6,(ser_lg_lmp),NR,2.78,'-,'-,"TTLL10-AS1, TTLL10",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,1:1175206
rs9791676-<b>?</b>,8 x 10-6,(clearcell),NR,1.96,'-,'-,GLI3,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:42053156
rs113446565-<b>?</b>,4 x 10-6,(endometrioid),NR,1.43,'-,'-,RPS27AP20,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,X:3776745
rs7748275-<b>A</b>,9 x 10-9,(serous),0.16,1.4,'-,[1.2-1.5],'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:3580855
rs113732232-<b>?</b>,7 x 10-6,(serous_hg),NR,1.63,'-,'-,VEGFC,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:176652990
chr1:22569919-<b>?</b>,3 x 10-6,(lmp),NR,3.83,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs11451120-<b>?</b>,8 x 10-6,(overall),NR,1.24,'-,'-,PURG,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,8:31005773
chr12:128445504-<b>?</b>,3 x 10-7,(serous_hg),NR,1.49,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs11659469-<b>?</b>,5 x 10-6,(mucinous_all),NR,1.5,'-,'-,SMUG1P1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,18:49657424
chr12:98579587-<b>?</b>,9 x 10-6,(ser_lg_lmp),NR,6.95,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs11724690-<b>?</b>,2 x 10-6,(clearcell),NR,2.9,'-,'-,SORBS2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:185843593
chr14:106452461-<b>?</b>,2 x 10-6,(lmp),NR,4.73,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs11980115-<b>?</b>,2 x 10-6,(ser_lg_lmp),NR,4.45,'-,'-,"ST13P7, RNU6-92P",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:133141119
rs12546957-<b>?</b>,3 x 10-6,(serous_hg),NR,1.24,'-,'-,CASC11,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,8:127619425
chr2:29228648-<b>?</b>,8 x 10-6,(clearcell),NR,6.32,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs12603880-<b>?</b>,7 x 10-6,(clearcell),NR,1.59,'-,'-,MSI2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,17:57668632
chr12:118425547-<b>?</b>,6 x 10-6,(ser_lg_lmp),NR,2.1,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
chr6:168526822-<b>?</b>,7 x 10-6,(clearcell),NR,1.55,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
chrX:107586364-<b>?</b>,3 x 10-6,(overall),NR,1.29,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs135573-<b>?</b>,3 x 10-6,(mucinous_all),NR,2.45,'-,'-,"PPARA, MIRLET7BHG",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,22:46131359
kgp7556451-<b>?</b>,9 x 10-8,(serous_hg),NR,1.27,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs1413017-<b>?</b>,4 x 10-6,(ser_lg_lmp),NR,1.75,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,20:12691366
rs142825068-<b>?</b>,8 x 10-6,(overall),NR,1.24,'-,'-,PTPRN2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:157716799
rs144055451-<b>?</b>,2 x 10-6,(serous_hg),NR,1.91,'-,'-,KRT18P55,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,17:28302026
rs144199732-<b>?</b>,7 x 10-7,(lmp),NR,2.86,'-,'-,SMIM15P1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,X:43022624
rs145022376-<b>?</b>,1 x 10-6,(clearcell),NR,4.1,'-,'-,"LINC00200, ADARB2",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,10:1186289
rs146343288-<b>?</b>,3 x 10-6,(serous_hg),NR,1.48,'-,'-,NUP153,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:17689625
rs11150225-<b>?</b>,7 x 10-6,(overall),NR,1.21,'-,'-,LINC01228,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,16:79856062
rs111970895-<b>?</b>,3 x 10-7,(clearcell),NR,2.34,'-,'-,"SLCO4C1, RN7SKP68",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:102301954
rs1934363-<b>C</b>,3 x 10-10,(CCOC),0.94,11,'-,[5.3-24],LINC02652,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,10:28484549
rs113494645-<b>?</b>,9 x 10-6,(mucinous_all),NR,1.79,'-,'-,GALNT17,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:71128079
rs7748275-<b>A</b>,4 x 10-8,(HGSOC),0.16,1.4,'-,[1.2-1.5],'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:3580855
rs11426758-<b>?</b>,7 x 10-6,(mucinous_all),NR,1.56,'-,'-,UBE2G1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,17:4274200
chr12:121386263-<b>?</b>,2 x 10-7,(lmp),NR,2.6,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs1164587-<b>?</b>,3 x 10-6,(mucinous_all),NR,1.53,'-,'-,HS6ST3,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,13:96391464
chr12:45837095-<b>?</b>,2 x 10-6,(serous_hg),NR,1.4,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs11684751-<b>?</b>,4 x 10-6,(ser_lg_lmp),NR,1.74,'-,'-,"RND3, LINC01818",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:150393944
chr13:45661665-<b>?</b>,9 x 10-6,(endometrioid),NR,1.54,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs11973028-<b>?</b>,1 x 10-6,(mucinous_all),NR,1.51,'-,'-,JAZF1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:27853217
chr16:76182702-<b>?</b>,1 x 10-6,(mucinous_all),NR,1.84,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs12568748-<b>?</b>,9 x 10-6,(mucinous_all),NR,1.9,'-,'-,DUSP10,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,1:221657667
chr1:150718602-<b>?</b>,7 x 10-7,(ser_lg_lmp),NR,2.43,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs12623068-<b>?</b>,4 x 10-6,(overall),NR,1.24,'-,'-,RN7SKP112,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:7182908
rs13420007-<b>?</b>,6 x 10-6,(endometrioid),NR,1.56,'-,'-,RNU6-566P,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:44110941
kgp7416783-<b>?</b>,9 x 10-6,(clearcell),NR,1.6,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs140884924-<b>?</b>,8 x 10-6,(lmp),NR,1.76,'-,'-,LINC00410,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,13:90884180
rs10009522-<b>?</b>,9 x 10-6,(overall),NR,1.27,'-,'-,TRIM2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:153242242
rs10260419-<b>?</b>,1 x 10-7,(overall),NR,1.33,'-,'-,THSD7A,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:11524758
rs10400919-<b>?</b>,6 x 10-6,(clearcell),NR,1.55,'-,'-,"GABRG3-AS1, GABRG3",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,15:27084081
rs10627733-<b>?</b>,2 x 10-6,(endometrioid),NR,1.89,'-,'-,EIF4G3,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,1:21141378
rs111478044-<b>?</b>,9 x 10-7,(ser_lg_lmp),NR,2,'-,'-,NCAM2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,21:21308069
rs146917711-<b>?</b>,4 x 10-6,(mucinous_all),NR,2.33,'-,'-,CCDC80,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:112609782
rs1763604-<b>C</b>,7 x 10-9,,0.42085,'-,0.0372 unit decrease,[0.025-0.05],"HSPB7, SRARP","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,1:16013277
rs77548871-<b>C</b>,5 x 10-9,,0.0472,'-,0.0991 unit decrease,[0.066-0.132],ZBTB7B,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,1:155016057
rs13007211-<b>A</b>,1 x 10-9,,0.6935,'-,0.0432 unit increase,[0.029-0.057],VAMP8,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,2:85573959
rs17041869-<b>A</b>,2 x 10-9,,0.8804,'-,0.0571 unit decrease,[0.038-0.076],"MIR4435-2HG, BCL2L11","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,2:111138666
rs57251748-<b>CT</b>,9 x 10-12,,0.15,'-,0.0598 unit decrease,[0.043-0.077],TET2,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,4:105137029
rs739704-<b>A</b>,3 x 10-14,,0.2515,'-,0.0542 unit decrease,[0.04-0.068],JAZF1,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,7:27950149
rs720475-<b>A</b>,7 x 10-12,,0.25455,'-,0.0495 unit decrease,[0.035-0.064],ARHGEF5,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,7:144377836
rs17762342-<b>A</b>,2 x 10-15,,0.7935,'-,0.061 unit increase,[0.046-0.076],PCAT1,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,8:126990792
rs3802173-<b>T</b>,3 x 10-11,,0.2261,'-,0.0521 unit increase,[0.037-0.068],"RN7SKP226, PVT1","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,8:128187668
rs9657608-<b>T</b>,1 x 10-10,,0.0923,'-,0.0685 unit increase,[0.048-0.089],"CDKN2A-DT, MTAP","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,9:21956231
rs7898685-<b>A</b>,3 x 10-10,,0.2913,'-,0.0428 unit increase,[0.029-0.056],DNAJC1,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,10:22010574
rs568110-<b>T</b>,5 x 10-12,,0.2057,'-,0.0523 unit increase,[0.037-0.067],"PPIAP39, RNU7-165P","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,10:113390512
rs7937840-<b>T</b>,2 x 10-9,,0.26465,'-,0.0446 unit increase,[0.03-0.059],INCENP,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,11:62126500
rs118151305-<b>A</b>,6 x 10-9,,0.12005,'-,0.0672 unit decrease,[0.045-0.09],"CD248, RIN1","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,11:66324772
rs72932523-<b>A</b>,1 x 10-9,,0.10565,'-,0.0601 unit increase,[0.041-0.08],"TPCN2, SMIM38","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,11:69138652
rs2277509-<b>A</b>,9 x 10-12,,0.69865,'-,0.0466 unit increase,[0.033-0.06],CCDC88C,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,14:91283251
rs2628317-<b>A</b>,4 x 10-16,,0.72985,'-,0.0582 unit increase,[0.044-0.072],STXBP4,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,17:55135212
rs1469713-<b>A</b>,1 x 10-10,,0.64405,'-,0.043 unit decrease,[0.03-0.056],GATAD2A,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,19:19417997
rs186507655-<b>A</b>,5 x 10-10,(subset analysis),NR,'-,'-,'-,"DVL1, MXRA8",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,1:1351675
rs2075570-<b>T</b>,5 x 10-6,(subset analysis),NR,'-,'-,'-,MTX1,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,1:155212373
rs481519-<b>T</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,NEK10,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,3:27285723
rs7679673-<b>A</b>,1 x 10-10,(subset analysis),NR,'-,'-,'-,TET2,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,4:105140377
rs7725218-<b>A</b>,2 x 10-10,(subset analysis),NR,'-,'-,'-,TERT,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,5:1282299
rs1862626-<b>T</b>,4 x 10-12,(subset analysis),NR,'-,'-,'-,MAP3K1,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,5:56737113
rs147680653-<b>G</b>,1 x 10-6,(subset analysis),NR,'-,'-,'-,"HLA-V, IFITM4P",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:29785031
rs115707823-<b>A</b>,5 x 10-7,(subset analysis),NR,'-,'-,'-,"MICC, UBQLN1P1",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:30374976
rs115392158-<b>G</b>,3 x 10-7,(subset analysis),NR,'-,'-,'-,"LINC02571, HLA-B",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:31347004
rs147527678-<b>C</b>,6 x 10-8,(subset analysis),NR,'-,'-,'-,"HLA-DQB1, MTCO3P1",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:32699696
rs1011970-<b>T</b>,5 x 10-6,(subset analysis),NR,'-,'-,'-,CDKN2B-AS1,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,9:22062135
rs11200014-<b>A</b>,8 x 10-35,(subset analysis),NR,'-,'-,'-,FGFR2,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,10:121575416
rs7931342-<b>G</b>,4 x 10-14,(subset analysis),NR,'-,'-,'-,"MYEOV, SMIM38",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,11:69227030
rs148883465-<b>G</b>,3 x 10-8,(subset analysis),NR,'-,'-,'-,MIR4693,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,11:103813371
rs11168936-<b>C</b>,9 x 10-7,(subset analysis),NR,'-,'-,'-,TUBA1C,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,12:49251457
rs73110464-<b>T</b>,2 x 10-15,(subset analysis),NR,'-,'-,'-,KRT8,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,12:52918828
rs3184504-<b>C</b>,1 x 10-6,(subset analysis),NR,'-,'-,'-,"SH2B3, ATXN2",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma",GCST003588,12:111446804
rs11571818-<b>C</b>,5 x 10-10,(subset analysis),NR,'-,'-,'-,BRCA2,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,13:32394673
rs11844632-<b>A</b>,3 x 10-10,(subset analysis),NR,'-,'-,'-,RAD51B,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,14:68559662
rs12601991-<b>T</b>,7 x 10-28,(subset analysis),NR,'-,'-,'-,HNF1B,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,17:37741642
rs4808075-<b>C</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,"BABAM1, USHBP1",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,19:17279482
rs11907546-<b>T</b>,3 x 10-6,(subset analysis),NR,'-,'-,'-,"RPS2P1, ASIP",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,20:34131991
rs141752671-<b>G</b>,1 x 10-7,(subset analysis),NR,'-,'-,'-,'-,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,11:103745837
rs11065979-<b>T</b>,5 x 10-6,(subset analysis),NR,'-,'-,'-,"BRAP, ATXN2-AS",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,12:111621753
rs2300206-<b>C</b>,6 x 10-6,(subset analysis),NR,'-,'-,'-,RALY,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,20:34002002
rs56084662-<b>A</b>,4 x 10-9,(subset analysis),NR,'-,'-,'-,FRY,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,13:32295727
rs1057941-<b>A</b>,2 x 10-7,,NR,1.1,'-,[NR],GBAP1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,1:155216951
rs2974935-<b>T</b>,2 x 10-7,,NR,1.1,'-,[NR],MTX1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,1:155212052
rs11119608-<b>T</b>,1 x 10-7,,NR,1.1111112,'-,[NR],KCNH1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,1:210816167
rs75316749-<b>G</b>,2 x 10-7,,NR,1.1,'-,[NR],"MECOM, LINC01997",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,3:169043635
rs115707823-<b>A</b>,2 x 10-6,,NR,1.1,'-,[NR],"MICC, UBQLN1P1",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:30374976
rs115392158-<b>G</b>,9 x 10-6,,NR,1.1,'-,[NR],"LINC02571, HLA-B",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:31347004
rs147527678-<b>C</b>,5 x 10-7,,NR,1.1,'-,[NR],"HLA-DQB1, MTCO3P1",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:32699696
rs4604234-<b>C</b>,6 x 10-6,,NR,1.1,'-,[NR],"RPSAP72, RPL17P25",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:80398959
rs12349081-<b>A</b>,6 x 10-6,,NR,1.1,'-,[NR],"CDKN2A-DT, MTAP",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,9:21951903
rs1011970-<b>T</b>,2 x 10-7,,NR,1.1,'-,[NR],CDKN2B-AS1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,9:22062135
rs3184504-<b>C</b>,2 x 10-6,,NR,1.1,'-,[NR],"SH2B3, ATXN2",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,12:111446804
rs11571833-<b>T</b>,8 x 10-12,,NR,1.6,'-,[NR],BRCA2,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,13:32398489
rs12601991-<b>T</b>,1 x 10-9,,NR,1.1,'-,[NR],HNF1B,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,17:37741642
rs4808075-<b>C</b>,4 x 10-7,,NR,1.1,'-,[NR],"BABAM1, USHBP1",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,19:17279482
rs11907546-<b>C</b>,3 x 10-9,,NR,1.1111112,'-,[NR],"RPS2P1, ASIP",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,20:34131991
rs56404467-<b>A</b>,1 x 10-7,,NR,1.2,'-,[NR],FRY,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,13:32265853
rs2300206-<b>G</b>,2 x 10-8,,NR,1.1111112,'-,[NR],RALY,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,20:34002002
rs6782972-<b>G</b>,3 x 10-9,,NR,1.2048193,'-,[1.15-1.26],RN7SL216P,Endometriosis or endometrial cancer (pleiotropy),"endometrial carcinoma, endometriosis",GCST005906,3:24922859
rs10008492-<b>T</b>,2 x 10-6,,NR,1.14,'-,[1.08-1.2],"TLR10, RNA5SP158",Endometriosis or endometrial cancer (pleiotropy),"endometrial carcinoma, endometriosis",GCST005906,4:38764099
rs9349553-<b>T</b>,5 x 10-6,,NR,1.14,'-,[1.08-1.2],TFAP2D,Endometriosis or endometrial cancer (pleiotropy),"endometrial carcinoma, endometriosis",GCST005906,6:50747694
rs2475335-<b>T</b>,2 x 10-6,,NR,1.15,'-,[1.09-1.21],PTPRD,Endometriosis or endometrial cancer (pleiotropy),"endometrial carcinoma, endometriosis",GCST005906,9:10260263
rs2218868-<b>T</b>,4 x 10-8,,NR,1.15,'-,[1.09-1.21],OR9Q1,Endometriosis or endometrial cancer (pleiotropy),"endometrial carcinoma, endometriosis",GCST005906,11:58158505
rs523332-<b>G</b>,5 x 10-6,,NR,1.1494253,'-,[1.09-1.21],"ARHGAP42, PGR",Endometriosis or endometrial cancer (pleiotropy),"endometrial carcinoma, endometriosis",GCST005906,11:101003588
rs2278868-<b>T</b>,5 x 10-7,,NR,1.1494253,'-,[1.09-1.21],SKAP1,Endometriosis or endometrial cancer (pleiotropy),"endometrial carcinoma, endometriosis",GCST005906,17:48184809
rs9915454-<b>A</b>,5 x 10-6,,NR,1.13,'-,[1.07-1.19],"AXIN2, CEP112",Endometriosis or endometrial cancer (pleiotropy),"endometrial carcinoma, endometriosis",GCST005906,17:65633120
rs3847153-<b>?</b>,9 x 10-8,,0.38,1.42,'-,[NR],"RNU4-83P, RPS20P23",Premature ovarian failure,primary ovarian insufficiency,GCST001284,8:100800928
chr17:41200107-<b>?</b>,1 x 10-8,(ovarian cancer),'-,'-,'-,'-,'-,Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,Mapping not available
chr17:70097851-<b>?</b>,4 x 10-8,(uterine cervical cancer),'-,'-,'-,'-,'-,Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,Mapping not available
rs9257985-<b>?</b>,2 x 10-8,"(uterine fibroid, uterine cervical cancer)",'-,'-,'-,'-,"ZDHHC20P1, ZFP57",Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,6:29684476
rs117670375-<b>?</b>,1 x 10-8,(uterine cervical cancer),'-,'-,'-,'-,TUBB,Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,6:30719695
rs2507968-<b>?</b>,3 x 10-9,"(uterine fibroid, uterine cervical cancer)",'-,'-,'-,'-,MICA,Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,6:31404941
rs9271215-<b>?</b>,2 x 10-8,"(uterine fibroid, uterine cervical cancer)",'-,'-,'-,'-,"HLA-DRB1, HLA-DQA1",Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,6:32611500
rs116832992-<b>?</b>,3 x 10-9,"(endometriosis, uterine cervical cancer)",'-,'-,'-,'-,"PPP1R17, PDE1C",Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,7:31745141
rs73494486-<b>?</b>,5 x 10-8,"(uterine fibroid, ovarian cancer)",'-,'-,'-,'-,GABBR2,Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,9:98579569
rs147427629-<b>?</b>,4 x 10-8,"(ovarian cancer, uterine endometriosisometrial cancer)",'-,'-,'-,'-,"RPL23AP12, LINC01700",Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,21:39047396
rs7412010-<b>?</b>,5 x 10-11,,'-,1.12,'-,[1.08-1.15],"WNT4, CDC42",Gynecologic disease,female reproductive system disease,GCST009824,1:22109953
rs202217993-<b>?</b>,1 x 10-8,,'-,1.18,'-,[1.11-1.25],OR5V1,Gynecologic disease,female reproductive system disease,GCST009824,6:29419199
rs17179851-<b>?</b>,7 x 10-8,,'-,1.11,'-,[1.07-1.15],HLA-W,Gynecologic disease,female reproductive system disease,GCST009824,6:29956663
rs117670375-<b>?</b>,1 x 10-7,,'-,1.16,'-,[1.10-1.22],TUBB,Gynecologic disease,female reproductive system disease,GCST009824,6:30719695
rs12225799-<b>?</b>,3 x 10-16,,'-,0.81,'-,'-,PSMD13,Gynecologic disease,female reproductive system disease,GCST009824,11:241124
rs17332320-<b>?</b>,7 x 10-9,,'-,1.1,'-,[1.07-1.14],TNRC6B,Gynecologic disease,female reproductive system disease,GCST009824,22:40315616
rs17332320-<b>?</b>,5 x 10-13,"(uterine fibroid, endometriosis)",'-,'-,'-,'-,TNRC6B,Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,22:40315616
rs138060871-<b>?</b>,8 x 10-16,(uterine fibroid),'-,'-,'-,'-,PSMD13,Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,11:241284
rs7412010-<b>?</b>,7 x 10-11,(uterine fibroid),'-,'-,'-,'-,"WNT4, CDC42",Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,1:22109953
rs6432216-<b>?</b>,5 x 10-8,"(uterine fibroid,endometriosis)",'-,'-,'-,'-,GREB1,Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,2:11562834
rs937380553-<b>?</b>,4 x 10-11,"(endometriosis, ovarian cancer, uterine endometriosisometrial cancer)",'-,'-,'-,'-,"CRYGGP, CCDC12P1",Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,2:51836223
rs145152209-<b>?</b>,3 x 10-8,(uterine fibroid),'-,'-,'-,'-,SH3GL3,Gynecologic disease (multivariate analysis),female reproductive system disease,GCST009823,15:83408460
rs7412010-<b>?</b>,4 x 10-10,,'-,'-,'-,'-,"WNT4, CDC42",Gynecologic disease,female reproductive system disease,GCST009822,1:22109953
rs937380553-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,"CRYGGP, CCDC12P1",Gynecologic disease,female reproductive system disease,GCST009822,2:51836223
rs202217993-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,OR5V1,Gynecologic disease,female reproductive system disease,GCST009822,6:29419199
rs17179851-<b>?</b>,7 x 10-7,,'-,'-,'-,'-,HLA-W,Gynecologic disease,female reproductive system disease,GCST009822,6:29956663
rs117670375-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,TUBB,Gynecologic disease,female reproductive system disease,GCST009822,6:30719695
rs12225799-<b>?</b>,4 x 10-17,,'-,'-,'-,'-,PSMD13,Gynecologic disease,female reproductive system disease,GCST009822,11:241124
rs17332320-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,TNRC6B,Gynecologic disease,female reproductive system disease,GCST009822,22:40315616
rs752590-<b>?</b>,3 x 10-8,,0.21,1.34,'-,[1.21-1.49],PAX8-AS1,Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST002967,2:113215368
rs711830-<b>?</b>,8 x 10-12,,0.32,1.3,'-,[1.20-1.40],"HAGLR, HOXD3",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST002967,2:176172583
rs688187-<b>?</b>,7 x 10-13,,0.68,1.4925373,'-,[1.33-1.67],"IFNL3P1, IFNL3",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST002967,19:39242112
rs72831838-<b>?</b>,8 x 10-7,(Invasive Only),0.14,1.39,'-,[1.22-1.58],"PAX8-AS1, PAX8",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST002967,2:113258824
rs711830-<b>?</b>,8 x 10-7,(Invasive Only),0.32,1.26,'-,[1.15-1.39],"HAGLR, HOXD3",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST002967,2:176172583
rs688187-<b>?</b>,1 x 10-8,(Invasive Only),0.68,1.4084507,'-,[1.25-1.59],"IFNL3P1, IFNL3",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST002967,19:39242112
rs11193561-<b>A</b>,6 x 10-6,,0.239,1.19,'-,[NR],LINC01435,Endometriosis,endometriosis,GCST001894,10:107614626
rs12449465-<b>G</b>,1 x 10-6,,0.125,1.26,'-,[NR],"OR1E3, OR1G1",Endometriosis,endometriosis,GCST001894,17:3126260
rs6757804-<b>G</b>,6 x 10-8,,0.401,1.2,'-,[1.13-1.29],'-,Endometriosis,endometriosis,GCST001894,2:150779318
rs10975519-<b>A</b>,9 x 10-7,,0.3,1.19,'-,[NR],IL33,Endometriosis,endometriosis,GCST001894,9:6253571
rs2235529-<b>A</b>,3 x 10-9,,0.153,1.3,'-,[1.19-1.41],WNT4,Endometriosis,endometriosis,GCST001894,1:22123994
rs6907340-<b>A</b>,2 x 10-7,,0.371,1.2,'-,[1.12-1.28],LNC-LBCS,Endometriosis,endometriosis,GCST001894,6:19803537
rs2270221-<b>A</b>,1 x 10-6,,0.267,1.2,'-,[NR],PDE1C,Endometriosis,endometriosis,GCST001894,7:31864413
rs7816936-<b>A</b>,6 x 10-6,,0.446,1.1628,'-,[NR],RN7SL318P,Endometriosis,endometriosis,GCST001894,8:5213890
rs10508881-<b>A</b>,4 x 10-7,,0.405,1.19,'-,[1.11-1.27],LINC00841,Endometriosis,endometriosis,GCST001894,10:44046117
rs3596-<b>G</b>,2 x 10-6,,0.472,1.17,'-,[NR],VEZT,Endometriosis,endometriosis,GCST001894,12:95302644
rs10431397-<b>A</b>,7 x 10-6,,0.012,1.73,'-,[NR],KSR2,Endometriosis,endometriosis,GCST001894,12:117668389
rs1268843-<b>A</b>,3 x 10-6,,0.263,1.19,'-,[NR],"MOAP1, CYB5AP3",Endometriosis,endometriosis,GCST001894,14:93178034
rs7666129-<b>A</b>,6 x 10-6,,0.75,1.59,'-,[NR],LINC01060,Polycystic ovary syndrome,polycystic ovary syndrome,GCST002741,4:188576910
rs10505648-<b>A</b>,5 x 10-8,,0.906,1.92,'-,[NR],LINC02055,Polycystic ovary syndrome,polycystic ovary syndrome,GCST002741,8:136144207
rs1159315-<b>G</b>,2 x 10-7,,0.3655,'-,1.117 unit increase,NR,GABRB1,Polycystic ovary syndrome,polycystic ovary syndrome,GCST006659,4:47001059
rs12450465-<b>G</b>,8 x 10-6,,0.3312,'-,0.8755 unit decrease,NR,ASIC2,Polycystic ovary syndrome,polycystic ovary syndrome,GCST006659,17:33053293
rs2060941-<b>A</b>,5 x 10-8,,0.02708,'-,2.139 unit decrease,NR,IKZF3,Polycystic ovary syndrome,polycystic ovary syndrome,GCST006659,17:39826630
rs11206912-<b>?</b>,9 x 10-6,,'-,1.25,'-,[1.13-1.38],FYB2,Endometrial cancer,endometrial carcinoma,GCST009828,1:56745531
rs151165466-<b>?</b>,6 x 10-6,,'-,2.09,'-,[1.52-2.87],NGF-AS1,Endometrial cancer,endometrial carcinoma,GCST009828,1:115385095
rs74226487-<b>?</b>,4 x 10-6,,'-,2.86,'-,[1.83-4.46],KIF26B,Endometrial cancer,endometrial carcinoma,GCST009828,1:245242946
rs183838592-<b>?</b>,9 x 10-6,,'-,2.62,'-,[1.71-4.00],CCDC85A,Endometrial cancer,endometrial carcinoma,GCST009828,2:56216112
rs76460014-<b>?</b>,5 x 10-6,,'-,1.88,'-,[1.44-2.47],'-,Endometrial cancer,endometrial carcinoma,GCST009828,3:5672970
rs1039906-<b>?</b>,3 x 10-6,,'-,1.31,'-,[1.17-1.47],STX18-AS1,Endometrial cancer,endometrial carcinoma,GCST009828,4:4762299
rs150688018-<b>?</b>,2 x 10-6,,'-,2.31,'-,[1.63-3.27],'-,Endometrial cancer,endometrial carcinoma,GCST009828,4:28588594
rs78634984-<b>?</b>,7 x 10-6,,'-,2.85,'-,[1.81-4.50],RNF150,Endometrial cancer,endometrial carcinoma,GCST009828,4:141079518
rs147462252-<b>?</b>,9 x 10-8,,'-,2.17,'-,[1.63-2.88],"LY86, LY86-AS1",Endometrial cancer,endometrial carcinoma,GCST009828,6:6615596
rs113549253-<b>?</b>,4 x 10-6,,'-,2.86,'-,[1.83-4.47],"H4C8, H3C9P",Endometrial cancer,endometrial carcinoma,GCST009828,6:26306264
rs72915912-<b>?</b>,4 x 10-6,,'-,2.73,'-,[1.78-4.19],MDN1,Endometrial cancer,endometrial carcinoma,GCST009828,6:89720606
rs60966143-<b>?</b>,3 x 10-6,,'-,2.73,'-,[1.79-4.16],CASP8AP2,Endometrial cancer,endometrial carcinoma,GCST009828,6:89867883
rs11206911-<b>?</b>,5 x 10-6,,'-,1.03,'-,[1.02-1.05],FYB2,Endometrial cancer (MTAG),endometrial carcinoma,GCST009827,1:56743350
rs117721752-<b>?</b>,9 x 10-6,,'-,1.1,'-,[1.05-1.14],CAPN8,Endometrial cancer (MTAG),endometrial carcinoma,GCST009827,1:223506622
rs76460014-<b>?</b>,9 x 10-6,,'-,1.08,'-,[1.04-1.12],'-,Endometrial cancer (MTAG),endometrial carcinoma,GCST009827,3:5672970
rs1039906-<b>?</b>,2 x 10-6,,'-,1.04,'-,[1.02-1.06],STX18-AS1,Endometrial cancer (MTAG),endometrial carcinoma,GCST009827,4:4762299
rs150688018-<b>?</b>,8 x 10-6,,'-,1.12,'-,[1.07-1.18],'-,Endometrial cancer (MTAG),endometrial carcinoma,GCST009827,4:28588594
rs10900892-<b>?</b>,7 x 10-6,,'-,1.03,'-,[1.02-1.05],LINC01950,Endometrial cancer (MTAG),endometrial carcinoma,GCST009827,5:106807627
rs147462252-<b>?</b>,8 x 10-8,,'-,1.12,'-,[1.07-1.16],"LY86, LY86-AS1",Endometrial cancer (MTAG),endometrial carcinoma,GCST009827,6:6615596
rs113549253-<b>?</b>,8 x 10-6,,'-,1.16,'-,[1.09-1.24],"H4C8, H3C9P",Endometrial cancer (MTAG),endometrial carcinoma,GCST009827,6:26306264
rs60966143-<b>?</b>,8 x 10-6,,'-,1.15,'-,[1.08-1.22],CASP8AP2,Endometrial cancer (MTAG),endometrial carcinoma,GCST009827,6:89867883
rs78025940-<b>A</b>,2 x 10-10,,0.02,4.75,'-,[2.82-7.98],"KAZN, KAZN-AS1",Polycystic ovary syndrome (reproductive subtype),polycystic ovary syndrome,GCST010570,1:14404304
rs76182733-<b>G</b>,3 x 10-9,,0.01,5.68,'-,3.00-10.78,"IQCA1, ACKR3",Polycystic ovary syndrome (reproductive subtype),polycystic ovary syndrome,GCST010570,2:236518238
rs17023134-<b>G</b>,1 x 10-8,,0.05,3.02,'-,2.06-4.42,UNC5C,Polycystic ovary syndrome (reproductive subtype),polycystic ovary syndrome,GCST010570,4:95183520
rs7735176-<b>A</b>,1 x 10-8,,0.01,5.09,'-,2.62-9.86,"BTG4P1, CDH10",Polycystic ovary syndrome (reproductive subtype),polycystic ovary syndrome,GCST010570,5:24728347
rs11031006-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,FSHB,Polycystic ovary syndrome (reproductive subtype),polycystic ovary syndrome,GCST010570,11:30204981
rs55762028-<b>C</b>,1 x 10-8,,0.01,1.86,'-,0.92-3.75,RNU6-627P,Polycystic ovary syndrome (metabolic subtype),polycystic ovary syndrome,GCST010569,2:163325912
rs10835638-<b>T</b>,5 x 10-12,,0.16,1.81,'-,1.44-2.27,FSHB,Polycystic ovary syndrome (indeterminate subtype),polycystic ovary syndrome,GCST010568,11:30230805
rs500492-<b>A</b>,6 x 10-6,,0.65,1.32,'-,[NR],"SOX8, SSTR5-AS1",Polycystic ovary syndrome,polycystic ovary syndrome,GCST002741,16:1000877
rs55846951-<b>G</b>,6 x 10-7,,0.016533,1.6702857,'-,NR,LHFPL3,Endometrial cancer,endometrial carcinoma,GCST90011820,7:104808117
rs75883022-<b>T</b>,1 x 10-7,,0.02319,1.5898252,'-,NR,CDKN2B-AS1,Endometrial cancer,endometrial carcinoma,GCST90011820,9:22067911
rs117173527-<b>G</b>,6 x 10-7,,0.027767,1.5482272,'-,NR,"LINC02182, BANP",Endometrial cancer,endometrial carcinoma,GCST90011820,16:88108157
rs80073993-<b>T</b>,3 x 10-7,,0.070109,1.3331555,'-,NR,RNA5SP231,Endometrial cancer,endometrial carcinoma,GCST90011820,7:68766403
rs138243157-<b>G</b>,4 x 10-7,,0.130334,1.2507818,'-,NR,"HAUS6P2, RPL31P3",Endometrial cancer,endometrial carcinoma,GCST90011820,20:31333052
rs3815795-<b>T</b>,5 x 10-7,,0.303681,1.1838523,'-,NR,GINS2,Endometrial cancer,endometrial carcinoma,GCST90011820,16:85678499
rs2796443-<b>T</b>,9 x 10-8,,0.384686,1.1888,'-,NR,TLE1,Endometrial cancer,endometrial carcinoma,GCST90011820,9:81677392
rs766432-<b>C</b>,3 x 10-10,,0.29,'-,'-,'-,'-,Hemoglobin A2 levels in sickle cell anemia,"Sickle cell anemia, hemoglobin A2 measurement",GCST002536,Mapping not available
rs17020489-<b>A</b>,3 x 10-6,(AA),0.3,'-,'-,'-,RNA5SP99,Hemoglobin A2 levels in sickle cell anemia,"Sickle cell anemia, hemoglobin A2 measurement",GCST002536,2:81595057
rs67072384-<b>T</b>,7 x 10-7,,0.11,6.22,'-,[NR],ARAP1,Alloimmunization response to red blood cell transfusion in sickle cell anemia,"Sickle cell anemia, alloimmunization, response to red blood cell transfusion",GCST002691,11:72739679
rs1318772-<b>G</b>,1 x 10-6,,0.33,'-,0.91 unit decrease,[0.54-1.28],MCC,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,5:113387870
rs12559632-<b>A</b>,3 x 10-6,,0.25,'-,1.16 unit decrease,[0.69-1.63],PHEX,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,X:22142875
rs2577720-<b>C</b>,8 x 10-6,,0.33,'-,0.82 unit decrease,[0.47-1.17],KLHL29,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,2:23325743
rs11968814-<b>A</b>,9 x 10-7,,0.16,'-,1.17 unit decrease,[0.70-1.64],BECN1P2,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,6:71067268
rs3800569-<b>C</b>,6 x 10-6,,0.13,'-,1.2 unit increase,[0.69-1.71],ATP6V0A4,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,7:138726680
rs1845344-<b>T</b>,7 x 10-6,,0.27,'-,0.97 unit increase,[0.56-1.38],"LINC02502, MAD2L1",F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,4:120041230
rs10017284-<b>G</b>,6 x 10-6,,0.43,'-,0.85 unit decrease,[0.50-1.20],PRDM5,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,4:120592060
rs17135859-<b>C</b>,8 x 10-6,,0.19,'-,0.97 unit increase,[0.54-1.40],YTHDC2,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,5:113660957
rs12073837-<b>T</b>,2 x 10-6,,0.19,'-,1.39 unit increase,[0.82-1.96],HLX-AS1,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,1:220836863
rs2663839-<b>T</b>,9 x 10-6,,0.2345,1.769,'-,[1.372-2.281],"RSL24D1P11, ATP8B1",Endometriosis,endometriosis,GCST004873,18:57818282
rs144824657-<b>T</b>,1 x 10-6,,0.01631,3.521,'-,[2.042-6.072],BSG,Endometriosis,endometriosis,GCST004873,19:577782
rs11085835-<b>T</b>,3 x 10-7,,0.2908,2.047,'-,[1.546-2.709],CACNA1A,Endometriosis,endometriosis,GCST004873,19:13221196
rs10419023-<b>T</b>,6 x 10-7,,0.04694,3.013,'-,[1.91-4.75],GRIN2D,Endometriosis,endometriosis,GCST004873,19:48427965
rs2327293-<b>G</b>,7 x 10-6,,0.2299,1.846,'-,[1.409-2.42],"SNAP25-AS1, SDAD1P2",Endometriosis,endometriosis,GCST004873,20:10385750
rs6075004-<b>A</b>,9 x 10-6,,0.309,1.68,'-,[1.333-2.119],MACROD2,Endometriosis,endometriosis,GCST004873,20:16086119
rs2929986-<b>T</b>,4 x 10-6,,0.4485,1.67,'-,[1.34-2.083],CCN4,Endometriosis,endometriosis,GCST004873,8:133199283
rs116250606-<b>T</b>,1 x 10-7,,0.028,3.242,'-,[2.052-5.121],CALHM3,Endometriosis,endometriosis,GCST004873,10:103473496
rs3820445-<b>G</b>,6 x 10-7,,0.1312,2.042,'-,[1.534-2.719],"AGBL4, BEND5",Endometriosis,endometriosis,GCST004873,1:48758912
rs1009077-<b>A</b>,4 x 10-6,,0.2234,1.783,'-,[1.389-2.29],"LINC01365, PDE5A",Endometriosis,endometriosis,GCST004873,4:119706266
rs1432089-<b>A</b>,6 x 10-8,,0.263,1.928,'-,[1.516-2.452],RNU6ATAC13P,Endometriosis,endometriosis,GCST004873,4:170869637
rs11132055-<b>T</b>,8 x 10-8,,0.169,2.092,'-,[1.588-2.755],'-,Endometriosis,endometriosis,GCST004873,4:181401652
rs458649-<b>A</b>,6 x 10-6,,0.189,1.846,'-,[1.409-2.418],'-,Endometriosis,endometriosis,GCST004873,5:4269377
rs62355900-<b>C</b>,5 x 10-8,,0.1394,2.115,'-,[1.608-2.783],MAP3K1,Endometriosis,endometriosis,GCST004873,5:56756868
rs644045-<b>T</b>,2 x 10-8,,0.2853,1.955,'-,[1.541-2.48],C2,Endometriosis,endometriosis,GCST004873,6:31916180
rs2300795-<b>C</b>,5 x 10-7,,0.01436,3.591,'-,[2.107-6.119],COL12A1,Endometriosis,endometriosis,GCST004873,6:75115465
rs1750034-<b>T</b>,7 x 10-7,,0.1042,2.018,'-,[1.521-2.678],SYNJ2,Endometriosis,endometriosis,GCST004873,6:158059112
rs75801644-<b>A</b>,8 x 10-10,,0.01823,3.882,'-,[2.44-6.176],GPNMB,Endometriosis,endometriosis,GCST004873,7:23266522
rs7781172-<b>T</b>,1 x 10-6,,0.04686,2.393,'-,[1.659-3.45],'-,Endometriosis,endometriosis,GCST004873,7:49030398
rs16901004-<b>T</b>,9 x 10-7,,0.198,1.866,'-,[1.45-2.403],LINC00861,Endometriosis,endometriosis,GCST004873,8:125958758
rs6578185-<b>A</b>,2 x 10-6,,0.4932,1.805706,'-,[1.41-2.31],MROH5,Endometriosis,endometriosis,GCST004873,8:141447953
rs17277593-<b>A</b>,5 x 10-6,,0.2127,1.802,'-,[1.396-2.327],"PES1P2, LINC00583",Endometriosis,endometriosis,GCST004873,9:13950594
rs6540-<b>A</b>,3 x 10-6,,0.02028,3.038,'-,[1.867-4.944],PSMD13,Endometriosis,endometriosis,GCST004873,11:252649
rs2615943-<b>T</b>,7 x 10-6,,0.2895,1.661,'-,[1.328-2.076],KIAA1549L,Endometriosis,endometriosis,GCST004873,11:33417589
rs7942368-<b>T</b>,9 x 10-9,,0.2423,2.072,'-,[1.609-2.668],"TSKU, GUCY2EP",Endometriosis,endometriosis,GCST004873,11:76754318
rs427244-<b>A</b>,4 x 10-7,,0.165,1.926,'-,[1.489-2.493],RFLNA,Endometriosis,endometriosis,GCST004873,12:124120741
rs10131751-<b>A</b>,9 x 10-7,,0.05641,2.495,'-,[1.711-3.637],BNIP3P1,Endometriosis,endometriosis,GCST004873,14:28212010
rs1380131-<b>A</b>,9 x 10-6,,0.1011,2.087,'-,[1.497-2.909],RPS3AP46,Endometriosis,endometriosis,GCST004873,14:53606140
rs10129516-<b>T</b>,5 x 10-16,,0.1156,3.104,'-,[2.329-4.136],"PARP1P2, RHOJ",Endometriosis,endometriosis,GCST004873,14:63133372
rs7149767-<b>A</b>,7 x 10-6,,0.274,1.736,'-,[1.361-2.213],MARK3,Endometriosis,endometriosis,GCST004873,14:103397208
rs74781061-<b>G</b>,1 x 10-6,,0.121,2.188,'-,[1.579-3.032],ARID3B,Endometriosis,endometriosis,GCST004873,15:74595855
rs12943477-<b>T</b>,6 x 10-6,,0.6407,1.83621,'-,[1.4-2.4],COX10-AS1,Endometriosis,endometriosis,GCST004873,17:13912543
rs10799737-<b>?</b>,1 x 10-6,,'-,1.3157895,'-,[1.18-1.47],WNT4,Endometriosis,endometriosis,GCST009832,1:22135638
rs6432216-<b>?</b>,2 x 10-7,,'-,1.3888888,'-,[1.22-1.56],GREB1,Endometriosis,endometriosis,GCST009832,2:11562834
rs146467657-<b>?</b>,4 x 10-6,,'-,3.57,'-,[2.08-6.13],RPS15AP14,Endometriosis,endometriosis,GCST009832,2:175271278
rs899269-<b>?</b>,8 x 10-6,,'-,1.3333333,'-,[1.18-1.54],LINC01967,Endometriosis,endometriosis,GCST009832,3:27976587
rs2218611-<b>?</b>,6 x 10-6,,'-,1.38,'-,[1.20-1.58],"MIR513A1, MIR513B",Endometriosis,endometriosis,GCST009832,X:147212189
rs12037376-<b>?</b>,1 x 10-6,,'-,1.31,'-,(1.17-1.46),WNT4,Endometriosis,endometriosis,GCST009832,1:22135618
rs117631020-<b>?</b>,2 x 10-6,,'-,1.0752687,'-,[1.04-1.11],DIPK1A,Endometriosis (MTAG),endometriosis,GCST009831,1:92898985
rs142412260-<b>?</b>,1 x 10-6,,'-,1.1,'-,[1.06-1.14],MIR181A1HG,Endometriosis (MTAG),endometriosis,GCST009831,1:198808540
rs192897046-<b>?</b>,6 x 10-6,,'-,1.1,'-,[1.06-1.15],OBI1-AS1,Endometriosis (MTAG),endometriosis,GCST009831,13:78524671
rs142527987-<b>?</b>,7 x 10-6,,'-,1.14,'-,[1.08-1.20],SH3BP4,Endometriosis (MTAG),endometriosis,GCST009831,2:234998703
rs821492-<b>?</b>,3 x 10-6,,'-,1.098901,'-,[1.06-1.15],UBE2F-SCLY,Endometriosis (MTAG),endometriosis,GCST009831,2:238050409
rs80235011-<b>?</b>,4 x 10-6,,'-,1.08,'-,[1.05-1.12],GPATCH2L,Endometriosis (MTAG),endometriosis,GCST009831,14:76223645
rs6767661-<b>?</b>,8 x 10-6,,'-,1.0309278,'-,[1.02-1.05],"LINC02044, NEPRO",Endometriosis (MTAG),endometriosis,GCST009831,3:113073831
rs7170666-<b>?</b>,4 x 10-6,,'-,1.03,'-,[1.02-1.04],"MIR1179, MIR7-2",Endometriosis (MTAG),endometriosis,GCST009831,15:88611735
rs59618069-<b>?</b>,8 x 10-7,,'-,1.05,'-,[1.03-1.07],"CIR1P2, RN7SL808P",Endometriosis (MTAG),endometriosis,GCST009831,4:114744719
rs140574374-<b>?</b>,6 x 10-6,,'-,1.11,'-,[1.06-1.16],RBM48P1,Endometriosis (MTAG),endometriosis,GCST009831,4:126617656
rs118025155-<b>?</b>,2 x 10-6,,'-,1.11,'-,[1.07-1.16],"RN7SL50P, COP1P1",Endometriosis (MTAG),endometriosis,GCST009831,18:8431083
rs75339189-<b>?</b>,3 x 10-6,,'-,1.1,'-,[1.05-1.14],KCNG2,Endometriosis (MTAG),endometriosis,GCST009831,18:79899553
rs116832992-<b>?</b>,9 x 10-6,,'-,1.06,'-,[1.03-1.09],"PPP1R17, PDE1C",Endometriosis (MTAG),endometriosis,GCST009831,7:31745141
rs76274733-<b>?</b>,7 x 10-6,,'-,1.09,'-,[1.05-1.13],LINC01605,Endometriosis (MTAG),endometriosis,GCST009831,8:37520631
rs190312022-<b>?</b>,2 x 10-6,,'-,1.13,'-,[1.07-1.19],ITGB1-DT,Endometriosis (MTAG),endometriosis,GCST009831,10:33013148
rs59618069-<b>?</b>,6 x 10-7,,'-,1.51,'-,[1.28-1.77],"CIR1P2, RN7SL808P",Endometriosis,endometriosis,GCST009832,4:114744719
rs140574374-<b>?</b>,7 x 10-6,,'-,2.58,'-,[1.71-3.90],RBM48P1,Endometriosis,endometriosis,GCST009832,4:126617656
rs142903570-<b>?</b>,5 x 10-6,,'-,2.58,'-,[1.71-3.88],"LINC02504, MIR6082",Endometriosis,endometriosis,GCST009832,4:171283490
rs73005745-<b>?</b>,8 x 10-6,,'-,2.91,'-,[1.82-4.65],'-,Endometriosis,endometriosis,GCST009832,4:179748675
rs2145735-<b>?</b>,9 x 10-6,,'-,1.369863,'-,[1.19-1.56],TRDN,Endometriosis,endometriosis,GCST009832,6:123570856
rs12193197-<b>?</b>,9 x 10-6,,'-,1.4084507,'-,[1.22-1.64],WDR27,Endometriosis,endometriosis,GCST009832,6:169509938
rs76280028-<b>?</b>,6 x 10-6,,'-,1.92,'-,[1.45-2.55],SEPTIN7,Endometriosis,endometriosis,GCST009832,7:35906649
rs77060522-<b>?</b>,5 x 10-6,,'-,2.9,'-,[1.83-4.57],XKR4,Endometriosis,endometriosis,GCST009832,8:55224726
rs112755922-<b>?</b>,5 x 10-6,,'-,1.31,'-,[1.17-1.47],U8,Endometriosis,endometriosis,GCST009832,8:71785294
rs149472935-<b>?</b>,3 x 10-6,,'-,3.31,'-,[2.00-5.49],'-,Endometriosis,endometriosis,GCST009832,8:116466081
rs150445207-<b>?</b>,7 x 10-7,,'-,3.91,'-,[2.28-6.70],EIF3H,Endometriosis,endometriosis,GCST009832,8:116575863
rs76329314-<b>?</b>,2 x 10-6,,'-,2.38,'-,[1.66-3.41],'-,Endometriosis,endometriosis,GCST009832,8:141966149
rs140369471-<b>?</b>,1 x 10-6,,'-,2.98,'-,[1.91-4.63],ITGB1-DT,Endometriosis,endometriosis,GCST009832,10:33051630
rs145528548-<b>?</b>,5 x 10-6,,'-,2.11,'-,[1.53-2.91],"DDX6, RNU6-376P",Endometriosis,endometriosis,GCST009832,11:118724436
rs181692738-<b>?</b>,5 x 10-6,,'-,2.99,'-,[1.87-4.79],TMTC1,Endometriosis,endometriosis,GCST009832,12:29523791
rs192897046-<b>?</b>,6 x 10-6,,'-,2.5,'-,[1.68-3.71],OBI1-AS1,Endometriosis,endometriosis,GCST009832,13:78524671
rs576308820-<b>?</b>,7 x 10-6,,'-,3.41,'-,[2.00-5.81],GPC5,Endometriosis,endometriosis,GCST009832,13:91985331
rs1772557-<b>?</b>,4 x 10-6,,'-,1.34,'-,[1.18-1.52],'-,Endometriosis,endometriosis,GCST009832,13:103712876
rs80235011-<b>?</b>,4 x 10-6,,'-,2,'-,[1.49-2.69],GPATCH2L,Endometriosis,endometriosis,GCST009832,14:76223645
rs12934561-<b>?</b>,8 x 10-6,,'-,1.2987013,'-,[1.15-1.45],IL32,Endometriosis,endometriosis,GCST009832,16:3068864
rs933376-<b>?</b>,1 x 10-6,,'-,1.54,'-,[1.29-1.84],COX10-AS1,Endometriosis,endometriosis,GCST009832,17:13898274
rs118025155-<b>?</b>,1 x 10-6,,'-,2.61,'-,[1.77-3.85],"RN7SL50P, COP1P1",Endometriosis,endometriosis,GCST009832,18:8431083
rs149551327-<b>?</b>,4 x 10-6,,'-,1.9,'-,[1.44-2.49],"SLC44A2, AP1M2",Endometriosis,endometriosis,GCST009832,19:10592480
rs285682-<b>?</b>,5 x 10-6,,'-,1.35,'-,[1.19-1.53],"CHST8, KCTD15",Endometriosis,endometriosis,GCST009832,19:33784343
rs118172039-<b>?</b>,3 x 10-6,,'-,1.9,'-,[1.45-2.48],PLCB1,Endometriosis,endometriosis,GCST009832,20:8083907
rs6908034-<b>?</b>,5 x 10-7,,NR,1.22,'-,[1.12-1.32],LNC-LBCS,Endometriosis,endometriosis,GCST004368,6:19773699
rs12700667-<b>?</b>,6 x 10-7,,NR,1.17,'-,[1.09-1.25],MIR148A,Endometriosis,endometriosis,GCST004368,7:25862019
rs55938609-<b>?</b>,6 x 10-7,,NR,1.24,'-,[1.15-1.35],WNT4,Endometriosis,endometriosis,GCST004368,1:22143958
rs116175374-<b>?</b>,6 x 10-7,,NR,1.4492754,'-,[1.23-1.69],CAPN14,Endometriosis,endometriosis,GCST004368,2:31202319
rs60966186-<b>?</b>,1 x 10-6,,NR,1.1764705,'-,[1.09-1.27],"DEFA1, DEFA10P",Endometriosis,endometriosis,GCST004368,8:6973682
rs138913144-<b>?</b>,6 x 10-7,,NR,1.2987013,'-,[1.15-1.45],LAMC3,Endometriosis,endometriosis,GCST004368,9:131022553
rs144240142-<b>?</b>,6 x 10-8,,NR,1.71,'-,[1.23-2.37],MAP3K4,Ovarian disease with few adhesions,endometriosis,GCST004369,6:161081992
rs200922190-<b>?</b>,2 x 10-7,,NR,1.2048193,'-,[1.10-1.33],CDC73,Ovarian disease with few adhesions,endometriosis,GCST004369,1:193234362
rs855965-<b>?</b>,4 x 10-7,,NR,1.2345679,'-,[1.14-1.35],LINC02674,Ovarian disease with few adhesions,endometriosis,GCST004369,10:117684248
rs113850637-<b>?</b>,8 x 10-7,,NR,1.28,'-,[1.16-1.41],RAP1BP2,Ovarian disease with few adhesions,endometriosis,GCST004369,3:104131556
rs12700667-<b>?</b>,2 x 10-9,,NR,1.32,'-,[1.20-1.46],MIR148A,Deep ovarian and/or rectovaginal disease with dense adhesions,endometriosis,GCST004370,7:25862019
rs517875-<b>?</b>,1 x 10-7,,NR,1.23,'-,[1.13-1.33],NAALADL2,Deep ovarian and/or rectovaginal disease with dense adhesions,endometriosis,GCST004370,3:174633096
rs7041895-<b>?</b>,1 x 10-7,,NR,1.26,'-,[1.16-1.37],CDKN2B-AS1,Deep ovarian and/or rectovaginal disease with dense adhesions,endometriosis,GCST004370,9:22162795
rs1250258-<b>?</b>,3 x 10-8,,NR,1.2345679,'-,[1.14-1.35],FN1,Deep ovarian and/or rectovaginal disease with dense adhesions,endometriosis,GCST004370,2:215435462
rs71415016-<b>?</b>,3 x 10-7,,NR,1.38,'-,[1.20-1.59],"C14orf132, TUNAR",Deep ovarian and/or rectovaginal disease with dense adhesions,endometriosis,GCST004370,14:95977621
rs62469231-<b>?</b>,5 x 10-7,,NR,1.77,'-,[1.37-2.27],FOXP2,Deep ovarian and/or rectovaginal disease with dense adhesions,endometriosis,GCST004370,7:114391119
rs3920498-<b>?</b>,6 x 10-7,,NR,1.3,'-,[1.18-1.43],"MIR4418, WNT4",Deep ovarian and/or rectovaginal disease with dense adhesions,endometriosis,GCST004370,1:22166394
rs6908034-<b>?</b>,7 x 10-7,,NR,1.3,'-,[1.17-1.45],LNC-LBCS,Deep ovarian and/or rectovaginal disease with dense adhesions,endometriosis,GCST004370,6:19773699
rs12455952-<b>?</b>,1 x 10-6,,NR,1.27,'-,[1.15-1.40],'-,Deep ovarian and/or rectovaginal disease with dense adhesions,endometriosis,GCST004370,18:61173285
rs138913144-<b>?</b>,1 x 10-6,,NR,1.4705882,'-,[1.23-1.75],LAMC3,Deep ovarian and/or rectovaginal disease with dense adhesions,endometriosis,GCST004370,9:131022553
"rs10917151-<b>A</b>, rs4654783-<b>T</b>, rs2235529-<b>T</b>",7 x 10-9,,0.152,1.28,'-,[NR],CDC42; No mapped genes; WNT4,Endometriosis,endometriosis,GCST001894,1:22096228|1:22123994
"rs10917151-<b>G</b>, rs4654783-<b>G</b>, rs2235529-<b>C</b>",6 x 10-6,,0.709,1.19,'-,[NR],CDC42; No mapped genes; WNT4,Endometriosis,endometriosis,GCST001894,1:22096228|1:22123994
"rs10917151-<b>A</b>, rs7521902-<b>A</b>, rs4654783-<b>T</b>, rs2235529-<b>T</b>, rs16826658-<b>G</b>",8 x 10-7,,0.134,1.25,'-,[NR],CDC42; WNT4 - N/A; No mapped genes; WNT4; No mapped genes,Endometriosis,endometriosis,GCST001894,1:22096228|1:22164231|1:22123994
rs801112-<b>C</b>,5 x 10-6,,0.11,1.65,'-,[1.33-2.05],SPTA1,Endometriosis,endometriosis,GCST000797,1:228860875
rs6542095-<b>C</b>,3 x 10-6,,0.72,1.5,'-,[1.27-1.78],"CKAP2L, IL1A",Endometriosis,endometriosis,GCST000797,2:112771606
rs10965235-<b>C</b>,6 x 10-12,,0.802,1.44,'-,[1.30-1.59],CDKN2B-AS1,Endometriosis,endometriosis,GCST000721,9:22115106
rs16826658-<b>G</b>,2 x 10-6,,0.523,1.2,'-,[1.11-1.29],'-,Endometriosis,endometriosis,GCST000721,Mapping not available
rs13328298-<b>G</b>,1 x 10-11,,0.58,1.15,'-,[1.11-1.20],LINC02523,Endometrial endometrioid carcinoma,endometrial endometrioid carcinoma,GCST003525,6:125695434
rs4733613-<b>C</b>,8 x 10-9,,0.13,1.1904762,'-,[1.12-1.27],"LINC00824, CCDC26",Endometrial endometrioid carcinoma,endometrial endometrioid carcinoma,GCST003525,8:128587032
rs937213-<b>C</b>,2 x 10-7,,0.42,1.1111112,'-,[1.06-1.16],EIF2AK4,Endometrial endometrioid carcinoma,endometrial endometrioid carcinoma,GCST003525,15:40029923
rs2498796-<b>A</b>,4 x 10-8,,0.3,1.1363636,'-,[1.09-1.18],AKT1,Endometrial endometrioid carcinoma,endometrial endometrioid carcinoma,GCST003525,14:104776883
rs11263763-<b>A</b>,7 x 10-17,,0.54,1.2,'-,[1.15-1.25],HNF1B,Endometrial endometrioid carcinoma,endometrial endometrioid carcinoma,GCST003525,17:37743574
rs2414098-<b>C</b>,2 x 10-13,,0.62,1.18,'-,[1.13-1.23],"CYP19A1, MIR4713HG",Endometrial endometrioid carcinoma,endometrial endometrioid carcinoma,GCST003525,15:51245609
rs11841589-<b>G</b>,6 x 10-10,,0.74,1.16,'-,[1.10-1.21],RNY1P8,Endometrial endometrioid carcinoma,endometrial endometrioid carcinoma,GCST003525,13:73240754
rs1192691-<b>C</b>,3 x 10-8,,0.54,1.23,'-,[1.05-1.43],MKNK2P1,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002576,10:36880367
rs11175194-<b>G</b>,1 x 10-7,,0.59,1.19,'-,[1.02-1.39],SRGAP1,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002576,12:63871057
rs633862-<b>A</b>,9 x 10-7,,0.54,1.19,'-,[1.02-1.39],"Y_RNA, ABO",Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002576,9:133279871
rs1413299-<b>C</b>,2 x 10-8,,0.38,1.2,'-,[1.03-1.41],COL15A1,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002576,9:98998959
rs2500488-<b>C</b>,4 x 10-6,,0.33,1.472,'-,[1.246-1.739],"RN7SL148P, ZBTB18",Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002576,1:244077146
rs6976769-<b>C</b>,4 x 10-6,,0.05,1.458,'-,[1.056-2.012],RAD23BP2,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002576,7:83667946
rs145023077-<b>?</b>,7 x 10-8,,'-,1.06,'-,[1.04-1.09],HLA-G,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:29829266
rs142979264-<b>?</b>,6 x 10-8,,'-,1.06,'-,[1.04-1.09],RNF39,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:30075223
rs78868683-<b>?</b>,3 x 10-7,,'-,1.05,'-,[1.03-1.08],LINC00243,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:30830500
rs2530710-<b>?</b>,4 x 10-7,,'-,1.0416667,'-,[1.03-1.06],"MUC21, NAPGP2",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:30972610
rs117759870-<b>?</b>,6 x 10-8,,'-,1.06,'-,[1.04-1.09],"HCG27, HLA-C",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:31245753
rs28752857-<b>?</b>,5 x 10-8,,'-,1.06,'-,[1.04-1.08],"LINC02571, HLA-B",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:31330644
rs28399987-<b>?</b>,7 x 10-8,,'-,1.06,'-,[1.04-1.09],MSH5-SAPCD1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:31762974
rs75393409-<b>?</b>,2 x 10-7,,'-,1.06,'-,[1.04-1.09],STK19,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:31972441
rs57079996-<b>?</b>,1 x 10-7,,'-,1.06,'-,[1.04-1.09],TNXB,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:32093562
rs380911-<b>?</b>,9 x 10-6,,'-,1.04,'-,[1.02-1.06],"TSBP1-AS1, NOTCH4",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:32241674
rs36022506-<b>?</b>,2 x 10-6,,'-,1.06,'-,[1.03-1.08],"HLA-DRB1, HLA-DQA1",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:32609610
rs113721192-<b>?</b>,1 x 10-6,,'-,1.06,'-,[1.03-1.08],"HLA-DQB3, MTCO3P1",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:32714813
rs117231810-<b>?</b>,4 x 10-6,,'-,1.06,'-,[1.03-1.08],"HLA-Z, HLA-DMB",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:32920459
rs910320-<b>?</b>,8 x 10-8,,'-,1.05,'-,[1.03-1.07],"HLA-DPB2, COL11A2P1",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:33107666
rs9375182-<b>?</b>,3 x 10-6,,'-,1.0309278,'-,[1.02-1.05],"RN7SL564P, FABP7",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:122773922
rs10272208-<b>?</b>,5 x 10-7,,'-,1.0309278,'-,[1.02-1.05],ATXN7L1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,7:105691372
rs147175877-<b>?</b>,6 x 10-6,,'-,1.1,'-,[1.05-1.14],EXOC4,Cervical cancer (MTAG),cervical carcinoma,GCST009825,7:133504366
rs149996974-<b>?</b>,3 x 10-6,,'-,1.14,'-,[1.08-1.21],"EXOC4, RPS3AP27",Cervical cancer (MTAG),cervical carcinoma,GCST009825,7:133732785
rs2090064-<b>?</b>,3 x 10-7,,'-,1.0416667,'-,[1.02-1.05],"MIR124-1HG, TNKS",Cervical cancer (MTAG),cervical carcinoma,GCST009825,8:9854826
rs4077818-<b>?</b>,2 x 10-6,,'-,1.04,'-,[1.02-1.06],"SDR16C5, CHCHD7",Cervical cancer (MTAG),cervical carcinoma,GCST009825,8:56298047
rs17784899-<b>?</b>,5 x 10-7,,'-,1.05,'-,[1.03-1.07],"PRUNE2, PCA3",Cervical cancer (MTAG),cervical carcinoma,GCST009825,9:76775287
rs140330106-<b>?</b>,8 x 10-6,,'-,1.1,'-,[1.06-1.15],PTBP3,Cervical cancer (MTAG),cervical carcinoma,GCST009825,9:112272205
rs147380957-<b>?</b>,7 x 10-6,,'-,1.07,'-,[1.04-1.10],TRDMT1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,10:17199011
rs150806792-<b>?</b>,8 x 10-8,,'-,1.19,'-,[1.12-1.26],INS-IGF2,Cervical cancer (MTAG),cervical carcinoma,GCST009825,11:2158112
rs377042484-<b>?</b>,3 x 10-6,,'-,1.12,'-,[1.07-1.17],TMTC1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,12:29599423
rs75874947-<b>?</b>,1 x 10-7,,'-,2.84,'-,[1.93-4.19],"NPBWR2, MYT1",Cervical cancer,cervical carcinoma,GCST009826,20:64106159
rs140668832-<b>?</b>,2 x 10-9,,'-,1.07,'-,[1.05-1.09],"LINC02569, HLA-E",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:30512137
rs117670375-<b>?</b>,2 x 10-9,,'-,1.07,'-,[1.05-1.09],TUBB,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:30719695
rs150806792-<b>?</b>,8 x 10-8,,'-,1.19,'-,[1.12-1.26],INS-IGF2,Cervical cancer (MTAG),cervical carcinoma,GCST009825,11:2158112
rs140991990-<b>?</b>,7 x 10-8,,'-,1.16,'-,[1.10-1.23],"SOX9-AS1, LINC02097",Cervical cancer (MTAG),cervical carcinoma,GCST009825,17:72101710
rs1885560-<b>?</b>,6 x 10-6,,'-,1.0526316,'-,[1.03-1.09],FCRL4,Cervical cancer (MTAG),cervical carcinoma,GCST009825,1:157596180
rs75068199-<b>?</b>,4 x 10-7,,'-,1.07,'-,[1.04-1.10],DDR2,Cervical cancer (MTAG),cervical carcinoma,GCST009825,1:162660256
rs76883373-<b>?</b>,5 x 10-6,,'-,1.07,'-,[1.04-1.10],"LINC01249, NPM1P48",Cervical cancer (MTAG),cervical carcinoma,GCST009825,2:4581682
rs62133116-<b>?</b>,2 x 10-6,,'-,1.05,'-,[1.03-1.07],NRXN1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,2:50256810
rs11684858-<b>?</b>,4 x 10-6,,'-,1.06,'-,[1.03-1.09],ALMS1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,2:73416499
rs190074712-<b>?</b>,2 x 10-6,,'-,1.17,'-,[1.10-1.25],"CYP2C56P, PRPS1P1",Cervical cancer (MTAG),cervical carcinoma,GCST009825,2:164262092
rs183319101-<b>?</b>,6 x 10-6,,'-,1.0309278,'-,[1.02-1.05],FSIP2,Cervical cancer (MTAG),cervical carcinoma,GCST009825,2:185844965
rs559021322-<b>?</b>,4 x 10-6,,'-,1.13,'-,[1.07-1.19],MIR5702,Cervical cancer (MTAG),cervical carcinoma,GCST009825,2:226586765
rs59692692-<b>?</b>,6 x 10-6,,'-,1.06,'-,[1.03-1.09],"HDAC11, FBLN2",Cervical cancer (MTAG),cervical carcinoma,GCST009825,3:13530464
chr3:59866982-<b>?</b>,3 x 10-6,,'-,1.16,'-,[1.09-1.24],'-,Cervical cancer (MTAG),cervical carcinoma,GCST009825,Mapping not available
rs117143670-<b>?</b>,7 x 10-6,,'-,1.13,'-,[1.07-1.20],"CLDN1, NMNAT1P3",Cervical cancer (MTAG),cervical carcinoma,GCST009825,3:190245452
rs556607390-<b>?</b>,3 x 10-6,,'-,1.1,'-,[1.05-1.14],ZFYVE28,Cervical cancer (MTAG),cervical carcinoma,GCST009825,4:2279800
rs146513397-<b>?</b>,1 x 10-6,,'-,1.16,'-,[1.09-1.23],CAMK2D,Cervical cancer (MTAG),cervical carcinoma,GCST009825,4:113726137
rs185348880-<b>?</b>,6 x 10-6,,'-,1.13,'-,[1.07-1.19],TTC29,Cervical cancer (MTAG),cervical carcinoma,GCST009825,4:146884350
rs74994185-<b>?</b>,6 x 10-6,,'-,1.06,'-,[1.04-1.09],ZSCAN16-AS1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:28031037
rs79476506-<b>?</b>,7 x 10-6,,'-,1.06,'-,[1.03-1.09],ZSCAN16-AS1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:28137256
rs213237-<b>?</b>,2 x 10-6,,'-,1.03,'-,[1.02-1.05],"ZKSCAN3, ZSCAN31",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:28356161
rs146362527-<b>?</b>,7 x 10-6,,'-,1.06,'-,[1.03-1.09],"OR2E1P, GPX6",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:28499293
rs138803712-<b>?</b>,8 x 10-6,,'-,1.06,'-,[1.03-1.09],"ZBED9, LINC00533",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:28639807
rs3129795-<b>?</b>,8 x 10-6,,'-,1.0526316,'-,[1.03-1.08],"ZNF311, OR2AD1P",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:29016978
rs147175877-<b>?</b>,3 x 10-6,,'-,2.66,'-,[1.77-4.02],EXOC4,Cervical cancer,cervical carcinoma,GCST009826,7:133504366
rs149996974-<b>?</b>,1 x 10-6,,'-,3.79,'-,[2.21-6.51],"EXOC4, RPS3AP27",Cervical cancer,cervical carcinoma,GCST009826,7:133732785
rs141588684-<b>?</b>,5 x 10-6,,'-,3.6,'-,[2.07-6.23],EXOC4,Cervical cancer,cervical carcinoma,GCST009826,7:133922241
rs2090064-<b>?</b>,5 x 10-7,,'-,1.4492754,'-,[1.25-1.67],"MIR124-1HG, TNKS",Cervical cancer,cervical carcinoma,GCST009826,8:9854826
rs75951998-<b>?</b>,1 x 10-6,,'-,1.86,'-,[1.45-2.38],"SDR16C5, CHCHD7",Cervical cancer,cervical carcinoma,GCST009826,8:56246637
rs58726170-<b>?</b>,7 x 10-6,,'-,2.01,'-,[1.48-2.72],"TOX, GML",Cervical cancer,cervical carcinoma,GCST009826,8:59197008
chr9:22422311-<b>?</b>,5 x 10-6,,'-,4.82,'-,[2.46-9.45],'-,Cervical cancer,cervical carcinoma,GCST009826,Mapping not available
rs17784899-<b>?</b>,6 x 10-7,,'-,1.5,'-,[1.28-1.76],"PRUNE2, PCA3",Cervical cancer,cervical carcinoma,GCST009826,9:76775287
rs147380957-<b>?</b>,4 x 10-6,,'-,1.86,'-,[1.43-2.42],TRDMT1,Cervical cancer,cervical carcinoma,GCST009826,10:17199011
rs150806792-<b>?</b>,5 x 10-8,,'-,4.96,'-,[2.79-8.83],INS-IGF2,Cervical cancer,cervical carcinoma,GCST009826,11:2158112
rs184467454-<b>?</b>,9 x 10-6,,'-,2.47,'-,[1.66-3.67],OR5B1P,Cervical cancer,cervical carcinoma,GCST009826,11:58366737
rs377042484-<b>?</b>,4 x 10-6,,'-,2.65,'-,[1.75-4.01],TMTC1,Cervical cancer,cervical carcinoma,GCST009826,12:29599423
rs142761815-<b>?</b>,2 x 10-6,,'-,2.73,'-,[1.81-4.12],TMEM233,Cervical cancer,cervical carcinoma,GCST009826,12:119604245
rs146343995-<b>?</b>,2 x 10-7,,'-,4.31,'-,[2.49-7.46],LINC00540,Cervical cancer,cervical carcinoma,GCST009826,13:22100187
rs141629209-<b>?</b>,9 x 10-8,,'-,4.67,'-,[2.65-8.22],"RPL35P9, LINC00460",Cervical cancer,cervical carcinoma,GCST009826,13:106422664
rs145233920-<b>?</b>,1 x 10-6,,'-,2.12,'-,[1.57-2.87],TTC5,Cervical cancer,cervical carcinoma,GCST009826,14:20259308
rs149049108-<b>?</b>,4 x 10-6,,'-,2.22,'-,[1.58-3.11],TEP1,Cervical cancer,cervical carcinoma,GCST009826,14:20368118
rs138523818-<b>?</b>,3 x 10-7,,'-,3.57,'-,[2.19-5.83],LRFN5,Cervical cancer,cervical carcinoma,GCST009826,14:41755191
rs41286572-<b>?</b>,4 x 10-6,,'-,2.19,'-,[1.57-3.06],"MIR496, MIR154",Cervical cancer,cervical carcinoma,GCST009826,14:101059844
rs72764914-<b>?</b>,2 x 10-7,,'-,1.87,'-,[1.47-2.37],RBFOX1,Cervical cancer,cervical carcinoma,GCST009826,16:6687493
rs140991990-<b>?</b>,3 x 10-8,,'-,4.94,'-,[2.80-8.71],"SOX9-AS1, LINC02097",Cervical cancer,cervical carcinoma,GCST009826,17:72101710
rs56182403-<b>?</b>,8 x 10-7,,'-,2.72,'-,[1.83-4.04],"RN7SL836P, GIPR",Cervical cancer,cervical carcinoma,GCST009826,19:45666590
rs75724373-<b>?</b>,5 x 10-6,,'-,1.45,'-,[1.24-1.70],"HAS1, FPR1",Cervical cancer,cervical carcinoma,GCST009826,19:51734303
rs201524967-<b>?</b>,2 x 10-6,,'-,3.71,'-,[2.17-6.36],RASSF2,Cervical cancer,cervical carcinoma,GCST009826,20:4817030
rs6513380-<b>?</b>,7 x 10-6,,'-,2.98,'-,[1.85-4.79],"VAPB, RAB22A",Cervical cancer,cervical carcinoma,GCST009826,20:58375898
rs142761815-<b>?</b>,4 x 10-6,,'-,1.1,'-,[1.06-1.14],TMEM233,Cervical cancer (MTAG),cervical carcinoma,GCST009825,12:119604245
rs146343995-<b>?</b>,5 x 10-7,,'-,1.16,'-,[1.09-1.23],LINC00540,Cervical cancer (MTAG),cervical carcinoma,GCST009825,13:22100187
rs141629209-<b>?</b>,4 x 10-7,,'-,1.17,'-,[1.10-1.25],"RPL35P9, LINC00460",Cervical cancer (MTAG),cervical carcinoma,GCST009825,13:106422664
rs145233920-<b>?</b>,2 x 10-6,,'-,1.08,'-,[1.05-1.11],TTC5,Cervical cancer (MTAG),cervical carcinoma,GCST009825,14:20259308
rs149049108-<b>?</b>,4 x 10-6,,'-,1.09,'-,[1.05-1.13],TEP1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,14:20368118
rs138523818-<b>?</b>,2 x 10-6,,'-,1.14,'-,[1.08-1.20],LRFN5,Cervical cancer (MTAG),cervical carcinoma,GCST009825,14:41755191
rs41286572-<b>?</b>,4 x 10-6,,'-,1.09,'-,[1.05-1.13],"MIR496, MIR154",Cervical cancer (MTAG),cervical carcinoma,GCST009825,14:101059844
rs72764914-<b>?</b>,3 x 10-7,,'-,1.07,'-,[1.04-1.10],RBFOX1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,16:6687493
rs140991990-<b>?</b>,7 x 10-8,,'-,1.16,'-,[1.10-1.23],"SOX9-AS1, LINC02097",Cervical cancer (MTAG),cervical carcinoma,GCST009825,17:72101710
rs56182403-<b>?</b>,9 x 10-7,,'-,1.11,'-,[1.06-1.15],"RN7SL836P, GIPR",Cervical cancer (MTAG),cervical carcinoma,GCST009825,19:45666590
rs75724373-<b>?</b>,8 x 10-6,,'-,1.04,'-,[1.02-1.06],"HAS1, FPR1",Cervical cancer (MTAG),cervical carcinoma,GCST009825,19:51734303
rs201524967-<b>?</b>,3 x 10-6,,'-,1.14,'-,[1.08-1.20],RASSF2,Cervical cancer (MTAG),cervical carcinoma,GCST009825,20:4817030
rs75874947-<b>?</b>,2 x 10-7,,'-,1.12,'-,[1.07-1.17],"NPBWR2, MYT1",Cervical cancer (MTAG),cervical carcinoma,GCST009825,20:64106159
rs144335201-<b>?</b>,3 x 10-6,,'-,1.78,'-,[1.40-2.27],"H3C10, H2AC14",Cervical cancer,cervical carcinoma,GCST009826,6:27811880
rs79476506-<b>?</b>,1 x 10-6,,'-,1.79,'-,[1.41-2.26],ZSCAN16-AS1,Cervical cancer,cervical carcinoma,GCST009826,6:28137256
rs213237-<b>?</b>,7 x 10-7,,'-,1.36,'-,[1.21-1.54],"ZKSCAN3, ZSCAN31",Cervical cancer,cervical carcinoma,GCST009826,6:28356161
rs77011267-<b>?</b>,1 x 10-6,,'-,1.79,'-,[1.41-2.26],"OR2E1P, GPX6",Cervical cancer,cervical carcinoma,GCST009826,6:28467717
rs138803712-<b>?</b>,2 x 10-6,,'-,1.82,'-,[1.43-2.33],"ZBED9, LINC00533",Cervical cancer,cervical carcinoma,GCST009826,6:28639807
rs141456208-<b>?</b>,4 x 10-6,,'-,1.75,'-,[1.38-2.23],"NOP56P1, LINC01623",Cervical cancer,cervical carcinoma,GCST009826,6:28800350
rs3129795-<b>?</b>,2 x 10-6,,'-,1.6129031,'-,[1.32-1.96],"ZNF311, OR2AD1P",Cervical cancer,cervical carcinoma,GCST009826,6:29016978
rs149016863-<b>?</b>,3 x 10-6,,'-,1.74,'-,[1.38-2.20],"OR2G1P, OR2U1P",Cervical cancer,cervical carcinoma,GCST009826,6:29256134
rs9257927-<b>?</b>,1 x 10-8,,'-,1.66,'-,[1.39-1.97],"MOG, SUMO2P1",Cervical cancer,cervical carcinoma,GCST009826,6:29641918
rs145023077-<b>?</b>,8 x 10-9,,'-,1.83,'-,[1.49-2.25],HLA-G,Cervical cancer,cervical carcinoma,GCST009826,6:29829266
rs142979264-<b>?</b>,7 x 10-9,,'-,1.84,'-,[1.50-2.26],RNF39,Cervical cancer,cervical carcinoma,GCST009826,6:30075223
rs78868683-<b>?</b>,1 x 10-7,,'-,1.68,'-,[1.39-2.04],LINC00243,Cervical cancer,cervical carcinoma,GCST009826,6:30830500
rs2530710-<b>?</b>,1 x 10-7,,'-,1.5151515,'-,[1.3-1.75],"MUC21, NAPGP2",Cervical cancer,cervical carcinoma,GCST009826,6:30972610
rs28380833-<b>?</b>,8 x 10-9,,'-,1.8,'-,[1.47-2.20],"LINC02571, HLA-B",Cervical cancer,cervical carcinoma,GCST009826,6:31343518
rs138885312-<b>?</b>,2 x 10-8,,'-,1.8,'-,[1.47-2.20],"LTA, NFKBIL1",Cervical cancer,cervical carcinoma,GCST009826,6:31562896
rs143029752-<b>?</b>,3 x 10-8,,'-,1.78,'-,[1.45-2.19],VWA7,Cervical cancer,cervical carcinoma,GCST009826,6:31771721
rs75393409-<b>?</b>,4 x 10-8,,'-,1.78,'-,[1.45-2.18],STK19,Cervical cancer,cervical carcinoma,GCST009826,6:31972441
rs57079996-<b>?</b>,4 x 10-8,,'-,1.77,'-,[1.45-2.18],TNXB,Cervical cancer,cervical carcinoma,GCST009826,6:32093562
rs380911-<b>?</b>,3 x 10-6,,'-,1.51,'-,[1.27-1.80],"TSBP1-AS1, NOTCH4",Cervical cancer,cervical carcinoma,GCST009826,6:32241674
rs367607265-<b>?</b>,2 x 10-7,,'-,1.74,'-,[1.41-2.14],"HLA-DRB9, HLA-DRB5",Cervical cancer,cervical carcinoma,GCST009826,6:32482186
rs113721192-<b>?</b>,3 x 10-7,,'-,1.76,'-,[1.42-2.18],"HLA-DQB3, MTCO3P1",Cervical cancer,cervical carcinoma,GCST009826,6:32714813
rs117231810-<b>?</b>,1 x 10-6,,'-,1.69,'-,[1.37-2.09],"HLA-Z, HLA-DMB",Cervical cancer,cervical carcinoma,GCST009826,6:32920459
rs872956-<b>?</b>,8 x 10-8,,'-,1.58,'-,[1.34-1.86],"HLA-DPB2, COL11A2P1",Cervical cancer,cervical carcinoma,GCST009826,6:33108313
rs9375182-<b>?</b>,3 x 10-6,,'-,1.3513513,'-,[1.19-1.54],"RN7SL564P, FABP7",Cervical cancer,cervical carcinoma,GCST009826,6:122773922
rs10272208-<b>?</b>,2 x 10-6,,'-,1.3333333,'-,[1.19-1.52],ATXN7L1,Cervical cancer,cervical carcinoma,GCST009826,7:105691372
rs140668832-<b>?</b>,3 x 10-10,,'-,1.92,'-,[1.57-2.35],"LINC02569, HLA-E",Cervical cancer,cervical carcinoma,GCST009826,6:30512137
rs117670375-<b>?</b>,3 x 10-10,,'-,1.92,'-,[1.57-2.35],TUBB,Cervical cancer,cervical carcinoma,GCST009826,6:30719695
rs150806792-<b>?</b>,5 x 10-8,,'-,4.96,'-,[2.79-8.83],INS-IGF2,Cervical cancer,cervical carcinoma,GCST009826,11:2158112
rs140991990-<b>?</b>,3 x 10-8,,'-,4.94,'-,[2.80-8.71],"SOX9-AS1, LINC02097",Cervical cancer,cervical carcinoma,GCST009826,17:72101710
rs57561731-<b>?</b>,9 x 10-6,,'-,1.7,'-,[1.34-2.14],UHMK1,Cervical cancer,cervical carcinoma,GCST009826,1:162498796
rs75068199-<b>?</b>,4 x 10-7,,'-,1.82,'-,[1.44-2.30],DDR2,Cervical cancer,cervical carcinoma,GCST009826,1:162660256
rs76883373-<b>?</b>,8 x 10-6,,'-,1.97,'-,[1.46-2.65],"LINC01249, NPM1P48",Cervical cancer,cervical carcinoma,GCST009826,2:4581682
rs62133116-<b>?</b>,2 x 10-6,,'-,1.48,'-,[1.26-1.74],NRXN1,Cervical cancer,cervical carcinoma,GCST009826,2:50256810
rs11684858-<b>?</b>,7 x 10-6,,'-,1.79,'-,[1.39-2.30],ALMS1,Cervical cancer,cervical carcinoma,GCST009826,2:73416499
rs2679850-<b>?</b>,4 x 10-6,,'-,2.2222223,'-,[1.59-3.12],"GPR45, LINC01918",Cervical cancer,cervical carcinoma,GCST009826,2:105183335
rs190074712-<b>?</b>,3 x 10-7,,'-,4.68,'-,[2.60-8.43],"CYP2C56P, PRPS1P1",Cervical cancer,cervical carcinoma,GCST009826,2:164262092
rs183319101-<b>?</b>,8 x 10-6,,'-,1.3333333,'-,[1.18-1.52],FSIP2,Cervical cancer,cervical carcinoma,GCST009826,2:185844965
rs559021322-<b>?</b>,2 x 10-6,,'-,3.63,'-,[2.14-6.17],MIR5702,Cervical cancer,cervical carcinoma,GCST009826,2:226586765
chr3:59760625-<b>?</b>,3 x 10-6,,'-,4.15,'-,[2.28-7.58],'-,Cervical cancer,cervical carcinoma,GCST009826,Mapping not available
chr3:59866982-<b>?</b>,5 x 10-7,,'-,4.98,'-,[2.67-9.30],'-,Cervical cancer,cervical carcinoma,GCST009826,Mapping not available
rs76537691-<b>?</b>,8 x 10-6,,'-,2.81,'-,[1.78-4.43],GBE1,Cervical cancer,cervical carcinoma,GCST009826,3:81782913
rs117143670-<b>?</b>,5 x 10-6,,'-,3.45,'-,[2.03-5.86],"CLDN1, NMNAT1P3",Cervical cancer,cervical carcinoma,GCST009826,3:190245452
rs556607390-<b>?</b>,6 x 10-6,,'-,2.25,'-,[1.58-3.21],ZFYVE28,Cervical cancer,cervical carcinoma,GCST009826,4:2279800
rs146513397-<b>?</b>,7 x 10-7,,'-,3.95,'-,[2.30-6.79],CAMK2D,Cervical cancer,cervical carcinoma,GCST009826,4:113726137
rs185348880-<b>?</b>,8 x 10-7,,'-,3.42,'-,[2.10-5.57],TTC29,Cervical cancer,cervical carcinoma,GCST009826,4:146884350
rs77050118-<b>?</b>,3 x 10-6,,'-,1.79,'-,[1.40-2.28],"RPL8P1, LINC01012",Cervical cancer,cervical carcinoma,GCST009826,6:27685380
rs73730372-<b>?</b>,3 x 10-19,,'-,1.67,'-,[1.49-1.85],"HLA-DRB1, HLA-DQA1",Cervical cancer,cervical carcinoma,GCST003565,6:32616804
rs4782151-<b>C</b>,5 x 10-6,,0.4677,1.91,'-,[1.44-2.52],RPL21P119,Cervical cancer,cervical carcinoma,GCST002405,16:9232128
rs11985951-<b>T</b>,6 x 10-6,,0.871,3.36,'-,[1.94-5.83],'-,Cervical cancer,cervical carcinoma,GCST002405,8:20734998
rs6558578-<b>G</b>,7 x 10-6,,0.7608,2.31,'-,[1.59-3.34],"MYOM2, KBTBD11",Cervical cancer,cervical carcinoma,GCST002405,8:2021565
rs3899697-<b>A</b>,9 x 10-6,,0.2787,1.949,'-,[1.449-2.621],ZNF804B,Cervical cancer,cervical carcinoma,GCST002405,7:88970471
rs997363-<b>C</b>,1 x 10-6,,0.4032,1.986,'-,[1.50-2.62],C2orf83,Cervical cancer,cervical carcinoma,GCST002405,2:227644742
rs7780883-<b>A</b>,2 x 10-6,,0.05376,3.28,'-,[1.956-5.50],"GCNT1P5, GSAP",Cervical cancer,cervical carcinoma,GCST002405,7:77433395
rs6726538-<b>A</b>,3 x 10-6,,0.3871,1.946,'-,[1.471-2.573],"THORLNC, INSIG2",Cervical cancer,cervical carcinoma,GCST002405,2:118131653
rs8088832-<b>C</b>,4 x 10-6,,0.508,1.94,'-,[1.46-2.57],'-,Cervical cancer,cervical carcinoma,GCST002405,18:72259522
rs12068654-<b>T</b>,5 x 10-6,,0.885,3.23,'-,[2.06-6.93],"SLAMF7, LY9",Cervical cancer,cervical carcinoma,GCST002405,1:160773959
DRB1*1301-DQA1*0103-DQB1*0603-<b>?</b>,9 x 10-10,,NR,2.13,'-,[1.67-2.70],'-,Cervical cancer,cervical carcinoma,GCST001900,Mapping not available
DRB1*1501-DQB1*0602-<b>?</b>,4 x 10-7,,0.15,1.39,'-,[1.23-1.58],'-,Cervical cancer,cervical carcinoma,GCST001900,Mapping not available
rs2516448-<b>?</b>,4 x 10-18,,NR,1.42,'-,[1.31-1.54],"LINC01149, MICA",Cervical cancer,cervical carcinoma,GCST001900,6:31422633
rs9272143-<b>?</b>,3 x 10-22,,NR,1.49,'-,[1.37-1.61],HLA-DQA1,Cervical cancer,cervical carcinoma,GCST001900,6:32633026
rs3117027-<b>?</b>,1 x 10-7,,NR,1.25,'-,[1.15-1.36],HLA-DPB2,Cervical cancer,cervical carcinoma,GCST001900,6:33121846
HLA-B*0702-<b>?</b>,8 x 10-8,,0.14,1.42,'-,[1.25-1.61],'-,Cervical cancer,cervical carcinoma,GCST001900,Mapping not available
rs13429458-<b>A</b>,2 x 10-23,,0.91,1.49,'-,[1.39-1.61],THADA,Polycystic ovary syndrome,polycystic ovary syndrome,GCST000914,2:43411699
rs10818854-<b>A</b>,9 x 10-18,,0.09,1.51,'-,[1.37-1.65],DENND1A,Polycystic ovary syndrome,polycystic ovary syndrome,GCST000914,9:123684499
rs2479106-<b>G</b>,8 x 10-19,,0.22,1.34,'-,[1.26-1.43],DENND1A,Polycystic ovary syndrome,polycystic ovary syndrome,GCST000914,9:123762933
rs13405728-<b>A</b>,8 x 10-21,,0.76,1.41,'-,[1.30-1.49],"STON1-GTF2A1L, LHCGR",Polycystic ovary syndrome,polycystic ovary syndrome,GCST000914,2:48751020
rs12478601-<b>C</b>,3 x 10-23,,0.71,1.39,'-,[1.30-1.49],THADA,Polycystic ovary syndrome,polycystic ovary syndrome,GCST000914,2:43494369
rs673604-<b>?</b>,6 x 10-6,,NR,1.21,'-,[1.12-1.32],"Y_RNA, ZMYM4",Endometrial cancer,endometrial neoplasm,GCST001040,1:35222214
rs4430796-<b>A</b>,7 x 10-10,,0.52,1.19,'-,[1.12-1.27],HNF1B,Endometrial cancer,endometrial neoplasm,GCST001040,17:37738049
rs11679180-<b>?</b>,3 x 10-6,"(European, All type I)",NR,'-,'-,'-,LINC01807,Endometrial cancer,endometrial neoplasm,GCST002218,2:228777706
rs12778749-<b>?</b>,9 x 10-6,"(European, All type I)",NR,'-,'-,'-,ADAM12,Endometrial cancer,endometrial neoplasm,GCST002218,10:126158100
rs2891316-<b>?</b>,9 x 10-6,"(European, All type I)",NR,'-,'-,'-,LINGO2,Endometrial cancer,endometrial neoplasm,GCST002218,9:28587996
rs1777220-<b>?</b>,2 x 10-6,"(European, All type I)",NR,'-,'-,'-,LINC02523,Endometrial cancer,endometrial neoplasm,GCST002218,6:125701456
rs4407-<b>?</b>,3 x 10-6,"(European, Endometroid subtype)",NR,'-,'-,'-,MIR3201,Endometrial cancer,endometrial neoplasm,GCST002218,22:48345986
rs12778749-<b>?</b>,8 x 10-6,"(European, Endometroid subtype)",NR,'-,'-,'-,ADAM12,Endometrial cancer,endometrial neoplasm,GCST002218,10:126158100
rs9459805-<b>?</b>,8 x 10-6,"(European, Endometroid subtype)",NR,'-,'-,'-,RNASET2,Endometrial cancer,endometrial neoplasm,GCST002218,6:166922663
rs3773582-<b>?</b>,8 x 10-6,"(European, Endometroid subtype)",NR,'-,'-,'-,CACNA2D3,Endometrial cancer,endometrial neoplasm,GCST002218,3:54983722
rs4407-<b>?</b>,2 x 10-6,(Endometroid subtype),NR,'-,'-,'-,MIR3201,Endometrial cancer,endometrial neoplasm,GCST002218,22:48345986
rs37792-<b>A</b>,6 x 10-8,,0.658,1.5384616,'-,[1.32-1.82],'-,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST009007,5:53348817
rs57403204-<b>G</b>,2 x 10-7,,0.064,2.62,'-,[1.83-3.76],MAGEC1,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST009007,X:141990766
rs79079890-<b>G</b>,3 x 10-7,,0.032,3.2,'-,[2.05-4.99],'-,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST009007,10:3641956
rs66459581-<b>A</b>,5 x 10-7,,0.234,1.63,'-,[1.35-1.97],PRPSAP1,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST009007,17:76359184
rs116046250-<b>G</b>,9 x 10-7,,0.046,2.95,'-,[1.92-4.54],GABRG3,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST009007,15:26986803
rs192876988-<b>C</b>,9 x 10-7,,0.046,3.01,'-,[1.94-4.68],"GK2, NAA11",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST009007,4:79376097
rs79219469-<b>?</b>,3 x 10-8,,'-,2.25,'-,[1.12-1.26],LINC02183,Ovarian cancer,ovarian carcinoma,GCST009830,16:54553941
rs567534295-<b>?</b>,3 x 10-8,,'-,4.75,'-,[2.73-8.24],BRCA1,Ovarian cancer,ovarian carcinoma,GCST009830,17:43048090
rs143623984-<b>?</b>,9 x 10-6,,'-,3.25,'-,[1.93-5.48],"PPIAP7, LINC01307",Ovarian cancer,ovarian carcinoma,GCST009830,1:101301117
rs12031579-<b>?</b>,1 x 10-6,,'-,1.73,'-,[1.39-2.16],"WARS2-AS1, LINC01780",Ovarian cancer,ovarian carcinoma,GCST009830,1:119307920
rs484686-<b>?</b>,8 x 10-6,,'-,1.3,'-,[1.16-1.46],DNM3,Ovarian cancer,ovarian carcinoma,GCST009830,1:172183062
rs537364753-<b>?</b>,6 x 10-6,,'-,3.06,'-,[1.89-4.96],MIR548AE1,Ovarian cancer,ovarian carcinoma,GCST009830,2:184453308
rs75693602-<b>?</b>,7 x 10-6,,'-,1.89,'-,[1.43-2.49],"NRP2, PARD3B",Ovarian cancer,ovarian carcinoma,GCST009830,2:205631096
rs13402729-<b>?</b>,1 x 10-6,,'-,1.74,'-,[1.39-2.18],'-,Ovarian cancer,ovarian carcinoma,GCST009830,2:226482173
rs7563767-<b>?</b>,2 x 10-6,,'-,1.34,'-,[1.19-1.51],LINC01237,Ovarian cancer,ovarian carcinoma,GCST009830,2:242012658
rs146572601-<b>?</b>,5 x 10-6,,'-,2.64,'-,[1.74-4.02],SAMMSON,Ovarian cancer,ovarian carcinoma,GCST009830,3:70110053
rs191223340-<b>?</b>,3 x 10-6,,'-,2.74,'-,[1.80-4.18],"MDFIC2, SAMMSON",Ovarian cancer,ovarian carcinoma,GCST009830,3:70224942
rs150007914-<b>?</b>,7 x 10-6,,'-,2.23,'-,[1.57-3.16],TNIK,Ovarian cancer,ovarian carcinoma,GCST009830,3:171410134
rs7671115-<b>?</b>,6 x 10-6,,'-,1.2987013,'-,[1.16-1.45],MARCHF1,Ovarian cancer,ovarian carcinoma,GCST009830,4:164203350
rs57490377-<b>?</b>,9 x 10-6,,'-,2.3,'-,[1.59-3.32],SORBS2,Ovarian cancer,ovarian carcinoma,GCST009830,4:185621753
rs1366161-<b>?</b>,6 x 10-6,,'-,1.2987013,'-,[1.16-1.45],ADAMTS16,Ovarian cancer,ovarian carcinoma,GCST009830,5:5174755
rs148570926-<b>?</b>,3 x 10-6,,'-,2.9,'-,[1.86-4.52],"CXXC5, RNU6-236P",Ovarian cancer,ovarian carcinoma,GCST009830,5:139690696
rs151055883-<b>?</b>,6 x 10-7,,'-,1.99,'-,[1.52-2.60],HMHB1,Ovarian cancer,ovarian carcinoma,GCST009830,5:143894315
rs77663385-<b>?</b>,8 x 10-6,,'-,3.17,'-,[1.91-5.26],"SPATS1, AARS2",Ovarian cancer,ovarian carcinoma,GCST009830,6:44327218
rs7740903-<b>?</b>,4 x 10-7,,'-,2.19,'-,[1.62-2.97],ADGB,Ovarian cancer,ovarian carcinoma,GCST009830,6:146677054
rs76926936-<b>?</b>,8 x 10-6,,'-,1.84,'-,[1.41-2.41],RNU6-274P,Ovarian cancer,ovarian carcinoma,GCST009830,7:89698682
rs148037216-<b>?</b>,2 x 10-6,,'-,3.09,'-,[1.95-4.91],"EFCAB1, LINC02847",Ovarian cancer,ovarian carcinoma,GCST009830,8:48645458
rs147476757-<b>?</b>,8 x 10-6,,'-,2.6,'-,[1.71-3.96],PBX3,Ovarian cancer,ovarian carcinoma,GCST009830,9:126011262
rs77336990-<b>?</b>,2 x 10-6,,'-,2.77,'-,[1.82-4.20],FRMPD2,Ovarian cancer,ovarian carcinoma,GCST009830,10:48270719
rs78375425-<b>?</b>,3 x 10-6,,'-,1.62,'-,[1.33-1.99],LHFPL6,Ovarian cancer,ovarian carcinoma,GCST009830,13:39329007
rs141118132-<b>?</b>,8 x 10-6,,'-,3.12,'-,[1.89-5.14],"MRPS31P4, LINC00345",Ovarian cancer,ovarian carcinoma,GCST009830,13:52517465
chr14:37233727-<b>?</b>,9 x 10-6,,'-,3.06,'-,[1.87-5.02],'-,Ovarian cancer,ovarian carcinoma,GCST009830,Mapping not available
rs201368489-<b>?</b>,4 x 10-6,,'-,2.8,'-,[1.81-4.34],MTHFD1,Ovarian cancer,ovarian carcinoma,GCST009830,14:64414689
rs141803457-<b>?</b>,1 x 10-6,,'-,3.04,'-,[1.94-4.77],SMPD3,Ovarian cancer,ovarian carcinoma,GCST009830,16:68366522
rs137866923-<b>?</b>,3 x 10-7,,'-,3.82,'-,[2.29-6.36],"ZFP90, RPL35AP33",Ovarian cancer,ovarian carcinoma,GCST009830,16:68497433
rs572011593-<b>?</b>,4 x 10-6,,'-,2.89,'-,[1.84-4.55],"CPDP1, LGALS9DP",Ovarian cancer,ovarian carcinoma,GCST009830,17:27694464
rs139505845-<b>?</b>,1 x 10-6,,'-,4.52,'-,[2.47-8.30],MSI2,Ovarian cancer,ovarian carcinoma,GCST009830,17:57289728
rs146540010-<b>?</b>,9 x 10-6,,'-,2.84,'-,[1.79-4.50],ABCA10,Ovarian cancer,ovarian carcinoma,GCST009830,17:69216249
rs138807553-<b>?</b>,2 x 10-6,,'-,3.57,'-,[2.12-6.01],ASXL3,Ovarian cancer,ovarian carcinoma,GCST009830,18:33625004
rs192503876-<b>?</b>,8 x 10-6,,'-,3.31,'-,[1.96-5.61],'-,Ovarian cancer,ovarian carcinoma,GCST009830,18:65045831
rs80314337-<b>?</b>,5 x 10-6,,'-,2.89,'-,[1.83-4.56],'-,Ovarian cancer,ovarian carcinoma,GCST009830,18:65221472
rs11873753-<b>?</b>,1 x 10-6,,'-,1.85,'-,[1.44-2.38],'-,Ovarian cancer,ovarian carcinoma,GCST009830,18:75985500
rs137657-<b>?</b>,8 x 10-6,,'-,1.72,'-,[1.35-2.17],"RPL3, SYNGR1",Ovarian cancer,ovarian carcinoma,GCST009830,22:39337237
rs79219469-<b>?</b>,2 x 10-7,,'-,1.1,'-,[1.06-1.14],LINC02183,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,16:54553941
rs567534295-<b>?</b>,5 x 10-8,,'-,1.19,'-,[1.12-1.26],BRCA1,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,17:43048090
rs12031579-<b>?</b>,2 x 10-6,,'-,1.07,'-,[1.04-1.10],"WARS2-AS1, LINC01780",Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,1:119307920
rs13402729-<b>?</b>,3 x 10-6,,'-,1.07,'-,[1.04-1.09],'-,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,2:226482173
rs7563767-<b>?</b>,2 x 10-6,,'-,1.03,'-,[1.02-1.05],LINC01237,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,2:242012658
rs7671115-<b>?</b>,8 x 10-6,,'-,1.0309278,'-,[1.02-1.04],MARCHF1,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,4:164203350
rs1366161-<b>?</b>,3 x 10-6,,'-,1.0309278,'-,[1.02-1.05],ADAMTS16,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,5:5174755
rs151055883-<b>?</b>,2 x 10-6,,'-,1.08,'-,[1.05-1.12],HMHB1,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,5:143894315
rs77663385-<b>?</b>,9 x 10-6,,'-,1.14,'-,[1.07-1.21],"SPATS1, AARS2",Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,6:44327218
rs7740903-<b>?</b>,5 x 10-7,,'-,1.1,'-,[1.06-1.14],ADGB,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,6:146677054
rs76926936-<b>?</b>,9 x 10-6,,'-,1.07,'-,[1.04-1.11],RNU6-274P,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,7:89698682
rs73494486-<b>?</b>,7 x 10-6,,'-,1.05,'-,[1.03-1.07],GABBR2,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,9:98579569
rs77336990-<b>?</b>,2 x 10-6,,'-,1.12,'-,[1.07-1.17],FRMPD2,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,10:48270719
rs78375425-<b>?</b>,3 x 10-6,,'-,1.06,'-,[1.03-1.09],LHFPL6,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,13:39329007
rs79219469-<b>?</b>,2 x 10-7,,'-,1.1,'-,[1.06-1.14],LINC02183,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,16:54553941
rs9989364-<b>?</b>,9 x 10-6,,'-,1.04,'-,[1.02-1.06],'-,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,16:63960276
rs141803457-<b>?</b>,3 x 10-6,,'-,1.13,'-,[1.07-1.19],SMPD3,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,16:68366522
rs137866923-<b>?</b>,8 x 10-7,,'-,1.15,'-,[1.09-1.22],"ZFP90, RPL35AP33",Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,16:68497433
rs139505845-<b>?</b>,6 x 10-6,,'-,1.17,'-,[1.09-1.25],MSI2,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,17:57289728
rs138807553-<b>?</b>,2 x 10-6,,'-,1.15,'-,[1.08-1.22],ASXL3,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,18:33625004
rs78286182-<b>?</b>,1 x 10-6,,'-,1.08,'-,[1.05-1.11],'-,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,18:75988278
rs972834-<b>?</b>,7 x 10-6,,'-,1.03,'-,[1.02-1.05],"PDCL2P1, PTCHD1",Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,X:23276803
rs7521902-<b>A</b>,3 x 10-11,,0.238,1.19,'-,[1.13-1.25],WNT4,Endometriosis,endometriosis,GCST001720,1:22164231
rs13394619-<b>G</b>,6 x 10-9,,0.521,1.15,'-,[1.09-1.20],GREB1,Endometriosis,endometriosis,GCST001720,2:11587381
rs4141819-<b>C</b>,9 x 10-8,,0.309,1.15,'-,[1.09-1.21],"LINC02831, XIAPP3",Endometriosis,endometriosis,GCST001720,2:67637543
rs7739264-<b>T</b>,4 x 10-10,,0.515,1.17,'-,[1.11-1.23],LNC-LBCS,Endometriosis,endometriosis,GCST001720,6:19785357
rs12700667-<b>A</b>,4 x 10-9,,0.744,1.18,'-,[1.11-1.25],MIR148A,Endometriosis,endometriosis,GCST001720,7:25862019
rs1537377-<b>C</b>,2 x 10-9,,0.401,1.15,'-,[1.10-1.21],CDKN2B-AS1,Endometriosis,endometriosis,GCST001720,9:22169701
rs10859871-<b>C</b>,5 x 10-13,,0.295,1.2,'-,[1.14-1.26],MIR3685,Endometriosis,endometriosis,GCST001720,12:95318100
rs12024204-<b>G</b>,6 x 10-6,,0.52,1.22,'-,[1.07-1.18],'-,Endometriosis,endometriosis,GCST000916,1:79777316
rs2738113-<b>G</b>,3 x 10-7,,0.44,1.15,'-,[1.09-1.22],"DEFA10P, DEFA1",Endometriosis,endometriosis,GCST000916,8:6971563
rs12700667-<b>A</b>,1 x 10-9,,0.74,1.2,'-,[1.13-1.27],MIR148A,Endometriosis,endometriosis,GCST000916,7:25862019
rs75853687-<b>A</b>,7 x 10-9,,0.008,16.5,'-,[3.9-69.3],LINC01847,Alloimmunization response to red blood cell transfusion in sickle cell anemia,"Sickle cell anemia, alloimmunization, response to red blood cell transfusion",GCST007210,5:159850278
rs766432-<b>?</b>,9 x 10-7,,NR,'-,0.22 unit increase,NR,'-,Sickle cell anemia (haemolysis),Sickle cell anemia,GCST001862,Mapping not available
rs7948471-<b>A</b>,3 x 10-10,,0.21,'-,0.26 unit decrease,[0.18-0.34],"OR51B5, HBG2, OR51I2, HBE1",Sickle cell anemia (haemolysis),Sickle cell anemia,GCST001862,11:5450516
rs7203560-<b>C</b>,2 x 10-9,,0.07,'-,0.44 unit decrease,[0.30-0.58],NPRL3,Sickle cell anemia (haemolysis),Sickle cell anemia,GCST001862,16:134391
rs2445284-<b>G</b>,1 x 10-29,,0.05,'-,0.82 unit decrease,[0.68-0.96],"OR51L1, OR51P1P",Sickle cell anemia (haemolysis),Sickle cell anemia,GCST001862,11:5008473
rs1113932-<b>G</b>,9 x 10-6,(AA),0.06,'-,0.2881 unit increase,[NR],TMEFF2,Hemoglobin A2 levels in sickle cell anemia,"Sickle cell anemia, hemoglobin A2 measurement",GCST002536,2:192187627
"rs7557939-<b>?</b>, rs766432-<b>?</b>, rs1896296-<b>?</b>, rs10172646-<b>?</b>, rs10195871-<b>?</b>, rs11886868-<b>?</b>, rs7565301-<b>?</b>, rs7584113-<b>?</b>, rs7599488-<b>?</b>, rs7606173-<b>?</b>, rs6738440-<b>?</b>, rs1427407-<b>?</b>, rs1896294-<b>?</b>, rs6545816-<b>?</b>, rs4671393-<b>?</b>, rs6729815-<b>?</b>, rs6545817-<b>?</b>, rs1896295-<b>?</b>, rs10189857-<b>?</b>, rs6706648-<b>?</b>",2 x 10-7,,0.42,'-,1.07 unit increase,[0.68-1.46],BCL11A; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; BCL11A; BCL11A; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; BCL11A; BCL11A; BCL11A; BCL11A; No mapped genes,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,2:60494212|2:60491212|2:60498316|2:60496537|2:60488044|2:60496951|2:60486100
"rs7557939-<b>?</b>, rs766432-<b>?</b>, rs1896296-<b>?</b>, rs10172646-<b>?</b>, rs10195871-<b>?</b>, rs11886868-<b>?</b>, rs7565301-<b>?</b>, rs7584113-<b>?</b>, rs7599488-<b>?</b>, rs7606173-<b>?</b>, rs6738440-<b>?</b>, rs1427407-<b>?</b>, rs1896294-<b>?</b>, rs6545816-<b>?</b>, rs4671393-<b>?</b>, rs6729815-<b>?</b>, rs6545817-<b>?</b>, rs1896295-<b>?</b>, rs10189857-<b>?</b>, rs6706648-<b>?</b>",2 x 10-16,,0.254,'-,1.98 unit increase,[1.57-2.39],BCL11A; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; BCL11A; BCL11A; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; BCL11A; BCL11A; BCL11A; BCL11A; No mapped genes,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,2:60494212|2:60491212|2:60498316|2:60496537|2:60488044|2:60496951|2:60486100
rs887829-<b>A</b>,5 x 10-25,,0.45,'-,0.19 unit increase,[NR],"UGT1A10, UGT1A3, UGT1A5, UGT1A6, UGT1A8, UGT1A7, UGT1A9, UGT1A4",Cholelithiasis-related traits in sickle cell anemia,"Sickle cell anemia, cholelithiasis, bilirubin measurement",GCST001497,2:233759924
rs7643459-<b>T</b>,8 x 10-7,,0.362,1.4,'-,[1.22-1.60],LMCD1-AS1,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST009008,3:7963141
rs4286604-<b>G</b>,9 x 10-7,,0.732,1.4492754,'-,[1.25-1.69],"UGT2A1, UGT2B4",Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST009008,4:69576447
rs142091544-<b>T</b>,9 x 10-7,,0.034,3.22,'-,[2.02-5.13],"CTB-178M22.2, WWC1",Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST009008,5:168286995
rs4525119-<b>C</b>,5 x 10-7,,0.669,1.4285715,'-,[1.23-1.64],AKR1C3,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST009008,10:5049762
rs8091660-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,CTIF,Response to carboplatin in ovarian cancer (MTT IC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement",GCST003440,18:48561565
rs150303591-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,FRAS1,Response to carboplatin in ovarian cancer (MTT IC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement",GCST003440,4:78088155
rs12025262-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,ZNF731P,Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel",GCST003443,1:247193430
rs10674174-<b>?</b>,8 x 10-7,,NR,'-,'-,'-,PCDH20,Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel",GCST003443,13:61317943
rs7572644-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,BABAM2,Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel",GCST003443,2:28097166
rs201083182-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,EYS,Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement",GCST003439,6:65027022
rs3842595-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,"MGC32805, SNCAIP",Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement",GCST003439,5:122442912
rs185229225-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,BOD1L1,Response to paclitaxel in ovarian cancer (MTT IC50),"ovarian carcinoma, cytotoxicity measurement, response to paclitaxel",GCST003441,4:13607505
rs201023017-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,SLC9A9,Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel",GCST003444,3:143384827
rs66696671-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,"RAD1P1, TIAL1",Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel",GCST003444,10:119607441
rs12061931-<b>T</b>,6 x 10-8,,NR,5.79,'-,NR,LRRC47,Ovarian cancer,ovarian carcinoma,GCST90011821,1:3779792
rs185345278-<b>A</b>,5 x 10-6,,0.0216,2.8735633,'-,[1.83-4.52],"MTCO1P21, ABCA4",Ovarian cancer,ovarian carcinoma,GCST007239,1:93933038
rs12031579-<b>G</b>,8 x 10-7,,0.0547,1.8248177,'-,[1.44-2.31],"WARS2-AS1, LINC01780",Ovarian cancer,ovarian carcinoma,GCST007239,1:119307920
rs188625872-<b>C</b>,2 x 10-6,,0.0034,3.7593985,'-,[2.17-6.49],LMNA,Ovarian cancer,ovarian carcinoma,GCST007239,1:156114696
rs12117623-<b>C</b>,1 x 10-6,,0.5306,1.312336,'-,[1.18-1.46],DNM3,Ovarian cancer,ovarian carcinoma,GCST007239,1:172072640
rs17027263-<b>C</b>,2 x 10-6,,0.1172,1.4430014,'-,[1.24-1.68],KDM3A,Ovarian cancer,ovarian carcinoma,GCST007239,2:86459965
rs6801612-<b>A</b>,8 x 10-6,,0.683,1.328,'-,[1.174-1.503],"ST6GAL1, RPS20P14",Ovarian cancer,ovarian carcinoma,GCST007239,3:186920430
rs12658731-<b>G</b>,9 x 10-7,,0.6438,1.405,'-,[1.227-1.608],ADAMTS16,Ovarian cancer,ovarian carcinoma,GCST007239,5:5169477
rs147867139-<b>A</b>,8 x 10-6,,0.0175,2.197802,'-,[1.56-3.11],"RNU6-236P, CXXC5",Ovarian cancer,ovarian carcinoma,GCST007239,5:139712729
rs60982503-<b>G</b>,5 x 10-6,,0.7345,1.384,'-,[1.204-1.591],"RNU6-525P, CNOT6",Ovarian cancer,ovarian carcinoma,GCST007239,5:180485036
rs303051-<b>A</b>,6 x 10-6,,0.3947,1.2886598,'-,[1.15-1.44],TFAP2A,Ovarian cancer,ovarian carcinoma,GCST007239,6:10403963
rs56855829-<b>C</b>,2 x 10-6,,0.0036,3.8022811,'-,[2.18-6.62],FANCE,Ovarian cancer,ovarian carcinoma,GCST007239,6:35464877
rs4599655-<b>A</b>,8 x 10-6,,0.1365,1.3927578,'-,[1.21-1.61],UFL1-AS1,Ovarian cancer,ovarian carcinoma,GCST007239,6:96284381
rs73589840-<b>C</b>,7 x 10-6,,0.0329,1.7452006,'-,[1.37-2.22],ADGB,Ovarian cancer,ovarian carcinoma,GCST007239,6:146688554
rs181474944-<b>C</b>,6 x 10-6,,0.015,2.4570024,'-,[1.67-3.62],PKD1L1,Ovarian cancer,ovarian carcinoma,GCST007239,7:47770503
rs76926936-<b>T</b>,9 x 10-6,,0.0517,1.923077,'-,[1.44-2.56],RNU6-274P,Ovarian cancer,ovarian carcinoma,GCST007239,7:89698682
rs10117922-<b>A</b>,7 x 10-6,,0.325,1.3351135,'-,[1.18-1.51],DAPK1,Ovarian cancer,ovarian carcinoma,GCST007239,9:87680655
rs10858374-<b>T</b>,1 x 10-6,,0.1106,1.4684289,'-,[1.26-1.72],C9orf62,Ovarian cancer,ovarian carcinoma,GCST007239,9:135247660
rs2615880-<b>A</b>,8 x 10-6,,0.1234,1.4025246,'-,[1.21-1.63],ATRNL1,Ovarian cancer,ovarian carcinoma,GCST007239,10:115937294
rs789336-<b>C</b>,1 x 10-7,,0.6082,1.369,'-,[1.217-1.540],PRANCR,Ovarian cancer,ovarian carcinoma,GCST007239,12:70028700
rs7969255-<b>T</b>,8 x 10-7,,0.5313,1.325,'-,[1.184-1.481],PRANCR,Ovarian cancer,ovarian carcinoma,GCST007239,12:70148026
rs58355101-<b>T</b>,9 x 10-7,,0.5658,1.35,'-,[1.198-1.521],CNOT2,Ovarian cancer,ovarian carcinoma,GCST007239,12:70257391
rs1495352-<b>A</b>,3 x 10-6,,0.5489,1.31,'-,[1.169-1.468],"KCNMB4, CNOT2",Ovarian cancer,ovarian carcinoma,GCST007239,12:70359064
rs75921351-<b>C</b>,8 x 10-7,,0.0304,2.1691973,'-,[1.59-2.95],LINC02183,Ovarian cancer,ovarian carcinoma,GCST007239,16:54596587
rs145065165-<b>G</b>,2 x 10-7,,0.0223,2.8735633,'-,[1.93-4.29],"RPL31P56, IRX6",Ovarian cancer,ovarian carcinoma,GCST007239,16:55347327
rs11870446-<b>C</b>,3 x 10-6,,0.1238,1.4836795,'-,[1.26-1.75],'-,Ovarian cancer,ovarian carcinoma,GCST007239,17:5857509
rs12151036-<b>G</b>,5 x 10-6,,0.0119,2.2075055,'-,[1.57-3.11],ZNF274,Ovarian cancer,ovarian carcinoma,GCST007239,19:58202868
rs1884920-<b>A</b>,8 x 10-6,,0.5027,1.4064697,'-,[1.21-1.64],"TFAP2C, RNU6-1146P",Ovarian cancer,ovarian carcinoma,GCST007239,20:56648010
rs137672-<b>C</b>,1 x 10-7,,0.0601,1.7452006,'-,[1.42-2.15],"SYNGR1, RPL3",Ovarian cancer,ovarian carcinoma,GCST007239,22:39341089
rs7563201-<b>A</b>,4 x 10-10,,0.45,'-,0.1081 unit decrease,[0.074-0.142],THADA,Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,2:43334641
rs2178575-<b>A</b>,3 x 10-14,,0.15,'-,0.1663 unit increase,[0.12-0.21],ERBB4,Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,2:212527042
rs13164856-<b>T</b>,1 x 10-10,,0.73,'-,0.1235 unit increase,[0.086-0.161],"IRF1-AS1, IRF1",Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,5:132477512
rs804279-<b>A</b>,4 x 10-12,,0.26,'-,0.1276 unit increase,[0.092-0.164],"NEIL2, GATA4",Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,8:11766380
rs10739076-<b>A</b>,3 x 10-8,,0.31,'-,0.1097 unit increase,[0.071-0.148],"CD274, PLGRKT",Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,9:5440589
rs7864171-<b>A</b>,3 x 10-8,,0.43,'-,0.0933 unit decrease,[0.06-0.126],AOPEP,Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,9:94960984
rs9696009-<b>A</b>,8 x 10-11,,0.07,'-,0.202 unit increase,[0.14-0.26],DENND1A,Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,9:123856954
rs11031005-<b>T</b>,9 x 10-13,,0.85,'-,0.1593 unit decrease,[0.12-0.2],FSHB,Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,11:30204809
rs11225154-<b>A</b>,5 x 10-11,,0.09,'-,0.1787 unit increase,[0.13-0.23],YAP1,Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,11:102172509
rs1784692-<b>T</b>,2 x 10-10,,0.82,'-,0.1438 unit increase,[0.1-0.188],ZBTB16,Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,11:114078510
rs2271194-<b>A</b>,5 x 10-9,,0.42,'-,0.0971 unit increase,[0.065-0.13],ERBB3,Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,12:56083910
rs1795379-<b>T</b>,2 x 10-9,,0.24,'-,0.1174 unit decrease,[0.079-0.156],KRR1,Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,12:75547262
rs8043701-<b>A</b>,1 x 10-9,,0.82,'-,0.1273 unit decrease,[0.087-0.168],"CASC22, TOX3",Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,16:52341865
rs853854-<b>T</b>,2 x 10-9,,0.5,'-,0.0975 unit decrease,[0.066-0.129],MAPRE1,Polycystic ovary syndrome,polycystic ovary syndrome,GCST007089,20:32832951
rs13429458-<b>A</b>,4 x 10-13,,NR,1.49,'-,[NR],THADA,Polycystic ovary syndrome,polycystic ovary syndrome,GCST001634,2:43411699
rs2479106-<b>G</b>,5 x 10-10,,NR,1.35,'-,[NR],DENND1A,Polycystic ovary syndrome,polycystic ovary syndrome,GCST001634,9:123762933
rs13405728-<b>A</b>,4 x 10-9,,NR,1.35,'-,[NR],"STON1-GTF2A1L, LHCGR",Polycystic ovary syndrome,polycystic ovary syndrome,GCST001634,2:48751020
rs2268361-<b>C</b>,1 x 10-12,,0.504,1.15,'-,[NR],FSHR,Polycystic ovary syndrome,polycystic ovary syndrome,GCST001634,2:48974473
rs3802457-<b>G</b>,5 x 10-14,,0.904,1.3,'-,[NR],AOPEP,Polycystic ovary syndrome,polycystic ovary syndrome,GCST001634,9:94979054
rs1894116-<b>G</b>,1 x 10-22,,0.194,1.27,'-,[NR],YAP1,Polycystic ovary syndrome,polycystic ovary syndrome,GCST001634,11:102199908
rs705702-<b>G</b>,9 x 10-26,,0.245,1.27,'-,[NR],"RAB5B, SUOX",Polycystic ovary syndrome,polycystic ovary syndrome,GCST001634,12:55996852
rs2272046-<b>A</b>,2 x 10-21,,0.907,1.43,'-,[NR],HMGA2,Polycystic ovary syndrome,polycystic ovary syndrome,GCST001634,12:65830681
rs4784165-<b>G</b>,4 x 10-11,,0.325,1.15,'-,[NR],CASC22,Polycystic ovary syndrome,polycystic ovary syndrome,GCST001634,16:52313907
rs2059807-<b>G</b>,1 x 10-8,,0.301,1.14,'-,[NR],INSR,Polycystic ovary syndrome,polycystic ovary syndrome,GCST001634,19:7166098
rs6022786-<b>A</b>,2 x 10-9,,0.339,1.13,'-,[NR],SUMO1P1,Polycystic ovary syndrome,polycystic ovary syndrome,GCST001634,20:53830764
rs9885896-<b>A</b>,4 x 10-9,,'-,'-,0.0241602 unit decrease,[0.016-0.032],ADH5P4,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,6:65886038
rs12206488-<b>T</b>,2 x 10-9,,'-,'-,0.0302724 unit increase,[0.02-0.04],'-,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,6:66290024
rs2328370-<b>A</b>,3 x 10-8,,'-,'-,0.0231486 unit increase,[0.015-0.031],HIVEP2,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,6:142685569
rs9347896-<b>A</b>,1 x 10-8,,'-,'-,0.0281251 unit increase,[0.018-0.038],'-,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,6:164656716
rs11561993-<b>T</b>,2 x 10-9,,'-,'-,0.0244869 unit increase,[0.016-0.033],'-,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,7:109462798
rs11784932-<b>A</b>,3 x 10-8,,'-,'-,0.0258772 unit increase,[0.017-0.035],CCDC26,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,8:129083232
rs1931391-<b>A</b>,8 x 10-9,,'-,'-,0.0235744 unit increase,[0.016-0.032],'-,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,9:11213674
rs62553458-<b>A</b>,9 x 10-9,,'-,'-,0.0499565 unit decrease,[0.033-0.067],KLF9,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,9:11695224
rs13299293-<b>A</b>,2 x 10-8,,'-,'-,0.0241789 unit decrease,[0.016-0.033],SLC25A6P2,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,9:31234707
rs2212333-<b>A</b>,8 x 10-9,,'-,'-,0.0242113 unit increase,[0.016-0.032],GRM5,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,11:89035729
rs7358418-<b>T</b>,6 x 10-9,,'-,'-,0.0260823 unit decrease,[0.017-0.035],TYR,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,11:89236970
rs9538160-<b>A</b>,3 x 10-8,,'-,'-,0.0238311 unit decrease,[0.015-0.032],DNAJA1P1,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,13:58680025
rs35625885-<b>A</b>,1 x 10-8,,'-,'-,0.0357605 unit decrease,[0.023-0.048],"PGAM1P12, TUBAP12",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,15:96414739
rs1395455-<b>A</b>,4 x 10-8,,'-,'-,0.0245324 unit increase,[0.016-0.033],"FTLP18, GRIK3",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:36719589
rs1620977-<b>A</b>,1 x 10-8,,'-,'-,0.02653 unit increase,[0.017-0.036],NEGR1,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:72263459
rs6680839-<b>T</b>,9 x 10-10,,'-,'-,0.025214 unit decrease,[0.017-0.033],"COP1, RPS29P5",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:175933460
rs2175177-<b>A</b>,1 x 10-8,,'-,'-,0.0234815 unit decrease,[0.015-0.032],"COP1, U7",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:176214920
rs11809140-<b>T</b>,2 x 10-8,,'-,'-,0.0229278 unit decrease,[0.015-0.031],MORF4L1P7,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:176349468
rs72740410-<b>T</b>,1 x 10-8,,'-,'-,0.0465852 unit increase,[0.031-0.063],"HNRNPA1P46, UBE2V1P8",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:191145969
rs78108344-<b>T</b>,2 x 10-9,,'-,'-,0.0299671 unit decrease,[0.02-0.04],CRB1,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:197419740
rs12118913-<b>T</b>,2 x 10-9,,'-,'-,0.0292513 unit increase,[0.02-0.039],DENND1B,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:197543274
rs2224873-<b>A</b>,1 x 10-9,,'-,'-,0.0300135 unit decrease,[0.02-0.04],DENND1B,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:197676319
rs12121863-<b>A</b>,4 x 10-10,,'-,'-,0.0328269 unit increase,[0.023-0.043],"DENND1B, C1orf53",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:197816290
rs9586-<b>T</b>,2 x 10-10,,'-,'-,0.0313868 unit decrease,[0.022-0.041],KLHDC8B,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,3:49176204
rs6778080-<b>T</b>,3 x 10-9,,'-,'-,0.0271179 unit increase,[0.018-0.036],USP4,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,3:49279905
rs2797160-<b>?</b>,4 x 10-13,,0.578,1.21,'-,[NR],LINC02523,Endometrial cancer,endometrial carcinoma,GCST003436,6:125688970
rs9600103-<b>?</b>,4 x 10-12,,0.722,1.23,'-,[NR],RNY1P8,Endometrial cancer,endometrial carcinoma,GCST003436,13:73237742
rs1740828-<b>?</b>,2 x 10-8,,0.516,1.2,'-,[NR],"BOLA2P3, CASC15",Endometrial cancer,endometrial carcinoma,GCST003436,6:21648854
rs11651052-<b>?</b>,1 x 10-8,,0.535,1.16,'-,[NR],HNF1B,Endometrial cancer,endometrial carcinoma,GCST003436,17:37742390
rs7405776-<b>A</b>,2 x 10-7,,0.58811,1.25,'-,[1.15-1.35],HNF1B,Ovarian clear cell cancer,ovarian clear cell adenocarcinoma,GCST004417,17:37733029
rs11651755-<b>T</b>,7 x 10-9,,0.513535,1.27,'-,[1.16-1.37],HNF1B,Ovarian clear cell cancer,ovarian clear cell adenocarcinoma,GCST004417,17:37739849
rs6812281-<b>T</b>,9 x 10-9,,0.18,2.37,'-,[1.77-3.18],'-,Response to platinum-based neoadjuvant chemotherapy in cervical cancer,"cervical carcinoma, response to platinum-based neoadjuvant chemotherapy",GCST004097,4:179391655
rs1742101-<b>G</b>,7 x 10-6,,0.5,1.92,'-,[1.45-2.56],TTC7B,Response to platinum-based neoadjuvant chemotherapy in cervical cancer,"cervical carcinoma, response to platinum-based neoadjuvant chemotherapy",GCST004097,14:90698719
rs1364121-<b>A</b>,3 x 10-6,,0.25,1.98,'-,[1.49-2.64],CDH13,Response to platinum-based neoadjuvant chemotherapy in cervical cancer,"cervical carcinoma, response to platinum-based neoadjuvant chemotherapy",GCST004097,16:83706502
rs34289250-<b>C</b>,6 x 10-13,,0.0089,7.95,'-,[NR],BRIP1,Ovarian cancer,ovarian carcinoma,GCST001258,17:61803285
rs7412010-<b>?</b>,1 x 10-12,,'-,1.15,'-,[1.10-1.19],"WNT4, CDC42",Uterine fibroids,uterine fibroid,GCST009834,1:22109953
rs12415148-<b>?</b>,4 x 10-10,,'-,1.25,'-,[1.16-1.33],"SLK, STN1",Uterine fibroids,uterine fibroid,GCST009834,10:103920828
rs12225799-<b>?</b>,1 x 10-21,,'-,1.3157895,'-,[1.25-1.39],PSMD13,Uterine fibroids,uterine fibroid,GCST009834,11:241124
rs17332320-<b>?</b>,2 x 10-12,,'-,1.15,'-,[1.10-1.19],TNRC6B,Uterine fibroids,uterine fibroid,GCST009834,22:40315616
rs284247-<b>?</b>,4 x 10-6,,'-,1.098901,'-,[1.05-1.14],CASZ1,Uterine fibroids,uterine fibroid,GCST009834,1:10714799
rs6432216-<b>?</b>,5 x 10-7,,'-,1.1111112,'-,[1.06-1.16],GREB1,Uterine fibroids,uterine fibroid,GCST009834,2:11562834
rs11887109-<b>?</b>,1 x 10-6,,'-,1.1,'-,[1.06-1.14],REV1,Uterine fibroids,uterine fibroid,GCST009834,2:99428722
rs149966361-<b>?</b>,1 x 10-6,,'-,1.42,'-,[1.23-1.63],"DIRC1, GULP1",Uterine fibroids,uterine fibroid,GCST009834,2:188635309
rs16830721-<b>?</b>,2 x 10-6,,'-,1.52,'-,[1.27-1.81],DIRC1,Uterine fibroids,uterine fibroid,GCST009834,2:188858004
rs648153-<b>?</b>,2 x 10-6,,'-,1.1,'-,[1.06-1.14],RAD18,Uterine fibroids,uterine fibroid,GCST009834,3:8962110
rs11926999-<b>?</b>,6 x 10-6,,'-,1.1627907,'-,[1.09-1.25],KCNAB1,Uterine fibroids,uterine fibroid,GCST009834,3:156518773
rs6772835-<b>?</b>,3 x 10-6,,'-,1.4705882,'-,[1.25-1.72],NAALADL2,Uterine fibroids,uterine fibroid,GCST009834,3:175345406
rs1604744-<b>?</b>,7 x 10-6,,'-,1.09,'-,[1.05-1.13],SULT1B1,Uterine fibroids,uterine fibroid,GCST009834,4:69743154
rs10030758-<b>?</b>,1 x 10-6,,'-,1.12,'-,[1.07-1.17],"GUCY1B1, GUCY1A1",Uterine fibroids,uterine fibroid,GCST009834,4:155747570
rs6897196-<b>?</b>,1 x 10-6,,'-,1.11,'-,[1.06-1.15],TERT,Uterine fibroids,uterine fibroid,GCST009834,5:1280823
rs10472003-<b>?</b>,6 x 10-6,,'-,1.1111112,'-,[1.06-1.18],"ACTBL2, SALL4P1",Uterine fibroids,uterine fibroid,GCST009834,5:57434556
rs185133894-<b>?</b>,6 x 10-6,,'-,1.44,'-,[1.23-1.70],"ERBIN-DT, NLN",Uterine fibroids,uterine fibroid,GCST009834,5:65879023
rs12199205-<b>?</b>,6 x 10-6,,'-,1.11,'-,[1.06-1.16],RPL15P3,Uterine fibroids,uterine fibroid,GCST009834,6:12510798
rs2025251-<b>?</b>,9 x 10-6,,'-,1.0869565,'-,[1.05-1.12],"RNF217-AS1, NKAIN2",Uterine fibroids,uterine fibroid,GCST009834,6:124823206
rs62425513-<b>?</b>,9 x 10-6,,'-,1.1764705,'-,[1.09-1.25],THEMIS,Uterine fibroids,uterine fibroid,GCST009834,6:127756593
rs1333765-<b>?</b>,6 x 10-6,,'-,1.1764705,'-,[1.1-1.27],THEMIS,Uterine fibroids,uterine fibroid,GCST009834,6:127860275
rs11246001-<b>?</b>,1 x 10-20,,'-,1.2987013,'-,[1.23-1.39],RIC8A,Uterine fibroids,uterine fibroid,GCST009834,11:210899
rs76437931-<b>?</b>,5 x 10-6,,'-,1.29,'-,[1.16-1.43],RTN3,Uterine fibroids,uterine fibroid,GCST009834,11:63707282
rs11231598-<b>?</b>,2 x 10-6,,'-,1.23,'-,[1.13-1.34],"SPINDOC, ATP5MGP1",Uterine fibroids,uterine fibroid,GCST009834,11:63831522
rs884444-<b>?</b>,7 x 10-6,,'-,1.0869565,'-,[1.05-1.14],RNA5SP349,Uterine fibroids,uterine fibroid,GCST009834,11:109158070
rs34176300-<b>?</b>,7 x 10-6,,'-,1.26,'-,[1.14-1.40],SVOP,Uterine fibroids,uterine fibroid,GCST009834,12:108939526
rs80040116-<b>?</b>,4 x 10-6,,'-,1.17,'-,[1.10-1.25],FNDC3A,Uterine fibroids,uterine fibroid,GCST009834,13:48920751
rs76555819-<b>?</b>,5 x 10-6,,'-,1.19,'-,[1.10-1.28],FNDC3A,Uterine fibroids,uterine fibroid,GCST009834,13:49037911
rs78036026-<b>?</b>,6 x 10-6,,'-,1.19,'-,[1.10-1.28],FNDC3A,Uterine fibroids,uterine fibroid,GCST009834,13:49209079
rs11634026-<b>?</b>,3 x 10-6,,'-,1.4084507,'-,[1.22-1.61],ITGA11,Uterine fibroids,uterine fibroid,GCST009834,15:68305668
rs79951027-<b>?</b>,7 x 10-6,,'-,1.19,'-,[1.11-1.29],'-,Uterine fibroids,uterine fibroid,GCST009834,15:81837937
rs145152209-<b>?</b>,6 x 10-7,,'-,1.19,'-,[1.11-1.28],SH3GL3,Uterine fibroids,uterine fibroid,GCST009834,15:83408460
rs76906291-<b>?</b>,4 x 10-6,,'-,1.25,'-,[1.14-1.37],'-,Uterine fibroids,uterine fibroid,GCST009834,15:97103804
rs76801069-<b>?</b>,7 x 10-6,,'-,1.48,'-,[1.25-1.76],LINC01989,Uterine fibroids,uterine fibroid,GCST009834,17:34192451
rs149813805-<b>?</b>,6 x 10-6,,'-,1.41,'-,[1.21-1.63],LINC01695,Uterine fibroids,uterine fibroid,GCST009834,21:28233989
rs149173751-<b>?</b>,2 x 10-6,,'-,1.53,'-,[1.28-1.81],"SIM2, LINC00161",Uterine fibroids,uterine fibroid,GCST009834,21:28619230
rs12484438-<b>?</b>,1 x 10-8,,'-,1.11,'-,[1.07-1.15],TNRC6B,Uterine fibroids,uterine fibroid,GCST009834,22:40162060
rs5933120-<b>?</b>,7 x 10-6,,'-,1.2,'-,[1.11-1.31],"AGKP2, RAP2C",Uterine fibroids,uterine fibroid,GCST009834,X:132197564
rs148851274-<b>?</b>,2 x 10-6,,'-,1.14,'-,[1.08-1.20],"SPANXN3, SLITRK4",Uterine fibroids,uterine fibroid,GCST009834,X:143588574
rs12484951-<b>?</b>,2 x 10-12,,'-,1.15,'-,(1.1-1.19),TNRC6B,Uterine fibroids,uterine fibroid,GCST009834,22:40307071
rs10917151-<b>?</b>,5 x 10-12,,'-,1.14,'-,(1.1-1.18),CDC42,Uterine fibroids,uterine fibroid,GCST009834,1:22096228
rs7412010-<b>?</b>,5 x 10-8,,'-,1.03,'-,[1.02-1.05],"WNT4, CDC42",Uterine fibroids (MTAG),uterine fibroid,GCST009833,1:22109953
rs12225799-<b>?</b>,4 x 10-17,,'-,1.0752687,'-,[1.06-1.1],PSMD13,Uterine fibroids (MTAG),uterine fibroid,GCST009833,11:241124
rs17332320-<b>?</b>,4 x 10-13,,'-,1.05,'-,[1.03-1.06],TNRC6B,Uterine fibroids (MTAG),uterine fibroid,GCST009833,22:40315616
rs284247-<b>?</b>,3 x 10-6,,'-,1.0309278,'-,[1.02-1.04],CASZ1,Uterine fibroids (MTAG),uterine fibroid,GCST009833,1:10714799
rs75428193-<b>?</b>,6 x 10-7,,'-,1.11,'-,[1.07-1.16],RBMS1,Uterine fibroids (MTAG),uterine fibroid,GCST009833,2:160383707
rs1122986-<b>?</b>,9 x 10-6,,'-,1.03,'-,[1.02-1.04],TNS1,Uterine fibroids (MTAG),uterine fibroid,GCST009833,2:217839951
rs16884388-<b>?</b>,7 x 10-6,,'-,1.03,'-,[1.02-1.04],PCDH7,Uterine fibroids (MTAG),uterine fibroid,GCST009833,4:31131945
rs1604744-<b>?</b>,7 x 10-6,,'-,1.03,'-,[1.02-1.04],SULT1B1,Uterine fibroids (MTAG),uterine fibroid,GCST009833,4:69743154
rs4691052-<b>?</b>,3 x 10-6,,'-,1.04,'-,[1.02-1.05],GUCY1A1,Uterine fibroids (MTAG),uterine fibroid,GCST009833,4:155692026
rs143300607-<b>?</b>,8 x 10-6,,'-,1.0526316,'-,[1.03-1.09],"SALL4P1, GPBP1",Uterine fibroids (MTAG),uterine fibroid,GCST009833,5:57343818
rs385492-<b>?</b>,5 x 10-6,,'-,1.0309278,'-,[1.02-1.04],"ZFP57, ZDHHC20P1",Uterine fibroids (MTAG),uterine fibroid,GCST009833,6:29681770
rs186353318-<b>?</b>,4 x 10-6,,'-,1.07,'-,[1.04-1.10],'-,Uterine fibroids (MTAG),uterine fibroid,GCST009833,7:13557041
rs145920874-<b>?</b>,5 x 10-6,,'-,1.05,'-,[1.03-1.08],FUBP3,Uterine fibroids (MTAG),uterine fibroid,GCST009833,9:130606548
rs11246001-<b>?</b>,3 x 10-15,,'-,1.0752687,'-,[1.05-1.1],RIC8A,Uterine fibroids (MTAG),uterine fibroid,GCST009833,11:210899
rs142207117-<b>?</b>,3 x 10-6,,'-,1.0526316,'-,[1.03-1.08],NELL1,Uterine fibroids (MTAG),uterine fibroid,GCST009833,11:20940329
rs884444-<b>?</b>,9 x 10-7,,'-,1.0309278,'-,[1.02-1.04],RNA5SP349,Uterine fibroids (MTAG),uterine fibroid,GCST009833,11:109158070
rs80040116-<b>?</b>,2 x 10-6,,'-,1.05,'-,[1.03-1.07],FNDC3A,Uterine fibroids (MTAG),uterine fibroid,GCST009833,13:48920751
rs9542094-<b>?</b>,9 x 10-6,,'-,1.04,'-,[1.02-1.06],KLHL1,Uterine fibroids (MTAG),uterine fibroid,GCST009833,13:69824871
rs11634026-<b>?</b>,1 x 10-6,,'-,1.1235955,'-,[1.06-1.16],ITGA11,Uterine fibroids (MTAG),uterine fibroid,GCST009833,15:68305668
rs145152209-<b>?</b>,3 x 10-6,,'-,1.05,'-,[1.03-1.08],SH3GL3,Uterine fibroids (MTAG),uterine fibroid,GCST009833,15:83408460
rs76906291-<b>?</b>,6 x 10-6,,'-,1.07,'-,[1.04-1.10],'-,Uterine fibroids (MTAG),uterine fibroid,GCST009833,15:97103804
rs2070107-<b>?</b>,2 x 10-6,,'-,1.03,'-,[1.02-1.05],"TSPOAP1-AS1, SUPT4H1",Uterine fibroids (MTAG),uterine fibroid,GCST009833,17:58345840
rs34920953-<b>?</b>,9 x 10-6,,'-,1.03,'-,[1.02-1.05],MTMR4,Uterine fibroids (MTAG),uterine fibroid,GCST009833,17:58512045
rs192024971-<b>?</b>,8 x 10-6,,'-,1.09,'-,[1.05-1.13],ANKRD12,Uterine fibroids (MTAG),uterine fibroid,GCST009833,18:9234398
rs695670-<b>?</b>,6 x 10-6,,'-,1.0309278,'-,[1.02-1.05],"MYO18B-AS1, MYO18B",Uterine fibroids (MTAG),uterine fibroid,GCST009833,22:25882501
rs12484951-<b>?</b>,1 x 10-12,,'-,1.04,'-,[1.03-1.06],TNRC6B,Uterine fibroids (MTAG),uterine fibroid,GCST009833,22:40307071
rs4506367-<b>?</b>,7 x 10-6,,'-,1.03,'-,[1.02-1.04],DYNLT3,Uterine fibroids (MTAG),uterine fibroid,GCST009833,X:37841575
rs1987421-<b>?</b>,2 x 10-6,,'-,1.07,'-,[1.04-1.09],"AGKP2, RAP2C",Uterine fibroids (MTAG),uterine fibroid,GCST009833,X:132194809
rs6637027-<b>?</b>,3 x 10-6,,'-,1.0309278,'-,[1.02-1.04],"SPANXN3, SLITRK4",Uterine fibroids (MTAG),uterine fibroid,GCST009833,X:143568611
rs10917151-<b>?</b>,3 x 10-7,,'-,1.03,'-,(1.02-1.04),CDC42,Uterine fibroids (MTAG),uterine fibroid,GCST009833,1:22096228
rs7913069-<b>A</b>,9 x 10-14,,0.07,1.47,'-,[1.23-1.75],"SLK, STN1",Uterine fibroids,uterine fibroid,GCST001027,10:103954641
rs12484776-<b>G</b>,3 x 10-12,,0.36,1.23,'-,[1.11-1.37],TNRC6B,Uterine fibroids,uterine fibroid,GCST001027,22:40256869
rs2280543-<b>G</b>,4 x 10-12,,0.88,1.39,'-,[1.17-1.64],BET1L,Uterine fibroids,uterine fibroid,GCST001027,11:203788
rs991964-<b>A</b>,9 x 10-6,,0.34,1.15,'-,[1.03-1.28],LINC01122,Uterine fibroids,uterine fibroid,GCST001027,2:59055456
rs2172873-<b>A</b>,2 x 10-6,,0.22,1.18,'-,[1.04-1.34],LINC00485,Uterine fibroids,uterine fibroid,GCST001027,12:102731912
rs10017134-<b>C</b>,1 x 10-6,,0.73,1.4,'-,[1.2-1.7],"UGT2A2, UGT2A1",Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST009896,4:69591303
rs11841589-<b>G</b>,5 x 10-11,,0.74,1.15,'-,[1.11-1.21],RNY1P8,Endometrial cancer,endometrial carcinoma,GCST003524,13:73240754
rs13328298-<b>G</b>,4 x 10-10,,0.58,1.13,'-,[1.09-1.18],LINC02523,Endometrial cancer,endometrial carcinoma,GCST003524,6:125695434
rs4733613-<b>C</b>,3 x 10-9,,0.13,1.1904762,'-,[1.12-1.25],"LINC00824, CCDC26",Endometrial cancer,endometrial carcinoma,GCST003524,8:128587032
rs937213-<b>C</b>,2 x 10-8,,0.42,1.1111112,'-,[1.08-1.16],EIF2AK4,Endometrial cancer,endometrial carcinoma,GCST003524,15:40029923
rs2498796-<b>A</b>,4 x 10-8,,0.3,1.1235955,'-,[1.08-1.18],AKT1,Endometrial cancer,endometrial carcinoma,GCST003524,14:104776883
rs11263763-<b>A</b>,3 x 10-19,,0.54,1.2,'-,[1.15-1.25],HNF1B,Endometrial cancer,endometrial carcinoma,GCST003524,17:37743574
rs2414098-<b>C</b>,5 x 10-13,,0.62,1.17,'-,[1.13-1.23],"CYP19A1, MIR4713HG",Endometrial cancer,endometrial carcinoma,GCST003524,15:51245609
rs17232730-<b>G</b>,4 x 10-7,,0.88,1.14,'-,[1.07-1.2],LINC00824,Endometrial cancer,endometrial carcinoma,GCST003524,8:128525500
rs711830-<b>A</b>,1 x 10-14,,0.319016,1.2736082,'-,[1.19835894617868-1.35358269315725],"HAGLR, HOXD3",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,2:176172583
rs112071820-<b>GCCAG</b>,2 x 10-13,,0.283067,1.2854952,'-,[1.20336051010928-1.37323590882365],MRPS22,Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,3:139130269
rs320203-<b>A</b>,2 x 10-8,,0.850197,1.2856314,'-,[1.17544642545976-1.4061450991104],RNU6-329P,Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,9:102180944
rs11651755-<b>T</b>,2 x 10-6,,0.513535,1.1539987,'-,'-,HNF1B,Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,17:37739849
rs688187-<b>A</b>,1 x 10-22,,0.312892,1.4258754,'-,[1.32592116400102-1.5333648423891],"IFNL3P1, IFNL3",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,19:39242112
rs752590-<b>G</b>,2 x 10-12,,0.210808,1.2968692,'-,[1.20743024891207-1.39293308913389],PAX8-AS1,Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,2:113215368
rs6755777-<b>T</b>,1 x 10-13,,0.319447,1.2623247,'-,[1.18761263149067-1.34173680787849],"HAGLR, HAGLROS",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,2:176178498
rs139337062-<b>A</b>,3 x 10-8,,0.488027204,0.7036727,'-,[0.621442066-0.796784242],"RN7SL564P, FABP7",Cervical cancer,cervical carcinoma,GCST90013696,6:122775829
rs13117307-<b>T</b>,3 x 10-10,(Matched),0.1,1.28,'-,[1.19-1.38],EXOC1,Cervical cancer,cervical carcinoma,GCST002082,4:55885574
rs4282438-<b>?</b>,5 x 10-27,(Stringently Matched),0.56,1.35,'-,[1.27-1.41],COL11A2P1,Cervical cancer,cervical carcinoma,GCST002082,6:33104395
rs8067378-<b>G</b>,9 x 10-10,(Matched),0.22,1.19,'-,[1.13-1.26],"ZPBP2, GSDMB",Cervical cancer,cervical carcinoma,GCST002082,17:39895095
rs9277952-<b>?</b>,2 x 10-9,(Matched),0.53,1.18,'-,[1.12-1.23],"ZNF70P1, HTATSF1P1",Cervical cancer,cervical carcinoma,GCST002082,6:33236497
rs2456181-<b>G</b>,4 x 10-10,,0.48,1.1494253,'-,[1.1-1.2],ZNF346,Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,5:177023836
rs72709458-<b>T</b>,4 x 10-8,,0.21,1.16,'-,[1.11-1.23],TERT,Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,5:1283640
rs149934734-<b>T</b>,6 x 10-8,,0.03,1.45,'-,[1.28-1.69],C11orf65,Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,11:108444879
rs12392108-<b>A</b>,5 x 10-7,,0.31,1.13,'-,[1.08-1.19],"AGKP2, RAP2C",Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,X:132180234
rs547025-<b>T</b>,2 x 10-6,,0.93,1.22,'-,[1.13-1.34],SIRT3,Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,11:232855
rs10976689-<b>?</b>,4 x 10-6,,0.4,1.1111112,'-,[1.06-1.16],"DMRT1, KANK1",Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,9:804886
rs78378222-<b>G</b>,2 x 10-7,,0.99,1.69,'-,[1.39-2.08],TP53,Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,17:7668434
rs58415480-<b>C</b>,2 x 10-54,,0.84,1.19,'-,[1.17-1.22],SYNE1,Uterine fibroids,uterine fibroid,GCST009158,6:152241136
rs12392108-<b>A</b>,6 x 10-46,,0.31,1.13,'-,[1.11-1.15],"AGKP2, RAP2C",Uterine fibroids,uterine fibroid,GCST009158,X:132180234
rs78378222-<b>T</b>,7 x 10-31,,0.99,1.54,'-,[1.43-1.66],TP53,Uterine fibroids,uterine fibroid,GCST009158,17:7668434
rs7412010-<b>C</b>,2 x 10-29,,0.15,1.13,'-,[1.11-1.16],"WNT4, CDC42",Uterine fibroids,uterine fibroid,GCST009158,1:22109953
rs149934734-<b>T</b>,1 x 10-27,,0.03,1.33,'-,[1.26-1.40],C11orf65,Uterine fibroids,uterine fibroid,GCST009158,11:108444879
rs61889186-<b>C</b>,1 x 10-25,,0.86,1.12,'-,[1.10-1.15],"THEM7P, WT1",Uterine fibroids,uterine fibroid,GCST009158,11:32346024
rs72709458-<b>T</b>,5 x 10-21,,0.23,1.1,'-,[1.08-1.13],TERT,Uterine fibroids,uterine fibroid,GCST009158,5:1283640
rs35417544-<b>T</b>,2 x 10-19,,0.69,1.09,'-,[1.07-1.10],GREB1,Uterine fibroids,uterine fibroid,GCST009158,2:11540277
rs62323682-<b>T</b>,5 x 10-18,,0.94,1.15,'-,[1.12-1.19],LNX1,Uterine fibroids,uterine fibroid,GCST009158,4:53684007
rs2131371-<b>A</b>,2 x 10-18,,0.28,1.08,'-,[1.06-1.10],SLC38A2,Uterine fibroids,uterine fibroid,GCST009158,12:46402739
rs4360450-<b>A</b>,2 x 10-18,,0.37,1.08,'-,[1.06-1.10],SLC7A3,Uterine fibroids,uterine fibroid,GCST009158,X:70926548
rs9419958-<b>T</b>,1 x 10-16,,0.13,1.1,'-,[1.08-1.13],STN1,Uterine fibroids,uterine fibroid,GCST009158,10:103916188
rs4821939-<b>A</b>,8 x 10-16,,0.2,1.08,'-,[1.06-1.10],TNRC6B,Uterine fibroids,uterine fibroid,GCST009158,22:40263247
rs11031006-<b>A</b>,6 x 10-15,,0.14,1.1,'-,[1.07-1.12],FSHB,Uterine fibroids,uterine fibroid,GCST009158,11:30204981
rs12640488-<b>A</b>,4 x 10-14,,0.52,1.06,'-,[1.05-1.08],SULT1B1,Uterine fibroids,uterine fibroid,GCST009158,4:69735020
rs547025-<b>T</b>,2 x 10-14,,0.92,1.13,'-,[1.09-1.16],SIRT3,Uterine fibroids,uterine fibroid,GCST009158,11:232855
rs2785202-<b>C</b>,7 x 10-14,,0.55,1.06,'-,[1.05-1.08],"CD44, PDHX",Uterine fibroids,uterine fibroid,GCST009158,11:35063288
rs117245733-<b>A</b>,6 x 10-14,,0.02,1.31,'-,[1.21-1.39],LINC00598,Uterine fibroids,uterine fibroid,GCST009158,13:40149807
rs10976689-<b>A</b>,2 x 10-13,,0.6,1.06,'-,[1.05-1.08],"DMRT1, KANK1",Uterine fibroids,uterine fibroid,GCST009158,9:804886
rs2456181-<b>C</b>,1 x 10-11,,0.49,1.06,'-,[1.04-1.08],ZNF346,Uterine fibroids,uterine fibroid,GCST009158,5:177023836
rs10508765-<b>A</b>,2 x 10-10,,0.8,1.07,'-,[1.05-1.09],MACORIS,Uterine fibroids,uterine fibroid,GCST009158,10:31679855
rs16991615-<b>A</b>,9 x 10-10,,0.07,1.11,'-,[1.07-1.14],MCM8,Uterine fibroids,uterine fibroid,GCST009158,20:5967581
rs55819434-<b>A</b>,6 x 10-9,,0.91,1.09,'-,[1.06-1.12],BABAM2,Uterine fibroids,uterine fibroid,GCST009158,2:28110242
rs35446936-<b>A</b>,1 x 10-8,,0.24,1.06,'-,[1.04-1.08],ACTRT3,Uterine fibroids,uterine fibroid,GCST009158,3:169768720
rs4699299-<b>T</b>,5 x 10-8,,0.69,1.05,'-,[1.03-1.07],PDLIM5,Uterine fibroids,uterine fibroid,GCST009158,4:94580015
rs116251328-<b>A</b>,3 x 10-8,,0.02,1.15,'-,[1.09-1.21],"KRT18P9, CYCSP55",Uterine fibroids,uterine fibroid,GCST009158,6:34209733
rs2270206-<b>A</b>,5 x 10-8,,0.16,1.06,'-,[1.04-1.09],"MTCYBP6, WNT2",Uterine fibroids,uterine fibroid,GCST009158,7:117273513
rs11178393-<b>T</b>,3 x 10-8,,0.89,1.08,'-,[1.05-1.10],PTPRR,Uterine fibroids,uterine fibroid,GCST009158,12:70756878
rs28583837-<b>A</b>,2 x 10-8,,0.22,1.06,'-,[1.04-1.08],"SBNO1-AS1, KMT5A",Uterine fibroids,uterine fibroid,GCST009158,12:123379073
rs3951242-<b>A</b>,3 x 10-8,,0.4697,'-,0.0461 unit decrease,[0.03-0.062],SLC66A3,Uterine fibroids,uterine fibroid,GCST009158,2:11166852
rs35417544-<b>T</b>,2 x 10-19,,0.7058,'-,0.0812 unit increase,[0.064-0.099],GREB1,Uterine fibroids,uterine fibroid,GCST009158,2:11540277
rs62115045-<b>A</b>,7 x 10-8,,0.1836,'-,0.056 unit increase,[0.036-0.076],MIR3681HG,Uterine fibroids,uterine fibroid,GCST009158,2:11961997
rs17021300-<b>A</b>,7 x 10-6,(conditional),0.0431,'-,0.0803 unit decrease,[0.041-0.12],'-,Uterine fibroids,uterine fibroid,GCST009158,4:94038061
rs4699299-<b>T</b>,5 x 10-8,,0.6903,'-,0.0477 unit decrease,[0.031-0.065],PDLIM5,Uterine fibroids,uterine fibroid,GCST009158,4:94580015
rs11735529-<b>C</b>,2 x 10-6,,0.5938,'-,0.0517 unit decrease,[0.03-0.073],SCFD2,Uterine fibroids,uterine fibroid,GCST009158,4:52992781
rs62323682-<b>T</b>,5 x 10-18,,0.9305,'-,0.1411 unit decrease,[0.11-0.17],LNX1,Uterine fibroids,uterine fibroid,GCST009158,4:53684007
rs72709458-<b>T</b>,5 x 10-21,,0.2114,'-,0.0983 unit increase,[0.078-0.119],TERT,Uterine fibroids,uterine fibroid,GCST009158,5:1283640
rs2853676-<b>T</b>,8 x 10-14,,0.2705,'-,0.0681 unit increase,[0.05-0.086],TERT,Uterine fibroids,uterine fibroid,GCST009158,5:1288432
rs58415480-<b>C</b>,2 x 10-54,,0.8439,'-,0.1748 unit decrease,[0.15-0.2],SYNE1,Uterine fibroids,uterine fibroid,GCST009158,6:152241136
rs6901631-<b>T</b>,2 x 10-15,,0.8634,'-,0.0946 unit increase,[0.071-0.118],SYNE1,Uterine fibroids,uterine fibroid,GCST009158,6:152245912
rs10815466-<b>A</b>,2 x 10-12,,0.1509,'-,0.0798 unit increase,[0.057-0.102],KANK1,Uterine fibroids,uterine fibroid,GCST009158,9:680714
rs10976689-<b>A</b>,2 x 10-13,,0.598,'-,0.0608 unit decrease,[0.045-0.077],"DMRT1, KANK1",Uterine fibroids,uterine fibroid,GCST009158,9:804886
rs11031006-<b>A</b>,6 x 10-15,,0.1432,'-,0.0925 unit decrease,[0.069-0.116],FSHB,Uterine fibroids,uterine fibroid,GCST009158,11:30204981
rs12224688-<b>T</b>,9 x 10-8,(conditional),0.2405,'-,0.0242 unit increase,[0.0054-0.043],THEM7P,Uterine fibroids,uterine fibroid,GCST009158,11:32305471
rs61889186-<b>C</b>,1 x 10-25,,0.8457,'-,0.1167 unit decrease,[0.095-0.139],"THEM7P, WT1",Uterine fibroids,uterine fibroid,GCST009158,11:32346024
rs2732552-<b>T</b>,7 x 10-14,,0.447,'-,0.0608 unit decrease,[0.045-0.077],"CD44, PDHX",Uterine fibroids,uterine fibroid,GCST009158,11:35063045
rs149934734-<b>T</b>,1 x 10-27,,0.0255,'-,0.2824 unit increase,[0.23-0.33],C11orf65,Uterine fibroids,uterine fibroid,GCST009158,11:108444879
rs72993806-<b>C</b>,5 x 10-15,,0.847,'-,0.0895 unit increase,[0.067-0.112],POGLUT3,Uterine fibroids,uterine fibroid,GCST009158,11:108488962
rs11246003-<b>T</b>,3 x 10-10,,0.9583,'-,0.1283 unit increase,[0.089-0.168],RIC8A,Uterine fibroids,uterine fibroid,GCST009158,11:213723
rs547025-<b>T</b>,1 x 10-14,,0.9241,'-,0.1189 unit increase,[0.089-0.149],SIRT3,Uterine fibroids,uterine fibroid,GCST009158,11:232855
rs9548898-<b>A</b>,3 x 10-9,,0.5109,'-,0.0478 unit increase,[0.032-0.064],COG6,Uterine fibroids,uterine fibroid,GCST009158,13:39726408
rs9548980-<b>T</b>,4 x 10-7,,0.413,'-,0.0422 unit decrease,[0.026-0.058],SNORD116,Uterine fibroids,uterine fibroid,GCST009158,13:39921324
rs117245733-<b>A</b>,6 x 10-14,,0.0171,'-,0.2614 unit increase,[0.19-0.33],LINC00598,Uterine fibroids,uterine fibroid,GCST009158,13:40149807
rs6563812-<b>C</b>,8 x 10-9,,0.4791,'-,0.0478 unit decrease,[0.032-0.064],LINC00598,Uterine fibroids,uterine fibroid,GCST009158,13:40269668
rs7986407-<b>A</b>,2 x 10-13,,0.6908,'-,0.064 unit decrease,[0.047-0.081],FOXO1,Uterine fibroids,uterine fibroid,GCST009158,13:40605661
rs3820282-<b>T</b>,2 x 10-15,,0.546288213,1.1827276,'-,[1.134949999-1.232516418],WNT4,Uterine fibroids,uterine fibroid,GCST90013720,1:22141722
rs17116149-<b>A</b>,1 x 10-14,,0.075315114,1.3587967,'-,[1.25666984-1.46922335],"SLK, STN1",Uterine fibroids,uterine fibroid,GCST90013720,10:103928292
rs12222188-<b>A</b>,1 x 10-24,,0.124840433,0.7155242,'-,[0.671147676-0.762834869],SIRT3,Uterine fibroids,uterine fibroid,GCST90013720,11:224063
rs4821936-<b>G</b>,7 x 10-19,,0.355925413,1.2110424,'-,[1.160905801-1.263344225],TNRC6B,Uterine fibroids,uterine fibroid,GCST90013720,22:40236506
rs10069690-<b>T</b>,4 x 10-18,,0.25878,1.12,'-,[1.1-1.15],TERT,Uterine fibroids,uterine fibroid,GCST006462,5:1279675
rs6861925-<b>C</b>,3 x 10-9,,0.47596,1.07,'-,[1.05-1.1],HK3,Uterine fibroids,uterine fibroid,GCST006462,5:176897728
rs58400555-<b>T</b>,2 x 10-9,,0.47497,1.07,'-,[1.05-1.1],ZNF346,Uterine fibroids,uterine fibroid,GCST006462,5:177027080
rs58415480-<b>G</b>,9 x 10-24,,0.14157,1.18,'-,[1.14-1.22],SYNE1,Uterine fibroids,uterine fibroid,GCST006462,6:152241136
rs35569312-<b>T</b>,5 x 10-10,,0.13579,1.11,'-,[1.08-1.15],SYNE1,Uterine fibroids,uterine fibroid,GCST006462,6:152343404
rs73639400-<b>C</b>,3 x 10-12,,0.14247,1.12,'-,[1.09-1.16],KANK1,Uterine fibroids,uterine fibroid,GCST006462,9:683423
rs7030354-<b>T</b>,4 x 10-18,,0.40694,1.11,'-,[1.09-1.14],"KANK1, DMRT1",Uterine fibroids,uterine fibroid,GCST006462,9:804231
rs7907606-<b>G</b>,3 x 10-9,,0.15533,1.1,'-,[1.07-1.14],"STN1, SLK",Uterine fibroids,uterine fibroid,GCST006462,10:103920874
rs507139-<b>G</b>,3 x 10-16,,0.91118,1.2048193,'-,[1.16-1.27],SIRT3,Uterine fibroids,uterine fibroid,GCST006462,11:225196
rs11031731-<b>A</b>,5 x 10-16,,0.15803,1.14,'-,[1.1-1.17],"THEM7P, WT1",Uterine fibroids,uterine fibroid,GCST006462,11:32343884
rs2785152-<b>T</b>,2 x 10-9,,0.51015,1.08,'-,[1.05-1.1],"CD44, PDHX",Uterine fibroids,uterine fibroid,GCST006462,11:35048521
rs141379009-<b>G</b>,3 x 10-12,,0.01997,1.29,'-,[1.2-1.38],ATM,Uterine fibroids,uterine fibroid,GCST006462,11:108278480
rs149934734-<b>T</b>,3 x 10-12,,0.01997,1.29,'-,[1.2-1.38],C11orf65,Uterine fibroids,uterine fibroid,GCST006462,11:108444879
rs117245733-<b>A</b>,5 x 10-10,,0.02319,1.3,'-,[1.2-1.41],LINC00598,Uterine fibroids,uterine fibroid,GCST006462,13:40149807
rs66998222-<b>G</b>,1 x 10-9,,0.84407,1.098901,'-,[1.06-1.14],'-,Uterine fibroids,uterine fibroid,GCST006462,16:51447685
rs72842813-<b>A</b>,2 x 10-10,,0.04483,1.23,'-,[1.15-1.3],NLGN2,Uterine fibroids,uterine fibroid,GCST006462,17:7408930
rs143094271-<b>A</b>,3 x 10-23,,0.02686,1.43,'-,[1.34-1.54],"TNFSF12-TNFSF13, TNFSF13",Uterine fibroids,uterine fibroid,GCST006462,17:7559785
rs78378222-<b>G</b>,4 x 10-37,,0.01827,1.74,'-,[1.6-1.89],TP53,Uterine fibroids,uterine fibroid,GCST006462,17:7668434
rs138420351-<b>T</b>,3 x 10-30,,0.01311,1.76,'-,[1.6-1.94],DNAH2,Uterine fibroids,uterine fibroid,GCST006462,17:7796745
rs16991615-<b>A</b>,2 x 10-10,,0.08139,1.16,'-,[1.11-1.21],MCM8,Uterine fibroids,uterine fibroid,GCST006462,20:5967581
rs4402860-<b>T</b>,1 x 10-12,,0.24728,1.11,'-,[1.08-1.14],TNRC6B,Uterine fibroids,uterine fibroid,GCST006462,22:40158441
rs12484951-<b>G</b>,3 x 10-13,,0.25232,1.11,'-,[1.08-1.14],TNRC6B,Uterine fibroids,uterine fibroid,GCST006462,22:40307071
rs729982-<b>C</b>,5 x 10-9,,0.19039,1.14,'-,[1.09-1.19],MRTFA,Uterine fibroids,uterine fibroid,GCST006462,22:40414942
rs148143917-<b>A</b>,8 x 10-10,,0.981,1.3513513,'-,[1.22-1.49],GREB1,Uterine fibroids,uterine fibroid,GCST006462,2:11524625
rs11246001-<b>C</b>,5 x 10-12,,0.956,1.2195122,'-,[1.15-1.28],RIC8A,Uterine fibroids,uterine fibroid,GCST006462,11:210899
rs12037376-<b>A</b>,4 x 10-8,,NR,1.15,'-,[1.09-1.21],WNT4,Uterine fibroids,uterine fibroid,GCST006462,1:22135618
rs71575922-<b>G</b>,4 x 10-8,,NR,1.17,'-,[1.11-1.24],SYNE1,Uterine fibroids,uterine fibroid,GCST006462,6:152232879
rs10917151-<b>A</b>,5 x 10-14,,0.20124,1.12,'-,[1.09-1.16],CDC42,Uterine fibroids,uterine fibroid,GCST006462,1:22096228
rs4335411-<b>A</b>,4 x 10-9,,0.73729,1.09,'-,[1.06-1.12],"ZNF692, PGBD2",Uterine fibroids,uterine fibroid,GCST006462,1:248897507
rs10929757-<b>C</b>,7 x 10-10,,0.60029,1.08,'-,[1.05-1.1],GREB1,Uterine fibroids,uterine fibroid,GCST006462,2:11562535
rs4684433-<b>T</b>,3 x 10-8,,0.62773,1.0752687,'-,[1.05-1.1],ITPR1,Uterine fibroids,uterine fibroid,GCST006462,3:4677552
rs479404-<b>C</b>,9 x 10-11,,0.32175,1.09,'-,[1.06-1.12],NEK10,Uterine fibroids,uterine fibroid,GCST006462,3:27321573
rs6771541-<b>T</b>,3 x 10-9,,0.38564,1.08,'-,[1.05-1.1],"SLC4A7, RNU1-96P",Uterine fibroids,uterine fibroid,GCST006462,3:27485025
rs12638862-<b>A</b>,3 x 10-8,,0.7851,1.0752687,'-,[1.05-1.11],"RNU6-637P, TERC",Uterine fibroids,uterine fibroid,GCST006462,3:169759718
rs780590302-<b>A</b>,4 x 10-10,,0.00305,2.45,'-,[1.86-3.23],"YIPF7, KCTD8",Uterine fibroids,uterine fibroid,GCST006462,4:44530629
rs540409605-<b>G</b>,2 x 10-10,,0.00305,2.48,'-,[1.88-3.26],'-,Uterine fibroids,uterine fibroid,GCST006462,4:45654814
rs754058883-<b>C</b>,2 x 10-11,,0.0027,2.71,'-,[2.04-3.6],'-,Uterine fibroids,uterine fibroid,GCST006462,4:45786110
rs779929745-<b>G</b>,3 x 10-11,,0.00272,2.68,'-,[2.01-3.56],"GABRG1, RN7SKP199",Uterine fibroids,uterine fibroid,GCST006462,4:46002240
rs772494879-<b>T</b>,3 x 10-11,,0.00272,2.68,'-,[2.01-3.56],GABRG1,Uterine fibroids,uterine fibroid,GCST006462,4:46136789
rs142274555-<b>C</b>,4 x 10-8,,0.00797,1.68,'-,[1.4-2.02],NIPAL1,Uterine fibroids,uterine fibroid,GCST006462,4:48034600
rs551980034-<b>T</b>,4 x 10-12,,0.00288,2.71,'-,[2.05-3.57],SLAIN2,Uterine fibroids,uterine fibroid,GCST006462,4:48374339
rs760402913-<b>T</b>,3 x 10-13,,0.00298,2.79,'-,[2.13-3.66],"RNU6-158P, CWH43",Uterine fibroids,uterine fibroid,GCST006462,4:48948860
rs149787529-<b>T</b>,1 x 10-8,,0.00957,1.66,'-,[1.4-1.97],SPATA18,Uterine fibroids,uterine fibroid,GCST006462,4:52165349
rs188539274-<b>T</b>,7 x 10-9,,0.00397,1.74,'-,[1.45-2.08],SCFD2,Uterine fibroids,uterine fibroid,GCST006462,4:52893799
rs765333492-<b>C</b>,2 x 10-13,,0.00314,2.76,'-,[2.11-3.6],SCFD2,Uterine fibroids,uterine fibroid,GCST006462,4:53021103
rs183241934-<b>C</b>,3 x 10-9,,0.00414,1.96,'-,[1.58-2.44],SCFD2,Uterine fibroids,uterine fibroid,GCST006462,4:53140760
rs745398820-<b>G</b>,8 x 10-10,,0.00412,2.18,'-,[1.71-2.79],LNX1,Uterine fibroids,uterine fibroid,GCST006462,4:53466157
rs191692776-<b>T</b>,2 x 10-8,,0.00412,2.03,'-,[1.6-2.59],LNX1,Uterine fibroids,uterine fibroid,GCST006462,4:53718356
rs775444277-<b>G</b>,9 x 10-10,,0.00248,2.63,'-,[1.94-3.57],"RPL22P13, GSX2",Uterine fibroids,uterine fibroid,GCST006462,4:54199163
rs2202282-<b>T</b>,6 x 10-13,,0.48514,1.09,'-,[1.06-1.12],SULT1B1,Uterine fibroids,uterine fibroid,GCST006462,4:69768723
rs1800057-<b>G</b>,3 x 10-11,,0.02,1.28,'-,[1.19-1.38],ATM,Uterine fibroids,uterine fibroid,GCST006462,11:108272729
rs1801516-<b>G</b>,7 x 10-8,,0.848,1.098901,'-,[1.06-1.14],ATM,Uterine fibroids,uterine fibroid,GCST006462,11:108304735
rs7986407-<b>G</b>,7 x 10-8,,0.305,1.07,'-,[1.04-1.10],FOXO1,Uterine fibroids,uterine fibroid,GCST006462,13:40605661
rs17361789-<b>G</b>,5 x 10-8,,0.32,1.0638298,'-,[1.04-1.09],DNM3,Uterine fibroids,uterine fibroid,GCST008423,1:172153461
rs4785384-<b>T</b>,1 x 10-9,,0.73,1.08,'-,[1.05-1.10],"RPL10P14, HEATR3",Uterine fibroids,uterine fibroid,GCST008423,16:50114082
rs6094982-<b>A</b>,3 x 10-8,,0.04,2.09,'-,[1.61-2.70],'-,Uterine fibroids,uterine fibroid,GCST008423,20:48132514
rs10917151-<b>A</b>,2 x 10-24,,0.16,1.16,'-,[1.13-1.19],CDC42,Uterine fibroids,uterine fibroid,GCST008423,1:22096228
rs58415480-<b>G</b>,2 x 10-31,,0.16,1.1904762,'-,[1.15-1.22],SYNE1,Uterine fibroids,uterine fibroid,GCST008423,6:152241136
rs1812264-<b>G</b>,1 x 10-18,,0.39,1.098901,'-,[1.08-1.12],"DMRT1, KANK1",Uterine fibroids,uterine fibroid,GCST008423,9:805427
rs7907606-<b>G</b>,2 x 10-16,,0.19,1.1235955,'-,[1.09-1.15],"STN1, SLK",Uterine fibroids,uterine fibroid,GCST008423,10:103920874
rs7124615-<b>C</b>,1 x 10-20,,0.86,1.1627907,'-,[1.12-1.2],BET1L,Uterine fibroids,uterine fibroid,GCST008423,11:186604
rs10835889-<b>A</b>,1 x 10-24,,0.18,1.16,'-,[1.13-1.19],"WT1, THEM7P",Uterine fibroids,uterine fibroid,GCST008423,11:32348834
rs78378222-<b>G</b>,3 x 10-33,,0.01,1.8518518,'-,[1.67-2.04],TP53,Uterine fibroids,uterine fibroid,GCST008423,17:7668434
rs3830738-<b>AT</b>,3 x 10-13,,0.21,1.098901,'-,[1.08-1.12],TNRC6B,Uterine fibroids,uterine fibroid,GCST008423,22:40315224
rs555025179-<b>GACAC</b>,5 x 10-8,,0.531475,1.18,'-,[1.11364451527015-1.25657782750532],MAST4,Endometrioid ovarian cancer,ovarian endometrioid carcinoma,GCST004418,5:66825262
rs2665390-<b>C</b>,3 x 10-7,,NR,1.19,'-,[1.11-1.27],TIPARP,Ovarian cancer,ovarian carcinoma,GCST000802,3:156679960
rs7521902-<b>?</b>,5 x 10-6,,NR,1.12,'-,[1.07-1.18],WNT4,Ovarian cancer,ovarian carcinoma,GCST000802,1:22164231
rs12794435-<b>?</b>,5 x 10-6,,NR,1.16,'-,[1.09-1.23],'-,Ovarian cancer,ovarian carcinoma,GCST000802,11:25186158
rs2072590-<b>T</b>,5 x 10-14,,NR,1.16,'-,[1.12-1.21],"HAGLROS, HAGLR",Ovarian cancer,ovarian carcinoma,GCST000802,2:176177905
rs10088218-<b>G</b>,3 x 10-9,,NR,1.19,'-,[1.12-1.25],LINC00824,Ovarian cancer,ovarian carcinoma,GCST000802,8:128531703
rs9303542-<b>G</b>,1 x 10-6,,NR,1.11,'-,[1.06-1.16],SKAP1,Ovarian cancer,ovarian carcinoma,GCST000802,17:48334138
rs2084881-<b>?</b>,2 x 10-6,,NR,1.12,'-,[1.07-1.18],SKAP1,Ovarian cancer,ovarian carcinoma,GCST000802,17:48279758
rs8170-<b>T</b>,4 x 10-6,(Susceptibility),NR,1.12,'-,[1.07-1.17],"BABAM1, USHBP1",Ovarian cancer,ovarian carcinoma,GCST000800,19:17278895
rs2363956-<b>T</b>,1 x 10-7,(Susceptibility),NR,1.1,'-,[1.06-1.15],ANKLE1,Ovarian cancer,ovarian carcinoma,GCST000800,19:17283315
rs3814113-<b>T</b>,5 x 10-19,,0.68,1.22,'-,[1.16-1.27],BNC2,Ovarian cancer,ovarian carcinoma,GCST000455,9:16915023
rs3814113-<b>G</b>,6 x 10-50,,0.32,1.2658228,'-,[1.22-1.32],BNC2,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,9:16915023
rs10088218-<b>A</b>,1 x 10-20,,0.13,1.2987013,'-,[1.22-1.37],LINC00824,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,8:128531703
rs2072590-<b>A</b>,9 x 10-14,,0.68,1.14,'-,[1.10-1.19],"HAGLROS, HAGLR",Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,2:176177905
rs7651446-<b>A</b>,6 x 10-51,,0.05,1.59,'-,[1.48-1.70],TIPARP,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,3:156689208
rs8170-<b>A</b>,5 x 10-14,,0.19,1.18,'-,[1.13-1.23],"BABAM1, USHBP1",Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,19:17278895
rs9303542-<b>G</b>,5 x 10-15,,0.27,1.14,'-,[1.10-1.19],SKAP1,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,17:48334138
rs11782652-<b>G</b>,3 x 10-10,,0.07,'-,'-,[1.16-1.32],CHMP4C,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,8:81741409
rs1243180-<b>A</b>,1 x 10-9,,0.31,1.1,'-,[1.06-1.14],MLLT10,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,10:21626690
rs757210-<b>A</b>,2 x 10-8,,0.63,1.11,'-,[1.07-1.15],HNF1B,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,17:37736525
rs10069690-<b>A</b>,9 x 10-9,,0.26,1.14,'-,[1.10-1.19],TERT,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,5:1279675
rs183211-<b>A</b>,2 x 10-13,,0.24,1.11,'-,[1.07-1.16],NSF,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,17:46710944
rs3820282-<b>?</b>,2 x 10-8,,NR,1.11,'-,[1.06-1.15],WNT4,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,1:22141722
rs12039431-<b>?</b>,1 x 10-8,,NR,1.07,'-,[1.03-1.11],RSPO1,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,1:37616450
rs17329882-<b>?</b>,2 x 10-8,,NR,1.09,'-,[1.06-1.13],SYNPO2,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,4:119028805
rs115344852-<b>?</b>,6 x 10-6,,NR,1.0638298,'-,[1.03-1.1],GPX6,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,6:28518321
rs8044477-<b>?</b>,1 x 10-8,,NR,1.1,'-,'-,Metazoa_SRP,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,16:58942687
rs3820282-<b>?</b>,8 x 10-8,(Serous),NR,1.12,'-,[1.07-1.17],WNT4,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,1:22141722
rs12039431-<b>?</b>,1 x 10-11,(Serous),NR,1.11,'-,[1.07-1.16],RSPO1,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,1:37616450
rs17329882-<b>?</b>,2 x 10-8,(Serous),NR,1.11,'-,[1.07-1.16],SYNPO2,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,4:119028805
rs115344852-<b>?</b>,3 x 10-8,(Serous),NR,1.098901,'-,[1.06-1.15],GPX6,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,6:28518321
rs8044477-<b>?</b>,2 x 10-7,(Serous),NR,1.1,'-,[1.06-1.15],Metazoa_SRP,Epithelial ovarian cancer,Malignant epithelial tumor of ovary,GCST002748,16:58942687
rs3814113-<b>?</b>,4 x 10-29,(All invasive),0.68,1.21,'-,[1.17-1.25],BNC2,Ovarian cancer,ovarian carcinoma,GCST001941,9:16915023
rs3814113-<b>?</b>,4 x 10-32,(Serious invasive),0.68,1.28,'-,[1.23-1.33],BNC2,Ovarian cancer,ovarian carcinoma,GCST001941,9:16915023
rs10088218-<b>?</b>,3 x 10-12,(All invasive),0.87,1.18,'-,[1.13-1.24],LINC00824,Ovarian cancer,ovarian carcinoma,GCST001941,8:128531703
rs10088218-<b>?</b>,1 x 10-17,(Serious invasive),0.87,1.29,'-,[1.21-1.36],LINC00824,Ovarian cancer,ovarian carcinoma,GCST001941,8:128531703
rs2072590-<b>?</b>,5 x 10-11,(All invasive),0.32,1.11,'-,[1.08-1.15],"HAGLROS, HAGLR",Ovarian cancer,ovarian carcinoma,GCST001941,2:176177905
rs2072590-<b>?</b>,3 x 10-10,(Serious invasive),0.32,1.13,'-,[1.09-1.18],"HAGLROS, HAGLR",Ovarian cancer,ovarian carcinoma,GCST001941,2:176177905
rs7651446-<b>?</b>,2 x 10-29,(All invasive),0.05,1.44,'-,[1.35-1.54],TIPARP,Ovarian cancer,ovarian carcinoma,GCST001941,3:156689208
rs7651446-<b>?</b>,2 x 10-34,(Serious invasive),0.05,1.59,'-,[1.48-1.71],TIPARP,Ovarian cancer,ovarian carcinoma,GCST001941,3:156689208
rs8170-<b>?</b>,2 x 10-7,(All invasive),0.19,1.11,'-,[1.07-1.15],"BABAM1, USHBP1",Ovarian cancer,ovarian carcinoma,GCST001941,19:17278895
rs8170-<b>?</b>,3 x 10-14,(Serious invasive),0.19,1.19,'-,[1.14-1.25],"BABAM1, USHBP1",Ovarian cancer,ovarian carcinoma,GCST001941,19:17278895
rs9303542-<b>?</b>,6 x 10-9,(All invasive),0.27,1.12,'-,[1.08-1.16],SKAP1,Ovarian cancer,ovarian carcinoma,GCST001941,17:48334138
rs9303542-<b>?</b>,3 x 10-10,(Serious invasive),0.27,1.14,'-,[1.09-1.18],SKAP1,Ovarian cancer,ovarian carcinoma,GCST001941,17:48334138
rs11782652-<b>A</b>,6 x 10-9,(All invasive),0.07,1.19,'-,[1.12-1.26],CHMP4C,Ovarian cancer,ovarian carcinoma,GCST001941,8:81741409
rs1243180-<b>T</b>,2 x 10-8,(All invasive),0.31,1.1,'-,[1.06-1.13],MLLT10,Ovarian cancer,ovarian carcinoma,GCST001941,10:21626690
rs1243180-<b>T</b>,1 x 10-7,(Serious invasive),0.31,1.11,'-,[1.07-1.15],MLLT10,Ovarian cancer,ovarian carcinoma,GCST001941,10:21626690
rs757210-<b>G</b>,8 x 10-10,(Serious invasive),0.37,1.12,'-,[1.08-1.17],HNF1B,Ovarian cancer,ovarian carcinoma,GCST001941,17:37736525
rs11782652-<b>A</b>,7 x 10-10,(Serious invasive),0.07,1.24,'-,[1.16-1.33],CHMP4C,Ovarian cancer,ovarian carcinoma,GCST001941,8:81741409
rs62274041-<b>G</b>,3 x 10-46,,0.0481682,1.5885553,'-,[1.49139660538722-1.69204355063709],"LINC00886, METTL15P1",Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,3:156717851
rs10069690-<b>T</b>,2 x 10-12,,0.259806,1.1303236,'-,[1.09267833241685-1.16926591871766],TERT,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,5:1279675
rs7705526-<b>A</b>,6 x 10-10,,0.332078,1.1067635,'-,[1.07188995128973-1.14277166876843],TERT,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,5:1285859
chr8:82668818-<b>G</b>,2 x 10-9,,0.0663033,1.1915798,'-,[1.12527496598389-1.26179155485818],'-,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,Mapping not available
rs1400482-<b>G</b>,2 x 10-24,,0.867974,1.2746594,'-,[1.21607733088533-1.33606352682139],LINC00824,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,8:128529685
rs10962692-<b>G</b>,3 x 10-43,,0.799624,1.3252935,'-,[1.27262437839255-1.38014255146877],BNC2,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,9:16915876
chr9:136138765-<b>G</b>,7 x 10-11,,0.194216,1.1340009,'-,[1.0921011879635-1.17750814490349],'-,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,Mapping not available
rs144962376-<b>T</b>,7 x 10-9,,0.309302,1.0992962,'-,[1.06472642475689-1.13498849236897],MLLT10,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,10:21589903
rs8037137-<b>C</b>,1 x 10-7,,0.133619,1.1235955,'-,[1.08-1.18],"RCCD1, PRC1",Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,15:90963407
rs7405776-<b>G</b>,2 x 10-10,,0.41189,1.1048253,'-,[1.07145224223974-1.13923779281726],HNF1B,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,17:37733029
rs11651755-<b>C</b>,1 x 10-8,,0.486465,1.0903314,'-,[1.05822261240111-1.12341446823123],HNF1B,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,17:37739849
rs1879586-<b>G</b>,3 x 10-12,,0.181254,1.1472089,'-,[1.10406141518038-1.19204274035159],PLEKHM1,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,17:45489971
rs7207826-<b>C</b>,1 x 10-14,,0.267801,1.13894,'-,[1.10200256244972-1.17711551141243],SKAP1,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,17:48423311
rs4808075-<b>C</b>,4 x 10-24,,0.295975,1.1823713,'-,[1.14473972413471-1.22123996090847],"BABAM1, USHBP1",Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,19:17279482
rs6005807-<b>C</b>,5 x 10-9,,0.898635,1.1651025,'-,[1.10668774857942-1.22660041924],TTC28,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,22:28538325
rs2165109-<b>C</b>,4 x 10-7,,0.251869,1.0926361,'-,[1.05582163841262-1.13073417257807],"ACOXL, MIR4435-2HG",Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,2:111061081
rs9886651-<b>G</b>,8 x 10-6,,0.461222,1.0710524,'-,[1.03930535696901-1.10376916464823],PVT1,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,8:127805637
rs7953249-<b>G</b>,3 x 10-7,,0.417632,1.0817573,'-,[1.04973458497305-1.11475700006623],HNF1A-AS1,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,12:120965921
rs13113999-<b>T</b>,5 x 10-8,,0.515696,1.2250321,'-,[1.13870977824743-1.31789814351814],Y_RNA,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,4:166265894
rs10069690-<b>T</b>,4 x 10-9,,0.259806,1.2546542,'-,[1.16419555293272-1.35214154339342],TERT,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,5:1279675
rs7705526-<b>A</b>,6 x 10-19,,0.332078,1.3829999,'-,[1.28830538018993-1.48465482476452],TERT,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,5:1285859
rs1400482-<b>G</b>,2 x 10-12,,0.867974,1.4812524,'-,[1.32210226140915-1.65956066549562],LINC00824,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,8:128529685
rs7902587-<b>T</b>,9 x 10-7,,0.0975691,1.3209459,'-,[1.18528926703463-1.47212825755187],"STN1, SLK",Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,10:103934543
rs11651755-<b>C</b>,5 x 10-6,,0.486465,1.1726217,'-,[1.09521694178849-1.25549703248424],HNF1B,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,17:37739849
rs7207826-<b>C</b>,8 x 10-6,,0.267801,1.1832383,'-,[1.09949355363646-1.27336159916358],SKAP1,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,17:48423311
rs8098244-<b>A</b>,9 x 10-6,,0.275361,1.1853783,'-,[1.10016620517041-1.27719049018494],LAMA3,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,18:23825589
rs711830-<b>A</b>,5 x 10-8,,0.319016,1.1790794,'-,[1.11145306187694-1.25082055006039],"HAGLR, HOXD3",Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,2:176172583
rs6755777-<b>T</b>,3 x 10-6,,0.319447,1.1861752,'-,[1.1045500086088-1.27383238173854],"HAGLR, HAGLROS",Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,2:176178498
rs58722170-<b>C</b>,8 x 10-8,,0.220826,1.1063784,'-,[1.06640418255445-1.14785110269475],RSPO1,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,1:37630749
rs711830-<b>A</b>,8 x 10-13,,0.319016,1.1268522,'-,[1.09069613461779-1.16420663147032],"HAGLR, HOXD3",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,2:176172583
rs6755777-<b>T</b>,5 x 10-13,,0.319447,1.1282876,'-,[1.09203474654839-1.16574376009934],"HAGLR, HAGLROS",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,2:176178498
rs62274041-<b>G</b>,4 x 10-49,,0.0481682,1.630706,'-,[1.52886835426178-1.73932685946596],"LINC00886, METTL15P1",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,3:156717851
rs10069690-<b>T</b>,5 x 10-12,,0.259806,1.1310111,'-,[1.09226786405932-1.17112854934655],TERT,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,5:1279675
rs7705526-<b>A</b>,2 x 10-8,,0.332078,1.099452,'-,[1.06380317084564-1.13629550714478],TERT,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,5:1285859
chr8:82668818-<b>G</b>,9 x 10-10,,0.0663033,1.2026194,'-,[1.13408089642882-1.27530001906482],'-,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,Mapping not available
rs1400482-<b>G</b>,7 x 10-22,,0.867974,1.2638669,'-,[1.20425676967645-1.32642773080558],LINC00824,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,8:128529685
rs10962692-<b>G</b>,1 x 10-47,,0.799624,1.358497,'-,[1.30256836396842-1.41682722055063],BNC2,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,9:16915876
rs4742903-<b>T</b>,6 x 10-6,,0.563,1.0740868,'-,[1.04130585570624-1.10789968145028],SMC2,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,9:104094512
chr9:136138765-<b>G</b>,5 x 10-12,,0.194216,1.146201,'-,[1.10275565491329-1.19135797504449],'-,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,Mapping not available
rs144962376-<b>T</b>,2 x 10-8,,0.309302,1.09834,'-,[1.06283348839533-1.13503280772478],MLLT10,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,10:21589903
rs8037137-<b>C</b>,7 x 10-8,,0.133619,1.1363636,'-,[1.09-1.19],"RCCD1, PRC1",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,15:90963407
rs7405776-<b>G</b>,3 x 10-9,,0.41189,1.1008928,'-,[1.06665802122163-1.1362263861189],HNF1B,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,17:37733029
rs11651755-<b>C</b>,2 x 10-8,,0.486465,1.0924964,'-,[1.05939221330271-1.12663514204283],HNF1B,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,17:37739849
rs7207826-<b>C</b>,8 x 10-14,,0.267801,1.1383171,'-,[1.1003320875334-1.17761354130912],SKAP1,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,17:48423311
rs4808075-<b>C</b>,3 x 10-26,,0.295975,1.1971419,'-,[1.15799210345029-1.23761537074498],"BABAM1, USHBP1",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,19:17279482
rs2165109-<b>C</b>,4 x 10-7,,0.251869,1.0954511,'-,[1.05748739051043-1.1347778353567],"ACOXL, MIR4435-2HG",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,2:111061081
rs7953249-<b>G</b>,8 x 10-7,,0.417632,1.0811644,'-,[1.04824881016487-1.11511353852335],HNF1A-AS1,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,12:120965921
rs1879586-<b>G</b>,3 x 10-13,,0.181254,1.1585579,'-,[1.11378456264581-1.20513099189349],PLEKHM1,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,17:45489971
rs6005807-<b>C</b>,1 x 10-8,,0.898635,1.1650093,'-,[1.10493126343643-1.22835376686122],TTC28,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,22:28538325
rs150293538-<b>T</b>,1 x 10-6,,0.978,3,'-,[1.79409543681435-5.01001565578963],LINC01111,Low-grade serous ovarian cancer,ovarian serous carcinoma,GCST004461,8:76408119
rs9870207-<b>A</b>,5 x 10-8,,0.691354,1.1929355,'-,[1.11921837700174-1.27150779447142],"CCT6P4, GMNC",Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,3:190807727
rs10069690-<b>T</b>,1 x 10-9,,0.259806,1.2150546,'-,[1.14168685260085-1.29313711208919],TERT,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,5:1279675
rs7902587-<b>T</b>,4 x 10-8,,0.0975691,1.2930167,'-,[1.18179536270929-1.41470527615789],"STN1, SLK",Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,10:103934543
rs7405776-<b>G</b>,1 x 10-6,,0.41189,1.1517414,'-,[1.0876255656695-1.21963673962283],HNF1B,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,17:37733029
rs7207826-<b>C</b>,1 x 10-7,,0.267801,1.1787505,'-,[1.10925120766678-1.25260426998392],SKAP1,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,17:48423311
rs8098244-<b>A</b>,4 x 10-8,,0.275361,1.1902364,'-,[1.11903760649588-1.2659653630658],LAMA3,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,18:23825589
rs150293538-<b>T</b>,2 x 10-9,,0.9784417,2.1880746,'-,[1.65336168482279-2.89571888582476],LINC01111,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,8:76408119
rs11651755-<b>C</b>,6 x 10-6,,0.486465,1.1389422,'-,[1.07652961941979-1.20497334696891],HNF1B,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,17:37739849
rs711830-<b>A</b>,3 x 10-6,,0.319016,1.1855859,'-,[1.10400745880938-1.27319220749772],"HAGLR, HOXD3",Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,2:176172583
rs58722170-<b>C</b>,2 x 10-7,,0.220826,1.099984,'-,[1.06129080940929-1.14008804057615],RSPO1,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,1:37630749
rs711830-<b>A</b>,3 x 10-14,,0.319016,1.1312215,'-,[1.09591680302958-1.16766347713436],"HAGLR, HOXD3",Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,2:176172583
rs6755777-<b>T</b>,2 x 10-14,,0.319447,1.1323612,'-,[1.09696977445389-1.1688944318043],"HAGLR, HAGLROS",Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,2:176178498
rs6755777-<b>T</b>,6 x 10-8,,0.319447,1.1783675,'-,[1.11072142428685-1.25013339797474],"HAGLR, HAGLROS",Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,2:176178498
rs7705526-<b>A</b>,2 x 10-20,,0.332078,1.3236618,'-,[1.24799798080348-1.40391301421926],TERT,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,5:1285859
rs1400482-<b>G</b>,1 x 10-16,,0.867974,1.465133,'-,[1.33389097997879-1.60928789514469],LINC00824,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,8:128529685
rs17631303-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,PLEKHM1,Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,17:45439036
rs183211-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,NSF,Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,17:46710944
rs3814113-<b>A</b>,6 x 10-11,,0.66,1.3,'-,[1.2-1.41],BNC2,Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,9:16915023
rs2665390-<b>C</b>,7 x 10-6,,0.043,1.46,'-,[1.25-1.71],TIPARP,Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,3:156679960
rs17631303-<b>G</b>,1 x 10-8,,0.19,1.27,'-,[1.17-1.38],PLEKHM1,Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,17:45439036
rs183211-<b>A</b>,3 x 10-8,,0.23,1.25,'-,[1.16-1.35],NSF,Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,17:46710944
rs4691139-<b>G</b>,3 x 10-8,,0.48,1.2,'-,[1.17-1.38],"TRIM60, TRIM61",Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,4:164987569
rs62274041-<b>G</b>,5 x 10-7,,0.0481682,1.4226197,'-,[1.23974783491848-1.63246639995579],"LINC00886, METTL15P1",Ovarian cancer in BRCA1 mutation carriers,"carrier status, ovarian carcinoma",GCST004414,3:156717851
rs4691139-<b>G</b>,4 x 10-7,,0.467,1.1581223,'-,[1.09413051760919-1.22585676557555],"TRIM60, TRIM61",Ovarian cancer in BRCA1 mutation carriers,"carrier status, ovarian carcinoma",GCST004414,4:164987569
rs10962692-<b>G</b>,1 x 10-14,,0.799624,1.3346913,'-,[1.24035297950519-1.43620468676761],BNC2,Ovarian cancer in BRCA1 mutation carriers,"carrier status, ovarian carcinoma",GCST004414,9:16915876
rs1879586-<b>G</b>,7 x 10-6,,0.181254,1.1804551,'-,[1.0983093028467-1.26874471717965],PLEKHM1,Ovarian cancer in BRCA1 mutation carriers,"carrier status, ovarian carcinoma",GCST004414,17:45489971
rs711830-<b>A</b>,4 x 10-14,,0.319016,1.1120843,'-,[1.08193543636327-1.14307327686388],"HAGLR, HOXD3",Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,2:176172583
rs6755777-<b>T</b>,4 x 10-14,,0.319447,1.1121821,'-,[1.0819829343715-1.14322428681774],"HAGLR, HAGLROS",Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,2:176178498
rs62274041-<b>G</b>,5 x 10-38,,0.0481682,1.4494933,'-,[1.3698151996842-1.53380589540381],"LINC00886, METTL15P1",Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,3:156717851
rs17329882-<b>C</b>,3 x 10-6,,0.241,1.07509,'-,[1.0431816063-1.1079744406],SYNPO2,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,4:119028805
rs10069690-<b>T</b>,3 x 10-8,,0.259806,1.0865872,'-,[1.05501477967445-1.11910451351639],TERT,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,5:1279675
rs7705526-<b>A</b>,7 x 10-10,,0.332078,1.0913801,'-,[1.06151189081851-1.12208885346329],TERT,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,5:1285859
chr8:82668818-<b>G</b>,2 x 10-8,,0.0663033,1.1555611,'-,[1.09892839652449-1.21511227508431],'-,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,Mapping not available
rs1400482-<b>G</b>,7 x 10-16,,0.867974,1.1769707,'-,[1.13116083835271-1.22463593511406],LINC00824,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,8:128529685
rs10962692-<b>G</b>,9 x 10-36,,0.799624,1.2424945,'-,[1.20065901834152-1.28578755258347],BNC2,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,9:16915876
chr9:136138765-<b>G</b>,8 x 10-10,,0.194216,1.1083262,'-,[1.07253217567565-1.14531490798434],'-,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,Mapping not available
rs144962376-<b>T</b>,8 x 10-10,,0.309302,1.0908245,'-,[1.06101278339562-1.12147377629663],MLLT10,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,10:21589903
rs8037137-<b>C</b>,5 x 10-7,,0.134,1.098901,'-,[1.06-1.15],"RCCD1, PRC1",Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,15:90963407
rs143663961-<b>A</b>,1 x 10-7,,0.72942,1.0819896,'-,[1.05072828447598-1.11418107368593],ATAD5,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,17:30854203
rs1879586-<b>G</b>,2 x 10-13,,0.181254,1.1339011,'-,[1.09660984313914-1.1724605092959],PLEKHM1,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,17:45489971
rs7207826-<b>C</b>,8 x 10-13,,0.267801,1.1105318,'-,[1.07914609971847-1.14283031731538],SKAP1,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,17:48423311
rs4808075-<b>C</b>,2 x 10-17,,0.295975,1.1302502,'-,[1.09887004937136-1.1625264094177],"BABAM1, USHBP1",Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,19:17279482
rs6005807-<b>C</b>,3 x 10-7,,0.898635,1.1211612,'-,[1.07314763387262-1.17132308995474],TTC28,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,22:28538325
rs2165109-<b>C</b>,8 x 10-7,,0.251869,1.0780069,'-,[1.04637703624974-1.11059270801828],"ACOXL, MIR4435-2HG",Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,2:111061081
rs7953249-<b>G</b>,6 x 10-6,,0.417632,1.0621586,'-,[1.0348111352015-1.09022867520121],HNF1A-AS1,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,12:120965921
rs7705526-<b>A</b>,8 x 10-8,,0.332078,1.0766991,'-,[1.04796689850078-1.10621911687371],TERT,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,5:1285859
chr8:82668818-<b>G</b>,4 x 10-10,,0.0663033,1.1702297,'-,[1.11383386875217-1.22948084125145],'-,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,Mapping not available
rs7405776-<b>G</b>,2 x 10-10,,0.41189,1.09,'-,[1.06-1.12],HNF1B,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,17:37733029
rs10962692-<b>G</b>,9 x 10-11,,0.799624,1.5,'-,[1.32777950250739-1.69772989025038],BNC2,Ovarian cancer in BRCA2 mutation carriers,"carrier status, ovarian carcinoma",GCST004416,9:16915876
rs1879586-<b>G</b>,2 x 10-19,,0.181254,1.1611373,'-,[1.12396655984348-1.19953742102822],PLEKHM1,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,17:45489971
rs7207826-<b>C</b>,2 x 10-17,,0.267801,1.1311107,'-,[1.09941695678777-1.16371793958399],SKAP1,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,17:48423311
rs4808075-<b>C</b>,2 x 10-19,,0.295975,1.1357577,'-,[1.10479964302488-1.16758323338693],"BABAM1, USHBP1",Epithelial ovarian cancer,ovarian carcinoma,GCST004462,19:17279482
rs9886651-<b>G</b>,2 x 10-9,,0.461222,1.0802044,'-,[1.05286500127646-1.10825354962066],PVT1,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,8:127805637
rs9870207-<b>A</b>,3 x 10-6,,0.691354,1.0994674,'-,[1.05569458307584-1.14505523813592],"CCT6P4, GMNC",Epithelial ovarian cancer,ovarian carcinoma,GCST004462,3:190807727
rs6456822-<b>T</b>,1 x 10-6,,0.690887,1.0714362,'-,[1.04202715140265-1.10167527662683],GPX6,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,6:28512858
rs1400482-<b>G</b>,7 x 10-26,,0.867974,1.232938,'-,[1.18577432499114-1.28197774659809],LINC00824,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,8:128529685
rs10962692-<b>G</b>,5 x 10-64,,0.799624,1.3368285,'-,[1.29251250189538-1.38266389898672],BNC2,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,9:16915876
chr9:136138765-<b>G</b>,2 x 10-11,,0.194216,1.11572,'-,[1.08085025008502-1.15171484355914],'-,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,Mapping not available
rs144962376-<b>T</b>,4 x 10-11,,0.309302,1.0959264,'-,[1.06647199521962-1.12619421828606],MLLT10,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,10:21589903
rs62274041-<b>G</b>,3 x 10-7,,0.048,1.85,'-,[1.46354854927152-2.33435588308994],"LINC00886, METTL15P1",Ovarian cancer in BRCA2 mutation carriers,"carrier status, ovarian carcinoma",GCST004416,3:156717851
rs11651755-<b>C</b>,8 x 10-9,,0.486465,1.077992,'-,[1.05087168925156-1.10581210313382],HNF1B,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,17:37739849
rs62274041-<b>G</b>,2 x 10-57,,0.048,1.57,'-,[1.48-1.66],"LINC00886, METTL15P1",Epithelial ovarian cancer,ovarian carcinoma,GCST004462,3:156717851
rs6755777-<b>T</b>,3 x 10-15,,0.319,1.12,'-,[1.09-1.15],"HAGLR, HAGLROS",Epithelial ovarian cancer,ovarian carcinoma,GCST004462,2:176178498
rs711830-<b>A</b>,3 x 10-15,,0.319,1.12,'-,[1.09-1.15],"HAGLR, HOXD3",Epithelial ovarian cancer,ovarian carcinoma,GCST004462,2:176172583
rs58722170-<b>C</b>,1 x 10-9,,0.221,1.1,'-,[1.07-1.13],RSPO1,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,1:37630749
rs8098244-<b>A</b>,2 x 10-7,,0.275,1.11,'-,[1.07-1.16],LAMA3,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,18:23825589
rs6005807-<b>C</b>,9 x 10-6,,0.899,1.1,'-,[1.05-1.15],TTC28,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,22:28538325
rs2165109-<b>C</b>,2 x 10-8,,0.251869,1.086051,'-,[1.05456961053472-1.11847227897416],"ACOXL, MIR4435-2HG",Epithelial ovarian cancer,ovarian carcinoma,GCST004462,2:111061081
rs7953249-<b>G</b>,5 x 10-10,,0.417632,1.0834533,'-,[1.05604177574809-1.1115762691869],HNF1A-AS1,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,12:120965921
rs10069690-<b>T</b>,1 x 10-7,,0.259806,1.0802581,'-,[1.04978354993499-1.11161732010102],TERT,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,5:1279675
rs630602-<b>?</b>,1 x 10-8,,NR,'-,0.026 unit increase,[0.017-0.034],SSBP3,Menarche (age at onset),age at menarche,GCST003993,1:54263191
rs35413307-<b>?</b>,1 x 10-8,,NR,'-,0.026 unit increase,[0.017-0.034],LINC02337,Menarche (age at onset),age at menarche,GCST003993,13:111539431
rs7306275-<b>?</b>,1 x 10-8,,NR,'-,0.027 unit increase,[0.018-0.036],"RPL35AP28, BCDIN3D",Menarche (age at onset),age at menarche,GCST003993,12:49856328
rs13068899-<b>?</b>,1 x 10-8,,NR,'-,0.027 unit increase,[0.018-0.036],VGLL3,Menarche (age at onset),age at menarche,GCST003993,3:86895788
rs11031005-<b>?</b>,2 x 10-8,,NR,'-,0.035 unit decrease,[0.047-0.023],FSHB,Menarche (age at onset),age at menarche,GCST003993,11:30204809
rs10217747-<b>?</b>,2 x 10-8,,NR,'-,0.025 unit increase,[0.017-0.034],ZNF483,Menarche (age at onset),age at menarche,GCST003993,9:111547655
rs35273932-<b>?</b>,2 x 10-8,,NR,'-,0.116 unit increase,[0.075-0.157],ALMS1,Menarche (age at onset),age at menarche,GCST003993,2:73512721
rs10094574-<b>?</b>,3 x 10-8,,NR,'-,0.027 unit increase,[0.018-0.037],'-,Menarche (age at onset),age at menarche,GCST003993,8:77203831
rs112217694-<b>?</b>,3 x 10-8,,NR,'-,0.053 unit decrease,[0.072-0.034],TACR3,Menarche (age at onset),age at menarche,GCST003993,4:103719907
rs13178130-<b>?</b>,4 x 10-8,,NR,'-,0.025 unit increase,[0.016-0.034],JADE2,Menarche (age at onset),age at menarche,GCST003993,5:134570139
rs9349203-<b>?</b>,5 x 10-8,,NR,'-,0.024 unit increase,[0.015-0.032],BYSL,Menarche (age at onset),age at menarche,GCST003993,6:41925585
rs35212912-<b>?</b>,5 x 10-8,,NR,'-,0.03 unit decrease,[0.040-0.019],DLGAP1,Menarche (age at onset),age at menarche,GCST003993,18:3816055
rs9635759-<b>?</b>,1 x 10-10,,NR,'-,0.03 unit decrease,[0.039-0.021],"CA10, LINC02073",Menarche (age at onset),age at menarche,GCST003993,17:51536424
rs6439371-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,NPHP3-AS1,Menarche (age at onset),age at menarche,GCST003993,3:132891908
rs2002675-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,"IGF2BP2, TRA2B",Menarche (age at onset),age at menarche,GCST003993,3:185911780
rs4929923-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,TRIM66,Menarche (age at onset),age at menarche,GCST003993,11:8617653
rs900145-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,ARNTL,Menarche (age at onset),age at menarche,GCST003993,11:13272358
rs1862471-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,OLFM2,Menarche (age at onset),age at menarche,GCST003993,19:9889646
rs12686569-<b>?</b>,2 x 10-34,,NR,'-,0.057 unit decrease,[0.066-0.048],LINC01505,Menarche (age at onset),age at menarche,GCST003993,9:106154430
rs201205097-<b>?</b>,3 x 10-15,,NR,'-,0.044 unit decrease,[0.055-0.033],"TMEM18, LINC01875",Menarche (age at onset),age at menarche,GCST003993,2:613045
rs100537-<b>?</b>,4 x 10-15,,NR,'-,0.034 unit decrease,[0.042-0.026],RXRG,Menarche (age at onset),age at menarche,GCST003993,1:165444407
rs12894936-<b>?</b>,1 x 10-14,,NR,'-,0.037 unit decrease,[0.046-0.028],WDR25,Menarche (age at onset),age at menarche,GCST003993,14:100380654
rs6438424-<b>?</b>,4 x 10-13,,NR,'-,0.031 unit increase,[0.023-0.040],'-,Menarche (age at onset),age at menarche,GCST003993,3:117855975
rs1254309-<b>?</b>,1 x 10-12,,NR,'-,0.038 unit increase,[0.028-0.049],C14orf39,Menarche (age at onset),age at menarche,GCST003993,14:60423704
rs1558902-<b>?</b>,1 x 10-12,,NR,'-,0.031 unit increase,[0.023-0.040],FTO,Menarche (age at onset),age at menarche,GCST003993,16:53769662
rs1040070-<b>?</b>,2 x 10-12,,NR,'-,0.031 unit decrease,[0.040-0.022],"LRRC53, TNNI3K, FPGT-TNNI3K",Menarche (age at onset),age at menarche,GCST003993,1:74512186
rs1704528-<b>?</b>,6 x 10-12,,NR,'-,0.033 unit decrease,[0.042-0.024],"Y_RNA, MIR193BHG",Menarche (age at onset),age at menarche,GCST003993,16:14294893
rs762080-<b>?</b>,7 x 10-12,,NR,'-,0.035 unit increase,[0.025-0.044],IGSF1,Menarche (age at onset),age at menarche,GCST003993,X:131400056
rs7113019-<b>?</b>,7 x 10-12,,NR,'-,0.03 unit increase,[0.021-0.038],JHY,Menarche (age at onset),age at menarche,GCST003993,11:122948411
rs2378662-<b>?</b>,1 x 10-11,,NR,'-,0.03 unit increase,[0.021-0.038],RMI1,Menarche (age at onset),age at menarche,GCST003993,9:84092374
rs2048523-<b>?</b>,1 x 10-11,,NR,'-,0.029 unit decrease,[0.038-0.021],"MIR4527HG, SKOR2",Menarche (age at onset),age at menarche,GCST003993,18:47273144
rs2679894-<b>?</b>,2 x 10-11,,NR,'-,0.032 unit decrease,[0.042-0.023],"TGFBRAP1, GPR45",Menarche (age at onset),age at menarche,GCST003993,2:105254322
rs571567-<b>?</b>,5 x 10-11,,NR,'-,0.036 unit increase,[0.025-0.047],SEC16B,Menarche (age at onset),age at menarche,GCST003993,1:177903770
rs6499244-<b>?</b>,9 x 10-11,,NR,'-,0.028 unit increase,[0.020-0.037],NFAT5,Menarche (age at onset),age at menarche,GCST003993,16:69701368
rs1490384-<b>?</b>,1 x 10-10,,NR,'-,0.028 unit decrease,[0.036-0.019],"MIR588, RNU6-200P",Menarche (age at onset),age at menarche,GCST003993,6:126530014
rs4141153-<b>?</b>,4 x 10-10,,NR,'-,0.034 unit increase,[0.023-0.044],'-,Menarche (age at onset),age at menarche,GCST003993,7:41428348
rs5794958-<b>?</b>,1 x 10-9,,NR,'-,0.031 unit increase,[0.021-0.041],CADM1,Menarche (age at onset),age at menarche,GCST003993,11:115173642
rs1456522-<b>?</b>,1 x 10-9,,NR,'-,0.028 unit decrease,[0.038-0.019],'-,Menarche (age at onset),age at menarche,GCST003993,2:198904459
rs35051342-<b>?</b>,1 x 10-9,,NR,'-,0.032 unit decrease,[0.043-0.022],BDNF-AS,Menarche (age at onset),age at menarche,GCST003993,11:27612826
rs5914101-<b>?</b>,2 x 10-9,,NR,'-,0.033 unit increase,[0.022-0.043],FAAH2,Menarche (age at onset),age at menarche,GCST003993,X:57413512
rs11349289-<b>?</b>,3 x 10-9,,NR,'-,0.027 unit increase,[0.018-0.036],ATRNL1,Menarche (age at onset),age at menarche,GCST003993,10:115724059
rs11703376-<b>?</b>,4 x 10-9,,NR,'-,0.028 unit decrease,[0.038-0.019],RPL35P8,Menarche (age at onset),age at menarche,GCST003993,22:49282787
rs4072705-<b>?</b>,1 x 10-8,,NR,'-,0.025 unit decrease,[0.033-0.016],NR6A1,Menarche (age at onset),age at menarche,GCST003993,9:124611184
rs7766336-<b>?</b>,4 x 10-57,,NR,'-,0.074 unit increase,[0.065-0.083],"LIN28B-AS1, LIN28B",Menarche (age at onset),age at menarche,GCST003993,6:104940530
rs314277-<b>A</b>,3 x 10-13,(age at menarche),0.14,'-,0.16 years increase,[0.12-0.20],LIN28B,Menarche and menopause (age at onset),age at menarche,GCST000403,6:104959787
rs7861820-<b>C</b>,3 x 10-9,(age at menarche),0.48,'-,0.09 years decrease,[0.06-0.12],LINC01505,Menarche and menopause (age at onset),age at menarche,GCST000403,9:106174393
rs364663-<b>A</b>,5 x 10-7,,0.72,'-,0.089 year decrease,[0.054-0.124],LIN28B,Menarche (age at onset),age at menarche,GCST002013,6:104995314
rs310008-<b>G</b>,4 x 10-6,,0.13392,'-,0.1076 year decrease,[0.062-0.153],"GAN, CMIP",Menarche (age at onset),age at menarche,GCST002013,16:81440044
rs6431393-<b>A</b>,4 x 10-6,,0.4948,'-,0.0776 year increase,[0.045-0.111],AGAP1,Menarche (age at onset),age at menarche,GCST002013,2:235630663
rs4735738-<b>A</b>,5 x 10-6,,0.49918,'-,0.0728 year increase,[0.042-0.104],ZFHX4,Menarche (age at onset),age at menarche,GCST002013,8:76699390
rs12800752-<b>T</b>,3 x 10-6,,0.80147,'-,0.0946 year increase,[0.055-0.134],'-,Menarche (age at onset),age at menarche,GCST002013,11:100535909
rs7114467-<b>A</b>,9 x 10-6,,0.45957,'-,0.0713 year decrease,[0.040-0.103],'-,Menarche (age at onset),age at menarche,GCST002013,11:15435921
rs7114000-<b>A</b>,2 x 10-6,,0.06837,'-,0.1503 year increase,[0.088-0.212],KIRREL3,Menarche (age at onset),age at menarche,GCST002013,11:126737685
rs2076751-<b>A</b>,7 x 10-6,,0.23377,'-,0.087 year decrease,[0.049-0.125],"SFTA3, NKX2-1-AS1, NKX2-1",Menarche (age at onset),age at menarche,GCST002013,14:36520214
rs301803-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,RERE,Menarche (age at onset),age at menarche,GCST007078,1:8438620
rs2697963-<b>?</b>,2 x 10-18,,NR,'-,'-,'-,PRDM2,Menarche (age at onset),age at menarche,GCST007078,1:13824245
rs17449243-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,EIF4G3,Menarche (age at onset),age at menarche,GCST007078,1:20847936
rs113184243-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,ARID1A,Menarche (age at onset),age at menarche,GCST007078,1:26737891
rs1032728-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,SCMH1,Menarche (age at onset),age at menarche,GCST007078,1:41213894
rs35011283-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,FOXJ3,Menarche (age at onset),age at menarche,GCST007078,1:42300612
rs4660257-<b>?</b>,3 x 10-19,,NR,'-,'-,'-,KDM4A,Menarche (age at onset),age at menarche,GCST007078,1:43682497
rs643428-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SSBP3,Menarche (age at onset),age at menarche,GCST007078,1:54263185
rs61779781-<b>?</b>,1 x 10-13,,NR,'-,'-,'-,LEPR,Menarche (age at onset),age at menarche,GCST007078,1:65468671
rs66461782-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,ZRANB2,Menarche (age at onset),age at menarche,GCST007078,1:71067604
rs143875052-<b>?</b>,7 x 10-14,,NR,'-,'-,'-,TET2,Menarche (age at onset),age at menarche,GCST007078,4:105229398
rs10857036-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,NDST4,Menarche (age at onset),age at menarche,GCST007078,4:115075517
rs2391504-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,LINC02465,Menarche (age at onset),age at menarche,GCST007078,4:129809917
rs17464835-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,"RPL7AP28, SNHG27",Menarche (age at onset),age at menarche,GCST007078,4:131843326
rs9312937-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,MYO10,Menarche (age at onset),age at menarche,GCST007078,5:16835896
rs10941225-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"DNAJC21, AGXT2",Menarche (age at onset),age at menarche,GCST007078,5:34961375
rs35375873-<b>?</b>,4 x 10-13,,NR,'-,'-,'-,ZNF131,Menarche (age at onset),age at menarche,GCST007078,5:43190545
rs77470973-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,FST,Menarche (age at onset),age at menarche,GCST007078,5:53391091
rs298088-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,PDE4D,Menarche (age at onset),age at menarche,GCST007078,5:59698700
rs80170948-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,SREK1IP1,Menarche (age at onset),age at menarche,GCST007078,5:64724489
rs10060622-<b>?</b>,9 x 10-8,,NR,'-,'-,'-,LINC00461,Menarche (age at onset),age at menarche,GCST007078,5:88634051
rs114489117-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"FAM172A, NR2F1",Menarche (age at onset),age at menarche,GCST007078,5:93612779
rs10063744-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,"MIR583HG, PCSK1",Menarche (age at onset),age at menarche,GCST007078,5:96314068
rs1618689-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,CAMK4,Menarche (age at onset),age at menarche,GCST007078,5:111270357
rs247520-<b>?</b>,2 x 10-13,,NR,'-,'-,'-,STARD4-AS1,Menarche (age at onset),age at menarche,GCST007078,5:111540359
rs141344917-<b>?</b>,2 x 10-18,,NR,'-,'-,'-,NREP,Menarche (age at onset),age at menarche,GCST007078,5:111799100
rs13179411-<b>?</b>,3 x 10-34,,NR,'-,'-,'-,JADE2,Menarche (age at onset),age at menarche,GCST007078,5:134564823
rs56289631-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,KLHL3,Menarche (age at onset),age at menarche,GCST007078,5:137683069
rs12374521-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,HTR4,Menarche (age at onset),age at menarche,GCST007078,5:148457317
rs11738611-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,CYFIP2,Menarche (age at onset),age at menarche,GCST007078,5:157345966
rs2861809-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,5:166466938
rs12656569-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SLIT3,Menarche (age at onset),age at menarche,GCST007078,5:169311587
rs7727787-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,TRIM41,Menarche (age at onset),age at menarche,GCST007078,5:181226039
rs9295482-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,CDKAL1,Menarche (age at onset),age at menarche,GCST007078,6:20761003
rs2254479-<b>?</b>,9 x 10-15,,NR,'-,'-,'-,USP49,Menarche (age at onset),age at menarche,GCST007078,6:41863405
rs11209943-<b>?</b>,3 x 10-21,,NR,'-,'-,'-,"NEGR1, RPL31P12",Menarche (age at onset),age at menarche,GCST007078,1:72284817
rs7553348-<b>?</b>,6 x 10-39,,NR,'-,'-,'-,"TNNI3K, FPGT-TNNI3K",Menarche (age at onset),age at menarche,GCST007078,1:74539383
rs10874340-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,1:82793397
rs11165924-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,DPYD,Menarche (age at onset),age at menarche,GCST007078,1:97909892
rs4133019-<b>?</b>,4 x 10-15,,NR,'-,'-,'-,OLFM3,Menarche (age at onset),age at menarche,GCST007078,1:102042537
rs4360524-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"GABPB2, SEMA6C",Menarche (age at onset),age at menarche,GCST007078,1:151127081
rs2343506-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,CCDC190,Menarche (age at onset),age at menarche,GCST007078,1:162923134
rs2194899-<b>?</b>,5 x 10-44,,NR,'-,'-,'-,RXRG,Menarche (age at onset),age at menarche,GCST007078,1:165441548
rs10913213-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,PAPPA2,Menarche (age at onset),age at menarche,GCST007078,1:176594124
rs506589-<b>?</b>,2 x 10-39,,NR,'-,'-,'-,SEC16B,Menarche (age at onset),age at menarche,GCST007078,1:177925152
rs2809969-<b>?</b>,9 x 10-14,,NR,'-,'-,'-,RNU6-778P,Menarche (age at onset),age at menarche,GCST007078,1:199832888
rs4889-<b>?</b>,1 x 10-13,,NR,'-,'-,'-,KISS1,Menarche (age at onset),age at menarche,GCST007078,1:204190659
rs12040029-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,RPS6KC1,Menarche (age at onset),age at menarche,GCST007078,1:213278615
rs1973284-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,AKT3,Menarche (age at onset),age at menarche,GCST007078,1:243693379
rs62106258-<b>?</b>,3 x 10-41,,NR,'-,'-,'-,"LINC01874, LINC01865",Menarche (age at onset),age at menarche,GCST007078,2:417167
rs5017302-<b>?</b>,5 x 10-38,,NR,'-,'-,'-,"TMEM18, LINC01875",Menarche (age at onset),age at menarche,GCST007078,2:631069
rs56277911-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,"RN7SL66P, RRM2",Menarche (age at onset),age at menarche,GCST007078,2:10257226
rs113467400-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,GREB1,Menarche (age at onset),age at menarche,GCST007078,2:11580173
rs11125803-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,ADCY3,Menarche (age at onset),age at menarche,GCST007078,2:24829308
rs338070-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"KRTCAP2P1, SIX3",Menarche (age at onset),age at menarche,GCST007078,2:44948150
rs3136247-<b>?</b>,3 x 10-12,,NR,'-,'-,'-,MSH6,Menarche (age at onset),age at menarche,GCST007078,2:47785960
rs11893331-<b>?</b>,6 x 10-37,,NR,'-,'-,'-,CCDC85A,Menarche (age at onset),age at menarche,GCST007078,2:56350271
rs2539679-<b>?</b>,4 x 10-13,,NR,'-,'-,'-,RNU6-508P,Menarche (age at onset),age at menarche,GCST007078,2:59629578
rs4353638-<b>?</b>,6 x 10-18,,NR,'-,'-,'-,USP34,Menarche (age at onset),age at menarche,GCST007078,2:61271884
rs57171084-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,AAK1,Menarche (age at onset),age at menarche,GCST007078,2:69466615
rs3828755-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,PTK7,Menarche (age at onset),age at menarche,GCST007078,6:43147482
rs2206271-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,"TFAP2B, TFAP2D",Menarche (age at onset),age at menarche,GCST007078,6:50818295
rs7452200-<b>?</b>,1 x 10-15,,NR,'-,'-,'-,"RNU6-1023P, FAM83B",Menarche (age at onset),age at menarche,GCST007078,6:54798370
rs34399458-<b>?</b>,1 x 10-18,,NR,'-,'-,'-,BEND6,Menarche (age at onset),age at menarche,GCST007078,6:56984044
rs62415601-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,"MYO6, SENP6",Menarche (age at onset),age at menarche,GCST007078,6:75722400
rs6917291-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,"LINC02540, RNU6-261P",Menarche (age at onset),age at menarche,GCST007078,6:76451096
rs34613202-<b>?</b>,3 x 10-25,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,6:77000599
rs12193842-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,SNAP91,Menarche (age at onset),age at menarche,GCST007078,6:83612439
rs7749175-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,HLA-DRB1,Menarche (age at onset),age at menarche,GCST007078,6:98322469
rs9321659-<b>?</b>,4 x 10-23,,NR,'-,'-,'-,Y_RNA,Menarche (age at onset),age at menarche,GCST007078,6:99668216
rs13199764-<b>?</b>,6 x 10-14,,NR,'-,'-,'-,SIM1,Menarche (age at onset),age at menarche,GCST007078,6:100296258
rs12206564-<b>?</b>,6 x 10-26,,NR,'-,'-,'-,ASCC3,Menarche (age at onset),age at menarche,GCST007078,6:100539133
rs7746459-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,6:104623505
rs145812241-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,HACE1,Menarche (age at onset),age at menarche,GCST007078,6:104670869
rs1933801-<b>?</b>,1 x 10-202,,NR,'-,'-,'-,LIN28B-AS1,Menarche (age at onset),age at menarche,GCST007078,6:104917850
rs2764261-<b>?</b>,5 x 10-13,,NR,'-,'-,'-,FOXO3,Menarche (age at onset),age at menarche,GCST007078,6:108606639
rs1844594-<b>?</b>,2 x 10-26,,NR,'-,'-,'-,MIR588,Menarche (age at onset),age at menarche,GCST007078,6:126466961
rs9321106-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,"PTPRK, PTPRK-AS1",Menarche (age at onset),age at menarche,GCST007078,6:128034171
rs78928932-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,PDE7B,Menarche (age at onset),age at menarche,GCST007078,6:135907479
rs9397414-<b>?</b>,4 x 10-16,,NR,'-,'-,'-,"ARMT1, CCDC170",Menarche (age at onset),age at menarche,GCST007078,6:151485148
rs6456198-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,FAM120B,Menarche (age at onset),age at menarche,GCST007078,6:170313834
rs113772882-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,"TFAMP1, PSMG3-AS1",Menarche (age at onset),age at menarche,GCST007078,7:1602560
rs1860826-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,MAD1L1,Menarche (age at onset),age at menarche,GCST007078,7:2072871
rs10226266-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"KBTBD2, RP9P",Menarche (age at onset),age at menarche,GCST007078,7:32901507
rs4141153-<b>?</b>,8 x 10-32,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,7:41428348
rs141829833-<b>?</b>,6 x 10-25,,NR,'-,'-,'-,"GRM2, IQCF6",Menarche (age at onset),age at menarche,GCST007078,3:51742088
rs7639267-<b>?</b>,6 x 10-15,,NR,'-,'-,'-,"SMIM4, NT5DC2",Menarche (age at onset),age at menarche,GCST007078,3:52534789
rs815715-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,FHIT,Menarche (age at onset),age at menarche,GCST007078,3:61278410
rs9681954-<b>?</b>,8 x 10-25,,NR,'-,'-,'-,VGLL3,Menarche (age at onset),age at menarche,GCST007078,3:86843214
rs28672845-<b>?</b>,7 x 10-14,,NR,'-,'-,'-,"ABCF2P1, C3orf38",Menarche (age at onset),age at menarche,GCST007078,3:88221477
rs7643617-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,ZBTB20,Menarche (age at onset),age at menarche,GCST007078,3:115034231
rs7433864-<b>?</b>,7 x 10-33,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,3:117874636
rs3849531-<b>?</b>,3 x 10-18,,NR,'-,'-,'-,EEFSEC,Menarche (age at onset),age at menarche,GCST007078,3:128339774
rs6439371-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,NPHP3-AS1,Menarche (age at onset),age at menarche,GCST007078,3:132891908
rs13064915-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,3:137402401
rs13322435-<b>?</b>,2 x 10-15,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,Mapping not available
rs9849338-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,"BZW1P1, FNDC3B",Menarche (age at onset),age at menarche,GCST007078,3:172408686
rs865809-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,"ECE2, EEF1AKMT4-ECE2",Menarche (age at onset),age at menarche,GCST007078,3:184279947
rs16860342-<b>?</b>,9 x 10-17,,NR,'-,'-,'-,TRA2B,Menarche (age at onset),age at menarche,GCST007078,3:185935159
rs1452201-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SST,Menarche (age at onset),age at menarche,GCST007078,3:187631221
rs2798224-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,MSANTD1,Menarche (age at onset),age at menarche,GCST007078,4:3265941
rs34811474-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,ANAPC4,Menarche (age at onset),age at menarche,GCST007078,4:25407216
rs9991479-<b>?</b>,2 x 10-14,,NR,'-,'-,'-,"MIR4275, RN7SL101P",Menarche (age at onset),age at menarche,GCST007078,4:28793250
rs1347901-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,KCTD8,Menarche (age at onset),age at menarche,GCST007078,4:44516218
rs10938397-<b>?</b>,5 x 10-22,,NR,'-,'-,'-,LINC02273,Menarche (age at onset),age at menarche,GCST007078,4:45180510
rs28535294-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,EPHA5,Menarche (age at onset),age at menarche,GCST007078,4:65604825
rs7438414-<b>?</b>,2 x 10-18,,NR,'-,'-,'-,"HPGDS, RPL35AP11",Menarche (age at onset),age at menarche,GCST007078,4:94344671
rs6844340-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,LINC02428,Menarche (age at onset),age at menarche,GCST007078,4:103346097
rs1351623-<b>?</b>,1 x 10-21,,NR,'-,'-,'-,TACR3,Menarche (age at onset),age at menarche,GCST007078,4:103666820
rs115260227-<b>?</b>,2 x 10-32,,NR,'-,'-,'-,RNU6-635P,Menarche (age at onset),age at menarche,GCST007078,4:103853541
rs59072247-<b>?</b>,2 x 10-16,,NR,'-,'-,'-,"RPSAP28, RNU6-111P",Menarche (age at onset),age at menarche,GCST007078,2:73309561
rs6719214-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,AFF3,Menarche (age at onset),age at menarche,GCST007078,2:99990959
rs2679894-<b>?</b>,5 x 10-32,,NR,'-,'-,'-,"TGFBRAP1, GPR45",Menarche (age at onset),age at menarche,GCST007078,2:105254322
rs10170108-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,THSD7B,Menarche (age at onset),age at menarche,GCST007078,2:136692386
rs6429912-<b>?</b>,4 x 10-17,,NR,'-,'-,'-,LRP1B,Menarche (age at onset),age at menarche,GCST007078,2:141589886
rs4664602-<b>?</b>,3 x 10-19,,NR,'-,'-,'-,PRPF40A,Menarche (age at onset),age at menarche,GCST007078,2:152686071
rs142058842-<b>?</b>,3 x 10-38,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,2:155765213
rs72892124-<b>?</b>,4 x 10-16,,NR,'-,'-,'-,"NR4A2, LINC01876",Menarche (age at onset),age at menarche,GCST007078,2:156277985
rs62178545-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"LINC01958, RPLP0P7",Menarche (age at onset),age at menarche,GCST007078,2:156724280
rs2060199-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,SCN2A,Menarche (age at onset),age at menarche,GCST007078,2:165340171
rs566465-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"SPC25, NOSTRIN",Menarche (age at onset),age at menarche,GCST007078,2:168848594
rs842545-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,2:183396845
rs1518086-<b>?</b>,9 x 10-37,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,2:198760669
rs1526070-<b>?</b>,6 x 10-14,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,2:198918872
rs12476703-<b>?</b>,2 x 10-17,,NR,'-,'-,'-,"RNU7-147P, SATB2",Menarche (age at onset),age at menarche,GCST007078,2:199254540
rs112753638-<b>?</b>,4 x 10-13,,NR,'-,'-,'-,"PIMREGP1, RN7SL753P",Menarche (age at onset),age at menarche,GCST007078,2:202334496
rs16841741-<b>?</b>,5 x 10-15,,NR,'-,'-,'-,PTH2R,Menarche (age at onset),age at menarche,GCST007078,2:208772874
rs1861072-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,UNC80,Menarche (age at onset),age at menarche,GCST007078,2:209986910
rs6735626-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,ERBB4,Menarche (age at onset),age at menarche,GCST007078,2:212539248
rs9756797-<b>?</b>,4 x 10-10,,NR,'-,'-,'-,"SATB1, TBC1D5",Menarche (age at onset),age at menarche,GCST007078,3:18385985
rs7652234-<b>?</b>,5 x 10-13,,NR,'-,'-,'-,THRB,Menarche (age at onset),age at menarche,GCST007078,3:24148968
rs1984870-<b>?</b>,2 x 10-15,,NR,'-,'-,'-,THRB-AS1,Menarche (age at onset),age at menarche,GCST007078,3:24673644
rs75412999-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"RBMS3, RBMS3-AS2",Menarche (age at onset),age at menarche,GCST007078,3:29583625
rs2067082-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,XYLB,Menarche (age at onset),age at menarche,GCST007078,3:38396691
rs35999162-<b>?</b>,6 x 10-13,,NR,'-,'-,'-,BSN,Menarche (age at onset),age at menarche,GCST007078,3:49559797
rs35005436-<b>?</b>,1 x 10-21,,NR,'-,'-,'-,GTF2I,Menarche (age at onset),age at menarche,GCST007078,7:74720592
rs794358-<b>?</b>,8 x 10-10,,NR,'-,'-,'-,HIP1,Menarche (age at onset),age at menarche,GCST007078,7:75565785
rs62468583-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,MAGI2,Menarche (age at onset),age at menarche,GCST007078,7:78534107
rs9640621-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,"COL1A2, RNU6-1328P",Menarche (age at onset),age at menarche,GCST007078,7:94464841
rs999885-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,AP4M1,Menarche (age at onset),age at menarche,GCST007078,7:100103553
rs1899692-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,CADPS2,Menarche (age at onset),age at menarche,GCST007078,7:122338012
rs11556924-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,ZC3HC1,Menarche (age at onset),age at menarche,GCST007078,7:130023656
rs113766063-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,CPA5,Menarche (age at onset),age at menarche,GCST007078,7:130349609
rs35775580-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,"KLF14, H4P1",Menarche (age at onset),age at menarche,GCST007078,7:130735979
rs13233438-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,CHCHD3,Menarche (age at onset),age at menarche,GCST007078,7:133005924
rs13233916-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,TTC26,Menarche (age at onset),age at menarche,GCST007078,7:139189670
rs56283944-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,PTPRN2,Menarche (age at onset),age at menarche,GCST007078,7:158191148
rs2688326-<b>?</b>,9 x 10-16,,NR,'-,'-,'-,CSMD1,Menarche (age at onset),age at menarche,GCST007078,8:3910101
rs12550650-<b>?</b>,5 x 10-20,,NR,'-,'-,'-,CSMD1,Menarche (age at onset),age at menarche,GCST007078,8:4693468
rs4266671-<b>?</b>,4 x 10-18,,NR,'-,'-,'-,CSMD1,Menarche (age at onset),age at menarche,GCST007078,8:4971671
rs17053711-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,KCTD9,Menarche (age at onset),age at menarche,GCST007078,8:25453753
rs11988076-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,ST18,Menarche (age at onset),age at menarche,GCST007078,8:52216069
rs62507083-<b>?</b>,7 x 10-11,,NR,'-,'-,'-,NPBWR1,Menarche (age at onset),age at menarche,GCST007078,8:52930220
rs34726119-<b>?</b>,6 x 10-15,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,8:53113585
rs28624558-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,RNU6-13P,Menarche (age at onset),age at menarche,GCST007078,8:56890157
rs349356-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,KCNB2,Menarche (age at onset),age at menarche,GCST007078,8:72541711
rs16939126-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,HNF4G,Menarche (age at onset),age at menarche,GCST007078,8:75660218
rs7007681-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,ZFHX4,Menarche (age at onset),age at menarche,GCST007078,8:76783308
rs7846385-<b>?</b>,5 x 10-19,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,8:77247943
rs34746747-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,8:77727378
rs2953511-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,"SLC7A13, WWP1",Menarche (age at onset),age at menarche,GCST007078,8:86328641
rs3133974-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,RBM12B,Menarche (age at onset),age at menarche,GCST007078,8:93734470
rs62520182-<b>?</b>,8 x 10-20,,NR,'-,'-,'-,KCNK9,Menarche (age at onset),age at menarche,GCST007078,8:139633808
rs480263-<b>?</b>,7 x 10-11,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,9:1709382
rs58029167-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,"ERMP1, AK4P4",Menarche (age at onset),age at menarche,GCST007078,9:5850375
rs913588-<b>?</b>,1 x 10-19,,NR,'-,'-,'-,KDM4C,Menarche (age at onset),age at menarche,GCST007078,9:7174673
rs1322148-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,PTPRD,Menarche (age at onset),age at menarche,GCST007078,9:10251492
rs2152261-<b>?</b>,2 x 10-13,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,9:11353512
rs10960303-<b>?</b>,8 x 10-15,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,9:11839805
rs10810071-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,"PES1P2, RPL3P11",Menarche (age at onset),age at menarche,GCST007078,9:13992264
rs1329767-<b>?</b>,2 x 10-14,,NR,'-,'-,'-,TRPM3,Menarche (age at onset),age at menarche,GCST007078,9:71183455
rs62539060-<b>?</b>,1 x 10-14,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,9:73299042
rs2604264-<b>?</b>,1 x 10-18,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,9:74289671
rs35436838-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,RORB,Menarche (age at onset),age at menarche,GCST007078,9:74658994
rs11145656-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,GNAQ,Menarche (age at onset),age at menarche,GCST007078,9:78024379
rs10867332-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,KRT18P24,Menarche (age at onset),age at menarche,GCST007078,9:79036617
rs11534296-<b>?</b>,3 x 10-18,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,9:80667487
rs10780649-<b>?</b>,7 x 10-25,,NR,'-,'-,'-,RMI1,Menarche (age at onset),age at menarche,GCST007078,9:84088646
rs1888072-<b>?</b>,1 x 10-18,,NR,'-,'-,'-,"GADD45G, SEMA4D",Menarche (age at onset),age at menarche,GCST007078,9:89591072
rs10908948-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,UNQ6494,Menarche (age at onset),age at menarche,GCST007078,9:89806050
rs10820310-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,CYLC2,Menarche (age at onset),age at menarche,GCST007078,9:102923803
rs10978430-<b>?</b>,4 x 10-104,,NR,'-,'-,'-,LINC01505,Menarche (age at onset),age at menarche,GCST007078,9:106153728
rs7048022-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,"RNA5SP292, ZNF462",Menarche (age at onset),age at menarche,GCST007078,9:106847273
rs57314245-<b>?</b>,8 x 10-14,,NR,'-,'-,'-,TMEM245,Menarche (age at onset),age at menarche,GCST007078,9:109051552
rs7852169-<b>?</b>,4 x 10-42,,NR,'-,'-,'-,"PTGR1, ZNF483",Menarche (age at onset),age at menarche,GCST007078,9:111556114
rs484353-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,"EXOSC3P2, EVI5L",Menarche (age at onset),age at menarche,GCST007078,19:7826881
rs8112411-<b>?</b>,4 x 10-31,,NR,'-,'-,'-,OLFM2,Menarche (age at onset),age at menarche,GCST007078,19:9881059
rs3115524-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,"SYCE2, GCDH",Menarche (age at onset),age at menarche,GCST007078,19:12910545
rs10401175-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,MAST3,Menarche (age at onset),age at menarche,GCST007078,19:18119464
rs2003476-<b>?</b>,6 x 10-11,,NR,'-,'-,'-,CRTC1,Menarche (age at onset),age at menarche,GCST007078,19:18695858
rs55939240-<b>?</b>,5 x 10-13,,NR,'-,'-,'-,"ZBTB32, TYMSP2",Menarche (age at onset),age at menarche,GCST007078,19:35694201
rs3810291-<b>?</b>,3 x 10-19,,NR,'-,'-,'-,ZC3H4,Menarche (age at onset),age at menarche,GCST007078,19:47065746
rs12462111-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,"NTN5, SEC1P",Menarche (age at onset),age at menarche,GCST007078,19:48668049
rs61744130-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,ZNF331,Menarche (age at onset),age at menarche,GCST007078,19:53576813
rs882609-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"SLC27A5, ZNF446",Menarche (age at onset),age at menarche,GCST007078,19:58480112
rs6039251-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,PLCB1,Menarche (age at onset),age at menarche,GCST007078,20:8748849
rs73898513-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,MACROD2,Menarche (age at onset),age at menarche,GCST007078,20:15825565
rs852033-<b>?</b>,3 x 10-16,,NR,'-,'-,'-,RNU6-27P,Menarche (age at onset),age at menarche,GCST007078,20:17104848
rs6136033-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,PCSK2,Menarche (age at onset),age at menarche,GCST007078,20:17227859
rs6045400-<b>?</b>,5 x 10-11,,NR,'-,'-,'-,DZANK1,Menarche (age at onset),age at menarche,GCST007078,20:18441344
rs3828002-<b>?</b>,8 x 10-11,,NR,'-,'-,'-,SLC24A3,Menarche (age at onset),age at menarche,GCST007078,20:19721405
rs6046818-<b>?</b>,8 x 10-10,,NR,'-,'-,'-,"INSM1, CFAP61",Menarche (age at onset),age at menarche,GCST007078,20:20365534
rs7273470-<b>?</b>,5 x 10-12,,NR,'-,'-,'-,GGT7,Menarche (age at onset),age at menarche,GCST007078,20:34869118
rs6087709-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"UQCC1, GDF5-AS1",Menarche (age at onset),age at menarche,GCST007078,20:35430145
rs35255016-<b>?</b>,6 x 10-13,,NR,'-,'-,'-,"ARHGAP40, Metazoa_SRP",Menarche (age at onset),age at menarche,GCST007078,20:38666096
rs2425670-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,YWHAB,Menarche (age at onset),age at menarche,GCST007078,20:44893088
rs6066454-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,SULF2,Menarche (age at onset),age at menarche,GCST007078,20:47735538
rs3746619-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,MC3R,Menarche (age at onset),age at menarche,GCST007078,20:56248749
rs6010651-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,ZBTB46,Menarche (age at onset),age at menarche,GCST007078,20:63786890
rs35184820-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,LINC00649,Menarche (age at onset),age at menarche,GCST007078,21:33948637
rs73204208-<b>?</b>,2 x 10-13,,NR,'-,'-,'-,"CHAF1B, CLDN14",Menarche (age at onset),age at menarche,GCST007078,21:36419168
rs4818008-<b>?</b>,9 x 10-27,,NR,'-,'-,'-,BRWD1,Menarche (age at onset),age at menarche,GCST007078,21:39239516
rs5756052-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,"PPM1F, MAPK1",Menarche (age at onset),age at menarche,GCST007078,22:21914386
rs12167144-<b>?</b>,5 x 10-12,,NR,'-,'-,'-,"OSBP2, EIF4HP2",Menarche (age at onset),age at menarche,GCST007078,22:30902221
rs9616551-<b>?</b>,7 x 10-10,,NR,'-,'-,'-,RPL35P8,Menarche (age at onset),age at menarche,GCST007078,22:49284503
rs1555406-<b>?</b>,4 x 10-10,,NR,'-,'-,'-,DLK1,Menarche (age at onset),age at menarche,GCST007078,14:100737898
rs6575806-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,RTL1,Menarche (age at onset),age at menarche,GCST007078,14:100886874
rs7161194-<b>?</b>,2 x 10-13,,NR,'-,'-,'-,"MIR541, MIR377",Menarche (age at onset),age at menarche,GCST007078,14:101062668
rs6576457-<b>?</b>,6 x 10-20,,NR,'-,'-,'-,"MKRN3, MIR4508",Menarche (age at onset),age at menarche,GCST007078,15:23564729
rs75389281-<b>?</b>,3 x 10-12,,NR,'-,'-,'-,PWRN4,Menarche (age at onset),age at menarche,GCST007078,15:23914525
rs112036939-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,CHAC1,Menarche (age at onset),age at menarche,GCST007078,15:40955661
rs561821-<b>?</b>,8 x 10-16,,NR,'-,'-,'-,"CIBAR1P1, INO80",Menarche (age at onset),age at menarche,GCST007078,15:41135666
rs8032760-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,SEMA6D,Menarche (age at onset),age at menarche,GCST007078,15:47701857
rs11071027-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,UNC13C,Menarche (age at onset),age at menarche,GCST007078,15:54072564
rs3743266-<b>?</b>,2 x 10-23,,NR,'-,'-,'-,"RORA, RORA-AS1",Menarche (age at onset),age at menarche,GCST007078,15:60489314
rs72741332-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,TRIP4,Menarche (age at onset),age at menarche,GCST007078,15:64452591
rs3784710-<b>?</b>,2 x 10-16,,NR,'-,'-,'-,MAP2K5,Menarche (age at onset),age at menarche,GCST007078,15:67780120
rs5742915-<b>?</b>,4 x 10-17,,NR,'-,'-,'-,PML,Menarche (age at onset),age at menarche,GCST007078,15:74044292
rs62009090-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"HMG20A, LINGO1",Menarche (age at onset),age at menarche,GCST007078,15:77544713
rs4243084-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,CHRNA3,Menarche (age at onset),age at menarche,GCST007078,15:78619330
rs111491984-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,EFL1,Menarche (age at onset),age at menarche,GCST007078,15:82195898
rs13835-<b>?</b>,4 x 10-28,,NR,'-,'-,'-,DET1,Menarche (age at onset),age at menarche,GCST007078,15:88512809
rs62023121-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,CHD2,Menarche (age at onset),age at menarche,GCST007078,15:92916223
rs72767997-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,IGF1R,Menarche (age at onset),age at menarche,GCST007078,15:98745512
rs7199766-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,SLX4,Menarche (age at onset),age at menarche,GCST007078,16:3587428
rs4786084-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,RBFOX1,Menarche (age at onset),age at menarche,GCST007078,16:6122772
rs12933772-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,RBFOX1,Menarche (age at onset),age at menarche,GCST007078,16:6510429
rs1704528-<b>?</b>,5 x 10-33,,NR,'-,'-,'-,"Y_RNA, MIR193BHG",Menarche (age at onset),age at menarche,GCST007078,16:14294893
rs114285994-<b>?</b>,6 x 10-18,,NR,'-,'-,'-,GPRC5B,Menarche (age at onset),age at menarche,GCST007078,16:19924441
rs9652589-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,PDILT,Menarche (age at onset),age at menarche,GCST007078,16:20359494
rs112927956-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,TNRC6A,Menarche (age at onset),age at menarche,GCST007078,16:24712680
rs57149692-<b>?</b>,3 x 10-12,,NR,'-,'-,'-,"MAPK3, CORO1A",Menarche (age at onset),age at menarche,GCST007078,16:30130700
rs1362376-<b>?</b>,2 x 10-16,,NR,'-,'-,'-,CASC22,Menarche (age at onset),age at menarche,GCST007078,16:52258027
rs11642015-<b>?</b>,1 x 10-57,,NR,'-,'-,'-,FTO,Menarche (age at onset),age at menarche,GCST007078,16:53768582
rs12926791-<b>?</b>,1 x 10-36,,NR,'-,'-,'-,WWP2,Menarche (age at onset),age at menarche,GCST007078,16:69815643
rs139309976-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,VAC14,Menarche (age at onset),age at menarche,GCST007078,16:70751506
rs12603280-<b>?</b>,3 x 10-12,,NR,'-,'-,'-,"WSCD1, RNU6-1264P",Menarche (age at onset),age at menarche,GCST007078,17:6131434
rs12603355-<b>?</b>,4 x 10-10,,NR,'-,'-,'-,DNAH2,Menarche (age at onset),age at menarche,GCST007078,17:7829719
rs241036-<b>?</b>,7 x 10-13,,NR,'-,'-,'-,"LINC02210, LINC02210-CRHR1",Menarche (age at onset),age at menarche,GCST007078,17:45654353
rs9635759-<b>?</b>,1 x 10-48,,NR,'-,'-,'-,"CA10, LINC02073",Menarche (age at onset),age at menarche,GCST007078,17:51536424
rs17817628-<b>?</b>,2 x 10-17,,NR,'-,'-,'-,STXBP4,Menarche (age at onset),age at menarche,GCST007078,17:55097366
rs17817995-<b>?</b>,8 x 10-10,,NR,'-,'-,'-,"MMD, HLF",Menarche (age at onset),age at menarche,GCST007078,17:55335233
rs1285245-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,LINC01977,Menarche (age at onset),age at menarche,GCST007078,17:79823090
rs34768269-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,TBC1D16,Menarche (age at onset),age at menarche,GCST007078,17:79978952
rs58418838-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,RPTOR,Menarche (age at onset),age at menarche,GCST007078,17:80727155
rs2725405-<b>?</b>,7 x 10-12,,NR,'-,'-,'-,SLC38A10,Menarche (age at onset),age at menarche,GCST007078,17:81246424
rs12607903-<b>?</b>,9 x 10-27,,NR,'-,'-,'-,DLGAP1,Menarche (age at onset),age at menarche,GCST007078,18:3817134
rs9945304-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,NOL4,Menarche (age at onset),age at menarche,GCST007078,18:34123100
rs2668767-<b>?</b>,2 x 10-35,,NR,'-,'-,'-,"MIR4527HG, SKOR2",Menarche (age at onset),age at menarche,GCST007078,18:47258931
rs72661148-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,SMAD2,Menarche (age at onset),age at menarche,GCST007078,18:47845324
rs12607857-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,TCF4,Menarche (age at onset),age at menarche,GCST007078,18:55546095
rs9957921-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,RNU4-17P,Menarche (age at onset),age at menarche,GCST007078,18:60223839
rs8087694-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,18:64672065
rs35917007-<b>?</b>,4 x 10-23,,NR,'-,'-,'-,"REXO1, KLF16",Menarche (age at onset),age at menarche,GCST007078,19:1849148
rs16992771-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,KDM4B,Menarche (age at onset),age at menarche,GCST007078,19:5046059
rs4073513-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,PHF21A,Menarche (age at onset),age at menarche,GCST007078,11:46049702
rs4752978-<b>?</b>,9 x 10-8,,NR,'-,'-,'-,MADD,Menarche (age at onset),age at menarche,GCST007078,11:47303311
rs11039266-<b>?</b>,3 x 10-17,,NR,'-,'-,'-,CELF1,Menarche (age at onset),age at menarche,GCST007078,11:47510843
rs568442-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,"OR4C15, OR4C14P",Menarche (age at onset),age at menarche,GCST007078,11:55542346
rs7949608-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,"SPINDOC, ATP5MGP1",Menarche (age at onset),age at menarche,GCST007078,11:63828453
rs17854357-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"SNX32, CFL1",Menarche (age at onset),age at menarche,GCST007078,11:65834089
rs1045590-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,RSF1,Menarche (age at onset),age at menarche,GCST007078,11:77665761
rs2256464-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,USP35,Menarche (age at onset),age at menarche,GCST007078,11:78206259
rs11823251-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,DLG2,Menarche (age at onset),age at menarche,GCST007078,11:85041870
rs7102513-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,FZD4-DT,Menarche (age at onset),age at menarche,GCST007078,11:87006945
rs545075-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,"GPR83, IZUMO1R",Menarche (age at onset),age at menarche,GCST007078,11:94338512
rs10895141-<b>?</b>,1 x 10-22,,NR,'-,'-,'-,TRPC6,Menarche (age at onset),age at menarche,GCST007078,11:101566010
rs72992070-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,CADM1,Menarche (age at onset),age at menarche,GCST007078,11:115153970
rs7942122-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,CRTAM,Menarche (age at onset),age at menarche,GCST007078,11:122858399
rs7115813-<b>?</b>,3 x 10-50,,NR,'-,'-,'-,JHY,Menarche (age at onset),age at menarche,GCST007078,11:122961366
rs11047447-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,SOX5,Menarche (age at onset),age at menarche,GCST007078,12:24448114
rs112335739-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,"ADI1P3, LINC02156",Menarche (age at onset),age at menarche,GCST007078,12:47450879
rs1054442-<b>?</b>,3 x 10-15,,NR,'-,'-,'-,DDN,Menarche (age at onset),age at menarche,GCST007078,12:48995537
rs1131017-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,RPS26,Menarche (age at onset),age at menarche,GCST007078,12:56042145
rs141773786-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,NEMP1,Menarche (age at onset),age at menarche,GCST007078,12:57081818
rs76439972-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,LINC01619,Menarche (age at onset),age at menarche,GCST007078,12:92062801
rs10860153-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,12:97147754
rs76369685-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,RMST,Menarche (age at onset),age at menarche,GCST007078,12:97456812
rs10861880-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,WSCD2,Menarche (age at onset),age at menarche,GCST007078,12:108217697
rs7973253-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,MYO1H,Menarche (age at onset),age at menarche,GCST007078,12:109440310
rs7028185-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,9:117897330
rs10984237-<b>?</b>,7 x 10-11,,NR,'-,'-,'-,TUBB4BP6,Menarche (age at onset),age at menarche,GCST007078,9:118806262
rs2297605-<b>?</b>,2 x 10-18,,NR,'-,'-,'-,NR5A1,Menarche (age at onset),age at menarche,GCST007078,9:124493169
rs2267958-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,DNM1,Menarche (age at onset),age at menarche,GCST007078,9:128253000
rs1874984-<b>?</b>,2 x 10-22,,NR,'-,'-,'-,ADARB2,Menarche (age at onset),age at menarche,GCST007078,10:1689677
rs7073746-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,NRBF2,Menarche (age at onset),age at menarche,GCST007078,10:63144311
rs10740399-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,"DDIT4, DNAJB12",Menarche (age at onset),age at menarche,GCST007078,10:72300443
rs1172955-<b>?</b>,6 x 10-33,,NR,'-,'-,'-,"RNU6-271P, ZNF518A",Menarche (age at onset),age at menarche,GCST007078,10:96117563
rs10786610-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"PAX2, Y_RNA",Menarche (age at onset),age at menarche,GCST007078,10:100880906
rs2532718-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,ATRNL1,Menarche (age at onset),age at menarche,GCST007078,10:115721354
rs7077302-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,ATE1,Menarche (age at onset),age at menarche,GCST007078,10:121917147
rs2919290-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,CTBP2,Menarche (age at onset),age at menarche,GCST007078,10:125049964
rs4021186-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,CTBP2,Menarche (age at onset),age at menarche,GCST007078,10:125073268
rs9423024-<b>?</b>,3 x 10-18,,NR,'-,'-,'-,MRPS21P6,Menarche (age at onset),age at menarche,GCST007078,10:125173687
rs67221163-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"LINC02870, LINC01165",Menarche (age at onset),age at menarche,GCST007078,10:132484405
rs9795476-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,SIRT3,Menarche (age at onset),age at menarche,GCST007078,11:235894
rs12360772-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,LSP1,Menarche (age at onset),age at menarche,GCST007078,11:1878732
rs16937956-<b>?</b>,3 x 10-23,,NR,'-,'-,'-,STK33,Menarche (age at onset),age at menarche,GCST007078,11:8382954
rs11605776-<b>?</b>,1 x 10-30,,NR,'-,'-,'-,ARNTL,Menarche (age at onset),age at menarche,GCST007078,11:13296977
rs61371450-<b>?</b>,1 x 10-14,,NR,'-,'-,'-,"C11orf58, PLEKHA7",Menarche (age at onset),age at menarche,GCST007078,11:16765358
rs16917237-<b>?</b>,9 x 10-16,,NR,'-,'-,'-,"BDNF, BDNF-AS",Menarche (age at onset),age at menarche,GCST007078,11:27680836
rs11030282-<b>?</b>,7 x 10-14,,NR,'-,'-,'-,METTL15,Menarche (age at onset),age at menarche,GCST007078,11:28340253
rs11031006-<b>?</b>,3 x 10-15,,NR,'-,'-,'-,FSHB,Menarche (age at onset),age at menarche,GCST007078,11:30204981
rs4755720-<b>?</b>,2 x 10-16,,NR,'-,'-,'-,"HSD17B12, MIR129-2",Menarche (age at onset),age at menarche,GCST007078,11:43607199
rs7943688-<b>?</b>,7 x 10-10,,NR,'-,'-,'-,LINC02687,Menarche (age at onset),age at menarche,GCST007078,11:45425174
rs7135337-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,HNF1A-AS1,Menarche (age at onset),age at menarche,GCST007078,12:120966352
rs10902475-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,"PUS1, ULK1",Menarche (age at onset),age at menarche,GCST007078,12:131925700
rs10870546-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,FBRSL1,Menarche (age at onset),age at menarche,GCST007078,12:132478023
rs7992832-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,MTIF3,Menarche (age at onset),age at menarche,GCST007078,13:27439364
rs1933437-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,FLT3,Menarche (age at onset),age at menarche,GCST007078,13:28050157
rs9554311-<b>?</b>,4 x 10-10,,NR,'-,'-,'-,PAN3,Menarche (age at onset),age at menarche,GCST007078,13:28293131
rs9603605-<b>?</b>,5 x 10-14,,NR,'-,'-,'-,COG6,Menarche (age at onset),age at menarche,GCST007078,13:39734170
rs9568125-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,FNDC3A,Menarche (age at onset),age at menarche,GCST007078,13:48902179
rs1327942-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,RPP40P2,Menarche (age at onset),age at menarche,GCST007078,13:59258976
rs3829388-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,PCDH20,Menarche (age at onset),age at menarche,GCST007078,13:61410648
rs803821-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,"LINC00348, MTCL1P1",Menarche (age at onset),age at menarche,GCST007078,13:70984877
rs7329599-<b>?</b>,6 x 10-12,,NR,'-,'-,'-,KLF12,Menarche (age at onset),age at menarche,GCST007078,13:73987569
rs7995668-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,KLF12,Menarche (age at onset),age at menarche,GCST007078,13:74131042
rs12019957-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,MBNL2,Menarche (age at onset),age at menarche,GCST007078,13:97315747
rs9517913-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,"CLYBL, ZIC5",Menarche (age at onset),age at menarche,GCST007078,13:99912254
rs11619721-<b>?</b>,4 x 10-10,,NR,'-,'-,'-,TEX29,Menarche (age at onset),age at menarche,GCST007078,13:111430166
rs9560114-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,LINC02337,Menarche (age at onset),age at menarche,GCST007078,13:111535535
rs10136330-<b>?</b>,4 x 10-12,,NR,'-,'-,'-,PRKD1,Menarche (age at onset),age at menarche,GCST007078,14:30045129
rs12433775-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"RPL29P3, PHKBP2",Menarche (age at onset),age at menarche,GCST007078,14:36534633
rs10150590-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,14:40456677
rs4365199-<b>?</b>,3 x 10-25,,NR,'-,'-,'-,C14orf39,Menarche (age at onset),age at menarche,GCST007078,14:60527495
rs12879819-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,ADCK1,Menarche (age at onset),age at menarche,GCST007078,14:77958440
rs8007087-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,UNC79,Menarche (age at onset),age at menarche,GCST007078,14:93452539
rs55658396-<b>?</b>,5 x 10-11,,NR,'-,'-,'-,'-,Menarche (age at onset),age at menarche,GCST007078,14:97307210
rs78352137-<b>?</b>,5 x 10-30,,NR,'-,'-,'-,WDR25,Menarche (age at onset),age at menarche,GCST007078,14:100454079
rs291269-<b>G</b>,2 x 10-7,,0.37,'-,'-,'-,PTPRD,Menarche (age at onset),age at menarche,GCST005867,9:10043773
rs2076751-<b>C</b>,2 x 10-15,,0.75,'-,'-,'-,"SFTA3, NKX2-1-AS1, NKX2-1",Menarche (age at onset),age at menarche,GCST005867,14:36520214
rs77001758-<b>A</b>,1 x 10-9,,0.4,'-,'-,'-,"THOC1-DT, COLEC12",Menarche (age at onset),age at menarche,GCST005867,18:273610
rs4693089-<b>A</b>,7 x 10-8,(japanese),0.3826,'-,0.144 year decrease,[0.091-0.197],HELQ,Menarche (age at onset),age at menarche,GCST005867,4:83452469
rs365132-<b>G</b>,9 x 10-13,(japanese),0.4936,'-,0.192 year decrease,[0.14-0.24],UIMC1,Menarche (age at onset),age at menarche,GCST005867,5:176951573
rs6899676-<b>A</b>,3 x 10-7,(japanese),0.6297,'-,0.141 year decrease,[0.088-0.194],SYCP2L,Menarche (age at onset),age at menarche,GCST005867,6:10895027
rs9393800-<b>A</b>,1 x 10-8,(japanese),0.7523,'-,0.172 year increase,[0.11-0.23],SYCP2L,Menarche (age at onset),age at menarche,GCST005867,6:10951504
rs707938-<b>A</b>,1 x 10-12,(japanese),0.5873,'-,0.189 year increase,[0.14-0.24],"MSH5, MSH5-SAPCD1",Menarche (age at onset),age at menarche,GCST005867,6:31761582
rs2277339-<b>T</b>,8 x 10-20,(japanese),0.7964,'-,0.294 year increase,[0.23-0.36],"HSD17B6, PRIM1",Menarche (age at onset),age at menarche,GCST005867,12:56752285
rs1799949-<b>G</b>,3 x 10-8,(japanese),0.6614,'-,0.152 year decrease,[0.099-0.205],BRCA1,Menarche (age at onset),age at menarche,GCST005867,17:43093449
rs11668344-<b>A</b>,2 x 10-7,(japanese),0.9602,'-,0.343 year increase,[0.21-0.47],TMEM150B,Menarche (age at onset),age at menarche,GCST005867,19:55322296
rs5762534-<b>T</b>,6 x 10-6,(japanese),0.8222,'-,0.155 year decrease,[0.088-0.222],TTC28,Menarche (age at onset),age at menarche,GCST005867,22:28237583
rs7759938-<b>C</b>,4 x 10-16,(Japanese),0.28,'-,0.079 year increase,[0.059-0.099],LIN28B-AS1,Menarche (age at onset),age at menarche,GCST005867,6:104931079
rs10453225-<b>G</b>,3 x 10-11,(Japanese),0.5226,'-,0.058 year increase,[0.04-0.076],LINC01505,Menarche (age at onset),age at menarche,GCST005867,9:106157939
rs10980921-<b>T</b>,1 x 10-7,(Japanese),0.7794,'-,0.056 year decrease,[0.034-0.078],"ZNF483, ECPAS",Menarche (age at onset),age at menarche,GCST005867,9:111517632
rs9635759-<b>G</b>,2 x 10-7,(Japanese),0.5694,'-,0.047 year decrease,[0.029-0.065],"CA10, LINC02073",Menarche (age at onset),age at menarche,GCST005867,17:51536424
rs466639-<b>T</b>,2 x 10-6,(Japanese),0.2085,'-,0.052 year decrease,[0.03-0.074],RXRG,Menarche (age at onset),age at menarche,GCST005867,1:165425645
rs11715566-<b>C</b>,1 x 10-6,(Japanese),0.37,'-,0.044 year decrease,[0.026-0.062],'-,Menarche (age at onset),age at menarche,GCST005867,3:117843589
rs1400974-<b>G</b>,4 x 10-9,(Japanese),0.5942,'-,0.053 year decrease,[0.035-0.071],SOCAR,Menarche (age at onset),age at menarche,GCST005867,2:198773966
rs7103411-<b>C</b>,1 x 10-7,(Japanese),0.4006,'-,0.047 year increase,[0.029-0.065],"BDNF, BDNF-AS",Menarche (age at onset),age at menarche,GCST005867,11:27678578
rs6758290-<b>T</b>,4 x 10-7,(Japanese),0.6946,'-,0.053 year increase,[0.033-0.073],"GPR45, TGFBRAP1",Menarche (age at onset),age at menarche,GCST005867,2:105248369
rs2076751-<b>C</b>,1 x 10-11,(japanese),0.75,'-,0.07 year increase,[0.05-0.09],"SFTA3, NKX2-1-AS1, NKX2-1",Menarche (age at onset),age at menarche,GCST005867,14:36520214
rs77001758-<b>A</b>,5 x 10-9,(japanese),0.4,'-,0.05 year increase,[0.03-0.07],"THOC1-DT, COLEC12",Menarche (age at onset),age at menarche,GCST005867,18:273610
rs291269-<b>G</b>,2 x 10-8,(japanese),0.37,'-,0.05 year increase,[0.03-0.07],PTPRD,Menarche (age at onset),age at menarche,GCST005867,9:10043773
rs78408536-<b>CT</b>,5 x 10-8,(japanese),0.72,'-,0.05 year increase,[0.03-0.07],'-,Menarche (age at onset),age at menarche,GCST005867,Mapping not available
rs35020808-<b>GT</b>,5 x 10-11,(japanese),0.5,'-,0.06 year increase,[0.04-0.08],'-,Menarche (age at onset),age at menarche,GCST005867,2:198743564
rs11285463-<b>AT</b>,3 x 10-16,(japanese),0.29,'-,0.08 year increase,[0.06-0.1],LIN28B,Menarche (age at onset),age at menarche,GCST005867,6:104944130
rs7821604-<b>C</b>,2 x 10-8,(japanese),0.51,'-,0.05 year increase,[0.03-0.07],ZFHX4,Menarche (age at onset),age at menarche,GCST005867,8:76763076
rs1516883-<b>G</b>,4 x 10-12,(japanese),0.53,'-,0.06 year increase,[0.04-0.08],LINC01505,Menarche (age at onset),age at menarche,GCST005867,9:106144986
rs144048300-<b>T</b>,1 x 10-8,(japanese),0.16,'-,0.07 year increase,[0.05-0.09],JHY,Menarche (age at onset),age at menarche,GCST005867,11:122934355
rs142252570-<b>CTAAT</b>,2 x 10-9,(japanese),0.82,'-,0.07 year increase,[0.05-0.09],'-,Menarche (age at onset),age at menarche,GCST005867,14:97296313
rs10119582-<b>C</b>,9 x 10-13,,NR,1.17,'-,[1.12-1.23],PTPRD,Early age at menarche,age at menarche,GCST005865,9:10060803
rs1697621-<b>?</b>,2 x 10-6,(East Asian),'-,'-,'-,'-,KCNH1,Bone mineral density (spine) and age at menarche,"age at menarche, spine bone mineral density",GCST003101,1:210907839
rs10264856-<b>?</b>,8 x 10-7,(East Asian),'-,'-,'-,'-,"ABCB1, RUNDC3B",Bone mineral density (spine) and age at menarche,"age at menarche, spine bone mineral density",GCST003101,7:87633265
rs2157926-<b>?</b>,2 x 10-6,(East Asian),'-,'-,'-,'-,"ABCB1, RUNDC3B",Bone mineral density (spine) and age at menarche,"age at menarche, spine bone mineral density",GCST003101,7:87641184
rs10232457-<b>?</b>,9 x 10-7,(East Asian),'-,'-,'-,'-,"SLC25A40, RUNDC3B",Bone mineral density (spine) and age at menarche,"age at menarche, spine bone mineral density",GCST003101,7:87833200
rs10738889-<b>?</b>,2 x 10-6,(East Asian),'-,'-,'-,'-,DDX58,Bone mineral density (spine) and age at menarche,"age at menarche, spine bone mineral density",GCST003101,9:32458055
rs1930170-<b>?</b>,6 x 10-8,(East Asian),'-,'-,'-,'-,PCDH15,Bone mineral density (spine) and age at menarche,"age at menarche, spine bone mineral density",GCST003101,10:54457992
rs3893384-<b>?</b>,1 x 10-6,(East Asian),'-,'-,'-,'-,'-,Bone mineral density (spine) and age at menarche,"age at menarche, spine bone mineral density",GCST003101,Mapping not available
rs8041943-<b>?</b>,2 x 10-6,(East Asian),'-,'-,'-,'-,'-,Bone mineral density (spine) and age at menarche,"age at menarche, spine bone mineral density",GCST003101,15:79674258
rs10982287-<b>?</b>,9 x 10-6,,'-,'-,'-,'-,"ATP6V1G1, WHRN",Bone mineral density (spine) and age at menarche,"age at menarche, spine bone mineral density",GCST003101,9:114551935
rs1930170-<b>?</b>,6 x 10-8,(East Asian),'-,'-,'-,'-,PCDH15,Bone mineral density (hip) and age at menarche,"hip bone mineral density, age at menarche",GCST003102,10:54457992
rs10817638-<b>G</b>,5 x 10-7,(East Asian),'-,'-,'-,'-,"WHRN, ATP6V1G1",Bone mineral density (hip) and age at menarche,"hip bone mineral density, age at menarche",GCST003102,9:114560262
rs7598908-<b>?</b>,1 x 10-6,(East Asian),'-,'-,'-,'-,"LINC01807, SNF8P1",Bone mineral density (hip) and age at menarche,"hip bone mineral density, age at menarche",GCST003102,2:228433116
rs10846260-<b>?</b>,3 x 10-6,(East Asian),'-,'-,'-,'-,DERA,Bone mineral density (hip) and age at menarche,"hip bone mineral density, age at menarche",GCST003102,12:15971208
rs2429676-<b>?</b>,4 x 10-6,(East Asian),'-,'-,'-,'-,'-,Bone mineral density (hip) and age at menarche,"hip bone mineral density, age at menarche",GCST003102,X:121716468
rs802075-<b>?</b>,9 x 10-6,(East Asian),'-,'-,'-,'-,"RHAG, CRISP2",Bone mineral density (hip) and age at menarche,"hip bone mineral density, age at menarche",GCST003102,6:49686453
rs1469181-<b>?</b>,7 x 10-6,,'-,'-,'-,'-,"LINC01807, SNF8P1",Bone mineral density (hip) and age at menarche,"hip bone mineral density, age at menarche",GCST003102,2:228405109
rs10817638-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,"WHRN, ATP6V1G1",Bone mineral density (hip) and age at menarche,"hip bone mineral density, age at menarche",GCST003102,9:114560262
rs3027009-<b>?</b>,7 x 10-7,(Bivariate),NR,'-,'-,'-,"CADM3-AS1, ACKR1",Lean body mass and age at menarche (combined),"body fat distribution, age at menarche",GCST001584,1:159204097
rs314276-<b>C</b>,4 x 10-16,,0.67,'-,0.14 year decrease,[0.11-0.17],LIN28B,Menarche (age at onset),age at menarche,GCST000405,6:104960124
rs314280-<b>T</b>,2 x 10-14,,0.48,'-,1.2 months increase,[0.9-1.5],LIN28B,Menarche (age at onset),age at menarche,GCST000400,6:104952962
rs2090409-<b>A</b>,2 x 10-9,,0.31,'-,0.1 years decrease,[0.06-0.14],LINC01505,Menarche (age at onset),age at menarche,GCST000404,9:106204807
rs7759938-<b>C</b>,7 x 10-9,,0.33,'-,0.09 years increase,[0.05-0.13],LIN28B-AS1,Menarche (age at onset),age at menarche,GCST000404,6:104931079
rs12907866-<b>A</b>,4 x 10-7,(AA),0.84,'-,6.06 unit increase,[3.71-8.41],"MIR4713HG, CYP19A1",Menarche (age at onset),age at menarche,GCST001973,15:51253257
rs11071033-<b>T</b>,3 x 10-6,(AA),0.71,'-,4.49 unit increase,[2.61-6.37],UNC13C,Menarche (age at onset),age at menarche,GCST001973,15:54088003
rs320320-<b>A</b>,1 x 10-7,(EA),0.8,'-,1.659 unit increase,[0.74-2.58],AKT3,Menarche (age at onset),age at menarche,GCST001973,1:243671884
rs11071033-<b>T</b>,7 x 10-6,(EA),0.41,'-,1.134 unit increase,[0.42-1.85],UNC13C,Menarche (age at onset),age at menarche,GCST001973,15:54088003
rs10441737-<b>T</b>,4 x 10-15,(EA),0.64,'-,2.777 unit decrease,[4.31-5.94],ZNF483,Menarche (age at onset),age at menarche,GCST001973,9:111539305
rs980000-<b>T</b>,2 x 10-6,(AA),0.26,'-,4.69 unit increase,[2.75-6.63],"RORA, RORA-AS1",Menarche (age at onset),age at menarche,GCST001973,15:60608764
rs7807441-<b>T</b>,3 x 10-6,(AA),0.55,'-,4.02 unit decrease,[2.31-5.73],MTCO3P41,Menarche (age at onset),age at menarche,GCST001973,7:67723801
rs17669535-<b>C</b>,6 x 10-7,(AA),0.97,'-,14.5 unit increase,[8.80-20.20],DLGAP2,Menarche (age at onset),age at menarche,GCST001973,8:1295964
rs8014131-<b>A</b>,3 x 10-7,(AA),0.42,'-,4.61 unit decrease,[2.85-6.37],"LINC00911, FLRT2",Menarche (age at onset),age at menarche,GCST001973,14:85497512
rs4557202-<b>C</b>,2 x 10-6,(AA),0.43,'-,4.21 unit decrease,[2.49-5.93],B3GALNT1,Menarche (age at onset),age at menarche,GCST001973,3:161102736
rs11216435-<b>T</b>,3 x 10-6,(AA),0.32,'-,4.41 unit increase,[2.55-6.27],DSCAML1,Menarche (age at onset),age at menarche,GCST001973,11:117518217
rs339978-<b>T</b>,2 x 10-6,(AA),0.2,'-,5.31 unit increase,[3.13-7.49],RORA,Menarche (age at onset),age at menarche,GCST001973,15:60645203
rs7873730-<b>A</b>,2 x 10-6,(AA),0.88,'-,6.82 unit decrease,[4.00-9.64],ZNF483,Menarche (age at onset),age at menarche,GCST001973,9:111541399
rs10940138-<b>T</b>,4 x 10-7,(AA),0.19,'-,5.64 unit increase,[3.46-7.82],'-,Menarche (age at onset),age at menarche,GCST001973,5:67898641
rs320320-<b>A</b>,5 x 10-6,(AA),0.48,'-,4.03 unit increase,[2.31-5.75],AKT3,Menarche (age at onset),age at menarche,GCST001973,1:243671884
rs11792861-<b>A</b>,2 x 10-11,,0.7,'-,0.04 unit increase,[0.03-0.05],TMEM245,Menarche (age at onset),age at menarche,GCST002541,9:109047015
rs10980854-<b>A</b>,1 x 10-8,,0.06,'-,0.06 unit increase,[0.038-0.082],"MIR7702, OR2K2",Menarche (age at onset),age at menarche,GCST002541,9:111288077
rs10980921-<b>C</b>,2 x 10-23,,0.09,'-,0.09 unit increase,[0.072-0.108],"ZNF483, ECPAS",Menarche (age at onset),age at menarche,GCST002541,9:111517632
rs1874984-<b>C</b>,2 x 10-12,,0.47,'-,0.04 unit increase,[0.03-0.05],ADARB2,Menarche (age at onset),age at menarche,GCST002541,10:1689677
rs12571664-<b>T</b>,3 x 10-10,,0.79,'-,0.04 unit increase,[0.028-0.052],"MIR4682, SEC23IP",Menarche (age at onset),age at menarche,GCST002541,10:119949417
rs1915146-<b>G</b>,4 x 10-8,,0.4,'-,0.03 unit increase,[0.02-0.04],CTBP2,Menarche (age at onset),age at menarche,GCST002541,10:125157645
rs7104764-<b>G</b>,4 x 10-8,,0.25,'-,0.03 unit increase,[0.018-0.042],SIRT3,Menarche (age at onset),age at menarche,GCST002541,11:229977
rs4929947-<b>G</b>,3 x 10-12,,0.36,'-,0.04 unit increase,[0.03-0.05],TRIM66,Menarche (age at onset),age at menarche,GCST002541,11:8618447
rs11022756-<b>A</b>,7 x 10-20,,0.29,'-,0.05 unit increase,[0.038-0.062],ARNTL,Menarche (age at onset),age at menarche,GCST002541,11:13293892
rs7103411-<b>C</b>,3 x 10-11,,0.21,'-,0.04 unit increase,[0.028-0.052],"BDNF, BDNF-AS",Menarche (age at onset),age at menarche,GCST002541,11:27678578
rs16918636-<b>T</b>,3 x 10-8,,0.79,'-,0.03 unit increase,[0.018-0.042],LINC02742,Menarche (age at onset),age at menarche,GCST002541,11:29102635
rs4756059-<b>T</b>,5 x 10-13,,0.92,'-,0.07 unit increase,[0.05-0.09],"FBLIM1P2, PHF21A",Menarche (age at onset),age at menarche,GCST002541,11:46129068
rs2063730-<b>C</b>,2 x 10-12,,0.18,'-,0.05 unit increase,[0.036-0.064],GAB2,Menarche (age at onset),age at menarche,GCST002541,11:78337478
rs10895140-<b>G</b>,7 x 10-14,,0.66,'-,0.04 unit increase,[0.03-0.05],TRPC6,Menarche (age at onset),age at menarche,GCST002541,11:101565990
rs11215400-<b>C</b>,7 x 10-11,,0.27,'-,0.04 unit increase,[0.028-0.052],CADM1,Menarche (age at onset),age at menarche,GCST002541,11:115181915
rs1461503-<b>C</b>,3 x 10-26,,0.57,'-,0.05 unit increase,[0.04-0.06],"JHY, BSX",Menarche (age at onset),age at menarche,GCST002541,11:122974367
rs7955374-<b>T</b>,1 x 10-8,,0.13,'-,0.04 unit increase,[0.024-0.056],ADI1P3,Menarche (age at onset),age at menarche,GCST002541,12:47486366
rs7138803-<b>G</b>,2 x 10-12,,0.62,'-,0.04 unit increase,[0.03-0.05],"BCDIN3D, RPL35AP28",Menarche (age at onset),age at menarche,GCST002541,12:49853685
rs6563739-<b>G</b>,2 x 10-11,,0.34,'-,0.03 unit increase,[0.02-0.04],COG6,Menarche (age at onset),age at menarche,GCST002541,13:39665648
rs1324913-<b>G</b>,3 x 10-10,,0.65,'-,0.03 unit increase,[0.02-0.04],KLF12,Menarche (age at onset),age at menarche,GCST002541,13:74061451
rs9560113-<b>G</b>,2 x 10-17,,0.28,'-,0.05 unit increase,[0.038-0.062],LINC02337,Menarche (age at onset),age at menarche,GCST002541,13:111531001
rs1254337-<b>T</b>,2 x 10-16,,0.31,'-,0.04 unit increase,[0.03-0.05],C14orf39,Menarche (age at onset),age at menarche,GCST002541,14:60453807
rs1958560-<b>A</b>,4 x 10-8,,0.59,'-,0.03 unit increase,[0.02-0.04],FUT8,Menarche (age at onset),age at menarche,GCST002541,14:65570077
rs10144321-<b>A</b>,9 x 10-15,,0.75,'-,0.04 unit increase,[0.028-0.052],WDR25,Menarche (age at onset),age at menarche,GCST002541,14:100416068
rs7141210-<b>T</b>,6 x 10-9,,0.34,'-,0.03 unit increase,[0.02-0.04],"LINC00523, DLK1",Menarche (age at onset),age at menarche,GCST002541,14:100716133
rs4840086-<b>A</b>,9 x 10-14,,0.58,'-,0.04 unit increase,[0.03-0.05],'-,Menarche (age at onset),age at menarche,GCST002541,6:99760562
rs13196561-<b>C</b>,8 x 10-12,,0.78,'-,0.04 unit increase,[0.028-0.052],SIM1,Menarche (age at onset),age at menarche,GCST002541,6:100312294
rs239198-<b>T</b>,3 x 10-8,,0.46,'-,0.03 unit increase,[0.02-0.04],ASCC3,Menarche (age at onset),age at menarche,GCST002541,6:100686201
rs2153127-<b>T</b>,6 x 10-59,,0.52,'-,0.08 unit increase,[0.07-0.09],LIN28B-AS1,Menarche (age at onset),age at menarche,GCST002541,6:104900669
rs7759938-<b>C</b>,8 x 10-110,,0.32,'-,0.12 unit increase,[0.11-0.13],LIN28B-AS1,Menarche (age at onset),age at menarche,GCST002541,6:104931079
rs4895808-<b>C</b>,5 x 10-13,,0.54,'-,0.03 unit increase,[0.02-0.04],MIR588,Menarche (age at onset),age at menarche,GCST002541,6:126460288
rs6938574-<b>T</b>,2 x 10-9,,0.16,'-,0.04 unit increase,[0.026-0.054],"PTPRK-AS1, PTPRK",Menarche (age at onset),age at menarche,GCST002541,6:128069835
rs6933660-<b>C</b>,1 x 10-9,,0.69,'-,0.03 unit increase,[0.02-0.04],"CCDC170, ARMT1",Menarche (age at onset),age at menarche,GCST002541,6:151482619
rs1079866-<b>G</b>,9 x 10-24,,0.15,'-,0.07 unit increase,[0.056-0.084],'-,Menarche (age at onset),age at menarche,GCST002541,7:41430495
rs6964833-<b>T</b>,5 x 10-12,,0.75,'-,0.04 unit increase,[0.028-0.052],GTF2I,Menarche (age at onset),age at menarche,GCST002541,7:74687575
rs11767400-<b>A</b>,4 x 10-11,,0.3,'-,0.04 unit increase,[0.028-0.052],CADPS2,Menarche (age at onset),age at menarche,GCST002541,7:122520688
rs2688325-<b>T</b>,2 x 10-9,,0.29,'-,0.03 unit increase,[0.018-0.042],CSMD1,Menarche (age at onset),age at menarche,GCST002541,8:3909688
rs7828501-<b>G</b>,1 x 10-13,,0.45,'-,0.04 unit increase,[0.03-0.05],CSMD1,Menarche (age at onset),age at menarche,GCST002541,8:4702559
rs7463166-<b>A</b>,1 x 10-8,,0.63,'-,0.03 unit increase,[0.02-0.04],CSMD1,Menarche (age at onset),age at menarche,GCST002541,8:4976268
rs16918254-<b>A</b>,1 x 10-8,,0.92,'-,0.05 unit increase,[0.032-0.068],NPBWR1,Menarche (age at onset),age at menarche,GCST002541,8:52856653
rs7821178-<b>C</b>,7 x 10-17,,0.65,'-,0.04 unit increase,[0.03-0.05],'-,Menarche (age at onset),age at menarche,GCST002541,8:77181601
rs1469039-<b>A</b>,4 x 10-12,,0.19,'-,0.05 unit increase,[0.036-0.064],KCNK9,Menarche (age at onset),age at menarche,GCST002541,8:139639536
rs4875053-<b>G</b>,1 x 10-8,,0.44,'-,0.03 unit increase,[0.018-0.042],IQANK1,Menarche (age at onset),age at menarche,GCST002541,8:143790241
rs7037266-<b>A</b>,5 x 10-9,,0.37,'-,0.03 unit increase,[0.02-0.04],KDM4C,Menarche (age at onset),age at menarche,GCST002541,9:6942940
rs913588-<b>G</b>,6 x 10-11,,0.49,'-,0.03 unit increase,[0.02-0.04],KDM4C,Menarche (age at onset),age at menarche,GCST002541,9:7174673
rs7865468-<b>A</b>,1 x 10-7,,0.7,'-,0.03 unit increase,[0.02-0.04],PTPRD,Menarche (age at onset),age at menarche,GCST002541,9:10274080
rs7853970-<b>T</b>,2 x 10-9,,0.47,'-,0.03 unit increase,[0.02-0.04],"C9orf153, RMI1",Menarche (age at onset),age at menarche,GCST002541,9:84100651
rs10816359-<b>T</b>,2 x 10-8,,0.86,'-,0.04 unit increase,[0.024-0.056],LINC01505,Menarche (age at onset),age at menarche,GCST002541,9:105995389
rs10453225-<b>G</b>,6 x 10-66,,0.68,'-,0.09 unit increase,[0.08-0.1],LINC01505,Menarche (age at onset),age at menarche,GCST002541,9:106157939
rs10739221-<b>C</b>,4 x 10-41,,0.77,'-,0.08 unit increase,[0.068-0.092],LINC01505,Menarche (age at onset),age at menarche,GCST002541,9:106298549
rs12148769-<b>G</b>,5 x 10-11,,0.9,'-,0.05 unit increase,[0.034-0.066],PWRN4,Menarche (age at onset),age at menarche,GCST002541,15:23906947
rs3743266-<b>T</b>,2 x 10-13,,0.68,'-,0.04 unit increase,[0.03-0.05],"RORA, RORA-AS1",Menarche (age at onset),age at menarche,GCST002541,15:60489314
rs8032675-<b>T</b>,2 x 10-13,,0.4,'-,0.04 unit increase,[0.03-0.05],MAP2K5,Menarche (age at onset),age at menarche,GCST002541,15:67667126
rs12915845-<b>C</b>,3 x 10-12,,0.58,'-,0.03 unit increase,[0.02-0.04],DET1,Menarche (age at onset),age at menarche,GCST002541,15:88499236
rs246185-<b>C</b>,7 x 10-16,,0.33,'-,0.04 unit increase,[0.028-0.052],MIR193BHG,Menarche (age at onset),age at menarche,GCST002541,16:14301575
rs12446632-<b>A</b>,1 x 10-8,,0.13,'-,0.04 unit increase,[0.026-0.054],GPRC5B,Menarche (age at onset),age at menarche,GCST002541,16:19924067
rs1129700-<b>T</b>,2 x 10-9,,0.44,'-,0.03 unit increase,[0.02-0.04],"ASPHD1, KCTD13",Menarche (age at onset),age at menarche,GCST002541,16:29906713
rs8050136-<b>C</b>,2 x 10-17,,0.6,'-,0.04 unit increase,[0.03-0.05],FTO,Menarche (age at onset),age at menarche,GCST002541,16:53782363
rs1364063-<b>C</b>,6 x 10-21,,0.43,'-,0.05 unit increase,[0.04-0.06],"CYB5B, NFAT5",Menarche (age at onset),age at menarche,GCST002541,16:69554669
rs929843-<b>A</b>,1 x 10-11,,0.23,'-,0.04 unit increase,[0.028-0.052],"PDXDC2P-NPIPB14P, PDXDC2P",Menarche (age at onset),age at menarche,GCST002541,16:70011845
rs7215990-<b>G</b>,2 x 10-8,,0.76,'-,0.04 unit increase,[0.028-0.052],"RNU6-1264P, WSCD1",Menarche (age at onset),age at menarche,GCST002541,17:6131511
rs9635759-<b>A</b>,2 x 10-24,,0.32,'-,0.05 unit increase,[0.04-0.06],"CA10, LINC02073",Menarche (age at onset),age at menarche,GCST002541,17:51536424
rs244293-<b>G</b>,4 x 10-11,,0.6,'-,0.03 unit increase,[0.02-0.04],STXBP4,Menarche (age at onset),age at menarche,GCST002541,17:55153361
rs12607903-<b>C</b>,5 x 10-11,,0.3,'-,0.04 unit increase,[0.03-0.05],DLGAP1,Menarche (age at onset),age at menarche,GCST002541,18:3817134
rs2137289-<b>A</b>,8 x 10-20,,0.59,'-,0.05 unit increase,[0.04-0.06],SKOR2,Menarche (age at onset),age at menarche,GCST002541,18:47225754
rs652260-<b>T</b>,1 x 10-8,,0.54,'-,0.03 unit increase,[0.02-0.04],EVI5L,Menarche (age at onset),age at menarche,GCST002541,19:7835676
rs889122-<b>G</b>,2 x 10-13,,0.72,'-,0.04 unit increase,[0.028-0.052],OLFM2,Menarche (age at onset),age at menarche,GCST002541,19:9885191
rs10423674-<b>A</b>,9 x 10-12,,0.34,'-,0.04 unit increase,[0.03-0.05],CRTC1,Menarche (age at onset),age at menarche,GCST002541,19:18707093
rs852069-<b>G</b>,1 x 10-13,,0.64,'-,0.04 unit increase,[0.03-0.05],RNU6-27P,Menarche (age at onset),age at menarche,GCST002541,20:17141948
rs2836950-<b>C</b>,6 x 10-11,,0.64,'-,0.03 unit increase,[0.02-0.04],BRWD1,Menarche (age at onset),age at menarche,GCST002541,21:39232503
rs13053505-<b>G</b>,3 x 10-8,,0.8,'-,0.04 unit increase,[0.026-0.054],"NPTXR, CBX6",Menarche (age at onset),age at menarche,GCST002541,22:38849613
rs6009583-<b>C</b>,5 x 10-8,,0.74,'-,0.03 unit increase,[0.018-0.042],RPL35P8,Menarche (age at onset),age at menarche,GCST002541,22:49281720
rs11715566-<b>T</b>,2 x 10-27,,0.5,'-,0.05 unit increase,[0.04-0.06],'-,Menarche (age at onset),age at menarche,GCST002541,3:117843589
rs2687729-<b>G</b>,1 x 10-10,,0.27,'-,0.04 unit increase,[0.028-0.052],EEFSEC,Menarche (age at onset),age at menarche,GCST002541,3:128176383
rs2600959-<b>A</b>,4 x 10-11,,0.34,'-,0.04 unit increase,[0.03-0.05],NPHP3-AS1,Menarche (age at onset),age at menarche,GCST002541,3:132896620
rs13067731-<b>T</b>,1 x 10-9,,0.16,'-,0.04 unit increase,[0.026-0.054],'-,Menarche (age at onset),age at menarche,GCST002541,3:137271149
rs900400-<b>T</b>,2 x 10-11,,0.61,'-,0.03 unit increase,[0.02-0.04],"LEKR1, LINC00880",Menarche (age at onset),age at menarche,GCST002541,3:157080986
rs939317-<b>G</b>,3 x 10-12,,0.74,'-,0.04 unit increase,[0.028-0.052],EIF4G1,Menarche (age at onset),age at menarche,GCST002541,3:184328011
rs16860328-<b>G</b>,1 x 10-16,,0.42,'-,0.04 unit increase,[0.03-0.05],TRA2B,Menarche (age at onset),age at menarche,GCST002541,3:185917897
rs1038903-<b>T</b>,2 x 10-11,,0.73,'-,0.04 unit increase,[0.028-0.052],"RN7SL101P, MIR4275",Menarche (age at onset),age at menarche,GCST002541,4:28750432
rs10938397-<b>A</b>,4 x 10-13,,0.57,'-,0.04 unit increase,[0.03-0.05],LINC02273,Menarche (age at onset),age at menarche,GCST002541,4:45180510
rs13135934-<b>C</b>,1 x 10-10,,0.4,'-,0.03 unit increase,[0.02-0.04],SMARCAD1,Menarche (age at onset),age at menarche,GCST002541,4:94286537
rs3733631-<b>C</b>,5 x 10-13,,0.15,'-,0.05 unit increase,[0.036-0.064],TACR3,Menarche (age at onset),age at menarche,GCST002541,4:103719946
rs1532331-<b>G</b>,4 x 10-9,,0.32,'-,0.03 unit increase,[0.02-0.04],ZNF131,Menarche (age at onset),age at menarche,GCST002541,5:43116728
rs17086188-<b>A</b>,4 x 10-8,,0.94,'-,0.07 unit increase,[0.045-0.095],"PCSK1, CAST",Menarche (age at onset),age at menarche,GCST002541,5:96510150
rs251130-<b>G</b>,3 x 10-10,,0.73,'-,0.04 unit increase,[0.028-0.052],STARD4-AS1,Menarche (age at onset),age at menarche,GCST002541,5:111524099
rs13179411-<b>T</b>,3 x 10-20,,0.17,'-,0.06 unit increase,[0.046-0.074],JADE2,Menarche (age at onset),age at menarche,GCST002541,5:134564823
rs17171818-<b>C</b>,9 x 10-14,,0.77,'-,0.04 unit increase,[0.028-0.052],KDM3B,Menarche (age at onset),age at menarche,GCST002541,5:138389314
rs7701886-<b>A</b>,5 x 10-8,,0.58,'-,0.03 unit increase,[0.02-0.04],MFAP3,Menarche (age at onset),age at menarche,GCST002541,5:154167849
rs9647570-<b>G</b>,1 x 10-11,,0.14,'-,0.05 unit increase,[0.036-0.064],TENM2,Menarche (age at onset),age at menarche,GCST002541,5:167943258
rs6555855-<b>G</b>,2 x 10-9,,0.23,'-,0.04 unit increase,[0.028-0.052],SLIT3,Menarche (age at onset),age at menarche,GCST002541,5:169322733
rs16896742-<b>G</b>,3 x 10-10,,0.38,'-,0.04 unit increase,[0.028-0.052],"HLA-W, HLA-A",Menarche (age at onset),age at menarche,GCST002541,6:29954963
rs2479724-<b>T</b>,1 x 10-12,,0.45,'-,0.03 unit increase,[0.02-0.04],BYSL,Menarche (age at onset),age at menarche,GCST002541,6:41923244
rs988913-<b>C</b>,1 x 10-12,,0.66,'-,0.04 unit increase,[0.03-0.05],FAM83B,Menarche (age at onset),age at menarche,GCST002541,6:54891510
rs9475752-<b>C</b>,8 x 10-12,,0.81,'-,0.04 unit increase,[0.028-0.052],DST,Menarche (age at onset),age at menarche,GCST002541,6:56915943
rs9447700-<b>C</b>,6 x 10-9,,0.69,'-,0.03 unit increase,[0.02-0.04],"LINC02540, RNU6-261P",Menarche (age at onset),age at menarche,GCST002541,6:76458369
rs9321659-<b>A</b>,3 x 10-16,,0.13,'-,0.06 unit increase,[0.044-0.076],Y_RNA,Menarche (age at onset),age at menarche,GCST002541,6:99668216
rs2274465-<b>C</b>,2 x 10-9,,0.66,'-,0.03 unit increase,[0.02-0.04],KDM4A,Menarche (age at onset),age at menarche,GCST002541,1:43655886
rs10789181-<b>A</b>,4 x 10-8,,0.39,'-,0.03 unit increase,[0.02-0.04],DNAJC6,Menarche (age at onset),age at menarche,GCST002541,1:65350884
rs3101336-<b>T</b>,5 x 10-13,,0.4,'-,0.04 unit increase,[0.03-0.05],"NEGR1, RPL31P12",Menarche (age at onset),age at menarche,GCST002541,1:72285502
rs7514705-<b>C</b>,2 x 10-16,,0.56,'-,0.04 unit increase,[0.03-0.05],"TNNI3K, FPGT-TNNI3K",Menarche (age at onset),age at menarche,GCST002541,1:74541036
rs11165924-<b>A</b>,2 x 10-9,,0.69,'-,0.03 unit increase,[0.018-0.042],DPYD,Menarche (age at onset),age at menarche,GCST002541,1:97909892
rs11578152-<b>G</b>,5 x 10-8,,0.44,'-,0.03 unit increase,[0.02-0.04],'-,Menarche (age at onset),age at menarche,GCST002541,1:102111465
rs466639-<b>C</b>,2 x 10-24,,0.87,'-,0.08 unit increase,[0.066-0.094],RXRG,Menarche (age at onset),age at menarche,GCST002541,1:165425645
rs543874-<b>A</b>,1 x 10-15,,0.8,'-,0.05 unit increase,[0.038-0.062],SEC16B,Menarche (age at onset),age at menarche,GCST002541,1:177920345
rs6427782-<b>A</b>,5 x 10-8,,0.51,'-,0.03 unit increase,[0.02-0.04],RNU6-778P,Menarche (age at onset),age at menarche,GCST002541,1:199829211
rs951366-<b>T</b>,2 x 10-8,,0.6,'-,0.03 unit increase,[0.02-0.04],'-,Menarche (age at onset),age at menarche,GCST002541,Mapping not available
rs2947411-<b>A</b>,2 x 10-19,,0.17,'-,0.06 unit increase,[0.046-0.074],"LINC01875, TMEM18",Menarche (age at onset),age at menarche,GCST002541,2:614168
rs6747380-<b>A</b>,6 x 10-28,,0.17,'-,0.07 unit increase,[0.056-0.084],CCDC85A,Menarche (age at onset),age at menarche,GCST002541,2:56360614
rs268067-<b>A</b>,3 x 10-8,,0.8,'-,0.04 unit increase,[0.028-0.052],"RNU6-508P, RNA5SP94",Menarche (age at onset),age at menarche,GCST002541,2:59653910
rs6758290-<b>T</b>,7 x 10-13,,0.5,'-,0.04 unit increase,[0.03-0.05],"GPR45, TGFBRAP1",Menarche (age at onset),age at menarche,GCST002541,2:105248369
rs12472911-<b>C</b>,7 x 10-10,,0.2,'-,0.04 unit increase,[0.028-0.052],LRP1B,Menarche (age at onset),age at menarche,GCST002541,2:141470940
rs4369815-<b>T</b>,2 x 10-10,,0.93,'-,0.06 unit increase,[0.04-0.08],"LINC01876, NR4A2",Menarche (age at onset),age at menarche,GCST002541,2:156270452
rs17236969-<b>T</b>,3 x 10-9,,0.14,'-,0.05 unit increase,[0.034-0.066],'-,Menarche (age at onset),age at menarche,GCST002541,2:155895947
rs17233066-<b>C</b>,6 x 10-11,,0.93,'-,0.09 unit increase,[0.063-0.117],'-,Menarche (age at onset),age at menarche,GCST002541,2:198779314
rs17266097-<b>T</b>,3 x 10-18,,0.42,'-,0.04 unit increase,[0.03-0.05],SATB2,Menarche (age at onset),age at menarche,GCST002541,2:199410486
rs1400974-<b>A</b>,8 x 10-20,,0.64,'-,0.05 unit increase,[0.04-0.06],SOCAR,Menarche (age at onset),age at menarche,GCST002541,2:198773966
rs6770162-<b>A</b>,2 x 10-12,,0.51,'-,0.04 unit increase,[0.03-0.05],THRB-AS1,Menarche (age at onset),age at menarche,GCST002541,3:24669522
rs7647973-<b>A</b>,1 x 10-16,,0.26,'-,0.05 unit increase,[0.038-0.062],DAG1,Menarche (age at onset),age at menarche,GCST002541,3:49473498
rs6762477-<b>G</b>,8 x 10-12,,0.44,'-,0.04 unit increase,[0.028-0.052],RBM6,Menarche (age at onset),age at menarche,GCST002541,3:50055776
rs7642134-<b>G</b>,3 x 10-16,,0.61,'-,0.04 unit increase,[0.03-0.05],VGLL3,Menarche (age at onset),age at menarche,GCST002541,3:86867732
rs9849248-<b>C</b>,2 x 10-8,,0.15,'-,0.04 unit increase,[0.026-0.054],C3orf38,Menarche (age at onset),age at menarche,GCST002541,3:88192124
rs4929923-<b>T</b>,1 x 10-8,,0.36,'-,2.3 week increase,[1.52-3.08],TRIM66,Menarche (age at onset),age at menarche,GCST000880,11:8617653
rs6439371-<b>G</b>,1 x 10-8,,0.34,'-,2.3 week increase,[1.52-3.08],NPHP3-AS1,Menarche (age at onset),age at menarche,GCST000880,3:132891908
rs12472911-<b>C</b>,2 x 10-7,,0.2,'-,2.5 week increase,[1.52-3.48],LRP1B,Menarche (age at onset),age at menarche,GCST000880,2:141470940
rs3914188-<b>G</b>,3 x 10-7,,0.27,'-,2.2 week decrease,[1.42-2.98],"ECE2, EEF1AKMT4-ECE2",Menarche (age at onset),age at menarche,GCST000880,3:184292260
rs7617480-<b>A</b>,3 x 10-8,,0.22,'-,2.4 week decrease,[1.62-3.18],KLHDC8B,Menarche (age at onset),age at menarche,GCST000880,3:49173299
rs757647-<b>A</b>,5 x 10-8,,0.22,'-,2.4 week decrease,[1.62-3.18],KDM3B,Menarche (age at onset),age at menarche,GCST000880,5:138371626
rs7359257-<b>A</b>,2 x 10-6,,0.45,'-,1.7 week increase,[0.92-2.48],"IQCH-AS1, IQCH",Menarche (age at onset),age at menarche,GCST000880,15:67410569
rs7821178-<b>A</b>,3 x 10-9,,0.34,'-,2.4 week decrease,[1.62-3.18],'-,Menarche (age at onset),age at menarche,GCST000880,8:77181601
rs1659127-<b>A</b>,4 x 10-9,,0.34,'-,2.4 week decrease,[1.62-3.18],"Y_RNA, MIR193BHG",Menarche (age at onset),age at menarche,GCST000880,16:14294448
rs1862471-<b>G</b>,2 x 10-7,,0.47,'-,2 week increase,[1.22-2.78],OLFM2,Menarche (age at onset),age at menarche,GCST000880,19:9889646
rs2243803-<b>A</b>,3 x 10-7,,0.4,'-,2 week increase,[1.22-2.78],SLC14A2,Menarche (age at onset),age at menarche,GCST000880,18:45376707
rs7759938-<b>C</b>,5 x 10-60,,0.32,'-,6.4 week increase,[5.62-7.18],LIN28B-AS1,Menarche (age at onset),age at menarche,GCST000880,6:104931079
rs1079866-<b>G</b>,6 x 10-14,,0.15,'-,3.9 week increase,[2.92-4.88],'-,Menarche (age at onset),age at menarche,GCST000880,7:41430495
rs12617311-<b>A</b>,6 x 10-13,,0.32,'-,3 week decrease,[2.22-3.78],'-,Menarche (age at onset),age at menarche,GCST000880,2:198767841
rs6589964-<b>A</b>,2 x 10-12,,0.48,'-,2.7 week decrease,[1.92-3.48],"RPL34P23, BSX",Menarche (age at onset),age at menarche,GCST000880,11:122999975
rs13187289-<b>G</b>,2 x 10-10,,0.2,'-,3 week increase,[2.02-3.98],"RN7SL541P, LINC01843",Menarche (age at onset),age at menarche,GCST000880,5:134513486
rs2002675-<b>G</b>,1 x 10-9,,0.42,'-,2.2 week increase,[1.42-2.98],"IGF2BP2, TRA2B",Menarche (age at onset),age at menarche,GCST000880,3:185911780
rs3743266-<b>C</b>,8 x 10-7,,0.32,'-,2 week decrease,[1.22-2.78],"RORA, RORA-AS1",Menarche (age at onset),age at menarche,GCST000880,15:60489314
rs9555810-<b>G</b>,6 x 10-8,,0.28,'-,2.3 week decrease,[1.52-3.08],LINC02337,Menarche (age at onset),age at menarche,GCST000880,13:111529090
rs16938437-<b>T</b>,6 x 10-8,,0.09,'-,3.7 week decrease,[2.33-5.07],PHF21A,Menarche (age at onset),age at menarche,GCST000880,11:46031024
rs2687729-<b>G</b>,1 x 10-7,,0.27,'-,2.3 week increase,[1.52-3.08],EEFSEC,Menarche (age at onset),age at menarche,GCST000880,3:128176383
rs2947411-<b>A</b>,2 x 10-8,,0.17,'-,2.8 week increase,[1.82-3.78],"LINC01875, TMEM18",Menarche (age at onset),age at menarche,GCST000880,2:614168
rs1361108-<b>T</b>,2 x 10-8,,0.46,'-,2.1 week decrease,[1.32-2.88],"MIR588, CENPW",Menarche (age at onset),age at menarche,GCST000880,6:126446454
rs1364063-<b>C</b>,2 x 10-8,,0.43,'-,2.1 week increase,[1.32-2.88],"CYB5B, NFAT5",Menarche (age at onset),age at menarche,GCST000880,16:69554669
rs633715-<b>C</b>,2 x 10-8,,0.2,'-,2.6 week decrease,[1.62-3.58],SEC16B,Menarche (age at onset),age at menarche,GCST000880,1:177883445
rs4840086-<b>G</b>,2 x 10-8,,0.42,'-,2.1 week decrease,[1.32-2.88],'-,Menarche (age at onset),age at menarche,GCST000880,6:99760562
rs9939609-<b>A</b>,3 x 10-8,,0.4,'-,2.1 week decrease,[1.32-2.88],FTO,Menarche (age at onset),age at menarche,GCST000880,16:53786615
rs10980926-<b>A</b>,4 x 10-11,,0.36,'-,2.5 week increase,[1.72-3.28],ZNF483,Menarche (age at onset),age at menarche,GCST000880,9:111531354
rs17268785-<b>G</b>,1 x 10-10,,0.17,'-,3.2 week increase,[2.22-4.18],CCDC85A,Menarche (age at onset),age at menarche,GCST000880,2:56364948
rs6438424-<b>A</b>,1 x 10-13,,0.5,'-,2.7 week decrease,[1.92-3.48],'-,Menarche (age at onset),age at menarche,GCST000880,3:117855975
rs1398217-<b>G</b>,2 x 10-13,,0.43,'-,2.7 week decrease,[1.92-3.48],SKOR2,Menarche (age at onset),age at menarche,GCST000880,18:47225867
rs9635759-<b>A</b>,7 x 10-13,,0.32,'-,3 week decrease,[2.22-3.78],"CA10, LINC02073",Menarche (age at onset),age at menarche,GCST000880,17:51536424
rs466639-<b>T</b>,1 x 10-13,,0.13,'-,4.2 week decrease,[3.02-5.38],RXRG,Menarche (age at onset),age at menarche,GCST000880,1:165425645
rs2090409-<b>A</b>,2 x 10-33,,0.31,'-,4.7 week decrease,[3.92-5.48],LINC01505,Menarche (age at onset),age at menarche,GCST000880,9:106204807
rs10899489-<b>A</b>,8 x 10-9,,0.15,'-,3.1 week increase,[2.12-4.08],GAB2,Menarche (age at onset),age at menarche,GCST000880,11:78384327
rs6575793-<b>C</b>,1 x 10-8,,0.42,'-,2.3 week increase,[1.52-3.08],BEGAIN,Menarche (age at onset),age at menarche,GCST000880,14:100565880
rs900145-<b>C</b>,2 x 10-8,,0.3,'-,2.3 week increase,[1.52-3.08],ARNTL,Menarche (age at onset),age at menarche,GCST000880,11:13272358
rs6762477-<b>G</b>,2 x 10-8,,0.44,'-,2.5 week increase,[1.72-3.28],RBM6,Menarche (age at onset),age at menarche,GCST000880,3:50055776
rs852069-<b>A</b>,3 x 10-8,,0.37,'-,2.1 week decrease,[1.32-2.88],RNU6-27P,Menarche (age at onset),age at menarche,GCST000880,20:17141948
rs7642134-<b>A</b>,4 x 10-10,,0.38,'-,2.4 week decrease,[1.62-3.18],VGLL3,Menarche (age at onset),age at menarche,GCST000880,3:86867732
rs17188434-<b>C</b>,1 x 10-9,,0.07,'-,4.5 week decrease,[3.13-5.87],LINC01876,Menarche (age at onset),age at menarche,GCST000880,2:156240264
rs10423674-<b>A</b>,6 x 10-9,,0.35,'-,2.3 week decrease,[1.52-3.08],CRTC1,Menarche (age at onset),age at menarche,GCST000880,19:18707093
rs11597068-<b>G</b>,1 x 10-7,,0.939,'-,1.37 unit increase,[0.86-1.88],RPS26P39,Menopause (age at onset),age at menopause,GCST002192,10:123228637
rs6495785-<b>A</b>,5 x 10-6,,0.787,'-,0.69 unit decrease,[0.40-0.98],DPH6-DT,Menopause (age at onset),age at menopause,GCST002192,15:35566382
rs16991615-<b>A</b>,1 x 10-21,(age at natural menopause),0.06,'-,1.07 years increase,[0.85-1.29],MCM8,Menarche and menopause (age at onset),age at menopause,GCST000403,20:5967581
rs2153157-<b>T</b>,5 x 10-8,(age at natural menopause),0.49,'-,0.29 years increase,[0.19-0.39],SYCP2L,Menarche and menopause (age at onset),age at menopause,GCST000403,6:10897255
rs1172822-<b>T</b>,2 x 10-19,(age at natural menopause),0.37,'-,0.49 years decrease,[0.38-0.60],BRSK1,Menarche and menopause (age at onset),age at menopause,GCST000403,19:55308477
rs365132-<b>T</b>,8 x 10-14,(age at natural menopause),0.49,'-,0.39 years increase,[0.29-0.49],UIMC1,Menarche and menopause (age at onset),age at menopause,GCST000403,5:176951573
rs4575545-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,"MAFTRR, LINC01229",Age at menopause,age at menopause,GCST007079,16:79721549
rs4782369-<b>?</b>,4 x 10-12,,NR,'-,'-,'-,ZFPM1,Age at menopause,age at menopause,GCST007079,16:88465453
rs56283750-<b>?</b>,3 x 10-13,,NR,'-,'-,'-,VPS9D1,Age at menopause,age at menopause,GCST007079,16:89720353
rs13335395-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,TCF25,Age at menopause,age at menopause,GCST007079,16:89886435
rs11650324-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,RPAIN,Age at menopause,age at menopause,GCST007079,17:5426866
rs8077172-<b>?</b>,2 x 10-18,,NR,'-,'-,'-,PGAP3,Age at menopause,age at menopause,GCST007079,17:39678724
rs9915489-<b>?</b>,7 x 10-21,,NR,'-,'-,'-,VAT1,Age at menopause,age at menopause,GCST007079,17:43021209
rs1815198-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,MSI2,Age at menopause,age at menopause,GCST007079,17:57283224
rs17650301-<b>?</b>,6 x 10-20,,NR,'-,'-,'-,POLG2,Age at menopause,age at menopause,GCST007079,17:64483156
rs75544834-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,"FBXO36P1, KPNA2",Age at menopause,age at menopause,GCST007079,17:68070322
rs349306-<b>?</b>,4 x 10-17,,NR,'-,'-,'-,ARID3A,Age at menopause,age at menopause,GCST007079,19:950694
rs2304192-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,NMRK2,Age at menopause,age at menopause,GCST007079,19:3933316
rs147068659-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,"MAP2K2, ZBTB7A",Age at menopause,age at menopause,GCST007079,19:4080520
rs60907808-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,"VN1R88P, ZNF728",Age at menopause,age at menopause,GCST007079,19:22921266
rs8106745-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,PPP5C,Age at menopause,age at menopause,GCST007079,19:46388911
rs34962991-<b>?</b>,1 x 10-105,,NR,'-,'-,'-,TMEM150B,Age at menopause,age at menopause,GCST007079,19:55315807
rs299163-<b>?</b>,8 x 10-15,,NR,'-,'-,'-,NLRP11,Age at menopause,age at menopause,GCST007079,19:55810048
rs16991615-<b>?</b>,1 x 10-143,,NR,'-,'-,'-,MCM8,Age at menopause,age at menopause,GCST007079,20:5967581
rs746748-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,ABHD12,Age at menopause,age at menopause,GCST007079,20:25302331
rs7347500-<b>?</b>,2 x 10-17,,NR,'-,'-,'-,SLCO4A1,Age at menopause,age at menopause,GCST007079,20:62656317
rs10854167-<b>?</b>,1 x 10-14,,NR,'-,'-,'-,DIDO1,Age at menopause,age at menopause,GCST007079,20:62901687
rs71325459-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"STMN3, MHENCR",Age at menopause,age at menopause,GCST007079,20:63636988
rs1837988-<b>?</b>,1 x 10-23,,NR,'-,'-,'-,DDX17,Age at menopause,age at menopause,GCST007079,22:38505089
rs200448-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,DNAJC11,Age at menopause,age at menopause,GCST007079,1:6641918
rs4970634-<b>?</b>,6 x 10-27,,NR,'-,'-,'-,RHBDL2,Age at menopause,age at menopause,GCST007079,1:38898945
rs72661322-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,CCDC30,Age at menopause,age at menopause,GCST007079,1:42641504
rs112869704-<b>?</b>,4 x 10-13,,NR,'-,'-,'-,UQCRH,Age at menopause,age at menopause,GCST007079,1:46314613
rs72708144-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,H2BC19P,Age at menopause,age at menopause,GCST007079,1:149844173
rs12132692-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"C1orf112, SELE",Age at menopause,age at menopause,GCST007079,1:169763602
rs11586493-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,STX6,Age at menopause,age at menopause,GCST007079,1:180992109
rs1635506-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,EXO1,Age at menopause,age at menopause,GCST007079,1:241865502
rs7521072-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,ADSS2,Age at menopause,age at menopause,GCST007079,1:244429978
rs780088-<b>?</b>,6 x 10-21,,NR,'-,'-,'-,FNDC4,Age at menopause,age at menopause,GCST007079,2:27493137
rs58387006-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,"YIPF4, BIRC6",Age at menopause,age at menopause,GCST007079,2:32354931
rs76928871-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,MSH6,Age at menopause,age at menopause,GCST007079,2:47778682
rs62156695-<b>?</b>,5 x 10-21,,NR,'-,'-,'-,ETAA1,Age at menopause,age at menopause,GCST007079,2:67422636
rs72827480-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,"LINC01101, INHBB",Age at menopause,age at menopause,GCST007079,2:120388925
rs1979033-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,CCNT2,Age at menopause,age at menopause,GCST007079,2:134947988
rs4491723-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,RIF1,Age at menopause,age at menopause,GCST007079,2:151423732
rs4668354-<b>?</b>,9 x 10-15,,NR,'-,'-,'-,GORASP2,Age at menopause,age at menopause,GCST007079,2:170958240
rs1991371-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,BMPR2,Age at menopause,age at menopause,GCST007079,2:202553814
rs2624847-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,SEMA3F-AS1,Age at menopause,age at menopause,GCST007079,3:50136764
rs777513-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,UROC1,Age at menopause,age at menopause,GCST007079,3:126481303
rs9818740-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,"PCCB, MSL2",Age at menopause,age at menopause,GCST007079,3:136220744
rs345985-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,TIPARP,Age at menopause,age at menopause,GCST007079,3:156679385
rs10937153-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,PARL,Age at menopause,age at menopause,GCST007079,3:183845137
rs7661090-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,BOD1L1,Age at menopause,age at menopause,GCST007079,4:13570277
rs7665209-<b>?</b>,7 x 10-14,,NR,'-,'-,'-,OCIAD1,Age at menopause,age at menopause,GCST007079,4:48812670
rs1565909-<b>?</b>,9 x 10-45,,NR,'-,'-,'-,ABRAXAS1,Age at menopause,age at menopause,GCST007079,4:83479177
rs11935767-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,H2AZ1-DT,Age at menopause,age at menopause,GCST007079,4:100093652
rs12503643-<b>?</b>,6 x 10-25,,NR,'-,'-,'-,ACSL1,Age at menopause,age at menopause,GCST007079,4:184824934
rs169285-<b>?</b>,1 x 10-14,,NR,'-,'-,'-,TENT4A,Age at menopause,age at menopause,GCST007079,5:6736474
rs2688194-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,"GEMIN5, CNOT8",Age at menopause,age at menopause,GCST007079,5:154878308
rs66736981-<b>?</b>,1 x 10-15,,NR,'-,'-,'-,C5orf47,Age at menopause,age at menopause,GCST007079,5:173982710
rs9313736-<b>?</b>,8 x 10-11,,NR,'-,'-,'-,"FAF2, RNF44",Age at menopause,age at menopause,GCST007079,5:176521315
rs58279426-<b>?</b>,9 x 10-48,,NR,'-,'-,'-,UIMC1,Age at menopause,age at menopause,GCST007079,5:177021138
rs17876044-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,"GRK6, F12",Age at menopause,age at menopause,GCST007079,5:177406361
rs9358956-<b>?</b>,3 x 10-25,,NR,'-,'-,'-,SYCP2L,Age at menopause,age at menopause,GCST007079,6:10887020
rs6912979-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,SOD2,Age at menopause,age at menopause,GCST007079,6:159699767
rs71531304-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,TNRC18,Age at menopause,age at menopause,GCST007079,7:5413906
rs148727829-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,CCZ1,Age at menopause,age at menopause,GCST007079,7:5910286
rs4275190-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,PSPH,Age at menopause,age at menopause,GCST007079,7:56036695
rs112241539-<b>?</b>,4 x 10-10,,NR,'-,'-,'-,CASTOR3,Age at menopause,age at menopause,GCST007079,7:100249614
rs2519673-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,LARP1BP2,Age at menopause,age at menopause,GCST007079,7:106354280
rs6961014-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,TNPO3,Age at menopause,age at menopause,GCST007079,7:129052656
rs112190116-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,NOBOX,Age at menopause,age at menopause,GCST007079,7:144399065
rs34119683-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,ESYT2,Age at menopause,age at menopause,GCST007079,7:158733200
rs28797500-<b>?</b>,2 x 10-56,,NR,'-,'-,'-,"RPL12P48, EIF4EBP1",Age at menopause,age at menopause,GCST007079,8:38026792
rs10813912-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,APTX,Age at menopause,age at menopause,GCST007079,9:32975212
rs10998203-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,DNA2,Age at menopause,age at menopause,GCST007079,10:68464775
rs4918985-<b>?</b>,3 x 10-17,,NR,'-,'-,'-,ENTPD1-AS1,Age at menopause,age at menopause,GCST007079,10:96070326
rs17882802-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,CHUK,Age at menopause,age at menopause,GCST007079,10:100223656
rs11245450-<b>?</b>,4 x 10-13,,NR,'-,'-,'-,ZRANB1,Age at menopause,age at menopause,GCST007079,10:124969506
rs728900-<b>?</b>,9 x 10-13,,NR,'-,'-,'-,LINC02666,Age at menopause,age at menopause,GCST007079,10:129792036
rs11031005-<b>?</b>,7 x 10-20,,NR,'-,'-,'-,FSHB,Age at menopause,age at menopause,GCST007079,11:30204809
rs10734411-<b>?</b>,4 x 10-10,,NR,'-,'-,'-,"EIF3M, WT1-AS",Age at menopause,age at menopause,GCST007079,11:32520238
rs77100210-<b>?</b>,3 x 10-29,,NR,'-,'-,'-,"YBX3, LINC02366",Age at menopause,age at menopause,GCST007079,12:10723329
rs2277339-<b>?</b>,2 x 10-23,,NR,'-,'-,'-,"HSD17B6, PRIM1",Age at menopause,age at menopause,GCST007079,12:56752285
rs75770066-<b>?</b>,2 x 10-65,,NR,'-,'-,'-,HELB,Age at menopause,age at menopause,GCST007079,12:66310445
rs11180609-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,RPL10P13,Age at menopause,age at menopause,GCST007079,12:75646612
rs10840614-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,TMEM120B,Age at menopause,age at menopause,GCST007079,12:121753584
rs4930718-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,RILPL2,Age at menopause,age at menopause,GCST007079,12:123428886
rs28416520-<b>?</b>,7 x 10-15,,NR,'-,'-,'-,PIWIL1,Age at menopause,age at menopause,GCST007079,12:130339112
rs7322160-<b>?</b>,6 x 10-18,,NR,'-,'-,'-,TDRD3,Age at menopause,age at menopause,GCST007079,13:60487322
rs1760940-<b>?</b>,1 x 10-15,,NR,'-,'-,'-,PNP,Age at menopause,age at menopause,GCST007079,14:20470092
rs28880687-<b>?</b>,3 x 10-14,,NR,'-,'-,'-,"CIBAR1P1, INO80",Age at menopause,age at menopause,GCST007079,15:41145395
rs4924570-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,MGA,Age at menopause,age at menopause,GCST007079,15:41682462
rs55848327-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,USP3,Age at menopause,age at menopause,GCST007079,15:63527228
rs888368-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"KLHL25, LINC02883",Age at menopause,age at menopause,GCST007079,15:85759052
rs9788714-<b>?</b>,6 x 10-19,,NR,'-,'-,'-,"RLBP1, FANCI",Age at menopause,age at menopause,GCST007079,15:89238624
rs1029285-<b>?</b>,1 x 10-29,,NR,'-,'-,'-,"RSL1D1-DT, GSPT1",Age at menopause,age at menopause,GCST007079,16:11893261
rs9674439-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,BCAP31P1,Age at menopause,age at menopause,GCST007079,16:34034043
rs10521305-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,FTO,Age at menopause,age at menopause,GCST007079,16:53874572
rs157877-<b>A</b>,2 x 10-6,(Japanese),0.2086,'-,0.052 year decrease,[0.03-0.074],RXRG,Menopause (age at onset),age at menopause,GCST005863,1:165429507
rs2679894-<b>A</b>,4 x 10-7,(Japanese),0.6922,'-,0.054 year increase,[0.032-0.076],"TGFBRAP1, GPR45",Menopause (age at onset),age at menopause,GCST005863,2:105254322
rs10931831-<b>C</b>,1 x 10-10,(Japanese),0.4638,'-,0.058 year increase,[0.04-0.076],'-,Menopause (age at onset),age at menopause,GCST005863,2:198756917
rs10934420-<b>T</b>,7 x 10-7,(Japanese),0.3657,'-,0.045 year decrease,[0.027-0.063],'-,Menopause (age at onset),age at menopause,GCST005863,3:117833264
rs395962-<b>T</b>,5 x 10-16,(Japanese),0.2826,'-,0.079 year increase,[0.059-0.099],LIN28B,Menopause (age at onset),age at menopause,GCST005863,6:104949543
rs11786868-<b>C</b>,3 x 10-8,(Japanese),0.5126,'-,0.049 year increase,[0.031-0.067],ZFHX4,Menopause (age at onset),age at menopause,GCST005863,8:76741709
rs10156597-<b>A</b>,2 x 10-10,(Japanese),0.5265,'-,0.056 year increase,[0.038-0.074],LINC01505,Menopause (age at onset),age at menopause,GCST005863,9:106179228
rs7852169-<b>C</b>,9 x 10-7,(Japanese),0.76,'-,0.052 year decrease,[0.03-0.074],"PTGR1, ZNF483",Menopause (age at onset),age at menopause,GCST005863,9:111556114
rs16917237-<b>G</b>,2 x 10-7,(Japanese),0.5995,'-,0.047 year decrease,[0.029-0.065],"BDNF, BDNF-AS",Menopause (age at onset),age at menopause,GCST005863,11:27680836
rs10145469-<b>C</b>,3 x 10-9,(Japanese),0.8157,'-,0.068 year increase,[0.046-0.09],'-,Menopause (age at onset),age at menopause,GCST005863,14:97303497
rs9635759-<b>G</b>,2 x 10-7,(Japanese),0.5694,'-,0.047 year decrease,[0.029-0.065],"CA10, LINC02073",Menopause (age at onset),age at menopause,GCST005863,17:51536424
rs4853-<b>T</b>,2 x 10-18,(japanese),0.94,'-,0.48 year increase,[0.38-0.58],H1-10,Menopause (age at onset),age at menopause,GCST005863,3:129314893
rs10049761-<b>T</b>,3 x 10-15,(japanese),0.36,'-,0.22 year increase,[0.16-0.28],FRYL,Menopause (age at onset),age at menopause,GCST005863,4:48684940
rs199646819-<b>A</b>,3 x 10-8,(japanese),0.61,'-,0.15 year increase,[0.091-0.209],EIF4E,Menopause (age at onset),age at menopause,GCST005863,4:98927473
rs6185-<b>G</b>,3 x 10-13,(japanese),0.51,'-,0.19 year increase,[0.13-0.25],GNRH1,Menopause (age at onset),age at menopause,GCST005863,8:25423284
rs2921759-<b>T</b>,2 x 10-8,(japanese),0.82,'-,0.19 year increase,[0.13-0.25],"AARD, RAD21-AS1",Menopause (age at onset),age at menopause,GCST005863,8:116898565
rs1889921-<b>T</b>,2 x 10-20,(japanese),0.53,'-,0.24 year increase,[0.18-0.3],"CCNJ, ENTPD1-AS1",Menopause (age at onset),age at menopause,GCST005863,10:96044240
rs8010674-<b>C</b>,3 x 10-8,(japanese),0.63,'-,0.15 year increase,[0.091-0.209],"ZFYVE1, DCAF4",Menopause (age at onset),age at menopause,GCST005863,14:72962458
rs200296776-<b>C</b>,1 x 10-8,(japanese),0.99,'-,1.15 year increase,[0.76-1.54],ZCCHC2,Menopause (age at onset),age at menopause,GCST005863,18:62570172
rs76498344-<b>C</b>,4 x 10-12,(japanese),0.23,'-,0.22 year increase,[0.16-0.28],MCM8,Menopause (age at onset),age at menopause,GCST005863,20:5970805
rs7665103-<b>G</b>,4 x 10-8,(japanese),0.62,'-,0.15 year increase,[0.091-0.209],HELQ,Menopause (age at onset),age at menopause,GCST005863,4:83443598
rs34933909-<b>T</b>,9 x 10-14,(japanese),0.49,'-,0.2 year increase,[0.14-0.26],ZNF346,Menopause (age at onset),age at menopause,GCST005863,5:177038269
rs12211124-<b>T</b>,2 x 10-12,(japanese),0.69,'-,0.2 year increase,[0.14-0.26],"SYCP2L, GCM2",Menopause (age at onset),age at menopause,GCST005863,6:10886352
rs28474889-<b>C</b>,5 x 10-16,(japanese),0.73,'-,0.24 year increase,[0.18-0.3],"NCR3, UQCRHP1",Menopause (age at onset),age at menopause,GCST005863,6:31607296
rs28807105-<b>G</b>,2 x 10-8,(japanese),0.3,'-,0.16 year increase,[0.1-0.22],EIF4EBP1,Menopause (age at onset),age at menopause,GCST005863,8:38035999
rs2277339-<b>T</b>,8 x 10-20,(japanese),0.8,'-,0.29 year increase,[0.23-0.35],"HSD17B6, PRIM1",Menopause (age at onset),age at menopause,GCST005863,12:56752285
rs8176071-<b>GTGT</b>,1 x 10-8,(japanese),0.34,'-,0.16 year increase,[0.1-0.22],"NBR2, BRCA1",Menopause (age at onset),age at menopause,GCST005863,17:43125989
rs4853-<b>T</b>,1 x 10-16,,0.94,'-,'-,'-,H1-10,Menopause (age at onset),age at menopause,GCST005863,3:129314893
rs10049761-<b>T</b>,4 x 10-15,,0.36,'-,'-,'-,FRYL,Menopause (age at onset),age at menopause,GCST005863,4:48684940
rs199646819-<b>A</b>,1 x 10-8,,0.61,'-,'-,'-,EIF4E,Menopause (age at onset),age at menopause,GCST005863,4:98927473
rs6185-<b>G</b>,4 x 10-12,,0.51,'-,'-,'-,GNRH1,Menopause (age at onset),age at menopause,GCST005863,8:25423284
rs2921759-<b>T</b>,3 x 10-7,,0.82,'-,'-,'-,"AARD, RAD21-AS1",Menopause (age at onset),age at menopause,GCST005863,8:116898565
rs1889921-<b>T</b>,3 x 10-22,,0.53,'-,'-,'-,"CCNJ, ENTPD1-AS1",Menopause (age at onset),age at menopause,GCST005863,10:96044240
rs8010674-<b>C</b>,1 x 10-8,,0.63,'-,'-,'-,"ZFYVE1, DCAF4",Menopause (age at onset),age at menopause,GCST005863,14:72962458
rs200296776-<b>C</b>,2 x 10-8,,0.99,'-,'-,'-,ZCCHC2,Menopause (age at onset),age at menopause,GCST005863,18:62570172
rs76498344-<b>C</b>,7 x 10-11,,0.23,'-,'-,'-,MCM8,Menopause (age at onset),age at menopause,GCST005863,20:5970805
rs4141232-<b>?</b>,2 x 10-7,"(AAM-CT, EA)",NR,'-,'-,'-,'-,Femoral neck bone geometry and menarche (age at onset),age at menopause,GCST001950,19:28544649
rs8113142-<b>?</b>,5 x 10-6,"(AAM-CT, Chinese)",NR,'-,'-,'-,'-,Femoral neck bone geometry and menarche (age at onset),age at menopause,GCST001950,19:28522014
rs6578985-<b>?</b>,6 x 10-6,"(AAM-CT, EA)",NR,'-,'-,'-,IGF2,Femoral neck bone geometry and menarche (age at onset),age at menopause,GCST001950,11:2116909
rs6578987-<b>?</b>,3 x 10-6,"(AAM-CT, Chinese)",NR,'-,'-,'-,IGF2,Femoral neck bone geometry and menarche (age at onset),age at menopause,GCST001950,11:2116909
rs6975557-<b>?</b>,5 x 10-8,"(AAM-W, EA)",NR,'-,'-,'-,NRCAM,Femoral neck bone geometry and menarche (age at onset),age at menopause,GCST001950,7:108332853
rs4141232-<b>?</b>,9 x 10-6,"(AAM-BR, Chinese)",NR,'-,'-,'-,'-,Femoral neck bone geometry and menarche (age at onset),age at menopause,GCST001950,19:28544649
rs236114-<b>A</b>,1 x 10-10,,0.21,'-,0.5 years increase,[0.34-0.65],MCM8,Menopause (age at onset),age at menopause,GCST000401,20:5954739
rs4397868-<b>?</b>,3 x 10-7,,NR,'-,0.4 years decrease,[0.25-0.55],"LINC02743, TRPC6",Menopause (age at onset),age at menopause,GCST000401,11:133697090
rs11889862-<b>?</b>,2 x 10-6,,NR,'-,0.36 years decrease,[0.21-0.51],"LINC01931, MMADHC-DT",Menopause (age at onset),age at menopause,GCST000401,2:149840634
rs17153527-<b>?</b>,4 x 10-7,,NR,'-,0.51 years increase,[0.31-0.71],"PIK3CG, LINC02577",Menopause (age at onset),age at menopause,GCST000401,7:106855364
rs2326679-<b>?</b>,2 x 10-6,,NR,'-,0.32 years increase,[0.19-0.45],"FERMT1, LRRN4",Menopause (age at onset),age at menopause,GCST000401,20:6054582
rs1172822-<b>T</b>,6 x 10-11,,0.39,'-,0.39 years decrease,[0.27-0.51],BRSK1,Menopause (age at onset),age at menopause,GCST000401,19:55308477
rs4843747-<b>?</b>,2 x 10-7,,NR,'-,0.39 years increase,[0.24-0.54],BANP,Menopause (age at onset),age at menopause,GCST000401,16:87957445
rs6468442-<b>?</b>,3 x 10-7,,NR,'-,0.39 years decrease,[0.24-0.54],ADGRA2,Menopause (age at onset),age at menopause,GCST000401,8:37829231
rs2151145-<b>?</b>,1 x 10-7,,NR,'-,0.41 years increase,[0.26-0.56],TLE4,Menopause (age at onset),age at menopause,GCST000401,9:79730966
rs4906172-<b>?</b>,3 x 10-6,,NR,'-,0.36 years decrease,[0.21-0.51],DYNC1H1,Menopause (age at onset),age at menopause,GCST000401,14:101988596
rs4955755-<b>?</b>,7 x 10-7,,NR,'-,0.34 years increase,[0.21-0.47],SLC7A14-AS1,Menopause (age at onset),age at menopause,GCST000401,3:170776620
rs7333181-<b>A</b>,3 x 10-8,,0.12,'-,0.52 years increase,[0.34-0.70],LINC02337,Menopause (age at onset),age at menopause,GCST000401,13:111568950
rs10496265-<b>?</b>,1 x 10-8,(age at natural menopause),NR,'-,'-,'-,"LINC01815, CHMP4AP1",Aging traits,age at menopause,GCST000096,2:81441684
rs291353-<b>?</b>,6 x 10-6,(age at natural menopause),NR,'-,'-,'-,GNG4,Aging traits,age at menopause,GCST000096,1:235557598
rs10496262-<b>?</b>,3 x 10-7,(age at natural menopause),NR,'-,'-,'-,RNA5SP99,Aging traits,age at menopause,GCST000096,2:81524000
rs958672-<b>?</b>,2 x 10-6,(age at natural menopause),NR,'-,'-,'-,GALNT13,Aging traits,age at menopause,GCST000096,2:154214054
rs494620-<b>?</b>,5 x 10-7,,NR,'-,0.3 years increase,[0.18-0.42],SLC44A4,Menopause (age at onset),age at menopause,GCST000401,6:31870936
rs1867631-<b>A</b>,5 x 10-6,,0.2892,'-,0.1071 years decrease,[0.060-0.154],SGIP1,Menopause (age at onset),age at menopause,GCST001810,1:66580443
rs11668344-<b>A</b>,5 x 10-26,,0.636,'-,0.3043 years decrease,[0.25-0.36],TMEM150B,Menopause (age at onset),age at menopause,GCST001810,19:55322296
rs16991615-<b>A</b>,5 x 10-12,,0.0785,'-,0.4608 years decrease,[0.33-0.59],MCM8,Menopause (age at onset),age at menopause,GCST001810,20:5967581
rs1046089-<b>A</b>,4 x 10-11,,0.3492,'-,0.1919 years increase,[0.13-0.25],PRRC2A,Menopause (age at onset),age at menopause,GCST001810,6:31635190
rs10852344-<b>T</b>,5 x 10-8,,0.5835,'-,0.158 years increase,[0.10-0.21],"NPIPB2, GSPT1",Menopause (age at onset),age at menopause,GCST001810,16:11923062
rs12461110-<b>A</b>,9 x 10-8,,0.3594,'-,0.1553 years increase,[0.098-0.212],NLRP11,Menopause (age at onset),age at menopause,GCST001810,19:55809297
rs2517388-<b>T</b>,1 x 10-7,,0.8234,'-,0.2146 years increase,[0.13-0.29],ASH2L,Menopause (age at onset),age at menopause,GCST001810,8:38120214
rs1473307-<b>T</b>,3 x 10-7,,0.5715,'-,0.1441 years decrease,[0.089-0.199],NYAP2,Menopause (age at onset),age at menopause,GCST001810,2:225360907
rs2277339-<b>G</b>,2 x 10-19,,0.102,'-,0.38 years decrease,[0.3-0.46],"HSD17B6, PRIM1",Menopause (age at onset),age at menopause,GCST001381,12:56752285
rs3736830-<b>G</b>,9 x 10-8,,0.157,'-,0.18 years decrease,[0.11-0.25],KPNA3,Menopause (age at onset),age at menopause,GCST001381,13:49732085
rs4886238-<b>A</b>,1 x 10-10,,0.334,'-,0.17 years increase,[0.12-0.22],TDRD3,Menopause (age at onset),age at menopause,GCST001381,13:60539605
rs2307449-<b>G</b>,4 x 10-13,,0.405,'-,0.184 years decrease,[0.14-0.23],POLG,Menopause (age at onset),age at menopause,GCST001381,15:89320697
rs10852344-<b>C</b>,1 x 10-11,,0.415,'-,0.168 years increase,[0.12-0.22],"NPIPB2, GSPT1",Menopause (age at onset),age at menopause,GCST001381,16:11923062
rs11668344-<b>G</b>,1 x 10-59,,0.363,'-,0.416 years decrease,[0.37-0.47],TMEM150B,Menopause (age at onset),age at menopause,GCST001381,19:55322296
rs12461110-<b>A</b>,9 x 10-10,,0.356,'-,0.158 years decrease,[0.11-0.21],NLRP11,Menopause (age at onset),age at menopause,GCST001381,19:55809297
rs16991615-<b>A</b>,1 x 10-73,,0.069,'-,0.948 years increase,[0.85-1.05],MCM8,Menopause (age at onset),age at menopause,GCST001381,20:5967581
rs4246511-<b>T</b>,9 x 10-17,,0.271,'-,0.24 years increase,[0.18-0.3],RHBDL2,Menopause (age at onset),age at menopause,GCST001381,1:38914713
rs1635501-<b>C</b>,8 x 10-10,,0.478,'-,0.164 years decrease,[0.11-0.22],EXO1,Menopause (age at onset),age at menopause,GCST001381,1:241877473
rs2303369-<b>T</b>,2 x 10-12,,0.388,'-,0.175 years decrease,[0.13-0.22],FNDC4,Menopause (age at onset),age at menopause,GCST001381,2:27492549
rs10183486-<b>T</b>,2 x 10-14,,0.366,'-,0.196 years decrease,[0.15-0.25],TLK1,Menopause (age at onset),age at menopause,GCST001381,2:171134461
rs4693089-<b>G</b>,2 x 10-19,,0.486,'-,0.228 years increase,[0.18-0.28],HELQ,Menopause (age at onset),age at menopause,GCST001381,4:83452469
rs890835-<b>A</b>,6 x 10-6,,0.112,'-,0.177 years increase,[0.1-0.25],RNF44,Menopause (age at onset),age at menopause,GCST001381,5:176529270
rs365132-<b>T</b>,9 x 10-32,,0.49,'-,0.287 years increase,[0.24-0.34],UIMC1,Menopause (age at onset),age at menopause,GCST001381,5:176951573
rs2153157-<b>A</b>,8 x 10-12,,0.492,'-,0.165 years increase,[0.12-0.21],SYCP2L,Menopause (age at onset),age at menopause,GCST001381,6:10897255
rs1046089-<b>A</b>,2 x 10-16,,0.353,'-,0.213 years decrease,[0.16-0.26],PRRC2A,Menopause (age at onset),age at menopause,GCST001381,6:31635190
rs2517388-<b>G</b>,9 x 10-15,,0.174,'-,0.262 years increase,[0.2-0.33],ASH2L,Menopause (age at onset),age at menopause,GCST001381,8:38120214
rs12294104-<b>T</b>,1 x 10-11,,0.172,'-,0.225 years increase,[0.16-0.29],"RPL12P30, ARL14EP",Menopause (age at onset),age at menopause,GCST001381,11:30361352
rs2277339-<b>G</b>,2 x 10-19,,0.1,'-,0.31 years decrease,[0.25-0.37],"HSD17B6, PRIM1",Menopause (age at onset),age at menopause,GCST005312,12:56752285
rs7397861-<b>G</b>,7 x 10-6,,0.64,'-,0.1 years decrease,[0.061-0.139],GRIP1,Menopause (age at onset),age at menopause,GCST005312,12:66420686
rs12142240-<b>T</b>,7 x 10-9,,0.68,'-,0.13 years decrease,[0.091-0.169],LRRC41,Menopause (age at onset),age at menopause,GCST005312,1:46281629
rs1727326-<b>C</b>,2 x 10-9,,0.15,'-,0.19 years decrease,[0.13-0.25],PITPNM2,Menopause (age at onset),age at menopause,GCST005312,12:123115539
rs1713460-<b>G</b>,2 x 10-10,,0.3,'-,0.14 years decrease,[0.1-0.18],"PNP, PIP4P1",Menopause (age at onset),age at menopause,GCST005312,14:20465456
rs4693089-<b>A</b>,9 x 10-23,,0.51,'-,0.2 years decrease,[0.16-0.24],HELQ,Menopause (age at onset),age at menopause,GCST005312,4:83452469
rs6856693-<b>A</b>,1 x 10-16,,0.58,'-,0.16 years decrease,[0.12-0.2],"MIR3945HG, ACSL1",Menopause (age at onset),age at menopause,GCST005312,4:184827652
rs427394-<b>G</b>,4 x 10-9,,0.41,'-,0.13 years decrease,[0.091-0.169],TENT4A,Menopause (age at onset),age at menopause,GCST005312,5:6745762
rs10852344-<b>T</b>,1 x 10-15,,0.59,'-,0.16 years decrease,[0.12-0.2],"NPIPB2, GSPT1",Menopause (age at onset),age at menopause,GCST005312,16:11923062
rs12599106-<b>A</b>,3 x 10-8,,0.51,'-,0.12 years decrease,[0.081-0.159],"AGGF1P8, FRG2HP",Menopause (age at onset),age at menopause,GCST005312,16:35263654
rs8070740-<b>A</b>,2 x 10-9,,0.76,'-,0.15 years decrease,[0.11-0.19],RPAIN,Menopause (age at onset),age at menopause,GCST005312,17:5428576
rs2941505-<b>A</b>,2 x 10-9,,0.32,'-,0.13 years decrease,[0.091-0.169],PGAP3,Menopause (age at onset),age at menopause,GCST005312,17:39676451
rs1799949-<b>G</b>,8 x 10-11,,0.68,'-,0.14 years decrease,[0.1-0.18],BRCA1,Menopause (age at onset),age at menopause,GCST005312,17:43093449
rs349306-<b>G</b>,2 x 10-10,,0.13,'-,0.23 years decrease,[0.15-0.31],ARID3A,Menopause (age at onset),age at menopause,GCST005312,19:950694
rs11738223-<b>A</b>,2 x 10-8,,0.68,'-,0.12 years decrease,[0.081-0.159],"LINC01944, SH3PXD2B",Menopause (age at onset),age at menopause,GCST005312,5:172507488
rs2241584-<b>A</b>,2 x 10-11,,0.38,'-,0.14 years decrease,[0.1-0.18],RNF44,Menopause (age at onset),age at menopause,GCST005312,5:176529176
rs365132-<b>G</b>,1 x 10-33,,0.51,'-,0.24 years decrease,[0.2-0.28],UIMC1,Menopause (age at onset),age at menopause,GCST005312,5:176951573
rs11668344-<b>G</b>,6 x 10-85,,0.36,'-,0.41 years decrease,[0.37-0.45],TMEM150B,Menopause (age at onset),age at menopause,GCST005312,19:55322296
rs9393800-<b>G</b>,4 x 10-13,,0.27,'-,0.17 years decrease,[0.13-0.21],SYCP2L,Menopause (age at onset),age at menopause,GCST005312,6:10951504
rs2230365-<b>C</b>,8 x 10-10,,0.84,'-,0.17 years decrease,[0.11-0.23],NFKBIL1,Menopause (age at onset),age at menopause,GCST005312,6:31557671
rs16991615-<b>G</b>,2 x 10-89,,0.93,'-,0.88 years decrease,[0.8-0.96],MCM8,Menopause (age at onset),age at menopause,GCST005312,20:5967581
rs2236553-<b>C</b>,6 x 10-10,,0.24,'-,0.16 years decrease,[0.1-0.22],SLCO4A1,Menopause (age at onset),age at menopause,GCST005312,20:62658391
rs13040088-<b>G</b>,2 x 10-10,,0.21,'-,0.16 years decrease,[0.12-0.2],DIDO1,Menopause (age at onset),age at menopause,GCST005312,20:62917850
rs5762534-<b>T</b>,6 x 10-9,,0.84,'-,0.16 years decrease,[0.1-0.22],TTC28,Menopause (age at onset),age at menopause,GCST005312,22:28237583
rs7259376-<b>A</b>,4 x 10-8,,0.46,'-,0.11 years decrease,[0.071-0.149],"ZNF729, RPL34P34",Menopause (age at onset),age at menopause,GCST005312,19:22324903
rs6899676-<b>A</b>,2 x 10-19,,0.8,'-,0.23 years decrease,[0.17-0.29],SYCP2L,Menopause (age at onset),age at menopause,GCST005312,6:10895027
rs2547274-<b>G</b>,3 x 10-13,,0.91,'-,0.28 years decrease,[0.2-0.36],NLRP11,Menopause (age at onset),age at menopause,GCST005312,19:55798862
rs12461110-<b>A</b>,8 x 10-16,,0.35,'-,0.17 years decrease,[0.13-0.21],NLRP11,Menopause (age at onset),age at menopause,GCST005312,19:55809297
rs451417-<b>A</b>,5 x 10-9,,0.12,'-,0.2 years decrease,[0.14-0.26],MCM8,Menopause (age at onset),age at menopause,GCST005312,20:5961353
rs707938-<b>G</b>,7 x 10-15,,0.32,'-,0.17 years decrease,[0.13-0.21],"MSH5, MSH5-SAPCD1",Menopause (age at onset),age at menopause,GCST005312,6:31761582
rs12196873-<b>A</b>,3 x 10-8,,0.85,'-,0.16 years decrease,[0.1-0.22],MFSD4B,Menopause (age at onset),age at menopause,GCST005312,6:111276855
rs2720044-<b>A</b>,7 x 10-22,,0.84,'-,0.29 years decrease,[0.23-0.35],ASH2L,Menopause (age at onset),age at menopause,GCST005312,8:38123069
rs10957156-<b>A</b>,5 x 10-9,,0.76,'-,0.14 years decrease,[0.1-0.18],CHD7,Menopause (age at onset),age at menopause,GCST005312,8:60716842
rs4879656-<b>A</b>,2 x 10-8,,0.37,'-,0.12 years decrease,[0.081-0.159],APTX,Menopause (age at onset),age at menopause,GCST005312,9:33012384
rs10905065-<b>A</b>,4 x 10-8,,0.61,'-,0.11 years decrease,[0.071-0.149],TASOR2,Menopause (age at onset),age at menopause,GCST005312,10:5727864
rs11031006-<b>G</b>,9 x 10-14,,0.85,'-,0.22 years decrease,[0.16-0.28],FSHB,Menopause (age at onset),age at menopause,GCST005312,11:30204981
rs10734411-<b>A</b>,3 x 10-9,,0.47,'-,0.12 years decrease,[0.081-0.159],"EIF3M, WT1-AS",Menopause (age at onset),age at menopause,GCST005312,11:32520238
rs12824058-<b>G</b>,6 x 10-11,,0.43,'-,0.14 years decrease,[0.1-0.18],PIWIL1,Menopause (age at onset),age at menopause,GCST005312,12:130319789
rs4886238-<b>G</b>,3 x 10-16,,0.66,'-,0.18 years decrease,[0.14-0.22],TDRD3,Menopause (age at onset),age at menopause,GCST005312,13:60539605
rs9796-<b>T</b>,1 x 10-10,,0.46,'-,0.13 years decrease,[0.091-0.169],INO80,Menopause (age at onset),age at menopause,GCST005312,15:40979249
rs1054875-<b>T</b>,2 x 10-19,,0.4,'-,0.19 years decrease,[0.15-0.23],POLG-DT,Menopause (age at onset),age at menopause,GCST005312,15:89335895
rs9039-<b>C</b>,3 x 10-8,,0.28,'-,0.12 years decrease,[0.081-0.159],C16orf72,Menopause (age at onset),age at menopause,GCST005312,16:9111506
rs4246511-<b>C</b>,5 x 10-21,,0.71,'-,0.22 years decrease,[0.18-0.26],RHBDL2,Menopause (age at onset),age at menopause,GCST005312,1:38914713
rs551087-<b>G</b>,4 x 10-8,,0.29,'-,0.13 years decrease,[0.091-0.169],SPPL3,Menopause (age at onset),age at menopause,GCST005312,12:120771390
rs1411478-<b>A</b>,1 x 10-10,,0.41,'-,0.13 years decrease,[0.091-0.169],STX6,Menopause (age at onset),age at menopause,GCST005312,1:180993146
rs2236918-<b>C</b>,8 x 10-14,,0.45,'-,0.15 years decrease,[0.11-0.19],EXO1,Menopause (age at onset),age at menopause,GCST005312,1:241854524
rs704795-<b>A</b>,2 x 10-15,,0.4,'-,0.16 years decrease,[0.12-0.2],FNDC4,Menopause (age at onset),age at menopause,GCST005312,2:27493627
rs1800932-<b>A</b>,3 x 10-11,,0.81,'-,0.17 years decrease,[0.11-0.23],"FBXO11, MSH6",Menopause (age at onset),age at menopause,GCST005312,2:47790942
rs930036-<b>A</b>,3 x 10-19,,0.38,'-,0.19 years decrease,[0.15-0.23],TLK1,Menopause (age at onset),age at menopause,GCST005312,2:171084508
rs16858210-<b>G</b>,3 x 10-9,,0.75,'-,0.14 years decrease,[0.1-0.18],CYP2AB1P,Menopause (age at onset),age at menopause,GCST005312,3:183906222
rs763121-<b>G</b>,2 x 10-13,,0.36,'-,0.16 years decrease,[0.12-0.2],DDX17,Menopause (age at onset),age at menopause,GCST005312,22:38483935
rs75770066-<b>G</b>,1 x 10-31,,0.034,'-,0.8542 year increase,[0.71-1],HELB,Menopause (age at onset),age at menopause,GCST005560,12:66310445
rs140267842-<b>A</b>,2 x 10-8,,0.0091,'-,0.7854 year increase,[0.51-1.06],SLCO4A1,Menopause (age at onset),age at menopause,GCST005560,20:62657241
rs1378770-<b>G</b>,2 x 10-6,,0.15,1.8,'-,'-,FOXP2,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,7:114723511
rs7308116-<b>A</b>,2 x 10-6,,0.64,1.61,'-,'-,ASCL4,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,12:107806819
rs17459044-<b>C</b>,2 x 10-6,,0.62,1.6129031,'-,'-,"CRAT, DOLPP1",Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,9:129091345
rs112881630-<b>G</b>,3 x 10-6,,0.14,2.19,'-,'-,"LY86, BTF3P7",Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,6:6722724
rs1335802-<b>C</b>,4 x 10-6,,0.58,1.61,'-,'-,SGK1,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,6:134197374
rs3850352-<b>T</b>,4 x 10-6,,0.18,1.6666665,'-,'-,MIR217HG,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,2:56028361
rs12692119-<b>A</b>,5 x 10-6,,0.44,1.6949153,'-,'-,TEX51,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,2:126863513
rs11231420-<b>T</b>,5 x 10-6,,0.68,1.6393442,'-,'-,"OR9M1P, TRIM51",Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,11:55877258
rs1584120-<b>T</b>,6 x 10-6,,0.62,1.64,'-,'-,SOX5,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,12:23446319
rs34333482-<b>A</b>,6 x 10-6,,0.52,1.5384616,'-,'-,"CALHM4, TRAPPC3L",Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,6:116534790
rs311392-<b>C</b>,7 x 10-6,,0.75,1.61,'-,'-,RNU6ATAC32P,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,8:54172222
rs7623488-<b>T</b>,7 x 10-6,,0.5,1.5873016,'-,'-,LINC02618,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,3:141715561
rs11525841-<b>A</b>,8 x 10-6,,0.12,1.81,'-,'-,LINC00972,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,7:85553852
rs6678723-<b>G</b>,8 x 10-6,,0.78,1.724138,'-,'-,DISC1,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,1:232020499
rs7007076-<b>C</b>,9 x 10-6,,0.21,1.84,'-,'-,ANXA13,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,8:123717789
rs13418288-<b>C</b>,9 x 10-6,,0.62,1.724138,'-,'-,HOXD3,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,2:176151284
rs202229006-<b>TG</b>,9 x 10-6,,0.88,2.2222223,'-,'-,"KLHDC7A, IGSF21",Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,1:18475362
rs512279-<b>C</b>,9 x 10-6,,0.59,1.6,'-,'-,"CTBP2P3, MRPS5P4",Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,18:60564867
rs1335802-<b>C</b>,6 x 10-6,(AA),0.58,1.87,'-,'-,SGK1,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,6:134197374
rs3850352-<b>T</b>,3 x 10-7,(AA),0.18,2.38,'-,[1.69-3.23],MIR217HG,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,2:56028361
rs12692119-<b>A</b>,2 x 10-6,(AA),0.44,1.89,'-,'-,TEX51,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,2:126863513
rs28573326-<b>G</b>,2 x 10-6,,0.29,1.67,'-,'-,CPE,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,4:165417176
rs28573326-<b>G</b>,1 x 10-7,(AA),0.29,2.14,'-,[1.62-2.83],CPE,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,4:165417176
rs9772809-<b>T</b>,2 x 10-7,(AA),0.07,5,'-,[2.78-9.09],"CHRNA6, THAP1",Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,8:42803038
rs201058683-<b>AT</b>,2 x 10-7,(AA),0.21,2.47,'-,[1.76-3.47],CDH9,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,5:26876559
rs1335802-<b>C</b>,7 x 10-6,(AA),0.58,1.41,'-,'-,SGK1,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,6:134197374
rs7035589-<b>T</b>,3 x 10-7,(AA),0.39,1.44,'-,[1.26-1.65],CT70,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,9:104990077
rs139563135-<b>A</b>,7 x 10-7,(AA),0.15,1.64,'-,[1.35-2.00],FHAD1,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,1:15307321
rs144039930-<b>C</b>,4 x 10-7,(Hispanic),0.95,6.666666,'-,[3.23-14.29],"CRYM, ANKS4B",Pelvic organ prolapse,pelvic organ prolapse,GCST003226,16:21240939
rs10160713-<b>A</b>,1 x 10-6,(Hispanic),0.94,4.5454545,'-,[2.5-8.33],MED28P5,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,11:97027237
rs11243354-<b>C</b>,5 x 10-7,,0.45,1.36,'-,'-,DPP6,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,7:154587524
rs1335802-<b>C</b>,2 x 10-6,,0.58,1.34,'-,'-,SGK1,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,6:134197374
rs12122043-<b>G</b>,2 x 10-6,,0.09,1.5,'-,'-,"LINC01735, LINC02769",Pelvic organ prolapse,pelvic organ prolapse,GCST003226,1:208616604
rs12018439-<b>G</b>,2 x 10-6,,0.63,1.3333333,'-,'-,'-,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,13:84816938
rs10793273-<b>T</b>,2 x 10-6,,0.81,1.4084507,'-,'-,"NDUFC2-KCTD14, KCTD14",Pelvic organ prolapse,pelvic organ prolapse,GCST003226,11:78031549
rs10776501-<b>A</b>,2 x 10-6,,0.69,1.38,'-,'-,"LINC02435, SPRY1",Pelvic organ prolapse,pelvic organ prolapse,GCST003226,4:123466324
rs61173913-<b>TA</b>,3 x 10-6,,0.87,1.4925373,'-,'-,"SPATS2L, KCTD18",Pelvic organ prolapse,pelvic organ prolapse,GCST003226,2:200487152
rs6669972-<b>C</b>,3 x 10-6,,0.91,1.5625,'-,'-,'-,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,1:29858120
rs56156301-<b>G</b>,4 x 10-6,,0.9,1.6393442,'-,'-,BAALC-AS2,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,8:103135576
rs7147087-<b>T</b>,5 x 10-6,,0.92,1.5873016,'-,'-,LINC01500,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,14:58769589
rs13289122-<b>T</b>,5 x 10-6,,0.47,1.3,'-,'-,CT70,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,9:104994722
rs10826468-<b>T</b>,5 x 10-6,,0.59,1.2987013,'-,'-,"U3, LINC02652",Pelvic organ prolapse,pelvic organ prolapse,GCST003226,10:28420676
rs72636617-<b>A</b>,6 x 10-6,,0.09,1.49,'-,'-,"DCT, GPC6",Pelvic organ prolapse,pelvic organ prolapse,GCST003226,13:94422965
rs2236521-<b>A</b>,6 x 10-6,,0.16,1.37,'-,'-,LAMA5,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,20:62317060
rs181766936-<b>C</b>,6 x 10-6,,0.8,1.4705882,'-,'-,"IQCJ, IQCJ-SCHIP1",Pelvic organ prolapse,pelvic organ prolapse,GCST003226,3:159011654
rs72655104-<b>G</b>,7 x 10-6,,0.14,1.45,'-,'-,FARP1,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,13:98170892
rs2019216-<b>C</b>,7 x 10-6,,0.36,1.2987013,'-,'-,FLJ36000,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,17:22410321
rs6947471-<b>T</b>,7 x 10-6,,0.43,1.32,'-,'-,DPP6,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,7:154589765
rs7290192-<b>A</b>,7 x 10-6,,0.93,1.754386,'-,'-,LINC01310,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,22:48922714
rs200147305-<b>T</b>,9 x 10-6,,0.67,1.34,'-,'-,PSME2P2,Pelvic organ prolapse,pelvic organ prolapse,GCST003226,13:48857160
rs7187140-<b>C</b>,3 x 10-7,(AA),0.09,5.35,'-,[2.82-10.16],"RPL15P20, CEP20",Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,16:15917823
rs113872281-<b>G</b>,6 x 10-7,(AA),0.17,2.27,'-,[1.65-3.14],GUCA1C,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,3:108934985
rs73318770-<b>G</b>,8 x 10-7,(AA),0.07,3.21,'-,[2.02-5.11],STAU2,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,8:73450680
rs1950626-<b>G</b>,3 x 10-7,(Hispanic),0.79,2.96,'-,[1.96-4.48],MEG8,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,14:100907636
rs10110287-<b>T</b>,7 x 10-7,(Hispanic),0.08,3.69,'-,[2.20-6.18],GFRA2,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,8:21629619
rs58823963-<b>A</b>,9 x 10-7,(Hispanic),0.12,2.69,'-,[1.81-3.99],PTPRD,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,9:9550389
rs740494-<b>G</b>,9 x 10-7,,0.12,2.17,'-,'-,"LINC01737, PGBD5",Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,1:230509181
rs2209875-<b>G</b>,9 x 10-7,,0.69,1.6666665,'-,'-,SHC3,Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,9:89198546
rs3820282-<b>C</b>,3 x 10-21,,0.8283,1.1764705,'-,[1.14-1.22],WNT4,Pelvic organ prolapse,pelvic organ prolapse,GCST010174,1:22141722
rs9306894-<b>G</b>,3 x 10-17,,0.3448,1.11,'-,[1.09-1.14],GDF7,Pelvic organ prolapse,pelvic organ prolapse,GCST010174,2:20678345
rs7682992-<b>T</b>,5 x 10-16,,0.2063,1.13,'-,[1.10-1.16],LINC02379,Pelvic organ prolapse,pelvic organ prolapse,GCST010174,4:126037217
rs1247943-<b>G</b>,2 x 10-13,,0.4603,1.09,'-,[1.07-1.12],LINC02459,Pelvic organ prolapse,pelvic organ prolapse,GCST010174,12:114235616
rs72624976-<b>C</b>,4 x 10-12,,0.9513,1.25,'-,[1.18-1.33],IMPDH1,Pelvic organ prolapse,pelvic organ prolapse,GCST010174,7:128392779
rs12325192-<b>C</b>,3 x 10-12,,0.821,1.1235955,'-,[1.09-1.15],HNRNPA1P48,Pelvic organ prolapse,pelvic organ prolapse,GCST010174,16:51454218
rs3791675-<b>C</b>,3 x 10-11,,0.7893,1.1111112,'-,NR,EFEMP1,Pelvic organ prolapse,pelvic organ prolapse,GCST010174,2:55884174
rs1430191-<b>T</b>,1 x 10-9,(conditioned on rs3791675),0.4785,1.09,'-,[1.06-1.12],EFEMP1,Pelvic organ prolapse,pelvic organ prolapse,GCST010174,2:55806292
rs3809060-<b>G</b>,8 x 10-7,,0.63,1.07,'-,[1.04-1.09],WT1-AS,Pelvic organ prolapse,pelvic organ prolapse,GCST010174,11:32437261
rs251215-<b>A</b>,1 x 10-6,,0.5311,1.06276,'-,[1.04-1.09],"SLC12A2, FBN2",Pelvic organ prolapse,pelvic organ prolapse,GCST010174,5:128207930
rs11962800-<b>A</b>,3 x 10-6,,0.8938,1.09901,'-,[1.06-1.14],"TXNDC5, BLOC1S5-TXNDC5",Pelvic organ prolapse,pelvic organ prolapse,GCST010174,6:7886672
rs12440667-<b>C</b>,4 x 10-6,,0.5162,1.0590752,'-,[1.03-1.09],LOXL1,Pelvic organ prolapse,pelvic organ prolapse,GCST010174,15:73939098
rs7136488-<b>T</b>,9 x 10-6,,0.439122205,'-,0.16040507 unit decrease,[0.089-0.231],'-,Menstruation quality of life impact (aggressiveness),"quality of life during menstruation measurement, aggressive behavior",GCST006641,12:125812444
rs4410042-<b>G</b>,4 x 10-6,,0.345607582,'-,0.17629494 unit decrease,[0.1-0.25],"GABRG3-AS1, GABRG3",Menstruation quality of life impact (aggressiveness),"quality of life during menstruation measurement, aggressive behavior",GCST006641,15:27114416
rs9790919-<b>A</b>,2 x 10-6,,0.154318579,'-,0.24943858 unit decrease,[0.15-0.35],"LINC02159, ATP10B",Menstruation quality of life impact (aggressiveness),"quality of life during menstruation measurement, aggressive behavior",GCST006641,5:160904903
rs7242599-<b>G</b>,9 x 10-6,,0.645120631,'-,0.16764931 unit increase,[0.094-0.242],PMAIP1,Menstruation quality of life impact (aggressiveness),"quality of life during menstruation measurement, aggressive behavior",GCST006641,18:59882031
rs17054506-<b>C</b>,7 x 10-6,,0.563352667,'-,0.1610547 unit decrease,[0.091-0.231],MIR4289,Menstruation quality of life impact (aggressiveness),"quality of life during menstruation measurement, aggressive behavior",GCST006641,9:88803827
rs11740905-<b>A</b>,3 x 10-6,,0.201888267,'-,0.23431596 unit decrease,[0.14-0.33],DAP-DT,Menstruation quality of life impact (increased appetite),"quality of life during menstruation measurement, eating behaviour",GCST006642,5:10861935
rs8073426-<b>C</b>,4 x 10-7,,0.378918051,'-,0.20019282 unit decrease,[0.12-0.28],"AXIN2, CEP112",Menstruation quality of life impact (increased appetite),"quality of life during menstruation measurement, eating behaviour",GCST006642,17:65567163
rs62524444-<b>C</b>,6 x 10-6,,0.102326688,'-,0.26506448 unit increase,[0.15-0.38],C8orf37-AS1,Menstruation quality of life impact (increased appetite),"quality of life during menstruation measurement, eating behaviour",GCST006642,8:95357972
rs319748-<b>A</b>,5 x 10-7,,0.439014079,'-,0.1860469 unit decrease,[0.11-0.26],ASIC2,Menstruation quality of life impact (bowel movement),quality of life during menstruation measurement,GCST006643,17:33227515
rs7048743-<b>A</b>,3 x 10-6,,0.07340219,'-,0.3000387 unit increase,[0.17-0.43],VLDLR-AS1,Menstruation quality of life impact (bowel movement),quality of life during menstruation measurement,GCST006643,9:2426985
rs1007994-<b>C</b>,3 x 10-6,,0.444195005,'-,0.17260958 unit decrease,[0.1-0.24],RNU6-1035P,Menstruation quality of life impact (bowel movement),quality of life during menstruation measurement,GCST006643,9:81757195
rs2184120-<b>C</b>,3 x 10-6,,0.136164303,'-,0.23205099 unit increase,[0.13-0.33],TMEM245,Menstruation quality of life impact (bowel movement),quality of life during menstruation measurement,GCST006643,9:109026278
rs77063336-<b>T</b>,6 x 10-7,,0.143491153,'-,0.24622668 unit increase,[0.15-0.34],ASTN2,Menstruation quality of life impact (bowel movement),quality of life during menstruation measurement,GCST006643,9:116932295
rs10167914-<b>G</b>,3 x 10-12,,0.738617113,'-,0.22788282 unit decrease,[0.16-0.29],"IL1A, IL1B",Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,2:112805784
rs17817634-<b>T</b>,5 x 10-6,,0.162392088,'-,0.17600146 unit increase,[0.1-0.25],ETV6,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,12:11687543
rs12030576-<b>T</b>,8 x 10-12,,0.59489742,'-,0.1975494 unit decrease,[0.14-0.25],NGF-AS1,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,1:115274600
rs7653663-<b>A</b>,4 x 10-6,,0.48623665,'-,0.13090697 unit increase,[0.076-0.186],MGLL,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,3:127756783
rs1420044-<b>T</b>,1 x 10-7,,0.065290717,'-,0.2902695 unit decrease,[0.18-0.4],GRIN2A,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,16:9820276
rs10808874-<b>C</b>,4 x 10-6,,0.803879945,'-,0.16748436 unit decrease,[0.097-0.238],RB1CC1,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,8:52793206
rs35018432-<b>T</b>,6 x 10-6,,0.375217674,'-,0.13321592 unit increase,[0.076-0.191],VPS13B,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,8:99182067
rs10989462-<b>G</b>,4 x 10-6,,0.35727413,'-,0.13606437 unit increase,[0.078-0.194],PLPPR1,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,9:101273624
rs140328416-<b>A</b>,8 x 10-6,,0.029617897,'-,0.36805844 unit increase,[0.21-0.53],SYCP1,Pain medicine use during menstruation,"drug use measurement, quality of life during menstruation measurement",GCST006637,1:114936845
rs79926686-<b>A</b>,2 x 10-6,,0.04003235,'-,0.33901066 unit increase,[0.2-0.48],LINC01765,Pain medicine use during menstruation,"drug use measurement, quality of life during menstruation measurement",GCST006637,1:115120512
rs6657049-<b>A</b>,2 x 10-13,,0.595484796,'-,0.22132388 unit decrease,[0.16-0.28],NGF-AS1,Pain medicine use during menstruation,"drug use measurement, quality of life during menstruation measurement",GCST006637,1:115282910
rs3783553-<b>TTGAA</b>,3 x 10-9,,0.25975383,'-,0.19852114 unit increase,[0.13-0.26],IL1A,Pain medicine use during menstruation,"drug use measurement, quality of life during menstruation measurement",GCST006637,2:112774139
rs11123155-<b>C</b>,2 x 10-9,,0.722,'-,0.1937211 unit decrease,[0.13-0.26],IL36B,Pain medicine use during menstruation,"drug use measurement, quality of life during menstruation measurement",GCST006637,2:113032681
rs17223839-<b>G</b>,9 x 10-6,,0.454465482,'-,0.13206975 unit decrease,[0.074-0.19],KCNH5,Pain medicine use during menstruation,"drug use measurement, quality of life during menstruation measurement",GCST006637,14:62921940
rs73302247-<b>T</b>,4 x 10-6,,0.415273047,'-,0.13955176 unit decrease,[0.08-0.199],SDK1,Pain medicine use during menstruation,"drug use measurement, quality of life during menstruation measurement",GCST006637,7:3697775
rs17181171-<b>A</b>,2 x 10-8,,0.028315429,'-,1.0238161 unit increase,[0.67-1.38],OPRM1,Menstruation quality of life impact (fever),"quality of life during menstruation measurement, Fever",GCST006638,6:154088681
rs60074929-<b>A</b>,8 x 10-6,,0.15495693,'-,0.27508697 unit increase,[0.15-0.4],ERRFI1,Heavy vaginal discharge,"quality of life during menstruation measurement, vaginal discharge",GCST006639,1:8077340
rs11678347-<b>G</b>,5 x 10-6,,0.468275225,'-,0.22653061 unit decrease,[0.13-0.32],CCDC88A,Heavy vaginal discharge,"quality of life during menstruation measurement, vaginal discharge",GCST006639,2:55378049
rs2051839-<b>G</b>,6 x 10-6,,0.816396102,'-,0.26762575 unit decrease,[0.15-0.38],CHN2,Heavy vaginal discharge,"quality of life during menstruation measurement, vaginal discharge",GCST006639,7:29288659
rs10897308-<b>A</b>,6 x 10-7,,0.424588226,'-,0.14750205 unit decrease,[0.09-0.205],SLC22A6,Menstruation quality of life impact (headache),"quality of life during menstruation measurement, Headache",GCST006646,11:62965121
rs11236806-<b>G</b>,9 x 10-6,,0.303168183,'-,0.138 unit increase,[0.077-0.199],LINC02757,Menstruation quality of life impact (headache),"quality of life during menstruation measurement, Headache",GCST006646,11:76611208
rs9563613-<b>A</b>,4 x 10-6,,0.220356881,'-,0.15932293 unit increase,[0.092-0.227],'-,Menstruation quality of life impact (headache),"quality of life during menstruation measurement, Headache",GCST006646,13:33614126
rs35648590-<b>C</b>,2 x 10-7,,0.642119745,'-,0.15414548 unit decrease,[0.096-0.212],MRPL1,Menstruation quality of life impact (headache),"quality of life during menstruation measurement, Headache",GCST006646,4:77922761
rs10848582-<b>C</b>,7 x 10-6,,0.333165165,'-,0.32168108 unit decrease,[0.18-0.46],CACNA2D4,Menstruation quality of life impact (joint pain),"quality of life during menstruation measurement, Arthralgia",GCST006647,12:1860096
rs67784164-<b>A</b>,2 x 10-6,,0.417098773,'-,0.32047647 unit decrease,[0.19-0.45],"IFNG-AS1, IL22",Menstruation quality of life impact (joint pain),"quality of life during menstruation measurement, Arthralgia",GCST006647,12:68239223
rs10828963-<b>G</b>,4 x 10-6,,0.484979044,'-,0.29585403 unit decrease,[0.17-0.42],GAD2,Menstruation quality of life impact (joint pain),"quality of life during menstruation measurement, Arthralgia",GCST006647,10:26236001
rs41418546-<b>G</b>,9 x 10-7,,0.174143485,'-,0.37595135 unit increase,[0.23-0.53],DOP1B,Menstruation quality of life impact (joint pain),"quality of life during menstruation measurement, Arthralgia",GCST006647,21:36261009
rs1436124-<b>G</b>,9 x 10-6,,0.720134929,'-,0.1649891 unit decrease,[0.092-0.238],"SNRPF, CCDC38",Menstruation quality of life impact (acne),"quality of life during menstruation measurement, acne",GCST006640,12:95889654
rs7711329-<b>T</b>,4 x 10-6,,0.2395869,'-,0.18926059 unit decrease,[0.11-0.27],NLN,Menstruation quality of life impact (acne),"quality of life during menstruation measurement, acne",GCST006640,5:65830201
rs79757024-<b>T</b>,7 x 10-6,,0.096090822,'-,0.24425165 unit increase,[0.14-0.35],FHOD3,Menstruation quality of life impact (acne),"quality of life during menstruation measurement, acne",GCST006640,18:36677628
rs55865143-<b>G</b>,7 x 10-6,,0.161107421,'-,0.19965 unit increase,[0.11-0.29],SDK1,Menstruation quality of life impact (acne),"quality of life during menstruation measurement, acne",GCST006640,7:3788268
rs34180-<b>A</b>,9 x 10-6,,0.704857903,'-,0.16777869 unit increase,[0.094-0.242],PPP1R17,Menstruation quality of life impact (acne),"quality of life during menstruation measurement, acne",GCST006640,7:31702050
rs987034-<b>T</b>,7 x 10-6,,0.304062857,'-,0.16414963 unit increase,[0.092-0.236],CALN1,Menstruation quality of life impact (acne),"quality of life during menstruation measurement, acne",GCST006640,7:71842387
rs2242095-<b>T</b>,1 x 10-6,,0.150026652,'-,0.21825656 unit increase,[0.13-0.31],EEF1D,Menstruation quality of life impact (acne),"quality of life during menstruation measurement, acne",GCST006640,8:143596704
rs3967101-<b>A</b>,9 x 10-6,,0.286455799,'-,0.16903496 unit decrease,[0.094-0.244],'-,Menstruation quality of life impact (acne),"quality of life during menstruation measurement, acne",GCST006640,6:80898141
rs12042620-<b>C</b>,5 x 10-6,,0.259450726,'-,0.1669636 unit increase,[0.095-0.239],PLPPR5,Menstruation quality of life impact (edema),"quality of life during menstruation measurement, edema",GCST006645,1:98992210
rs73412205-<b>C</b>,6 x 10-6,,0.187663078,'-,0.19654813 unit decrease,[0.11-0.28],DSG1-AS1,Menstruation quality of life impact (edema),"quality of life during menstruation measurement, edema",GCST006645,18:31426660
rs4752321-<b>C</b>,4 x 10-6,,0.343205576,'-,0.1611582 unit decrease,[0.093-0.229],RGS10,Menstruation quality of life impact (edema),"quality of life during menstruation measurement, edema",GCST006645,10:119518086
rs4784797-<b>C</b>,2 x 10-6,,0.880238975,'-,0.53531784 unit decrease,[0.31-0.76],"RPL23AP91, CCL22",Menstruation quality of life impact (fever),"quality of life during menstruation measurement, Fever",GCST006638,16:57349494
rs6589075-<b>T</b>,3 x 10-7,,0.118184092,'-,0.2592224 unit increase,[0.16-0.36],LINC02713,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,11:97888820
rs12477098-<b>T</b>,7 x 10-6,,0.527396834,'-,0.15764286 unit increase,[0.089-0.226],SNTG2,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,2:1099816
rs6437450-<b>C</b>,4 x 10-6,,0.829839437,'-,0.22219077 unit increase,[0.13-0.32],XXYLT1,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,3:195016009
rs13113956-<b>A</b>,3 x 10-6,,0.26968404,'-,0.18722807 unit decrease,[0.11-0.27],'-,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,4:125938393
rs1158326-<b>G</b>,7 x 10-6,,0.127768339,'-,0.2249695 unit increase,[0.13-0.32],MAML3,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,4:139810806
rs870306-<b>G</b>,3 x 10-7,,0.240383055,'-,0.20160586 unit increase,[0.12-0.28],IGF1R,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,15:98776578
rs508296-<b>T</b>,9 x 10-6,,0.288755799,'-,0.16685836 unit increase,[0.093-0.241],'-,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,5:114791832
rs1925191-<b>G</b>,6 x 10-6,,0.573070651,'-,0.1554631 unit decrease,[0.088-0.223],SPTLC1P2,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,6:23835115
rs6854861-<b>C</b>,8 x 10-6,,0.784706911,'-,0.15640192 unit increase,[0.088-0.225],USP38,Menstruation quality of life impact (nervousness),"nervousness, quality of life during menstruation measurement",GCST006649,4:143131938
rs11100785-<b>C</b>,4 x 10-6,,0.786230458,'-,0.16219163 unit increase,[0.093-0.231],"USP38, Y_RNA",Menstruation quality of life impact (nervousness),"nervousness, quality of life during menstruation measurement",GCST006649,4:143274404
rs56261590-<b>A</b>,2 x 10-6,,0.323082228,'-,0.22040759 unit decrease,[0.13-0.31],ANKRD17,Menstruation quality of life impact (pressure in breast),"quality of life during menstruation measurement, breast pressure measurement",GCST006650,4:73189781
rs11099757-<b>T</b>,7 x 10-6,,0.298158338,'-,0.19953223 unit increase,[0.11-0.29],DCLK2,Menstruation quality of life impact (pressure in breast),"quality of life during menstruation measurement, breast pressure measurement",GCST006650,4:150143216
rs16871509-<b>A</b>,2 x 10-6,,0.119707494,'-,0.28391933 unit increase,[0.17-0.4],CARTPT,Menstruation quality of life impact (pressure in breast),"quality of life during menstruation measurement, breast pressure measurement",GCST006650,5:71726395
rs4725504-<b>G</b>,9 x 10-6,,0.550647176,'-,0.18980134 unit increase,[0.11-0.27],'-,Menstruation quality of life impact (pressure in breast),"quality of life during menstruation measurement, breast pressure measurement",GCST006650,7:153608338
rs60924036-<b>G</b>,8 x 10-6,,0.321933348,'-,0.13361064 unit increase,[0.075-0.192],"GJD2, LINC02252",Menstruation quality of life impact (sleepiness),"quality of life during menstruation measurement, sleepiness",GCST006651,15:34743665
rs9327007-<b>G</b>,8 x 10-6,,0.319504311,'-,0.13501824 unit decrease,[0.076-0.194],SEMA6A,Menstruation quality of life impact (sleepiness),"quality of life during menstruation measurement, sleepiness",GCST006651,5:116563436
rs7207701-<b>T</b>,5 x 10-7,,0.30059775,'-,0.15388642 unit increase,[0.094-0.214],"CDRT7, CDRT8",Menstruation quality of life impact (sleepiness),"quality of life during menstruation measurement, sleepiness",GCST006651,17:15052017
rs77866669-<b>C</b>,2 x 10-7,,0.126807442,'-,0.30520967 unit decrease,[0.19-0.42],'-,Menstruation quality of life impact (stiff neck),"quality of life during menstruation measurement, Stiff neck",GCST006652,12:115245190
rs12988164-<b>G</b>,7 x 10-6,,0.442518934,'-,0.16096936 unit increase,[0.091-0.231],LRRTM4,Menstruation quality of life impact (stiff neck),"quality of life during menstruation measurement, Stiff neck",GCST006652,2:76789223
rs9641968-<b>C</b>,5 x 10-6,,0.394293589,'-,0.16574138 unit increase,[0.094-0.237],'-,Menstruation quality of life impact (stiff neck),"quality of life during menstruation measurement, Stiff neck",GCST006652,7:81038465
rs12217499-<b>A</b>,6 x 10-6,,0.122581358,'-,0.26540968 unit decrease,[0.15-0.38],"MIR607, RPL13AP5",Menstruation quality of life impact (stiff neck),"quality of life during menstruation measurement, Stiff neck",GCST006652,10:96791054
rs4846314-<b>A</b>,6 x 10-6,,0.25004333,'-,0.14602003 unit increase,[0.083-0.209],XRCC6P3,Menstruation quality of life impact (depression),"quality of life during menstruation measurement, unipolar depression",GCST006644,1:220325294
rs7523086-<b>G</b>,4 x 10-14,,0.621,'-,0.1 unit increase,[0.074-0.126],NGF-AS1,Dysmenorrheic pain,dysmenorrheic pain measurement,GCST003927,1:115280766
rs201074342-<b>I</b>,5 x 10-7,,0.896,'-,0.138 unit decrease,[0.085-0.192],"SBK3, SBK2",Dysmenorrheic pain,dysmenorrheic pain measurement,GCST003927,19:55539945
rs7137301-<b>T</b>,6 x 10-7,,0.453,'-,0.068 unit increase,[0.041-0.095],KRAS,Dysmenorrheic pain,dysmenorrheic pain measurement,GCST003927,12:25297882
rs189805869-<b>G</b>,7 x 10-7,,0.007,'-,0.409 unit decrease,[0.247-0.571],"MIR5681A, GDAP1",Dysmenorrheic pain,dysmenorrheic pain measurement,GCST003927,8:74523076
rs315934-<b>T</b>,7 x 10-7,,0.796,'-,0.078 unit increase,[0.047-0.109],IL1RN,Dysmenorrheic pain,dysmenorrheic pain measurement,GCST003927,2:113126129
rs186838326-<b>T</b>,8 x 10-7,,0.059,'-,0.193 unit increase,[0.116-0.270],"RPSAP22, Y_RNA",Dysmenorrheic pain,dysmenorrheic pain measurement,GCST003927,2:85488020
rs12030576-<b>T</b>,1 x 10-19,,0.5949,'-,0.4196692 unit decrease,[0.33-0.51],NGF-AS1,Dysmenorrheic pain severity,dysmenorrheic pain measurement,GCST006656,1:115274600
rs80111889-<b>G</b>,2 x 10-16,,0.7379,'-,0.4249356 unit decrease,[0.32-0.53],"IL1B, IL1A",Dysmenorrheic pain severity,dysmenorrheic pain measurement,GCST006656,2:112809853
rs2034260-<b>C</b>,3 x 10-7,,0.70645,'-,0.25411773 unit decrease,[0.16-0.35],IL36B,Dysmenorrheic pain severity,dysmenorrheic pain measurement,GCST006656,2:113044321
rs8022306-<b>A</b>,7 x 10-6,,0.504987059,'-,0.20192496 unit increase,[0.11-0.29],EFCAB11,Dysmenorrheic pain severity,dysmenorrheic pain measurement,GCST006656,14:89941475
rs73376040-<b>T</b>,5 x 10-7,,0.117365839,'-,0.35476956 unit decrease,[0.22-0.49],L3MBTL4,Dysmenorrheic pain severity,dysmenorrheic pain measurement,GCST006656,18:6016416
rs10167914-<b>G</b>,3 x 10-12,,0.738617113,'-,0.22788282 unit decrease,[0.16-0.29],"IL1A, IL1B",Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,2:112805784
rs17817634-<b>T</b>,5 x 10-6,,0.162392088,'-,0.17600146 unit increase,[0.1-0.25],ETV6,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,12:11687543
rs12030576-<b>T</b>,8 x 10-12,,0.59489742,'-,0.1975494 unit decrease,[0.14-0.25],NGF-AS1,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,1:115274600
rs7653663-<b>A</b>,4 x 10-6,,0.48623665,'-,0.13090697 unit increase,[0.076-0.186],MGLL,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,3:127756783
rs1420044-<b>T</b>,1 x 10-7,,0.065290717,'-,0.2902695 unit decrease,[0.18-0.4],GRIN2A,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,16:9820276
rs10808874-<b>C</b>,4 x 10-6,,0.803879945,'-,0.16748436 unit decrease,[0.097-0.238],RB1CC1,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,8:52793206
rs35018432-<b>T</b>,6 x 10-6,,0.375217674,'-,0.13321592 unit increase,[0.076-0.191],VPS13B,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,8:99182067
rs10989462-<b>G</b>,4 x 10-6,,0.35727413,'-,0.13606437 unit increase,[0.078-0.194],PLPPR1,Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,9:101273624
rs564036233-<b>GA</b>,1 x 10-16,,NR,'-,0.16 SD increase,[0.12-0.20],"FSHB, ARL14EP",Length of menstrual cycle,menstrual cycle measurement,GCST003334,11:30297462
rs3124592-<b>G</b>,2 x 10-8,,0.45,'-,0.08 SD increase,[0.05-0.11],NOTCH1,Length of menstrual cycle,menstrual cycle measurement,GCST003334,9:136498710
rs11031006-<b>A</b>,4 x 10-36,,0.86,'-,0.16 unit decrease,[0.14-0.18],FSHB,Length of menstrual cycle,menstrual cycle measurement,GCST006958,11:30204981
rs6670899-<b>A</b>,7 x 10-13,,0.57,'-,0.05 unit decrease,[0.030-0.070],"RNU6-778P, RNU6-716P",Length of menstrual cycle,menstrual cycle measurement,GCST006958,1:199922310
rs13261573-<b>A</b>,1 x 10-10,,0.75,'-,0.07 unit decrease,[0.050-0.090],DOCK5,Length of menstrual cycle,menstrual cycle measurement,GCST006958,8:25391099
rs471811-<b>C</b>,3 x 10-8,,0.31,'-,0.03 unit decrease,[0.010-0.050],PGR-AS1,Length of menstrual cycle,menstrual cycle measurement,GCST006958,11:101173472
rs11042596-<b>G</b>,5 x 10-8,,0.34,'-,0.04 unit increase,[0.020-0.060],"H19, IGF2",Length of menstrual cycle,menstrual cycle measurement,GCST006958,11:2097630
rs11031006-<b>G</b>,2 x 10-13,,0.86,1.1904762,'-,[1.14-1.25],FSHB,Heavy menstrual bleeding,Menorrhagia,GCST009157,11:30204981
rs72709458-<b>T</b>,2 x 10-8,,0.21,1.13,'-,[1.08-1.17],TERT,Heavy menstrual bleeding,Menorrhagia,GCST009157,5:1283640
rs16991615-<b>A</b>,3 x 10-8,,0.07,1.21,'-,[1.13-1.29],MCM8,Heavy menstrual bleeding,Menorrhagia,GCST009157,20:5967581
rs2456181-<b>G</b>,4 x 10-10,,0.48,1.1494253,'-,[1.1-1.2],ZNF346,Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,5:177023836
rs72709458-<b>T</b>,4 x 10-8,,0.21,1.16,'-,[1.11-1.23],TERT,Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,5:1283640
rs149934734-<b>T</b>,6 x 10-8,,0.03,1.45,'-,[1.28-1.69],C11orf65,Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,11:108444879
rs12392108-<b>A</b>,5 x 10-7,,0.31,1.13,'-,[1.08-1.19],"AGKP2, RAP2C",Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,X:132180234
rs547025-<b>T</b>,2 x 10-6,,0.93,1.22,'-,[1.13-1.34],SIRT3,Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,11:232855
rs10976689-<b>?</b>,4 x 10-6,,0.4,1.1111112,'-,[1.06-1.16],"DMRT1, KANK1",Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,9:804886
rs78378222-<b>G</b>,2 x 10-7,,0.99,1.69,'-,[1.39-2.08],TP53,Uterine fibroids and heavy menstrual bleeding,"uterine fibroid, Menorrhagia",GCST009156,17:7668434
rs752590-<b>?</b>,3 x 10-8,,0.21,1.34,'-,[1.21-1.49],PAX8-AS1,Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST002967,2:113215368
rs711830-<b>?</b>,8 x 10-12,,0.32,1.3,'-,[1.20-1.40],"HAGLR, HOXD3",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST002967,2:176172583
rs688187-<b>?</b>,7 x 10-13,,0.68,1.4925373,'-,[1.33-1.67],"IFNL3P1, IFNL3",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST002967,19:39242112
rs72831838-<b>?</b>,8 x 10-7,(Invasive Only),0.14,1.39,'-,[1.22-1.58],"PAX8-AS1, PAX8",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST002967,2:113258824
rs711830-<b>?</b>,8 x 10-7,(Invasive Only),0.32,1.26,'-,[1.15-1.39],"HAGLR, HOXD3",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST002967,2:176172583
rs688187-<b>?</b>,1 x 10-8,(Invasive Only),0.68,1.4084507,'-,[1.25-1.59],"IFNL3P1, IFNL3",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST002967,19:39242112
rs37792-<b>A</b>,6 x 10-8,,0.658,1.5384616,'-,[1.32-1.82],'-,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST009007,5:53348817
rs57403204-<b>G</b>,2 x 10-7,,0.064,2.62,'-,[1.83-3.76],MAGEC1,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST009007,X:141990766
rs79079890-<b>G</b>,3 x 10-7,,0.032,3.2,'-,[2.05-4.99],'-,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST009007,10:3641956
rs66459581-<b>A</b>,5 x 10-7,,0.234,1.63,'-,[1.35-1.97],PRPSAP1,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST009007,17:76359184
rs116046250-<b>G</b>,9 x 10-7,,0.046,2.95,'-,[1.92-4.54],GABRG3,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST009007,15:26986803
rs192876988-<b>C</b>,9 x 10-7,,0.046,3.01,'-,[1.94-4.68],"GK2, NAA11",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST009007,4:79376097
rs79219469-<b>?</b>,3 x 10-8,,'-,2.25,'-,[1.12-1.26],LINC02183,Ovarian cancer,ovarian carcinoma,GCST009830,16:54553941
rs567534295-<b>?</b>,3 x 10-8,,'-,4.75,'-,[2.73-8.24],BRCA1,Ovarian cancer,ovarian carcinoma,GCST009830,17:43048090
rs143623984-<b>?</b>,9 x 10-6,,'-,3.25,'-,[1.93-5.48],"PPIAP7, LINC01307",Ovarian cancer,ovarian carcinoma,GCST009830,1:101301117
rs12031579-<b>?</b>,1 x 10-6,,'-,1.73,'-,[1.39-2.16],"WARS2-AS1, LINC01780",Ovarian cancer,ovarian carcinoma,GCST009830,1:119307920
rs484686-<b>?</b>,8 x 10-6,,'-,1.3,'-,[1.16-1.46],DNM3,Ovarian cancer,ovarian carcinoma,GCST009830,1:172183062
rs537364753-<b>?</b>,6 x 10-6,,'-,3.06,'-,[1.89-4.96],MIR548AE1,Ovarian cancer,ovarian carcinoma,GCST009830,2:184453308
rs75693602-<b>?</b>,7 x 10-6,,'-,1.89,'-,[1.43-2.49],"NRP2, PARD3B",Ovarian cancer,ovarian carcinoma,GCST009830,2:205631096
rs13402729-<b>?</b>,1 x 10-6,,'-,1.74,'-,[1.39-2.18],'-,Ovarian cancer,ovarian carcinoma,GCST009830,2:226482173
rs7563767-<b>?</b>,2 x 10-6,,'-,1.34,'-,[1.19-1.51],LINC01237,Ovarian cancer,ovarian carcinoma,GCST009830,2:242012658
rs146572601-<b>?</b>,5 x 10-6,,'-,2.64,'-,[1.74-4.02],SAMMSON,Ovarian cancer,ovarian carcinoma,GCST009830,3:70110053
rs191223340-<b>?</b>,3 x 10-6,,'-,2.74,'-,[1.80-4.18],"MDFIC2, SAMMSON",Ovarian cancer,ovarian carcinoma,GCST009830,3:70224942
rs150007914-<b>?</b>,7 x 10-6,,'-,2.23,'-,[1.57-3.16],TNIK,Ovarian cancer,ovarian carcinoma,GCST009830,3:171410134
rs7671115-<b>?</b>,6 x 10-6,,'-,1.2987013,'-,[1.16-1.45],MARCHF1,Ovarian cancer,ovarian carcinoma,GCST009830,4:164203350
rs57490377-<b>?</b>,9 x 10-6,,'-,2.3,'-,[1.59-3.32],SORBS2,Ovarian cancer,ovarian carcinoma,GCST009830,4:185621753
rs1366161-<b>?</b>,6 x 10-6,,'-,1.2987013,'-,[1.16-1.45],ADAMTS16,Ovarian cancer,ovarian carcinoma,GCST009830,5:5174755
rs148570926-<b>?</b>,3 x 10-6,,'-,2.9,'-,[1.86-4.52],"CXXC5, RNU6-236P",Ovarian cancer,ovarian carcinoma,GCST009830,5:139690696
rs151055883-<b>?</b>,6 x 10-7,,'-,1.99,'-,[1.52-2.60],HMHB1,Ovarian cancer,ovarian carcinoma,GCST009830,5:143894315
rs77663385-<b>?</b>,8 x 10-6,,'-,3.17,'-,[1.91-5.26],"SPATS1, AARS2",Ovarian cancer,ovarian carcinoma,GCST009830,6:44327218
rs7740903-<b>?</b>,4 x 10-7,,'-,2.19,'-,[1.62-2.97],ADGB,Ovarian cancer,ovarian carcinoma,GCST009830,6:146677054
rs76926936-<b>?</b>,8 x 10-6,,'-,1.84,'-,[1.41-2.41],RNU6-274P,Ovarian cancer,ovarian carcinoma,GCST009830,7:89698682
rs148037216-<b>?</b>,2 x 10-6,,'-,3.09,'-,[1.95-4.91],"EFCAB1, LINC02847",Ovarian cancer,ovarian carcinoma,GCST009830,8:48645458
rs147476757-<b>?</b>,8 x 10-6,,'-,2.6,'-,[1.71-3.96],PBX3,Ovarian cancer,ovarian carcinoma,GCST009830,9:126011262
rs77336990-<b>?</b>,2 x 10-6,,'-,2.77,'-,[1.82-4.20],FRMPD2,Ovarian cancer,ovarian carcinoma,GCST009830,10:48270719
rs78375425-<b>?</b>,3 x 10-6,,'-,1.62,'-,[1.33-1.99],LHFPL6,Ovarian cancer,ovarian carcinoma,GCST009830,13:39329007
rs141118132-<b>?</b>,8 x 10-6,,'-,3.12,'-,[1.89-5.14],"MRPS31P4, LINC00345",Ovarian cancer,ovarian carcinoma,GCST009830,13:52517465
chr14:37233727-<b>?</b>,9 x 10-6,,'-,3.06,'-,[1.87-5.02],'-,Ovarian cancer,ovarian carcinoma,GCST009830,Mapping not available
rs201368489-<b>?</b>,4 x 10-6,,'-,2.8,'-,[1.81-4.34],MTHFD1,Ovarian cancer,ovarian carcinoma,GCST009830,14:64414689
rs141803457-<b>?</b>,1 x 10-6,,'-,3.04,'-,[1.94-4.77],SMPD3,Ovarian cancer,ovarian carcinoma,GCST009830,16:68366522
rs137866923-<b>?</b>,3 x 10-7,,'-,3.82,'-,[2.29-6.36],"ZFP90, RPL35AP33",Ovarian cancer,ovarian carcinoma,GCST009830,16:68497433
rs572011593-<b>?</b>,4 x 10-6,,'-,2.89,'-,[1.84-4.55],"CPDP1, LGALS9DP",Ovarian cancer,ovarian carcinoma,GCST009830,17:27694464
rs139505845-<b>?</b>,1 x 10-6,,'-,4.52,'-,[2.47-8.30],MSI2,Ovarian cancer,ovarian carcinoma,GCST009830,17:57289728
rs146540010-<b>?</b>,9 x 10-6,,'-,2.84,'-,[1.79-4.50],ABCA10,Ovarian cancer,ovarian carcinoma,GCST009830,17:69216249
rs138807553-<b>?</b>,2 x 10-6,,'-,3.57,'-,[2.12-6.01],ASXL3,Ovarian cancer,ovarian carcinoma,GCST009830,18:33625004
rs192503876-<b>?</b>,8 x 10-6,,'-,3.31,'-,[1.96-5.61],'-,Ovarian cancer,ovarian carcinoma,GCST009830,18:65045831
rs80314337-<b>?</b>,5 x 10-6,,'-,2.89,'-,[1.83-4.56],'-,Ovarian cancer,ovarian carcinoma,GCST009830,18:65221472
rs11873753-<b>?</b>,1 x 10-6,,'-,1.85,'-,[1.44-2.38],'-,Ovarian cancer,ovarian carcinoma,GCST009830,18:75985500
rs137657-<b>?</b>,8 x 10-6,,'-,1.72,'-,[1.35-2.17],"RPL3, SYNGR1",Ovarian cancer,ovarian carcinoma,GCST009830,22:39337237
rs79219469-<b>?</b>,2 x 10-7,,'-,1.1,'-,[1.06-1.14],LINC02183,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,16:54553941
rs567534295-<b>?</b>,5 x 10-8,,'-,1.19,'-,[1.12-1.26],BRCA1,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,17:43048090
rs12031579-<b>?</b>,2 x 10-6,,'-,1.07,'-,[1.04-1.10],"WARS2-AS1, LINC01780",Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,1:119307920
rs13402729-<b>?</b>,3 x 10-6,,'-,1.07,'-,[1.04-1.09],'-,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,2:226482173
rs7563767-<b>?</b>,2 x 10-6,,'-,1.03,'-,[1.02-1.05],LINC01237,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,2:242012658
rs7671115-<b>?</b>,8 x 10-6,,'-,1.0309278,'-,[1.02-1.04],MARCHF1,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,4:164203350
rs1366161-<b>?</b>,3 x 10-6,,'-,1.0309278,'-,[1.02-1.05],ADAMTS16,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,5:5174755
rs151055883-<b>?</b>,2 x 10-6,,'-,1.08,'-,[1.05-1.12],HMHB1,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,5:143894315
rs77663385-<b>?</b>,9 x 10-6,,'-,1.14,'-,[1.07-1.21],"SPATS1, AARS2",Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,6:44327218
rs7740903-<b>?</b>,5 x 10-7,,'-,1.1,'-,[1.06-1.14],ADGB,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,6:146677054
rs76926936-<b>?</b>,9 x 10-6,,'-,1.07,'-,[1.04-1.11],RNU6-274P,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,7:89698682
rs73494486-<b>?</b>,7 x 10-6,,'-,1.05,'-,[1.03-1.07],GABBR2,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,9:98579569
rs77336990-<b>?</b>,2 x 10-6,,'-,1.12,'-,[1.07-1.17],FRMPD2,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,10:48270719
rs78375425-<b>?</b>,3 x 10-6,,'-,1.06,'-,[1.03-1.09],LHFPL6,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,13:39329007
rs79219469-<b>?</b>,2 x 10-7,,'-,1.1,'-,[1.06-1.14],LINC02183,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,16:54553941
rs9989364-<b>?</b>,9 x 10-6,,'-,1.04,'-,[1.02-1.06],'-,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,16:63960276
rs141803457-<b>?</b>,3 x 10-6,,'-,1.13,'-,[1.07-1.19],SMPD3,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,16:68366522
rs137866923-<b>?</b>,8 x 10-7,,'-,1.15,'-,[1.09-1.22],"ZFP90, RPL35AP33",Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,16:68497433
rs139505845-<b>?</b>,6 x 10-6,,'-,1.17,'-,[1.09-1.25],MSI2,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,17:57289728
rs138807553-<b>?</b>,2 x 10-6,,'-,1.15,'-,[1.08-1.22],ASXL3,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,18:33625004
rs78286182-<b>?</b>,1 x 10-6,,'-,1.08,'-,[1.05-1.11],'-,Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,18:75988278
rs972834-<b>?</b>,7 x 10-6,,'-,1.03,'-,[1.02-1.05],"PDCL2P1, PTCHD1",Ovarian cancer (MTAG),ovarian carcinoma,GCST009829,X:23276803
rs12061931-<b>T</b>,6 x 10-8,,NR,5.79,'-,NR,LRRC47,Ovarian cancer,ovarian carcinoma,GCST90011821,1:3779792
rs185345278-<b>A</b>,5 x 10-6,,0.0216,2.8735633,'-,[1.83-4.52],"MTCO1P21, ABCA4",Ovarian cancer,ovarian carcinoma,GCST007239,1:93933038
rs12031579-<b>G</b>,8 x 10-7,,0.0547,1.8248177,'-,[1.44-2.31],"WARS2-AS1, LINC01780",Ovarian cancer,ovarian carcinoma,GCST007239,1:119307920
rs188625872-<b>C</b>,2 x 10-6,,0.0034,3.7593985,'-,[2.17-6.49],LMNA,Ovarian cancer,ovarian carcinoma,GCST007239,1:156114696
rs12117623-<b>C</b>,1 x 10-6,,0.5306,1.312336,'-,[1.18-1.46],DNM3,Ovarian cancer,ovarian carcinoma,GCST007239,1:172072640
rs17027263-<b>C</b>,2 x 10-6,,0.1172,1.4430014,'-,[1.24-1.68],KDM3A,Ovarian cancer,ovarian carcinoma,GCST007239,2:86459965
rs6801612-<b>A</b>,8 x 10-6,,0.683,1.328,'-,[1.174-1.503],"ST6GAL1, RPS20P14",Ovarian cancer,ovarian carcinoma,GCST007239,3:186920430
rs12658731-<b>G</b>,9 x 10-7,,0.6438,1.405,'-,[1.227-1.608],ADAMTS16,Ovarian cancer,ovarian carcinoma,GCST007239,5:5169477
rs147867139-<b>A</b>,8 x 10-6,,0.0175,2.197802,'-,[1.56-3.11],"RNU6-236P, CXXC5",Ovarian cancer,ovarian carcinoma,GCST007239,5:139712729
rs60982503-<b>G</b>,5 x 10-6,,0.7345,1.384,'-,[1.204-1.591],"RNU6-525P, CNOT6",Ovarian cancer,ovarian carcinoma,GCST007239,5:180485036
rs303051-<b>A</b>,6 x 10-6,,0.3947,1.2886598,'-,[1.15-1.44],TFAP2A,Ovarian cancer,ovarian carcinoma,GCST007239,6:10403963
rs56855829-<b>C</b>,2 x 10-6,,0.0036,3.8022811,'-,[2.18-6.62],FANCE,Ovarian cancer,ovarian carcinoma,GCST007239,6:35464877
rs4599655-<b>A</b>,8 x 10-6,,0.1365,1.3927578,'-,[1.21-1.61],UFL1-AS1,Ovarian cancer,ovarian carcinoma,GCST007239,6:96284381
rs73589840-<b>C</b>,7 x 10-6,,0.0329,1.7452006,'-,[1.37-2.22],ADGB,Ovarian cancer,ovarian carcinoma,GCST007239,6:146688554
rs181474944-<b>C</b>,6 x 10-6,,0.015,2.4570024,'-,[1.67-3.62],PKD1L1,Ovarian cancer,ovarian carcinoma,GCST007239,7:47770503
rs76926936-<b>T</b>,9 x 10-6,,0.0517,1.923077,'-,[1.44-2.56],RNU6-274P,Ovarian cancer,ovarian carcinoma,GCST007239,7:89698682
rs10117922-<b>A</b>,7 x 10-6,,0.325,1.3351135,'-,[1.18-1.51],DAPK1,Ovarian cancer,ovarian carcinoma,GCST007239,9:87680655
rs10858374-<b>T</b>,1 x 10-6,,0.1106,1.4684289,'-,[1.26-1.72],C9orf62,Ovarian cancer,ovarian carcinoma,GCST007239,9:135247660
rs2615880-<b>A</b>,8 x 10-6,,0.1234,1.4025246,'-,[1.21-1.63],ATRNL1,Ovarian cancer,ovarian carcinoma,GCST007239,10:115937294
rs789336-<b>C</b>,1 x 10-7,,0.6082,1.369,'-,[1.217-1.540],PRANCR,Ovarian cancer,ovarian carcinoma,GCST007239,12:70028700
rs7969255-<b>T</b>,8 x 10-7,,0.5313,1.325,'-,[1.184-1.481],PRANCR,Ovarian cancer,ovarian carcinoma,GCST007239,12:70148026
rs58355101-<b>T</b>,9 x 10-7,,0.5658,1.35,'-,[1.198-1.521],CNOT2,Ovarian cancer,ovarian carcinoma,GCST007239,12:70257391
rs1495352-<b>A</b>,3 x 10-6,,0.5489,1.31,'-,[1.169-1.468],"KCNMB4, CNOT2",Ovarian cancer,ovarian carcinoma,GCST007239,12:70359064
rs75921351-<b>C</b>,8 x 10-7,,0.0304,2.1691973,'-,[1.59-2.95],LINC02183,Ovarian cancer,ovarian carcinoma,GCST007239,16:54596587
rs145065165-<b>G</b>,2 x 10-7,,0.0223,2.8735633,'-,[1.93-4.29],"RPL31P56, IRX6",Ovarian cancer,ovarian carcinoma,GCST007239,16:55347327
rs11870446-<b>C</b>,3 x 10-6,,0.1238,1.4836795,'-,[1.26-1.75],'-,Ovarian cancer,ovarian carcinoma,GCST007239,17:5857509
rs12151036-<b>G</b>,5 x 10-6,,0.0119,2.2075055,'-,[1.57-3.11],ZNF274,Ovarian cancer,ovarian carcinoma,GCST007239,19:58202868
rs1884920-<b>A</b>,8 x 10-6,,0.5027,1.4064697,'-,[1.21-1.64],"TFAP2C, RNU6-1146P",Ovarian cancer,ovarian carcinoma,GCST007239,20:56648010
rs137672-<b>C</b>,1 x 10-7,,0.0601,1.7452006,'-,[1.42-2.15],"SYNGR1, RPL3",Ovarian cancer,ovarian carcinoma,GCST007239,22:39341089
rs10899426-<b>?</b>,2 x 10-7,,NR,2.74,'-,'-,"KCTD14, INTS4",Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel,"progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004897,11:78008566
rs6256-<b>?</b>,1 x 10-6,,NR,1.93,'-,'-,PTH,Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel,"progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004897,11:13492506
rs10832063-<b>?</b>,5 x 10-6,,NR,1.8,'-,'-,"PTH, HMGN2P36",Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel,"progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004897,11:13553087
rs10500780-<b>?</b>,5 x 10-6,,NR,1.79,'-,'-,BTBD10,Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel,"progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004897,11:13401400
rs1564271-<b>?</b>,9 x 10-6,,NR,1.62,'-,'-,PDSS1,Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,10:26722183
rs10899426-<b>?</b>,9 x 10-6,,NR,2.29,'-,'-,"KCTD14, INTS4",Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,11:78008566
rs4618572-<b>?</b>,9 x 10-6,,NR,1.86,'-,'-,"FOXF2, RN7SL352P",Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,6:1492427
rs295315-<b>?</b>,8 x 10-7,,NR,1.82,'-,'-,"RASA2, LINC02618",Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,3:141643383
rs17693104-<b>?</b>,8 x 10-7,,NR,1.65,'-,'-,SH2D4B,Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,10:80608465
rs868767-<b>?</b>,2 x 10-6,,NR,2.12,'-,'-,"LINC02618, RASA2",Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,3:141658488
rs2050203-<b>?</b>,4 x 10-6,,NR,1.78,'-,'-,"GAPDHP53, SYNDIG1",Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,20:24451198
rs11621975-<b>?</b>,5 x 10-6,,NR,2.31,'-,'-,"DIO3, LINC02320",Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,14:101629499
rs17548007-<b>?</b>,5 x 10-6,,NR,1.86,'-,'-,ASCL1,Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,12:102981636
rs202280-<b>?</b>,6 x 10-6,,NR,2,'-,'-,FABP5,Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin,"overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel",GCST004896,8:81290982
rs34289250-<b>C</b>,6 x 10-13,,0.0089,7.95,'-,[NR],BRIP1,Ovarian cancer,ovarian carcinoma,GCST001258,17:61803285
rs376296328-<b>?</b>,8 x 10-6,(serous_hg),NR,1.48,'-,'-,SPINK9,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:148321490
rs3867263-<b>?</b>,4 x 10-6,(serous_hg),NR,1.25,'-,'-,SERPINB11,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,18:63664376
rs40409-<b>?</b>,2 x 10-6,(clearcell),NR,1.57,'-,'-,PTPRG,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:61992237
rs4362851-<b>?</b>,2 x 10-6,(ser_lg_lmp),NR,1.81,'-,'-,RN7SL776P,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:167363437
rs4709698-<b>?</b>,3 x 10-6,(serous_hg),NR,1.24,'-,'-,PACRG,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:163301732
rs4918665-<b>?</b>,7 x 10-6,(serous),NR,1.24,'-,'-,RPS6P15,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,10:111552672
rs4936453-<b>?</b>,8 x 10-6,(clearcell),NR,1.54,'-,'-,POU2AF1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,11:111430057
rs56236040-<b>?</b>,4 x 10-6,(ser_lg_lmp),NR,6.6,'-,'-,CICP17,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:51423896
rs57960590-<b>?</b>,4 x 10-6,(serous),NR,1.61,'-,'-,CCDC170,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:151590844
rs58142303-<b>?</b>,7 x 10-6,(serous),NR,1.63,'-,'-,ADGRV1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:90981864
rs5932545-<b>?</b>,3 x 10-6,(endometrioid),NR,1.45,'-,'-,RPL32P35,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,X:128926215
rs59923016-<b>?</b>,1 x 10-6,(overall),NR,1.21,'-,'-,ZNF423,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,16:49765545
rs5993791-<b>?</b>,8 x 10-6,(clearcell),NR,3.94,'-,'-,SEPTIN5,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,22:19681497
rs60930737-<b>?</b>,2 x 10-6,(ser_lg_lmp),NR,2.09,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs6134303-<b>?</b>,8 x 10-7,(mucinous_all),NR,1.59,'-,'-,PGAM3P,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,20:11586401
rs61658193-<b>?</b>,9 x 10-6,(serous),NR,1.3,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,9:74295222
rs61974021-<b>?</b>,4 x 10-6,(ser_lg_lmp),NR,4.17,'-,'-,LINC02588,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,14:26740487
rs62397673-<b>?</b>,3 x 10-6,(endometrioid),NR,1.97,'-,'-,"FAM153A, OR1X5P",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:177806110
rs6461701-<b>?</b>,5 x 10-6,(clearcell),NR,1.6,'-,'-,CARD11,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:2916633
rs67729017-<b>?</b>,8 x 10-6,(mucinous_all),NR,2.53,'-,'-,SNTG1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,8:50701586
rs70959845-<b>?</b>,4 x 10-6,(overall),NR,1.22,'-,'-,"RN7SL361P, BCL11A",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:60572849
rs7172033-<b>?</b>,7 x 10-6,(lmp),NR,1.97,'-,'-,NMNAT1P5,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,15:59949310
rs71877790-<b>?</b>,5 x 10-6,(endometrioid),NR,1.56,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs7206411-<b>?</b>,2 x 10-7,(clearcell),NR,1.65,'-,'-,CMIP,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,16:81619883
rs72492309-<b>?</b>,2 x 10-6,(serous),NR,1.27,'-,'-,"HLA-DRB5, RNU1-61P",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:32541977
rs151224156-<b>?</b>,3 x 10-6,(overall),NR,1.43,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:57784687
rs169225-<b>?</b>,7 x 10-7,(serous_hg),NR,1.24,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,20:22393040
rs17057973-<b>?</b>,8 x 10-6,(ser_lg_lmp),NR,2.77,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:97730186
rs1728807-<b>?</b>,9 x 10-6,(serous),NR,1.23,'-,'-,"SLC6A1, SLC6A1-AS1",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:11007643
rs17808848-<b>?</b>,3 x 10-6,(ser_lg_lmp),NR,2.11,'-,'-,ARL2BPP6,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:175210799
rs1791890-<b>?</b>,3 x 10-7,(mucinous_all),NR,1.61,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,11:116120763
rs1800351-<b>?</b>,7 x 10-6,(lmp),NR,1.62,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs185335029-<b>?</b>,8 x 10-6,(overall),NR,1.18,'-,'-,LRRC3B,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:26787883
rs185652178-<b>?</b>,8 x 10-7,(serous_hg),NR,1.55,'-,'-,JAKMIP2-AS1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:147579243
rs199256-<b>?</b>,8 x 10-6,(mucinous_all),NR,1.52,'-,'-,LINC01277,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:143007986
rs200114742-<b>?</b>,8 x 10-6,(serous_hg),NR,1.25,'-,'-,LINC01085,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:14172253
rs200529678-<b>?</b>,5 x 10-6,(lmp),NR,2.59,'-,'-,"LINC01949, MIR4280HG",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:87170215
rs2119438-<b>?</b>,6 x 10-6,(ser_lg_lmp),NR,1.77,'-,'-,LINC02232,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:64932417
rs2371271-<b>?</b>,6 x 10-6,(endometrioid),NR,1.46,'-,'-,ERBB4,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:211451963
rs243172-<b>?</b>,4 x 10-6,(serous),NR,1.22,'-,'-,FOXN3,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,14:89546219
rs2829235-<b>?</b>,7 x 10-6,(overall),NR,1.18,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,21:24659554
rs28568660-<b>?</b>,2 x 10-6,(serous_hg),NR,1.28,'-,'-,OSBPL10,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:31878815
rs28734075-<b>?</b>,7 x 10-6,(clearcell),NR,3.22,'-,'-,"ADRA2C, OR7E163P",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:3824215
rs34097398-<b>?</b>,4 x 10-7,(ser_lg_lmp),NR,2.1,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,X:33452415
rs34344307-<b>?</b>,1 x 10-6,(endometrioid),NR,1.51,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,16:77008512
rs34350340-<b>?</b>,4 x 10-6,(clearcell),NR,1.87,'-,'-,UPF3B,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,X:119837616
rs34357515-<b>?</b>,1 x 10-6,(clearcell),NR,1.69,'-,'-,NCLN,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,19:3197622
rs34470775-<b>?</b>,8 x 10-6,(clearcell),NR,2.19,'-,'-,RN7SKP60,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:165518039
rs35941888-<b>?</b>,5 x 10-6,(lmp),NR,1.66,'-,'-,TTC28,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,22:28343530
rs3754464-<b>?</b>,2 x 10-6,(serous),NR,1.29,'-,'-,IFI16,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,1:159009146
rs987254-<b>?</b>,8 x 10-6,(lmp),NR,1.83,'-,'-,MECOM,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:169266197
rs72745575-<b>?</b>,2 x 10-6,(lmp),NR,2.07,'-,'-,"TLE1, GLIS3",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,9:81548365
rs73468194-<b>?</b>,8 x 10-6,(mucinous_all),NR,1.48,'-,'-,"FAM3C2P, PDCL2P1",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,X:23151499
rs74477043-<b>?</b>,7 x 10-6,(overall),NR,1.51,'-,'-,LINC02655,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,10:80653667
rs7455465-<b>?</b>,8 x 10-6,(lmp),NR,3.32,'-,'-,NPSR1-AS1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:34585100
rs74828133-<b>?</b>,6 x 10-6,(endometrioid),NR,1.53,'-,'-,PGM5P4-AS1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:113530775
rs74917072-<b>?</b>,5 x 10-7,(overall),NR,1.25,'-,'-,"UBE2F-SCLY, UBE2F",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:238022053
rs75157307-<b>?</b>,3 x 10-6,(serous_hg),NR,1.27,'-,'-,KCNS3,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:18193172
rs7559097-<b>?</b>,6 x 10-6,(mucinous_all),NR,1.61,'-,'-,"LINC02613, HNRNPLL",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:38517625
rs7644028-<b>?</b>,3 x 10-6,(clearcell),NR,1.57,'-,'-,MTND5P15,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:176972255
rs76731728-<b>?</b>,4 x 10-6,(endometrioid),NR,1.95,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,10:41850928
rs77122835-<b>?</b>,9 x 10-6,(overall),NR,1.29,'-,'-,LSAMP,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:116459821
rs78649302-<b>?</b>,3 x 10-6,(lmp),NR,1.86,'-,'-,DCUN1D2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,13:113481059
rs78720768-<b>?</b>,4 x 10-6,(lmp),NR,2.2,'-,'-,LINC00466,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,1:63315469
rs78950910-<b>?</b>,9 x 10-6,(lmp),NR,4.82,'-,'-,MTUS2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,13:29266071
rs79812184-<b>?</b>,7 x 10-6,(overall),NR,1.48,'-,'-,BRD8,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:138171416
rs79925169-<b>?</b>,5 x 10-6,(overall),NR,1.23,'-,'-,SEMA4D,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,9:89469330
rs80119973-<b>?</b>,2 x 10-6,(endometrioid),NR,3.03,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,8:13963095
rs8060270-<b>?</b>,3 x 10-6,(mucinous_all),NR,1.67,'-,'-,"LINC01568, ZFHX3",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,16:73418955
rs8069681-<b>?</b>,1 x 10-6,(lmp),NR,1.7,'-,'-,"SLC52A1, ZFP3-DT",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,17:5064847
rs845930-<b>?</b>,8 x 10-6,(overall),NR,1.18,'-,'-,TIAM1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,21:31347809
rs870274-<b>?</b>,7 x 10-6,(ser_lg_lmp),NR,1.7,'-,'-,TACC2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,10:122120548
rs9316411-<b>?</b>,2 x 10-6,(overall),NR,1.37,'-,'-,"PSME2P2, CYSLTR2",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,13:48747718
rs9382808-<b>?</b>,2 x 10-6,(clearcell),NR,1.82,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:60484461
rs9442387-<b>?</b>,8 x 10-6,(ser_lg_lmp),NR,2.78,'-,'-,"TTLL10-AS1, TTLL10",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,1:1175206
rs9791676-<b>?</b>,8 x 10-6,(clearcell),NR,1.96,'-,'-,GLI3,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:42053156
rs113446565-<b>?</b>,4 x 10-6,(endometrioid),NR,1.43,'-,'-,RPS27AP20,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,X:3776745
rs7748275-<b>A</b>,9 x 10-9,(serous),0.16,1.4,'-,[1.2-1.5],'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:3580855
rs113732232-<b>?</b>,7 x 10-6,(serous_hg),NR,1.63,'-,'-,VEGFC,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:176652990
chr1:22569919-<b>?</b>,3 x 10-6,(lmp),NR,3.83,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs11451120-<b>?</b>,8 x 10-6,(overall),NR,1.24,'-,'-,PURG,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,8:31005773
chr12:128445504-<b>?</b>,3 x 10-7,(serous_hg),NR,1.49,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs11659469-<b>?</b>,5 x 10-6,(mucinous_all),NR,1.5,'-,'-,SMUG1P1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,18:49657424
chr12:98579587-<b>?</b>,9 x 10-6,(ser_lg_lmp),NR,6.95,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs11724690-<b>?</b>,2 x 10-6,(clearcell),NR,2.9,'-,'-,SORBS2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:185843593
chr14:106452461-<b>?</b>,2 x 10-6,(lmp),NR,4.73,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs11980115-<b>?</b>,2 x 10-6,(ser_lg_lmp),NR,4.45,'-,'-,"ST13P7, RNU6-92P",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:133141119
rs12546957-<b>?</b>,3 x 10-6,(serous_hg),NR,1.24,'-,'-,CASC11,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,8:127619425
chr2:29228648-<b>?</b>,8 x 10-6,(clearcell),NR,6.32,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs12603880-<b>?</b>,7 x 10-6,(clearcell),NR,1.59,'-,'-,MSI2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,17:57668632
chr12:118425547-<b>?</b>,6 x 10-6,(ser_lg_lmp),NR,2.1,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
chr6:168526822-<b>?</b>,7 x 10-6,(clearcell),NR,1.55,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
chrX:107586364-<b>?</b>,3 x 10-6,(overall),NR,1.29,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs135573-<b>?</b>,3 x 10-6,(mucinous_all),NR,2.45,'-,'-,"PPARA, MIRLET7BHG",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,22:46131359
kgp7556451-<b>?</b>,9 x 10-8,(serous_hg),NR,1.27,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs1413017-<b>?</b>,4 x 10-6,(ser_lg_lmp),NR,1.75,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,20:12691366
rs142825068-<b>?</b>,8 x 10-6,(overall),NR,1.24,'-,'-,PTPRN2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:157716799
rs144055451-<b>?</b>,2 x 10-6,(serous_hg),NR,1.91,'-,'-,KRT18P55,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,17:28302026
rs144199732-<b>?</b>,7 x 10-7,(lmp),NR,2.86,'-,'-,SMIM15P1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,X:43022624
rs145022376-<b>?</b>,1 x 10-6,(clearcell),NR,4.1,'-,'-,"LINC00200, ADARB2",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,10:1186289
rs146343288-<b>?</b>,3 x 10-6,(serous_hg),NR,1.48,'-,'-,NUP153,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:17689625
rs11150225-<b>?</b>,7 x 10-6,(overall),NR,1.21,'-,'-,LINC01228,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,16:79856062
rs111970895-<b>?</b>,3 x 10-7,(clearcell),NR,2.34,'-,'-,"SLCO4C1, RN7SKP68",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,5:102301954
rs1934363-<b>C</b>,3 x 10-10,(CCOC),0.94,11,'-,[5.3-24],LINC02652,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,10:28484549
rs113494645-<b>?</b>,9 x 10-6,(mucinous_all),NR,1.79,'-,'-,GALNT17,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:71128079
rs7748275-<b>A</b>,4 x 10-8,(HGSOC),0.16,1.4,'-,[1.2-1.5],'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,6:3580855
rs11426758-<b>?</b>,7 x 10-6,(mucinous_all),NR,1.56,'-,'-,UBE2G1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,17:4274200
chr12:121386263-<b>?</b>,2 x 10-7,(lmp),NR,2.6,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs1164587-<b>?</b>,3 x 10-6,(mucinous_all),NR,1.53,'-,'-,HS6ST3,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,13:96391464
chr12:45837095-<b>?</b>,2 x 10-6,(serous_hg),NR,1.4,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs11684751-<b>?</b>,4 x 10-6,(ser_lg_lmp),NR,1.74,'-,'-,"RND3, LINC01818",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:150393944
chr13:45661665-<b>?</b>,9 x 10-6,(endometrioid),NR,1.54,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs11973028-<b>?</b>,1 x 10-6,(mucinous_all),NR,1.51,'-,'-,JAZF1,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:27853217
chr16:76182702-<b>?</b>,1 x 10-6,(mucinous_all),NR,1.84,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs12568748-<b>?</b>,9 x 10-6,(mucinous_all),NR,1.9,'-,'-,DUSP10,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,1:221657667
chr1:150718602-<b>?</b>,7 x 10-7,(ser_lg_lmp),NR,2.43,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs12623068-<b>?</b>,4 x 10-6,(overall),NR,1.24,'-,'-,RN7SKP112,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:7182908
rs13420007-<b>?</b>,6 x 10-6,(endometrioid),NR,1.56,'-,'-,RNU6-566P,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,2:44110941
kgp7416783-<b>?</b>,9 x 10-6,(clearcell),NR,1.6,'-,'-,'-,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,Mapping not available
rs140884924-<b>?</b>,8 x 10-6,(lmp),NR,1.76,'-,'-,LINC00410,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,13:90884180
rs10009522-<b>?</b>,9 x 10-6,(overall),NR,1.27,'-,'-,TRIM2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,4:153242242
rs10260419-<b>?</b>,1 x 10-7,(overall),NR,1.33,'-,'-,THSD7A,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,7:11524758
rs10400919-<b>?</b>,6 x 10-6,(clearcell),NR,1.55,'-,'-,"GABRG3-AS1, GABRG3",Epithelial ovarian cancer,ovarian carcinoma,GCST007728,15:27084081
rs10627733-<b>?</b>,2 x 10-6,(endometrioid),NR,1.89,'-,'-,EIF4G3,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,1:21141378
rs111478044-<b>?</b>,9 x 10-7,(ser_lg_lmp),NR,2,'-,'-,NCAM2,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,21:21308069
rs146917711-<b>?</b>,4 x 10-6,(mucinous_all),NR,2.33,'-,'-,CCDC80,Epithelial ovarian cancer,ovarian carcinoma,GCST007728,3:112609782
rs2665390-<b>C</b>,3 x 10-7,,NR,1.19,'-,[1.11-1.27],TIPARP,Ovarian cancer,ovarian carcinoma,GCST000802,3:156679960
rs7521902-<b>?</b>,5 x 10-6,,NR,1.12,'-,[1.07-1.18],WNT4,Ovarian cancer,ovarian carcinoma,GCST000802,1:22164231
rs12794435-<b>?</b>,5 x 10-6,,NR,1.16,'-,[1.09-1.23],'-,Ovarian cancer,ovarian carcinoma,GCST000802,11:25186158
rs2072590-<b>T</b>,5 x 10-14,,NR,1.16,'-,[1.12-1.21],"HAGLROS, HAGLR",Ovarian cancer,ovarian carcinoma,GCST000802,2:176177905
rs10088218-<b>G</b>,3 x 10-9,,NR,1.19,'-,[1.12-1.25],LINC00824,Ovarian cancer,ovarian carcinoma,GCST000802,8:128531703
rs9303542-<b>G</b>,1 x 10-6,,NR,1.11,'-,[1.06-1.16],SKAP1,Ovarian cancer,ovarian carcinoma,GCST000802,17:48334138
rs2084881-<b>?</b>,2 x 10-6,,NR,1.12,'-,[1.07-1.18],SKAP1,Ovarian cancer,ovarian carcinoma,GCST000802,17:48279758
rs8170-<b>T</b>,4 x 10-6,(Susceptibility),NR,1.12,'-,[1.07-1.17],"BABAM1, USHBP1",Ovarian cancer,ovarian carcinoma,GCST000800,19:17278895
rs2363956-<b>T</b>,1 x 10-7,(Susceptibility),NR,1.1,'-,[1.06-1.15],ANKLE1,Ovarian cancer,ovarian carcinoma,GCST000800,19:17283315
rs3814113-<b>T</b>,5 x 10-19,,0.68,1.22,'-,[1.16-1.27],BNC2,Ovarian cancer,ovarian carcinoma,GCST000455,9:16915023
rs186507655-<b>A</b>,5 x 10-10,(subset analysis),NR,'-,'-,'-,"DVL1, MXRA8",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,1:1351675
rs2075570-<b>T</b>,5 x 10-6,(subset analysis),NR,'-,'-,'-,MTX1,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,1:155212373
rs481519-<b>T</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,NEK10,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,3:27285723
rs7679673-<b>A</b>,1 x 10-10,(subset analysis),NR,'-,'-,'-,TET2,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,4:105140377
rs7725218-<b>A</b>,2 x 10-10,(subset analysis),NR,'-,'-,'-,TERT,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,5:1282299
rs1862626-<b>T</b>,4 x 10-12,(subset analysis),NR,'-,'-,'-,MAP3K1,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,5:56737113
rs147680653-<b>G</b>,1 x 10-6,(subset analysis),NR,'-,'-,'-,"HLA-V, IFITM4P",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:29785031
rs115707823-<b>A</b>,5 x 10-7,(subset analysis),NR,'-,'-,'-,"MICC, UBQLN1P1",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:30374976
rs115392158-<b>G</b>,3 x 10-7,(subset analysis),NR,'-,'-,'-,"LINC02571, HLA-B",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:31347004
rs147527678-<b>C</b>,6 x 10-8,(subset analysis),NR,'-,'-,'-,"HLA-DQB1, MTCO3P1",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:32699696
rs1011970-<b>T</b>,5 x 10-6,(subset analysis),NR,'-,'-,'-,CDKN2B-AS1,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,9:22062135
rs11200014-<b>A</b>,8 x 10-35,(subset analysis),NR,'-,'-,'-,FGFR2,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,10:121575416
rs7931342-<b>G</b>,4 x 10-14,(subset analysis),NR,'-,'-,'-,"MYEOV, SMIM38",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,11:69227030
rs148883465-<b>G</b>,3 x 10-8,(subset analysis),NR,'-,'-,'-,MIR4693,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,11:103813371
rs11168936-<b>C</b>,9 x 10-7,(subset analysis),NR,'-,'-,'-,TUBA1C,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,12:49251457
rs73110464-<b>T</b>,2 x 10-15,(subset analysis),NR,'-,'-,'-,KRT8,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,12:52918828
rs3184504-<b>C</b>,1 x 10-6,(subset analysis),NR,'-,'-,'-,"SH2B3, ATXN2",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma",GCST003588,12:111446804
rs11571818-<b>C</b>,5 x 10-10,(subset analysis),NR,'-,'-,'-,BRCA2,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,13:32394673
rs11844632-<b>A</b>,3 x 10-10,(subset analysis),NR,'-,'-,'-,RAD51B,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,14:68559662
rs12601991-<b>T</b>,7 x 10-28,(subset analysis),NR,'-,'-,'-,HNF1B,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,17:37741642
rs4808075-<b>C</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,"BABAM1, USHBP1",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,19:17279482
rs11907546-<b>T</b>,3 x 10-6,(subset analysis),NR,'-,'-,'-,"RPS2P1, ASIP",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,20:34131991
rs141752671-<b>G</b>,1 x 10-7,(subset analysis),NR,'-,'-,'-,'-,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,11:103745837
rs11065979-<b>T</b>,5 x 10-6,(subset analysis),NR,'-,'-,'-,"BRAP, ATXN2-AS",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,12:111621753
rs2300206-<b>C</b>,6 x 10-6,(subset analysis),NR,'-,'-,'-,RALY,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,20:34002002
rs56084662-<b>A</b>,4 x 10-9,(subset analysis),NR,'-,'-,'-,FRY,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,13:32295727
rs1057941-<b>A</b>,2 x 10-7,,NR,1.1,'-,[NR],GBAP1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,1:155216951
rs2974935-<b>T</b>,2 x 10-7,,NR,1.1,'-,[NR],MTX1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,1:155212052
rs11119608-<b>T</b>,1 x 10-7,,NR,1.1111112,'-,[NR],KCNH1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,1:210816167
rs75316749-<b>G</b>,2 x 10-7,,NR,1.1,'-,[NR],"MECOM, LINC01997",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,3:169043635
rs115707823-<b>A</b>,2 x 10-6,,NR,1.1,'-,[NR],"MICC, UBQLN1P1",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:30374976
rs115392158-<b>G</b>,9 x 10-6,,NR,1.1,'-,[NR],"LINC02571, HLA-B",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:31347004
rs147527678-<b>C</b>,5 x 10-7,,NR,1.1,'-,[NR],"HLA-DQB1, MTCO3P1",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:32699696
rs4604234-<b>C</b>,6 x 10-6,,NR,1.1,'-,[NR],"RPSAP72, RPL17P25",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:80398959
rs12349081-<b>A</b>,6 x 10-6,,NR,1.1,'-,[NR],"CDKN2A-DT, MTAP",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,9:21951903
rs1011970-<b>T</b>,2 x 10-7,,NR,1.1,'-,[NR],CDKN2B-AS1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,9:22062135
rs3184504-<b>C</b>,2 x 10-6,,NR,1.1,'-,[NR],"SH2B3, ATXN2",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,12:111446804
rs11571833-<b>T</b>,8 x 10-12,,NR,1.6,'-,[NR],BRCA2,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,13:32398489
rs12601991-<b>T</b>,1 x 10-9,,NR,1.1,'-,[NR],HNF1B,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,17:37741642
rs4808075-<b>C</b>,4 x 10-7,,NR,1.1,'-,[NR],"BABAM1, USHBP1",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,19:17279482
rs11907546-<b>C</b>,3 x 10-9,,NR,1.1111112,'-,[NR],"RPS2P1, ASIP",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,20:34131991
rs56404467-<b>A</b>,1 x 10-7,,NR,1.2,'-,[NR],FRY,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,13:32265853
rs2300206-<b>G</b>,2 x 10-8,,NR,1.1111112,'-,[NR],RALY,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,20:34002002
rs3814113-<b>?</b>,4 x 10-29,(All invasive),0.68,1.21,'-,[1.17-1.25],BNC2,Ovarian cancer,ovarian carcinoma,GCST001941,9:16915023
rs3814113-<b>?</b>,4 x 10-32,(Serious invasive),0.68,1.28,'-,[1.23-1.33],BNC2,Ovarian cancer,ovarian carcinoma,GCST001941,9:16915023
rs10088218-<b>?</b>,3 x 10-12,(All invasive),0.87,1.18,'-,[1.13-1.24],LINC00824,Ovarian cancer,ovarian carcinoma,GCST001941,8:128531703
rs10088218-<b>?</b>,1 x 10-17,(Serious invasive),0.87,1.29,'-,[1.21-1.36],LINC00824,Ovarian cancer,ovarian carcinoma,GCST001941,8:128531703
rs2072590-<b>?</b>,5 x 10-11,(All invasive),0.32,1.11,'-,[1.08-1.15],"HAGLROS, HAGLR",Ovarian cancer,ovarian carcinoma,GCST001941,2:176177905
rs2072590-<b>?</b>,3 x 10-10,(Serious invasive),0.32,1.13,'-,[1.09-1.18],"HAGLROS, HAGLR",Ovarian cancer,ovarian carcinoma,GCST001941,2:176177905
rs7651446-<b>?</b>,2 x 10-29,(All invasive),0.05,1.44,'-,[1.35-1.54],TIPARP,Ovarian cancer,ovarian carcinoma,GCST001941,3:156689208
rs7651446-<b>?</b>,2 x 10-34,(Serious invasive),0.05,1.59,'-,[1.48-1.71],TIPARP,Ovarian cancer,ovarian carcinoma,GCST001941,3:156689208
rs8170-<b>?</b>,2 x 10-7,(All invasive),0.19,1.11,'-,[1.07-1.15],"BABAM1, USHBP1",Ovarian cancer,ovarian carcinoma,GCST001941,19:17278895
rs8170-<b>?</b>,3 x 10-14,(Serious invasive),0.19,1.19,'-,[1.14-1.25],"BABAM1, USHBP1",Ovarian cancer,ovarian carcinoma,GCST001941,19:17278895
rs9303542-<b>?</b>,6 x 10-9,(All invasive),0.27,1.12,'-,[1.08-1.16],SKAP1,Ovarian cancer,ovarian carcinoma,GCST001941,17:48334138
rs9303542-<b>?</b>,3 x 10-10,(Serious invasive),0.27,1.14,'-,[1.09-1.18],SKAP1,Ovarian cancer,ovarian carcinoma,GCST001941,17:48334138
rs11782652-<b>A</b>,6 x 10-9,(All invasive),0.07,1.19,'-,[1.12-1.26],CHMP4C,Ovarian cancer,ovarian carcinoma,GCST001941,8:81741409
rs1243180-<b>T</b>,2 x 10-8,(All invasive),0.31,1.1,'-,[1.06-1.13],MLLT10,Ovarian cancer,ovarian carcinoma,GCST001941,10:21626690
rs1243180-<b>T</b>,1 x 10-7,(Serious invasive),0.31,1.11,'-,[1.07-1.15],MLLT10,Ovarian cancer,ovarian carcinoma,GCST001941,10:21626690
rs757210-<b>G</b>,8 x 10-10,(Serious invasive),0.37,1.12,'-,[1.08-1.17],HNF1B,Ovarian cancer,ovarian carcinoma,GCST001941,17:37736525
rs11782652-<b>A</b>,7 x 10-10,(Serious invasive),0.07,1.24,'-,[1.16-1.33],CHMP4C,Ovarian cancer,ovarian carcinoma,GCST001941,8:81741409
rs1763604-<b>C</b>,7 x 10-9,,0.42085,'-,0.0372 unit decrease,[0.025-0.05],"HSPB7, SRARP","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,1:16013277
rs77548871-<b>C</b>,5 x 10-9,,0.0472,'-,0.0991 unit decrease,[0.066-0.132],ZBTB7B,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,1:155016057
rs13007211-<b>A</b>,1 x 10-9,,0.6935,'-,0.0432 unit increase,[0.029-0.057],VAMP8,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,2:85573959
rs17041869-<b>A</b>,2 x 10-9,,0.8804,'-,0.0571 unit decrease,[0.038-0.076],"MIR4435-2HG, BCL2L11","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,2:111138666
rs57251748-<b>CT</b>,9 x 10-12,,0.15,'-,0.0598 unit decrease,[0.043-0.077],TET2,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,4:105137029
rs739704-<b>A</b>,3 x 10-14,,0.2515,'-,0.0542 unit decrease,[0.04-0.068],JAZF1,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,7:27950149
rs720475-<b>A</b>,7 x 10-12,,0.25455,'-,0.0495 unit decrease,[0.035-0.064],ARHGEF5,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,7:144377836
rs17762342-<b>A</b>,2 x 10-15,,0.7935,'-,0.061 unit increase,[0.046-0.076],PCAT1,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,8:126990792
rs3802173-<b>T</b>,3 x 10-11,,0.2261,'-,0.0521 unit increase,[0.037-0.068],"RN7SKP226, PVT1","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,8:128187668
rs9657608-<b>T</b>,1 x 10-10,,0.0923,'-,0.0685 unit increase,[0.048-0.089],"CDKN2A-DT, MTAP","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,9:21956231
rs7898685-<b>A</b>,3 x 10-10,,0.2913,'-,0.0428 unit increase,[0.029-0.056],DNAJC1,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,10:22010574
rs568110-<b>T</b>,5 x 10-12,,0.2057,'-,0.0523 unit increase,[0.037-0.067],"PPIAP39, RNU7-165P","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,10:113390512
rs7937840-<b>T</b>,2 x 10-9,,0.26465,'-,0.0446 unit increase,[0.03-0.059],INCENP,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,11:62126500
rs118151305-<b>A</b>,6 x 10-9,,0.12005,'-,0.0672 unit decrease,[0.045-0.09],"CD248, RIN1","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,11:66324772
rs72932523-<b>A</b>,1 x 10-9,,0.10565,'-,0.0601 unit increase,[0.041-0.08],"TPCN2, SMIM38","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,11:69138652
rs2277509-<b>A</b>,9 x 10-12,,0.69865,'-,0.0466 unit increase,[0.033-0.06],CCDC88C,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,14:91283251
rs2628317-<b>A</b>,4 x 10-16,,0.72985,'-,0.0582 unit increase,[0.044-0.072],STXBP4,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,17:55135212
rs1469713-<b>A</b>,1 x 10-10,,0.64405,'-,0.043 unit decrease,[0.03-0.056],GATAD2A,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,19:19417997
rs17631303-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,PLEKHM1,Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,17:45439036
rs183211-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,NSF,Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,17:46710944
rs3814113-<b>A</b>,6 x 10-11,,0.66,1.3,'-,[1.2-1.41],BNC2,Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,9:16915023
rs2665390-<b>C</b>,7 x 10-6,,0.043,1.46,'-,[1.25-1.71],TIPARP,Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,3:156679960
rs17631303-<b>G</b>,1 x 10-8,,0.19,1.27,'-,[1.17-1.38],PLEKHM1,Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,17:45439036
rs183211-<b>A</b>,3 x 10-8,,0.23,1.25,'-,[1.16-1.35],NSF,Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,17:46710944
rs4691139-<b>G</b>,3 x 10-8,,0.48,1.2,'-,[1.17-1.38],"TRIM60, TRIM61",Ovarian cancer in BRCA1 mutation carriers,ovarian carcinoma,GCST001917,4:164987569
rs8091660-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,CTIF,Response to carboplatin in ovarian cancer (MTT IC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement",GCST003440,18:48561565
rs150303591-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,FRAS1,Response to carboplatin in ovarian cancer (MTT IC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement",GCST003440,4:78088155
rs12025262-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,ZNF731P,Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel",GCST003443,1:247193430
rs10674174-<b>?</b>,8 x 10-7,,NR,'-,'-,'-,PCDH20,Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel",GCST003443,13:61317943
rs7572644-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,BABAM2,Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel",GCST003443,2:28097166
rs201083182-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,EYS,Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement",GCST003439,6:65027022
rs3842595-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,"MGC32805, SNCAIP",Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement",GCST003439,5:122442912
rs185229225-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,BOD1L1,Response to paclitaxel in ovarian cancer (MTT IC50),"ovarian carcinoma, cytotoxicity measurement, response to paclitaxel",GCST003441,4:13607505
rs201023017-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,SLC9A9,Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel",GCST003444,3:143384827
rs66696671-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,"RAD1P1, TIAL1",Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50),"response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel",GCST003444,10:119607441
rs7405776-<b>A</b>,2 x 10-7,,0.58811,1.25,'-,[1.15-1.35],HNF1B,Ovarian clear cell cancer,ovarian clear cell adenocarcinoma,GCST004417,17:37733029
rs11651755-<b>T</b>,7 x 10-9,,0.513535,1.27,'-,[1.16-1.37],HNF1B,Ovarian clear cell cancer,ovarian clear cell adenocarcinoma,GCST004417,17:37739849
rs711830-<b>A</b>,1 x 10-14,,0.319016,1.2736082,'-,[1.19835894617868-1.35358269315725],"HAGLR, HOXD3",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,2:176172583
rs112071820-<b>GCCAG</b>,2 x 10-13,,0.283067,1.2854952,'-,[1.20336051010928-1.37323590882365],MRPS22,Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,3:139130269
rs320203-<b>A</b>,2 x 10-8,,0.850197,1.2856314,'-,[1.17544642545976-1.4061450991104],RNU6-329P,Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,9:102180944
rs11651755-<b>T</b>,2 x 10-6,,0.513535,1.1539987,'-,'-,HNF1B,Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,17:37739849
rs688187-<b>A</b>,1 x 10-22,,0.312892,1.4258754,'-,[1.32592116400102-1.5333648423891],"IFNL3P1, IFNL3",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,19:39242112
rs752590-<b>G</b>,2 x 10-12,,0.210808,1.2968692,'-,[1.20743024891207-1.39293308913389],PAX8-AS1,Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,2:113215368
rs6755777-<b>T</b>,1 x 10-13,,0.319447,1.2623247,'-,[1.18761263149067-1.34173680787849],"HAGLR, HAGLROS",Mucinous ovarian carcinoma,ovarian mucinous adenocarcinoma,GCST004419,2:176178498
rs62274041-<b>G</b>,3 x 10-46,,0.0481682,1.5885553,'-,[1.49139660538722-1.69204355063709],"LINC00886, METTL15P1",Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,3:156717851
rs10069690-<b>T</b>,2 x 10-12,,0.259806,1.1303236,'-,[1.09267833241685-1.16926591871766],TERT,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,5:1279675
rs7705526-<b>A</b>,6 x 10-10,,0.332078,1.1067635,'-,[1.07188995128973-1.14277166876843],TERT,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,5:1285859
chr8:82668818-<b>G</b>,2 x 10-9,,0.0663033,1.1915798,'-,[1.12527496598389-1.26179155485818],'-,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,Mapping not available
rs1400482-<b>G</b>,2 x 10-24,,0.867974,1.2746594,'-,[1.21607733088533-1.33606352682139],LINC00824,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,8:128529685
rs10962692-<b>G</b>,3 x 10-43,,0.799624,1.3252935,'-,[1.27262437839255-1.38014255146877],BNC2,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,9:16915876
chr9:136138765-<b>G</b>,7 x 10-11,,0.194216,1.1340009,'-,[1.0921011879635-1.17750814490349],'-,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,Mapping not available
rs144962376-<b>T</b>,7 x 10-9,,0.309302,1.0992962,'-,[1.06472642475689-1.13498849236897],MLLT10,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,10:21589903
rs8037137-<b>C</b>,1 x 10-7,,0.133619,1.1235955,'-,[1.08-1.18],"RCCD1, PRC1",Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,15:90963407
rs7405776-<b>G</b>,2 x 10-10,,0.41189,1.1048253,'-,[1.07145224223974-1.13923779281726],HNF1B,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,17:37733029
rs11651755-<b>C</b>,1 x 10-8,,0.486465,1.0903314,'-,[1.05822261240111-1.12341446823123],HNF1B,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,17:37739849
rs1879586-<b>G</b>,3 x 10-12,,0.181254,1.1472089,'-,[1.10406141518038-1.19204274035159],PLEKHM1,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,17:45489971
rs7207826-<b>C</b>,1 x 10-14,,0.267801,1.13894,'-,[1.10200256244972-1.17711551141243],SKAP1,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,17:48423311
rs4808075-<b>C</b>,4 x 10-24,,0.295975,1.1823713,'-,[1.14473972413471-1.22123996090847],"BABAM1, USHBP1",Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,19:17279482
rs6005807-<b>C</b>,5 x 10-9,,0.898635,1.1651025,'-,[1.10668774857942-1.22660041924],TTC28,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,22:28538325
rs2165109-<b>C</b>,4 x 10-7,,0.251869,1.0926361,'-,[1.05582163841262-1.13073417257807],"ACOXL, MIR4435-2HG",Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,2:111061081
rs9886651-<b>G</b>,8 x 10-6,,0.461222,1.0710524,'-,[1.03930535696901-1.10376916464823],PVT1,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,8:127805637
rs7953249-<b>G</b>,3 x 10-7,,0.417632,1.0817573,'-,[1.04973458497305-1.11475700006623],HNF1A-AS1,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,12:120965921
rs13113999-<b>T</b>,5 x 10-8,,0.515696,1.2250321,'-,[1.13870977824743-1.31789814351814],Y_RNA,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,4:166265894
rs10069690-<b>T</b>,4 x 10-9,,0.259806,1.2546542,'-,[1.16419555293272-1.35214154339342],TERT,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,5:1279675
rs7705526-<b>A</b>,6 x 10-19,,0.332078,1.3829999,'-,[1.28830538018993-1.48465482476452],TERT,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,5:1285859
rs1400482-<b>G</b>,2 x 10-12,,0.867974,1.4812524,'-,[1.32210226140915-1.65956066549562],LINC00824,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,8:128529685
rs7902587-<b>T</b>,9 x 10-7,,0.0975691,1.3209459,'-,[1.18528926703463-1.47212825755187],"STN1, SLK",Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,10:103934543
rs11651755-<b>C</b>,5 x 10-6,,0.486465,1.1726217,'-,[1.09521694178849-1.25549703248424],HNF1B,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,17:37739849
rs7207826-<b>C</b>,8 x 10-6,,0.267801,1.1832383,'-,[1.09949355363646-1.27336159916358],SKAP1,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,17:48423311
rs8098244-<b>A</b>,9 x 10-6,,0.275361,1.1853783,'-,[1.10016620517041-1.27719049018494],LAMA3,Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,18:23825589
rs711830-<b>A</b>,5 x 10-8,,0.319016,1.1790794,'-,[1.11145306187694-1.25082055006039],"HAGLR, HOXD3",Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,2:176172583
rs6755777-<b>T</b>,3 x 10-6,,0.319447,1.1861752,'-,[1.1045500086088-1.27383238173854],"HAGLR, HAGLROS",Serous borderline ovarian cancer,ovarian serous carcinoma,GCST004479,2:176178498
rs58722170-<b>C</b>,8 x 10-8,,0.220826,1.1063784,'-,[1.06640418255445-1.14785110269475],RSPO1,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,1:37630749
rs711830-<b>A</b>,8 x 10-13,,0.319016,1.1268522,'-,[1.09069613461779-1.16420663147032],"HAGLR, HOXD3",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,2:176172583
rs6755777-<b>T</b>,5 x 10-13,,0.319447,1.1282876,'-,[1.09203474654839-1.16574376009934],"HAGLR, HAGLROS",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,2:176178498
rs62274041-<b>G</b>,4 x 10-49,,0.0481682,1.630706,'-,[1.52886835426178-1.73932685946596],"LINC00886, METTL15P1",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,3:156717851
rs10069690-<b>T</b>,5 x 10-12,,0.259806,1.1310111,'-,[1.09226786405932-1.17112854934655],TERT,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,5:1279675
rs7705526-<b>A</b>,2 x 10-8,,0.332078,1.099452,'-,[1.06380317084564-1.13629550714478],TERT,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,5:1285859
chr8:82668818-<b>G</b>,9 x 10-10,,0.0663033,1.2026194,'-,[1.13408089642882-1.27530001906482],'-,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,Mapping not available
rs1400482-<b>G</b>,7 x 10-22,,0.867974,1.2638669,'-,[1.20425676967645-1.32642773080558],LINC00824,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,8:128529685
rs10962692-<b>G</b>,1 x 10-47,,0.799624,1.358497,'-,[1.30256836396842-1.41682722055063],BNC2,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,9:16915876
rs4742903-<b>T</b>,6 x 10-6,,0.563,1.0740868,'-,[1.04130585570624-1.10789968145028],SMC2,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,9:104094512
chr9:136138765-<b>G</b>,5 x 10-12,,0.194216,1.146201,'-,[1.10275565491329-1.19135797504449],'-,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,Mapping not available
rs144962376-<b>T</b>,2 x 10-8,,0.309302,1.09834,'-,[1.06283348839533-1.13503280772478],MLLT10,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,10:21589903
rs8037137-<b>C</b>,7 x 10-8,,0.133619,1.1363636,'-,[1.09-1.19],"RCCD1, PRC1",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,15:90963407
rs7405776-<b>G</b>,3 x 10-9,,0.41189,1.1008928,'-,[1.06665802122163-1.1362263861189],HNF1B,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,17:37733029
rs11651755-<b>C</b>,2 x 10-8,,0.486465,1.0924964,'-,[1.05939221330271-1.12663514204283],HNF1B,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,17:37739849
rs7207826-<b>C</b>,8 x 10-14,,0.267801,1.1383171,'-,[1.1003320875334-1.17761354130912],SKAP1,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,17:48423311
rs4808075-<b>C</b>,3 x 10-26,,0.295975,1.1971419,'-,[1.15799210345029-1.23761537074498],"BABAM1, USHBP1",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,19:17279482
rs2165109-<b>C</b>,4 x 10-7,,0.251869,1.0954511,'-,[1.05748739051043-1.1347778353567],"ACOXL, MIR4435-2HG",High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,2:111061081
rs7953249-<b>G</b>,8 x 10-7,,0.417632,1.0811644,'-,[1.04824881016487-1.11511353852335],HNF1A-AS1,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,12:120965921
rs1879586-<b>G</b>,3 x 10-13,,0.181254,1.1585579,'-,[1.11378456264581-1.20513099189349],PLEKHM1,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,17:45489971
rs6005807-<b>C</b>,1 x 10-8,,0.898635,1.1650093,'-,[1.10493126343643-1.22835376686122],TTC28,High-grade serous ovarian cancer,ovarian serous carcinoma,GCST004480,22:28538325
rs150293538-<b>T</b>,1 x 10-6,,0.978,3,'-,[1.79409543681435-5.01001565578963],LINC01111,Low-grade serous ovarian cancer,ovarian serous carcinoma,GCST004461,8:76408119
rs9870207-<b>A</b>,5 x 10-8,,0.691354,1.1929355,'-,[1.11921837700174-1.27150779447142],"CCT6P4, GMNC",Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,3:190807727
rs10069690-<b>T</b>,1 x 10-9,,0.259806,1.2150546,'-,[1.14168685260085-1.29313711208919],TERT,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,5:1279675
rs7902587-<b>T</b>,4 x 10-8,,0.0975691,1.2930167,'-,[1.18179536270929-1.41470527615789],"STN1, SLK",Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,10:103934543
rs7405776-<b>G</b>,1 x 10-6,,0.41189,1.1517414,'-,[1.0876255656695-1.21963673962283],HNF1B,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,17:37733029
rs7207826-<b>C</b>,1 x 10-7,,0.267801,1.1787505,'-,[1.10925120766678-1.25260426998392],SKAP1,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,17:48423311
rs8098244-<b>A</b>,4 x 10-8,,0.275361,1.1902364,'-,[1.11903760649588-1.2659653630658],LAMA3,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,18:23825589
rs150293538-<b>T</b>,2 x 10-9,,0.9784417,2.1880746,'-,[1.65336168482279-2.89571888582476],LINC01111,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,8:76408119
rs11651755-<b>C</b>,6 x 10-6,,0.486465,1.1389422,'-,[1.07652961941979-1.20497334696891],HNF1B,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,17:37739849
rs711830-<b>A</b>,3 x 10-6,,0.319016,1.1855859,'-,[1.10400745880938-1.27319220749772],"HAGLR, HOXD3",Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,2:176172583
rs58722170-<b>C</b>,2 x 10-7,,0.220826,1.099984,'-,[1.06129080940929-1.14008804057615],RSPO1,Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,1:37630749
rs711830-<b>A</b>,3 x 10-14,,0.319016,1.1312215,'-,[1.09591680302958-1.16766347713436],"HAGLR, HOXD3",Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,2:176172583
rs6755777-<b>T</b>,2 x 10-14,,0.319447,1.1323612,'-,[1.09696977445389-1.1688944318043],"HAGLR, HAGLROS",Serous invasive ovarian cancer,ovarian serous carcinoma,GCST004478,2:176178498
rs6755777-<b>T</b>,6 x 10-8,,0.319447,1.1783675,'-,[1.11072142428685-1.25013339797474],"HAGLR, HAGLROS",Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,2:176178498
rs7705526-<b>A</b>,2 x 10-20,,0.332078,1.3236618,'-,[1.24799798080348-1.40391301421926],TERT,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,5:1285859
rs1400482-<b>G</b>,1 x 10-16,,0.867974,1.465133,'-,[1.33389097997879-1.60928789514469],LINC00824,Low-grade serous and serous borderline ovarian cancer,ovarian serous carcinoma,GCST004481,8:128529685
rs62274041-<b>G</b>,5 x 10-7,,0.0481682,1.4226197,'-,[1.23974783491848-1.63246639995579],"LINC00886, METTL15P1",Ovarian cancer in BRCA1 mutation carriers,"carrier status, ovarian carcinoma",GCST004414,3:156717851
rs4691139-<b>G</b>,4 x 10-7,,0.467,1.1581223,'-,[1.09413051760919-1.22585676557555],"TRIM60, TRIM61",Ovarian cancer in BRCA1 mutation carriers,"carrier status, ovarian carcinoma",GCST004414,4:164987569
rs10962692-<b>G</b>,1 x 10-14,,0.799624,1.3346913,'-,[1.24035297950519-1.43620468676761],BNC2,Ovarian cancer in BRCA1 mutation carriers,"carrier status, ovarian carcinoma",GCST004414,9:16915876
rs1879586-<b>G</b>,7 x 10-6,,0.181254,1.1804551,'-,[1.0983093028467-1.26874471717965],PLEKHM1,Ovarian cancer in BRCA1 mutation carriers,"carrier status, ovarian carcinoma",GCST004414,17:45489971
rs711830-<b>A</b>,4 x 10-14,,0.319016,1.1120843,'-,[1.08193543636327-1.14307327686388],"HAGLR, HOXD3",Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,2:176172583
rs6755777-<b>T</b>,4 x 10-14,,0.319447,1.1121821,'-,[1.0819829343715-1.14322428681774],"HAGLR, HAGLROS",Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,2:176178498
rs62274041-<b>G</b>,5 x 10-38,,0.0481682,1.4494933,'-,[1.3698151996842-1.53380589540381],"LINC00886, METTL15P1",Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,3:156717851
rs17329882-<b>C</b>,3 x 10-6,,0.241,1.07509,'-,[1.0431816063-1.1079744406],SYNPO2,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,4:119028805
rs10069690-<b>T</b>,3 x 10-8,,0.259806,1.0865872,'-,[1.05501477967445-1.11910451351639],TERT,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,5:1279675
rs7705526-<b>A</b>,7 x 10-10,,0.332078,1.0913801,'-,[1.06151189081851-1.12208885346329],TERT,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,5:1285859
chr8:82668818-<b>G</b>,2 x 10-8,,0.0663033,1.1555611,'-,[1.09892839652449-1.21511227508431],'-,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,Mapping not available
rs1400482-<b>G</b>,7 x 10-16,,0.867974,1.1769707,'-,[1.13116083835271-1.22463593511406],LINC00824,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,8:128529685
rs10962692-<b>G</b>,9 x 10-36,,0.799624,1.2424945,'-,[1.20065901834152-1.28578755258347],BNC2,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,9:16915876
chr9:136138765-<b>G</b>,8 x 10-10,,0.194216,1.1083262,'-,[1.07253217567565-1.14531490798434],'-,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,Mapping not available
rs144962376-<b>T</b>,8 x 10-10,,0.309302,1.0908245,'-,[1.06101278339562-1.12147377629663],MLLT10,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,10:21589903
rs8037137-<b>C</b>,5 x 10-7,,0.134,1.098901,'-,[1.06-1.15],"RCCD1, PRC1",Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,15:90963407
rs143663961-<b>A</b>,1 x 10-7,,0.72942,1.0819896,'-,[1.05072828447598-1.11418107368593],ATAD5,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,17:30854203
rs1879586-<b>G</b>,2 x 10-13,,0.181254,1.1339011,'-,[1.09660984313914-1.1724605092959],PLEKHM1,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,17:45489971
rs7207826-<b>C</b>,8 x 10-13,,0.267801,1.1105318,'-,[1.07914609971847-1.14283031731538],SKAP1,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,17:48423311
rs4808075-<b>C</b>,2 x 10-17,,0.295975,1.1302502,'-,[1.09887004937136-1.1625264094177],"BABAM1, USHBP1",Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,19:17279482
rs6005807-<b>C</b>,3 x 10-7,,0.898635,1.1211612,'-,[1.07314763387262-1.17132308995474],TTC28,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,22:28538325
rs2165109-<b>C</b>,8 x 10-7,,0.251869,1.0780069,'-,[1.04637703624974-1.11059270801828],"ACOXL, MIR4435-2HG",Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,2:111061081
rs7953249-<b>G</b>,6 x 10-6,,0.417632,1.0621586,'-,[1.0348111352015-1.09022867520121],HNF1A-AS1,Invasive epithelial ovarian cancer,ovarian carcinoma,GCST004415,12:120965921
rs7705526-<b>A</b>,8 x 10-8,,0.332078,1.0766991,'-,[1.04796689850078-1.10621911687371],TERT,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,5:1285859
chr8:82668818-<b>G</b>,4 x 10-10,,0.0663033,1.1702297,'-,[1.11383386875217-1.22948084125145],'-,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,Mapping not available
rs7405776-<b>G</b>,2 x 10-10,,0.41189,1.09,'-,[1.06-1.12],HNF1B,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,17:37733029
rs10962692-<b>G</b>,9 x 10-11,,0.799624,1.5,'-,[1.32777950250739-1.69772989025038],BNC2,Ovarian cancer in BRCA2 mutation carriers,"carrier status, ovarian carcinoma",GCST004416,9:16915876
rs1879586-<b>G</b>,2 x 10-19,,0.181254,1.1611373,'-,[1.12396655984348-1.19953742102822],PLEKHM1,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,17:45489971
rs7207826-<b>C</b>,2 x 10-17,,0.267801,1.1311107,'-,[1.09941695678777-1.16371793958399],SKAP1,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,17:48423311
rs4808075-<b>C</b>,2 x 10-19,,0.295975,1.1357577,'-,[1.10479964302488-1.16758323338693],"BABAM1, USHBP1",Epithelial ovarian cancer,ovarian carcinoma,GCST004462,19:17279482
rs9886651-<b>G</b>,2 x 10-9,,0.461222,1.0802044,'-,[1.05286500127646-1.10825354962066],PVT1,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,8:127805637
rs9870207-<b>A</b>,3 x 10-6,,0.691354,1.0994674,'-,[1.05569458307584-1.14505523813592],"CCT6P4, GMNC",Epithelial ovarian cancer,ovarian carcinoma,GCST004462,3:190807727
rs6456822-<b>T</b>,1 x 10-6,,0.690887,1.0714362,'-,[1.04202715140265-1.10167527662683],GPX6,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,6:28512858
rs1400482-<b>G</b>,7 x 10-26,,0.867974,1.232938,'-,[1.18577432499114-1.28197774659809],LINC00824,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,8:128529685
rs10962692-<b>G</b>,5 x 10-64,,0.799624,1.3368285,'-,[1.29251250189538-1.38266389898672],BNC2,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,9:16915876
chr9:136138765-<b>G</b>,2 x 10-11,,0.194216,1.11572,'-,[1.08085025008502-1.15171484355914],'-,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,Mapping not available
rs144962376-<b>T</b>,4 x 10-11,,0.309302,1.0959264,'-,[1.06647199521962-1.12619421828606],MLLT10,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,10:21589903
rs62274041-<b>G</b>,3 x 10-7,,0.048,1.85,'-,[1.46354854927152-2.33435588308994],"LINC00886, METTL15P1",Ovarian cancer in BRCA2 mutation carriers,"carrier status, ovarian carcinoma",GCST004416,3:156717851
rs11651755-<b>C</b>,8 x 10-9,,0.486465,1.077992,'-,[1.05087168925156-1.10581210313382],HNF1B,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,17:37739849
rs62274041-<b>G</b>,2 x 10-57,,0.048,1.57,'-,[1.48-1.66],"LINC00886, METTL15P1",Epithelial ovarian cancer,ovarian carcinoma,GCST004462,3:156717851
rs6755777-<b>T</b>,3 x 10-15,,0.319,1.12,'-,[1.09-1.15],"HAGLR, HAGLROS",Epithelial ovarian cancer,ovarian carcinoma,GCST004462,2:176178498
rs711830-<b>A</b>,3 x 10-15,,0.319,1.12,'-,[1.09-1.15],"HAGLR, HOXD3",Epithelial ovarian cancer,ovarian carcinoma,GCST004462,2:176172583
rs58722170-<b>C</b>,1 x 10-9,,0.221,1.1,'-,[1.07-1.13],RSPO1,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,1:37630749
rs8098244-<b>A</b>,2 x 10-7,,0.275,1.11,'-,[1.07-1.16],LAMA3,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,18:23825589
rs6005807-<b>C</b>,9 x 10-6,,0.899,1.1,'-,[1.05-1.15],TTC28,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,22:28538325
rs2165109-<b>C</b>,2 x 10-8,,0.251869,1.086051,'-,[1.05456961053472-1.11847227897416],"ACOXL, MIR4435-2HG",Epithelial ovarian cancer,ovarian carcinoma,GCST004462,2:111061081
rs7953249-<b>G</b>,5 x 10-10,,0.417632,1.0834533,'-,[1.05604177574809-1.1115762691869],HNF1A-AS1,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,12:120965921
rs10069690-<b>T</b>,1 x 10-7,,0.259806,1.0802581,'-,[1.04978354993499-1.11161732010102],TERT,Epithelial ovarian cancer,ovarian carcinoma,GCST004462,5:1279675
rs76462307-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,"XCL1, XCL2",Survival in breast cancer (estrogen-receptor positive),"survival time, estrogen-receptor positive breast cancer",GCST010079,1:168570139
rs1401069-<b>?</b>,5 x 10-7,,'-,'-,'-,'-,"LSAMP, LINC00903",Survival in breast cancer (estrogen-receptor positive),"survival time, estrogen-receptor positive breast cancer",GCST010079,3:116561041
rs2178052-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,CYP39A1,Survival in breast cancer (estrogen-receptor positive),"survival time, estrogen-receptor positive breast cancer",GCST010079,6:46573494
rs1560409-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,"SC5D, RPS4XP12",Survival in breast cancer (estrogen-receptor positive),"survival time, estrogen-receptor positive breast cancer",GCST010079,11:121289351
rs2449598-<b>A</b>,2 x 10-10,,0.4808,'-,0.4897 unit decrease,[0.34-0.64],DLG2,Estrogen level change in anastrozole-treated breast cancer,"estrogen measurement, estrogen-receptor positive breast cancer, response to aromatase inhibitor",GCST011407,11:83983729
rs1437153-<b>G</b>,3 x 10-9,,0.0618,'-,0.4028 unit decrease,[0.27-0.53],'-,Estrogen level change in anastrozole-treated breast cancer,"estrogen measurement, estrogen-receptor positive breast cancer, response to aromatase inhibitor",GCST011407,16:64410685
rs6981827-<b>?</b>,2 x 10-8,(estradiol),NR,'-,'-,'-,CSMD1,Estrogen level change in anastrozole-treated breast cancer,"estrogen measurement, estrogen-receptor positive breast cancer, response to aromatase inhibitor",GCST011407,8:3217516
rs6981827-<b>?</b>,2 x 10-8,(estrone),NR,'-,'-,'-,CSMD1,Estrogen level change in anastrozole-treated breast cancer,"estrogen measurement, estrogen-receptor positive breast cancer, response to aromatase inhibitor",GCST011407,8:3217516
rs6981827-<b>C</b>,2 x 10-8,(estrone and estradiol),0.0502,'-,0.5978 unit decrease,[0.39-0.8],CSMD1,Estrogen level change in anastrozole-treated breast cancer,"estrogen measurement, estrogen-receptor positive breast cancer, response to aromatase inhibitor",GCST011407,8:3217516
rs9945654-<b>G</b>,4 x 10-6,,0.0124,'-,2.0652 unit decrease,[1.2-2.93],NETO1-DT,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,18:72975302
rs9945951-<b>A</b>,4 x 10-6,,0.0126,'-,2.0573 unit decrease,[1.19-2.93],NETO1-DT,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,18:72975319
rs4342892-<b>A</b>,5 x 10-6,,0.2555,'-,0.272 unit increase,[0.16-0.39],ST6GALNAC3,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,1:76398018
rs28845026-<b>T</b>,5 x 10-8,,0.1987,'-,0.3673 unit increase,[0.24-0.5],"ECEL1P3, ALPP",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,2:232355544
rs12518356-<b>G</b>,4 x 10-6,,0.3123,'-,0.2618 unit increase,[0.15-0.37],RPSAP37,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,5:126041980
rs6460664-<b>C</b>,2 x 10-6,,0.3768,'-,0.2535 unit increase,[0.15-0.36],GALNT17,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,7:71535629
rs4489302-<b>C</b>,3 x 10-6,,0.0143,'-,1.3599 unit decrease,[0.8-1.92],MATN2,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,8:97892687
rs77628230-<b>T</b>,5 x 10-7,,0.0278,'-,0.7739 unit decrease,[0.48-1.07],SVIL,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,10:29653623
rs77034926-<b>A</b>,2 x 10-6,,0.1805,'-,0.3403 unit decrease,[0.2-0.48],LINC02452,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,12:96161387
rs8038589-<b>T</b>,3 x 10-6,,0.0206,'-,0.9179 unit decrease,[0.54-1.3],RPL7P5,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,15:99507178
rs11648166-<b>G</b>,2 x 10-8,,0.1178,'-,0.4401 unit increase,[0.29-0.59],"CNOT1, SLC38A7",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58662802
rs62112924-<b>A</b>,2 x 10-6,,0.033,'-,1.188 unit decrease,[0.7-1.67],LINC00683,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,18:76553300
rs76164207-<b>A</b>,4 x 10-6,,0.1655,'-,0.4204 unit decrease,[0.24-0.6],MUC16,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,19:8857556
rs6106324-<b>C</b>,5 x 10-6,,0.381,'-,0.2473 unit decrease,[0.14-0.35],'-,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,20:20984347
rs883013-<b>T</b>,6 x 10-8,,0.1854,'-,0.3644 unit increase,[0.23-0.5],ECEL1P3,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,2:232350693
rs4996188-<b>A</b>,7 x 10-8,,0.1851,'-,0.3631 unit increase,[0.23-0.49],ECEL1P3,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,2:232350750
rs6715083-<b>T</b>,8 x 10-8,,0.1824,'-,0.3649 unit increase,[0.23-0.5],"ECEL1P3, ALPP",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,2:232353782
rs3784911-<b>T</b>,4 x 10-8,,0.1191,'-,0.4353 unit increase,[0.28-0.59],SLC38A7,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58669712
rs60979655-<b>T</b>,5 x 10-8,,0.1129,'-,0.4378 unit increase,[0.28-0.59],"CNOT1, SLC38A7",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58661235
rs16960359-<b>A</b>,5 x 10-8,,0.1189,'-,0.4324 unit increase,[0.28-0.59],SLC38A7,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58670592
rs76733922-<b>C</b>,6 x 10-8,,0.1213,'-,0.4257 unit increase,[0.27-0.58],SLC38A7,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58668637
rs12149056-<b>A</b>,7 x 10-8,,0.1162,'-,0.4341 unit increase,[0.28-0.59],"CNOT1, SLC38A7",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58657060
rs4245739-<b>C</b>,4 x 10-6,,'-,1.19,'-,[1.11-1.29],MDM4,"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)",triple-negative breast cancer,GCST002305,1:204549714
rs10069690-<b>A</b>,1 x 10-7,,'-,1.24,'-,[1.14-1.34],TERT,"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)",triple-negative breast cancer,GCST002305,5:1279675
rs3757318-<b>A</b>,9 x 10-6,,'-,1.33,'-,[1.17-1.51],CCDC170,"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)",triple-negative breast cancer,GCST002305,6:151592978
rs2363956-<b>C</b>,2 x 10-8,,'-,1.2195,'-,[1.14-1.3],ANKLE1,"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)",triple-negative breast cancer,GCST002305,19:17283315
rs10771399-<b>G</b>,2 x 10-8,,'-,1.3889,'-,[1.25-1.56],PTHLH,"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)",triple-negative breast cancer,GCST002305,12:28002147
rs4861477-<b>C</b>,8 x 10-6,,0.15,'-,'-,'-,'-,Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer,"response to tamoxifen, HER2 status, estrogen-receptor positive breast cancer",GCST006615,4:181490427
rs17198973-<b>C</b>,6 x 10-6,,0.35,'-,'-,'-,'-,Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer,"response to tamoxifen, HER2 status, estrogen-receptor positive breast cancer",GCST006615,4:181486725
rs4442975-<b>?</b>,5 x 10-18,,'-,1.15,'-,[NR],'-,Breast cancer,breast carcinoma,GCST011433,2:217056046
rs11715126-<b>?</b>,2 x 10-12,,'-,0.89,'-,[NR],NEK10,Breast cancer,breast carcinoma,GCST011433,3:27359756
rs10043344-<b>?</b>,5 x 10-10,,'-,1.11,'-,[NR],'-,Breast cancer,breast carcinoma,GCST011433,5:44926416
rs7714232-<b>?</b>,6 x 10-22,,'-,1.22,'-,[NR],'-,Breast cancer,breast carcinoma,GCST011433,5:56715530
rs2981575-<b>?</b>,2 x 10-54,,'-,1.29,'-,[NR],FGFR2,Breast cancer,breast carcinoma,GCST011433,10:121586602
rs661204-<b>?</b>,9 x 10-23,,'-,1.25,'-,[NR],LINC01488,Breast cancer,breast carcinoma,GCST011433,11:69516215
rs4784227-<b>?</b>,7 x 10-39,,'-,1.27,'-,[NR],CASC16,Breast cancer,breast carcinoma,GCST011433,16:52565276
rs62237617-<b>?</b>,8 x 10-16,,'-,2.86,'-,[NR],TTC28,Breast cancer,breast carcinoma,GCST011433,22:28365160
rs1092913-<b>T</b>,2 x 10-6,,0.13,1.45,'-,[1.24-1.69],ROPN1L,Breast cancer,breast carcinoma,GCST001012,5:10467590
rs10411161-<b>T</b>,7 x 10-6,,0.13,1.42,'-,[1.22-1.65],ZNF577,Breast cancer,breast carcinoma,GCST001012,19:51869723
rs2981578-<b>C</b>,1 x 10-12,,0.514,1.225,'-,[1.158-1.296],FGFR2,Breast cancer,breast carcinoma,GCST002234,10:121580797
rs12922061-<b>T</b>,4 x 10-10,,0.241,1.231,'-,[1.153-1.314],CASC16,Breast cancer,breast carcinoma,GCST002234,16:52601088
rs3803662-<b>T</b>,3 x 10-11,,0.522,1.213,'-,[1.146-1.284],CASC16,Breast cancer,breast carcinoma,GCST002234,16:52552429
rs17221259-<b>G</b>,7 x 10-6,,0.204,1.252,'-,[1.136-1.381],"GNAI2P1, RPL30P11",Breast cancer,breast carcinoma,GCST002234,12:14257551
rs10490113-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,LINC01793,Breast cancer,breast carcinoma,GCST000079,2:59272212
rs1876206-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,FBN1,Breast cancer,breast carcinoma,GCST000079,15:48608389
rs1154865-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,RNU6-1012P,Breast cancer,breast carcinoma,GCST000079,12:73596057
rs1978503-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,LINC01416,Breast cancer,breast carcinoma,GCST000079,18:55997051
rs10263639-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,MTATP6P21,Breast cancer,breast carcinoma,GCST000079,7:67594280
rs2075555-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,COL1A1,Breast cancer,breast carcinoma,GCST000079,17:50196930
rs458685-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,GRIK1,Breast cancer,breast carcinoma,GCST000079,21:29805194
rs6556756-<b>?</b>,5 x 10-7,,NR,'-,'-,'-,LINC02143,Breast cancer,breast carcinoma,GCST000079,5:164462274
rs1926657-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,ABCC4,Breast cancer,breast carcinoma,GCST000079,13:95222702
rs9913477-<b>G</b>,3 x 10-7,,0.06,1.44,'-,[1.26–1.65],BAIAP2,Breast cancer,breast carcinoma,GCST010347,17:81041898
rs17530621-<b>T</b>,4 x 10-6,,0.107,'-,'-,'-,BEND4,Anthracycline-induced cardiotoxicity in early breast cancer,"breast carcinoma, cardiotoxicity, response to anthracycline-based chemotherapy",GCST010456,4:42225480
rs6804462-<b>C</b>,3 x 10-6,,0.039,'-,'-,'-,'-,Anthracycline-induced cardiotoxicity in early breast cancer,"breast carcinoma, cardiotoxicity, response to anthracycline-based chemotherapy",GCST010456,3:103342570
rs11894115-<b>T</b>,5 x 10-6,(adjusted),0.395,'-,'-,'-,MPP4,Anthracycline-induced cardiotoxicity in early breast cancer,"breast carcinoma, cardiotoxicity, response to anthracycline-based chemotherapy",GCST010456,2:201647726
rs58328254-<b>A</b>,6 x 10-6,(adjusted),0.194,'-,'-,'-,RPL7,Anthracycline-induced cardiotoxicity in early breast cancer,"breast carcinoma, cardiotoxicity, response to anthracycline-based chemotherapy",GCST010456,8:73291487
rs2113374-<b>T</b>,1 x 10-6,,0.061,'-,'-,'-,LINC01982,Anthracycline-induced cardiotoxicity in early breast cancer,"breast carcinoma, cardiotoxicity, response to anthracycline-based chemotherapy",GCST010456,17:52431359
rs117299725-<b>A</b>,3 x 10-6,,0.055,'-,'-,'-,"PRUNE2, PCA3",Anthracycline-induced cardiotoxicity in early breast cancer,"breast carcinoma, cardiotoxicity, response to anthracycline-based chemotherapy",GCST010456,9:76808695
rs147631684-<b>A</b>,5 x 10-6,,0.03,'-,'-,'-,CDH13,Anthracycline-induced cardiotoxicity in early breast cancer,"breast carcinoma, cardiotoxicity, response to anthracycline-based chemotherapy",GCST010456,16:83599215
rs2774307-<b>?</b>,8 x 10-6,,0.26,1.3,'-,[1.16-1.47],SYT6,Breast cancer (prognosis),breast carcinoma,GCST001816,1:114128347
rs1387389-<b>?</b>,4 x 10-6,,0.36,1.28,'-,[1.16-1.43],PBX1,Breast cancer (prognosis),breast carcinoma,GCST001816,1:164720525
rs421379-<b>?</b>,1 x 10-6,,0.05,1.61,'-,[1.33-1.96],'-,Breast cancer (prognosis),breast carcinoma,GCST001816,5:91979496
rs3884558-<b>?</b>,4 x 10-6,,0.07,1.46,'-,[1.24-1.72],'-,Breast cancer (prognosis),breast carcinoma,GCST001816,15:61410580
rs3785982-<b>?</b>,8 x 10-6,,0.12,1.4,'-,[1.21-1.62],NTN1,Breast cancer (prognosis),breast carcinoma,GCST001816,17:9186907
rs1728400-<b>?</b>,6 x 10-6,,NR,1.25,'-,[1.13-1.39],"LINC00917, FENDRR",Breast cancer (survival),"survival time, breast carcinoma",GCST002727,16:86400840
rs12358475-<b>?</b>,2 x 10-6,,NR,1.33,'-,[1.19-1.49],"PROSER2, ECHDC3",Breast cancer (survival),"survival time, breast carcinoma",GCST002727,10:11806793
rs421379-<b>?</b>,1 x 10-6,,NR,1.49,'-,[1.27-1.75],'-,Breast cancer (survival),"survival time, breast carcinoma",GCST002727,5:91979496
rs9934948-<b>C</b>,6 x 10-6,(Total Mortality),NR,1.29,'-,[1.16-1.44],"LINC01568, ZFHX3",Breast cancer (survival),"survival time, breast carcinoma",GCST001373,16:73405456
rs3784099-<b>A</b>,1 x 10-7,(Total Mortality),NR,1.49,'-,[1.28-1.72],RAD51B,Breast cancer (survival),"survival time, breast carcinoma",GCST001373,14:68283210
rs3784099-<b>A</b>,3 x 10-7,(Recurrence),NR,1.43,'-,[1.25-1.64],RAD51B,Breast cancer (survival),"event free survival time, breast carcinoma",GCST001373,14:68283210
"SNP_A-2032347-<b>?</b>, SNP_A-2196879-<b>?</b>, rs10871290-<b>?</b>",4 x 10-7,,0.34,'-,'-,'-,No mapped genes; No mapped genes; No mapped genes,Breast cancer,breast carcinoma,GCST000187,Mapping not available
rs2180341-<b>G</b>,3 x 10-8,,0.21,1.41,'-,[1.25-1.59],RNF146,Breast cancer,breast carcinoma,GCST000162,6:127279485
"rs17435444-<b>A</b>, rs13116936-<b>G</b>",3 x 10-7,,0.64,1.23,'-,[1.13-1.33],No mapped genes; No mapped genes,Breast cancer,breast carcinoma,GCST001879,Mapping not available
"rs4414128-<b>?</b>, rs2386661-<b>?</b>, rs17141741-<b>?</b>",5 x 10-6,,NR,1.27,'-,[1.14-1.39],LASTR; No mapped genes; No mapped genes,Breast cancer,breast carcinoma,GCST001879,10:5630056
rs12355688-<b>T</b>,6 x 10-6,,0.22,1.24,'-,[1.13-1.36],ZMIZ1,Breast cancer,breast carcinoma,GCST001879,10:79295869
"rs9628987-<b>?</b>, rs7535752-<b>?</b>",5 x 10-6,,NR,'-,'-,'-,SLC45A1; No mapped genes,Breast cancer,breast carcinoma,GCST001879,1:8326670
"rs6797852-<b>?</b>, rs1810320-<b>?</b>",3 x 10-6,,NR,'-,'-,'-,GRM7; No mapped genes,Breast cancer,breast carcinoma,GCST001879,3:7220327
"rs17051310-<b>?</b>, rs13116936-<b>?</b>",2 x 10-6,,NR,'-,'-,'-,TNIP3; No mapped genes,Breast cancer,breast carcinoma,GCST001879,4:121185138
"rs4455437-<b>?</b>, rs921551-<b>?</b>",2 x 10-6,,NR,'-,'-,'-,TNIP3; No mapped genes,Breast cancer,breast carcinoma,GCST001879,4:121215608
"rs6835704-<b>?</b>, rs17435444-<b>?</b>",2 x 10-6,,NR,'-,'-,'-,TNIP3; No mapped genes,Breast cancer,breast carcinoma,GCST001879,4:121222509
"rs3806872-<b>?</b>, rs16875333-<b>?</b>",3 x 10-6,,NR,'-,'-,'-,ADAMTS16; No mapped genes,Breast cancer,breast carcinoma,GCST001879,5:5320143
"rs11613298-<b>?</b>, rs2230754-<b>?</b>",5 x 10-6,,NR,'-,'-,'-,N/A - PLXNC1; No mapped genes,Breast cancer,breast carcinoma,GCST001879,12:94138989
"rs10853029-<b>?</b>, rs3785856-<b>?</b>",8 x 10-6,(Haplotype-?????),NR,'-,'-,'-,BCAS3; BCAS3,Breast cancer,breast carcinoma,GCST001879,17:61319088|17:61314018
rs2046210-<b>A</b>,2 x 10-15,,0.37,1.29,'-,[1.21-1.37],"ESR1, CCDC170",Breast cancer,breast carcinoma,GCST000343,6:151627231
rs16882214-<b>?</b>,2 x 10-6,(Meta P value),0.81,1.43,'-,[NR],LNC-LBCS,Breast cancer,breast carcinoma,GCST001831,6:19443704
rs12906542-<b>?</b>,7 x 10-7,(Meta P value),0.93,2,'-,[NR],ADAMTS7P3,Breast cancer,breast carcinoma,GCST001831,15:77977130
rs1078806-<b>C</b>,2 x 10-6,(Pooled P value),0.39,1.43,'-,[NR],FGFR2,Breast cancer,breast carcinoma,GCST001831,10:121579461
rs6788895-<b>G</b>,9 x 10-8,,0.65,1.22,'-,[1.13-1.31],SIAH2,Breast cancer,breast carcinoma,GCST001667,3:150750021
rs3750817-<b>T</b>,8 x 10-8,,0.49,1.22,'-,[NR],FGFR2,Breast cancer,breast carcinoma,GCST001667,10:121573063
rs578194564-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,GNB5,Breast cancer somatic mutation signature APOBEC C>T,breast carcinoma,GCST010760,15:52152636
rs578194564-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,GNB5,Breast cancer somatic mutation signature APOBEC C>G,breast carcinoma,GCST010759,15:52152636
rs1858826-<b>G</b>,1 x 10-7,,0.1,3.448276,'-,[2.17-5.56],GNGT1,Taxane-induced peripheral neuropathy in breast cancer,"peripheral neuropathy, breast carcinoma, response to taxane",GCST005804,7:93719703
rs910920-<b>A</b>,5 x 10-6,,0.31,1.754386,'-,[1.37-2.22],"MRM3, NXN",Taxane-induced peripheral neuropathy in breast cancer,"peripheral neuropathy, breast carcinoma, response to taxane",GCST005804,17:797882
rs1857798-<b>C</b>,8 x 10-6,,0.38,2.2727273,'-,[1.52-3.45],MARCHF1,Taxane-induced peripheral neuropathy in breast cancer,"peripheral neuropathy, breast carcinoma, response to taxane",GCST005804,4:164448974
rs68130068-<b>T</b>,4 x 10-6,,0.142,'-,'-,'-,'-,HER2 status in breast cancer,"HER2 status, breast carcinoma",GCST004528,2:172285284
rs13260300-<b>?</b>,2 x 10-7,,'-,1.64,'-,[1.35-2.00],"MIR2052HG, MIR5681A",Breast cancer-free interval (treatment with aromatase inhibitor),"disease recurrence, response to aromatase inhibitor, breast carcinoma",GCST003816,8:74567389
rs2540431-<b>T</b>,2 x 10-8,,0.313,1.131,'-,[1.083-1.181],C2CD6,Breast cancer,breast carcinoma,GCST009665,2:201502898
rs1838337-<b>G</b>,1 x 10-8,,0.627,1.128,'-,[1.082-1.176],"SIAH2, SIAH2-AS1",Breast cancer,breast carcinoma,GCST009665,3:150762029
rs7701466-<b>T</b>,2 x 10-10,,0.492,1.138,'-,[1.094-1.184],"LINC02224, RN7SL383P",Breast cancer,breast carcinoma,GCST009665,5:44663035
rs79160707-<b>T</b>,5 x 10-8,,0.1,1.2,'-,[1.124-1.282],MAP3K1,Breast cancer,breast carcinoma,GCST009665,5:56757111
rs6900157-<b>C</b>,5 x 10-10,,0.269,1.147,'-,[1.099-1.198],"CCDC170, ESR1",Breast cancer,breast carcinoma,GCST009665,6:151632992
rs2912778-<b>G</b>,1 x 10-19,,0.507,1.201,'-,[1.155-1.25],FGFR2,Breast cancer,breast carcinoma,GCST009665,10:121579140
rs805583-<b>G</b>,3 x 10-10,,0.76,1.17,'-,[1.114-1.228],PTHLH,Breast cancer,breast carcinoma,GCST009665,12:28000060
rs10744856-<b>G</b>,1 x 10-8,,0.626,1.13,'-,[1.083-1.178],'-,Breast cancer,breast carcinoma,GCST009665,12:115397580
rs4784227-<b>T</b>,2 x 10-24,,0.235,1.271,'-,[1.214-1.331],CASC16,Breast cancer,breast carcinoma,GCST009665,16:52565276
rs11161996-<b>C</b>,8 x 10-7,,0.6498,1.1040659,'-,[1.06-1.15],"LINC01364, RNA5SP52",Breast cancer,breast carcinoma,GCST009665,1:87385737
rs11119434-<b>T</b>,8 x 10-7,,0.1609,1.1362,'-,[1.08008-1.19525],"SERTAD4-AS1, SYT14",Breast cancer,breast carcinoma,GCST009665,1:210196877
rs6716937-<b>G</b>,4 x 10-7,,0.4074,1.10278,'-,[1.06198-1.14514],"MXD1, SNRNP27",Breast cancer,breast carcinoma,GCST009665,2:69900097
rs9862599-<b>G</b>,1 x 10-8,,0.0761,1.21574,'-,[1.13634-1.30069],'-,Breast cancer,breast carcinoma,GCST009665,3:105145487
rs61154548-<b>T</b>,8 x 10-7,,0.0645,1.20178,'-,[1.11733-1.29261],MIER3,Breast cancer,breast carcinoma,GCST009665,5:56928893
rs9479169-<b>C</b>,1 x 10-7,,0.4907,1.1070544,'-,[1.07-1.15],ESR1,Breast cancer,breast carcinoma,GCST009665,6:152034021
rs62578156-<b>G</b>,5 x 10-6,,0.1108,1.1455,'-,[1.08033-1.2146],"ZBTB43, LMX1B",Breast cancer,breast carcinoma,GCST009665,9:126707167
rs10842422-<b>T</b>,3 x 10-6,,0.3213,1.0985,'-,[1.05616-1.14253],BCAT1,Breast cancer,breast carcinoma,GCST009665,12:24884534
rs7315643-<b>T</b>,2 x 10-7,,0.7756,1.1332666,'-,[1.08-1.19],FAR2,Breast cancer,breast carcinoma,GCST009665,12:29205522
rs1004983-<b>A</b>,3 x 10-6,,0.3476,1.09858,'-,[1.05626-1.14259],CYP19A1,Breast cancer,breast carcinoma,GCST009665,15:51321455
rs9945779-<b>A</b>,7 x 10-7,,0.8892,1.1705326,'-,[1.1-1.25],SETBP1,Breast cancer,breast carcinoma,GCST009665,18:44813855
rs75286142-<b>G</b>,2 x 10-9,,0.1763,1.15694,'-,[1.10285-1.21369],LINC00160,Breast cancer,breast carcinoma,GCST009665,21:34726347
rs16992204-<b>?</b>,4 x 10-8,,NR,1.1516186,'-,[1.1-1.21],"LINC00160, LINC01426",Breast cancer,breast carcinoma,GCST009665,21:34738904
rs10941679-<b>?</b>,3 x 10-9,,NR,1.132975,'-,[1.09-1.18],"LINC02224, RN7SL383P",Breast cancer,breast carcinoma,GCST009665,5:44706396
rs4415084-<b>?</b>,3 x 10-9,,NR,1.12907,'-,[1.08486-1.17509],"LINC02224, RN7SL383P",Breast cancer,breast carcinoma,GCST009665,5:44662413
rs1292011-<b>?</b>,3 x 10-8,,NR,1.12981,'-,[1.08197-1.17975],'-,Breast cancer,breast carcinoma,GCST009665,12:115398717
rs3135724-<b>?</b>,5 x 10-11,,NR,1.79,'-,[1.49 - 2.13],FGFR2,Estrogen receptor status in HER2 negative breast cancer,"HER2 status, estrogen receptor status, breast carcinoma",GCST003823,10:121592706
rs3135718-<b>?</b>,6 x 10-12,,NR,1.33,'-,[1.23 - 1.45],FGFR2,Estrogen receptor status in breast cancer,"estrogen receptor status, breast carcinoma",GCST003821,10:121594355
rs3757318-<b>A</b>,1 x 10-6,,0.26,1.15,'-,[1.09-1.22],CCDC170,Breast cancer,breast carcinoma,GCST003520,6:151592978
rs2046210-<b>A</b>,7 x 10-15,,0.35,1.22,'-,[1.16-1.29],"ESR1, CCDC170",Breast cancer,breast carcinoma,GCST003520,6:151627231
rs2981579-<b>A</b>,3 x 10-11,,0.55,1.19,'-,[1.11-1.23],FGFR2,Breast cancer,breast carcinoma,GCST003520,10:121577821
rs12628403-<b>C</b>,4 x 10-6,,0.27,1.17,'-,[1.09-1.25],APOBEC3A,Breast cancer,breast carcinoma,GCST003520,22:38962032
rs1219648-<b>G</b>,6 x 10-9,,0.39,1.17,'-,[1.11-1.23],FGFR2,Breast cancer,breast carcinoma,GCST003520,10:121586676
rs2981582-<b>A</b>,2 x 10-8,,0.68,1.18,'-,[1.11-1.23],FGFR2,Breast cancer,breast carcinoma,GCST003520,10:121592803
rs12118297-<b>G</b>,4 x 10-8,,0.62,1.1,'-,[1.06-1.14],"LMO4, LINC02801",Breast cancer,breast carcinoma,GCST003520,1:87313534
rs16992204-<b>C</b>,5 x 10-8,,0.12,1.13,'-,[1.07-1.18],"LINC00160, LINC01426",Breast cancer,breast carcinoma,GCST003520,21:34738904
rs74497159-<b>?</b>,4 x 10-7,,'-,'-,0.591 unit increase,[NR],LINC01307,Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,1:101409030
rs3110366-<b>?</b>,1 x 10-6,,'-,'-,0.394 unit decrease,[NR],ZFPM2,Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,8:105277293
rs77526807-<b>?</b>,2 x 10-6,,'-,'-,0.818 unit increase,[NR],"LINC01503, RN7SL159P",Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,9:129361675
rs17076837-<b>?</b>,2 x 10-6,,'-,'-,0.578 unit increase,[NR],'-,Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,13:83495035
rs61963755-<b>?</b>,2 x 10-6,,'-,'-,0.674 unit increase,[NR],KLHL1,Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,13:69848530
rs2342780-<b>?</b>,2 x 10-6,,'-,'-,0.788 unit decrease,[NR],ZFPM2,Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,8:105251146
rs10771973-<b>?</b>,2 x 10-6,,'-,'-,0.451 unit increase,[NR],FGD4,Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,12:32640040
rs2342791-<b>?</b>,3 x 10-6,,'-,'-,0.414 unit decrease,[NR],ZFPM2,Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,8:105275744
rs11076190-<b>?</b>,3 x 10-6,,'-,'-,0.738 unit increase,[NR],"CCL17, CX3CL1",Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,16:57393024
rs78777495-<b>?</b>,3 x 10-6,,'-,'-,0.602 unit increase,[NR],"LINC01450, SUGCT",Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,7:40927299
rs9623812-<b>?</b>,3 x 10-6,,'-,'-,0.34 unit decrease,[NR],SCUBE1,Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,22:43328680
rs2060717-<b>?</b>,3 x 10-6,,'-,'-,0.496 unit increase,[NR],CALU,Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,7:128740695
rs6788186-<b>?</b>,5 x 10-6,,'-,'-,0.282 unit increase,[NR],LINC01326,Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,3:166544100
rs78017515-<b>?</b>,6 x 10-6,,'-,'-,0.621 unit increase,[NR],"SUGCT, LINC01450",Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,7:40947421
rs13168251-<b>?</b>,7 x 10-6,,'-,'-,0.295 unit increase,[NR],'-,Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,5:92138315
rs777619-<b>?</b>,8 x 10-6,,'-,'-,0.416 unit increase,[NR],LINC02549,Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,6:68149055
rs2188156-<b>?</b>,8 x 10-6,,'-,'-,0.8 unit increase,[NR],"LINC00895, SEPTIN5",Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,22:19651952
rs57940640-<b>?</b>,9 x 10-6,,'-,'-,0.552 unit increase,[NR],CNGB1,Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer,"peripheral neuropathy, breast carcinoma, response to antimicrotubule agent",GCST010732,16:57925334
rs4584690-<b>T</b>,5 x 10-6,,0.18,1.85,'-,[1.85-2.42],ABCC4,Acute post-radiotherapy pain in breast cancer,"response to radiation, pain, breast carcinoma",GCST008388,13:95027878
rs16970540-<b>T</b>,2 x 10-6,,0.1,2.2,'-,[1.59-3.04],RFFL,Acute post-radiotherapy pain in breast cancer,"response to radiation, pain, breast carcinoma",GCST008388,17:35011428
rs73633565-<b>G</b>,8 x 10-6,,0.16,1.9,'-,[1.43-2.52],LINC01203,Acute post-radiotherapy pain in breast cancer,"response to radiation, pain, breast carcinoma",GCST008388,X:13459192
rs4784227-<b>T</b>,3 x 10-9,,0.31,1.38,'-,[1.24-1.54],CASC16,Breast cancer,breast carcinoma,GCST002662,16:52565276
rs140068132-<b>A</b>,9 x 10-18,,0.93,1.67,'-,[1.49-1.89],"ESR1, CCDC170",Breast cancer,breast carcinoma,GCST002662,6:151633699
rs6453204-<b>?</b>,6 x 10-8,,NR,3.3,'-,[NR],SV2C,Response to chemotherapy in breast cancer (hypertension) (bevacizumab),"response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002567,5:76143375
rs130318-<b>?</b>,4 x 10-6,,NR,1.72,'-,[NR],PARVB,Response to chemotherapy in breast cancer (hypertension) (bevacizumab),"response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002567,22:44080184
rs1943466-<b>?</b>,1 x 10-6,,NR,1.82,'-,[NR],GRAMD1B,Response to chemotherapy in breast cancer (hypertension) (bevacizumab),"response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002567,11:123393934
rs6453204-<b>?</b>,5 x 10-8,,NR,2.2,'-,[NR],SV2C,Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),"cumulative dose response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002566,5:76143375
rs130318-<b>?</b>,4 x 10-7,,NR,1.7,'-,[NR],PARVB,Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),"cumulative dose response to bevacizumab, chemotherapy-induced hypertension, breast carcinoma",GCST002566,22:44080184
rs1943466-<b>?</b>,6 x 10-7,,NR,1.69,'-,[NR],GRAMD1B,Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),"cumulative dose response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002566,11:123393934
rs11685222-<b>?</b>,4 x 10-6,,NR,1.98,'-,[NR],"RPL27P7, PTPN4",Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),"cumulative dose response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002566,2:119990995
rs12467348-<b>?</b>,9 x 10-6,,NR,2.05,'-,[NR],KCNS3,Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),"cumulative dose response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002566,2:18106253
rs3773651-<b>?</b>,7 x 10-6,,NR,2.15,'-,[NR],TGFBR2,Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),"cumulative dose response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002566,3:30677040
rs2731620-<b>?</b>,7 x 10-6,,NR,1.59,'-,[NR],RNU1-146P,Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),"cumulative dose response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002566,12:19774866
rs6878584-<b>?</b>,7 x 10-6,,NR,2.27,'-,[NR],"NSG2, LINC01411",Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),"cumulative dose response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002566,5:174280232
rs2496589-<b>?</b>,5 x 10-6,,NR,1.7,'-,[NR],"AIG1, ADAT2",Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),"cumulative dose response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002566,6:143412439
rs1962073-<b>?</b>,2 x 10-6,,NR,1.69,'-,[NR],MSRA,Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),"cumulative dose response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002566,8:10403043
rs11786541-<b>?</b>,2 x 10-6,,NR,1.65,'-,[NR],MIR124-1HG,Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),"cumulative dose response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002566,8:9932039
rs11257188-<b>?</b>,9 x 10-6,,NR,2.19,'-,[NR],PFKFB3,Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),"cumulative dose response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002566,10:6195193
rs479825-<b>?</b>,6 x 10-6,,NR,1.64,'-,[NR],MAML2,Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),"cumulative dose response to bevacizumab, breast carcinoma, chemotherapy-induced hypertension",GCST002566,11:96198321
"rs765899-<b>?</b>, rs757369-<b>?</b>, rs10132579-<b>?</b>, rs2842347-<b>?</b>, rs737387-<b>?</b>, rs2842346-<b>?</b>",2 x 10-6,,NR,1.67,'-,[1.35-2.08],RAD51B; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes,Breast cancer,breast carcinoma,GCST001879,14:68497029
"rs2305016-<b>?</b>, rs7535752-<b>?</b>, rs9628987-<b>?</b>, rs12711517-<b>?</b>, rs2289731-<b>?</b>",5 x 10-6,,NR,1.23,'-,[1.12-1.35],SLC45A1; No mapped genes; SLC45A1; No mapped genes; SLC45A1,Breast cancer,breast carcinoma,GCST001879,1:8335381|1:8326670|1:8330828
rs1219648-<b>G</b>,1 x 10-10,,0.4,1.2,'-,[1.07-1.42],FGFR2,Breast cancer,breast carcinoma,GCST000036,10:121586676
rs889312-<b>C</b>,5 x 10-9,,0.28,1.22,'-,[1.14-1.30],MAP3K1,Breast cancer,breast carcinoma,GCST000678,5:56736057
rs2981579-<b>A</b>,4 x 10-31,,0.42,1.43,'-,[1.35-1.53],FGFR2,Breast cancer,breast carcinoma,GCST000678,10:121577821
rs10995190-<b>G</b>,5 x 10-15,,0.85,1.16,'-,[1.10-1.22],ZNF365,Breast cancer,breast carcinoma,GCST000678,10:62518923
rs1562430-<b>T</b>,6 x 10-7,,0.58,1.17,'-,[1.10-1.25],"CASC8, POU5F1B, PCAT1",Breast cancer,breast carcinoma,GCST000678,8:127375606
rs13387042-<b>A</b>,2 x 10-10,,0.49,1.21,'-,[1.14-1.29],'-,Breast cancer,breast carcinoma,GCST000678,2:217041109
rs909116-<b>T</b>,7 x 10-7,,0.53,1.17,'-,[1.10-1.24],TNNT3,Breast cancer,breast carcinoma,GCST000678,11:1920716
rs4973768-<b>T</b>,6 x 10-7,,0.47,1.16,'-,[1.10-1.24],SLC4A7,Breast cancer,breast carcinoma,GCST000678,3:27374522
rs1011970-<b>T</b>,3 x 10-8,,0.17,1.09,'-,[1.04-1.14],CDKN2B-AS1,Breast cancer,breast carcinoma,GCST000678,9:22062135
rs704010-<b>A</b>,4 x 10-9,,0.39,1.07,'-,[1.03-1.11],ZMIZ1,Breast cancer,breast carcinoma,GCST000678,10:79081391
rs3803662-<b>A</b>,3 x 10-15,,0.26,1.3,'-,[1.22-1.39],CASC16,Breast cancer,breast carcinoma,GCST000678,16:52552429
rs3757318-<b>A</b>,3 x 10-6,,0.07,1.3,'-,[1.17-1.46],CCDC170,Breast cancer,breast carcinoma,GCST000678,6:151592978
rs2380205-<b>C</b>,5 x 10-7,,0.57,1.06,'-,[1.02-1.10],'-,Breast cancer,breast carcinoma,GCST000678,Mapping not available
rs614367-<b>T</b>,3 x 10-15,,0.15,1.15,'-,[1.10-1.20],LINC01488,Breast cancer,breast carcinoma,GCST000678,11:69513996
rs13387042-<b>A</b>,2 x 10-10,,0.52,1.16,'-,[1.11-1.22],'-,Breast cancer,breast carcinoma,GCST000952,2:217041109
rs4973768-<b>C</b>,2 x 10-8,,0.49,1.14,'-,[1.09-1.19],SLC4A7,Breast cancer,breast carcinoma,GCST000952,3:27374522
rs1562430-<b>A</b>,3 x 10-11,,0.6,1.16,'-,[1.11-1.22],"CASC8, POU5F1B, PCAT1",Breast cancer,breast carcinoma,GCST000952,8:127375606
rs3112612-<b>T</b>,4 x 10-10,,0.43,1.15,'-,[1.10-1.21],CASC16,Breast cancer,breast carcinoma,GCST000952,16:52601252
rs3734805-<b>C</b>,1 x 10-7,,0.08,1.19,'-,[1.11-1.27],CCDC170,Breast cancer,breast carcinoma,GCST000952,6:151618215
rs10510102-<b>G</b>,2 x 10-6,,0.17,1.12,'-,[1.07-1.17],ATE1,Breast cancer,breast carcinoma,GCST000952,10:121865675
rs4415084-<b>T</b>,8 x 10-11,,0.42,1.17,'-,[1.11-1.22],"LINC02224, RN7SL383P",Breast cancer,breast carcinoma,GCST000952,5:44662413
rs1219648-<b>?</b>,1 x 10-30,,0.42,1.31,'-,[1.25-1.37],FGFR2,Breast cancer,breast carcinoma,GCST000952,10:121586676
rs865686-<b>T</b>,2 x 10-10,,0.61,1.12,'-,[1.09-1.18],CHCHD4P2,Breast cancer,breast carcinoma,GCST000952,9:108126198
rs13393577-<b>T</b>,9 x 10-14,,0.051,1.53,'-,[1.37-1.70],ERBB4,Breast cancer,breast carcinoma,GCST001457,2:212432139
rs375468501-<b>?</b>,3 x 10-6,,NR,1.3377686,'-,[1.18-1.51],CCDC71L,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,7:106631389
rs140538758-<b>?</b>,6 x 10-7,,NR,1.5044404,'-,[1.28-1.77],CBFB,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,16:67082698
rs55686336-<b>?</b>,3 x 10-6,,NR,1.5113994,'-,[1.27-1.80],"MAMDC2-AS1, MAMDC2",Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,9:70158086
rs62235635-<b>?</b>,1 x 10-6,,NR,1.6262683,'-,[1.34-1.98],PITPNB,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,22:27918624
rs62237617-<b>?</b>,2 x 10-6,,NR,1.6840287,'-,[1.36-2.09],TTC28,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,22:28365160
rs118021774-<b>?</b>,4 x 10-6,,NR,1.8284526,'-,[1.42-2.36],NXN,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,17:919380
chr5:1227088-<b>?</b>,2 x 10-6,,NR,1.1522056,'-,[1.09-1.22],'-,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,Mapping not available
rs73370840-<b>?</b>,9 x 10-7,,NR,1.1648589,'-,[1.10-1.24],"SLC19A1, COL18A1",Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,21:45497121
rs7160316-<b>?</b>,2 x 10-6,,NR,0.61414945,'-,[0.50-0.75],NYNRIN,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,14:24401845
rs79116769-<b>?</b>,6 x 10-7,,NR,0.7772595,'-,[0.70-0.86],"LINC02436, SLC25A4",Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,4:185141891
rs12938141-<b>?</b>,5 x 10-7,,NR,0.77756035,'-,[0.70-0.86],RAP1GAP2,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,17:3000998
rs6938753-<b>?</b>,1 x 10-6,,NR,0.8705196,'-,[0.82-0.92],LINC02521,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,6:2634705
chr7:41400313-<b>?</b>,3 x 10-6,,NR,0.8813266,'-,[0.84-0.93],'-,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,Mapping not available
rs4717568-<b>?</b>,1 x 10-7,,NR,0.88204163,'-,[0.84-0.92],'-,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,7:70935714
rs204517-<b>?</b>,3 x 10-6,,NR,0.8883291,'-,[0.85-0.93],PAPPA,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,9:116142133
rs11251942-<b>?</b>,5 x 10-7,,NR,1.1186024,'-,[1.07-1.17],LINC02669,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,10:3554755
rs7082321-<b>?</b>,1 x 10-6,,NR,1.1424168,'-,[1.08-1.21],SFMBT2,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,10:7272478
rs11289719-<b>?</b>,3 x 10-6,,NR,1.1424453,'-,[1.08-1.21],PDZD2,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,5:32017440
rs149479659-<b>?</b>,2 x 10-6,,NR,1.1531807,'-,[1.09-1.22],"CEMIP, ABHD17C",Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,15:80763524
chr12:27965596-<b>?</b>,4 x 10-6,,NR,1.1574948,'-,[1.09-1.23],'-,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,Mapping not available
rs12505589-<b>?</b>,4 x 10-6,,NR,1.1673031,'-,[1.09-1.25],'-,Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,4:136496076
rs587150-<b>?</b>,1 x 10-6,,NR,1.2127603,'-,[1.12-1.31],"AFDN-DT, LINC01558",Breast cancer specific mortality in estrogen receptor positive breast cancer,"estrogen-receptor positive breast cancer, mortality",GCST007475,6:167818409
rs111410779-<b>?</b>,2 x 10-6,,NR,0.7558102,'-,[0.67-0.85],"PEDS1, PEDS1-UBE2V1",Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,20:50148998
rs1223809-<b>?</b>,6 x 10-7,,NR,0.77497697,'-,[0.70-0.86],LINC02775,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,1:214187549
rs2074885-<b>?</b>,1 x 10-6,,NR,0.8028575,'-,[0.73-0.88],POLG,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,15:89326435
rs11846015-<b>?</b>,3 x 10-6,,NR,0.8028945,'-,[0.73-0.88],"TRAV20, TRAV19",Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,14:22010722
rs6628643-<b>?</b>,2 x 10-6,,NR,0.83806884,'-,[0.78-0.90],DMD,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,X:31787910
rs2825231-<b>?</b>,2 x 10-6,,NR,0.8523688,'-,[0.80-0.91],PPIAP22,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,21:18948980
rs6475992-<b>?</b>,2 x 10-6,,NR,0.852871,'-,[0.80-0.91],MOB3B,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,9:27382087
rs1895136-<b>?</b>,2 x 10-6,,NR,0.86301345,'-,[0.81-0.92],MYT1L,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,2:2250596
rs1809591-<b>?</b>,2 x 10-6,,NR,1.1678296,'-,[1.10-1.25],RPL38P2,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,2:77712387
rs67918676-<b>?</b>,1 x 10-7,,NR,1.274184,'-,[1.16-1.39],"HNRNPA1P73, EIF4HP1",Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,7:27406338
rs12617237-<b>?</b>,2 x 10-6,,NR,1.3453282,'-,[1.19-1.52],CCDC148,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,2:158326236
rs28716841-<b>?</b>,3 x 10-6,,NR,1.3696141,'-,[1.20-1.56],FSTL4,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,5:133397775
rs72804888-<b>?</b>,8 x 10-7,,NR,1.5575172,'-,[1.31-1.86],SVIL,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,10:29793048
rs35557655-<b>?</b>,8 x 10-7,,NR,1.6119925,'-,[1.33-1.95],HS3ST2,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,16:22796100
rs2937080-<b>?</b>,2 x 10-6,,NR,0.4252747,'-,[0.30-0.60],EDIL3,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,5:84311324
chr6:168438325-<b>?</b>,7 x 10-7,,NR,0.51752573,'-,[0.40-0.67],'-,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,Mapping not available
rs213667-<b>?</b>,2 x 10-6,,NR,0.34337574,'-,[0.22-0.53],"SSTR5-AS1, SOX8",Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,16:1056795
rs4784227-<b>T</b>,1 x 10-28,(all races combined),0.24,1.24,'-,[1.20-1.29],CASC16,Breast cancer,breast carcinoma,GCST000709,16:52565276
rs12243039-<b>?</b>,6 x 10-6,"(All samples, overall toxicity, multivariable analysis)",0.01,3.39,'-,'-,NEBL,Response to radiotherapy in cancer (late toxicity),"response to radiation, prostate carcinoma, breast carcinoma",GCST002431,10:21147293
rs16958536-<b>?</b>,4 x 10-6,"(Breast cancer, telangiectasia, multivariable analysis)",0.22,1.66,'-,'-,RN7SKP101,Response to radiotherapy in cancer (late toxicity),"response to radiation, breast carcinoma",GCST002431,15:46737708
rs12243039-<b>?</b>,8 x 10-6,"(Breast cancer, overall toxicity, multivariable analysis)",0.01,3.28,'-,'-,NEBL,Response to radiotherapy in cancer (late toxicity),"response to radiation, breast carcinoma",GCST002431,10:21147293
rs2840044-<b>?</b>,8 x 10-6,"(Breast cancer, overal toxicity, multivariable analysis)",0.33,1.56,'-,'-,"SLFN14, SNHG30",Response to radiotherapy in cancer (late toxicity),"response to radiation, breast carcinoma",GCST002431,17:35565049
rs575018-<b>?</b>,7 x 10-7,"(Breast cancer, overall toxicity, univariable analysis)",0.34,'-,0.13 unit decrease,[NR],'-,Response to radiotherapy in cancer (late toxicity),"response to radiation, breast carcinoma",GCST002431,5:101043689
rs17142289-<b>?</b>,4 x 10-6,"(Breast cancer, overall toxicity, univariable analysis)",0.02,'-,0.35 unit increase,[NR],LY86-AS1,Response to radiotherapy in cancer (late toxicity),"response to radiation, breast carcinoma",GCST002431,6:6550516
rs4951011-<b>G</b>,9 x 10-9,(East Asian),0.282,1.09,'-,[1.06-1.12],"ZBED6, ZC3H11A",Breast cancer,breast carcinoma,GCST002537,1:203797203
rs10474352-<b>C</b>,2 x 10-9,(East Asian),0.482,1.09,'-,[1.06-1.12],ARRDC3-AS1,Breast cancer,breast carcinoma,GCST002537,5:91436408
rs2290203-<b>G</b>,4 x 10-8,(East Asian),0.504,1.08,'-,[1.05-1.11],"PRC1, PRC1-AS1",Breast cancer,breast carcinoma,GCST002537,15:90968837
rs11082321-<b>A</b>,7 x 10-7,(East Asian),0.21,1.08,'-,[NR],CABLES1,Breast cancer,breast carcinoma,GCST002537,18:23196687
rs16886165-<b>G</b>,5 x 10-7,,0.15,1.23,'-,[1.12-1.35],MAP3K1,Breast cancer,breast carcinoma,GCST000365,5:56727256
rs11249433-<b>C</b>,7 x 10-10,,0.39,1.16,'-,[1.09-1.24],EMBP1,Breast cancer,breast carcinoma,GCST000365,1:121538815
rs999737-<b>C</b>,2 x 10-7,,0.76,1.06,'-,[1.01-1.14],RAD51B,Breast cancer,breast carcinoma,GCST000365,14:68567965
rs13387042-<b>A</b>,2 x 10-8,,0.51,1.25,'-,[1.15-1.37],'-,Breast cancer,breast carcinoma,GCST000365,2:217041109
rs3803662-<b>T</b>,1 x 10-9,,0.27,1.16,'-,[1.07-1.27],CASC16,Breast cancer,breast carcinoma,GCST000365,16:52552429
rs2981579-<b>T</b>,2 x 10-10,,0.41,1.17,'-,[1.07-1.27],FGFR2,Breast cancer,breast carcinoma,GCST000365,10:121577821
rs13387042-<b>A</b>,1 x 10-13,,0.5,1.2,'-,[1.14-1.26],'-,Breast cancer,breast carcinoma,GCST000037,2:217041109
rs3803662-<b>T</b>,6 x 10-19,,0.27,1.28,'-,[1.21-1.35],CASC16,Breast cancer,breast carcinoma,GCST000037,16:52552429
rs1265507-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"RN7SKP216, TBX5-AS1",Percent mammographic density,breast carcinoma,GCST001489,12:114430333
rs112319963-<b>?</b>,2 x 10-6,,0.01,4,'-,[2.22-7.69],'-,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,6:66197278
rs71564305-<b>?</b>,3 x 10-6,,0.04,2.3255813,'-,[1.59-20],CD83,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,6:14107800
rs9834244-<b>?</b>,8 x 10-7,,0.09,1.6949153,'-,[1.37-2.7],"LINC02066, AADACL2",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,3:151704793
rs12548629-<b>?</b>,3 x 10-7,,0.27,1.4084507,'-,[1.23-1.72],"BAALC-AS1, BAALC",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,8:103189173
rs13293114-<b>?</b>,4 x 10-6,,0.36,1.3157895,'-,[1.18-1.56],"FRMD3, RN7SKP242",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,9:83217469
rs6071641-<b>?</b>,6 x 10-6,,0.42,1.3157895,'-,[1.18-1.59],DHX35,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,20:39049018
rs4075454-<b>?</b>,5 x 10-6,,0.49,1.2987013,'-,[1.16-1.52],"SFT2D1, PRR18",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,6:166308998
rs7975553-<b>?</b>,6 x 10-6,,0.43,1.2987013,'-,[1.16-1.47],RIMBP2,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,12:130560585
rs742276-<b>?</b>,9 x 10-6,,0.44,1.2987013,'-,[1.15-1.52],DHX35,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,20:39051206
rs1023996-<b>G</b>,2 x 10-6,,0.58,1.32,'-,[1.18-1.48],SYT9,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,11:7379559
rs11013837-<b>T</b>,6 x 10-6,,0.77,1.37,'-,[1.19-1.58],KIAA1217,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,10:23995722
rs1468348-<b>T</b>,5 x 10-6,,0.8,1.39,'-,[1.25-1.6],VPS41,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,7:38728314
rs162277-<b>C</b>,7 x 10-6,,0.79,1.41,'-,[1.26-1.63],"ZNF808, ZNF578",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,19:52526945
rs7794030-<b>A</b>,1 x 10-6,,0.81,1.43,'-,[1.29-1.65],"FAM183BP, VPS41",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,7:38712494
rs34775372-<b>C</b>,6 x 10-6,,0.92,1.69,'-,[1.33-2.13],"LINC01396, STX18-AS1",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,4:4794716
chr1:34655226-<b>?</b>,7 x 10-6,,0.95,2.05,'-,[1.48-2.84]],'-,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,Mapping not available
rs112822051-<b>C</b>,3 x 10-6,,0.97,2.56,'-,[1.67-3.93],"GP6-AS1, GP6",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,19:55035675
rs113118767-<b>T</b>,9 x 10-6,,0.99,4.02,'-,[1.99-8.13],SLC24A3,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,20:19518790
rs4973768-<b>T</b>,4 x 10-23,,0.46,1.11,'-,[1.08-1.13],SLC4A7,Breast cancer,breast carcinoma,GCST004948,3:27374522
rs6504950-<b>G</b>,1 x 10-8,,0.73,1.05,'-,[1.03-1.09],STXBP4,Breast cancer,breast carcinoma,GCST004948,17:54979110
rs1357245-<b>G</b>,2 x 10-7,,0.54,1.06,'-,NR,NEK10,Breast cancer,breast carcinoma,GCST004949,3:27145111
rs377595512-<b>C</b>,4 x 10-24,,0.513325516,0.8166771,'-,[0.785289052-0.849319691],FGFR2,Breast cancer,breast carcinoma,GCST90013695,10:121581496
rs1314084-<b>T</b>,4 x 10-8,,0.837677862,1.1657724,'-,[1.10391199-1.231099387],PTHLH,Breast cancer,breast carcinoma,GCST90013695,12:27987344
rs4784227-<b>T</b>,4 x 10-21,,0.229797027,1.249785,'-,[1.19319124-1.309062956],CASC16,Breast cancer,breast carcinoma,GCST90013695,16:52565276
rs12455117-<b>T</b>,4 x 10-8,,0.302885169,0.8866379,'-,[0.849420099-0.925486452],SLC14A2,Breast cancer,breast carcinoma,GCST90013695,18:45304061
rs12483725-<b>A</b>,2 x 10-9,,0.168742185,1.1749938,'-,[1.114850279-1.238381921],LINC01426,Breast cancer,breast carcinoma,GCST90013695,21:34746798
rs146383533-<b>TTTTC</b>,1 x 10-11,,0.349384138,0.86398584,'-,[0.828337909-0.901167893],"SIAH2, SIAH2-AS1",Breast cancer,breast carcinoma,GCST90013695,3:150762314
rs10941678-<b>A</b>,7 x 10-12,,0.57826253,1.1487857,'-,[1.104188921-1.195183824],"RN7SL383P, LINC02224",Breast cancer,breast carcinoma,GCST90013695,5:44672681
rs112776581-<b>T</b>,6 x 10-9,,0.09528834,1.2234231,'-,[1.143234678-1.309236175],MAP3K1,Breast cancer,breast carcinoma,GCST90013695,5:56758507
rs7763637-<b>A</b>,5 x 10-13,,0.243384187,1.1814078,'-,[1.129184761-1.236046211],"CCDC170, ESR1",Breast cancer,breast carcinoma,GCST90013695,6:151628177
rs16886181-<b>?</b>,9 x 10-14,,0.18,1.26,'-,[1.18-1.34],MAP3K1,Breast cancer (early onset),breast carcinoma,GCST002346,5:56733416
rs3803662-<b>T</b>,1 x 10-36,,0.25,1.2,'-,[1.16-1.24],CASC16,Breast cancer,breast carcinoma,GCST000035,16:52552429
rs2981582-<b>A</b>,2 x 10-76,,0.38,1.26,'-,[1.23-1.30],FGFR2,Breast cancer,breast carcinoma,GCST000035,10:121592803
rs13281615-<b>C</b>,5 x 10-12,,0.4,1.08,'-,[1.05-1.11],"CASC8, POU5F1B, PCAT1",Breast cancer,breast carcinoma,GCST000035,8:127343372
rs981782-<b>C</b>,9 x 10-6,,0.53,1.04,'-,[1.01-1.08],HCN1,Breast cancer,breast carcinoma,GCST000035,5:45285616
rs889312-<b>C</b>,7 x 10-20,,0.28,1.13,'-,[1.10-1.16],MAP3K1,Breast cancer,breast carcinoma,GCST000035,5:56736057
rs3817198-<b>C</b>,3 x 10-9,,0.3,1.07,'-,[1.04-1.11],LSP1,Breast cancer,breast carcinoma,GCST000035,11:1887776
rs2981575-<b>?</b>,1 x 10-8,,0.42,1.28,'-,[1.18-1.39],FGFR2,Breast cancer in BRCA2 mutation carriers,breast carcinoma,GCST000846,10:121586602
rs2420946-<b>A</b>,2 x 10-14,,0.39,1.27,'-,[1.19-1.34],FGFR2,Breast cancer in BRCA2 mutation carriers,breast carcinoma,GCST007302,10:121591810
rs3803662-<b>A</b>,5 x 10-11,,0.27,1.24,'-,[1.16-1.32],CASC16,Breast cancer in BRCA2 mutation carriers,breast carcinoma,GCST007302,16:52552429
rs9348512-<b>C</b>,4 x 10-8,,0.65,1.18,'-,[1.11-1.25],MIR5689HG,Breast cancer in BRCA2 mutation carriers,breast carcinoma,GCST007302,6:10456473
rs619373-<b>A</b>,3 x 10-6,,0.07,1.3,'-,[1.17-1.45],FGF13,Breast cancer in BRCA2 mutation carriers,breast carcinoma,GCST007302,X:138931625
rs184577-<b>G</b>,4 x 10-6,,0.75,1.18,'-,[1.10-1.27],CYP1B1-AS1,Breast cancer in BRCA2 mutation carriers,breast carcinoma,GCST007302,2:38150263
rs8170-<b>A</b>,2 x 10-9,,0.17,1.26,'-,[1.17-1.35],"BABAM1, USHBP1",Breast cancer,breast carcinoma,GCST000801,19:17278895
rs8100241-<b>G</b>,4 x 10-8,,NR,1.14,'-,[NR],"USHBP1, ANKLE1",Breast cancer,breast carcinoma,GCST001683,19:17282085
rs9383938-<b>T</b>,2 x 10-10,,NR,1.28,'-,[NR],ESR1,Breast cancer,breast carcinoma,GCST001683,6:151666222
rs2284378-<b>T</b>,1 x 10-8,,0.31,1.16,'-,[1.10-1.22],RALY,Breast cancer,breast carcinoma,GCST001683,20:34000289
rs17530068-<b>C</b>,3 x 10-7,,0.24,1.16,'-,[1.10-1.23],TENT5A,Breast cancer,breast carcinoma,GCST001683,6:81483392
rs10069690-<b>T</b>,1 x 10-10,,0.26,1.18,'-,[1.13-1.25],TERT,Breast cancer,breast carcinoma,GCST001298,5:1279675
rs1763604-<b>C</b>,7 x 10-9,,0.42085,'-,0.0372 unit decrease,[0.025-0.05],"HSPB7, SRARP","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,1:16013277
rs77548871-<b>C</b>,5 x 10-9,,0.0472,'-,0.0991 unit decrease,[0.066-0.132],ZBTB7B,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,1:155016057
rs13007211-<b>A</b>,1 x 10-9,,0.6935,'-,0.0432 unit increase,[0.029-0.057],VAMP8,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,2:85573959
rs17041869-<b>A</b>,2 x 10-9,,0.8804,'-,0.0571 unit decrease,[0.038-0.076],"MIR4435-2HG, BCL2L11","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,2:111138666
rs57251748-<b>CT</b>,9 x 10-12,,0.15,'-,0.0598 unit decrease,[0.043-0.077],TET2,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,4:105137029
rs739704-<b>A</b>,3 x 10-14,,0.2515,'-,0.0542 unit decrease,[0.04-0.068],JAZF1,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,7:27950149
rs720475-<b>A</b>,7 x 10-12,,0.25455,'-,0.0495 unit decrease,[0.035-0.064],ARHGEF5,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,7:144377836
rs17762342-<b>A</b>,2 x 10-15,,0.7935,'-,0.061 unit increase,[0.046-0.076],PCAT1,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,8:126990792
rs3802173-<b>T</b>,3 x 10-11,,0.2261,'-,0.0521 unit increase,[0.037-0.068],"RN7SKP226, PVT1","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,8:128187668
rs9657608-<b>T</b>,1 x 10-10,,0.0923,'-,0.0685 unit increase,[0.048-0.089],"CDKN2A-DT, MTAP","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,9:21956231
rs7898685-<b>A</b>,3 x 10-10,,0.2913,'-,0.0428 unit increase,[0.029-0.056],DNAJC1,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,10:22010574
rs568110-<b>T</b>,5 x 10-12,,0.2057,'-,0.0523 unit increase,[0.037-0.067],"PPIAP39, RNU7-165P","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,10:113390512
rs7937840-<b>T</b>,2 x 10-9,,0.26465,'-,0.0446 unit increase,[0.03-0.059],INCENP,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,11:62126500
rs118151305-<b>A</b>,6 x 10-9,,0.12005,'-,0.0672 unit decrease,[0.045-0.09],"CD248, RIN1","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,11:66324772
rs72932523-<b>A</b>,1 x 10-9,,0.10565,'-,0.0601 unit increase,[0.041-0.08],"TPCN2, SMIM38","Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,11:69138652
rs2277509-<b>A</b>,9 x 10-12,,0.69865,'-,0.0466 unit increase,[0.033-0.06],CCDC88C,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,14:91283251
rs2628317-<b>A</b>,4 x 10-16,,0.72985,'-,0.0582 unit increase,[0.044-0.072],STXBP4,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,17:55135212
rs1469713-<b>A</b>,1 x 10-10,,0.64405,'-,0.043 unit decrease,[0.03-0.056],GATAD2A,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)","prostate carcinoma, breast carcinoma, ovarian carcinoma",GCST010797,19:19417997
rs9693444-<b>A</b>,1 x 10-10,,0.32,1.07,'-,[1.05-1.09],"RPL17P33, LINC00589",Breast cancer,breast carcinoma,GCST007236,8:29652100
rs6472903-<b>T</b>,3 x 10-13,,0.82,1.098901,'-,[1.08-1.12],CASC9,Breast cancer,breast carcinoma,GCST007236,8:75318066
rs2943559-<b>G</b>,7 x 10-11,,0.07,1.13,'-,[1.09-1.17],HNF4G,Breast cancer,breast carcinoma,GCST007236,8:75505702
rs13281615-<b>G</b>,3 x 10-22,,0.4,1.1,'-,[1.08-1.12],"CASC8, POU5F1B, PCAT1",Breast cancer,breast carcinoma,GCST007236,8:127343372
rs11780156-<b>T</b>,8 x 10-7,,0.16,1.07,'-,[1.04-1.09],PVT1,Breast cancer,breast carcinoma,GCST007236,8:128182395
rs10759243-<b>A</b>,7 x 10-7,,0.29,1.05,'-,[1.03-1.08],PPIAP88,Breast cancer,breast carcinoma,GCST007236,9:107543834
rs865686-<b>T</b>,4 x 10-27,,0.62,1.1111112,'-,[1.09-1.14],CHCHD4P2,Breast cancer,breast carcinoma,GCST007236,9:108126198
rs7072776-<b>A</b>,8 x 10-10,,0.29,1.07,'-,[1.05-1.09],"MLLT10, DNAJC1",Breast cancer,breast carcinoma,GCST007236,10:21744013
rs11814448-<b>C</b>,3 x 10-13,,0.02,1.27,'-,[1.19-1.36],DNAJC1,Breast cancer,breast carcinoma,GCST007236,10:22026914
rs10995190-<b>G</b>,2 x 10-29,,0.84,1.1627907,'-,[1.14-1.2],ZNF365,Breast cancer,breast carcinoma,GCST007236,10:62518923
rs704010-<b>T</b>,3 x 10-15,,0.38,1.08,'-,[1.06-1.1],ZMIZ1,Breast cancer,breast carcinoma,GCST007236,10:79081391
rs7904519-<b>G</b>,5 x 10-8,,0.46,1.05,'-,[1.03-1.07],TCF7L2,Breast cancer,breast carcinoma,GCST007236,10:113014168
rs2981579-<b>A</b>,1 x 10-128,,0.4,1.27,'-,[1.24-1.29],FGFR2,Breast cancer,breast carcinoma,GCST007236,10:121577821
rs3817198-<b>C</b>,1 x 10-10,,0.31,1.07,'-,[1.05-1.09],LSP1,Breast cancer,breast carcinoma,GCST007236,11:1887776
rs3903072-<b>G</b>,3 x 10-7,,0.53,1.0526316,'-,[1.03-1.08],"OVOL1, CFL1",Breast cancer,breast carcinoma,GCST007236,11:65815595
rs78540526-<b>T</b>,2 x 10-62,,0.08,1.34,'-,[1.29-1.38],LINC01488,Breast cancer,breast carcinoma,GCST007236,11:69516650
rs11820646-<b>C</b>,2 x 10-7,,0.59,1.0526316,'-,[1.03-1.08],"RPS27P20, LINC01395",Breast cancer,breast carcinoma,GCST007236,11:129591276
rs10771399-<b>A</b>,2 x 10-22,,0.88,1.1627907,'-,[1.12-1.2],PTHLH,Breast cancer,breast carcinoma,GCST007236,12:28002147
rs17356907-<b>A</b>,6 x 10-17,,0.7,1.098901,'-,[1.08-1.11],PGAM1P5,Breast cancer,breast carcinoma,GCST007236,12:95633983
rs1292011-<b>A</b>,1 x 10-16,,0.58,1.0869565,'-,[1.06-1.11],'-,Breast cancer,breast carcinoma,GCST007236,12:115398717
rs11571833-<b>T</b>,2 x 10-6,,0.01,1.27,'-,[1.15-1.4],BRCA2,Breast cancer,breast carcinoma,GCST007236,13:32398489
rs2236007-<b>G</b>,5 x 10-10,,0.79,1.0752687,'-,[1.05-1.1],PAX9,Breast cancer,breast carcinoma,GCST007236,14:36663564
rs2588809-<b>T</b>,4 x 10-9,,0.16,1.08,'-,[1.05-1.11],RAD51B,Breast cancer,breast carcinoma,GCST007236,14:68193711
rs999737-<b>C</b>,4 x 10-13,,0.77,1.0869565,'-,[1.06-1.11],RAD51B,Breast cancer,breast carcinoma,GCST007236,14:68567965
rs941764-<b>G</b>,2 x 10-10,,0.34,1.07,'-,[1.05-1.09],CCDC88C,Breast cancer,breast carcinoma,GCST007236,14:91374725
rs745570-<b>A</b>,5 x 10-7,,0.5,1.0526316,'-,'-,"LINC01977, CBX8",Breast cancer,breast carcinoma,GCST007236,17:79807926
rs6507583-<b>A</b>,1 x 10-6,,0.93,1.098901,'-,'-,SETBP1,Breast cancer,breast carcinoma,GCST007236,18:44819625
rs616488-<b>A</b>,9 x 10-9,,0.67,1.0638298,'-,[1.04-1.09],PEX14,Breast cancer,breast carcinoma,GCST007236,1:10506158
rs11552449-<b>T</b>,6 x 10-7,,0.16,1.07,'-,[1.04-1.09],DCLRE1B,Breast cancer,breast carcinoma,GCST007236,1:113905767
rs11249433-<b>G</b>,4 x 10-20,,0.4,1.09,'-,[1.07-1.12],EMBP1,Breast cancer,breast carcinoma,GCST007236,1:121538815
rs4849887-<b>C</b>,5 x 10-9,,0.9,1.098901,'-,[1.06-1.14],LINC01101,Breast cancer,breast carcinoma,GCST007236,2:120487546
rs2016394-<b>G</b>,2 x 10-6,,0.52,1.0526316,'-,[1.03-1.06],DLX2-DT,Breast cancer,breast carcinoma,GCST007236,2:172108243
rs13387042-<b>A</b>,9 x 10-41,,0.51,1.1363636,'-,[1.11-1.16],'-,Breast cancer,breast carcinoma,GCST007236,2:217041109
rs6762644-<b>G</b>,6 x 10-11,,0.4,1.07,'-,[1.05-1.09],ITPR1,Breast cancer,breast carcinoma,GCST007236,3:4700592
rs4973768-<b>T</b>,5 x 10-22,,0.47,1.1,'-,[1.08-1.12],SLC4A7,Breast cancer,breast carcinoma,GCST007236,3:27374522
rs12493607-<b>C</b>,7 x 10-8,,0.34,1.06,'-,[1.04-1.08],TGFBR2,Breast cancer,breast carcinoma,GCST007236,3:30641447
rs1053338-<b>G</b>,2 x 10-7,,0.13,1.08,'-,[1.05-1.11],ATXN7,Breast cancer,breast carcinoma,GCST007236,3:63982224
rs9790517-<b>T</b>,7 x 10-6,,0.22,1.05,'-,[1.03-1.08],TET2,Breast cancer,breast carcinoma,GCST007236,4:105163621
rs6828523-<b>C</b>,3 x 10-12,,0.88,1.1111112,'-,[1.08-1.15],ADAM29,Breast cancer,breast carcinoma,GCST007236,4:174925275
rs10069690-<b>T</b>,2 x 10-8,,0.26,1.06,'-,[1.04-1.09],TERT,Breast cancer,breast carcinoma,GCST007236,5:1279675
rs10941679-<b>G</b>,3 x 10-26,,0.25,1.12,'-,[1.1-1.15],"LINC02224, RN7SL383P",Breast cancer,breast carcinoma,GCST007236,5:44706396
rs889312-<b>C</b>,3 x 10-27,,0.28,1.12,'-,[1.1-1.15],MAP3K1,Breast cancer,breast carcinoma,GCST007236,5:56736057
rs10472076-<b>C</b>,2 x 10-6,,0.38,1.05,'-,[1.03-1.07],"RAB3C, PDE4D",Breast cancer,breast carcinoma,GCST007236,5:58888234
rs1353747-<b>T</b>,1 x 10-6,,0.9,1.0869565,'-,[1.05-1.12],'-,Breast cancer,breast carcinoma,GCST007236,Mapping not available
rs1432679-<b>C</b>,4 x 10-12,,0.43,1.07,'-,[1.05-1.09],EBF1,Breast cancer,breast carcinoma,GCST007236,5:158817075
rs204247-<b>G</b>,3 x 10-7,,0.44,1.05,'-,[1.03-1.07],"MCUR1, RANBP9",Breast cancer,breast carcinoma,GCST007236,6:13722291
rs17529111-<b>C</b>,5 x 10-7,,0.22,1.06,'-,[1.04-1.08],TENT5A,Breast cancer,breast carcinoma,GCST007236,6:81418669
rs12662670-<b>G</b>,1 x 10-18,,0.07,1.17,'-,[1.13-1.22],CCDC170,Breast cancer,breast carcinoma,GCST007236,6:151597721
rs6964587-<b>T</b>,1 x 10-6,,0.39,1.05,'-,[1.03-1.07],AKAP9,Breast cancer,breast carcinoma,GCST007236,7:92001306
rs720475-<b>G</b>,1 x 10-8,,0.75,1.0638298,'-,[1.04-1.09],ARHGEF5,Breast cancer,breast carcinoma,GCST007236,7:144377836
rs3803662-<b>A</b>,3 x 10-86,,0.26,1.24,'-,[1.21-1.26],CASC16,Breast cancer,breast carcinoma,GCST007236,16:52552429
rs17817449-<b>T</b>,7 x 10-13,,0.6,1.0752687,'-,[1.05-1.1],FTO,Breast cancer,breast carcinoma,GCST007236,16:53779455
rs13329835-<b>G</b>,6 x 10-12,,0.22,1.08,'-,[1.06-1.11],CDYL2,Breast cancer,breast carcinoma,GCST007236,16:80616908
rs6504950-<b>G</b>,8 x 10-9,,0.72,1.0638298,'-,[1.04-1.09],STXBP4,Breast cancer,breast carcinoma,GCST007236,17:54979110
rs527616-<b>G</b>,1 x 10-7,,0.62,1.0526316,'-,[1.03-1.08],AQP4-AS1,Breast cancer,breast carcinoma,GCST007236,18:26757460
rs1436904-<b>T</b>,5 x 10-6,,0.6,1.0416667,'-,[1.03-1.06],"AQP4-AS1, CHST9",Breast cancer,breast carcinoma,GCST007236,18:26990703
rs4808801-<b>A</b>,6 x 10-14,,0.65,1.0752687,'-,[1.06-1.1],ELL,Breast cancer,breast carcinoma,GCST007236,19:18460331
rs3760982-<b>A</b>,9 x 10-7,,0.46,1.05,'-,[1.03-1.07],"LYPD5, KCNN4",Breast cancer,breast carcinoma,GCST007236,19:43782361
rs2823093-<b>G</b>,2 x 10-12,,0.73,1.0752687,'-,[1.05-1.1],NRIP1,Breast cancer,breast carcinoma,GCST007236,21:15148511
rs17879961-<b>G</b>,8 x 10-7,,0.0049,1.37,'-,[1.21-1.55],CHEK2,Breast cancer,breast carcinoma,GCST007236,22:28725099
rs132390-<b>C</b>,4 x 10-7,,0.04,1.14,'-,[1.08-1.2],EMID1,Breast cancer,breast carcinoma,GCST007236,22:29225488
rs6001930-<b>C</b>,4 x 10-14,,0.11,1.12,'-,[1.09-1.16],MRTFA,Breast cancer,breast carcinoma,GCST007236,22:40480230
rs2046210-<b>C</b>,5 x 10-9,,0.08,1.28,'-,[1.18-1.39],"ESR1, CCDC170",Breast Cancer in BRCA1 mutation carriers,breast carcinoma,GCST001916,6:151627231
rs10771399-<b>A</b>,8 x 10-6,,0.86,1.18,'-,[1.1-1.27],PTHLH,Breast Cancer in BRCA1 mutation carriers,breast carcinoma,GCST001916,12:28002147
rs2290854-<b>A</b>,1 x 10-7,,0.31,1.13,'-,[1.08-1.18],MDM4,Breast Cancer in BRCA1 mutation carriers,breast carcinoma,GCST001916,1:204546897
rs11196174-<b>G</b>,8 x 10-7,,0.28,1.13,'-,[1.07-1.18],TCF7L2,Breast Cancer in BRCA1 mutation carriers,breast carcinoma,GCST001916,10:112974337
rs765855-<b>?</b>,4 x 10-6,,'-,'-,'-,'-,NXPH1,Breast Cancer in BRCA1 mutation carriers,breast carcinoma,GCST001916,7:8512984
rs8170-<b>G</b>,4 x 10-13,,0.48,1.19,'-,[1.14-1.25],"BABAM1, USHBP1",Breast Cancer in BRCA1 mutation carriers,breast carcinoma,GCST001916,19:17278895
rs10069690-<b>T</b>,5 x 10-12,,0.321,1.15,'-,[1.11-1.20],TERT,Breast cancer,breast carcinoma,GCST001930,5:1279675
rs17530068-<b>C</b>,3 x 10-6,,0.237,1.09,'-,[1.05-1.13],TENT5A,Breast cancer,breast carcinoma,GCST001930,6:81483392
rs2046210-<b>A</b>,5 x 10-16,,0.423,1.15,'-,[1.11-1.19],"ESR1, CCDC170",Breast cancer,breast carcinoma,GCST001930,6:151627231
rs10995190-<b>G</b>,1 x 10-7,,0.846,1.12,'-,[1.08-1.18],ZNF365,Breast cancer,breast carcinoma,GCST001930,10:62518923
rs10771399-<b>T</b>,2 x 10-12,,0.895,1.2,'-,[1.15-1.27],PTHLH,Breast cancer,breast carcinoma,GCST001930,12:28002147
rs3803662-<b>T</b>,6 x 10-13,,0.267,1.14,'-,[1.10-1.18],CASC16,Breast cancer,breast carcinoma,GCST001930,16:52552429
rs8170-<b>A</b>,9 x 10-13,,0.191,1.15,'-,[1.11-1.20],"BABAM1, USHBP1",Breast cancer,breast carcinoma,GCST001930,19:17278895
rs616488-<b>A</b>,1 x 10-8,,0.665,1.1,'-,[1.06-1.14],PEX14,Breast cancer,breast carcinoma,GCST001930,1:10506158
rs1432679-<b>C</b>,7 x 10-6,,0.435,1.08,'-,[1.04-1.11],EBF1,Breast cancer,breast carcinoma,GCST001930,5:158817075
rs17356907-<b>A</b>,9 x 10-6,,0.702,1.09,'-,[1.04-1.12],PGAM1P5,Breast cancer,breast carcinoma,GCST001930,12:95633983
rs11571833-<b>T</b>,6 x 10-6,,0.496,1.52,'-,[1.31-1.77],BRCA2,Breast cancer,breast carcinoma,GCST001930,13:32398489
rs17817449-<b>T</b>,6 x 10-7,,0.526,1.09,'-,[1.05-1.12],FTO,Breast cancer,breast carcinoma,GCST001930,16:53779455
rs6001930-<b>C</b>,2 x 10-6,,0.107,1.14,'-,[1.08-1.20],MRTFA,Breast cancer,breast carcinoma,GCST001930,22:40480230
rs4245739-<b>?</b>,2 x 10-12,,0.26,1.14,'-,[1.10-1.18],MDM4,Breast cancer,breast carcinoma,GCST001930,1:204549714
rs6678914-<b>?</b>,1 x 10-8,,0.59,1.1,'-,[1.06-1.13],LGR6,Breast cancer,breast carcinoma,GCST001930,1:202218048
rs12710696-<b>?</b>,5 x 10-8,,0.36,1.1,'-,[1.06-1.13],LINC01376,Breast cancer,breast carcinoma,GCST001930,2:19121042
rs11075995-<b>?</b>,4 x 10-8,,0.24,1.11,'-,[1.07-1.15],FTO,Breast cancer,breast carcinoma,GCST001930,16:53821379
rs4808801-<b>A</b>,5 x 10-15,,0.65,1.08,'-,[1.05-1.1],ELL,Breast cancer,breast carcinoma,GCST001937,19:18460331
rs3760982-<b>A</b>,2 x 10-10,,0.46,1.06,'-,[1.04-1.08],"LYPD5, KCNN4",Breast cancer,breast carcinoma,GCST001937,19:43782361
rs132390-<b>C</b>,3 x 10-9,,0.036,1.12,'-,[1.07-1.18],EMID1,Breast cancer,breast carcinoma,GCST001937,22:29225488
rs704010-<b>T</b>,7 x 10-22,,0.38,1.08,'-,[1.06-1.10],ZMIZ1,Breast cancer,breast carcinoma,GCST001937,10:79081391
rs13387042-<b>A</b>,2 x 10-57,,0.51,1.14,'-,[1.11-1.16],'-,Breast cancer,breast carcinoma,GCST001937,2:217041109
rs720475-<b>G</b>,7 x 10-11,,0.75,1.06,'-,[1.04-1.09],ARHGEF5,Breast cancer,breast carcinoma,GCST001937,7:144377836
rs10941679-<b>G</b>,2 x 10-37,,0.25,1.13,'-,[1.10-1.15],"LINC02224, RN7SL383P",Breast cancer,breast carcinoma,GCST001937,5:44706396
rs6472903-<b>T</b>,2 x 10-17,,0.82,1.1,'-,[1.08-1.12],CASC9,Breast cancer,breast carcinoma,GCST001937,8:75318066
rs3757318-<b>A</b>,2 x 10-21,,0.07,1.16,'-,[1.12-1.21],CCDC170,Breast cancer,breast carcinoma,GCST001937,6:151592978
rs10759243-<b>A</b>,1 x 10-8,,0.39,1.06,'-,[1.03-1.08],PPIAP88,Breast cancer,breast carcinoma,GCST001937,9:107543834
rs865686-<b>T</b>,1 x 10-34,,0.62,1.12,'-,[1.1-1.14],CHCHD4P2,Breast cancer,breast carcinoma,GCST001937,9:108126198
rs10995190-<b>G</b>,1 x 10-36,,0.84,1.16,'-,[1.14-1.19],ZNF365,Breast cancer,breast carcinoma,GCST001937,10:62518923
rs2981579-<b>A</b>,2 x 10-170,,0.4,1.27,'-,[1.24-1.29],FGFR2,Breast cancer,breast carcinoma,GCST001937,10:121577821
rs3817198-<b>C</b>,2 x 10-11,,0.31,1.07,'-,[1.05-1.09],LSP1,Breast cancer,breast carcinoma,GCST001937,11:1887776
rs614367-<b>T</b>,2 x 10-63,,0.15,1.21,'-,[1.18-1.24],LINC01488,Breast cancer,breast carcinoma,GCST001937,11:69513996
rs1292011-<b>A</b>,9 x 10-22,,0.58,1.09,'-,[1.06-1.11],'-,Breast cancer,breast carcinoma,GCST001937,12:115398717
rs3803662-<b>A</b>,2 x 10-114,,0.26,1.24,'-,[1.21-1.27],CASC16,Breast cancer,breast carcinoma,GCST001937,16:52552429
rs6504950-<b>G</b>,2 x 10-13,,0.72,1.06,'-,[1.04-1.09],STXBP4,Breast cancer,breast carcinoma,GCST001937,17:54979110
rs2823093-<b>G</b>,7 x 10-16,,0.73,1.09,'-,[1.06-1.11],NRIP1,Breast cancer,breast carcinoma,GCST001937,21:15148511
rs11249433-<b>G</b>,2 x 10-26,,0.4,1.09,'-,[1.07-1.11],EMBP1,Breast cancer,breast carcinoma,GCST001937,1:121538815
rs616488-<b>A</b>,2 x 10-10,,0.67,1.06,'-,[1.04-1.09],PEX14,Breast cancer,breast carcinoma,GCST001937,1:10506158
rs11552449-<b>T</b>,2 x 10-8,,0.17,1.07,'-,[1.04-1.09],DCLRE1B,Breast cancer,breast carcinoma,GCST001937,1:113905767
rs4849887-<b>C</b>,4 x 10-11,,0.902,1.1,'-,[1.06-1.14],LINC01101,Breast cancer,breast carcinoma,GCST001937,2:120487546
rs2016394-<b>G</b>,1 x 10-8,,0.52,1.05,'-,[1.03-1.08],DLX2-DT,Breast cancer,breast carcinoma,GCST001937,2:172108243
rs16857609-<b>T</b>,1 x 10-15,,0.26,1.08,'-,[1.06-1.10],DIRC3,Breast cancer,breast carcinoma,GCST001937,2:217431785
rs4973768-<b>T</b>,2 x 10-30,,0.47,1.1,'-,[1.08-1.12],SLC4A7,Breast cancer,breast carcinoma,GCST001937,3:27374522
rs889312-<b>C</b>,3 x 10-36,,0.28,1.12,'-,[1.10-1.15],MAP3K1,Breast cancer,breast carcinoma,GCST001937,5:56736057
rs1011970-<b>T</b>,6 x 10-8,,0.17,1.06,'-,[1.03-1.08],CDKN2B-AS1,Breast cancer,breast carcinoma,GCST001937,9:22062135
rs6001930-<b>C</b>,9 x 10-19,,0.11,1.12,'-,[1.09-1.16],MRTFA,Breast cancer,breast carcinoma,GCST001937,22:40480230
rs204247-<b>G</b>,8 x 10-9,,0.43,1.05,'-,[1.03-1.07],"MCUR1, RANBP9",Breast cancer,breast carcinoma,GCST001937,6:13722291
rs10069690-<b>T</b>,7 x 10-9,,0.26,1.06,'-,[1.04-1.09],TERT,Breast cancer,breast carcinoma,GCST001937,5:1279675
rs9693444-<b>A</b>,9 x 10-14,,0.32,1.07,'-,[1.05-1.09],"RPL17P33, LINC00589",Breast cancer,breast carcinoma,GCST001937,8:29652100
rs17530068-<b>G</b>,8 x 10-9,,0.22,1.05,'-,[1.03-1.08],TENT5A,Breast cancer,breast carcinoma,GCST001937,6:81483392
rs11780156-<b>T</b>,3 x 10-11,,0.16,1.07,'-,[1.04-1.10],PVT1,Breast cancer,breast carcinoma,GCST001937,8:128182395
rs13281615-<b>G</b>,1 x 10-27,,0.41,1.09,'-,[1.07-1.12],"CASC8, POU5F1B, PCAT1",Breast cancer,breast carcinoma,GCST001937,8:127343372
rs7072776-<b>A</b>,4 x 10-14,,0.29,1.07,'-,[1.05-1.09],"MLLT10, DNAJC1",Breast cancer,breast carcinoma,GCST001937,10:21744013
rs7904519-<b>G</b>,3 x 10-8,,0.46,1.06,'-,[1.04-1.08],TCF7L2,Breast cancer,breast carcinoma,GCST001937,10:113014168
rs11199914-<b>C</b>,2 x 10-8,,0.68,1.05,'-,[1.03-1.08],RN7SKP167,Breast cancer,breast carcinoma,GCST001937,10:121334387
rs1436904-<b>T</b>,3 x 10-8,,0.6,1.04,'-,[1.02-1.06],"AQP4-AS1, CHST9",Breast cancer,breast carcinoma,GCST001937,18:26990703
rs3903072-<b>G</b>,9 x 10-12,,0.53,1.05,'-,[1.04-1.08],"OVOL1, CFL1",Breast cancer,breast carcinoma,GCST001937,11:65815595
rs11820646-<b>C</b>,1 x 10-9,,0.59,1.05,'-,[1.03-1.08],"RPS27P20, LINC01395",Breast cancer,breast carcinoma,GCST001937,11:129591276
rs12422552-<b>C</b>,4 x 10-8,,0.26,1.05,'-,[1.03-1.07],"RPL30P11, GNAI2P1",Breast cancer,breast carcinoma,GCST001937,12:14260997
rs17356907-<b>A</b>,2 x 10-22,,0.7,1.1,'-,[1.08-1.12],PGAM1P5,Breast cancer,breast carcinoma,GCST001937,12:95633983
rs11571833-<b>T</b>,5 x 10-8,,0.008,1.26,'-,[1.14-1.39],BRCA2,Breast cancer,breast carcinoma,GCST001937,13:32398489
rs2236007-<b>G</b>,2 x 10-13,,0.79,1.08,'-,[1.05-1.1],PAX9,Breast cancer,breast carcinoma,GCST001937,14:36663564
rs2588809-<b>T</b>,1 x 10-10,,0.16,1.08,'-,[1.05-1.11],RAD51B,Breast cancer,breast carcinoma,GCST001937,14:68193711
rs941764-<b>G</b>,4 x 10-10,,0.34,1.06,'-,[1.04-1.09],CCDC88C,Breast cancer,breast carcinoma,GCST001937,14:91374725
rs17817449-<b>T</b>,6 x 10-14,,0.6,1.08,'-,[1.05-1.1],FTO,Breast cancer,breast carcinoma,GCST001937,16:53779455
rs13329835-<b>G</b>,2 x 10-16,,0.22,1.08,'-,[1.05-1.10],CDYL2,Breast cancer,breast carcinoma,GCST001937,16:80616908
rs527616-<b>G</b>,2 x 10-10,,0.62,1.05,'-,[1.03-1.08],AQP4-AS1,Breast cancer,breast carcinoma,GCST001937,18:26757460
rs6762644-<b>G</b>,2 x 10-12,,0.4,1.07,'-,[1.04-1.09],ITPR1,Breast cancer,breast carcinoma,GCST001937,3:4700592
rs12493607-<b>C</b>,2 x 10-8,,0.35,1.06,'-,[1.03-1.08],TGFBR2,Breast cancer,breast carcinoma,GCST001937,3:30641447
rs9790517-<b>T</b>,4 x 10-8,,0.23,1.05,'-,[1.03-1.08],TET2,Breast cancer,breast carcinoma,GCST001937,4:105163621
rs6828523-<b>C</b>,4 x 10-16,,0.87,1.11,'-,[1.09-1.15],ADAM29,Breast cancer,breast carcinoma,GCST001937,4:174925275
rs10472076-<b>C</b>,3 x 10-8,,0.38,1.05,'-,[1.03-1.07],"RAB3C, PDE4D",Breast cancer,breast carcinoma,GCST001937,5:58888234
rs1432679-<b>C</b>,2 x 10-14,,0.43,1.07,'-,[1.05-1.09],EBF1,Breast cancer,breast carcinoma,GCST001937,5:158817075
rs11242675-<b>T</b>,7 x 10-9,,0.61,1.06,'-,[1.04-1.09],"LINC01394, FOXQ1",Breast cancer,breast carcinoma,GCST001937,6:1318643
rs10771399-<b>A</b>,8 x 10-31,,0.88,1.16,'-,[1.14-1.2],PTHLH,Breast cancer,breast carcinoma,GCST001937,12:28002147
rs999737-<b>C</b>,3 x 10-19,,0.77,1.09,'-,[1.06-1.11],RAD51B,Breast cancer,breast carcinoma,GCST001937,14:68567965
rs1550623-<b>A</b>,3 x 10-8,,0.84,1.06,'-,[1.03-1.09],"RPS2P18, CDCA7",Breast cancer,breast carcinoma,GCST001937,2:173348166
rs1353747-<b>T</b>,3 x 10-8,,0.905,1.09,'-,[1.05-1.12],'-,Breast cancer,breast carcinoma,GCST001937,Mapping not available
rs2943559-<b>G</b>,6 x 10-15,,0.07,1.13,'-,[1.09-1.17,HNF4G,Breast cancer,breast carcinoma,GCST001937,8:75505702
rs11814448-<b>C</b>,9 x 10-16,,0.02,1.26,'-,[1.18-1.35],DNAJC1,Breast cancer,breast carcinoma,GCST001937,10:22026914
rs80221606-<b>AT</b>,1 x 10-10,,0.103914,0.76,'-,NR,CELF1,BRCA1 mutation in breast cancer,breast carcinoma,GCST011402,11:47538659
rs60882887-<b>A</b>,2 x 10-10,(adjusted),0.136868,0.82,'-,NR,"CELF1, RAPSN",BRCA1 mutation in breast cancer,breast carcinoma,GCST011402,11:47454123
rs7222250-<b>T</b>,6 x 10-14,(adjusted),0.56431,0.81,'-,NR,JUP,BRCA1 mutation in breast cancer,breast carcinoma,GCST011402,17:41782217
rs9901834-<b>A</b>,7 x 10-10,(adjusted),0.100527,0.72,'-,NR,JUP,BRCA1 mutation in breast cancer,breast carcinoma,GCST011402,17:41770559
rs2239711-<b>G</b>,5 x 10-11,(adjusted),0.707844,1.18,'-,NR,KRT35,BRCA1 mutation in breast cancer,breast carcinoma,GCST011402,17:41477065
rs10708222-<b>T</b>,8 x 10-7,(adjusted),0.171748,1.18,'-,NR,DNAJC7,BRCA1 mutation in breast cancer,breast carcinoma,GCST011402,17:41985420
rs41283425-<b>T</b>,4 x 10-7,(adjusted),0.0597041,0.73,'-,NR,JUP,BRCA1 mutation in breast cancer,breast carcinoma,GCST011402,17:41769461
rs56291217-<b>A</b>,7 x 10-8,(adjusted),0.563773,1.14,'-,NR,"GAST, EIF1",BRCA1 mutation in breast cancer,breast carcinoma,GCST011402,17:41701948
rs111637825-<b>A</b>,4 x 10-7,(adjusted),0.063862,0.74,'-,NR,DNAJC7,BRCA1 mutation in breast cancer,breast carcinoma,GCST011402,17:41982764
chr10:80841148-<b>T</b>,2 x 10-6,,0.4,0.91,'-,NR,'-,BRCA1 mutation in breast cancer,breast carcinoma,GCST011402,Mapping not available
chr16:52599188-<b>T</b>,2 x 10-13,,0.29,0.85,'-,NR,'-,BRCA1 mutation in breast cancer,breast carcinoma,GCST011402,Mapping not available
rs58117746-<b>TGGCAGCAGCTGGGGC</b>,4 x 10-10,,0.39,1.18,'-,NR,KRTAP4-5,BRCA1 mutation in breast cancer,breast carcinoma,GCST011402,17:41149524
rs5820435-<b>A</b>,1 x 10-11,,0.45,0.82,'-,NR,P3H4,BRCA1 mutation in breast cancer,breast carcinoma,GCST011402,17:41805306
rs114300732-<b>T</b>,2 x 10-8,(adjusted),0.07,0.67,'-,NR,WDR95P,BRCA2 mutation in breast cancer,breast carcinoma,GCST011401,13:31088850
rs2555605-<b>T</b>,5 x 10-8,(adjusted),0.64,1.15,'-,NR,"STARD13-AS, STARD13",BRCA2 mutation in breast cancer,breast carcinoma,GCST011401,13:33259673
rs10759243-<b>A</b>,5 x 10-6,,0.31,0.89,'-,NR,PPIAP88,BRCA2 mutation in breast cancer,breast carcinoma,GCST011401,9:107543834
rs12470785-<b>G</b>,3 x 10-11,,0.3,0.84,'-,NR,ETAA1,BRCA2 mutation in breast cancer,breast carcinoma,GCST011401,2:67406871
rs79183898-<b>A</b>,3 x 10-10,,0.07,1.33,'-,NR,RXFP2,BRCA2 mutation in breast cancer,breast carcinoma,GCST011401,13:31647657
rs736596-<b>T</b>,3 x 10-12,,0.09,1.37,'-,NR,"STARD13, STARD13-AS",BRCA2 mutation in breast cancer,breast carcinoma,GCST011401,13:33202369
rs4943263-<b>T</b>,8 x 10-11,,0.27,1.17,'-,NR,'-,BRCA2 mutation in breast cancer,breast carcinoma,GCST011401,13:34802220
rs1623189-<b>T</b>,1 x 10-31,(adjusted),0.74,0.37,'-,NR,RXFP2,BRCA2 mutation in breast cancer,breast carcinoma,GCST011401,13:31658546
rs77889880-<b>T</b>,3 x 10-21,(adjusted),0.1,0.51,'-,NR,"STARD13-AS, STARD13",BRCA2 mutation in breast cancer,breast carcinoma,GCST011401,13:33202024
rs67776313-<b>A</b>,8 x 10-12,(adjusted),0.33,0.81,'-,NR,STARD13,BRCA2 mutation in breast cancer,breast carcinoma,GCST011401,13:33360207
rs79539148-<b>?</b>,5 x 10-6,,NR,1.3718209,'-,[1.20-1.57],LINC01173,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,2:234605964
rs10684290-<b>?</b>,1 x 10-6,,NR,0.6117436,'-,[0.50-0.75],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,Mapping not available
chr23:116314278-<b>?</b>,2 x 10-6,,NR,1.4826204,'-,[1.26-1.75],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,Mapping not available
rs376045897-<b>?</b>,9 x 10-7,,NR,0.71651006,'-,[0.63-0.82],NLRC4,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,2:32224803
chr8:14246348-<b>?</b>,2 x 10-6,,NR,1.7325304,'-,[1.38-2.17],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,Mapping not available
rs77465470-<b>?</b>,6 x 10-6,,NR,3.9550767,'-,[2.18-7.16],LINC02267,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,4:96648409
chr2:197460073-<b>?</b>,7 x 10-6,,NR,0.09968899,'-,[0.04-0.27],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,Mapping not available
chr12:114419436-<b>?</b>,5 x 10-7,,NR,0.8426682,'-,[0.79-0.90],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,Mapping not available
rs5875324-<b>?</b>,2 x 10-6,,NR,0.8744475,'-,[0.83-0.92],"PPIAP9, MICB",Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,6:31513492
chr12:116347724-<b>?</b>,4 x 10-6,,NR,0.9158884,'-,[0.88-0.95],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,Mapping not available
rs12199978-<b>?</b>,7 x 10-6,,NR,0.9202764,'-,[0.89-0.95],FGD2,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,6:37015416
rs4525697-<b>?</b>,6 x 10-6,,NR,1.078501,'-,[1.04-1.11],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,2:18696829
rs2442690-<b>?</b>,4 x 10-6,,NR,1.087098,'-,[1.05-1.13],RAB39A,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,11:107933845
chr12:121601829-<b>?</b>,5 x 10-6,,NR,1.0858094,'-,[1.05-1.12],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,Mapping not available
rs370332736-<b>?</b>,2 x 10-7,,NR,1.1655464,'-,[1.10-1.24],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,6:50427424
rs4462981-<b>?</b>,4 x 10-6,,NR,1.1208384,'-,[1.07-1.18],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,3:96051005
rs61731483-<b>?</b>,7 x 10-6,,NR,1.2875215,'-,[1.15-1.44],POP4,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,19:29613964
rs12892107-<b>?</b>,6 x 10-6,,NR,1.1953834,'-,[1.11-1.29],NRXN3,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,14:79896239
rs71392427-<b>?</b>,2 x 10-6,,NR,1.1988671,'-,[1.11-1.29],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,10:4097356
rs112319461-<b>?</b>,1 x 10-6,,NR,1.2170854,'-,[1.12-1.32],LINC02702,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,11:116622438
rs34877263-<b>?</b>,2 x 10-6,,NR,1.280489,'-,[1.16-1.42],"LINC02279, DICER1",Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,14:95024488
chr12:69585594-<b>?</b>,5 x 10-6,,NR,1.3310552,'-,[1.18-1.51],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,Mapping not available
rs61755581-<b>?</b>,1 x 10-6,,NR,1.3394284,'-,[1.19-1.51],NIN,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,14:50772463
rs62237615-<b>?</b>,4 x 10-6,,NR,1.3701949,'-,[1.20-1.57],TTC28,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,22:28343127
rs113811441-<b>?</b>,7 x 10-6,,NR,0.017834153,'-,[0.003-0.103],CEP128,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,14:80908984
chr5:25384326-<b>?</b>,2 x 10-7,,NR,1.4273363,'-,[1.25-1.63],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,Mapping not available
rs115988318-<b>?</b>,4 x 10-6,,NR,0.6740945,'-,[0.57-0.80],IQCM,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,4:149498213
rs139983808-<b>?</b>,4 x 10-6,,NR,1.5360374,'-,[1.28-1.84],PDE3B,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,11:14841349
rs6738070-<b>?</b>,6 x 10-6,,NR,0.8472207,'-,[0.79-0.91],IKZF2,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,2:213147681
rs199600662-<b>?</b>,5 x 10-6,,NR,0.8728601,'-,[0.82-0.93],RFX3-AS1,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,9:3708602
rs1295683-<b>?</b>,6 x 10-7,,NR,0.88253576,'-,[0.84-0.93],TH2LCRR,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,5:132663184
rs57297613-<b>?</b>,2 x 10-6,,NR,0.9016192,'-,[0.86-0.94],NDUFA10,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,2:239835651
rs9807667-<b>?</b>,1 x 10-6,,NR,0.90965927,'-,[0.88-0.95],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,18:71174376
chr7:41400313-<b>?</b>,5 x 10-6,,NR,0.9135919,'-,[0.88-0.95],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,Mapping not available
rs2030217-<b>?</b>,2 x 10-6,,NR,0.9116632,'-,[0.88-0.95],ADAMTS9-AS2,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,3:65008088
rs10906806-<b>?</b>,1 x 10-6,,NR,0.9229462,'-,[0.89-0.95],"DCLRE1CP1, OLAH",Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,10:15029386
rs4720945-<b>?</b>,7 x 10-6,,NR,1.0825416,'-,[1.05-1.12],"PHF14, NPM1P11",Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,7:11181219
rs35523860-<b>?</b>,4 x 10-6,,NR,1.0850825,'-,[1.05-1.12],"LINC01742, C20orf85",Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,20:58062454
rs10998765-<b>?</b>,4 x 10-6,,NR,1.1018404,'-,[1.06-1.15],TACR2,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,10:69415853
rs9689308-<b>?</b>,6 x 10-6,,NR,1.0898786,'-,[1.05-1.13],RN7SKP211,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,6:105883853
rs10282989-<b>?</b>,5 x 10-6,,NR,1.2000822,'-,[1.11-1.30],SAMD12,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,8:118486185
rs72761829-<b>?</b>,4 x 10-6,,NR,1.1586424,'-,[1.09-1.23],CNIH3,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,1:224709789
chr1:60226999-<b>?</b>,1 x 10-6,,NR,1.3677144,'-,[1.20-1.55],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,Mapping not available
rs111310676-<b>?</b>,3 x 10-6,,NR,1.4154564,'-,[1.22-1.64],NXPE2,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,11:114708364
rs5970218-<b>?</b>,2 x 10-6,,NR,1.5139649,'-,[1.28-1.80],"MAGEA10-MAGEA5, MAGEA10",Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,X:152138067
chr5:156475855-<b>?</b>,3 x 10-6,,NR,3.6673157,'-,[2.13-6.33],'-,Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,Mapping not available
rs2784888-<b>?</b>,4 x 10-6,,NR,1.1000674,'-,[1.06-1.15],"LINC02487, LINC01558",Breast cancer specific mortality in breast cancer,"breast carcinoma, mortality",GCST007477,6:167735333
rs8113308-<b>G</b>,6 x 10-7,,0.152,1.69,'-,[1.37-2.07],ZNF613,Survival in endocrine treated breast cancer (estrogen-receptor positive),"survival time, estrogen-receptor positive breast cancer, breast carcinoma, response to endocrine therapy",GCST002901,19:51942133
rs58058861-<b>A</b>,2 x 10-10,(EA),0.21,1.06,'-,[1.04-1.09],LINC02068,Breast cancer,breast carcinoma,GCST004988,3:172567447
rs6815814-<b>C</b>,6 x 10-13,(EA),0.26,1.06,'-,[1.04-1.08],TLR1,Breast cancer,breast carcinoma,GCST004988,4:38814717
rs7529522-<b>C</b>,2 x 10-10,(EA),0.23,1.06,'-,[1.04-1.08],"VDAC2P3, PNRC2P1",Breast cancer,breast carcinoma,GCST004988,1:117687599
rs9833888-<b>T</b>,5 x 10-10,(EA),0.22,1.06,'-,[1.04-1.08],"CMSS1, FILIP1L",Breast cancer,breast carcinoma,GCST004988,3:100004736
rs116095464-<b>C</b>,4 x 10-9,(EA),0.05,1.06,'-,[1.02-1.1],"AHRR, PDCD6-AHRR",Breast cancer,breast carcinoma,GCST004988,5:344994
rs73161324-<b>T</b>,2 x 10-9,(EA),0.06,1.06,'-,[1.02-1.09],XRCC6,Breast cancer,breast carcinoma,GCST004988,22:41642782
rs113577745-<b>G</b>,4 x 10-10,(EA),0.1,1.08,'-,[1.05-1.11],GRHL1,Breast cancer,breast carcinoma,GCST004988,2:9995553
rs71801447-<b>C</b>,4 x 10-8,(EA),0.06,1.09,'-,[1.05-1.13],"MIR4435-2HG, BCL2L11",Breast cancer,breast carcinoma,GCST004988,2:111168155
rs67958007-<b>T</b>,2 x 10-10,(EA),0.12,1.09,'-,[1.06-1.12],'-,Breast cancer,breast carcinoma,GCST004988,10:9046151
rs16991615-<b>A</b>,2 x 10-9,(EA),0.06,1.1,'-,[1.06-1.14],MCM8,Breast cancer,breast carcinoma,GCST004988,20:5967581
rs35383942-<b>T</b>,4 x 10-13,(EA),0.06,1.12,'-,[1.08-1.17],PHLDA3,Breast cancer,breast carcinoma,GCST004988,1:201468704
rs72826962-<b>T</b>,5 x 10-9,(EA),0.01,1.2,'-,[1.11-1.3],CNTNAP1,Breast cancer,breast carcinoma,GCST004988,17:42684371
rs8176636-<b>?</b>,1 x 10-8,(EA),0.2,1.03,'-,[1.01-1.06],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs58847541-<b>A</b>,6 x 10-13,(EA),0.15,1.08,'-,[1.05-1.1],"KLHL38, RN7SKP155",Breast cancer,breast carcinoma,GCST004988,8:123597926
rs78269692-<b>C</b>,2 x 10-9,(EA),0.05,1.09,'-,[1.04-1.13],NFIX,Breast cancer,breast carcinoma,GCST004988,19:13047463
chr1:104145286-<b>A</b>,8 x 10-6,(EA),0.0937,'-,0.0582 unit increase,[0.033-0.084],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr1:168545508-<b>C</b>,6 x 10-6,(EA),0.0902,'-,0.0526 unit increase,[0.03-0.075],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr1:21023194-<b>C</b>,3 x 10-6,(EA),0.0051,'-,0.2414 unit increase,[0.14-0.34],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr1:45833328-<b>AT</b>,1 x 10-7,(EA),0.2323,'-,0.0407 unit decrease,[0.026-0.056],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr10:51462991-<b>GT</b>,7 x 10-6,(EA),0.9445,'-,0.0937 unit increase,[0.053-0.135],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs72810771-<b>T</b>,2 x 10-19,(EA),0.0187,'-,0.2026 unit increase,[0.16-0.25],ADIPOR1P1,Breast cancer,breast carcinoma,GCST004988,10:22108073
rs72814839-<b>C</b>,4 x 10-13,(EA),0.0137,'-,0.1943 unit increase,[0.14-0.25],SPAG6,Breast cancer,breast carcinoma,GCST004988,10:22383039
rs72856431-<b>T</b>,9 x 10-7,(EA),0.0219,'-,0.1135 unit increase,[0.068-0.159],CPNE5,Breast cancer,breast carcinoma,GCST004988,6:36795636
rs72932540-<b>G</b>,4 x 10-8,(EA),0.1056,'-,0.0553 unit increase,[0.036-0.075],"SMIM38, TPCN2",Breast cancer,breast carcinoma,GCST004988,11:69154575
rs72942597-<b>G</b>,2 x 10-6,(EA),0.0068,'-,0.2224 unit decrease,[0.13-0.31],'-,Breast cancer,breast carcinoma,GCST004988,18:64663607
rs73034872-<b>C</b>,8 x 10-6,(EA),0.0148,'-,0.1191 unit decrease,[0.067-0.172],COL5A2,Breast cancer,breast carcinoma,GCST004988,2:189205442
rs73077323-<b>A</b>,5 x 10-6,(EA),0.0999,'-,0.0563 unit decrease,[0.032-0.08],SHLD1,Breast cancer,breast carcinoma,GCST004988,20:5791630
rs73098691-<b>A</b>,3 x 10-6,(EA),0.0681,'-,0.0689 unit decrease,[0.04-0.098],CCL28,Breast cancer,breast carcinoma,GCST004988,5:43410515
rs73348588-<b>T</b>,8 x 10-7,(EA),0.0195,'-,0.1212 unit increase,[0.073-0.169],ADCY8,Breast cancer,breast carcinoma,GCST004988,8:130991174
rs73487618-<b>G</b>,6 x 10-6,(EA),0.0238,'-,0.0989 unit decrease,[0.056-0.142],LINC01924,Breast cancer,breast carcinoma,GCST004988,18:64514353
rs7378815-<b>T</b>,4 x 10-7,(EA),0.1244,'-,0.0494 unit decrease,[0.03-0.069],"HMGN1P17, RNU6ATAC2P",Breast cancer,breast carcinoma,GCST004988,5:56361879
rs73822569-<b>G</b>,1 x 10-6,(EA),0.0054,'-,0.2565 unit increase,[0.15-0.36],CMC1,Breast cancer,breast carcinoma,GCST004988,3:28290744
rs7430456-<b>G</b>,5 x 10-6,(EA),0.3718,'-,0.0292 unit decrease,[0.017-0.042],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs74433033-<b>A</b>,9 x 10-7,(EA),0.0332,'-,0.09 unit increase,[0.054-0.126],"CHCHD3P1, RNA5SP299",Breast cancer,breast carcinoma,GCST004988,10:8655165
rs7458786-<b>A</b>,9 x 10-6,(EA),0.1665,'-,0.0379 unit increase,[0.021-0.055],FBXL13,Breast cancer,breast carcinoma,GCST004988,7:103022031
rs748476-<b>C</b>,7 x 10-7,(EA),0.1763,'-,0.0399 unit increase,[0.024-0.056],RPL19P16,Breast cancer,breast carcinoma,GCST004988,10:121042949
rs7500067-<b>G</b>,4 x 10-27,(EA),0.2293,'-,0.0785 unit increase,[0.064-0.093],CDYL2,Breast cancer,breast carcinoma,GCST004988,16:80614399
rs75116627-<b>T</b>,1 x 10-6,(EA),0.0118,'-,0.1517 unit decrease,[0.091-0.213],"WDR75, PKDCC",Breast cancer,breast carcinoma,GCST004988,2:189440322
rs7513707-<b>A</b>,2 x 10-11,(EA),0.1661,'-,0.0554 unit increase,[0.039-0.071],AP4B1,Breast cancer,breast carcinoma,GCST004988,1:113903258
rs75282042-<b>C</b>,2 x 10-6,(EA),0.0247,'-,0.0971 unit increase,[0.057-0.137],HMGB1P47,Breast cancer,breast carcinoma,GCST004988,5:51439473
rs75282989-<b>A</b>,3 x 10-6,(EA),0.0134,'-,0.1716 unit decrease,[0.1-0.24],KCNS3,Breast cancer,breast carcinoma,GCST004988,2:18308590
rs75887402-<b>C</b>,3 x 10-7,(EA),0.0305,'-,0.0919 unit increase,[0.057-0.127],CEP120,Breast cancer,breast carcinoma,GCST004988,5:123338869
rs76007978-<b>A</b>,4 x 10-7,(EA),0.0123,'-,0.1781 unit decrease,[0.11-0.25],PTPRD,Breast cancer,breast carcinoma,GCST004988,9:8545593
rs76092474-<b>T</b>,3 x 10-6,(EA),0.113,'-,0.046 unit increase,[0.027-0.065],PKIB,Breast cancer,breast carcinoma,GCST004988,6:122554525
rs76340606-<b>A</b>,4 x 10-6,(EA),0.0145,'-,0.1643 unit decrease,[0.095-0.234],NRG3,Breast cancer,breast carcinoma,GCST004988,10:81950055
rs76375990-<b>C</b>,1 x 10-6,(EA),0.0248,'-,0.098 unit increase,[0.058-0.138],'-,Breast cancer,breast carcinoma,GCST004988,5:51555704
rs7637701-<b>A</b>,1 x 10-6,(EA),0.5108,'-,0.03 unit increase,[0.018-0.042],LEKR1,Breast cancer,breast carcinoma,GCST004988,3:156927968
rs7709328-<b>A</b>,3 x 10-7,(EA),0.4164,'-,0.0327 unit increase,[0.02-0.045],C5orf38,Breast cancer,breast carcinoma,GCST004988,5:2777197
rs77198337-<b>T</b>,4 x 10-6,(EA),0.0128,'-,0.1641 unit decrease,[0.095-0.234],LINC02505,Breast cancer,breast carcinoma,GCST004988,4:36590617
rs77457752-<b>A</b>,8 x 10-7,(EA),0.1294,'-,0.0462 unit decrease,[0.028-0.064],LINC00583,Breast cancer,breast carcinoma,GCST004988,9:13942941
rs77485526-<b>T</b>,2 x 10-6,(EA),0.0325,'-,0.0895 unit increase,[0.052-0.127],"SNORA75B, RPS7P6",Breast cancer,breast carcinoma,GCST004988,4:17386536
rs77554484-<b>A</b>,1 x 10-15,(EA),0.1319,'-,0.0741 unit decrease,[0.056-0.092],"RCCD1, PRC1",Breast cancer,breast carcinoma,GCST004988,15:90965985
rs77683187-<b>C</b>,2 x 10-6,(EA),0.0608,'-,0.0613 unit increase,[0.036-0.087],PCSK7,Breast cancer,breast carcinoma,GCST004988,11:117214494
rs77688320-<b>G</b>,3 x 10-9,(EA),0.1668,'-,0.0489 unit increase,[0.033-0.065],C2CD6,Breast cancer,breast carcinoma,GCST004988,2:201502866
rs7768862-<b>A</b>,6 x 10-6,(EA),0.5075,'-,0.028 unit decrease,[0.016-0.04],LINC01611,Breast cancer,breast carcinoma,GCST004988,6:84379128
rs77928427-<b>A</b>,3 x 10-8,(EA),0.2392,'-,0.04 unit increase,[0.026-0.054],PPA2,Breast cancer,breast carcinoma,GCST004988,4:105435604
rs7810893-<b>C</b>,4 x 10-6,(EA),0.3487,'-,0.0299 unit increase,[0.017-0.043],ARL4A,Breast cancer,breast carcinoma,GCST004988,7:12721416
rs7833090-<b>C</b>,2 x 10-6,(EA),0.2535,'-,0.0339 unit decrease,[0.02-0.048],CASC11,Breast cancer,breast carcinoma,GCST004988,8:127677080
rs7834448-<b>C</b>,7 x 10-6,(EA),0.667,'-,0.0309 unit decrease,[0.017-0.044],"RBPMS-AS1, TUBBP1",Breast cancer,breast carcinoma,GCST004988,8:30372068
rs7844233-<b>G</b>,6 x 10-11,(EA),0.0642,'-,0.0813 unit increase,[0.057-0.106],'-,Breast cancer,breast carcinoma,GCST004988,8:75751646
rs78540526-<b>T</b>,2 x 10-131,(EA),0.0756,'-,0.2758 unit increase,[0.25-0.3],LINC01488,Breast cancer,breast carcinoma,GCST004988,11:69516650
rs78579487-<b>GTT</b>,4 x 10-7,(EA),0.614,'-,0.0324 unit increase,[0.02-0.045],LINC00886,Breast cancer,breast carcinoma,GCST004988,3:156800880
rs7862618-<b>A</b>,5 x 10-6,(EA),0.0134,'-,0.1381 unit decrease,[0.079-0.197],AOPEP,Breast cancer,breast carcinoma,GCST004988,9:95008323
rs7906315-<b>G</b>,2 x 10-8,(EA),0.6218,'-,0.0357 unit increase,[0.023-0.048],TCF7L2,Breast cancer,breast carcinoma,GCST004988,10:113127459
rs7918232-<b>C</b>,8 x 10-6,(EA),0.8143,'-,0.036 unit increase,[0.02-0.052],ANKRD26,Breast cancer,breast carcinoma,GCST004988,10:27080233
rs7937840-<b>T</b>,1 x 10-6,(EA),0.2591,'-,0.035 unit increase,[0.021-0.049],INCENP,Breast cancer,breast carcinoma,GCST004988,11:62126500
rs79518236-<b>A</b>,1 x 10-7,(EA),0.2327,'-,0.0396 unit decrease,[0.025-0.054],BAIAP2L1,Breast cancer,breast carcinoma,GCST004988,7:98397243
rs80199833-<b>T</b>,7 x 10-6,(EA),0.2071,'-,0.0356 unit decrease,[0.02-0.051],"LINC01394, FOXQ1",Breast cancer,breast carcinoma,GCST004988,6:1319077
rs8027365-<b>C</b>,1 x 10-7,(EA),0.2707,'-,0.038 unit decrease,[0.024-0.052],PTPN9,Breast cancer,breast carcinoma,GCST004988,15:75516399
rs803903-<b>G</b>,8 x 10-12,(EA),0.6805,'-,0.0456 unit increase,[0.032-0.059],ASTN2,Breast cancer,breast carcinoma,GCST004988,9:116672011
rs8074440-<b>C</b>,3 x 10-6,(EA),0.5239,'-,0.0353 unit increase,[0.02-0.05],BAHCC1,Breast cancer,breast carcinoma,GCST004988,17:81397410
rs8081187-<b>A</b>,2 x 10-7,(EA),0.0843,'-,0.0607 unit decrease,[0.038-0.083],"LRRC37BP1, RN7SL316P",Breast cancer,breast carcinoma,GCST004988,17:30689342
rs8082452-<b>G</b>,1 x 10-10,(EA),0.4562,'-,0.0418 unit decrease,[0.029-0.055],CBX8,Breast cancer,breast carcinoma,GCST004988,17:79797749
rs847577-<b>A</b>,6 x 10-6,(EA),0.4176,'-,0.0284 unit decrease,[0.016-0.041],"RN7SL478P, LMTK2",Breast cancer,breast carcinoma,GCST004988,7:98065546
rs848087-<b>G</b>,6 x 10-11,(EA),0.5682,'-,0.0427 unit decrease,[0.03-0.055],SLC25A21,Breast cancer,breast carcinoma,GCST004988,14:36808438
rs113855064-<b>C</b>,1 x 10-7,(EA),0.0081,'-,0.1877 unit increase,[0.12-0.26],PDS5B,Breast cancer,breast carcinoma,GCST004988,13:32601963
rs924712-<b>G</b>,4 x 10-6,(EA),0.579,'-,0.0291 unit increase,[0.017-0.041],FAM83B,Breast cancer,breast carcinoma,GCST004988,6:54862053
chr17:44252468-<b>A</b>,7 x 10-13,(EA),0.182,'-,0.0605 unit decrease,[0.044-0.077],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr4:106507402-<b>?</b>,2 x 10-6,(EA),0.0752,'-,0.07 unit increase,[0.041-0.099],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr5:49484480-<b>G</b>,4 x 10-9,(EA),0.1506,'-,0.0664 unit decrease,[0.044-0.089],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr5:58680596-<b>G</b>,1 x 10-7,(EA),0.0444,'-,0.1061 unit increase,[0.067-0.145],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr9:136151579-<b>T</b>,1 x 10-8,(EA),0.2027,'-,0.0446 unit increase,[0.029-0.06],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs10096351-<b>G</b>,2 x 10-64,(EA),0.5441,'-,0.1055 unit increase,[0.093-0.118],"CASC8, POU5F1B, PCAT1",Breast cancer,breast carcinoma,GCST004988,8:127359926
rs10510097-<b>T</b>,2 x 10-58,(EA),0.1104,'-,0.1546 unit increase,[0.14-0.17],FGFR2,Breast cancer,breast carcinoma,GCST004988,10:121568362
rs10683143-<b>A</b>,2 x 10-6,(EA),0.4739,'-,0.0319 unit decrease,[0.019-0.045],TMEM69,Breast cancer,breast carcinoma,GCST004988,1:45688904
rs10832963-<b>G</b>,9 x 10-6,(EA),0.7217,'-,0.0331 unit increase,[0.019-0.048],"SPTY2D1, SRSF3P1",Breast cancer,breast carcinoma,GCST004988,11:18642694
rs10923574-<b>C</b>,4 x 10-7,(EA),0.3321,'-,0.0344 unit decrease,[0.021-0.048],'-,Breast cancer,breast carcinoma,GCST004988,1:118488075
rs1112956-<b>G</b>,9 x 10-6,(EA),0.7711,'-,0.0328 unit decrease,[0.018-0.047],SLC12A2,Breast cancer,breast carcinoma,GCST004988,5:128098106
rs11146838-<b>T</b>,1 x 10-6,(EA),0.4416,'-,0.0312 unit increase,[0.019-0.044],'-,Breast cancer,breast carcinoma,GCST004988,10:38856846
rs111780165-<b>A</b>,8 x 10-8,(EA),0.0706,'-,0.067 unit decrease,[0.043-0.092],TBC1D29P,Breast cancer,breast carcinoma,GCST004988,17:30560116
rs112257290-<b>A</b>,2 x 10-7,(EA),0.058,'-,0.07 unit increase,[0.044-0.096],FAM126B,Breast cancer,breast carcinoma,GCST004988,2:201003582
rs11288072-<b>C</b>,3 x 10-13,(EA),0.3116,'-,0.0501 unit decrease,[0.037-0.064],EBF1,Breast cancer,breast carcinoma,GCST004988,5:159008453
rs113167076-<b>A</b>,9 x 10-7,(EA),0.0228,'-,0.1213 unit decrease,[0.073-0.17],SMARCE1P4,Breast cancer,breast carcinoma,GCST004988,8:37106253
rs113319441-<b>T</b>,6 x 10-6,(EA),0.0308,'-,0.0908 unit decrease,[0.051-0.13],CCDC30,Breast cancer,breast carcinoma,GCST004988,1:42592453
rs113687142-<b>T</b>,2 x 10-6,(EA),0.0149,'-,0.1493 unit decrease,[0.089-0.21],'-,Breast cancer,breast carcinoma,GCST004988,8:36450915
rs7121616-<b>G</b>,7 x 10-6,(EA),0.2854,'-,0.0314 unit decrease,[0.018-0.045],CLMP,Breast cancer,breast carcinoma,GCST004988,11:123095918
rs7149262-<b>A</b>,2 x 10-21,(EA),0.2113,'-,0.0724 unit decrease,[0.058-0.087],PAX9,Breast cancer,breast carcinoma,GCST004988,14:36667340
rs72001329-<b>C</b>,3 x 10-6,(EA),0.4786,'-,0.0312 unit decrease,[0.018-0.044],MIR4432HG,Breast cancer,breast carcinoma,GCST004988,2:60408219
rs72396995-<b>T</b>,1 x 10-7,(EA),0.2556,'-,0.0383 unit increase,[0.024-0.052],"ZNF101, ZNF14",Breast cancer,breast carcinoma,GCST004988,19:19684648
rs7258465-<b>C</b>,3 x 10-28,(EA),0.3436,'-,0.0725 unit decrease,[0.06-0.085],SSBP4,Breast cancer,breast carcinoma,GCST004988,19:18422832
rs13186320-<b>T</b>,5 x 10-15,(EA),0.515,'-,0.0483 unit increase,[0.036-0.06],FGF10,Breast cancer,breast carcinoma,GCST004988,5:44302075
rs132289-<b>G</b>,1 x 10-24,(EA),0.9822,'-,0.2482 unit decrease,[0.2-0.3],KREMEN1,Breast cancer,breast carcinoma,GCST004988,22:29155884
rs13277568-<b>G</b>,8 x 10-7,(EA),0.3696,'-,0.0327 unit decrease,[0.02-0.046],TRPS1,Breast cancer,breast carcinoma,GCST004988,8:115667320
rs138060088-<b>TTGA</b>,9 x 10-43,(EA),0.5804,'-,0.0878 unit decrease,[0.075-0.1],'-,Breast cancer,breast carcinoma,GCST004988,5:44933883
rs139530473-<b>T</b>,1 x 10-10,(EA),0.2511,'-,0.0481 unit decrease,[0.033-0.063],"CATSPERB, PPP4R3A",Breast cancer,breast carcinoma,GCST004988,14:91545453
rs140091-<b>A</b>,4 x 10-10,(EA),0.0148,'-,0.1736 unit increase,[0.12-0.23],"NF2, CABP7",Breast cancer,breast carcinoma,GCST004988,22:29714557
rs140842923-<b>T</b>,3 x 10-6,(EA),0.0214,'-,0.1059 unit increase,[0.062-0.15],ARID1B,Breast cancer,breast carcinoma,GCST004988,6:157009956
rs141448180-<b>C</b>,6 x 10-6,(EA),0.0073,'-,0.2059 unit decrease,[0.12-0.29],CTNNA3,Breast cancer,breast carcinoma,GCST004988,10:67248381
rs141930488-<b>A</b>,8 x 10-6,(EA),0.0203,'-,0.111 unit increase,[0.062-0.16],"LINC02118, KATNBL1P4",Breast cancer,breast carcinoma,GCST004988,5:51952440
rs142890050-<b>C</b>,7 x 10-8,(EA),0.5577,'-,0.0345 unit increase,[0.022-0.047],"SINHCAFP3, RNU4-71P",Breast cancer,breast carcinoma,GCST004988,8:23622741
rs204247-<b>G</b>,8 x 10-13,(EA),0.44,1.04,'-,[1.02-1.06],"MCUR1, RANBP9",Breast cancer,breast carcinoma,GCST004988,6:13722291
rs132390-<b>C</b>,1 x 10-8,(EA),0.04,1.04,'-,[0.99-1.09],EMID1,Breast cancer,breast carcinoma,GCST004988,22:29225488
rs3817198-<b>C</b>,1 x 10-18,(EA),0.32,1.05,'-,[1.03-1.07],LSP1,Breast cancer,breast carcinoma,GCST004988,11:1887776
rs3760982-<b>A</b>,1 x 10-16,(EA),0.46,1.05,'-,[1.03-1.07],"LYPD5, KCNN4",Breast cancer,breast carcinoma,GCST004988,19:43782361
rs9693444-<b>A</b>,2 x 10-21,(EA),0.32,1.06,'-,[1.04-1.08],"RPL17P33, LINC00589",Breast cancer,breast carcinoma,GCST004988,8:29652100
rs1830298-<b>C</b>,2 x 10-16,,0.28,1.06,'-,[1.04-1.08],FLACC1,Breast cancer,breast carcinoma,GCST004988,2:201316524
rs1011970-<b>T</b>,1 x 10-15,(EA),0.16,1.07,'-,[1.04-1.09],CDKN2B-AS1,Breast cancer,breast carcinoma,GCST004988,9:22062135
rs2943559-<b>G</b>,4 x 10-24,(EA),0.08,1.1,'-,[1.07-1.14],HNF4G,Breast cancer,breast carcinoma,GCST004988,8:75505702
rs6001930-<b>C</b>,4 x 10-34,(EA),0.1,1.12,'-,[1.09-1.16],MRTFA,Breast cancer,breast carcinoma,GCST004988,22:40480230
rs62355902-<b>T</b>,7 x 10-98,(EA),0.16,1.18,'-,[1.15-1.21],MAP3K1,Breast cancer,breast carcinoma,GCST004988,5:56757896
rs35054928-<b>GC</b>,2 x 10-322,,0.4,1.27,'-,[1.25-1.3],FGFR2,Breast cancer,breast carcinoma,GCST004988,10:121580918
rs13162653-<b>G</b>,5 x 10-7,(EA),0.55,1.010101,'-,[0.99-1.03],"NACAP6, MARCHF11",Breast cancer,breast carcinoma,GCST004988,5:16187419
rs13329835-<b>G</b>,9 x 10-27,(EA),0.23,1.07,'-,[1.05-1.09],CDYL2,Breast cancer,breast carcinoma,GCST004988,16:80616908
rs9397437-<b>A</b>,5 x 10-54,,0.07,1.17,'-,[1.14-1.21],"CCDC170, ESR1",Breast cancer,breast carcinoma,GCST004988,6:151631197
rs11571833-<b>T</b>,3 x 10-15,(EA),0.01,1.35,'-,[1.23-1.48],BRCA2,Breast cancer,breast carcinoma,GCST004988,13:32398489
rs72765759-<b>T</b>,6 x 10-13,(EA),0.1345,'-,0.0693 unit decrease,[0.05-0.088],'-,Breast cancer,breast carcinoma,GCST004988,5:45846518
rs72807246-<b>G</b>,3 x 10-6,(EA),0.139,'-,0.0429 unit decrease,[0.025-0.061],CPEB3,Breast cancer,breast carcinoma,GCST004988,10:92172529
rs72820985-<b>G</b>,1 x 10-6,(EA),0.1609,'-,0.0423 unit decrease,[0.025-0.059],"ARLNC1, CDYL2",Breast cancer,breast carcinoma,GCST004988,16:80805081
rs72953532-<b>T</b>,2 x 10-18,(EA),0.0319,'-,0.1819 unit decrease,[0.14-0.22],"RN7SKP43, WDR12",Breast cancer,breast carcinoma,GCST004988,2:217177160
rs73176670-<b>T</b>,1 x 10-8,(EA),0.0618,'-,0.0751 unit increase,[0.049-0.101],ZC3H7B,Breast cancer,breast carcinoma,GCST004988,22:41323244
rs736801-<b>T</b>,8 x 10-8,(EA),0.3642,'-,0.0349 unit increase,[0.022-0.048],IRF1,Breast cancer,breast carcinoma,GCST004988,5:132497907
rs74392007-<b>T</b>,3 x 10-7,(EA),0.1102,'-,0.0514 unit increase,[0.032-0.071],HSF2,Breast cancer,breast carcinoma,GCST004988,6:122394099
rs74910854-<b>G</b>,5 x 10-6,(EA),0.0674,'-,0.0607 unit increase,[0.034-0.087],GTF2I,Breast cancer,breast carcinoma,GCST004988,7:74696373
rs7524950-<b>T</b>,3 x 10-9,(EA),0.2587,'-,0.0419 unit increase,[0.028-0.056],"PKLR, FDPS",Breast cancer,breast carcinoma,GCST004988,1:155302483
rs7570-<b>C</b>,8 x 10-6,(EA),0.2653,'-,0.0319 unit increase,[0.018-0.046],"C11orf80, RCE1",Breast cancer,breast carcinoma,GCST004988,11:66843174
rs7619833-<b>C</b>,3 x 10-45,(EA),0.5251,'-,0.0874 unit increase,[0.075-0.1],SLC4A7,Breast cancer,breast carcinoma,GCST004988,3:27468223
rs7697216-<b>C</b>,2 x 10-26,(EA),0.8819,'-,0.1039 unit increase,[0.085-0.123],ADAM29,Breast cancer,breast carcinoma,GCST004988,4:174906885
rs7721647-<b>T</b>,2 x 10-6,(EA),0.3015,'-,0.032 unit decrease,[0.019-0.045],ARRDC3-AS1,Breast cancer,breast carcinoma,GCST004988,5:91594201
rs77674461-<b>C</b>,6 x 10-6,(EA),0.0358,'-,0.0808 unit increase,[0.046-0.116],AGTPBP1,Breast cancer,breast carcinoma,GCST004988,9:85664713
rs77702473-<b>G</b>,2 x 10-6,(EA),0.1066,'-,0.0481 unit decrease,[0.028-0.068],CREB5,Breast cancer,breast carcinoma,GCST004988,7:28828469
rs78295797-<b>A</b>,9 x 10-6,(EA),0.0241,'-,0.0953 unit decrease,[0.053-0.137],HIVEP3,Breast cancer,breast carcinoma,GCST004988,1:41821259
rs7847854-<b>T</b>,5 x 10-18,(EA),0.6179,'-,0.055 unit increase,[0.042-0.068],'-,Breast cancer,breast carcinoma,GCST004988,9:108239892
rs78796841-<b>G</b>,8 x 10-7,(EA),0.0214,'-,0.1097 unit increase,[0.066-0.153],ESR1,Breast cancer,breast carcinoma,GCST004988,6:151859461
rs79108280-<b>GT</b>,9 x 10-6,(EA),0.1889,'-,0.0356 unit increase,[0.02-0.051],SNTG1,Breast cancer,breast carcinoma,GCST004988,8:50831133
rs800132-<b>G</b>,8 x 10-6,(EA),0.0493,'-,0.0689 unit increase,[0.039-0.099],CD81-AS1,Breast cancer,breast carcinoma,GCST004988,11:2369831
rs8050871-<b>G</b>,3 x 10-6,(EA),0.6727,'-,0.0315 unit decrease,[0.018-0.045],ZNF19,Breast cancer,breast carcinoma,GCST004988,16:71475893
rs8137282-<b>G</b>,2 x 10-7,(EA),0.0421,'-,0.0882 unit increase,[0.055-0.121],CCDC134,Breast cancer,breast carcinoma,GCST004988,22:41815785
rs898097-<b>T</b>,2 x 10-6,(EA),0.6532,'-,0.0311 unit increase,[0.018-0.044],B3GNTL1,Breast cancer,breast carcinoma,GCST004988,17:82946434
rs1293906-<b>T</b>,9 x 10-6,(EA),0.1708,'-,0.0408 unit decrease,[0.023-0.059],DMD,Breast cancer,breast carcinoma,GCST004988,X:32016153
rs13054095-<b>T</b>,4 x 10-16,(EA),0.0216,'-,0.1792 unit increase,[0.14-0.22],"ZNRF3-IT1, ZNRF3",Breast cancer,breast carcinoma,GCST004988,22:29010231
rs10472076-<b>C</b>,1 x 10-8,(EA),0.38,1.03,'-,[1.01-1.04],"RAB3C, PDE4D",Breast cancer,breast carcinoma,GCST004988,5:58888234
rs6964587-<b>T</b>,9 x 10-11,(EA),0.39,1.03,'-,[1.02-1.05],AKAP9,Breast cancer,breast carcinoma,GCST004988,7:92001306
rs13267382-<b>A</b>,2 x 10-11,(EA),0.36,1.03,'-,[1.01-1.05],LINC00536,Breast cancer,breast carcinoma,GCST004988,8:116197325
rs7904519-<b>G</b>,2 x 10-13,(EA),0.46,1.03,'-,[1.01-1.05],TCF7L2,Breast cancer,breast carcinoma,GCST004988,10:113014168
rs12710696-<b>T</b>,1 x 10-8,(EA),0.37,1.03,'-,[1.01-1.04],LINC01376,Breast cancer,breast carcinoma,GCST004988,2:19121042
rs941764-<b>G</b>,8 x 10-13,(EA),0.35,1.03,'-,[1.02-1.05],CCDC88C,Breast cancer,breast carcinoma,GCST004988,14:91374725
rs745570-<b>A</b>,4 x 10-10,(EA),0.5,1.03,'-,[1.01-1.05],"LINC01977, CBX8",Breast cancer,breast carcinoma,GCST004988,17:79807926
rs11075995-<b>A</b>,9 x 10-9,(EA),0.24,1.03,'-,[1.01-1.06],FTO,Breast cancer,breast carcinoma,GCST004988,16:53821379
rs67397200-<b>G</b>,2 x 10-8,(EA),0.3,1.03,'-,[1.01-1.05],"ABHD8, ANKLE1",Breast cancer,breast carcinoma,GCST004988,19:17290595
rs12048493-<b>C</b>,9 x 10-14,(EA),0.38,1.04,'-,[1.02-1.06],OTUD7B,Breast cancer,breast carcinoma,GCST004988,1:149955122
rs11552449-<b>T</b>,5 x 10-11,(EA),0.17,1.04,'-,[1.01-1.06],DCLRE1B,Breast cancer,breast carcinoma,GCST004988,1:113905767
rs9790517-<b>T</b>,5 x 10-11,(EA),0.23,1.04,'-,[1.01-1.06],TET2,Breast cancer,breast carcinoma,GCST004988,4:105163621
rs6762644-<b>G</b>,4 x 10-18,(EA),0.38,1.05,'-,[1.03-1.07],ITPR1,Breast cancer,breast carcinoma,GCST004988,3:4700592
rs12493607-<b>C</b>,7 x 10-14,(EA),0.34,1.05,'-,[1.03-1.07],TGFBR2,Breast cancer,breast carcinoma,GCST004988,3:30641447
rs1053338-<b>G</b>,5 x 10-11,(EA),0.14,1.05,'-,[1.02-1.07],ATXN7,Breast cancer,breast carcinoma,GCST004988,3:63982224
rs11780156-<b>T</b>,1 x 10-13,(EA),0.17,1.05,'-,[1.03-1.08],PVT1,Breast cancer,breast carcinoma,GCST004988,8:128182395
rs7072776-<b>A</b>,2 x 10-19,(EA),0.29,1.05,'-,[1.03-1.07],"MLLT10, DNAJC1",Breast cancer,breast carcinoma,GCST004988,10:21744013
rs11977670-<b>A</b>,1 x 10-16,(EA),0.43,1.06,'-,[1.04-1.08],"PPP1R2P6, RNU1-58P",Breast cancer,breast carcinoma,GCST004988,7:140242504
rs13294895-<b>T</b>,7 x 10-17,(EA),0.18,1.06,'-,[1.03-1.08],CHCHD4P2,Breast cancer,breast carcinoma,GCST004988,9:108074895
rs10069690-<b>T</b>,8 x 10-17,(EA),0.26,1.06,'-,[1.04-1.08],TERT,Breast cancer,breast carcinoma,GCST004988,5:1279675
rs10759243-<b>A</b>,2 x 10-18,(EA),0.29,1.06,'-,[1.04-1.08],PPIAP88,Breast cancer,breast carcinoma,GCST004988,9:107543834
rs16857609-<b>T</b>,2 x 10-25,(EA),0.26,1.06,'-,[1.04-1.09],DIRC3,Breast cancer,breast carcinoma,GCST004988,2:217431785
rs2588809-<b>T</b>,6 x 10-14,(EA),0.17,1.06,'-,[1.03-1.08],RAD51B,Breast cancer,breast carcinoma,GCST004988,14:68193711
rs704010-<b>T</b>,2 x 10-35,(EA),0.38,1.07,'-,[1.05-1.09],ZMIZ1,Breast cancer,breast carcinoma,GCST004988,10:79081391
rs1432679-<b>C</b>,7 x 10-31,(EA),0.43,1.08,'-,[1.06-1.1],EBF1,Breast cancer,breast carcinoma,GCST004988,5:158817075
rs146071273-<b>A</b>,7 x 10-6,(EA),0.0867,'-,0.052 unit decrease,[0.029-0.075],'-,Breast cancer,breast carcinoma,GCST004988,2:160772472
rs146331761-<b>A</b>,5 x 10-7,(EA),0.0367,'-,0.0875 unit decrease,[0.053-0.122],"PTPN23, KLHL18",Breast cancer,breast carcinoma,GCST004988,3:47364189
rs146817970-<b>T</b>,4 x 10-13,(EA),0.2459,'-,0.0532 unit decrease,[0.039-0.068],ATG10,Breast cancer,breast carcinoma,GCST004988,5:82217129
rs147032157-<b>A</b>,4 x 10-6,(EA),0.1018,'-,0.0483 unit decrease,[0.028-0.069],"LINC00639, Y_RNA",Breast cancer,breast carcinoma,GCST004988,14:38968140
rs148731571-<b>GCTTAGATATTAC</b>,6 x 10-6,(EA),0.0639,'-,0.0712 unit decrease,[0.04-0.102],'-,Breast cancer,breast carcinoma,GCST004988,13:107031171
rs149253773-<b>T</b>,6 x 10-40,(EA),0.5359,'-,0.0944 unit decrease,[0.08-0.108],'-,Breast cancer,breast carcinoma,GCST004988,1:121695219
rs149936356-<b>C</b>,1 x 10-18,(EA),0.0246,'-,0.176 unit increase,[0.14-0.22],TTC28,Breast cancer,breast carcinoma,GCST004988,22:28532870
rs150537328-<b>C</b>,2 x 10-6,(EA),0.0647,'-,0.0642 unit increase,[0.038-0.091],"KRTAP4-7, KRTAP4-8",Breast cancer,breast carcinoma,GCST004988,17:41094871
rs150658557-<b>TA</b>,2 x 10-13,(EA),0.2029,'-,0.0605 unit decrease,[0.044-0.077],"CCDC88C, PPP4R3A",Breast cancer,breast carcinoma,GCST004988,14:91422581
rs151090251-<b>GGACTTCTGTAGAGA</b>,2 x 10-6,(EA),0.0524,'-,0.0719 unit increase,[0.042-0.101],SMAD3,Breast cancer,breast carcinoma,GCST004988,15:67115961
rs151170584-<b>T</b>,9 x 10-6,(EA),0.0362,'-,0.0989 unit increase,[0.055-0.143],'-,Breast cancer,breast carcinoma,GCST004988,4:132819226
rs151329939-<b>A</b>,5 x 10-9,(EA),0.01,'-,0.1879 unit increase,[0.12-0.25],CNTD1,Breast cancer,breast carcinoma,GCST004988,17:42807276
rs1514964-<b>C</b>,9 x 10-6,(EA),0.0453,'-,0.071 unit increase,[0.04-0.102],RNU7-62P,Breast cancer,breast carcinoma,GCST004988,1:64370963
rs1519814-<b>G</b>,8 x 10-7,(EA),0.7773,'-,0.0365 unit decrease,[0.022-0.051],COL14A1,Breast cancer,breast carcinoma,GCST004988,8:120102785
rs1552172-<b>A</b>,1 x 10-8,(EA),0.3563,'-,0.0382 unit decrease,[0.025-0.051],CD160,Breast cancer,breast carcinoma,GCST004988,1:145730328
rs157554-<b>T</b>,7 x 10-6,(EA),0.3171,'-,0.0308 unit decrease,[0.017-0.044],ARHGEF28,Breast cancer,breast carcinoma,GCST004988,5:73943871
rs1611579-<b>C</b>,8 x 10-7,(EA),0.098,'-,0.058 unit decrease,[0.035-0.081],"HLA-H, HCP5B",Breast cancer,breast carcinoma,GCST004988,6:29882943
rs16342-<b>TAACA</b>,1 x 10-6,(EA),0.359,'-,0.0361 unit increase,[0.022-0.051],NELFA,Breast cancer,breast carcinoma,GCST004988,4:1983006
rs1685191-<b>T</b>,4 x 10-20,(EA),0.5647,'-,0.0586 unit decrease,[0.046-0.071],KCNN4,Breast cancer,breast carcinoma,GCST004988,19:43779080
rs16889471-<b>A</b>,9 x 10-6,(EA),0.2051,'-,0.0344 unit increase,[0.019-0.05],SLC30A8,Breast cancer,breast carcinoma,GCST004988,8:117178381
rs16907718-<b>T</b>,7 x 10-6,(EA),0.1658,'-,0.0404 unit increase,[0.023-0.058],"RNU6-1213P, Y_RNA",Breast cancer,breast carcinoma,GCST004988,8:80443628
rs16922097-<b>C</b>,1 x 10-18,(EA),0.0189,'-,0.1968 unit increase,[0.15-0.24],"EBLN1, PSME2P6",Breast cancer,breast carcinoma,GCST004988,10:22212015
rs16952006-<b>T</b>,3 x 10-6,(EA),0.1051,'-,0.0524 unit decrease,[0.031-0.074],SMG6,Breast cancer,breast carcinoma,GCST004988,17:2195889
rs1696803-<b>C</b>,2 x 10-45,(EA),0.8367,'-,0.116 unit decrease,[0.1-0.132],"RPS15AP5, FGFR2",Breast cancer,breast carcinoma,GCST004988,10:121677436
rs1697139-<b>G</b>,9 x 10-6,(EA),0.5355,'-,0.028 unit decrease,[0.016-0.04],CD180,Breast cancer,breast carcinoma,GCST004988,5:67215707
rs17029056-<b>C</b>,4 x 10-6,(EA),0.2148,'-,0.0354 unit decrease,[0.02-0.05],"LINC01914, LINC01913",Breast cancer,breast carcinoma,GCST004988,2:41931164
rs17080623-<b>G</b>,5 x 10-6,(EA),0.2314,'-,0.0344 unit increase,[0.02-0.049],'-,Breast cancer,breast carcinoma,GCST004988,18:69220817
rs172032-<b>C</b>,1 x 10-16,(EA),0.4209,'-,0.0531 unit decrease,[0.041-0.066],"ELL, FKBP8",Breast cancer,breast carcinoma,GCST004988,19:18522945
rs1744947-<b>T</b>,2 x 10-14,(EA),0.16,'-,0.0645 unit increase,[0.048-0.081],RAD51B,Breast cancer,breast carcinoma,GCST004988,14:68214759
rs17543752-<b>C</b>,2 x 10-19,(EA),0.3836,'-,0.0574 unit decrease,[0.045-0.07],EBF1,Breast cancer,breast carcinoma,GCST004988,5:158905372
rs17598658-<b>C</b>,2 x 10-9,(EA),0.0823,'-,0.0726 unit decrease,[0.049-0.097],H2BC6,Breast cancer,breast carcinoma,GCST004988,6:26175638
rs1783730-<b>G</b>,3 x 10-7,(EA),0.5553,'-,0.0339 unit decrease,[0.021-0.047],"TMEM151A, CD248",Breast cancer,breast carcinoma,GCST004988,11:66301747
rs17838698-<b>T</b>,2 x 10-14,(EA),0.2978,'-,0.0517 unit increase,[0.039-0.065],TGFBR2,Breast cancer,breast carcinoma,GCST004988,3:30643415
rs181270898-<b>A</b>,5 x 10-7,(EA),0.0298,'-,0.097 unit decrease,[0.059-0.135],HIVEP3,Breast cancer,breast carcinoma,GCST004988,1:41532093
rs181337095-<b>A</b>,3 x 10-7,(EA),0.8674,'-,0.0521 unit increase,[0.032-0.072],"SPATA41, CERS3-AS1",Breast cancer,breast carcinoma,GCST004988,15:100366889
rs182731523-<b>C</b>,8 x 10-8,(EA),0.1861,'-,0.0426 unit increase,[0.027-0.058],CFLAR,Breast cancer,breast carcinoma,GCST004988,2:201140114
rs183421746-<b>C</b>,3 x 10-11,(EA),0.0094,'-,0.2452 unit increase,[0.17-0.32],"NF2, NIPSNAP1",Breast cancer,breast carcinoma,GCST004988,22:29581329
rs184531260-<b>A</b>,4 x 10-7,(EA),0.0113,'-,0.21 unit decrease,[0.13-0.29],Metazoa_SRP,Breast cancer,breast carcinoma,GCST004988,15:37206970
rs184886-<b>C</b>,2 x 10-6,(EA),0.724,'-,0.0333 unit increase,[0.02-0.047],PIK3R1,Breast cancer,breast carcinoma,GCST004988,5:68315658
rs185004002-<b>T</b>,2 x 10-12,(EA),0.0148,'-,0.1896 unit increase,[0.14-0.24],RFPL1S,Breast cancer,breast carcinoma,GCST004988,22:29457633
rs185028854-<b>A</b>,7 x 10-6,(EA),0.0088,'-,0.1578 unit increase,[0.089-0.227],WARS2-AS1,Breast cancer,breast carcinoma,GCST004988,1:119254406
rs1855581-<b>G</b>,7 x 10-6,(EA),0.235,'-,0.0326 unit increase,[0.018-0.047],SORCS3,Breast cancer,breast carcinoma,GCST004988,10:104612026
rs186036693-<b>G</b>,2 x 10-6,(EA),0.007,'-,0.216 unit decrease,[0.13-0.31],CTNNA3,Breast cancer,breast carcinoma,GCST004988,10:67640136
rs187201341-<b>T</b>,1 x 10-6,(EA),0.0087,'-,0.1861 unit increase,[0.11-0.26],"SEC14L6, SEC14L4",Breast cancer,breast carcinoma,GCST004988,22:30509501
rs187408367-<b>A</b>,8 x 10-7,(EA),0.0051,'-,0.2318 unit increase,[0.14-0.32],SREBF1,Breast cancer,breast carcinoma,GCST004988,17:17835546
rs189157202-<b>T</b>,2 x 10-6,(EA),0.007,'-,0.2152 unit decrease,[0.13-0.3],"AKR1B10P1, CTNNA3",Breast cancer,breast carcinoma,GCST004988,10:67750937
rs1894633-<b>G</b>,2 x 10-6,(EA),0.3337,'-,0.0312 unit decrease,[0.018-0.044],DNM3,Breast cancer,breast carcinoma,GCST004988,1:172361919
rs1902066-<b>C</b>,7 x 10-6,(EA),0.5571,'-,0.0281 unit decrease,[0.016-0.04],'-,Breast cancer,breast carcinoma,GCST004988,6:80636316
rs190817902-<b>G</b>,7 x 10-7,(EA),0.055,'-,0.1165 unit increase,[0.07-0.163],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs191057893-<b>G</b>,8 x 10-6,(EA),0.0079,'-,0.2573 unit decrease,[0.14-0.37],PAIP1,Breast cancer,breast carcinoma,GCST004988,5:43545632
rs9292195-<b>C</b>,4 x 10-7,(EA),0.8454,'-,0.0434 unit decrease,[0.027-0.06],PDE4D,Breast cancer,breast carcinoma,GCST004988,5:59180291
rs930395-<b>A</b>,2 x 10-58,(EA),0.2206,'-,0.1187 unit increase,[0.1-0.13],"TMEM161B-AS1, MRPS30",Breast cancer,breast carcinoma,GCST004988,5:44822356
rs9323635-<b>T</b>,1 x 10-6,(EA),0.979,'-,0.1122 unit decrease,[0.067-0.157],"IRF2BPL, RN7SL356P",Breast cancer,breast carcinoma,GCST004988,14:77005236
rs9350395-<b>G</b>,3 x 10-7,(EA),0.5936,'-,0.0323 unit increase,[0.02-0.045],CASC15,Breast cancer,breast carcinoma,GCST004988,6:21905495
rs9361840-<b>G</b>,7 x 10-14,(EA),0.2368,'-,0.0541 unit increase,[0.04-0.068],TENT5A,Breast cancer,breast carcinoma,GCST004988,6:81545215
rs9379084-<b>A</b>,3 x 10-6,(EA),0.1206,'-,0.0486 unit increase,[0.028-0.069],RREB1,Breast cancer,breast carcinoma,GCST004988,6:7231610
rs9421352-<b>T</b>,1 x 10-7,(EA),0.2453,'-,0.0389 unit increase,[0.024-0.053],"RGS10, TIAL1",Breast cancer,breast carcinoma,GCST004988,10:119567672
rs9449003-<b>A</b>,3 x 10-6,(EA),0.4925,'-,0.0295 unit decrease,[0.017-0.042],RPSAP72,Breast cancer,breast carcinoma,GCST004988,6:80496839
rs9460578-<b>A</b>,1 x 10-6,(EA),0.2834,'-,0.0337 unit decrease,[0.02-0.047],CDKAL1,Breast cancer,breast carcinoma,GCST004988,6:20923044
rs9562987-<b>A</b>,4 x 10-6,(EA),0.3219,'-,0.0305 unit decrease,[0.018-0.043],"DLEU7, DLEU1",Breast cancer,breast carcinoma,GCST004988,13:50521772
rs9578106-<b>C</b>,7 x 10-6,(EA),0.1076,'-,0.0461 unit increase,[0.026-0.066],SLC7A1,Breast cancer,breast carcinoma,GCST004988,13:29543880
rs9619765-<b>T</b>,1 x 10-6,(EA),0.0324,'-,0.0914 unit decrease,[0.054-0.128],"DNAL4, NPTXR",Breast cancer,breast carcinoma,GCST004988,22:38798063
rs9675999-<b>A</b>,7 x 10-7,(EA),0.6392,'-,0.0319 unit decrease,[0.019-0.044],"RBBP8, CABLES1",Breast cancer,breast carcinoma,GCST004988,18:23047728
rs970821-<b>T</b>,2 x 10-12,(EA),0.401,'-,0.0445 unit increase,[0.032-0.057],ANXA13,Breast cancer,breast carcinoma,GCST004988,8:123726378
rs9712235-<b>A</b>,7 x 10-7,(EA),0.7397,'-,0.0357 unit decrease,[0.022-0.05],LINC02831,Breast cancer,breast carcinoma,GCST004988,2:67654625
rs9808759-<b>C</b>,4 x 10-7,(EA),0.9253,'-,0.0597 unit decrease,[0.037-0.083],PCNT,Breast cancer,breast carcinoma,GCST004988,21:46360308
rs9833726-<b>T</b>,6 x 10-6,(EA),0.1358,'-,0.0429 unit decrease,[0.024-0.062],"RNU6-1129P, CADM2",Breast cancer,breast carcinoma,GCST004988,3:86154659
rs9837602-<b>A</b>,1 x 10-9,(EA),0.2261,'-,0.0448 unit increase,[0.03-0.059],"FILIP1L, CMSS1",Breast cancer,breast carcinoma,GCST004988,3:100105841
rs9867461-<b>T</b>,2 x 10-6,(EA),0.0312,'-,0.0964 unit decrease,[0.057-0.136],"KIF9-AS1, KIF9",Breast cancer,breast carcinoma,GCST004988,3:47241865
rs9882792-<b>T</b>,2 x 10-6,(EA),0.2218,'-,0.0377 unit decrease,[0.022-0.053],P3H2,Breast cancer,breast carcinoma,GCST004988,3:190056667
rs9884765-<b>C</b>,5 x 10-7,(EA),0.3701,'-,0.0353 unit increase,[0.022-0.049],'-,Breast cancer,breast carcinoma,GCST004988,4:91717049
rs9952980-<b>C</b>,2 x 10-13,(EA),0.3504,'-,0.0478 unit decrease,[0.035-0.061],SLC14A2,Breast cancer,breast carcinoma,GCST004988,18:45308832
rs9954058-<b>C</b>,3 x 10-13,(EA),0.0721,'-,0.0891 unit decrease,[0.065-0.113],SETBP1,Breast cancer,breast carcinoma,GCST004988,18:44831838
rs9959491-<b>T</b>,5 x 10-7,(EA),0.7115,'-,0.0345 unit increase,[0.021-0.048],'-,Breast cancer,breast carcinoma,GCST004988,18:27826891
chr12:69124241-<b>T</b>,7 x 10-7,(EA),0.2711,'-,0.0358 unit decrease,[0.022-0.05],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs7899628-<b>T</b>,9 x 10-10,(EA),0.3585,'-,0.0396 unit decrease,[0.027-0.052],ATE1,Breast cancer,breast carcinoma,GCST004988,10:121904429
rs12152414-<b>A</b>,5 x 10-6,(EA),0.036,'-,0.083 unit increase,[0.048-0.118],FNDC3B,Breast cancer,breast carcinoma,GCST004988,3:172363569
rs3129178-<b>A</b>,6 x 10-9,(EA),0.0951,'-,0.0669 unit decrease,[0.044-0.089],"OR2J1, OR2J3",Breast cancer,breast carcinoma,GCST004988,6:29107311
rs59867004-<b>C</b>,1 x 10-10,(EA),0.2724,'-,0.0446 unit increase,[0.031-0.058],"ZBED6, ZC3H11A",Breast cancer,breast carcinoma,GCST004988,1:203832121
rs3130834-<b>C</b>,5 x 10-9,(EA),0.0955,'-,0.0672 unit decrease,[0.045-0.09],"OR14J1, OR2U2P",Breast cancer,breast carcinoma,GCST004988,6:29280372
rs3757322-<b>G</b>,3 x 10-41,,0.32,1.08,'-,[1.06-1.1],CCDC170,Breast cancer,breast carcinoma,GCST004988,6:151621059
rs11249433-<b>G</b>,2 x 10-52,(EA),0.41,1.11,'-,[1.09-1.13],EMBP1,Breast cancer,breast carcinoma,GCST004988,1:121538815
rs4973768-<b>T</b>,5 x 10-57,(EA),0.47,1.11,'-,[1.09-1.13],SLC4A7,Breast cancer,breast carcinoma,GCST004988,3:27374522
rs10816625-<b>G</b>,5 x 10-18,,0.06,1.11,'-,[1.07-1.15],CHCHD4P2,Breast cancer,breast carcinoma,GCST004988,9:108074792
rs10941679-<b>G</b>,6 x 10-73,,0.25,1.15,'-,[1.13-1.18],"LINC02224, RN7SL383P",Breast cancer,breast carcinoma,GCST004988,5:44706396
rs72755295-<b>G</b>,2 x 10-14,(EA),0.03,1.15,'-,[1.09-1.2],EXO1,Breast cancer,breast carcinoma,GCST004988,1:241870961
rs2981578-<b>C</b>,1 x 10-245,,0.47,1.23,'-,[1.21-1.25],FGFR2,Breast cancer,breast carcinoma,GCST004988,10:121580797
rs4784227-<b>T</b>,7 x 10-201,,0.24,1.23,'-,[1.2-1.25],CASC16,Breast cancer,breast carcinoma,GCST004988,16:52565276
rs75915166-<b>A</b>,4 x 10-95,(EA),0.06,1.28,'-,[1.24-1.33],"CCND1, LINC01488",Breast cancer,breast carcinoma,GCST004988,11:69564393
rs720475-<b>G</b>,1 x 10-11,(EA),0.75,1.0416667,'-,[1.02-1.06],ARHGEF5,Breast cancer,breast carcinoma,GCST004988,7:144377836
rs9485372-<b>G</b>,4 x 10-6,(EA),0.81,1.0416667,'-,[1.02-1.08],TAB2,Breast cancer,breast carcinoma,GCST004988,6:149287738
rs17529111-<b>C</b>,1 x 10-9,(EA),0.22,1.02,'-,[1-1.04],TENT5A,Breast cancer,breast carcinoma,GCST004988,6:81418669
rs12422552-<b>C</b>,4 x 10-15,(EA),0.26,1.06,'-,[1.04-1.08],"RPL30P11, GNAI2P1",Breast cancer,breast carcinoma,GCST004988,12:14260997
chr22:39359355-<b>D10</b>,5 x 10-12,(EA),0.1,1.1,'-,[1.07-1.14],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs13281615-<b>G</b>,2 x 10-57,(EA),0.41,1.11,'-,[1.09-1.13],"CASC8, POU5F1B, PCAT1",Breast cancer,breast carcinoma,GCST004988,8:127343372
rs11814448-<b>C</b>,6 x 10-18,(EA),0.02,1.12,'-,[1.06-1.19],DNAJC1,Breast cancer,breast carcinoma,GCST004988,10:22026914
rs554219-<b>G</b>,6 x 10-47,(EA),0.13,1.21,'-,[1.18-1.24],LINC01488,Breast cancer,breast carcinoma,GCST004988,11:69516874
rs17879961-<b>G</b>,1 x 10-8,(EA),0.005,1.26,'-,[1.11-1.42],CHEK2,Breast cancer,breast carcinoma,GCST004988,22:28725099
rs144366570-<b>ATT</b>,2 x 10-7,(EA),0.1936,'-,0.0423 unit decrease,[0.026-0.058],"PRDX1, AKR1A1",Breast cancer,breast carcinoma,GCST004988,1:45548287
rs144727871-<b>A</b>,4 x 10-6,(EA),0.0318,'-,0.0842 unit increase,[0.049-0.12],'-,Breast cancer,breast carcinoma,GCST004988,5:52398145
rs1450985-<b>A</b>,6 x 10-8,(EA),0.4155,'-,0.035 unit increase,[0.022-0.048],PRICKLE2-AS1,Breast cancer,breast carcinoma,GCST004988,3:64074452
rs145106188-<b>CT</b>,3 x 10-7,(EA),0.4459,'-,0.0343 unit decrease,[0.021-0.047],EMB,Breast cancer,breast carcinoma,GCST004988,5:50491020
rs145407011-<b>T</b>,1 x 10-6,(EA),0.0268,'-,0.0978 unit decrease,[0.059-0.137],MAP4,Breast cancer,breast carcinoma,GCST004988,3:48024338
rs145455135-<b>A</b>,9 x 10-6,(EA),0.0208,'-,0.1571 unit decrease,[0.088-0.227],DMD,Breast cancer,breast carcinoma,GCST004988,X:32564969
rs145711907-<b>T</b>,2 x 10-6,(EA),0.4615,'-,0.0299 unit increase,[0.018-0.042],"LINC02533, RNA5SP202",Breast cancer,breast carcinoma,GCST004988,6:4445101
rs3132610-<b>G</b>,1 x 10-6,(EA),0.1198,'-,0.0499 unit decrease,[0.03-0.07],ABCF1,Breast cancer,breast carcinoma,GCST004988,6:30576624
rs3132615-<b>T</b>,2 x 10-6,(EA),0.1154,'-,0.0507 unit decrease,[0.03-0.071],"SUCLA2P1, RANP1",Breast cancer,breast carcinoma,GCST004988,6:30473526
rs332529-<b>A</b>,9 x 10-12,(EA),0.1605,'-,0.0606 unit decrease,[0.043-0.078],ARRDC3-AS1,Breast cancer,breast carcinoma,GCST004988,5:91493653
rs33960734-<b>ATT</b>,5 x 10-6,(EA),0.8248,'-,0.0375 unit decrease,[0.021-0.054],"LINC02785, SLC25A24",Breast cancer,breast carcinoma,GCST004988,1:108114736
rs34044188-<b>T</b>,3 x 10-7,(EA),0.0373,'-,0.0953 unit decrease,[0.059-0.132],JMJD1C,Breast cancer,breast carcinoma,GCST004988,10:63497603
rs34119086-<b>T</b>,8 x 10-9,(EA),0.093,'-,0.0679 unit decrease,[0.045-0.091],ZBED9,Breast cancer,breast carcinoma,GCST004988,6:28594471
rs34146356-<b>T</b>,5 x 10-8,(EA),0.0418,'-,0.0861 unit decrease,[0.055-0.117],EGR2,Breast cancer,breast carcinoma,GCST004988,10:62961440
rs34196306-<b>C</b>,1 x 10-9,(EA),0.0846,'-,0.0747 unit decrease,[0.051-0.099],ZNF184,Breast cancer,breast carcinoma,GCST004988,6:27457865
rs34331122-<b>CTT</b>,7 x 10-6,(EA),0.4557,'-,0.0288 unit decrease,[0.016-0.041],TBX1,Breast cancer,breast carcinoma,GCST004988,22:19774906
rs34507830-<b>T</b>,7 x 10-31,(EA),0.0206,'-,0.2629 unit increase,[0.22-0.31],CCND1,Breast cancer,breast carcinoma,GCST004988,11:69646918
rs34546498-<b>T</b>,9 x 10-10,(EA),0.0846,'-,0.0747 unit decrease,[0.051-0.099],LINC00240,Breast cancer,breast carcinoma,GCST004988,6:26993501
rs34662244-<b>A</b>,3 x 10-9,(EA),0.092,'-,0.0691 unit decrease,[0.046-0.092],ZSCAN16-AS1,Breast cancer,breast carcinoma,GCST004988,6:28106103
rs348196-<b>C</b>,2 x 10-8,(EA),0.2375,'-,0.0407 unit increase,[0.027-0.055],DAP3,Breast cancer,breast carcinoma,GCST004988,1:155697170
rs34853779-<b>C</b>,9 x 10-6,(EA),0.584,'-,0.0288 unit decrease,[0.016-0.042],"GAB1, Y_RNA",Breast cancer,breast carcinoma,GCST004988,4:143318872
rs35029702-<b>A</b>,1 x 10-7,(EA),0.0911,'-,0.0609 unit decrease,[0.038-0.084],'-,Breast cancer,breast carcinoma,GCST004988,5:43891334
rs35072154-<b>T</b>,3 x 10-6,(EA),0.3652,'-,0.0301 unit increase,[0.018-0.043],"OR7E159P, GNG2",Breast cancer,breast carcinoma,GCST004988,14:51819674
rs35100619-<b>A</b>,6 x 10-6,(EA),0.1115,'-,0.0507 unit increase,[0.029-0.073],LINC02225,Breast cancer,breast carcinoma,GCST004988,5:57890836
rs35273427-<b>C</b>,2 x 10-7,(EA),0.0602,'-,0.0707 unit increase,[0.044-0.098],ADAM30,Breast cancer,breast carcinoma,GCST004988,1:119894128
rs35306388-<b>G</b>,2 x 10-10,(EA),0.0391,'-,0.1041 unit decrease,[0.072-0.136],ALDH7A1P4,Breast cancer,breast carcinoma,GCST004988,10:62719072
rs35409891-<b>C</b>,3 x 10-9,(EA),0.293,'-,0.0457 unit decrease,[0.031-0.061],TAB2,Breast cancer,breast carcinoma,GCST004988,6:149265193
rs11779988-<b>C</b>,2 x 10-6,(EA),0.6061,'-,0.0302 unit decrease,[0.018-0.043],PCM1,Breast cancer,breast carcinoma,GCST004988,8:17926905
rs117911427-<b>A</b>,7 x 10-6,(EA),0.02,'-,0.1046 unit increase,[0.059-0.15],PPP1R35-AS1,Breast cancer,breast carcinoma,GCST004988,7:100437651
rs11822830-<b>G</b>,2 x 10-14,(EA),0.5959,'-,0.0483 unit increase,[0.036-0.061],"LINC01395, RPS27P20",Breast cancer,breast carcinoma,GCST004988,11:129591121
rs11960470-<b>C</b>,3 x 10-6,(EA),0.6236,'-,0.0308 unit decrease,[0.018-0.044],"LINC02106, RNU6-480P",Breast cancer,breast carcinoma,GCST004988,5:51032423
rs1200921-<b>A</b>,6 x 10-6,(EA),0.4634,'-,0.0289 unit decrease,[0.016-0.041],ANKRD30A,Breast cancer,breast carcinoma,GCST004988,10:37101682
rs12077974-<b>A</b>,2 x 10-7,(EA),0.2825,'-,0.0364 unit decrease,[0.023-0.05],MAST2,Breast cancer,breast carcinoma,GCST004988,1:45918469
rs12091730-<b>A</b>,2 x 10-10,(EA),0.2322,'-,0.0464 unit increase,[0.032-0.061],DAP3P1,Breast cancer,breast carcinoma,GCST004988,1:155587180
rs12095761-<b>G</b>,3 x 10-6,(EA),0.2306,'-,0.037 unit increase,[0.022-0.052],ESRRG,Breast cancer,breast carcinoma,GCST004988,1:216850159
rs12110303-<b>T</b>,1 x 10-11,(EA),0.1597,'-,0.0606 unit decrease,[0.043-0.078],"ARRDC3, Metazoa_SRP",Breast cancer,breast carcinoma,GCST004988,5:91367022
rs12134245-<b>T</b>,4 x 10-6,(EA),0.4961,'-,0.0288 unit decrease,[0.017-0.041],"HSP90B3P, WDR82P2",Breast cancer,breast carcinoma,GCST004988,1:91555907
rs12189522-<b>G</b>,1 x 10-6,(EA),0.018,'-,0.1158 unit increase,[0.069-0.162],'-,Breast cancer,breast carcinoma,GCST004988,5:53298177
rs12250948-<b>C</b>,1 x 10-14,(EA),0.7844,'-,0.0576 unit decrease,[0.043-0.072],RNU7-165P,Breast cancer,breast carcinoma,GCST004988,10:113368732
rs1230666-<b>G</b>,4 x 10-10,(EA),0.8721,'-,0.0592 unit decrease,[0.041-0.078],MAGI3,Breast cancer,breast carcinoma,GCST004988,1:113630788
rs1233480-<b>T</b>,5 x 10-8,(EA),0.1095,'-,0.0586 unit decrease,[0.037-0.08],LINC02829,Breast cancer,breast carcinoma,GCST004988,6:29509637
rs12458099-<b>A</b>,1 x 10-12,(EA),0.4378,'-,0.0443 unit decrease,[0.032-0.056],"AQP4-AS1, CHST9",Breast cancer,breast carcinoma,GCST004988,18:27025475
rs12474538-<b>A</b>,9 x 10-8,(EA),0.1487,'-,0.0469 unit decrease,[0.03-0.064],ANTXR1,Breast cancer,breast carcinoma,GCST004988,2:69207095
rs12481286-<b>T</b>,1 x 10-7,(EA),0.2403,'-,0.0407 unit increase,[0.026-0.056],RNU7-14P,Breast cancer,breast carcinoma,GCST004988,20:53671071
rs12483853-<b>C</b>,1 x 10-18,(EA),0.1411,'-,0.0783 unit increase,[0.061-0.096],TNRC6B,Breast cancer,breast carcinoma,GCST004988,22:40143521
rs12506630-<b>C</b>,1 x 10-6,(EA),0.3734,'-,0.0323 unit decrease,[0.019-0.045],SCFD2,Breast cancer,breast carcinoma,GCST004988,4:53046426
rs12519859-<b>A</b>,6 x 10-9,(EA),0.4748,'-,0.0365 unit increase,[0.024-0.049],SUB1,Breast cancer,breast carcinoma,GCST004988,5:32581080
rs12682248-<b>A</b>,2 x 10-6,(EA),0.7442,'-,0.0347 unit increase,[0.02-0.049],'-,Breast cancer,breast carcinoma,GCST004988,8:75988094
rs1268974-<b>G</b>,4 x 10-36,(EA),0.6132,'-,0.0793 unit decrease,[0.067-0.092],ZMIZ1,Breast cancer,breast carcinoma,GCST004988,10:79092621
rs12718945-<b>G</b>,4 x 10-6,(EA),0.5535,'-,0.0289 unit decrease,[0.017-0.041],EGFR,Breast cancer,breast carcinoma,GCST004988,7:55125270
rs12765365-<b>C</b>,2 x 10-8,(EA),0.0376,'-,0.0979 unit decrease,[0.064-0.132],RNU6-543P,Breast cancer,breast carcinoma,GCST004988,10:63089177
rs12870942-<b>C</b>,4 x 10-9,(EA),0.3182,'-,0.0391 unit increase,[0.026-0.052],RNY1P8,Breast cancer,breast carcinoma,GCST004988,13:73232845
rs12904134-<b>A</b>,8 x 10-6,(EA),0.501,'-,0.0286 unit increase,[0.016-0.041],CCDC33,Breast cancer,breast carcinoma,GCST004988,15:74300521
rs12918713-<b>C</b>,1 x 10-7,(EA),0.0674,'-,0.0688 unit decrease,[0.043-0.094],"TEKT5, EMP2",Breast cancer,breast carcinoma,GCST004988,16:10609831
rs12920416-<b>T</b>,8 x 10-7,(EA),0.2475,'-,0.0412 unit decrease,[0.025-0.057],LINC02861,Breast cancer,breast carcinoma,GCST004988,16:3942751
rs12962334-<b>C</b>,1 x 10-6,(EA),0.678,'-,0.0324 unit decrease,[0.019-0.045],RBBP8,Breast cancer,breast carcinoma,GCST004988,18:22897971
rs13008686-<b>G</b>,7 x 10-6,(EA),0.3354,'-,0.0302 unit increase,[0.017-0.043],'-,Breast cancer,breast carcinoma,GCST004988,2:226474745
rs13079292-<b>G</b>,8 x 10-6,(EA),0.9798,'-,0.1064 unit increase,[0.06-0.153],PFKFB4,Breast cancer,breast carcinoma,GCST004988,3:48542329
rs13160295-<b>G</b>,4 x 10-6,(EA),0.0239,'-,0.1121 unit increase,[0.064-0.16],RPS17P11,Breast cancer,breast carcinoma,GCST004988,5:52225463
rs13183434-<b>A</b>,4 x 10-17,(EA),0.1235,'-,0.0777 unit increase,[0.06-0.096],'-,Breast cancer,breast carcinoma,GCST004988,5:45074531
rs13195401-<b>T</b>,2 x 10-9,(EA),0.0874,'-,0.0718 unit decrease,[0.048-0.095],BTN2A1,Breast cancer,breast carcinoma,GCST004988,6:26463346
rs13198474-<b>A</b>,2 x 10-7,(EA),0.0745,'-,0.0673 unit decrease,[0.042-0.092],SLC17A3,Breast cancer,breast carcinoma,GCST004988,6:25874195
rs13214023-<b>A</b>,1 x 10-9,(EA),0.0929,'-,0.071 unit decrease,[0.048-0.094],ZKSCAN3,Breast cancer,breast carcinoma,GCST004988,6:28364364
rs13230714-<b>G</b>,1 x 10-6,(EA),0.3026,'-,0.0338 unit decrease,[0.02-0.047],TPK1,Breast cancer,breast carcinoma,GCST004988,7:144477198
rs13256025-<b>T</b>,2 x 10-7,(EA),0.1999,'-,0.0428 unit increase,[0.027-0.059],EBF2,Breast cancer,breast carcinoma,GCST004988,8:25974262
rs13416342-<b>G</b>,6 x 10-6,(EA),0.428,'-,0.0285 unit decrease,[0.016-0.041],LINC01812,Breast cancer,breast carcinoma,GCST004988,2:67879434
rs1375631-<b>G</b>,2 x 10-7,(EA),0.4975,'-,0.0321 unit increase,[0.02-0.044],"CDYLP1, PLCL2",Breast cancer,breast carcinoma,GCST004988,3:16737360
rs138024639-<b>T</b>,3 x 10-9,(EA),0.0932,'-,0.0699 unit decrease,[0.047-0.093],"OR2E1P, GPX6",Breast cancer,breast carcinoma,GCST004988,6:28468238
rs138672638-<b>C</b>,1 x 10-8,(EA),0.0096,'-,0.1833 unit increase,[0.12-0.25],"CAVIN1, RNU7-97P",Breast cancer,breast carcinoma,GCST004988,17:42426015
rs139059349-<b>C</b>,2 x 10-7,(EA),0.0142,'-,0.1465 unit increase,[0.092-0.201],HORMAD2,Breast cancer,breast carcinoma,GCST004988,22:30168182
rs139424826-<b>A</b>,5 x 10-13,(EA),0.15,'-,0.0657 unit decrease,[0.048-0.084],HCN1,Breast cancer,breast carcinoma,GCST004988,5:45522877
rs139824696-<b>C</b>,4 x 10-6,(EA),0.1183,'-,0.0448 unit increase,[0.026-0.064],"LINC02202, RNF145",Breast cancer,breast carcinoma,GCST004988,5:159141388
rs140035696-<b>G</b>,5 x 10-6,(EA),0.0165,'-,0.1271 unit increase,[0.072-0.182],NKD1,Breast cancer,breast carcinoma,GCST004988,16:50499690
rs140494697-<b>T</b>,4 x 10-6,(EA),0.006,'-,0.2014 unit increase,[0.12-0.29],DRG2,Breast cancer,breast carcinoma,GCST004988,17:18094293
rs140614180-<b>C</b>,6 x 10-8,(EA),0.0176,'-,0.1449 unit increase,[0.092-0.197],"L3MBTL2-AS1, L3MBTL2",Breast cancer,breast carcinoma,GCST004988,22:41221553
rs140783387-<b>C</b>,3 x 10-7,(EA),0.0885,'-,0.0602 unit increase,[0.037-0.083],ARHGAP5,Breast cancer,breast carcinoma,GCST004988,14:32127443
rs140945602-<b>T</b>,7 x 10-8,(EA),0.4877,'-,0.0359 unit increase,[0.023-0.049],FAF1,Breast cancer,breast carcinoma,GCST004988,1:50882601
rs188460188-<b>C</b>,3 x 10-8,(EA),0.0077,'-,0.237 unit increase,[0.15-0.32],HORMAD2-AS1,Breast cancer,breast carcinoma,GCST004988,22:30051113
rs190811224-<b>T</b>,5 x 10-6,(EA),0.7316,'-,0.037 unit decrease,[0.021-0.053],"EXOC3, PP7080",Breast cancer,breast carcinoma,GCST004988,5:467862
rs1924553-<b>G</b>,5 x 10-7,(EA),0.2602,'-,0.0386 unit decrease,[0.024-0.054],PADI6,Breast cancer,breast carcinoma,GCST004988,1:17380437
rs1963045-<b>C</b>,2 x 10-6,(EA),0.4688,'-,0.0296 unit increase,[0.017-0.042],GPAT3,Breast cancer,breast carcinoma,GCST004988,4:83549680
rs1989796-<b>C</b>,2 x 10-6,(EA),0.5861,'-,0.0311 unit decrease,[0.018-0.044],GRM3,Breast cancer,breast carcinoma,GCST004988,7:86844997
rs199867187-<b>G</b>,1 x 10-6,(EA),0.2745,'-,0.0381 unit increase,[0.023-0.054],CASZ1,Breast cancer,breast carcinoma,GCST004988,1:10637822
rs200484318-<b>G</b>,7 x 10-6,(EA),0.571,'-,0.0431 unit decrease,[0.024-0.062],MIR4435-2HG,Breast cancer,breast carcinoma,GCST004988,2:111433700
rs201462698-<b>C</b>,1 x 10-6,(EA),0.0921,'-,0.0571 unit increase,[0.034-0.08],SIK3,Breast cancer,breast carcinoma,GCST004988,11:116897884
rs2822999-<b>G</b>,2 x 10-11,(EA),0.173,'-,0.0589 unit increase,[0.042-0.076],NRIP1,Breast cancer,breast carcinoma,GCST004988,21:14992435
rs28648619-<b>G</b>,5 x 10-6,(EA),0.0804,'-,0.0551 unit increase,[0.031-0.079],ARID1B,Breast cancer,breast carcinoma,GCST004988,6:156907180
rs2963155-<b>G</b>,7 x 10-6,(EA),0.2523,'-,0.0339 unit decrease,[0.019-0.049],NR3C1,Breast cancer,breast carcinoma,GCST004988,5:143376439
rs3094054-<b>T</b>,1 x 10-7,(EA),0.1132,'-,0.056 unit decrease,[0.035-0.077],"UBQLN1P1, MICC",Breast cancer,breast carcinoma,GCST004988,6:30365728
rs2136690-<b>G</b>,4 x 10-6,(EA),0.5774,'-,0.0289 unit increase,[0.017-0.041],"TIPARP-AS1, SSR3",Breast cancer,breast carcinoma,GCST004988,3:156645453
rs2253762-<b>C</b>,2 x 10-9,(EA),0.2971,'-,0.0419 unit increase,[0.028-0.056],TACC2,Breast cancer,breast carcinoma,GCST004988,10:122041907
rs2304098-<b>C</b>,2 x 10-11,(EA),0.3469,'-,0.0434 unit increase,[0.031-0.056],YJEFN3,Breast cancer,breast carcinoma,GCST004988,19:19535463
rs2405064-<b>T</b>,4 x 10-6,(EA),0.0992,'-,0.0484 unit increase,[0.028-0.069],PTCH1,Breast cancer,breast carcinoma,GCST004988,9:95606163
rs250677-<b>C</b>,8 x 10-6,(EA),0.2221,'-,0.0343 unit increase,[0.019-0.049],SH3TC2,Breast cancer,breast carcinoma,GCST004988,5:149053986
rs26067-<b>A</b>,2 x 10-8,(EA),0.6263,'-,0.0369 unit increase,[0.024-0.05],PARP8,Breast cancer,breast carcinoma,GCST004988,5:50793817
rs2725207-<b>A</b>,6 x 10-7,(EA),0.1439,'-,0.0455 unit decrease,[0.028-0.063],PKD2,Breast cancer,breast carcinoma,GCST004988,4:88058377
rs310291-<b>A</b>,6 x 10-8,(EA),0.4075,'-,0.0341 unit increase,[0.022-0.046],"NKX2-6, STC1",Breast cancer,breast carcinoma,GCST004988,8:23801998
rs3129984-<b>T</b>,8 x 10-6,(EA),0.1179,'-,0.0465 unit decrease,[0.026-0.067],"HCG20, LINC00243",Breast cancer,breast carcinoma,GCST004988,6:30793795
rs6020772-<b>T</b>,1 x 10-6,(EA),0.2491,'-,0.0348 unit decrease,[0.021-0.049],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs6062356-<b>G</b>,3 x 10-6,(EA),0.1495,'-,0.0405 unit increase,[0.023-0.058],"PCMTD2, MYT1",Breast cancer,breast carcinoma,GCST004988,20:64247978
rs61495451-<b>C</b>,3 x 10-6,(EA),0.7935,'-,0.0398 unit decrease,[0.023-0.056],VMP1,Breast cancer,breast carcinoma,GCST004988,17:59769155
rs62048402-<b>A</b>,4 x 10-23,(EA),0.4156,'-,0.0624 unit decrease,[0.05-0.075],FTO,Breast cancer,breast carcinoma,GCST004988,16:53769311
rs62084913-<b>T</b>,9 x 10-6,(EA),0.3982,'-,0.0307 unit increase,[0.017-0.044],TMEM104,Breast cancer,breast carcinoma,GCST004988,17:74776908
rs113953597-<b>A</b>,1 x 10-8,(EA),0.2188,'-,0.0446 unit increase,[0.029-0.06],"DNMT3A, LINC01381",Breast cancer,breast carcinoma,GCST004988,2:25222417
rs11406084-<b>CA</b>,7 x 10-6,(EA),0.1995,'-,0.0378 unit increase,[0.021-0.054],KHDC4,Breast cancer,breast carcinoma,GCST004988,1:155928952
rs11410354-<b>CT</b>,2 x 10-6,(EA),0.8001,'-,0.039 unit decrease,[0.023-0.055],"PTDSS2, ANO9",Breast cancer,breast carcinoma,GCST004988,11:442473
rs11462858-<b>GT</b>,2 x 10-12,(EA),0.3215,'-,0.0471 unit decrease,[0.034-0.06],RN7SKP167,Breast cancer,breast carcinoma,GCST004988,10:121334478
rs1154723-<b>C</b>,9 x 10-6,(EA),0.9475,'-,0.0681 unit increase,[0.038-0.098],RPS11P1,Breast cancer,breast carcinoma,GCST004988,20:11399194
rs11583393-<b>A</b>,4 x 10-8,(EA),0.249,'-,0.0396 unit decrease,[0.025-0.054],PKN2-AS1,Breast cancer,breast carcinoma,GCST004988,1:87963341
rs116183959-<b>C</b>,2 x 10-6,(EA),0.1291,'-,0.0439 unit increase,[0.026-0.062],LINC01090,Breast cancer,breast carcinoma,GCST004988,2:188005044
rs11624333-<b>C</b>,7 x 10-42,(EA),0.2595,'-,0.0968 unit decrease,[0.083-0.111],RAD51B,Breast cancer,breast carcinoma,GCST004988,14:68513118
rs116464256-<b>C</b>,4 x 10-6,(EA),0.0318,'-,0.0855 unit increase,[0.049-0.122],LINC02118,Breast cancer,breast carcinoma,GCST004988,5:52083172
rs11646723-<b>T</b>,4 x 10-6,(EA),0.0578,'-,0.0718 unit increase,[0.041-0.102],SLC12A3,Breast cancer,breast carcinoma,GCST004988,16:56871774
rs116478824-<b>C</b>,5 x 10-6,(EA),0.0455,'-,0.0675 unit increase,[0.038-0.097],NEBL,Breast cancer,breast carcinoma,GCST004988,10:21230606
rs11652463-<b>G</b>,8 x 10-8,(EA),0.3083,'-,0.04 unit decrease,[0.025-0.055],LINC00511,Breast cancer,breast carcinoma,GCST004988,17:72408954
rs11655740-<b>C</b>,7 x 10-6,(EA),0.0302,'-,0.0906 unit decrease,[0.051-0.13],FAM20A,Breast cancer,breast carcinoma,GCST004988,17:68557338
rs11680449-<b>A</b>,4 x 10-9,(EA),0.2823,'-,0.0404 unit decrease,[0.027-0.054],"RPS15P4, DAP3P2",Breast cancer,breast carcinoma,GCST004988,2:171513371
rs11684853-<b>T</b>,1 x 10-12,(EA),0.5606,'-,0.0442 unit decrease,[0.032-0.056],LINC01376,Breast cancer,breast carcinoma,GCST004988,2:19111157
rs11690035-<b>T</b>,6 x 10-6,(EA),0.0749,'-,0.0534 unit increase,[0.03-0.077],TEX41,Breast cancer,breast carcinoma,GCST004988,2:144845739
rs11693806-<b>G</b>,3 x 10-26,(EA),0.7288,'-,0.0739 unit decrease,[0.06-0.088],DIRC3,Breast cancer,breast carcinoma,GCST004988,2:217427435
rs11700530-<b>A</b>,4 x 10-6,(EA),0.6155,'-,0.0323 unit increase,[0.019-0.046],RNU6-113P,Breast cancer,breast carcinoma,GCST004988,21:17368480
rs117078955-<b>T</b>,1 x 10-6,(EA),0.0178,'-,0.1235 unit increase,[0.074-0.173],ACO2,Breast cancer,breast carcinoma,GCST004988,22:41501983
rs1172821-<b>T</b>,4 x 10-6,(EA),0.3632,'-,0.0297 unit decrease,[0.017-0.042],BRSK1,Breast cancer,breast carcinoma,GCST004988,19:55305310
rs117512673-<b>G</b>,6 x 10-6,(EA),0.0112,'-,0.1749 unit decrease,[0.099-0.25],'-,Breast cancer,breast carcinoma,GCST004988,21:15315098
rs117649165-<b>T</b>,1 x 10-6,(EA),0.016,'-,0.1396 unit increase,[0.083-0.196],LINC02646,Breast cancer,breast carcinoma,GCST004988,10:130453365
rs117698693-<b>G</b>,4 x 10-6,(EA),0.0224,'-,0.117 unit increase,[0.067-0.167],SBF2,Breast cancer,breast carcinoma,GCST004988,11:9906964
rs117758012-<b>T</b>,5 x 10-7,(EA),0.0574,'-,0.0718 unit increase,[0.044-0.1],"MAST1, HOOK2",Breast cancer,breast carcinoma,GCST004988,19:12846836
rs35417517-<b>C</b>,8 x 10-11,(EA),0.392,'-,0.0416 unit increase,[0.029-0.054],"LRRD1, CYP51A1-AS1",Breast cancer,breast carcinoma,GCST004988,7:92143417
rs35419901-<b>T</b>,8 x 10-11,(EA),0.0377,'-,0.1123 unit decrease,[0.078-0.146],LINC02621,Breast cancer,breast carcinoma,GCST004988,10:62303692
rs10016947-<b>C</b>,9 x 10-6,(EA),0.0567,'-,0.0611 unit decrease,[0.034-0.088],LINC02428,Breast cancer,breast carcinoma,GCST004988,4:103450498
rs10051199-<b>T</b>,2 x 10-6,(EA),0.476,'-,0.0293 unit decrease,[0.017-0.041],SPRY4,Breast cancer,breast carcinoma,GCST004988,5:142290274
rs10103490-<b>C</b>,4 x 10-6,(EA),0.3554,'-,0.0319 unit decrease,[0.018-0.045],EXT1,Breast cancer,breast carcinoma,GCST004988,8:117869627
rs10169133-<b>C</b>,1 x 10-8,(EA),0.6206,'-,0.0364 unit decrease,[0.024-0.049],LINC01376,Breast cancer,breast carcinoma,GCST004988,2:19212878
rs10269006-<b>T</b>,5 x 10-7,(EA),0.3178,'-,0.0335 unit increase,[0.021-0.046],"ATP5PBP2, GRPEL2P3",Breast cancer,breast carcinoma,GCST004988,7:94758031
rs10629804-<b>GCTTCA</b>,1 x 10-6,(EA),0.7425,'-,0.0345 unit decrease,[0.021-0.048],PRDM6,Breast cancer,breast carcinoma,GCST004988,5:123142308
rs10644111-<b>AAAC</b>,3 x 10-11,(EA),0.3903,'-,0.0424 unit increase,[0.03-0.055],AKAP9,Breast cancer,breast carcinoma,GCST004988,7:92022865
rs10695717-<b>ATTC</b>,1 x 10-6,(EA),0.5971,'-,0.0315 unit increase,[0.019-0.044],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs10796944-<b>A</b>,7 x 10-10,(EA),0.2299,'-,0.0457 unit increase,[0.031-0.06],ASH1L,Breast cancer,breast carcinoma,GCST004988,1:155446537
rs10811650-<b>G</b>,2 x 10-13,(EA),0.4205,'-,0.0461 unit decrease,[0.034-0.058],CDKN2B-AS1,Breast cancer,breast carcinoma,GCST004988,9:22067594
rs10883710-<b>C</b>,3 x 10-6,(EA),0.4601,'-,0.0291 unit decrease,[0.017-0.041],"PPRC1, LDB1",Breast cancer,breast carcinoma,GCST004988,10:102125800
rs10885405-<b>T</b>,5 x 10-14,(EA),0.46,'-,0.0465 unit increase,[0.034-0.059],TCF7L2,Breast cancer,breast carcinoma,GCST004988,10:113017911
rs10906522-<b>C</b>,1 x 10-7,(EA),0.4708,'-,0.0332 unit increase,[0.021-0.046],FRMD4A,Breast cancer,breast carcinoma,GCST004988,10:13865236
rs10975370-<b>G</b>,3 x 10-6,(EA),0.2043,'-,0.0356 unit increase,[0.021-0.05],KIAA2026,Breast cancer,breast carcinoma,GCST004988,9:5956008
rs11039183-<b>A</b>,6 x 10-6,(EA),0.3501,'-,0.0301 unit decrease,[0.017-0.043],MADD,Breast cancer,breast carcinoma,GCST004988,11:47325389
rs111307654-<b>GAAA</b>,1 x 10-12,(EA),0.7248,'-,0.0497 unit decrease,[0.036-0.063],SGCE,Breast cancer,breast carcinoma,GCST004988,7:94655778
rs111342015-<b>A</b>,9 x 10-8,(EA),0.098,'-,0.0571 unit decrease,[0.036-0.078],TTBK1,Breast cancer,breast carcinoma,GCST004988,6:43259403
rs11135046-<b>T</b>,5 x 10-31,(EA),0.5529,'-,0.0717 unit decrease,[0.06-0.084],EBF1,Breast cancer,breast carcinoma,GCST004988,5:158803005
rs111549985-<b>G</b>,6 x 10-12,(EA),0.2474,'-,0.0498 unit decrease,[0.036-0.064],ATG10,Breast cancer,breast carcinoma,GCST004988,5:81972251
rs111605422-<b>A</b>,9 x 10-13,(EA),0.0569,'-,0.0936 unit increase,[0.068-0.119],ATE1,Breast cancer,breast carcinoma,GCST004988,10:121795069
rs111730030-<b>T</b>,2 x 10-8,(EA),0.0484,'-,0.0837 unit increase,[0.054-0.113],RPL12P42,Breast cancer,breast carcinoma,GCST004988,19:13158012
rs11205303-<b>C</b>,1 x 10-14,(EA),0.3998,'-,0.0497 unit increase,[0.037-0.062],MTMR11,Breast cancer,breast carcinoma,GCST004988,1:149934520
rs112056657-<b>G</b>,2 x 10-6,(EA),0.0103,'-,0.1986 unit decrease,[0.12-0.28],NRXN3,Breast cancer,breast carcinoma,GCST004988,14:78743396
rs112332509-<b>C</b>,4 x 10-6,(EA),0.5004,'-,0.0335 unit increase,[0.019-0.048],KDM4C,Breast cancer,breast carcinoma,GCST004988,9:7195019
rs11264454-<b>G</b>,7 x 10-7,(EA),0.4278,'-,0.0327 unit increase,[0.02-0.046],"SEMA4A, SLC25A44",Breast cancer,breast carcinoma,GCST004988,1:156183252
rs72755643-<b>G</b>,3 x 10-11,(EA),0.1333,'-,0.0652 unit decrease,[0.046-0.084],CARD6,Breast cancer,breast carcinoma,GCST004988,5:46090449
rs72774916-<b>T</b>,2 x 10-8,(EA),0.0924,'-,0.0648 unit decrease,[0.042-0.088],"SEM1P1, SSBP2",Breast cancer,breast carcinoma,GCST004988,5:81820020
rs7278690-<b>G</b>,6 x 10-6,(EA),0.926,'-,0.0583 unit decrease,[0.033-0.084],LINC02246,Breast cancer,breast carcinoma,GCST004988,21:14855305
rs35522438-<b>AT</b>,1 x 10-9,(EA),0.3913,'-,0.0389 unit increase,[0.026-0.051],KRIT1,Breast cancer,breast carcinoma,GCST004988,7:92243559
rs35632171-<b>G</b>,3 x 10-7,(EA),0.0418,'-,0.0915 unit decrease,[0.057-0.126],JMJD1C,Breast cancer,breast carcinoma,GCST004988,10:63349742
rs35748790-<b>TA</b>,3 x 10-6,(EA),0.3649,'-,0.0317 unit decrease,[0.018-0.045],RNF19A,Breast cancer,breast carcinoma,GCST004988,8:100298199
rs370356098-<b>C</b>,2 x 10-7,(EA),0.0399,'-,0.0837 unit decrease,[0.052-0.115],PIP4K2A,Breast cancer,breast carcinoma,GCST004988,10:22681806
rs372562666-<b>G</b>,6 x 10-27,(EA),0.2648,'-,0.1005 unit increase,[0.082-0.119],NOTCH2,Breast cancer,breast carcinoma,GCST004988,1:120018691
rs375506010-<b>T</b>,5 x 10-6,(EA),0.1809,'-,0.0395 unit increase,[0.022-0.057],BCAS1,Breast cancer,breast carcinoma,GCST004988,20:53956286
rs3769821-<b>T</b>,4 x 10-18,(EA),0.6683,'-,0.0565 unit decrease,[0.044-0.069],CASP8,Breast cancer,breast carcinoma,GCST004988,2:201258707
rs377527229-<b>C</b>,6 x 10-6,(EA),0.2282,'-,0.0341 unit increase,[0.019-0.049],Y_RNA,Breast cancer,breast carcinoma,GCST004988,6:99643666
rs3815308-<b>A</b>,7 x 10-6,(EA),0.4348,'-,0.0288 unit increase,[0.016-0.041],DOT1L,Breast cancer,breast carcinoma,GCST004988,19:2226677
rs3821902-<b>G</b>,3 x 10-12,(EA),0.1358,'-,0.0623 unit increase,[0.045-0.08],ATXN7,Breast cancer,breast carcinoma,GCST004988,3:63956021
rs3829964-<b>C</b>,9 x 10-8,(EA),0.4864,'-,0.0331 unit increase,[0.021-0.045],CDKN1A,Breast cancer,breast carcinoma,GCST004988,6:36676721
rs35997229-<b>C</b>,3 x 10-7,(EA),0.0431,'-,0.0829 unit decrease,[0.051-0.115],JMJD1C,Breast cancer,breast carcinoma,GCST004988,10:63197831
rs36059695-<b>T</b>,6 x 10-8,(EA),0.035,'-,0.1031 unit decrease,[0.066-0.14],ABCA8,Breast cancer,breast carcinoma,GCST004988,17:68904663
rs36715-<b>A</b>,4 x 10-6,(EA),0.7576,'-,0.0339 unit decrease,[0.019-0.048],"FBN2, SLC12A2",Breast cancer,breast carcinoma,GCST004988,5:128227188
rs368032757-<b>G</b>,5 x 10-6,(EA),0.0183,'-,0.1759 unit increase,[0.1-0.25],NBPF25P,Breast cancer,breast carcinoma,GCST004988,1:145607339
rs368121891-<b>A</b>,9 x 10-8,(EA),0.3735,'-,0.0405 unit decrease,[0.026-0.055],NBPF10,Breast cancer,breast carcinoma,GCST004988,1:146069686
rs369304377-<b>G</b>,2 x 10-29,(EA),0.3892,'-,0.0885 unit increase,[0.073-0.104],"RPL22P6, H3P4",Breast cancer,breast carcinoma,GCST004988,1:121121848
rs369328859-<b>G</b>,2 x 10-8,(EA),0.3748,'-,0.0369 unit increase,[0.024-0.05],ANKIB1,Breast cancer,breast carcinoma,GCST004988,7:92344194
rs369832192-<b>C</b>,4 x 10-6,(EA),0.4764,'-,0.0302 unit increase,[0.017-0.043],"CASP7, NRAP",Breast cancer,breast carcinoma,GCST004988,10:113678604
rs3853291-<b>A</b>,3 x 10-7,(EA),0.5472,'-,0.0318 unit increase,[0.02-0.044],ALX4,Breast cancer,breast carcinoma,GCST004988,11:44347927
rs411624-<b>C</b>,2 x 10-6,(EA),0.9557,'-,0.0767 unit increase,[0.045-0.108],CUX1,Breast cancer,breast carcinoma,GCST004988,7:102160260
rs375066-<b>C</b>,2 x 10-14,(EA),0.5141,'-,0.0474 unit decrease,[0.035-0.06],"ZNF45-AS1, ZNF45",Breast cancer,breast carcinoma,GCST004988,19:43919418
rs377629160-<b>T</b>,6 x 10-7,(EA),0.1887,'-,0.0431 unit increase,[0.026-0.06],STAG3L2,Breast cancer,breast carcinoma,GCST004988,7:74860783
chr12:59581708-<b>A</b>,7 x 10-6,(EA),0.0108,'-,0.161 unit decrease,[0.091-0.231],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:78820565-<b>A</b>,7 x 10-6,(EA),0.0053,'-,0.4799 unit decrease,[0.27-0.69],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:83063443-<b>A</b>,2 x 10-6,(EA),0.1019,'-,0.0551 unit increase,[0.033-0.078],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:85009437-<b>C</b>,3 x 10-8,(EA),0.3376,'-,0.0387 unit decrease,[0.025-0.052],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:96027759-<b>G</b>,1 x 10-39,(EA),0.2985,'-,0.0898 unit decrease,[0.076-0.103],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:96141866-<b>G</b>,4 x 10-7,(EA),0.1717,'-,0.0438 unit decrease,[0.027-0.061],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr13:32866927-<b>CAATAAATA</b>,1 x 10-16,(EA),0.0104,'-,0.2691 unit increase,[0.21-0.33],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr14:35412105-<b>GA</b>,6 x 10-6,(EA),0.2975,'-,0.0325 unit decrease,[0.018-0.047],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr14:68118802-<b>GTGGGT</b>,2 x 10-7,(EA),0.0195,'-,0.1317 unit increase,[0.083-0.181],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr14:93112310-<b>A</b>,9 x 10-13,(EA),0.1751,'-,0.0598 unit decrease,[0.043-0.076],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr15:86218049-<b>ATATGTATG</b>,6 x 10-6,(EA),0.2897,'-,0.0333 unit increase,[0.019-0.048],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr16:53908992-<b>G</b>,9 x 10-6,(EA),0.1092,'-,0.0523 unit decrease,[0.029-0.075],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr17:43658516-<b>T</b>,5 x 10-12,(EA),0.1751,'-,0.0587 unit decrease,[0.042-0.075],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr17:44759766-<b>A</b>,2 x 10-8,(EA),0.1408,'-,0.0562 unit decrease,[0.037-0.076],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr18:42517419-<b>C</b>,7 x 10-8,(EA),0.1239,'-,0.0557 unit decrease,[0.036-0.076],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr2:6178372-<b>AGTT</b>,8 x 10-6,(EA),0.0083,'-,0.1885 unit decrease,[0.11-0.27],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr4:187503860-<b>GTCTCTCTC</b>,8 x 10-7,(EA),0.4564,'-,0.0312 unit increase,[0.019-0.044],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr4:84370124-<b>TA</b>,2 x 10-9,(EA),0.5328,'-,0.0384 unit decrease,[0.026-0.051],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr5:43263364-<b>T</b>,1 x 10-6,(EA),0.0112,'-,0.2075 unit decrease,[0.12-0.29],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr5:52482315-<b>C</b>,8 x 10-7,(EA),0.0183,'-,0.1168 unit increase,[0.07-0.163],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr5:58365353-<b>C</b>,2 x 10-10,(EA),0.0903,'-,0.0718 unit decrease,[0.05-0.094],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr6:151715281-<b>GA</b>,2 x 10-7,(EA),0.6249,'-,0.0367 unit increase,[0.023-0.051],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr6:28709151-<b>G</b>,1 x 10-8,(EA),0.0981,'-,0.0649 unit decrease,[0.043-0.087],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr6:32677587-<b>C</b>,5 x 10-6,(EA),0.0176,'-,0.1523 unit decrease,[0.087-0.218],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chrX:118630622-<b>G</b>,7 x 10-6,(EA),0.6807,'-,0.2721 unit increase,[0.15-0.39],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:112007756-<b>T</b>,6 x 10-7,(EA),0.5115,'-,0.0311 unit increase,[0.019-0.043],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:112200150-<b>C</b>,9 x 10-6,(EA),0.5706,'-,0.0282 unit increase,[0.016-0.041],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:112610714-<b>A</b>,2 x 10-6,(EA),0.4254,'-,0.0299 unit decrease,[0.018-0.042],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:112840766-<b>G</b>,3 x 10-6,(EA),0.4307,'-,0.0297 unit decrease,[0.017-0.042],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:115108361-<b>C</b>,1 x 10-9,(EA),0.2663,'-,0.0432 unit increase,[0.029-0.057],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:115558575-<b>C</b>,4 x 10-6,(EA),0.3599,'-,0.0296 unit increase,[0.017-0.042],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:115835798-<b>A</b>,2 x 10-39,(EA),0.4164,'-,0.0824 unit decrease,[0.07-0.095],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:115990594-<b>G</b>,1 x 10-6,(EA),0.5027,'-,0.0303 unit increase,[0.018-0.043],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:116347863-<b>G</b>,4 x 10-7,(EA),0.4696,'-,0.0334 unit decrease,[0.02-0.046],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:120832146-<b>T</b>,4 x 10-8,(EA),0.1566,'-,0.0487 unit increase,[0.031-0.066],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:14413931-<b>C</b>,4 x 10-15,(EA),0.2589,'-,0.0552 unit increase,[0.041-0.069],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:28347382-<b>T</b>,3 x 10-19,(EA),0.2168,'-,0.0687 unit decrease,[0.054-0.084],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:28452497-<b>A</b>,1 x 10-16,(EA),0.299,'-,0.0564 unit decrease,[0.043-0.07],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:28569325-<b>T</b>,3 x 10-15,(EA),0.3056,'-,0.0532 unit decrease,[0.04-0.066],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:28672110-<b>A</b>,4 x 10-14,(EA),0.3063,'-,0.0511 unit decrease,[0.038-0.064],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:28775813-<b>G</b>,2 x 10-6,(EA),0.019,'-,0.1157 unit decrease,[0.068-0.163],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:28928139-<b>G</b>,1 x 10-6,(EA),0.0139,'-,0.1404 unit decrease,[0.084-0.197],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:29140260-<b>A</b>,3 x 10-10,(EA),0.9138,'-,0.0713 unit increase,[0.049-0.093],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:29247350-<b>A</b>,3 x 10-9,(EA),0.0847,'-,0.0674 unit decrease,[0.045-0.09],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:29489004-<b>G</b>,1 x 10-6,(EA),0.0508,'-,0.0725 unit decrease,[0.043-0.102],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:31952412-<b>C</b>,4 x 10-6,(EA),0.314,'-,0.0329 unit increase,[0.019-0.047],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:57282235-<b>G</b>,2 x 10-7,(EA),0.0063,'-,0.2341 unit decrease,[0.15-0.32],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:57484602-<b>T</b>,1 x 10-7,(EA),0.0097,'-,0.1913 unit decrease,[0.12-0.26],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:57602279-<b>A</b>,4 x 10-6,(EA),0.0117,'-,0.1557 unit decrease,[0.089-0.222],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:57848639-<b>A</b>,4 x 10-6,(EA),0.559,'-,0.0291 unit increase,[0.017-0.041],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs6912005-<b>A</b>,2 x 10-11,(EA),0.2419,'-,0.0483 unit increase,[0.034-0.062],TENT5A,Breast cancer,breast carcinoma,GCST004988,6:81677422
rs6928012-<b>T</b>,2 x 10-6,(EA),0.5967,'-,0.0303 unit decrease,[0.018-0.043],CDKAL1,Breast cancer,breast carcinoma,GCST004988,6:20728282
rs6934651-<b>C</b>,6 x 10-6,(EA),0.0775,'-,0.0522 unit increase,[0.029-0.075],KRT18P64,Breast cancer,breast carcinoma,GCST004988,6:85210757
rs6938-<b>G</b>,9 x 10-8,(EA),0.6551,'-,0.0364 unit increase,[0.023-0.05],SCAMP2,Breast cancer,breast carcinoma,GCST004988,15:74843920
rs6940159-<b>C</b>,3 x 10-7,(EA),0.6162,'-,0.033 unit increase,[0.02-0.046],'-,Breast cancer,breast carcinoma,GCST004988,6:170017397
rs6946892-<b>C</b>,1 x 10-7,(EA),0.7489,'-,0.0413 unit decrease,[0.026-0.057],DPY19L2P2,Breast cancer,breast carcinoma,GCST004988,7:103251337
rs7017073-<b>C</b>,2 x 10-14,(EA),0.2115,'-,0.0572 unit increase,[0.043-0.072],"RN7SKP226, PVT1",Breast cancer,breast carcinoma,GCST004988,8:128192016
rs7017697-<b>T</b>,1 x 10-6,(EA),0.6711,'-,0.0319 unit decrease,[0.019-0.045],INTS10,Breast cancer,breast carcinoma,GCST004988,8:19828398
rs707475-<b>A</b>,1 x 10-7,(EA),0.393,'-,0.035 unit decrease,[0.022-0.048],"UTS2, TNFRSF9",Breast cancer,breast carcinoma,GCST004988,1:7857016
rs7098100-<b>A</b>,1 x 10-18,(EA),0.3537,'-,0.0572 unit increase,[0.044-0.07],MLLT10,Breast cancer,breast carcinoma,GCST004988,10:21545607
rs7102494-<b>T</b>,6 x 10-7,(EA),0.1044,'-,0.0508 unit increase,[0.031-0.071],"ZNF123P, BARX2",Breast cancer,breast carcinoma,GCST004988,11:129360950
rs71063528-<b>C</b>,8 x 10-7,(EA),0.7244,'-,0.0381 unit increase,[0.023-0.053],USP28,Breast cancer,breast carcinoma,GCST004988,11:113863644
rs71281886-<b>CAA</b>,2 x 10-6,(EA),0.0232,'-,0.1168 unit decrease,[0.069-0.165],SPINK8,Breast cancer,breast carcinoma,GCST004988,3:48311089
rs71386921-<b>A</b>,3 x 10-6,(EA),0.7961,'-,0.0366 unit increase,[0.021-0.052],ACBD5,Breast cancer,breast carcinoma,GCST004988,10:27189770
rs71599425-<b>A</b>,6 x 10-6,(EA),0.0382,'-,0.0797 unit decrease,[0.045-0.114],ARHGAP24,Breast cancer,breast carcinoma,GCST004988,4:85740190
rs71695136-<b>C</b>,7 x 10-7,(EA),0.7841,'-,0.0427 unit decrease,[0.026-0.06],IST1,Breast cancer,breast carcinoma,GCST004988,16:71918418
rs718857-<b>C</b>,2 x 10-6,(EA),0.6384,'-,0.0311 unit increase,[0.018-0.044],'-,Breast cancer,breast carcinoma,GCST004988,9:103912867
rs72127681-<b>CT</b>,6 x 10-11,(EA),0.3527,'-,0.0454 unit decrease,[0.032-0.059],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs72806318-<b>A</b>,5 x 10-19,(EA),0.0153,'-,0.2218 unit increase,[0.17-0.27],DNAJC1,Breast cancer,breast carcinoma,GCST004988,10:21863269
rs7223535-<b>A</b>,4 x 10-10,(EA),0.268,'-,0.0439 unit decrease,[0.03-0.058],ATAD5,Breast cancer,breast carcinoma,GCST004988,17:30884649
rs72314471-<b>C</b>,8 x 10-6,(EA),0.8389,'-,0.0385 unit decrease,[0.022-0.055],"LPA, PLG",Breast cancer,breast carcinoma,GCST004988,6:160665585
rs7240205-<b>T</b>,2 x 10-8,(EA),0.6096,'-,0.0365 unit decrease,[0.024-0.049],KCTD1,Breast cancer,breast carcinoma,GCST004988,18:26576054
rs7249698-<b>A</b>,4 x 10-7,(EA),0.3594,'-,0.0327 unit decrease,[0.02-0.045],MYO9B,Breast cancer,breast carcinoma,GCST004988,19:17099805
rs72658071-<b>T</b>,3 x 10-28,(EA),0.0877,'-,0.1182 unit increase,[0.097-0.139],"HNF4G, PKMP4",Breast cancer,breast carcinoma,GCST004988,8:75393550
rs72751936-<b>A</b>,4 x 10-12,(EA),0.1354,'-,0.0667 unit decrease,[0.048-0.086],'-,Breast cancer,breast carcinoma,GCST004988,5:45984331
rs6473252-<b>T</b>,8 x 10-7,(EA),0.4116,'-,0.0309 unit decrease,[0.019-0.043],"PAG1, ZNF704",Breast cancer,breast carcinoma,GCST004988,8:80887958
rs6558174-<b>G</b>,3 x 10-6,(EA),0.7027,'-,0.0362 unit increase,[0.021-0.051],BIN3,Breast cancer,breast carcinoma,GCST004988,8:22634616
rs66686620-<b>A</b>,1 x 10-7,(EA),0.1433,'-,0.0469 unit decrease,[0.029-0.064],ANTXR1,Breast cancer,breast carcinoma,GCST004988,2:69023500
rs666930-<b>C</b>,5 x 10-8,(EA),0.5338,'-,0.0347 unit increase,[0.022-0.047],PHGDH,Breast cancer,breast carcinoma,GCST004988,1:119716347
rs66783663-<b>T</b>,5 x 10-6,(EA),0.1419,'-,0.0408 unit decrease,[0.023-0.058],CDH12,Breast cancer,breast carcinoma,GCST004988,5:22642425
rs66823261-<b>C</b>,3 x 10-7,(EA),0.2289,'-,0.041 unit increase,[0.025-0.057],RPL23AP53,Breast cancer,breast carcinoma,GCST004988,8:220692
rs66849333-<b>T</b>,1 x 10-6,(EA),0.0561,'-,0.0693 unit decrease,[0.041-0.097],PHLDB3,Breast cancer,breast carcinoma,GCST004988,19:43484866
rs66964413-<b>C</b>,5 x 10-9,(EA),0.0368,'-,0.1034 unit decrease,[0.069-0.138],RTKN2,Breast cancer,breast carcinoma,GCST004988,10:62201406
rs66987842-<b>C</b>,3 x 10-35,(EA),0.11,'-,0.1233 unit increase,[0.1-0.14],MRTFA,Breast cancer,breast carcinoma,GCST004988,22:40508704
rs67079557-<b>A</b>,1 x 10-6,(EA),0.2423,'-,0.0362 unit decrease,[0.022-0.051],"SNUPN, IMP3",Breast cancer,breast carcinoma,GCST004988,15:75637960
rs6710503-<b>A</b>,5 x 10-6,(EA),0.2615,'-,0.0323 unit increase,[0.018-0.046],NCOA1,Breast cancer,breast carcinoma,GCST004988,2:24748307
rs67500807-<b>TG</b>,4 x 10-6,(EA),0.3727,'-,0.0396 unit increase,[0.023-0.056],"MAP1LC3BP1, ACER2",Breast cancer,breast carcinoma,GCST004988,9:19457614
rs6756513-<b>A</b>,4 x 10-7,(EA),0.2887,'-,0.0366 unit decrease,[0.022-0.051],"MXD1, ASPRV1",Breast cancer,breast carcinoma,GCST004988,2:69945455
rs6776003-<b>A</b>,3 x 10-10,(EA),0.4178,'-,0.0394 unit increase,[0.027-0.052],RASA2,Breast cancer,breast carcinoma,GCST004988,3:141547651
rs6787391-<b>T</b>,9 x 10-19,(EA),0.3807,'-,0.0567 unit increase,[0.044-0.069],ITPR1,Breast cancer,breast carcinoma,GCST004988,3:4686890
rs6789440-<b>A</b>,3 x 10-6,(EA),0.1495,'-,0.0403 unit increase,[0.023-0.057],FECHP1,Breast cancer,breast carcinoma,GCST004988,3:34938860
rs68006638-<b>A</b>,2 x 10-7,(EA),0.0774,'-,0.0646 unit decrease,[0.04-0.089],"H2AC1, SCGN",Breast cancer,breast carcinoma,GCST004988,6:25710343
rs68056147-<b>A</b>,5 x 10-13,(EA),0.299,'-,0.0501 unit increase,[0.037-0.064],LINC-PINT,Breast cancer,breast carcinoma,GCST004988,7:130989722
rs68140948-<b>T</b>,3 x 10-6,(EA),0.1201,'-,0.0481 unit increase,[0.028-0.068],'-,Breast cancer,breast carcinoma,GCST004988,10:9175196
rs6818581-<b>G</b>,9 x 10-6,(EA),0.0113,'-,0.1608 unit decrease,[0.09-0.232],ZNF827,Breast cancer,breast carcinoma,GCST004988,4:145775911
rs6860806-<b>G</b>,8 x 10-8,(EA),0.5391,'-,0.0335 unit increase,[0.021-0.046],SLC22A4,Breast cancer,breast carcinoma,GCST004988,5:132304843
rs6878727-<b>G</b>,6 x 10-6,(EA),0.3599,'-,0.0335 unit decrease,[0.019-0.048],LINC01170,Breast cancer,breast carcinoma,GCST004988,5:124400713
rs6890270-<b>G</b>,5 x 10-67,(EA),0.1871,'-,0.1349 unit increase,[0.12-0.15],MIER3,Breast cancer,breast carcinoma,GCST004988,5:56964779
rs6890610-<b>T</b>,6 x 10-6,(EA),0.2557,'-,0.0327 unit decrease,[0.019-0.047],"MRPL22, KIF4B",Breast cancer,breast carcinoma,GCST004988,5:154976135
rs6904031-<b>T</b>,7 x 10-26,(EA),0.0643,'-,0.1314 unit increase,[0.11-0.16],ESR1,Breast cancer,breast carcinoma,GCST004988,6:151734843
rs368131309-<b>GT</b>,4 x 10-6,(EA),0.2559,'-,0.0371 unit decrease,[0.021-0.053],TRAF3,Breast cancer,breast carcinoma,GCST004988,14:102882582
rs369574511-<b>C</b>,2 x 10-7,(EA),0.6318,'-,0.0364 unit decrease,[0.023-0.05],POLR2J,Breast cancer,breast carcinoma,GCST004988,7:102478605
rs418053-<b>C</b>,1 x 10-13,(EA),0.5685,'-,0.0465 unit decrease,[0.034-0.059],"MCUR1, RANBP9",Breast cancer,breast carcinoma,GCST004988,6:13713134
rs4286946-<b>G</b>,9 x 10-22,(EA),0.1739,'-,0.0799 unit decrease,[0.064-0.096],KCNU1,Breast cancer,breast carcinoma,GCST004988,8:36992428
rs4345958-<b>A</b>,3 x 10-6,(EA),0.2764,'-,0.0322 unit increase,[0.019-0.046],"SBF2, ADM",Breast cancer,breast carcinoma,GCST004988,11:10299114
rs45509595-<b>C</b>,5 x 10-9,(EA),0.0906,'-,0.0684 unit decrease,[0.045-0.091],H4C13,Breast cancer,breast carcinoma,GCST004988,6:27873148
rs4594370-<b>G</b>,7 x 10-6,(EA),0.0309,'-,0.1022 unit decrease,[0.058-0.147],"OR7A3P, OR7A1P",Breast cancer,breast carcinoma,GCST004988,19:14901422
rs4674124-<b>T</b>,1 x 10-11,(EA),0.1771,'-,0.056 unit decrease,[0.04-0.072],LINC01921,Breast cancer,breast carcinoma,GCST004988,2:216883915
rs4702131-<b>C</b>,1 x 10-11,(EA),0.5612,'-,0.0424 unit decrease,[0.03-0.055],NACAP6,Breast cancer,breast carcinoma,GCST004988,5:16233510
rs4757319-<b>G</b>,3 x 10-6,(EA),0.3857,'-,0.0298 unit increase,[0.017-0.042],'-,Breast cancer,breast carcinoma,GCST004988,11:15431096
rs4763-<b>A</b>,2 x 10-8,(EA),0.1745,'-,0.0464 unit decrease,[0.03-0.063],ARHGAP27,Breast cancer,breast carcinoma,GCST004988,17:45394123
rs4814894-<b>A</b>,7 x 10-7,(EA),0.4507,'-,0.0323 unit increase,[0.02-0.045],RIN2,Breast cancer,breast carcinoma,GCST004988,20:19772894
rs4820318-<b>A</b>,1 x 10-13,(EA),0.3753,'-,0.0475 unit decrease,[0.035-0.06],PLA2G6,Breast cancer,breast carcinoma,GCST004988,22:38174306
rs4820477-<b>C</b>,9 x 10-7,(EA),0.4847,'-,0.0307 unit increase,[0.019-0.043],"A4GALT, Y_RNA",Breast cancer,breast carcinoma,GCST004988,22:42745087
rs4848599-<b>C</b>,2 x 10-20,(EA),0.8845,'-,0.0933 unit increase,[0.074-0.113],LINC01101,Breast cancer,breast carcinoma,GCST004988,2:120481784
rs4865169-<b>T</b>,7 x 10-6,(EA),0.5239,'-,0.0278 unit increase,[0.016-0.04],POLR2B,Breast cancer,breast carcinoma,GCST004988,4:57013626
rs4940575-<b>C</b>,4 x 10-6,(EA),0.1666,'-,0.04 unit increase,[0.023-0.057],BCL2,Breast cancer,breast carcinoma,GCST004988,18:63178058
rs55821517-<b>C</b>,5 x 10-19,(EA),0.266,'-,0.0639 unit decrease,[0.05-0.078],HCN1,Breast cancer,breast carcinoma,GCST004988,5:45333758
rs55834529-<b>G</b>,3 x 10-9,(EA),0.0874,'-,0.071 unit decrease,[0.048-0.094],"RNU2-62P, VN1R11P",Breast cancer,breast carcinoma,GCST004988,6:27104763
rs55908905-<b>A</b>,8 x 10-6,(EA),0.2681,'-,0.032 unit increase,[0.018-0.046],SPTBN2,Breast cancer,breast carcinoma,GCST004988,11:66710394
rs55986698-<b>A</b>,4 x 10-6,(EA),0.183,'-,0.0421 unit decrease,[0.024-0.06],WWOX,Breast cancer,breast carcinoma,GCST004988,16:79190071
rs56069439-<b>A</b>,9 x 10-9,(EA),0.2968,'-,0.0387 unit increase,[0.026-0.052],ANKLE1,Breast cancer,breast carcinoma,GCST004988,19:17283116
rs56114371-<b>T</b>,2 x 10-9,(EA),0.0885,'-,0.071 unit decrease,[0.048-0.094],POM121L2,Breast cancer,breast carcinoma,GCST004988,6:27307055
rs56138756-<b>G</b>,7 x 10-9,(EA),0.1527,'-,0.0508 unit decrease,[0.034-0.068],"KIAA1143P2, Y_RNA",Breast cancer,breast carcinoma,GCST004988,3:27608457
rs56160832-<b>A</b>,5 x 10-6,(EA),0.1044,'-,0.0463 unit increase,[0.026-0.066],"PLA2G4A, PACERR",Breast cancer,breast carcinoma,GCST004988,1:186763038
rs56169712-<b>TAC</b>,7 x 10-6,(EA),0.5726,'-,0.0319 unit decrease,[0.018-0.046],HSD17B2,Breast cancer,breast carcinoma,GCST004988,16:82039249
rs56196003-<b>A</b>,5 x 10-6,(EA),0.2198,'-,0.0363 unit increase,[0.021-0.052],NAPEPLD,Breast cancer,breast carcinoma,GCST004988,7:103143080
rs56278937-<b>T</b>,1 x 10-6,(EA),0.5071,'-,0.0317 unit increase,[0.019-0.045],ADCY9,Breast cancer,breast carcinoma,GCST004988,16:4058158
rs56387622-<b>C</b>,5 x 10-19,(EA),0.1012,'-,0.0942 unit decrease,[0.073-0.115],MYL3,Breast cancer,breast carcinoma,GCST004988,3:46846708
rs56949123-<b>GTT</b>,4 x 10-6,(EA),0.0478,'-,0.0692 unit increase,[0.04-0.099],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs57275132-<b>CCGAGGTGGGCGGATCA</b>,9 x 10-6,(EA),0.6241,'-,0.0311 unit increase,[0.017-0.045],"YBX2, EIF5A",Breast cancer,breast carcinoma,GCST004988,17:7298013
rs57324102-<b>A</b>,6 x 10-6,(EA),0.0453,'-,0.0885 unit decrease,[0.05-0.127],H2BC18,Breast cancer,breast carcinoma,GCST004988,1:149811268
rs57380813-<b>AG</b>,8 x 10-6,(EA),0.7003,'-,0.0313 unit increase,[0.018-0.045],"LINC02123, Metazoa_SRP",Breast cancer,breast carcinoma,GCST004988,5:7290571
rs5776993-<b>C</b>,2 x 10-7,(EA),0.8767,'-,0.0563 unit increase,[0.035-0.077],GSTM2,Breast cancer,breast carcinoma,GCST004988,1:109680280
rs5780403-<b>CA</b>,9 x 10-6,(EA),0.2059,'-,0.0378 unit increase,[0.021-0.054],CD46,Breast cancer,breast carcinoma,GCST004988,1:207761719
rs5789877-<b>ACT</b>,2 x 10-6,(EA),0.6881,'-,0.0324 unit decrease,[0.019-0.046],INSC,Breast cancer,breast carcinoma,GCST004988,11:15309178
rs58327846-<b>C</b>,4 x 10-6,(EA),0.3512,'-,0.0311 unit decrease,[0.018-0.044],PRORP,Breast cancer,breast carcinoma,GCST004988,14:35130485
rs5837757-<b>C</b>,1 x 10-7,(EA),0.1716,'-,0.0438 unit increase,[0.028-0.06],"CLK1, RNA5SP115",Breast cancer,breast carcinoma,GCST004988,2:200849597
rs58685532-<b>A</b>,4 x 10-6,(EA),0.1721,'-,0.041 unit decrease,[0.024-0.058],CEP192,Breast cancer,breast carcinoma,GCST004988,18:13110432
rs6001982-<b>A</b>,1 x 10-34,(EA),0.1066,'-,0.1207 unit increase,[0.1-0.14],MRTFA,Breast cancer,breast carcinoma,GCST004988,22:40623944
rs60037937-<b>T</b>,1 x 10-26,(EA),0.2004,'-,0.0853 unit increase,[0.07-0.101],"PPIAP88, KLF4",Breast cancer,breast carcinoma,GCST004988,9:107541528
rs60504827-<b>T</b>,2 x 10-7,(EA),0.1245,'-,0.053 unit decrease,[0.033-0.073],GPR161,Breast cancer,breast carcinoma,GCST004988,1:168127440
rs60936670-<b>C</b>,8 x 10-64,(EA),0.5245,'-,0.1056 unit increase,[0.093-0.118],NEK10,Breast cancer,breast carcinoma,GCST004988,3:27290919
rs60954078-<b>G</b>,3 x 10-54,(EA),0.07,'-,0.1817 unit increase,[0.16-0.2],"CCDC170, ESR1",Breast cancer,breast carcinoma,GCST004988,6:151634779
rs61729152-<b>T</b>,6 x 10-6,(EA),0.0203,'-,0.1081 unit decrease,[0.061-0.155],LAMB2,Breast cancer,breast carcinoma,GCST004988,3:49129027
rs617791-<b>C</b>,7 x 10-6,(EA),0.501,'-,0.0281 unit decrease,[0.016-0.04],"TSGA10IP, DRAP1",Breast cancer,breast carcinoma,GCST004988,11:65935052
rs61865900-<b>C</b>,2 x 10-9,(EA),0.0623,'-,0.078 unit decrease,[0.053-0.103],EGR2,Breast cancer,breast carcinoma,GCST004988,10:62822722
rs62079673-<b>C</b>,1 x 10-6,(EA),0.5948,'-,0.0329 unit decrease,[0.02-0.046],FOXK2,Breast cancer,breast carcinoma,GCST004988,17:82597601
rs62193398-<b>C</b>,1 x 10-7,(EA),0.4196,'-,0.0332 unit increase,[0.021-0.046],MPP4,Breast cancer,breast carcinoma,GCST004988,2:201666541
rs4254863-<b>C</b>,5 x 10-6,(EA),0.0979,'-,0.0472 unit increase,[0.027-0.068],FST,Breast cancer,breast carcinoma,GCST004988,5:53399007
rs45589338-<b>A</b>,2 x 10-10,(EA),0.0352,'-,0.1112 unit increase,[0.077-0.145],MN1,Breast cancer,breast carcinoma,GCST004988,22:27799398
rs4742903-<b>C</b>,2 x 10-7,(EA),0.5563,'-,0.0325 unit increase,[0.02-0.045],SMC2,Breast cancer,breast carcinoma,GCST004988,9:104094512
rs4774565-<b>G</b>,2 x 10-6,(EA),0.3462,'-,0.0329 unit decrease,[0.019-0.046],"GABPB1-AS1, AHCYP7",Breast cancer,breast carcinoma,GCST004988,15:50402109
rs4820803-<b>C</b>,2 x 10-6,(EA),0.1732,'-,0.0394 unit decrease,[0.023-0.055],EWSR1,Breast cancer,breast carcinoma,GCST004988,22:29273659
rs505372-<b>C</b>,3 x 10-6,(EA),0.7201,'-,0.0322 unit increase,[0.019-0.046],SIK2,Breast cancer,breast carcinoma,GCST004988,11:111636465
rs55910451-<b>G</b>,4 x 10-7,(EA),0.218,'-,0.0377 unit increase,[0.023-0.052],TASOR2,Breast cancer,breast carcinoma,GCST004988,10:5752689
rs56077980-<b>CT</b>,2 x 10-7,(EA),0.3172,'-,0.0346 unit increase,[0.021-0.048],FTO,Breast cancer,breast carcinoma,GCST004988,16:54107655
rs56168262-<b>C</b>,2 x 10-8,(EA),0.4737,'-,0.0372 unit increase,[0.024-0.05],"CDKN2C, MIR4421",Breast cancer,breast carcinoma,GCST004988,1:51001425
rs56333866-<b>T</b>,3 x 10-8,(EA),0.9624,'-,0.0928 unit increase,[0.06-0.126],PIP4K2A,Breast cancer,breast carcinoma,GCST004988,10:22581150
rs57237364-<b>C</b>,5 x 10-7,(EA),0.3408,'-,0.0331 unit increase,[0.02-0.046],FBXL13,Breast cancer,breast carcinoma,GCST004988,7:102824786
rs575908-<b>C</b>,3 x 10-6,(EA),0.2891,'-,0.032 unit decrease,[0.019-0.045],"CRYZL2P-SEC16B, SEC16B",Breast cancer,breast carcinoma,GCST004988,1:177930963
rs57968892-<b>TTTTTGTTTTG</b>,5 x 10-6,(EA),0.3296,'-,0.0317 unit increase,[0.018-0.045],"RPL35AP35, RNU4-34P",Breast cancer,breast carcinoma,GCST004988,17:29372674
rs58742730-<b>G</b>,6 x 10-9,(EA),0.1799,'-,0.0467 unit increase,[0.031-0.062],"PPIAP39, HABP2",Breast cancer,breast carcinoma,GCST004988,10:113490891
rs60226654-<b>C</b>,8 x 10-6,(EA),0.4798,'-,0.0299 unit increase,[0.017-0.043],"COA8, KLC1",Breast cancer,breast carcinoma,GCST004988,14:103585480
rs612683-<b>T</b>,3 x 10-7,(EA),0.4047,'-,0.0327 unit increase,[0.02-0.045],CDC14A,Breast cancer,breast carcinoma,GCST004988,1:100414772
rs62061734-<b>C</b>,8 x 10-12,(EA),0.2103,'-,0.0526 unit decrease,[0.038-0.068],MAPT,Breast cancer,breast carcinoma,GCST004988,17:45941122
rs62235635-<b>A</b>,1 x 10-27,(EA),0.0065,'-,0.4659 unit increase,[0.38-0.55],PITPNB,Breast cancer,breast carcinoma,GCST004988,22:27918624
chr11:111742493-<b>CAAAAA</b>,2 x 10-7,(EA),0.3637,'-,0.0353 unit increase,[0.022-0.049],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr11:18403271-<b>C</b>,2 x 10-6,(EA),0.6699,'-,0.0336 unit increase,[0.02-0.048],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr11:65601650-<b>C</b>,2 x 10-13,(EA),0.4928,'-,0.0458 unit decrease,[0.034-0.058],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr11:9686139-<b>CG</b>,5 x 10-7,(EA),0.0061,'-,0.3415 unit decrease,[0.21-0.47],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:103097070-<b>G</b>,2 x 10-6,(EA),0.1128,'-,0.0459 unit increase,[0.027-0.065],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:111600134-<b>T</b>,9 x 10-8,(EA),0.3705,'-,0.0351 unit decrease,[0.022-0.048],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:111720125-<b>C</b>,2 x 10-6,(EA),0.4875,'-,0.0318 unit decrease,[0.019-0.045],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
chr12:111826477-<b>AAATT</b>,6 x 10-8,(EA),0.5084,'-,0.0345 unit increase,[0.022-0.047],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs11284646-<b>C</b>,4 x 10-6,(EA),0.2932,'-,0.032 unit decrease,[0.018-0.046],MAPK10,Breast cancer,breast carcinoma,GCST004988,4:86302033
rs11290052-<b>T</b>,8 x 10-6,(EA),0.4068,'-,0.0323 unit increase,[0.018-0.047],TOPORSLP,Breast cancer,breast carcinoma,GCST004988,9:104248836
rs11298677-<b>T</b>,5 x 10-9,(EA),0.6142,'-,0.0373 unit decrease,[0.025-0.05],COL8A1,Breast cancer,breast carcinoma,GCST004988,3:99682866
rs113084984-<b>A</b>,5 x 10-6,(EA),0.2192,'-,0.0367 unit decrease,[0.021-0.052],"GREB1, 5S_rRNA",Breast cancer,breast carcinoma,GCST004988,2:11561717
rs113289039-<b>AG</b>,3 x 10-7,(EA),0.3138,'-,0.0366 unit decrease,[0.023-0.051],"TBXT, GAPDHP72",Breast cancer,breast carcinoma,GCST004988,6:166087862
rs1133071-<b>G</b>,3 x 10-6,(EA),0.3001,'-,0.0335 unit decrease,[0.02-0.047],DDX58,Breast cancer,breast carcinoma,GCST004988,9:32455676
rs113410521-<b>T</b>,2 x 10-6,(EA),0.0645,'-,0.0603 unit decrease,[0.035-0.085],ZNF704,Breast cancer,breast carcinoma,GCST004988,8:80641622
rs11344495-<b>C</b>,2 x 10-6,(EA),0.334,'-,0.0327 unit increase,[0.019-0.046],"CTSF, CCDC87",Breast cancer,breast carcinoma,GCST004988,11:66569918
rs11354714-<b>C</b>,3 x 10-6,(EA),0.4193,'-,0.0318 unit increase,[0.018-0.045],"BBOX1-AS1, BBOX1",Breast cancer,breast carcinoma,GCST004988,11:27063657
rs113780580-<b>AACAC</b>,4 x 10-9,(EA),0.078,'-,0.0786 unit decrease,[0.053-0.105],"CD83P1, RNU6-471P",Breast cancer,breast carcinoma,GCST004988,6:27587278
rs11383827-<b>GA</b>,4 x 10-6,(EA),0.228,'-,0.0372 unit decrease,[0.022-0.053],EPSTI1,Breast cancer,breast carcinoma,GCST004988,13:42941617
rs62235681-<b>G</b>,2 x 10-37,(EA),0.0085,'-,0.4558 unit increase,[0.39-0.53],"CHEK2, TTC28",Breast cancer,breast carcinoma,GCST004988,22:28684743
rs62235753-<b>T</b>,3 x 10-20,(EA),0.0171,'-,0.2221 unit increase,[0.17-0.27],"ZNRF3, XBP1",Breast cancer,breast carcinoma,GCST004988,22:28876649
rs62237039-<b>G</b>,5 x 10-9,(EA),0.0366,'-,0.101 unit increase,[0.067-0.135],XPNPEP3,Breast cancer,breast carcinoma,GCST004988,22:40868537
rs62237573-<b>T</b>,7 x 10-36,(EA),0.0092,'-,0.4256 unit increase,[0.36-0.49],TTC28,Breast cancer,breast carcinoma,GCST004988,22:28156710
rs62237615-<b>G</b>,4 x 10-33,(EA),0.0082,'-,0.4404 unit increase,[0.37-0.51],TTC28,Breast cancer,breast carcinoma,GCST004988,22:28343127
rs62315512-<b>A</b>,5 x 10-6,(EA),0.1778,'-,0.04 unit decrease,[0.023-0.057],'-,Breast cancer,breast carcinoma,GCST004988,4:67215843
rs62331150-<b>T</b>,2 x 10-11,(EA),0.2263,'-,0.0494 unit increase,[0.035-0.064],TET2,Breast cancer,breast carcinoma,GCST004988,4:105147856
rs62355901-<b>C</b>,3 x 10-98,(EA),0.1602,'-,0.1734 unit increase,[0.16-0.19],MAP3K1,Breast cancer,breast carcinoma,GCST004988,5:56757708
rs62485509-<b>T</b>,4 x 10-12,(EA),0.2292,'-,0.0545 unit decrease,[0.039-0.07],OR2A1-AS1,Breast cancer,breast carcinoma,GCST004988,7:144351809
rs630965-<b>T</b>,3 x 10-54,(EA),0.6196,'-,0.0992 unit increase,[0.087-0.112],CHCHD4P2,Breast cancer,breast carcinoma,GCST004988,9:108123199
rs6432241-<b>C</b>,3 x 10-6,(EA),0.6883,'-,0.0313 unit decrease,[0.018-0.044],MIR3681HG,Breast cancer,breast carcinoma,GCST004988,2:11895429
rs643506-<b>G</b>,2 x 10-7,(EA),0.6757,'-,0.0344 unit decrease,[0.021-0.047],PPP2R1B,Breast cancer,breast carcinoma,GCST004988,11:111765903
rs6436017-<b>G</b>,3 x 10-10,(EA),0.5042,'-,0.0399 unit increase,[0.028-0.052],TNS1,Breast cancer,breast carcinoma,GCST004988,2:217858732
rs6449898-<b>T</b>,2 x 10-6,(EA),0.3027,'-,0.033 unit increase,[0.019-0.047],LINC02242,Breast cancer,breast carcinoma,GCST004988,5:67683422
rs2981579-<b>T</b>,5 x 10-7,,NR,1.23,'-,'-,FGFR2,Breast cancer (progesterone-receptor positive),progesterone-receptor negative breast cancer,GCST007420,10:121577821
rs60538652-<b>A</b>,6 x 10-7,,0.65,1.26,'-,[1.15-1.38],SIAH2,BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,3:150755819
rs11154838-<b>C</b>,1 x 10-6,,0.75,1.27,'-,[1.15-1.40],PDE7B,BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,6:135969804
rs9383936-<b>A</b>,1 x 10-10,,0.34,1.35,'-,[1.23-1.48],"CCDC170, ESR1",BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,6:151623479
rs10953105-<b>G</b>,1 x 10-6,,0.88,1.37,'-,[1.21-1.56],"BET1-AS1, BET1",BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,7:93992935
rs2350923-<b>T</b>,8 x 10-7,,0.76,1.28,'-,[1.16-1.42],ASPH,BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,8:61692700
rs78545330-<b>A</b>,3 x 10-6,,0.26,1.26,'-,[1.14-1.39],CDKN2B-AS1,BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,9:21995942
rs10814070-<b>T</b>,2 x 10-6,,0.75,1.26,'-,[1.15-1.39],"UBAP1, DCAF12",BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,9:34129841
rs2912774-<b>T</b>,6 x 10-7,,0.42,1.25,'-,[1.14-1.36],FGFR2,BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,10:121589148
rs9418690-<b>C</b>,1 x 10-6,,0.76,1.28,'-,[1.16-1.41],DOCK1,BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,10:127011685
rs4964006-<b>T</b>,2 x 10-6,,0.98,1.96,'-,[1.49-2.58],ITPR2,BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,12:26617956
rs67129489-<b>G</b>,9 x 10-7,,0.15,1.36,'-,[1.20-1.53],PGAM1P5,BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,12:95623181
rs278050-<b>C</b>,4 x 10-6,,0.21,1.28,'-,[1.15-1.42],"UBL3, Metazoa_SRP",BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,13:29862831
rs4784227-<b>T</b>,9 x 10-9,,0.32,1.31,'-,[1.19-1.44],CASC16,BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,16:52565276
rs4969001-<b>T</b>,7 x 10-6,,0.86,1.32,'-,[1.17-1.49],SLC39A11,BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,17:72983988
rs73107564-<b>A</b>,2 x 10-7,,0.89,1.43,'-,[1.25-1.63],"LINC00489, CTNNBL1",BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,20:37635373
rs6788895-<b>G</b>,2 x 10-6,,0.6,1.23,'-,[NR],SIAH2,BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,3:150750021
rs2046210-<b>A</b>,1 x 10-9,,0.36,1.3,'-,[NR],"ESR1, CCDC170",BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,6:151627231
rs2981575-<b>G</b>,2 x 10-8,,0.43,1.27,'-,[NR],FGFR2,BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,10:121586602
rs4784227-<b>T</b>,2 x 10-9,,0.26,1.31,'-,[NR],CASC16,BRCA1/2-negative high-risk breast cancer,BRCAX breast cancer,GCST006719,16:52565276
rs3757322-<b>G</b>,6 x 10-9,,NR,1.26,'-,1.16-1.36,CCDC170,Breast cancer (male),male breast carcinoma,GCST011526,6:151621059
rs9397437-<b>A</b>,5 x 10-9,,NR,1.5,'-,1.31-1.71,"CCDC170, ESR1",Breast cancer (male),male breast carcinoma,GCST011526,6:151631197
rs9383938-<b>T</b>,3 x 10-9,,NR,1.47,'-,1.30-1.67,ESR1,Breast cancer (male),male breast carcinoma,GCST011526,6:151666222
rs2183271-<b>C</b>,3 x 10-7,,NR,1.22,'-,1.13-1.31,MLLT10,Breast cancer (male),male breast carcinoma,GCST011526,10:21668300
rs78540526-<b>T</b>,1 x 10-11,,NR,1.61,'-,1.4-1.85,LINC01488,Breast cancer (male),male breast carcinoma,GCST011526,11:69516650
rs554219-<b>G</b>,3 x 10-11,,NR,1.45,'-,1.3-1.62,LINC01488,Breast cancer (male),male breast carcinoma,GCST011526,11:69516874
rs75915166-<b>A</b>,8 x 10-8,,NR,1.53,'-,1.31-1.79,"CCND1, LINC01488",Breast cancer (male),male breast carcinoma,GCST011526,11:69564393
rs7648642-<b>?</b>,5 x 10-6,,'-,1.5625,'-,[1.28-1.89],CD80,Lobular breast cancer (menopausal hormone therapy interaction),"invasive lobular carcinoma, hormone replacement therapy",GCST002266,3:119542528
rs11654964-<b>?</b>,3 x 10-6,,'-,1.67,'-,[1.35-2.06],TMEM132E,Lobular breast cancer (menopausal hormone therapy interaction),"invasive lobular carcinoma, hormone replacement therapy",GCST002266,17:34662519
rs186507655-<b>A</b>,5 x 10-10,(subset analysis),NR,'-,'-,'-,"DVL1, MXRA8",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,1:1351675
rs2075570-<b>T</b>,5 x 10-6,(subset analysis),NR,'-,'-,'-,MTX1,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,1:155212373
rs481519-<b>T</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,NEK10,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,3:27285723
rs7679673-<b>A</b>,1 x 10-10,(subset analysis),NR,'-,'-,'-,TET2,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,4:105140377
rs7725218-<b>A</b>,2 x 10-10,(subset analysis),NR,'-,'-,'-,TERT,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,5:1282299
rs1862626-<b>T</b>,4 x 10-12,(subset analysis),NR,'-,'-,'-,MAP3K1,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,5:56737113
rs147680653-<b>G</b>,1 x 10-6,(subset analysis),NR,'-,'-,'-,"HLA-V, IFITM4P",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:29785031
rs115707823-<b>A</b>,5 x 10-7,(subset analysis),NR,'-,'-,'-,"MICC, UBQLN1P1",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:30374976
rs115392158-<b>G</b>,3 x 10-7,(subset analysis),NR,'-,'-,'-,"LINC02571, HLA-B",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:31347004
rs147527678-<b>C</b>,6 x 10-8,(subset analysis),NR,'-,'-,'-,"HLA-DQB1, MTCO3P1",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:32699696
rs1011970-<b>T</b>,5 x 10-6,(subset analysis),NR,'-,'-,'-,CDKN2B-AS1,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,9:22062135
rs11200014-<b>A</b>,8 x 10-35,(subset analysis),NR,'-,'-,'-,FGFR2,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,10:121575416
rs7931342-<b>G</b>,4 x 10-14,(subset analysis),NR,'-,'-,'-,"MYEOV, SMIM38",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,11:69227030
rs148883465-<b>G</b>,3 x 10-8,(subset analysis),NR,'-,'-,'-,MIR4693,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,11:103813371
rs11168936-<b>C</b>,9 x 10-7,(subset analysis),NR,'-,'-,'-,TUBA1C,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,12:49251457
rs73110464-<b>T</b>,2 x 10-15,(subset analysis),NR,'-,'-,'-,KRT8,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,12:52918828
rs3184504-<b>C</b>,1 x 10-6,(subset analysis),NR,'-,'-,'-,"SH2B3, ATXN2",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma",GCST003588,12:111446804
rs11571818-<b>C</b>,5 x 10-10,(subset analysis),NR,'-,'-,'-,BRCA2,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,13:32394673
rs11844632-<b>A</b>,3 x 10-10,(subset analysis),NR,'-,'-,'-,RAD51B,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,14:68559662
rs12601991-<b>T</b>,7 x 10-28,(subset analysis),NR,'-,'-,'-,HNF1B,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,17:37741642
rs4808075-<b>C</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,"BABAM1, USHBP1",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,19:17279482
rs11907546-<b>T</b>,3 x 10-6,(subset analysis),NR,'-,'-,'-,"RPS2P1, ASIP",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,20:34131991
rs141752671-<b>G</b>,1 x 10-7,(subset analysis),NR,'-,'-,'-,'-,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,11:103745837
rs11065979-<b>T</b>,5 x 10-6,(subset analysis),NR,'-,'-,'-,"BRAP, ATXN2-AS",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,12:111621753
rs2300206-<b>C</b>,6 x 10-6,(subset analysis),NR,'-,'-,'-,RALY,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,20:34002002
rs56084662-<b>A</b>,4 x 10-9,(subset analysis),NR,'-,'-,'-,FRY,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,13:32295727
rs1057941-<b>A</b>,2 x 10-7,,NR,1.1,'-,[NR],GBAP1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,1:155216951
rs2974935-<b>T</b>,2 x 10-7,,NR,1.1,'-,[NR],MTX1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,1:155212052
rs11119608-<b>T</b>,1 x 10-7,,NR,1.1111112,'-,[NR],KCNH1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,1:210816167
rs75316749-<b>G</b>,2 x 10-7,,NR,1.1,'-,[NR],"MECOM, LINC01997",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,3:169043635
rs115707823-<b>A</b>,2 x 10-6,,NR,1.1,'-,[NR],"MICC, UBQLN1P1",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:30374976
rs115392158-<b>G</b>,9 x 10-6,,NR,1.1,'-,[NR],"LINC02571, HLA-B",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:31347004
rs147527678-<b>C</b>,5 x 10-7,,NR,1.1,'-,[NR],"HLA-DQB1, MTCO3P1",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:32699696
rs4604234-<b>C</b>,6 x 10-6,,NR,1.1,'-,[NR],"RPSAP72, RPL17P25",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:80398959
rs12349081-<b>A</b>,6 x 10-6,,NR,1.1,'-,[NR],"CDKN2A-DT, MTAP",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,9:21951903
rs1011970-<b>T</b>,2 x 10-7,,NR,1.1,'-,[NR],CDKN2B-AS1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,9:22062135
rs3184504-<b>C</b>,2 x 10-6,,NR,1.1,'-,[NR],"SH2B3, ATXN2",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,12:111446804
rs11571833-<b>T</b>,8 x 10-12,,NR,1.6,'-,[NR],BRCA2,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,13:32398489
rs12601991-<b>T</b>,1 x 10-9,,NR,1.1,'-,[NR],HNF1B,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,17:37741642
rs4808075-<b>C</b>,4 x 10-7,,NR,1.1,'-,[NR],"BABAM1, USHBP1",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,19:17279482
rs11907546-<b>C</b>,3 x 10-9,,NR,1.1111112,'-,[NR],"RPS2P1, ASIP",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,20:34131991
rs56404467-<b>A</b>,1 x 10-7,,NR,1.2,'-,[NR],FRY,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,13:32265853
rs2300206-<b>G</b>,2 x 10-8,,NR,1.1111112,'-,[NR],RALY,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,20:34002002
rs2314686-<b>?</b>,2 x 10-8,,'-,1.89,'-,[1.66-2.11],'-,Survival in breast cancer (estrogen-receptor positive),"event free survival time, estrogen-receptor positive breast cancer",GCST005901,Mapping not available
"rs4996307-<b>?</b>, rs992531-<b>?</b>, 2314686-<b>?</b>",2 x 10-7,,0.0693,1.71,'-,[1.4-2.07],SLC25A37 - RNU4-71P; No mapped genes; No mapped genes,Survival in breast cancer (estrogen-receptor positive),"event free survival time, estrogen-receptor positive breast cancer",GCST005901,8:23578869
rs2981579-<b>T</b>,4 x 10-7,,'-,1.23,'-,'-,FGFR2,Breast cancer (estrogen-receptor positive),estrogen-receptor positive breast cancer,GCST007415,10:121577821
rs4784227-<b>T</b>,7 x 10-6,,'-,1.23,'-,'-,CASC16,Breast cancer (estrogen-receptor positive),estrogen-receptor positive breast cancer,GCST007415,16:52565276
rs903263-<b>?</b>,1 x 10-6,,NR,1.27,'-,[1.10-1.34],PRKACB,Breast cancer (male),male breast carcinoma,GCST001690,1:84156830
rs1314913-<b>?</b>,3 x 10-13,,NR,1.57,'-,[1.39-1.77],RAD51B,Breast cancer (male),male breast carcinoma,GCST001690,14:68232877
rs3803662-<b>?</b>,4 x 10-15,,NR,1.5,'-,[1.35-1.66],CASC16,Breast cancer (male),male breast carcinoma,GCST001690,16:52552429
rs10841753-<b>C</b>,3 x 10-12,,0.208,'-,0.43 unit decrease,[0.31-0.55],SLCO1B1,Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer,"estrone conjugate measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004360,12:21168436
rs10953024-<b>C</b>,1 x 10-6,,0.088,'-,0.49 unit decrease,[0.29-0.69],CDK14,Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,7:90874752
rs1453308-<b>A</b>,2 x 10-6,,0.198,'-,0.33 unit decrease,[0.19-0.47],"ASB18, IQCA1",Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,2:236277682
rs16952550-<b>C</b>,2 x 10-6,,0.171,'-,0.33 unit decrease,[0.19-0.47],PTPRM,Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,18:7807950
rs17601876-<b>A</b>,4 x 10-6,,0.5,'-,0.24 unit increase,[0.14-0.34],"CYP19A1, MIR4713HG",Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,15:51261712
rs1453307-<b>G</b>,3 x 10-6,,0.1638,'-,0.3463 unit increase,[0.2-0.49],"ASB18, IQCA1",Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,2:236278055
rs16942732-<b>T</b>,8 x 10-6,,0.2054,'-,0.2847 unit decrease,[0.16-0.41],"OR4D1, OR4D2",Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,17:58163947
rs7105310-<b>G</b>,7 x 10-6,,0.1072,'-,0.3841 unit increase,[0.22-0.55],RPUSD4,Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,11:126175935
chr1:101579551-<b>A</b>,6 x 10-6,,0.1747,'-,0.322 unit decrease,[0.18-0.46],'-,Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,Mapping not available
rs16851421-<b>G</b>,8 x 10-6,,0.3271,'-,0.2489 unit decrease,[0.14-0.36],"GALNT2, PGBD5",Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,1:230289344
rs113883744-<b>T</b>,8 x 10-6,,0.2103,'-,0.2971 unit increase,[0.17-0.43],'-,Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,5:117038818
rs1468574-<b>A</b>,8 x 10-6,,0.2052,'-,0.2847 unit decrease,[0.16-0.41],"OR4D1, OR4D2",Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,17:58165213
rs1420338-<b>G</b>,7 x 10-6,,0.3988,'-,0.2432 unit decrease,[0.14-0.35],BMPER,Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,7:34103644
rs1416584-<b>G</b>,6 x 10-6,,0.0787,'-,0.4453 unit decrease,[0.25-0.64],'-,Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,9:8211949
rs3858207-<b>C</b>,5 x 10-6,,0.4898,'-,0.2398 unit decrease,[0.14-0.34],"ARMC3, MSRB2",Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer, estrone measurement",GCST004361,10:23061174
rs12586722-<b>A</b>,1 x 10-6,,0.155,'-,0.3 pg/mL increase,[0.18-0.42],ADAM21,Plasma estrone levels in resected estrogen-receptor positive breast cancer,"estrogen-receptor positive breast cancer, estrone measurement",GCST004362,14:70423423
rs8014252-<b>G</b>,2 x 10-6,,0.1556,'-,0.2981 pg/mL increase,[0.18-0.42],ADAM21,Plasma estrone levels in resected estrogen-receptor positive breast cancer,"estrogen-receptor positive breast cancer, estrone measurement",GCST004362,14:70452982
rs57712673-<b>A</b>,1 x 10-7,,0.349,'-,0.36 pg/mL increase,[0.23-0.49],ADGRE2,Plasma androstenedione levels in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer",GCST004363,19:14774988
rs59964204-<b>A</b>,3 x 10-7,,0.096,'-,0.45 pg/mL decrease,[0.28-0.62],ELMO1,Plasma androstenedione levels in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer",GCST004363,7:36899717
rs34346910-<b>C</b>,6 x 10-7,,0.111,'-,0.49 pg/mL increase,[0.3-0.68],"OPN4, LDB3",Plasma androstenedione levels in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer",GCST004363,10:86667452
rs6988985-<b>C</b>,7 x 10-7,,0.461,'-,0.25 pg/mL increase,[0.15-0.35],"CYP11B2, LY6E-DT",Plasma androstenedione levels in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer",GCST004363,8:142925688
rs7075481-<b>G</b>,8 x 10-7,,0.1279,'-,0.3776 pg/mL increase,[0.23-0.53],LINC00708,Plasma androstenedione levels in resected early stage-receptor positive breast cancer,"androstenedione measurement, estrogen-receptor positive breast cancer",GCST004363,10:8346355
rs4149056-<b>C</b>,4 x 10-11,,0.136,'-,0.5 pg/mL increase,[0.35-0.65],SLCO1B1,Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer,"estrone conjugate measurement, estrogen-receptor positive breast cancer",GCST004359,12:21178615
rs2900478-<b>A</b>,7 x 10-10,,0.14,'-,0.48 pg/mL increase,[0.33-0.63],SLCO1B1,Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer,"estrone conjugate measurement, estrogen-receptor positive breast cancer",GCST004359,12:21215863
rs7701292-<b>?</b>,2 x 10-8,,'-,1.79,'-,[1.59-1.99],'-,Survival in endocrine treated breast cancer (estrogen-receptor positive),"event free survival time, estrogen-receptor positive breast cancer, response to endocrine therapy",GCST005900,5:105742977
rs4369272-<b>G</b>,5 x 10-6,,0.2554,'-,0.2719 unit increase,[0.16-0.39],ST6GALNAC3,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,1:76397851
rs4949715-<b>A</b>,5 x 10-6,,0.2557,'-,0.2716 unit increase,[0.16-0.39],ST6GALNAC3,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,1:76398384
rs6715187-<b>G</b>,8 x 10-8,,0.1826,'-,0.3644 unit increase,[0.23-0.5],"ALPP, ECEL1P3",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,2:232353879
rs6715387-<b>A</b>,9 x 10-8,,0.1829,'-,0.3641 unit increase,[0.23-0.5],"ECEL1P3, ALPP",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,2:232353864
rs6729965-<b>C</b>,9 x 10-8,,0.183,'-,0.3641 unit increase,[0.23-0.5],"ECEL1P3, ALPP",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,2:232353552
rs55738617-<b>T</b>,9 x 10-8,,0.1812,'-,0.3646 unit increase,[0.23-0.5],"ECEL1P3, ALPP",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,2:232352849
rs1065643-<b>G</b>,1 x 10-6,,0.09075,'-,0.4449 unit increase,[0.27-0.62],"HAAO, FTOP1",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,2:42794053
rs10519881-<b>G</b>,4 x 10-6,,0.3156,'-,0.2607 unit increase,[0.15-0.37],RPSAP37,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,5:126046631
rs12658330-<b>G</b>,5 x 10-6,,0.0207,'-,0.902 unit increase,[0.52-1.28],SEMA5A,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,5:9317600
rs7724529-<b>T</b>,5 x 10-6,,0.3159,'-,0.2597 unit increase,[0.15-0.37],RPSAP37,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,5:126045975
rs62482803-<b>A</b>,3 x 10-6,,0.2132,'-,0.3058 unit decrease,[0.18-0.43],ATXN7L1,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,7:105858521
rs11769266-<b>G</b>,3 x 10-6,,0.3817,'-,0.2495 unit increase,[0.15-0.35],GALNT17,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,7:71534157
rs4557585-<b>G</b>,3 x 10-6,,0.3817,'-,0.2495 unit increase,[0.15-0.35],GALNT17,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,7:71534123
rs80082057-<b>T</b>,5 x 10-7,,0.0276,'-,0.7723 unit decrease,[0.47-1.07],SVIL,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,10:29652692
rs75690380-<b>G</b>,6 x 10-7,,0.0277,'-,0.7692 unit decrease,[0.47-1.07],SVIL,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,10:29647954
rs78721916-<b>T</b>,2 x 10-6,,0.0224,'-,0.8776 unit decrease,[0.52-1.23],SVIL,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,10:29655323
rs12598355-<b>C</b>,1 x 10-7,,0.1193,'-,0.4221 unit increase,[0.27-0.58],SLC38A7,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58669872
rs11639682-<b>A</b>,8 x 10-7,,0.1204,'-,0.3938 unit increase,[0.24-0.55],SLC38A7,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58673228
rs2280398-<b>T</b>,2 x 10-6,,0.1213,'-,0.3795 unit increase,[0.23-0.53],SLC38A7,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58678226
rs11643617-<b>C</b>,2 x 10-6,,0.1234,'-,0.3767 unit increase,[0.22-0.53],"SLC38A7, GOT2",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58698951
rs2280399-<b>A</b>,2 x 10-6,,0.1214,'-,0.3752 unit increase,[0.22-0.53],SLC38A7,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58677628
rs73549255-<b>A</b>,2 x 10-6,,0.1236,'-,0.3777 unit increase,[0.22-0.53],"SLC38A7, GOT2",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58701769
rs60388585-<b>C</b>,3 x 10-6,,0.1454,'-,0.3447 unit increase,[0.2-0.49],"CNOT1, SLC38A7",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58659688
rs59234479-<b>A</b>,3 x 10-6,,0.1178,'-,0.3738 unit increase,[0.22-0.53],SLC38A7,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58673724
rs11647748-<b>G</b>,3 x 10-6,,0.1185,'-,0.3743 unit increase,[0.22-0.53],"SLC38A7, GOT2",Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,"response to aromatase inhibitor, estrogen-receptor positive breast cancer",GCST007664,16:58697980
rs12998806-<b>G</b>,2 x 10-8,,0.86,1.34,'-,[1.21-1.48],'-,Breast cancer (estrogen-receptor positive),estrogen-receptor positive breast cancer,GCST003781,2:217029040
rs10069690-<b>T</b>,2 x 10-10,,0.6,1.3,'-,[1.20-1.41],TERT,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003780,5:1279675
rs13074711-<b>T</b>,2 x 10-8,,0.69,1.29,'-,[1.18-1.40],"LINC02068, TNFSF10",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003780,3:172550013
rs17215231-<b>C</b>,9 x 10-13,,0.92,1.1764705,'-,[1.12-1.23],RPS18,"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)",triple-negative breast cancer,GCST010100,6:33272092
rs2464195-<b>G</b>,3 x 10-8,,0.63,1.0752687,'-,[1.04-1.1],HNF1A,"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)",triple-negative breast cancer,GCST010100,12:120997672
rs78378222-<b>T</b>,1 x 10-8,,0.99,1.4492754,'-,[1.3-1.61],TP53,"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)",triple-negative breast cancer,GCST010100,17:7668434
rs2111836-<b>G</b>,7 x 10-6,,0.22,1.32,'-,[1.17-1.44],MTCL1,Breast cancer,breast carcinoma,GCST002735,18:8716323
rs13025833-<b>A</b>,1 x 10-7,,0.52,1.2,'-,[1.13-1.33],CTNNA2,Breast cancer,breast carcinoma,GCST002735,2:79716982
rs132383-<b>A</b>,5 x 10-7,,NR,1.2458,'-,NR,EMID1,Breast cancer,breast carcinoma,GCST90011804,22:29217531
chr10:123340431-<b>GC</b>,3 x 10-104,,NR,1.2751,'-,NR,'-,Breast cancer,breast carcinoma,GCST90011804,Mapping not available
rs17715065-<b>C</b>,1 x 10-11,,NR,1.078,'-,NR,EBF1,Breast cancer,breast carcinoma,GCST90011804,5:158834155
rs7282349-<b>C</b>,1 x 10-10,,NR,1.0809,'-,NR,'-,Breast cancer,breast carcinoma,GCST90011804,21:15192241
rs55821517-<b>T</b>,3 x 10-9,,NR,1.0813,'-,NR,HCN1,Breast cancer,breast carcinoma,GCST90011804,5:45333758
rs725677-<b>C</b>,7 x 10-12,,NR,1.0834,'-,NR,'-,Breast cancer,breast carcinoma,GCST90011804,12:115377060
rs5809370-<b>C</b>,9 x 10-7,,NR,1.084,'-,NR,RAD51B,Breast cancer,breast carcinoma,GCST90011804,14:68174380
rs9421409-<b>G</b>,4 x 10-9,,NR,1.084,'-,NR,"SMNDC1, RN7SKP167",Breast cancer,breast carcinoma,GCST90011804,10:121335694
rs2236007-<b>G</b>,2 x 10-9,,NR,1.0873,'-,NR,PAX9,Breast cancer,breast carcinoma,GCST90011804,14:36663564
rs11624333-<b>T</b>,4 x 10-11,,NR,1.0875,'-,NR,RAD51B,Breast cancer,breast carcinoma,GCST90011804,14:68513118
rs2463523-<b>A</b>,3 x 10-10,,NR,1.0887,'-,NR,"MAPK8IP1P2, DND1P1",Breast cancer,breast carcinoma,GCST90011804,17:45594371
rs62033406-<b>A</b>,3 x 10-14,,NR,1.0901,'-,NR,FTO,Breast cancer,breast carcinoma,GCST90011804,16:53790314
chr17:44184819-<b>CAAAGGT</b>,2 x 10-10,,NR,1.0906,'-,NR,'-,Breast cancer,breast carcinoma,GCST90011804,Mapping not available
rs11957276-<b>G</b>,5 x 10-11,,NR,1.0933,'-,NR,MIER3,Breast cancer,breast carcinoma,GCST90011804,5:56926293
rs4911315-<b>A</b>,8 x 10-7,,0.105592,1.0935,'-,NR,BPIFB1,Breast cancer,breast carcinoma,GCST90011804,20:33298440
rs10096213-<b>C</b>,3 x 10-9,,NR,1.094,'-,NR,"KCNU1, SMARCE1P4",Breast cancer,breast carcinoma,GCST90011804,8:36995695
rs12354821-<b>T</b>,3 x 10-10,,NR,1.0954,'-,NR,"RPS15AP5, FGFR2",Breast cancer,breast carcinoma,GCST90011804,10:121684227
rs1830298-<b>C</b>,9 x 10-14,,NR,1.0961,'-,NR,FLACC1,Breast cancer,breast carcinoma,GCST90011804,2:201316524
rs8027730-<b>C</b>,3 x 10-8,,0.516078,1.0638,'-,NR,FAM227B,Breast cancer,breast carcinoma,GCST90011804,15:49580388
rs11675683-<b>A</b>,4 x 10-8,,NR,1.0666,'-,NR,"CYBRD1, RPL21P38",Breast cancer,breast carcinoma,GCST90011804,2:171568284
rs514192-<b>A</b>,5 x 10-8,,NR,1.0667,'-,NR,"GRHL2, RN7SL563P",Breast cancer,breast carcinoma,GCST90011804,8:101466731
rs3974648-<b>C</b>,5 x 10-7,,NR,1.0724,'-,NR,AQP4-AS1,Breast cancer,breast carcinoma,GCST90011804,18:26904324
rs3731257-<b>G</b>,5 x 10-8,,NR,1.0733,'-,NR,"MTAP, CDKN2A-DT",Breast cancer,breast carcinoma,GCST90011804,9:21966222
rs2736109-<b>C</b>,2 x 10-8,,NR,1.0744,'-,NR,"MIR4457, TERT",Breast cancer,breast carcinoma,GCST90011804,5:1296644
rs576603-<b>C</b>,2 x 10-8,,NR,1.0767,'-,NR,"LSP1, LINC01150",Breast cancer,breast carcinoma,GCST90011804,11:1892909
rs62070652-<b>C</b>,6 x 10-9,,NR,1.0768,'-,NR,ATAD5,Breast cancer,breast carcinoma,GCST90011804,17:30894259
rs1250009-<b>G</b>,4 x 10-9,,NR,1.0778,'-,NR,ZMIZ1,Breast cancer,breast carcinoma,GCST90011804,10:79085654
rs199533-<b>G</b>,5 x 10-8,,NR,1.078,'-,NR,NSF,Breast cancer,breast carcinoma,GCST90011804,17:46751565
rs75174485-<b>G</b>,1 x 10-7,,NR,1.3468013,'-,NR,"TTC28, CHEK2",Breast cancer,breast carcinoma,GCST90011804,22:28682717
rs187373836-<b>A</b>,5 x 10-7,,NR,1.3374349,'-,NR,KIF1B,Breast cancer,breast carcinoma,GCST90011804,1:10370245
rs4784227-<b>T</b>,8 x 10-82,,NR,1.2685527,'-,NR,CASC16,Breast cancer,breast carcinoma,GCST90011804,16:52565276
chr10:22336421-<b>C</b>,2 x 10-8,,NR,1.2640626,'-,NR,'-,Breast cancer,breast carcinoma,GCST90011804,Mapping not available
rs34507830-<b>T</b>,3 x 10-8,,NR,1.2291052,'-,NR,CCND1,Breast cancer,breast carcinoma,GCST90011804,11:69646918
rs554219-<b>G</b>,1 x 10-34,,NR,1.2226434,'-,NR,LINC01488,Breast cancer,breast carcinoma,GCST90011804,11:69516874
rs138096085-<b>C</b>,4 x 10-9,,NR,1.2026458,'-,NR,LINC02224,Breast cancer,breast carcinoma,GCST90011804,5:44593979
rs7709971-<b>A</b>,6 x 10-35,,NR,1.1953143,'-,NR,'-,Breast cancer,breast carcinoma,GCST90011804,5:56711512
rs9397436-<b>G</b>,4 x 10-18,,NR,1.1938874,'-,NR,"ESR1, CCDC170",Breast cancer,breast carcinoma,GCST90011804,6:151630867
rs12520604-<b>C</b>,5 x 10-8,,NR,1.1734335,'-,NR,"FGF10-AS1, LINC02224",Breast cancer,breast carcinoma,GCST90011804,5:44476770
rs5995881-<b>G</b>,4 x 10-16,,NR,1.1558021,'-,NR,MRTFA,Breast cancer,breast carcinoma,GCST90011804,22:40619879
rs6904031-<b>T</b>,6 x 10-9,,NR,1.1423349,'-,NR,ESR1,Breast cancer,breast carcinoma,GCST90011804,6:151734843
rs10941679-<b>G</b>,8 x 10-25,,NR,1.1381744,'-,NR,"LINC02224, RN7SL383P",Breast cancer,breast carcinoma,GCST90011804,5:44706396
rs6752414-<b>T</b>,2 x 10-9,,0.07653,1.1307101,'-,NR,"GLI2, Y_RNA",Breast cancer,breast carcinoma,GCST90011804,2:120667763
rs4478919-<b>A</b>,5 x 10-8,,NR,1.1305822,'-,NR,ATE1,Breast cancer,breast carcinoma,GCST90011804,10:121819548
rs778040878-<b>A</b>,7 x 10-7,,NR,1.1304545,'-,NR,LAX1,Breast cancer,breast carcinoma,GCST90011804,1:203770556
rs189268208-<b>G</b>,7 x 10-10,,NR,1.1225865,'-,NR,HNF4G,Breast cancer,breast carcinoma,GCST90011804,8:75448402
rs12616849-<b>C</b>,3 x 10-9,,NR,1.1220826,'-,NR,LINC01101,Breast cancer,breast carcinoma,GCST90011804,2:120488037
rs559044903-<b>G</b>,6 x 10-7,,NR,1.1201972,'-,NR,NRIP1,Breast cancer,breast carcinoma,GCST90011804,21:14988523
rs35383942-<b>T</b>,6 x 10-7,,NR,1.1191941,'-,NR,PHLDA3,Breast cancer,breast carcinoma,GCST90011804,1:201468704
rs747171037-<b>C</b>,5 x 10-20,,NR,1.1087704,'-,NR,"POU5F1B, PCAT1, CASC8",Breast cancer,breast carcinoma,GCST90011804,8:127338463
rs5899787-<b>CT</b>,3 x 10-16,,NR,1.100352,'-,NR,CHCHD4P2,Breast cancer,breast carcinoma,GCST90011804,9:108131272
rs11150296-<b>C</b>,8 x 10-12,,NR,1.0952903,'-,NR,CDYL2,Breast cancer,breast carcinoma,GCST90011804,16:80610766
rs910416-<b>T</b>,6 x 10-16,,NR,1.0945709,'-,NR,ESR1,Breast cancer,breast carcinoma,GCST90011804,6:152111767
chr9:110303808-<b>T</b>,4 x 10-10,,NR,1.0912265,'-,NR,'-,Breast cancer,breast carcinoma,GCST90011804,Mapping not available
rs1852599-<b>C</b>,2 x 10-8,,NR,1.0896807,'-,NR,HCN1,Breast cancer,breast carcinoma,GCST90011804,5:45757203
rs10828247-<b>G</b>,3 x 10-13,,NR,1.0887316,'-,NR,MLLT10,Breast cancer,breast carcinoma,GCST90011804,10:21533927
rs60778117-<b>T</b>,5 x 10-9,,NR,1.0863662,'-,NR,"RPS15AP27, CHCHD4P2",Breast cancer,breast carcinoma,GCST90011804,9:108010759
rs11055888-<b>G</b>,6 x 10-9,,NR,1.0829543,'-,NR,"RPL30P11, GNAI2P1",Breast cancer,breast carcinoma,GCST90011804,12:14265892
rs62237573-<b>T</b>,8 x 10-9,,NR,1.3493456,'-,NR,TTC28,Breast cancer,breast carcinoma,GCST90011804,22:28156710
rs7686118-<b>A</b>,2 x 10-7,,NR,1.0778185,'-,NR,ADAM29,Breast cancer,breast carcinoma,GCST90011804,4:174932364
rs2407064-<b>A</b>,3 x 10-8,,NR,1.0743446,'-,NR,ATG10,Breast cancer,breast carcinoma,GCST90011804,5:82161539
rs9289981-<b>T</b>,4 x 10-10,,NR,1.0731916,'-,NR,CMSS1,Breast cancer,breast carcinoma,GCST90011804,3:100149260
rs9361840-<b>G</b>,8 x 10-8,,NR,1.0731916,'-,NR,TENT5A,Breast cancer,breast carcinoma,GCST90011804,6:81545215
rs774002109-<b>A</b>,4 x 10-8,,0.379307,1.0729614,'-,NR,'-,Breast cancer,breast carcinoma,GCST90011804,2:212679737
rs6020465-<b>G</b>,5 x 10-7,,NR,1.0705492,'-,NR,"LINC01271, RN7SL636P",Breast cancer,breast carcinoma,GCST90011804,20:50346469
rs56283082-<b>A</b>,2 x 10-7,,NR,1.06929,'-,NR,RPL17P33,Breast cancer,breast carcinoma,GCST90011804,8:29614831
rs61051244-<b>CAT</b>,8 x 10-7,,NR,1.0680337,'-,NR,ZFPM2,Breast cancer,breast carcinoma,GCST90011804,8:105330554
rs11249433-<b>G</b>,8 x 10-9,,NR,1.0668942,'-,NR,EMBP1,Breast cancer,breast carcinoma,GCST90011804,1:121538815
rs10736577-<b>G</b>,8 x 10-8,,NR,1.0634904,'-,NR,"RPS27P20, LINC01395",Breast cancer,breast carcinoma,GCST90011804,11:129584212
rs16857611-<b>T</b>,8 x 10-7,,NR,1.0633773,'-,NR,DIRC3,Breast cancer,breast carcinoma,GCST90011804,2:217432009
rs941764-<b>G</b>,2 x 10-7,,NR,1.0626993,'-,NR,CCDC88C,Breast cancer,breast carcinoma,GCST90011804,14:91374725
rs11205303-<b>C</b>,5 x 10-7,,NR,1.0584251,'-,NR,MTMR11,Breast cancer,breast carcinoma,GCST90011804,1:149934520
rs1321917-<b>G</b>,2 x 10-7,,NR,1.0604,'-,NR,ASTN2,Breast cancer,breast carcinoma,GCST90011804,9:116562650
rs112238765-<b>C</b>,1 x 10-18,,NR,1.1053,'-,NR,NEK10,Breast cancer,breast carcinoma,GCST90011804,3:27347329
rs7297051-<b>C</b>,5 x 10-15,,NR,1.1124,'-,NR,PTHLH,Breast cancer,breast carcinoma,GCST90011804,12:28021884
rs10995193-<b>A</b>,5 x 10-12,,NR,1.1194,'-,NR,ZNF365,Breast cancer,breast carcinoma,GCST90011804,10:62528323
rs61938093-<b>C</b>,8 x 10-18,,NR,1.1284,'-,NR,PGAM1P5,Breast cancer,breast carcinoma,GCST90011804,12:95632961
rs4442975-<b>G</b>,2 x 10-28,,NR,1.1311,'-,NR,'-,Breast cancer,breast carcinoma,GCST90011804,2:217056046
rs166870-<b>T</b>,3 x 10-7,(HR+ HER2-),0.13,2.3,'-,[1.67-3.15],RNU6-667P,Disease-free survival in breast cancer,"disease free survival, breast carcinoma",GCST002847,15:79777420
rs10825036-<b>G</b>,4 x 10-7,(HR- HER2-),0.32,2.26,'-,[1.34-3.81],RNA5SP318,Disease-free survival in breast cancer,"disease free survival, breast carcinoma",GCST002847,10:53506471
rs13387042-<b>?</b>,9 x 10-6,,0.53,1.18,'-,[1.10-1.27],'-,Breast cancer,breast carcinoma,GCST000811,2:217041109
rs7149859-<b>?</b>,7 x 10-7,(ER +ve),'-,1.22,'-,[1.13-1.33],PIGH,Breast cancer (survival),"survival time, estrogen-receptor positive breast cancer",GCST002861,14:67599772
rs2059614-<b>?</b>,1 x 10-9,(ER -ve),0.06,1.9,'-,[1.54-2.33],PKNOX2,Breast cancer (survival),"estrogen-receptor negative breast cancer, survival time",GCST002861,11:125389528
rs2912780-<b>?</b>,4 x 10-6,,0.506,1.302,'-,(1.164-1.456),FGFR2,Breast cancer,breast carcinoma,GCST002895,10:121577603
rs2193094-<b>?</b>,2 x 10-7,,0.478,1.337,'-,(1.198-1.491),TOX3,Breast cancer,breast carcinoma,GCST002895,16:52532542
rs1202179-<b>C</b>,4 x 10-8,,'-,4.05,'-,[2.46-6.67],ABCB1,Persistent chemotherapy-induced alopecia in breast cancer,"chemotherapy-induced alopecia, response to docetaxel, breast carcinoma",GCST011316,7:87574963
rs147451859-<b>G</b>,6 x 10-9,,0.07,1.74,'-,[NR],PPCDC,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,15:75039102
rs17587029-<b>G</b>,3 x 10-8,,0.05,1.84,'-,[NR],"CHCHD5, SLC20A1",Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,2:112624477
rs6488809-<b>T</b>,3 x 10-7,,0.06,1.74,'-,[NR],DERA,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,12:16001304
rs1410669-<b>G</b>,5 x 10-7,,0.07,1.71,'-,[NR],RNU4-66P,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,6:71740732
rs11096688-<b>T</b>,7 x 10-7,,0.1,1.45,'-,[NR],LINC02850,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,2:20885650
rs73419340-<b>A</b>,8 x 10-7,,0.06,0.49,'-,[NR],"VPS50, CALCR",Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,7:93388705
rs1189020-<b>T</b>,9 x 10-7,,0.06,1.61,'-,[NR],LINC02284,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,14:56410241
rs78264913-<b>C</b>,1 x 10-6,,0.05,1.53,'-,[NR],TMTC1,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,12:29733920
rs77569618-<b>A</b>,1 x 10-6,,0.09,1.48,'-,[NR],LINC02236,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,5:6784082
rs1119997-<b>G</b>,1 x 10-6,,0.46,1.3,'-,[NR],ADCY8,Adverse response to chemotherapy (amenorrhea) in breast cancer,"amenorrhea, breast carcinoma, response to antineoplastic agent",GCST009153,8:131109670
rs3803662-<b>A</b>,4 x 10-7,,0.3,1.22,'-,[1.13-1.32],CASC16,Breast cancer,breast carcinoma,GCST000811,16:52552429
rs7716600-<b>A</b>,7 x 10-7,,0.23,1.24,'-,[1.14-1.34],MRPS30,Breast cancer,breast carcinoma,GCST000811,5:44874903
rs1219648-<b>G</b>,2 x 10-13,,0.42,1.32,'-,[1.22-1.42],FGFR2,Breast cancer,breast carcinoma,GCST000811,10:121586676
rs12710696-<b>?</b>,2 x 10-8,,0.36,1.1,'-,[1.06-1.13],LINC01376,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,2:19121042
rs2242652-<b>?</b>,3 x 10-14,,0.2,1.18,'-,[1.13-1.23],TERT,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,5:1279913
rs4980383-<b>?</b>,3 x 10-6,,0.44,1.08,'-,[1.05-1.12],LSP1,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,11:1880867
rs11075995-<b>?</b>,3 x 10-8,,0.24,1.11,'-,[1.07-1.15],FTO,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,16:53821379
rs17489300-<b>?</b>,9 x 10-10,,0.6,1.1111112,'-,[1.08-1.15],LGR6,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,1:202209914
rs4245739-<b>?</b>,6 x 10-15,,0.26,1.13,'-,[1.11-1.19],MDM4,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,1:204549714
rs10864459-<b>?</b>,2 x 10-9,,0.68,1.1111112,'-,[1.08-1.15],PEX14,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,1:10503552
rs11903787-<b>?</b>,9 x 10-7,,0.75,1.1111112,'-,[1.06-1.16],"RALB, INHBB",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,2:120330606
rs7726159-<b>?</b>,2 x 10-6,,0.34,1.09,'-,[1.05-1.13],TERT,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,5:1282204
rs2736108-<b>?</b>,1 x 10-8,,0.71,1.1235955,'-,[1.08-1.16],"MIR4457, TERT",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,5:1297373
rs12662670-<b>?</b>,9 x 10-15,,0.08,1.2,'-,[1.18-1.32],CCDC170,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,6:151597721
rs11155804-<b>?</b>,8 x 10-18,,0.34,1.16,'-,[1.12-1.19],"CCDC170, ESR1",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,6:151625017
rs10995190-<b>?</b>,4 x 10-8,,0.84,1.1235955,'-,[1.08-1.18],ZNF365,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,10:62518923
rs7297051-<b>?</b>,1 x 10-14,,0.76,1.1627907,'-,[1.12-1.2],PTHLH,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,12:28021884
rs10771399-<b>?</b>,4 x 10-13,,0.88,1.2658228,'-,[1.15-1.28],PTHLH,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,12:28002147
rs4784227-<b>?</b>,1 x 10-14,,0.24,1.15,'-,[1.11-1.19],CASC16,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,16:52565276
rs17817449-<b>?</b>,3 x 10-7,,0.59,1.098901,'-,[1.05-1.12],FTO,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,16:53779455
rs56069439-<b>?</b>,8 x 10-19,,0.3,1.16,'-,[1.13-1.20],ANKLE1,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,19:17283116
rs8170-<b>?</b>,1 x 10-12,,0.19,1.15,'-,[1.11-1.20],"BABAM1, USHBP1",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,19:17278895
rs67073037-<b>?</b>,3 x 10-6,,0.76,1.0869565,'-,[1.05-1.14],WDR43,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,2:28896719
rs115635831-<b>?</b>,1 x 10-6,,0.015,1.36,'-,[1.20-1.54],PPIL3,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,2:200878871
rs12870942-<b>?</b>,3 x 10-7,,0.32,1.09,'-,[1.05-1.13],RNY1P8,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,13:73232845
rs1011970-<b>?</b>,2 x 10-6,,0.17,1.11,'-,[1.06-1.15],CDKN2B-AS1,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,9:22062135
rs17356907-<b>?</b>,3 x 10-6,,0.7,1.098901,'-,[1.69-1.14],PGAM1P5,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,12:95633983
rs11571833-<b>?</b>,6 x 10-6,,0.01,1.32,'-,[1.20-1.43],BRCA2,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST003842,13:32398489
rs111896170-<b>?</b>,1 x 10-6,,NR,1.7095189,'-,[1.38-2.12],LDB2,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,4:16585051
rs79991130-<b>?</b>,3 x 10-6,,NR,1.7924654,'-,[1.41-2.29],'-,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,1:193939892
rs139805484-<b>?</b>,2 x 10-6,,NR,1.8205888,'-,[1.42-2.34],ARAP2,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,4:36239381
rs147254607-<b>?</b>,5 x 10-7,,NR,1.9110351,'-,[1.48-2.46],LINC01470,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,5:152723754
rs6837069-<b>?</b>,1 x 10-6,,NR,1.9211789,'-,[1.48-2.50],'-,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,4:135748515
rs146081883-<b>?</b>,2 x 10-6,,NR,1.9596248,'-,[1.49-2.58],FBXL12P1,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,2:67936028
rs146768547-<b>?</b>,8 x 10-7,,NR,1.9677978,'-,[1.50-2.57],DICER1,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,14:95068893
rs117521942-<b>?</b>,3 x 10-6,,NR,2.0097754,'-,[1.50-2.69],LINC02671,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,10:64959483
rs117212863-<b>?</b>,1 x 10-6,,NR,2.051161,'-,[1.53-2.75],"ANXA2P3, LINC02671",Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,10:64846439
rs113232387-<b>?</b>,2 x 10-6,,NR,2.2127366,'-,[1.59-3.08],"RN7SKP251, U8",Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,5:68919169
rs184731128-<b>?</b>,1 x 10-6,,NR,2.901129,'-,[1.88-4.47],NCAM1,Breast cancer specific mortality in estrogen receptor negative breast cancer,"estrogen-receptor negative breast cancer, mortality",GCST007476,11:113190040
rs1519277-<b>T</b>,2 x 10-7,,0.06,3.12,'-,[1.96-4.96],'-,Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy,"breast carcinoma, childhood cancer",GCST005110,2:123261223
rs11651604-<b>C</b>,6 x 10-7,,0.16,2.12,'-,[1.50-3.01],'-,Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy,"breast carcinoma, childhood cancer",GCST005110,17:71440368
rs17020562-<b>C</b>,7 x 10-8,,0.0005,44.52,'-,[15.06-131.62],"RPS6KC1, RPL31P13",Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy,"breast carcinoma, childhood cancer",GCST005110,1:213369363
rs117114682-<b>G</b>,2 x 10-7,,0.02,2.55,'-,[1.61-4.02],PTPRN2,Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy,"response to radiation, breast carcinoma, childhood cancer",GCST005112,7:158170200
rs4342822-<b>G</b>,7 x 10-9,,0.46,1.92,'-,[1.49-2.44],PROX1-AS1,Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy,"response to radiation, breast carcinoma, childhood cancer",GCST005112,1:213850882
rs74949440-<b>T</b>,6 x 10-8,,0.02,2.59,'-,[1.62-4.16],TAGLN,Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy,"response to radiation, breast carcinoma, childhood cancer",GCST005112,11:117199645
rs114971217-<b>A</b>,6 x 10-7,,2.00E-04,'-,'-,'-,"ACKR3, IQCA1",Breast cancer in childhood cancer survivors,"breast carcinoma, childhood cancer",GCST005111,2:236525150
rs117114682-<b>G</b>,4 x 10-7,,0.03,2.23,'-,[1.52-3.26],PTPRN2,Breast cancer in childhood cancer survivors,"breast carcinoma, childhood cancer",GCST005111,7:158170200
rs4930561-<b>A</b>,3 x 10-7,,0.49,1.59,'-,[1.30-1.92],KMT5B,Breast cancer in childhood cancer survivors,"breast carcinoma, childhood cancer",GCST005111,11:68164294
rs147512482-<b>G</b>,2 x 10-7,,0.001,3.85,'-,[1.67-8.9],LINC01638,Breast cancer in childhood cancer survivors,"breast carcinoma, childhood cancer",GCST005111,22:27215781
rs17020562-<b>C</b>,3 x 10-7,,0.001,4.9,'-,[2.08-11.54],"RPS6KC1, RPL31P13",Breast cancer in childhood cancer survivors,"breast carcinoma, childhood cancer",GCST005111,1:213369363
rs13074711-<b>T</b>,2 x 10-6,,0.69,1.14,'-,[1.08-1.21],"LINC02068, TNFSF10",Breast cancer,breast carcinoma,GCST003782,3:172550013
rs10069690-<b>T</b>,5 x 10-6,,0.6,1.13,'-,[1.07-1.19],TERT,Breast cancer,breast carcinoma,GCST003782,5:1279675
rs9579199-<b>?</b>,8 x 10-6,,'-,1.2048,'-,[1.11-1.32],"EIF4A1P7, FLT1",Breast cancer (menopausal hormone therapy interaction),"breast carcinoma, hormone replacement therapy",GCST002265,13:28590646
rs7192724-<b>?</b>,3 x 10-6,,'-,1.24,'-,[1.13-1.36],PLCG2,Breast cancer (menopausal hormone therapy interaction),"breast carcinoma, hormone replacement therapy",GCST002265,16:81924693
rs4322600-<b>G</b>,4 x 10-6,,0.78,1.18,'-,[1.10-1.27],GALC,Breast cancer,breast carcinoma,GCST001648,14:87829256
rs9485372-<b>G</b>,4 x 10-12,,0.55,1.11,'-,[1.09-1.15],TAB2,Breast cancer,breast carcinoma,GCST001420,6:149287738
rs9383951-<b>G</b>,2 x 10-6,,0.9,1.14,'-,[1.08-1.19],ESR1,Breast cancer,breast carcinoma,GCST001420,6:151974478
rs7107217-<b>C</b>,5 x 10-7,,0.36,1.08,'-,[1.05-1.11],"LINC01395, RPS27P20",Breast cancer,breast carcinoma,GCST001420,11:129603795
rs2048672-<b>C</b>,6 x 10-6,,0.45,1.11,'-,[1.05-1.17],LINC-PINT,Breast cancer,breast carcinoma,GCST001224,7:130969092
rs10822013-<b>T</b>,6 x 10-9,,0.47,1.12,'-,[1.06-1.18],ZNF365,Breast cancer,breast carcinoma,GCST001224,10:62492218
rs16886448-<b>?</b>,2 x 10-12,,0.07,1.37,'-,[1.25-1.49],MAP3K1,Breast cancer (early onset),breast carcinoma,GCST002346,5:56874986
rs16886397-<b>?</b>,4 x 10-12,,0.07,1.36,'-,[1.25-1.49],MAP3K1,Breast cancer (early onset),breast carcinoma,GCST002346,5:56838449
rs3822625-<b>?</b>,5 x 10-12,,0.07,1.36,'-,[1.24-1.48],MAP3K1,Breast cancer (early onset),breast carcinoma,GCST002346,5:56882284
rs16886364-<b>?</b>,5 x 10-12,,0.07,1.36,'-,[1.25-1.48],MAP3K1,Breast cancer (early onset),breast carcinoma,GCST002346,5:56826517
rs16886113-<b>?</b>,4 x 10-11,,0.08,1.35,'-,[1.23-1.47],C5orf67,Breast cancer (early onset),breast carcinoma,GCST002346,5:56699208
rs1017226-<b>?</b>,6 x 10-11,,0.08,1.33,'-,[1.22-1.45],MAP3K1,Breast cancer (early onset),breast carcinoma,GCST002346,5:56857565
rs7726354-<b>?</b>,7 x 10-11,,0.06,1.37,'-,[1.24-1.50],MIER3,Breast cancer (early onset),breast carcinoma,GCST002346,5:56960656
rs12655019-<b>?</b>,3 x 10-10,,0.1,1.27,'-,[1.18-1.37],"MAP3K1, SETD9",Breast cancer (early onset),breast carcinoma,GCST002346,5:56899963
rs16886034-<b>?</b>,2 x 10-9,,0.08,1.36,'-,[1.23-1.51],C5orf67,Breast cancer (early onset),breast carcinoma,GCST002346,5:56688029
rs889312-<b>?</b>,1 x 10-8,,0.29,1.29,'-,[NR],MAP3K1,Breast cancer (early onset),breast carcinoma,GCST002346,5:56736057
rs614367-<b>?</b>,1 x 10-8,,0.16,1.34,'-,[NR],LINC01488,Breast cancer (early onset),breast carcinoma,GCST002346,11:69513996
rs653465-<b>?</b>,5 x 10-12,,0.54,1.18,'-,[1.12-1.23],NEK10,Breast cancer (early onset),breast carcinoma,GCST002346,3:27302153
rs2229882-<b>?</b>,1 x 10-14,,0.06,1.45,'-,[1.32-1.60],MAP3K1,Breast cancer (early onset),breast carcinoma,GCST002346,5:56872885
rs2392780-<b>?</b>,1 x 10-8,,0.6,1.15,'-,[1.10-1.20],"PCAT1, CASC8, POU5F1B",Breast cancer (early onset),breast carcinoma,GCST002346,8:127375779
rs2912774-<b>?</b>,3 x 10-27,,0.44,1.29,'-,[1.23-1.35],FGFR2,Breast cancer (early onset),breast carcinoma,GCST002346,10:121589148
rs537626-<b>?</b>,2 x 10-15,,0.18,1.29,'-,[1.21-1.37],LINC01488,Breast cancer (early onset),breast carcinoma,GCST002346,11:69492927
rs4784223-<b>?</b>,6 x 10-21,,0.29,1.27,'-,[1.21-1.34],TOX3,Breast cancer (early onset),breast carcinoma,GCST002346,16:52541995
rs999737-<b>C</b>,3 x 10-8,,0.77,1.0869565,'-,[1.04-1.12],RAD51B,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,14:68567965
rs2747652-<b>C</b>,2 x 10-18,,0.52,1.098901,'-,[1.08-1.12],ESR1,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,6:152115881
rs6562760-<b>G</b>,9 x 10-10,,0.76,1.0869565,'-,[1.05-1.11],MARK2P12,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,13:73383544
rs6678914-<b>G</b>,3 x 10-12,,0.59,1.0869565,'-,[1.06-1.11],LGR6,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,1:202218048
rs4577244-<b>C</b>,2 x 10-9,,0.66,1.0869565,'-,[1.05-1.11],WDR43,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,2:28897867
rs12710696-<b>T</b>,7 x 10-8,,0.37,1.06,'-,[1.04-1.09],LINC01376,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,2:19121042
rs11075995-<b>A</b>,1 x 10-10,,0.3,1.09,'-,[1.06-1.12],FTO,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,16:53821379
rs4245739-<b>C</b>,3 x 10-23,,0.26,1.14,'-,[1.11-1.16],MDM4,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,1:204549714
rs3757322-<b>G</b>,3 x 10-31,,0.32,1.15,'-,[1.12-1.18],CCDC170,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,6:151621059
rs67397200-<b>G</b>,3 x 10-37,,0.32,1.17,'-,[1.14-1.19],"ABHD8, ANKLE1",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,19:17290595
rs10069690-<b>T</b>,2 x 10-35,,0.26,1.18,'-,[1.15-1.21],TERT,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,5:1279675
rs11076805-<b>C</b>,2 x 10-8,,0.75,1.0869565,'-,[1.05-1.11],ADCY9,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,16:4056787
rs6569648-<b>T</b>,4 x 10-8,,0.77,1.0752687,'-,[1.05-1.11],L3MBTL3,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,6:130027974
rs11374964-<b>G</b>,4 x 10-8,,0.58,1.0638298,'-,[1.04-1.09],POGLUT3,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,11:108474789
rs36194942-<b>A</b>,3 x 10-7,,0.7,1.0638298,'-,[1.04-1.1],'-,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,18:27821241
rs113701136-<b>T</b>,2 x 10-7,,0.32,1.07,'-,[1.04-1.09],"CCNE1, C19orf12",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,19:29786822
rs17350191-<b>T</b>,2 x 10-8,,0.34,1.07,'-,[1.04-1.09],"ANXA13, FAM91A1",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,8:123745421
rs66823261-<b>C</b>,6 x 10-9,,0.23,1.09,'-,[1.06-1.12],RPL23AP53,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,8:220692
rs74911261-<b>G</b>,2 x 10-6,,0.98,1.2195122,'-,[1.12-1.33],POGLUT3,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,11:108486410
rs117618124-<b>T</b>,5 x 10-6,,0.95,1.1904762,'-,[1.1-1.3],GAREM1,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,18:32397726
rs4442975-<b>G</b>,3 x 10-6,,0.5,1.0638298,'-,[1.02-1.09],'-,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,2:217056046
rs1011970-<b>T</b>,5 x 10-7,,0.16,1.05,'-,[1.00-1.09],CDKN2B-AS1,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,9:22062135
rs10995201-<b>A</b>,2 x 10-9,,0.84,1.0752687,'-,[1.02-1.12],ZNF365,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,10:62540131
rs11571833-<b>T</b>,2 x 10-13,,0.01,1.58,'-,[1.35-1.84],BRCA2,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,13:32398489
rs11627032-<b>T</b>,2 x 10-6,,0.75,1.0526316,'-,[1.01-1.09],RIN3,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,14:92637727
rs11820646-<b>C</b>,2 x 10-7,,0.6,1.0638298,'-,[1.03-1.1],"RPS27P20, LINC01395",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,11:129591276
rs13281615-<b>G</b>,9 x 10-6,,0.41,1.07,'-,[1.03-1.10],"CASC8, POU5F1B, PCAT1",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,8:127343372
rs13365225-<b>A</b>,1 x 10-10,,0.82,1.1111112,'-,[1.06-1.16],"KCNU1, SMARCE1P4",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,8:37000965
rs1432679-<b>C</b>,1 x 10-10,,0.43,1.08,'-,[1.04-1.11],EBF1,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,5:158817075
rs16857609-<b>T</b>,2 x 10-8,,0.26,1.07,'-,[1.03-1.10],DIRC3,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,2:217431785
rs17356907-<b>A</b>,2 x 10-8,,0.7,1.0638298,'-,[1.03-1.1],PGAM1P5,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,12:95633983
rs17529111-<b>C</b>,2 x 10-6,,0.22,1.06,'-,[1.02-1.10],TENT5A,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,6:81418669
rs17817449-<b>T</b>,2 x 10-10,,0.59,1.0752687,'-,[1.04-1.11],FTO,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,16:53779455
rs1830298-<b>C</b>,7 x 10-7,,0.28,1.08,'-,[1.04-1.12],FLACC1,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,2:201316524
rs2943559-<b>G</b>,3 x 10-6,,0.08,1.1,'-,[1.04-1.16],HNF4G,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,8:75505702
rs3215401-<b>A</b>,6 x 10-21,,0.69,1.1363636,'-,[1.1-1.18],"TERT, MIR4457",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,5:1296141
rs3760982-<b>A</b>,5 x 10-8,,0.46,1.08,'-,[1.05-1.12],"LYPD5, KCNN4",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,19:43782361
rs4784227-<b>T</b>,2 x 10-26,,0.24,1.14,'-,[1.10-1.19],CASC16,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,16:52565276
rs4808801-<b>A</b>,6 x 10-6,,0.66,1.0416667,'-,[1.01-1.08],ELL,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,19:18460331
rs4849887-<b>C</b>,4 x 10-9,,0.9,1.1764705,'-,[1.11-1.23],LINC01101,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,2:120487546
rs6001930-<b>C</b>,2 x 10-11,,0.1,1.14,'-,[1.08-1.19],MRTFA,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,22:40480230
rs616488-<b>A</b>,4 x 10-18,,0.67,1.1235955,'-,[1.09-1.16],PEX14,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,1:10506158
rs62355902-<b>T</b>,2 x 10-6,,0.16,1.06,'-,[1.02-1.11],MAP3K1,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,5:56757896
rs7297051-<b>C</b>,9 x 10-25,,0.76,1.1494253,'-,[1.1-1.19],PTHLH,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,12:28021884
rs7904519-<b>G</b>,8 x 10-10,,0.46,1.08,'-,[1.04-1.11],TCF7L2,Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,10:113014168
rs9397437-<b>A</b>,3 x 10-40,,0.07,1.32,'-,[1.25-1.40],"CCDC170, ESR1",Breast cancer (estrogen-receptor negative),estrogen-receptor negative breast cancer,GCST005076,6:151631197
rs148760487-<b>?</b>,2 x 10-8,,0.01,1.88,'-,[1.51-2.34],KCNH7,Breast cancer (survival),"survival time, breast carcinoma",GCST002861,2:162922103
rs17817449-<b>T</b>,2 x 10-14,,0.6,1.0752687,'-,[1.05-1.1],FTO,Breast cancer,breast carcinoma,GCST004950,16:53779455
rs11075995-<b>A</b>,1 x 10-6,,0.24,1.04,'-,[1.02-1.06],FTO,Breast cancer,breast carcinoma,GCST004950,16:53821379
rs13329835-<b>G</b>,2 x 10-17,,0.22,1.08,'-,[1.06-1.11],CDYL2,Breast cancer,breast carcinoma,GCST004950,16:80616908
rs6504950-<b>G</b>,5 x 10-12,,0.72,1.0638298,'-,[1.04-1.09],STXBP4,Breast cancer,breast carcinoma,GCST004950,17:54979110
rs527616-<b>G</b>,8 x 10-13,,0.62,1.0526316,'-,[1.03-1.08],AQP4-AS1,Breast cancer,breast carcinoma,GCST004950,18:26757460
rs1436904-<b>T</b>,3 x 10-8,,0.6,1.0416667,'-,[1.03-1.06],"AQP4-AS1, CHST9",Breast cancer,breast carcinoma,GCST004950,18:26990703
rs8170-<b>A</b>,2 x 10-6,,0.19,1.04,'-,[1.02-1.07],"BABAM1, USHBP1",Breast cancer,breast carcinoma,GCST004950,19:17278895
rs2363956-<b>T</b>,2 x 10-6,,0.49,1.03,'-,[1.01-1.05],ANKLE1,Breast cancer,breast carcinoma,GCST004950,19:17283315
rs4808801-<b>A</b>,4 x 10-15,,0.65,1.0752687,'-,[1.06-1.1],ELL,Breast cancer,breast carcinoma,GCST004950,19:18460331
rs3760982-<b>A</b>,8 x 10-9,,0.46,1.05,'-,[1.03-1.07],"LYPD5, KCNN4",Breast cancer,breast carcinoma,GCST004950,19:43782361
rs2823093-<b>G</b>,3 x 10-13,,0.73,1.0752687,'-,[1.05-1.1],NRIP1,Breast cancer,breast carcinoma,GCST004950,21:15148511
rs132390-<b>C</b>,3 x 10-9,,0.04,1.14,'-,[1.08-1.2],EMID1,Breast cancer,breast carcinoma,GCST004950,22:29225488
rs6001930-<b>C</b>,2 x 10-20,,0.11,1.12,'-,[1.09-1.16],MRTFA,Breast cancer,breast carcinoma,GCST004950,22:40480230
rs12405132-<b>C</b>,2 x 10-7,,0.64,1.0526316,'-,'-,RNF115,Breast cancer,breast carcinoma,GCST007236,1:145790097
rs12048493-<b>C</b>,2 x 10-9,,0.34,1.07,'-,[1.05–1.10],OTUD7B,Breast cancer,breast carcinoma,GCST007236,1:149955122
rs72755295-<b>G</b>,3 x 10-7,,0.03,1.15,'-,[1.09–1.22],EXO1,Breast cancer,breast carcinoma,GCST007236,1:241870961
rs6796502-<b>G</b>,8 x 10-7,,0.81,1.0869565,'-,'-,"PRSS44P, PRSS42P",Breast cancer,breast carcinoma,GCST007236,3:46825376
rs13162653-<b>G</b>,2 x 10-6,,0.55,1.0526316,'-,'-,"NACAP6, MARCHF11",Breast cancer,breast carcinoma,GCST007236,5:16187419
rs2012709-<b>T</b>,2 x 10-6,,0.46,1.05,'-,[1.03–1.08],SUB1,Breast cancer,breast carcinoma,GCST007236,5:32567626
rs7707921-<b>A</b>,4 x 10-9,,0.77,1.0752687,'-,'-,ATG10,Breast cancer,breast carcinoma,GCST007236,5:82242227
rs9257408-<b>C</b>,5 x 10-7,,0.38,1.05,'-,[1.03–1.08],"KRT18P1, LINC01556",Breast cancer,breast carcinoma,GCST007236,6:28958443
rs4593472-<b>C</b>,4 x 10-6,,0.65,1.0526316,'-,'-,LINC-PINT,Breast cancer,breast carcinoma,GCST007236,7:130982362
rs13267382-<b>A</b>,5 x 10-6,,0.36,1.05,'-,[1.03–1.07],LINC00536,Breast cancer,breast carcinoma,GCST007236,8:116197325
rs11627032-<b>T</b>,1 x 10-6,,0.74,1.0638298,'-,'-,RIN3,Breast cancer,breast carcinoma,GCST007236,14:92637727
chr17:29230520-<b>G</b>,1 x 10-6,,0.8,1.0752687,'-,'-,'-,Breast cancer,breast carcinoma,GCST007236,Mapping not available
rs10759243-<b>A</b>,3 x 10-9,,0.29,1.05,'-,[1.03-1.08],PPIAP88,Breast cancer,breast carcinoma,GCST004950,9:107543834
rs865686-<b>T</b>,6 x 10-34,,0.62,1.1111112,'-,[1.09-1.14],CHCHD4P2,Breast cancer,breast carcinoma,GCST004950,9:108126198
rs7072776-<b>A</b>,1 x 10-14,,0.29,1.07,'-,[1.05-1.09],"MLLT10, DNAJC1",Breast cancer,breast carcinoma,GCST004950,10:21744013
rs11814448-<b>C</b>,6 x 10-17,,0.02,1.27,'-,[1.19-1.36],DNAJC1,Breast cancer,breast carcinoma,GCST004950,10:22026914
rs10995190-<b>G</b>,2 x 10-37,,0.84,1.1627907,'-,[1.14-1.2],ZNF365,Breast cancer,breast carcinoma,GCST004950,10:62518923
rs704010-<b>T</b>,3 x 10-23,,0.38,1.08,'-,[1.06-1.1],ZMIZ1,Breast cancer,breast carcinoma,GCST004950,10:79081391
rs7904519-<b>G</b>,9 x 10-13,,0.46,1.05,'-,[1.03-1.07],TCF7L2,Breast cancer,breast carcinoma,GCST004950,10:113014168
rs11199914-<b>C</b>,8 x 10-9,,0.68,1.0526316,'-,[1.03-1.08],RN7SKP167,Breast cancer,breast carcinoma,GCST004950,10:121334387
rs2981579-<b>A</b>,6 x 10-164,,0.4,1.27,'-,[1.24-1.29],FGFR2,Breast cancer,breast carcinoma,GCST004950,10:121577821
rs3817198-<b>C</b>,2 x 10-13,,0.31,1.07,'-,[1.05-1.09],LSP1,Breast cancer,breast carcinoma,GCST004950,11:1887776
rs3903072-<b>G</b>,1 x 10-10,,0.53,1.0526316,'-,[1.03-1.08],"OVOL1, CFL1",Breast cancer,breast carcinoma,GCST004950,11:65815595
rs78540526-<b>T</b>,2 x 10-86,,0.08,1.34,'-,[1.29-1.38],LINC01488,Breast cancer,breast carcinoma,GCST004950,11:69516650
rs554219-<b>G</b>,2 x 10-81,,0.12,1.26,'-,[1.23-1.3],LINC01488,Breast cancer,breast carcinoma,GCST004950,11:69516874
rs75915166-<b>A</b>,1 x 10-57,,0.06,1.31,'-,[1.26-1.36],"CCND1, LINC01488",Breast cancer,breast carcinoma,GCST004950,11:69564393
rs11820646-<b>C</b>,1 x 10-10,,0.59,1.0526316,'-,[1.03-1.08],"RPS27P20, LINC01395",Breast cancer,breast carcinoma,GCST004950,11:129591276
rs12422552-<b>C</b>,1 x 10-7,,0.26,1.04,'-,[1.02-1.07],"RPL30P11, GNAI2P1",Breast cancer,breast carcinoma,GCST004950,12:14260997
rs10771399-<b>A</b>,5 x 10-34,,0.88,1.1627907,'-,[1.12-1.2],PTHLH,Breast cancer,breast carcinoma,GCST004950,12:28002147
rs17356907-<b>A</b>,7 x 10-21,,0.7,1.098901,'-,[1.08-1.11],PGAM1P5,Breast cancer,breast carcinoma,GCST004950,12:95633983
rs1292011-<b>A</b>,2 x 10-21,,0.58,1.0869565,'-,[1.06-1.11],'-,Breast cancer,breast carcinoma,GCST004950,12:115398717
rs11571833-<b>T</b>,6 x 10-7,,0.01,1.27,'-,[1.15-1.4],BRCA2,Breast cancer,breast carcinoma,GCST004950,13:32398489
rs2236007-<b>G</b>,9 x 10-13,,0.79,1.0752687,'-,[1.05-1.1],PAX9,Breast cancer,breast carcinoma,GCST004950,14:36663564
rs2588809-<b>T</b>,2 x 10-8,,0.16,1.08,'-,[1.05-1.11],RAD51B,Breast cancer,breast carcinoma,GCST004950,14:68193711
rs999737-<b>C</b>,2 x 10-21,,0.77,1.0869565,'-,[1.06-1.11],RAD51B,Breast cancer,breast carcinoma,GCST004950,14:68567965
rs941764-<b>G</b>,6 x 10-11,,0.34,1.07,'-,[1.05-1.09],CCDC88C,Breast cancer,breast carcinoma,GCST004950,14:91374725
rs3803662-<b>A</b>,4 x 10-117,,0.26,1.24,'-,[1.21-1.26],CASC16,Breast cancer,breast carcinoma,GCST004950,16:52552429
rs13162653-<b>G</b>,1 x 10-10,,0.55,1.0526316,'-,[1.03-1.08],"NACAP6, MARCHF11",Breast cancer,breast carcinoma,GCST004950,5:16187419
rs2012709-<b>T</b>,6 x 10-9,,0.46,1.05,'-,[1.03-1.08],SUB1,Breast cancer,breast carcinoma,GCST004950,5:32567626
rs12405132-<b>C</b>,8 x 10-9,,0.64,1.0526316,'-,[1.03-1.08],RNF115,Breast cancer,breast carcinoma,GCST004950,1:145790097
rs12048493-<b>C</b>,1 x 10-9,,0.34,1.07,'-,[1.05-1.10],OTUD7B,Breast cancer,breast carcinoma,GCST004950,1:149955122
rs72755295-<b>G</b>,2 x 10-8,,0.03,1.15,'-,[1.09-1.22],EXO1,Breast cancer,breast carcinoma,GCST004950,1:241870961
rs6796502-<b>G</b>,2 x 10-8,,0.91,1.0869565,'-,[1.05-1.12],"PRSS44P, PRSS42P",Breast cancer,breast carcinoma,GCST004950,3:46825376
rs7707921-<b>A</b>,5 x 10-11,,0.77,1.0752687,'-,[1.05-1.1],ATG10,Breast cancer,breast carcinoma,GCST004950,5:82242227
rs9257408-<b>C</b>,5 x 10-8,,0.38,1.05,'-,[1.03-1.08],"KRT18P1, LINC01556",Breast cancer,breast carcinoma,GCST004950,6:28958443
rs4593472-<b>C</b>,2 x 10-9,,0.65,1.0526316,'-,[1.03-1.06],LINC-PINT,Breast cancer,breast carcinoma,GCST004950,7:130982362
rs13365225-<b>A</b>,1 x 10-8,,0.83,1.0526316,'-,[1.02-1.08],"KCNU1, SMARCE1P4",Breast cancer,breast carcinoma,GCST004950,8:37000965
rs13267382-<b>A</b>,2 x 10-8,,0.36,1.05,'-,[1.03-1.07],LINC00536,Breast cancer,breast carcinoma,GCST004950,8:116197325
rs11627032-<b>T</b>,4 x 10-9,,0.74,1.0638298,'-,[1.04-1.09],RIN3,Breast cancer,breast carcinoma,GCST004950,14:92637727
chr17:29230520-<b>GGT</b>,3 x 10-8,,0.8,1.0752687,'-,[1.04-1.1],'-,Breast cancer,breast carcinoma,GCST004950,Mapping not available
rs745570-<b>A</b>,1 x 10-9,,0.5,1.0526316,'-,[1.03-1.08],"LINC01977, CBX8",Breast cancer,breast carcinoma,GCST004950,17:79807926
rs6507583-<b>A</b>,3 x 10-8,,0.93,1.098901,'-,[1.05-1.14],SETBP1,Breast cancer,breast carcinoma,GCST004950,18:44819625
rs616488-<b>A</b>,4 x 10-11,,0.67,1.0638298,'-,[1.04-1.09],PEX14,Breast cancer,breast carcinoma,GCST004950,1:10506158
rs11552449-<b>T</b>,3 x 10-9,,0.16,1.07,'-,[1.04-1.09],DCLRE1B,Breast cancer,breast carcinoma,GCST004950,1:113905767
rs11249433-<b>G</b>,3 x 10-27,,0.4,1.09,'-,[1.07-1.12],EMBP1,Breast cancer,breast carcinoma,GCST004950,1:121538815
rs12710696-<b>T</b>,4 x 10-7,,0.36,1.04,'-,[1.02-1.06],LINC01376,Breast cancer,breast carcinoma,GCST004950,2:19121042
rs4849887-<b>C</b>,2 x 10-11,,0.9,1.098901,'-,[1.06-1.14],LINC01101,Breast cancer,breast carcinoma,GCST004950,2:120487546
rs2016394-<b>G</b>,8 x 10-6,,0.52,1.0526316,'-,[1.03-1.06],DLX2-DT,Breast cancer,breast carcinoma,GCST004950,2:172108243
rs1550623-<b>A</b>,1 x 10-6,,0.84,1.0526316,'-,[1.03-1.09],"RPS2P18, CDCA7",Breast cancer,breast carcinoma,GCST004950,2:173348166
rs13387042-<b>A</b>,1 x 10-55,,0.51,1.1363636,'-,[1.11-1.16],'-,Breast cancer,breast carcinoma,GCST004950,2:217041109
rs16857609-<b>T</b>,1 x 10-17,,0.26,1.08,'-,[1.06-1.11],DIRC3,Breast cancer,breast carcinoma,GCST004950,2:217431785
rs6762644-<b>G</b>,9 x 10-12,,0.4,1.07,'-,[1.05-1.09],ITPR1,Breast cancer,breast carcinoma,GCST004950,3:4700592
rs4973768-<b>T</b>,3 x 10-30,,0.47,1.1,'-,[1.08-1.12],SLC4A7,Breast cancer,breast carcinoma,GCST004950,3:27374522
rs12493607-<b>C</b>,1 x 10-8,,0.34,1.06,'-,[1.04-1.08],TGFBR2,Breast cancer,breast carcinoma,GCST004950,3:30641447
rs1053338-<b>G</b>,9 x 10-9,,0.13,1.08,'-,[1.05-1.11],ATXN7,Breast cancer,breast carcinoma,GCST004950,3:63982224
rs9790517-<b>T</b>,1 x 10-9,,0.22,1.05,'-,[1.03-1.08],TET2,Breast cancer,breast carcinoma,GCST004950,4:105163621
rs6828523-<b>C</b>,1 x 10-15,,0.88,1.1111112,'-,[1.08-1.15],ADAM29,Breast cancer,breast carcinoma,GCST004950,4:174925275
rs10069690-<b>T</b>,1 x 10-8,,0.26,1.06,'-,[1.04-1.09],TERT,Breast cancer,breast carcinoma,GCST004950,5:1279675
rs2736108-<b>C</b>,2 x 10-9,,0.71,1.0638298,'-,[1.04-1.09],"MIR4457, TERT",Breast cancer,breast carcinoma,GCST004950,5:1297373
rs10941679-<b>G</b>,5 x 10-32,,0.25,1.12,'-,[1.1-1.15],"LINC02224, RN7SL383P",Breast cancer,breast carcinoma,GCST004950,5:44706396
rs889312-<b>C</b>,1 x 10-39,,0.28,1.12,'-,[1.1-1.15],MAP3K1,Breast cancer,breast carcinoma,GCST004950,5:56736057
rs10472076-<b>C</b>,2 x 10-8,,0.38,1.05,'-,[1.03-1.07],"RAB3C, PDE4D",Breast cancer,breast carcinoma,GCST004950,5:58888234
rs1353747-<b>T</b>,3 x 10-8,,0.9,1.0869565,'-,[1.05-1.12],'-,Breast cancer,breast carcinoma,GCST004950,Mapping not available
rs1432679-<b>C</b>,4 x 10-16,,0.43,1.07,'-,[1.05-1.09],EBF1,Breast cancer,breast carcinoma,GCST004950,5:158817075
rs11242675-<b>T</b>,1 x 10-7,,0.62,1.0416667,'-,[1.02-1.06],"LINC01394, FOXQ1",Breast cancer,breast carcinoma,GCST004950,6:1318643
rs204247-<b>G</b>,4 x 10-10,,0.44,1.05,'-,[1.03-1.07],"MCUR1, RANBP9",Breast cancer,breast carcinoma,GCST004950,6:13722291
rs17529111-<b>C</b>,2 x 10-10,,0.22,1.06,'-,[1.04-1.08],TENT5A,Breast cancer,breast carcinoma,GCST004950,6:81418669
rs12662670-<b>G</b>,7 x 10-27,,0.07,1.17,'-,[1.13-1.22],CCDC170,Breast cancer,breast carcinoma,GCST004950,6:151597721
rs2046210-<b>A</b>,6 x 10-24,,0.34,1.08,'-,[1.06-1.1],"ESR1, CCDC170",Breast cancer,breast carcinoma,GCST004950,6:151627231
rs6964587-<b>T</b>,5 x 10-7,,0.39,1.05,'-,[1.03-1.07],AKAP9,Breast cancer,breast carcinoma,GCST004950,7:92001306
rs720475-<b>G</b>,4 x 10-10,,0.75,1.0638298,'-,[1.04-1.09],ARHGEF5,Breast cancer,breast carcinoma,GCST004950,7:144377836
rs9693444-<b>A</b>,1 x 10-12,,0.32,1.07,'-,[1.05-1.09],"RPL17P33, LINC00589",Breast cancer,breast carcinoma,GCST004950,8:29652100
rs6472903-<b>T</b>,1 x 10-16,,0.82,1.098901,'-,[1.08-1.12],CASC9,Breast cancer,breast carcinoma,GCST004950,8:75318066
rs2943559-<b>G</b>,1 x 10-16,,0.07,1.13,'-,[1.09-1.17],HNF4G,Breast cancer,breast carcinoma,GCST004950,8:75505702
rs13281615-<b>G</b>,6 x 10-31,,0.4,1.1,'-,[1.08-1.12],"CASC8, POU5F1B, PCAT1",Breast cancer,breast carcinoma,GCST004950,8:127343372
rs11780156-<b>T</b>,2 x 10-9,,0.16,1.07,'-,[1.04-1.09],PVT1,Breast cancer,breast carcinoma,GCST004950,8:128182395
rs1011970-<b>T</b>,4 x 10-9,,0.17,1.06,'-,[1.03-1.08],CDKN2B-AS1,Breast cancer,breast carcinoma,GCST004950,9:22062135
rs10864459-<b>?</b>,5 x 10-10,,0.69,1.0526316,'-,[1.01-1.1],PEX14,Breast cancer,breast carcinoma,GCST003845,1:10503552
rs17489300-<b>?</b>,2 x 10-8,,0.61,1.0309278,'-,[0.99-1.08],LGR6,Breast cancer,breast carcinoma,GCST003845,1:202209914
rs4245739-<b>?</b>,8 x 10-18,,0.28,1.09,'-,[1.05-1.14],MDM4,Breast cancer,breast carcinoma,GCST003845,1:204549714
rs12710696-<b>?</b>,2 x 10-6,,0.39,1.01,'-,[0.97-1.05],LINC01376,Breast cancer,breast carcinoma,GCST003845,2:19121042
rs11903787-<b>?</b>,7 x 10-10,,0.74,1.098901,'-,[1.04-1.15],"RALB, INHBB",Breast cancer,breast carcinoma,GCST003845,2:120330606
rs2242652-<b>?</b>,8 x 10-28,,0.22,1.22,'-,[1.16-1.28],TERT,Breast cancer,breast carcinoma,GCST003845,5:1279913
rs7726159-<b>?</b>,3 x 10-8,,0.35,1.07,'-,[1.02-1.11],TERT,Breast cancer,breast carcinoma,GCST003845,5:1282204
rs2736108-<b>?</b>,3 x 10-14,,0.71,1.1235955,'-,[1.08-1.16],"MIR4457, TERT",Breast cancer,breast carcinoma,GCST003845,5:1297373
rs12662670-<b>?</b>,1 x 10-19,,0.09,1.19,'-,[1.11-1.27],CCDC170,Breast cancer,breast carcinoma,GCST003845,6:151597721
rs10995190-<b>?</b>,8 x 10-6,,0.84,1.010101,'-,[0.96-1.06],ZNF365,Breast cancer,breast carcinoma,GCST003845,10:62518923
rs4980383-<b>?</b>,9 x 10-9,,0.45,1.07,'-,[1.03-1.11],LSP1,Breast cancer,breast carcinoma,GCST003845,11:1880867
rs7297051-<b>?</b>,3 x 10-20,,0.77,1.1235955,'-,[1.08-1.18],PTHLH,Breast cancer,breast carcinoma,GCST003845,12:28021884
rs10771399-<b>?</b>,7 x 10-18,,0.9,1.1627907,'-,[1.1-1.25],PTHLH,Breast cancer,breast carcinoma,GCST003845,12:28002147
rs4784227-<b>?</b>,6 x 10-15,,0.26,1.07,'-,[1.02-1.12],CASC16,Breast cancer,breast carcinoma,GCST003845,16:52565276
rs11075995-<b>?</b>,2 x 10-6,,0.24,1.01,'-,[0.97-1.06],FTO,Breast cancer,breast carcinoma,GCST003845,16:53821379
rs8170-<b>?</b>,7 x 10-21,,0.19,1.17,'-,[1.11-1.23],"BABAM1, USHBP1",Breast cancer,breast carcinoma,GCST003845,19:17278895
rs56069439-<b>?</b>,1 x 10-32,,0.3,1.19,'-,[1.14-1.24],ANKLE1,Breast cancer,breast carcinoma,GCST003845,19:17283116
rs114962751-<b>?</b>,7 x 10-8,,0.02,1.22,'-,[1.05-1.42],FAM126B,Breast cancer,breast carcinoma,GCST003845,2:201071148
rs6562760-<b>?</b>,5 x 10-10,,0.8,1.1235955,'-,[1.06-1.18],MARK2P12,Breast cancer,breast carcinoma,GCST003845,13:73383544
rs12870942-<b>?</b>,4 x 10-8,,0.3,1.06,'-,[1.01-1.10],RNY1P8,Breast cancer,breast carcinoma,GCST003845,13:73232845
rs16857609-<b>?</b>,7 x 10-6,,0.26,1.04,'-,[1.00-1.09],DIRC3,Breast cancer,breast carcinoma,GCST003845,2:217431785
rs1432679-<b>?</b>,2 x 10-6,,0.44,1.04,'-,[1.00-1.08],EBF1,Breast cancer,breast carcinoma,GCST003845,5:158817075
rs13365225-<b>?</b>,7 x 10-6,,0.81,1.0416667,'-,[0.99-1.1],"KCNU1, SMARCE1P4",Breast cancer,breast carcinoma,GCST003845,8:37000965
rs11820646-<b>?</b>,9 x 10-6,,0.62,1.0752687,'-,[1.03-1.14],"RPS27P20, LINC01395",Breast cancer,breast carcinoma,GCST003845,11:129591276
rs17356907-<b>?</b>,5 x 10-7,,0.71,1.0526316,'-,[1-1.1],PGAM1P5,Breast cancer,breast carcinoma,GCST003845,12:95633983
rs745570-<b>?</b>,6 x 10-6,,0.51,1.0416667,'-,[1-1.09],"LINC01977, CBX8",Breast cancer,breast carcinoma,GCST003845,17:79807926
rs6001930-<b>?</b>,2 x 10-6,,0.11,1.07,'-,[1.01-1.14],MRTFA,Breast cancer,breast carcinoma,GCST003845,22:40480230
rs11155804-<b>?</b>,4 x 10-28,,0.36,1.15,'-,[1.11-1.20],"CCDC170, ESR1",Breast cancer,breast carcinoma,GCST003845,6:151625017
rs6585202-<b>?</b>,1 x 10-9,,0.47,1.1,'-,[1.05-1.14],TCF7L2,Breast cancer,breast carcinoma,GCST003845,10:113023044
rs17817449-<b>?</b>,5 x 10-8,,0.59,1.0526316,'-,[1.01-1.09],FTO,Breast cancer,breast carcinoma,GCST003845,16:53779455
rs67073037-<b>?</b>,5 x 10-9,,0.8,1.0869565,'-,[1.04-1.15],WDR43,Breast cancer,breast carcinoma,GCST003845,2:28896719
rs3094146-<b>C</b>,7 x 10-7,(EA),0.1057,'-,0.0543 unit decrease,[0.033-0.076],ZNRD1ASP,Breast cancer,breast carcinoma,GCST004988,6:30003183
rs201681753-<b>CCCAT</b>,3 x 10-6,(EA),0.0337,'-,0.1129 unit decrease,[0.065-0.16],SHISAL1,Breast cancer,breast carcinoma,GCST004988,22:44323082
rs2045438-<b>T</b>,4 x 10-6,(EA),0.2669,'-,0.0323 unit decrease,[0.019-0.046],RNU4-17P,Breast cancer,breast carcinoma,GCST004988,18:60214129
rs217727-<b>A</b>,4 x 10-14,(EA),0.1929,'-,0.0598 unit decrease,[0.044-0.075],H19,Breast cancer,breast carcinoma,GCST004988,11:1995678
rs225132-<b>G</b>,3 x 10-6,(EA),0.187,'-,0.0375 unit decrease,[0.022-0.053],ERRFI1,Breast cancer,breast carcinoma,GCST004988,1:8035440
rs2271032-<b>G</b>,8 x 10-6,(EA),0.1372,'-,0.0407 unit increase,[0.023-0.059],"MTCO1P25, RNU6-229P",Breast cancer,breast carcinoma,GCST004988,7:69359109
rs2295389-<b>G</b>,2 x 10-6,(EA),0.3539,'-,0.0345 unit decrease,[0.02-0.049],MEG3,Breast cancer,breast carcinoma,GCST004988,14:100851974
rs2303282-<b>G</b>,3 x 10-7,(EA),0.6029,'-,0.0323 unit decrease,[0.02-0.045],BBS2,Breast cancer,breast carcinoma,GCST004988,16:56497273
rs2307561-<b>A</b>,8 x 10-18,(EA),0.2815,'-,0.0608 unit decrease,[0.047-0.075],"AQP4-AS1, CHST9",Breast cancer,breast carcinoma,GCST004988,18:26923543
rs2384736-<b>A</b>,1 x 10-6,(EA),0.3687,'-,0.0319 unit increase,[0.019-0.045],PLD5P1,Breast cancer,breast carcinoma,GCST004988,10:38234698
rs2403907-<b>A</b>,2 x 10-32,(EA),0.3159,'-,0.0796 unit decrease,[0.066-0.093],'-,Breast cancer,breast carcinoma,GCST004988,21:15202135
rs2407156-<b>G</b>,2 x 10-6,(EA),0.2383,'-,0.0354 unit decrease,[0.021-0.05],ATP6AP1L,Breast cancer,breast carcinoma,GCST004988,5:82340549
rs245279-<b>A</b>,9 x 10-7,(EA),0.1059,'-,0.0493 unit increase,[0.03-0.069],'-,Breast cancer,breast carcinoma,GCST004988,5:58332828
rs2506889-<b>T</b>,2 x 10-20,(EA),0.3185,'-,0.0615 unit decrease,[0.048-0.075],PEX14,Breast cancer,breast carcinoma,GCST004988,1:10535965
rs2523992-<b>G</b>,2 x 10-7,(EA),0.1571,'-,0.0468 unit decrease,[0.029-0.064],"TRIM31-AS1, TRIM31",Breast cancer,breast carcinoma,GCST004988,6:30107326
rs2589161-<b>C</b>,3 x 10-8,(EA),0.4172,'-,0.0348 unit increase,[0.022-0.047],HCN1,Breast cancer,breast carcinoma,GCST004988,5:45653810
rs2617583-<b>A</b>,9 x 10-7,(EA),0.5554,'-,0.0311 unit decrease,[0.019-0.043],"SLC6A3, LPCAT1",Breast cancer,breast carcinoma,GCST004988,5:1453229
rs2714486-<b>T</b>,7 x 10-10,(EA),0.1738,'-,0.0498 unit increase,[0.034-0.066],TRAK2,Breast cancer,breast carcinoma,GCST004988,2:201384985
rs2724379-<b>C</b>,2 x 10-7,(EA),0.3341,'-,0.0346 unit decrease,[0.022-0.048],CD34,Breast cancer,breast carcinoma,GCST004988,1:207903511
rs2726492-<b>C</b>,4 x 10-10,(EA),0.7943,'-,0.0475 unit decrease,[0.033-0.062],TET2,Breast cancer,breast carcinoma,GCST004988,4:105274384
rs2732699-<b>C</b>,1 x 10-10,(EA),0.8401,'-,0.0595 unit increase,[0.041-0.078],ARL17B,Breast cancer,breast carcinoma,GCST004988,17:46277538
rs3116813-<b>A</b>,6 x 10-7,(EA),0.1026,'-,0.0553 unit decrease,[0.034-0.077],"ZFP57, ZDHHC20P1",Breast cancer,breast carcinoma,GCST004988,6:29693039
rs3124765-<b>C</b>,2 x 10-6,(EA),0.8475,'-,0.0437 unit decrease,[0.026-0.062],CACFD1,Breast cancer,breast carcinoma,GCST004988,9:133463535
rs9257809-<b>G</b>,3 x 10-8,(EA),0.1004,'-,0.0627 unit decrease,[0.041-0.085],OR5V1,Breast cancer,breast carcinoma,GCST004988,6:29388554
rs9262142-<b>A</b>,3 x 10-6,(EA),0.1166,'-,0.0489 unit decrease,[0.028-0.069],PPP1R18,Breast cancer,breast carcinoma,GCST004988,6:30682249
rs191218575-<b>A</b>,8 x 10-6,(EA),0.0195,'-,0.1234 unit decrease,[0.069-0.177],WBP11P1,Breast cancer,breast carcinoma,GCST004988,18:32526319
rs1937680-<b>A</b>,3 x 10-7,(EA),0.6658,'-,0.0341 unit decrease,[0.021-0.047],PRKG1,Breast cancer,breast carcinoma,GCST004988,10:51918266
rs1962373-<b>A</b>,1 x 10-6,(EA),0.3161,'-,0.0335 unit increase,[0.02-0.047],SPAG17,Breast cancer,breast carcinoma,GCST004988,1:118111143
rs1966977-<b>C</b>,6 x 10-7,(EA),0.1984,'-,0.0422 unit decrease,[0.026-0.059],ADAM29,Breast cancer,breast carcinoma,GCST004988,4:175011701
rs1971136-<b>T</b>,5 x 10-9,(EA),0.5264,'-,0.0381 unit increase,[0.025-0.051],EFR3B,Breast cancer,breast carcinoma,GCST004988,2:25068670
rs1973765-<b>C</b>,1 x 10-37,(EA),0.4001,'-,0.0817 unit decrease,[0.069-0.094],LSP1,Breast cancer,breast carcinoma,GCST004988,11:1877434
rs199498-<b>C</b>,2 x 10-8,(EA),0.2094,'-,0.0433 unit decrease,[0.028-0.058],WNT3,Breast cancer,breast carcinoma,GCST004988,17:46788237
rs199501877-<b>G</b>,4 x 10-7,(EA),0.4866,'-,0.0315 unit decrease,[0.019-0.044],"TXK, NIPAL1",Breast cancer,breast carcinoma,GCST004988,4:48056416
rs199817973-<b>T</b>,1 x 10-6,(EA),0.05,'-,0.0722 unit decrease,[0.043-0.101],NREP-AS1,Breast cancer,breast carcinoma,GCST004988,5:112032901
rs200087884-<b>T</b>,7 x 10-7,(EA),0.7046,'-,0.0824 unit increase,[0.05-0.115],LINC00623,Breast cancer,breast carcinoma,GCST004988,1:120948545
rs200255906-<b>A</b>,2 x 10-14,(EA),0.081,'-,0.0911 unit increase,[0.068-0.114],HNF4G,Breast cancer,breast carcinoma,GCST004988,8:75626598
rs200725404-<b>A</b>,4 x 10-10,(EA),0.8437,'-,0.055 unit increase,[0.038-0.072],"CDCA7, RPS2P18",Breast cancer,breast carcinoma,GCST004988,2:173340858
rs201073821-<b>TG</b>,8 x 10-6,(EA),0.0485,'-,0.0738 unit increase,[0.041-0.106],TPTE2P6,Breast cancer,breast carcinoma,GCST004988,13:24412252
rs201177249-<b>C</b>,4 x 10-6,(EA),0.1351,'-,0.0462 unit increase,[0.027-0.066],PHF20,Breast cancer,breast carcinoma,GCST004988,20:35933106
rs2754412-<b>G</b>,6 x 10-7,(EA),0.4603,'-,0.0312 unit increase,[0.019-0.044],PLD5P1,Breast cancer,breast carcinoma,GCST004988,10:38338906
rs2771267-<b>T</b>,1 x 10-6,(EA),0.7549,'-,0.0393 unit increase,[0.023-0.055],"MARCHF5, MARK2P9",Breast cancer,breast carcinoma,GCST004988,10:92388574
rs2810650-<b>G</b>,3 x 10-9,(EA),0.2068,'-,0.0453 unit increase,[0.03-0.06],"HSPE1P6, CBX1P3",Breast cancer,breast carcinoma,GCST004988,1:203938990
rs2853669-<b>G</b>,4 x 10-21,(EA),0.3061,'-,0.0651 unit decrease,[0.052-0.079],"MIR4457, TERT",Breast cancer,breast carcinoma,GCST004988,5:1295234
rs28599928-<b>T</b>,2 x 10-6,(EA),0.113,'-,0.047 unit decrease,[0.028-0.066],TTLL1,Breast cancer,breast carcinoma,GCST004988,22:43072659
rs289997-<b>T</b>,3 x 10-7,(EA),0.1623,'-,0.0448 unit decrease,[0.028-0.062],'-,Breast cancer,breast carcinoma,GCST004988,7:25529928
rs2901157-<b>G</b>,2 x 10-6,(EA),0.1133,'-,0.0474 unit decrease,[0.028-0.067],EMX2OS,Breast cancer,breast carcinoma,GCST004988,10:117502854
rs2926585-<b>G</b>,3 x 10-24,(EA),0.0762,'-,0.1156 unit increase,[0.093-0.138],HNF4G,Breast cancer,breast carcinoma,GCST004988,8:75498626
rs3029748-<b>CTT</b>,4 x 10-6,(EA),0.535,'-,0.0298 unit increase,[0.017-0.043],GPC5,Breast cancer,breast carcinoma,GCST004988,13:91903032
rs3036802-<b>ACAT</b>,3 x 10-6,(EA),0.7844,'-,0.0426 unit decrease,[0.025-0.06],LINC01812,Breast cancer,breast carcinoma,GCST004988,2:67755147
rs3057314-<b>C</b>,7 x 10-25,(EA),0.3185,'-,0.0695 unit increase,[0.056-0.083],"CDKN2A-DT, MTAP",Breast cancer,breast carcinoma,GCST004988,9:21964884
rs4233486-<b>T</b>,9 x 10-9,(EA),0.64,1.0309278,'-,[1.02-1.05],"CITED4, UBE2V1P8",Breast cancer,breast carcinoma,GCST004988,1:40914768
rs1707302-<b>G</b>,3 x 10-8,(EA),0.66,1.0416667,'-,[1.02-1.05],P3R3URF-PIK3R3,Breast cancer,breast carcinoma,GCST004988,1:46135245
rs6882649-<b>T</b>,4 x 10-9,(EA),0.66,1.0309278,'-,[1.01-1.05],NREP,Breast cancer,breast carcinoma,GCST004988,5:111882089
rs6805189-<b>T</b>,5 x 10-8,(EA),0.52,1.0309278,'-,[1.01-1.05],FOXP1,Breast cancer,breast carcinoma,GCST004988,3:71482962
rs2432539-<b>A</b>,4 x 10-8,(EA),0.4,1.03,'-,[1.02-1.05],AMFR,Breast cancer,breast carcinoma,GCST004988,16:56387075
rs10760444-<b>G</b>,9 x 10-9,(EA),0.43,1.03,'-,[1.02-1.05],LMX1B,Breast cancer,breast carcinoma,GCST004988,9:126634155
4:84370124-<b>TAA</b>,2 x 10-9,(EA),0.47,1.04,'-,[1.02-1.05],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs2223621-<b>T</b>,3 x 10-10,(EA),0.38,1.04,'-,[1.02-1.06],CDKAL1,Breast cancer,breast carcinoma,GCST004988,6:20621007
rs2965183-<b>A</b>,6 x 10-12,(EA),0.35,1.04,'-,[1.02-1.06],GATAD2A,Breast cancer,breast carcinoma,GCST004988,19:19434887
rs10623258-<b>CTT</b>,2 x 10-8,(EA),0.45,1.04,'-,[1.02-1.06],ADSS1,Breast cancer,breast carcinoma,GCST004988,14:104745925
rs10022462-<b>T</b>,2 x 10-9,(EA),0.44,1.04,'-,[1.02-1.06],PPM1K-DT,Breast cancer,breast carcinoma,GCST004988,4:88322666
rs140936696-<b>CAA</b>,4 x 10-8,(EA),0.18,1.04,'-,[1.02-1.07],"CEP55, FFAR4",Breast cancer,breast carcinoma,GCST004988,10:93532431
rs4562056-<b>T</b>,5 x 10-10,(EA),0.33,1.05,'-,[1.03-1.07],"KRT18P41, LINC01187",Breast cancer,breast carcinoma,GCST004988,5:170164483
rs206966-<b>T</b>,4 x 10-8,(EA),0.16,1.05,'-,[1.02-1.07],"RPS27P25, COX6A1",Breast cancer,breast carcinoma,GCST004988,12:120394343
rs71338792-<b>AT</b>,4 x 10-9,(EA),0.23,1.05,'-,[1.03-1.07],GIPR,Breast cancer,breast carcinoma,GCST004988,19:45679774
rs28539243-<b>A</b>,9 x 10-15,(EA),0.49,1.05,'-,[1.03-1.07],LINC02183,Breast cancer,breast carcinoma,GCST004988,16:54648152
rs17426269-<b>A</b>,2 x 10-8,(EA),0.15,1.05,'-,[1.02-1.07],PKN2-AS1,Breast cancer,breast carcinoma,GCST004988,1:87691240
rs514192-<b>A</b>,6 x 10-9,(EA),0.32,1.05,'-,[1.03-1.07],"GRHL2, RN7SL563P",Breast cancer,breast carcinoma,GCST004988,8:101466731
rs28512361-<b>A</b>,2 x 10-8,(EA),0.11,1.05,'-,[1.02-1.08],"WNT7B, ATXN10",Breast cancer,breast carcinoma,GCST004988,22:45887417
rs4971059-<b>A</b>,5 x 10-11,(EA),0.35,1.05,'-,[1.03-1.07],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs17268829-<b>C</b>,5 x 10-13,(EA),0.28,1.05,'-,[1.03-1.07],"COL1A2, RNU6-1328P",Breast cancer,breast carcinoma,GCST004988,7:94484487
rs6122906-<b>G</b>,3 x 10-10,(EA),0.18,1.05,'-,[1.03-1.07],"LINC01271, RN7SL636P",Breast cancer,breast carcinoma,GCST004988,20:50329374
rs17156577-<b>C</b>,4 x 10-9,(EA),0.11,1.05,'-,[1.02-1.08],CREB5,Breast cancer,breast carcinoma,GCST004988,7:28317270
rs2992756-<b>T</b>,2 x 10-15,(EA),0.49,1.06,'-,[1.04-1.08],KLHDC7A,Breast cancer,breast carcinoma,GCST004988,1:18480845
rs34207738-<b>C</b>,3 x 10-15,(EA),0.41,1.06,'-,[1.04-1.08],ZBTB38,Breast cancer,breast carcinoma,GCST004988,3:141394018
rs117618124-<b>T</b>,6 x 10-12,(EA),0.95,1.1235955,'-,[1.09-1.18],GAREM1,Breast cancer,breast carcinoma,GCST004988,18:32397726
rs71557345-<b>G</b>,4 x 10-10,(EA),0.93,1.0869565,'-,[1.04-1.14],ZNF322,Breast cancer,breast carcinoma,GCST004988,6:26680470
rs79724016-<b>T</b>,4 x 10-8,(EA),0.97,1.0752687,'-,[1.03-1.14],HIVEP3,Breast cancer,breast carcinoma,GCST004988,1:41671640
rs72749841-<b>T</b>,7 x 10-10,(EA),0.84,1.0752687,'-,[1.04-1.1],EMB,Breast cancer,breast carcinoma,GCST004988,5:50345811
rs12546444-<b>A</b>,8 x 10-11,(EA),0.9,1.0752687,'-,[1.04-1.1],ZFPM2,Breast cancer,breast carcinoma,GCST004988,8:105346392
rs71559437-<b>G</b>,5 x 10-12,(EA),0.88,1.0752687,'-,[1.04-1.1],CUX1,Breast cancer,breast carcinoma,GCST004988,7:101909160
rs13066793-<b>A</b>,1 x 10-9,(EA),0.91,1.0638298,'-,[1.03-1.1],VGLL3,Breast cancer,breast carcinoma,GCST004988,3:86988393
rs6569648-<b>T</b>,3 x 10-12,(EA),0.76,1.0638298,'-,[1.04-1.09],L3MBTL3,Breast cancer,breast carcinoma,GCST004988,6:130027974
rs6596100-<b>C</b>,8 x 10-9,(EA),0.75,1.0638298,'-,[1.04-1.09],HSPA4,Breast cancer,breast carcinoma,GCST004988,5:133071366
rs1895062-<b>A</b>,1 x 10-14,(EA),0.59,1.0638298,'-,[1.05-1.09],"ASTN2, ASTN2-AS1",Breast cancer,breast carcinoma,GCST004988,9:116551207
rs77528541-<b>G</b>,1 x 10-9,(EA),0.87,1.0526316,'-,[1.03-1.09],'-,Breast cancer,breast carcinoma,GCST004988,4:125922349
rs2532263-<b>G</b>,7 x 10-13,(EA),0.81,1.0526316,'-,[1.03-1.08],KANSL1,Breast cancer,breast carcinoma,GCST004988,17:46175102
rs738321-<b>C</b>,1 x 10-13,(EA),0.62,1.0526316,'-,[1.03-1.08],PLA2G6,Breast cancer,breast carcinoma,GCST004988,22:38172826
rs11117758-<b>G</b>,4 x 10-9,(EA),0.79,1.0526316,'-,[1.03-1.08],ESRRG,Breast cancer,breast carcinoma,GCST004988,1:217047232
rs35951924-<b>A</b>,1 x 10-11,(EA),0.68,1.0526316,'-,[1.03-1.08],"PARP8, LINC02106",Breast cancer,breast carcinoma,GCST004988,5:50899260
rs202049448-<b>T</b>,3 x 10-8,(EA),0.66,1.0526316,'-,[1.03-1.08],'-,Breast cancer,breast carcinoma,GCST004988,12:84615658
rs3819405-<b>C</b>,2 x 10-8,(EA),0.67,1.0416667,'-,[1.03-1.06],ATXN1,Breast cancer,breast carcinoma,GCST004988,6:16399326
rs12479355-<b>A</b>,2 x 10-8,(EA),0.79,1.0416667,'-,[1.02-1.06],'-,Breast cancer,breast carcinoma,GCST004988,2:226362236
rs6725517-<b>A</b>,3 x 10-12,(EA),0.59,1.0416667,'-,[1.02-1.06],ADCY3,Breast cancer,breast carcinoma,GCST004988,2:24906604
rs6597981-<b>G</b>,1 x 10-12,(EA),0.52,1.0416667,'-,[1.03-1.06],PIDD1,Breast cancer,breast carcinoma,GCST004988,11:803017
rs4496150-<b>C</b>,8 x 10-9,(EA),0.75,1.0416667,'-,[1.02-1.06],LINC02181,Breast cancer,breast carcinoma,GCST004988,16:87051631
rs7971-<b>A</b>,2 x 10-8,(EA),0.65,1.0416667,'-,[1.02-1.06],"CDCA7L, DNAH11",Breast cancer,breast carcinoma,GCST004988,7:21901342
rs140850326-<b>CAAAGGGCAAGATCTCCTTTTT</b>,4 x 10-8,(EA),0.51,1.0309278,'-,[1.01-1.05],"LINC02808, HMGB1P45",Breast cancer,breast carcinoma,GCST004988,1:50380361
rs2594714-<b>G</b>,1 x 10-8,(EA),0.77,1.0309278,'-,[1.01-1.05],"MIR23AHG, NANOS3",Breast cancer,breast carcinoma,GCST004988,19:13843757
rs12207986-<b>A</b>,2 x 10-9,(EA),0.53,1.0309278,'-,[1.02-1.05],"RPL17P25, RPSAP72",Breast cancer,breast carcinoma,GCST004988,6:80384570
rs2787486-<b>A</b>,6 x 10-29,(EA),0.7,1.0752687,'-,[1.06-1.1],STXBP4,Breast cancer,breast carcinoma,GCST004988,17:55132413
rs4808801-<b>A</b>,5 x 10-28,(EA),0.66,1.0752687,'-,[1.05-1.1],ELL,Breast cancer,breast carcinoma,GCST004988,19:18460331
rs2747652-<b>C</b>,1 x 10-26,(EA),0.52,1.0638298,'-,[1.04-1.09],ESR1,Breast cancer,breast carcinoma,GCST004988,6:152115881
rs6472903-<b>T</b>,4 x 10-21,(EA),0.83,1.0638298,'-,[1.04-1.09],CASC9,Breast cancer,breast carcinoma,GCST004988,8:75318066
rs616488-<b>A</b>,5 x 10-20,(EA),0.67,1.0638298,'-,[1.04-1.08],PEX14,Breast cancer,breast carcinoma,GCST004988,1:10506158
rs10474352-<b>C</b>,5 x 10-11,(EA),0.84,1.0638298,'-,[1.03-1.09],ARRDC3-AS1,Breast cancer,breast carcinoma,GCST004988,5:91436408
rs2823093-<b>G</b>,2 x 10-20,(EA),0.73,1.0638298,'-,[1.04-1.09],NRIP1,Breast cancer,breast carcinoma,GCST004988,21:15148511
rs2290203-<b>G</b>,8 x 10-10,,0.79,1.0638298,'-,[1.04-1.09],"PRC1, PRC1-AS1",Breast cancer,breast carcinoma,GCST004988,15:90968837
rs1550623-<b>A</b>,5 x 10-10,(EA),0.85,1.0526316,'-,[1.02-1.08],"RPS2P18, CDCA7",Breast cancer,breast carcinoma,GCST004988,2:173348166
rs2016394-<b>G</b>,6 x 10-12,(EA),0.53,1.0526316,'-,[1.03-1.06],DLX2-DT,Breast cancer,breast carcinoma,GCST004988,2:172108243
rs6562760-<b>G</b>,2 x 10-9,(EA),0.76,1.0526316,'-,[1.03-1.08],MARK2P12,Breast cancer,breast carcinoma,GCST004988,13:73383544
rs1436904-<b>T</b>,1 x 10-14,(EA),0.6,1.0526316,'-,[1.03-1.06],"AQP4-AS1, CHST9",Breast cancer,breast carcinoma,GCST004988,18:26990703
rs17817449-<b>T</b>,3 x 10-21,(EA),0.59,1.0526316,'-,[1.04-1.08],FTO,Breast cancer,breast carcinoma,GCST004988,16:53779455
rs1353747-<b>T</b>,4 x 10-9,(EA),0.91,1.0416667,'-,[1.01-1.08],'-,Breast cancer,breast carcinoma,GCST004988,Mapping not available
rs7707921-<b>A</b>,2 x 10-12,(EA),0.75,1.0416667,'-,[1.02-1.06],ATG10,Breast cancer,breast carcinoma,GCST004988,5:82242227
rs11199914-<b>C</b>,7 x 10-12,(EA),0.68,1.0416667,'-,[1.02-1.06],RN7SKP167,Breast cancer,breast carcinoma,GCST004988,10:121334387
rs11820646-<b>C</b>,2 x 10-14,(EA),0.6,1.0416667,'-,[1.02-1.06],"RPS27P20, LINC01395",Breast cancer,breast carcinoma,GCST004988,11:129591276
rs11627032-<b>T</b>,4 x 10-11,(EA),0.75,1.0416667,'-,[1.02-1.06],RIN3,Breast cancer,breast carcinoma,GCST004988,14:92637727
rs4593472-<b>C</b>,2 x 10-11,(EA),0.65,1.0309278,'-,[1.01-1.05],LINC-PINT,Breast cancer,breast carcinoma,GCST004988,7:130982362
rs3903072-<b>G</b>,2 x 10-12,(EA),0.53,1.0309278,'-,[1.01-1.05],"OVOL1, CFL1",Breast cancer,breast carcinoma,GCST004988,11:65815595
rs12405132-<b>C</b>,6 x 10-10,(EA),0.63,1.0309278,'-,[1.01-1.05],RNF115,Breast cancer,breast carcinoma,GCST004988,1:145790097
rs527616-<b>G</b>,7 x 10-15,(EA),0.62,1.0309278,'-,[1.02-1.05],AQP4-AS1,Breast cancer,breast carcinoma,GCST004988,18:26757460
rs146699004-<b>GGT</b>,2 x 10-9,(EA),0.73,1.0309278,'-,[1.01-1.05],TEFM,Breast cancer,breast carcinoma,GCST004988,17:30903503
rs9257408-<b>C</b>,7 x 10-8,(EA),0.41,1.02,'-,[1-1.04],"KRT18P1, LINC01556",Breast cancer,breast carcinoma,GCST004988,6:28958443
rs2012709-<b>T</b>,1 x 10-8,(EA),0.48,1.02,'-,[1-1.04],SUB1,Breast cancer,breast carcinoma,GCST004988,5:32567626
rs142427110-<b>A</b>,1 x 10-12,(EA),0.1376,'-,0.069 unit decrease,[0.05-0.088],TENM2,Breast cancer,breast carcinoma,GCST004988,5:46394269
rs142471995-<b>T</b>,2 x 10-6,(EA),0.0096,'-,0.2003 unit decrease,[0.12-0.28],PDXK,Breast cancer,breast carcinoma,GCST004988,21:43733825
rs143072280-<b>TTTTC</b>,9 x 10-7,(EA),0.3518,'-,0.0342 unit increase,[0.02-0.048],"PLD5P1, ZNF37A",Breast cancer,breast carcinoma,GCST004988,10:38105004
rs144079028-<b>T</b>,9 x 10-6,(EA),0.7152,'-,0.0312 unit increase,[0.017-0.045],"NDUFB4P4, ASXL2",Breast cancer,breast carcinoma,GCST004988,2:25886882
rs45631563-<b>A</b>,7 x 10-37,(EA),0.95,1.2345679,'-,[1.18-1.28],FGFR2,Breast cancer,breast carcinoma,GCST004988,10:121589810
rs34005590-<b>C</b>,3 x 10-41,(EA),0.95,1.2195122,'-,[1.16-1.27],'-,Breast cancer,breast carcinoma,GCST004988,2:217098337
rs4442975-<b>G</b>,1 x 10-95,(EA),0.5,1.1235955,'-,[1.11-1.15],'-,Breast cancer,breast carcinoma,GCST004988,2:217056046
rs7297051-<b>C</b>,3 x 10-60,,0.76,1.1235955,'-,[1.1-1.15],PTHLH,Breast cancer,breast carcinoma,GCST004988,12:28021884
rs10995201-<b>A</b>,2 x 10-51,(EA),0.84,1.1111112,'-,[1.09-1.14],ZNF365,Breast cancer,breast carcinoma,GCST004988,10:62540131
rs6828523-<b>C</b>,2 x 10-25,(EA),0.88,1.098901,'-,[1.08-1.14],ADAM29,Breast cancer,breast carcinoma,GCST004988,4:174925275
rs13365225-<b>A</b>,1 x 10-20,(EA),0.82,1.098901,'-,[1.08-1.12],"KCNU1, SMARCE1P4",Breast cancer,breast carcinoma,GCST004988,8:37000965
rs676256-<b>T</b>,4 x 10-53,(EA),0.62,1.098901,'-,[1.08-1.11],CHCHD4P2,Breast cancer,breast carcinoma,GCST004988,9:108133073
rs4849887-<b>C</b>,7 x 10-20,(EA),0.9,1.098901,'-,[1.06-1.14],LINC01101,Breast cancer,breast carcinoma,GCST004988,2:120487546
rs999737-<b>C</b>,7 x 10-39,(EA),0.77,1.098901,'-,[1.08-1.12],RAD51B,Breast cancer,breast carcinoma,GCST004988,14:68567965
rs17356907-<b>A</b>,1 x 10-39,(EA),0.7,1.098901,'-,[1.08-1.11],PGAM1P5,Breast cancer,breast carcinoma,GCST004988,12:95633983
rs6796502-<b>G</b>,6 x 10-15,(EA),0.9,1.0869565,'-,[1.05-1.12],"PRSS44P, PRSS42P",Breast cancer,breast carcinoma,GCST004988,3:46825376
rs1292011-<b>A</b>,4 x 10-39,,0.58,1.0869565,'-,[1.06-1.11],'-,Breast cancer,breast carcinoma,GCST004988,12:115398717
rs6507583-<b>A</b>,2 x 10-12,(EA),0.93,1.0869565,'-,[1.04-1.12],SETBP1,Breast cancer,breast carcinoma,GCST004988,18:44819625
rs3215401-<b>A</b>,1 x 10-20,(EA),0.69,1.0752687,'-,[1.05-1.1],"TERT, MIR4457",Breast cancer,breast carcinoma,GCST004988,5:1296141
rs2236007-<b>G</b>,4 x 10-21,(EA),0.79,1.0752687,'-,[1.05-1.1],PAX9,Breast cancer,breast carcinoma,GCST004988,14:36663564
rs141061110-<b>C</b>,5 x 10-6,(EA),0.1578,'-,0.0408 unit decrease,[0.023-0.058],"FOXN3-AS1, FOXN3",Breast cancer,breast carcinoma,GCST004988,14:89418757
rs141447235-<b>C</b>,2 x 10-9,(EA),0.064,'-,0.0772 unit increase,[0.052-0.102],Y_RNA,Breast cancer,breast carcinoma,GCST004988,22:41061455
rs1415174-<b>C</b>,6 x 10-6,(EA),0.7544,'-,0.0328 unit decrease,[0.018-0.047],"RNA5SP52, LINC01364",Breast cancer,breast carcinoma,GCST004988,1:87384812
rs141634179-<b>C</b>,6 x 10-6,(EA),0.0235,'-,0.1019 unit decrease,[0.058-0.146],"SATB1, TBC1D5",Breast cancer,breast carcinoma,GCST004988,3:18422242
rs142253798-<b>T</b>,8 x 10-6,(EA),0.0175,'-,0.1218 unit decrease,[0.068-0.175],FOXL2NB,Breast cancer,breast carcinoma,GCST004988,3:138949667
chr12:29140260-<b>A</b>,8 x 10-12,,0.91,1.0752687,'-,[1.05-1.1],'-,Breast cancer,breast carcinoma,GCST010098,Mapping not available
rs150157076-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,NOTCH2,Breast cancer,breast carcinoma,GCST010098,1:120044057
rs11749176-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,RNU6-381P,Breast cancer,breast carcinoma,GCST010098,5:44145829
rs34052812-<b>A</b>,3 x 10-8,,0.67,1.0416667,'-,[1.02-1.05],"LEKR1, LINC00886",Breast cancer,breast carcinoma,GCST010098,3:156818170
rs7760611-<b>C</b>,2 x 10-9,,0.53,1.0416667,'-,[1.02-1.05],CASC15,Breast cancer,breast carcinoma,GCST010098,6:21903302
rs138044103-<b>?</b>,2 x 10-9,(mixed effect),NR,'-,'-,'-,RNU6-1232P,Invasive breast cancer,breast carcinoma,GCST010099,5:68128294
rs7924772-<b>?</b>,4 x 10-8,(fixed effect),NR,'-,'-,'-,ARHGEF12,Invasive breast cancer,breast carcinoma,GCST010099,11:120362917
rs78378222-<b>?</b>,2 x 10-9,(mixed effect),NR,'-,'-,'-,TP53,Invasive breast cancer,breast carcinoma,GCST010099,17:7668434
rs206435-<b>?</b>,2 x 10-7,(mixed effect),NR,'-,'-,'-,LINC01254,Invasive breast cancer,breast carcinoma,GCST010099,18:10354652
rs1375631-<b>G</b>,7 x 10-9,,0.5,1.0309278,'-,[1.02-1.05],"CDYLP1, PLCL2",Breast cancer,breast carcinoma,GCST010098,3:16737360
rs6065254-<b>?</b>,2 x 10-9,(mixed effect),NR,'-,'-,'-,MAFB,Invasive breast cancer,breast carcinoma,GCST010099,20:40619625
rs142890050-<b>C</b>,4 x 10-8,,0.54,1.0309278,'-,[1.02-1.05],"SINHCAFP3, RNU4-71P",Breast cancer,breast carcinoma,GCST010098,8:23622741
rs7760611-<b>?</b>,2 x 10-9,(mixed effect),NR,'-,'-,'-,CASC15,Invasive breast cancer,breast carcinoma,GCST010099,6:21903302
rs4742903-<b>C</b>,3 x 10-8,,0.56,1.0309278,'-,[1.02-1.04],SMC2,Breast cancer,breast carcinoma,GCST010098,9:104094512
chr12:29140260-<b>?</b>,4 x 10-9,(mixed effect),NR,'-,'-,'-,'-,Invasive breast cancer,breast carcinoma,GCST010099,Mapping not available
rs9712235-<b>G</b>,5 x 10-8,,0.26,1.04,'-,[1.02-1.05],LINC02831,Breast cancer,breast carcinoma,GCST010098,2:67654625
rs12962334-<b>?</b>,4 x 10-8,(mixed effect),NR,'-,'-,'-,RBBP8,Invasive breast cancer,breast carcinoma,GCST010099,18:22897971
rs1061657-<b>C</b>,3 x 10-10,,0.26,1.04,'-,[1.03-1.06],TBX3,Breast cancer,breast carcinoma,GCST010098,12:114670331
rs13039563-<b>?</b>,1 x 10-9,(mixed effect),NR,'-,'-,'-,RNU7-14P,Invasive breast cancer,breast carcinoma,GCST010099,20:53680310
rs13039563-<b>A</b>,3 x 10-9,,0.24,1.04,'-,[1.03-1.06],RNU7-14P,Breast cancer,breast carcinoma,GCST010098,20:53680310
rs188092014-<b>C</b>,2 x 10-8,,0.19,1.05,'-,[1.03-1.07],"CASTOR2, SPDYE12P",Breast cancer,breast carcinoma,GCST010098,7:74926919
rs13256025-<b>T</b>,1 x 10-8,,0.2,1.05,'-,[1.03-1.06],EBF2,Breast cancer,breast carcinoma,GCST010098,8:25974262
rs9808759-<b>T</b>,6 x 10-9,,0.07,1.07,'-,[1.05-1.09],PCNT,Breast cancer,breast carcinoma,GCST010098,21:46360308
rs6860806-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,SLC22A4,Breast cancer,breast carcinoma,GCST010098,5:132304843
rs141930488-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"LINC02118, KATNBL1P4",Breast cancer,breast carcinoma,GCST010098,5:51952440
rs11264454-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"SEMA4A, SLC25A44",Breast cancer,breast carcinoma,GCST010098,1:156183252
chr5:45333860-<b>?</b>,4 x 10-21,,NR,'-,'-,'-,'-,Breast cancer,breast carcinoma,GCST010098,Mapping not available
rs5776993-<b>C</b>,3 x 10-8,,0.88,1.0526316,'-,[1.04-1.09],GSTM2,Breast cancer,breast carcinoma,GCST010098,1:109680280
rs12765365-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,RNU6-543P,Breast cancer,breast carcinoma,GCST010098,10:63089177
chr1:145126177-<b>?</b>,1 x 10-8,(mixed effect),NR,'-,'-,'-,'-,Invasive breast cancer,breast carcinoma,GCST010099,Mapping not available
rs495367-<b>?</b>,2 x 10-8,(mixed effect),NR,'-,'-,'-,NELFA,Invasive breast cancer,breast carcinoma,GCST010099,4:1985245
rs79518236-<b>ACT</b>,7 x 10-9,,0.77,1.0416667,'-,[1.03-1.05],BAIAP2L1,Breast cancer,breast carcinoma,GCST010098,7:98397243
rs11065822-<b>G</b>,6 x 10-9,,0.63,1.0416667,'-,[1.02-1.05],CUX2,Breast cancer,breast carcinoma,GCST010098,12:111162330
rs11652463-<b>C</b>,4 x 10-8,,0.69,1.0416667,'-,[1.03-1.05],LINC00511,Breast cancer,breast carcinoma,GCST010098,17:72408954
rs17743054-<b>T</b>,2 x 10-10,,0.72,1.0416667,'-,[1.03-1.05],SLC14A2,Breast cancer,breast carcinoma,GCST010098,18:45320927
rs141526427-<b>?</b>,3 x 10-8,(mixed effect),NR,'-,'-,'-,PGAM3P,Invasive breast cancer,breast carcinoma,GCST010099,20:11521971
rs2886671-<b>C</b>,4 x 10-8,,0.57,1.0309278,'-,[1.02-1.05],'-,Breast cancer,breast carcinoma,GCST010098,3:59388019
rs9712235-<b>?</b>,2 x 10-7,(mixed effect),NR,'-,'-,'-,LINC02831,Invasive breast cancer,breast carcinoma,GCST010099,2:67654625
rs13277568-<b>A</b>,2 x 10-8,,0.63,1.0309278,'-,[1.02-1.05],TRPS1,Breast cancer,breast carcinoma,GCST010098,8:115667320
rs79518236-<b>?</b>,2 x 10-8,(mixed effect),NR,'-,'-,'-,BAIAP2L1,Invasive breast cancer,breast carcinoma,GCST010099,7:98397243
rs10838267-<b>A</b>,5 x 10-8,,0.55,1.0309278,'-,[1.02-1.04],ALX4,Breast cancer,breast carcinoma,GCST010098,11:44347342
rs1061657-<b>?</b>,6 x 10-9,(mixed effect),NR,'-,'-,'-,TBX3,Invasive breast cancer,breast carcinoma,GCST010099,12:114670331
rs4602255-<b>A</b>,2 x 10-9,,0.45,1.04,'-,[1.02-1.05],ANTXR1,Breast cancer,breast carcinoma,GCST010098,2:69164996
rs17743054-<b>?</b>,2 x 10-8,(mixed effect),NR,'-,'-,'-,SLC14A2,Invasive breast cancer,breast carcinoma,GCST010099,18:45320927
rs12962334-<b>G</b>,4 x 10-9,,0.32,1.04,'-,[1.03-1.05],RBBP8,Breast cancer,breast carcinoma,GCST010098,18:22897971
rs6697258-<b>?</b>,2 x 10-15,(mixed effect),NR,'-,'-,'-,NOTCH2,Invasive breast cancer,breast carcinoma,GCST010099,1:119942712
rs6677545-<b>?</b>,4 x 10-8,(mixed effect),NR,'-,'-,'-,LINC00862,Invasive breast cancer,breast carcinoma,GCST010099,1:200372918
rs56826596-<b>?</b>,8 x 10-12,(mixed effect),NR,'-,'-,'-,HCN1,Invasive breast cancer,breast carcinoma,GCST010099,5:45374788
rs139331653-<b>?</b>,2 x 10-9,(mixed effect),NR,'-,'-,'-,'-,Invasive breast cancer,breast carcinoma,GCST010099,5:45939192
rs34044188-<b>?</b>,9 x 10-9,(mixed effect),NR,'-,'-,'-,JMJD1C,Invasive breast cancer,breast carcinoma,GCST010099,10:63497603
rs16988381-<b>?</b>,3 x 10-9,(mixed effect),NR,'-,'-,'-,"HORMAD2, LIF-AS1",Invasive breast cancer,breast carcinoma,GCST010099,22:30196819
rs200648189-<b>CT</b>,1 x 10-8,,0.81,1.0638298,'-,[1.03-1.1],NCOA1,Breast cancer,breast carcinoma,GCST005077,2:24516826
rs322144-<b>C</b>,7 x 10-9,,0.53,1.0526316,'-,[1.03-1.08],TSPAN16,Breast cancer,breast carcinoma,GCST005077,19:11313027
rs113701136-<b>T</b>,7 x 10-9,,0.32,1.07,'-,[1.04-1.09],"CCNE1, C19orf12",Breast cancer,breast carcinoma,GCST005077,19:29786822
rs17350191-<b>T</b>,2 x 10-11,,0.34,1.07,'-,[1.04-1.09],"ANXA13, FAM91A1",Breast cancer,breast carcinoma,GCST005077,8:123745421
rs66823261-<b>C</b>,3 x 10-8,,0.23,1.09,'-,[1.06-1.12],RPL23AP53,Breast cancer,breast carcinoma,GCST005077,8:220692
rs74911261-<b>G</b>,5 x 10-11,,0.98,1.22,'-,[1.12-1.33],POGLUT3,Breast cancer,breast carcinoma,GCST005077,11:108486410
rs74911261-<b>G</b>,2 x 10-6,,0.98,1.3513513,'-,[1.19-1.54],POGLUT3,Breast Cancer in BRCA1 mutation carriers,"carrier status, breast carcinoma",GCST005075,11:108486410
rs200648189-<b>CT</b>,3 x 10-7,,0.8,1.1363636,'-,[1.09-1.19],NCOA1,Breast Cancer in BRCA1 mutation carriers,"carrier status, breast carcinoma",GCST005075,2:24516826
rs7297051-<b>C</b>,8 x 10-9,,0.76,1.1363636,'-,[1.09-1.18],PTHLH,Breast Cancer in BRCA1 mutation carriers,"carrier status, breast carcinoma",GCST005075,12:28021884
rs6562760-<b>G</b>,4 x 10-7,,0.76,1.1235955,'-,[1.08-1.16],MARK2P12,Breast Cancer in BRCA1 mutation carriers,"carrier status, breast carcinoma",GCST005075,13:73383544
rs3215401-<b>A</b>,3 x 10-7,,0.69,1.1111112,'-,[1.06-1.15],"TERT, MIR4457",Breast Cancer in BRCA1 mutation carriers,"carrier status, breast carcinoma",GCST005075,5:1296141
rs11374964-<b>G</b>,1 x 10-6,,0.57,1.098901,'-,[1.05-1.14],POGLUT3,Breast Cancer in BRCA1 mutation carriers,"carrier status, breast carcinoma",GCST005075,11:108474789
rs3757322-<b>G</b>,3 x 10-12,,0.32,1.14,'-,[1.10-1.19],CCDC170,Breast Cancer in BRCA1 mutation carriers,"carrier status, breast carcinoma",GCST005075,6:151621059
rs67397200-<b>G</b>,3 x 10-17,,0.32,1.18,'-,[1.14-1.23],"ABHD8, ANKLE1",Breast Cancer in BRCA1 mutation carriers,"carrier status, breast carcinoma",GCST005075,19:17290595
rs10069690-<b>T</b>,4 x 10-16,,0.26,1.18,'-,[1.14-1.23],TERT,Breast Cancer in BRCA1 mutation carriers,"carrier status, breast carcinoma",GCST005075,5:1279675
rs9397437-<b>A</b>,6 x 10-8,,0.07,1.2,'-,[1.12-1.28],"CCDC170, ESR1",Breast Cancer in BRCA1 mutation carriers,"carrier status, breast carcinoma",GCST005075,6:151631197
rs11076805-<b>C</b>,1 x 10-8,,0.75,1.0869565,'-,[1.05-1.11],ADCY9,Breast cancer,breast carcinoma,GCST005077,16:4056787
rs6569648-<b>T</b>,8 x 10-10,,0.77,1.0752687,'-,[1.05-1.11],L3MBTL3,Breast cancer,breast carcinoma,GCST005077,6:130027974
rs11374964-<b>G</b>,4 x 10-13,,0.58,1.0638298,'-,[1.04-1.09],POGLUT3,Breast cancer,breast carcinoma,GCST005077,11:108474789
rs36194942-<b>A</b>,1 x 10-8,,0.7,1.0638298,'-,[1.04-1.1],'-,Breast cancer,breast carcinoma,GCST005077,18:27821241
rs56261590-<b>A</b>,2 x 10-6,,0.323082228,'-,0.22040759 unit decrease,[0.13-0.31],ANKRD17,Menstruation quality of life impact (pressure in breast),"quality of life during menstruation measurement, breast pressure measurement",GCST006650,4:73189781
rs11099757-<b>T</b>,7 x 10-6,,0.298158338,'-,0.19953223 unit increase,[0.11-0.29],DCLK2,Menstruation quality of life impact (pressure in breast),"quality of life during menstruation measurement, breast pressure measurement",GCST006650,4:150143216
rs16871509-<b>A</b>,2 x 10-6,,0.119707494,'-,0.28391933 unit increase,[0.17-0.4],CARTPT,Menstruation quality of life impact (pressure in breast),"quality of life during menstruation measurement, breast pressure measurement",GCST006650,5:71726395
rs4725504-<b>G</b>,9 x 10-6,,0.550647176,'-,0.18980134 unit increase,[0.11-0.27],'-,Menstruation quality of life impact (pressure in breast),"quality of life during menstruation measurement, breast pressure measurement",GCST006650,7:153608338
rs10110651-<b>?</b>,7 x 10-31,,NR,'-,0.177 unit increase,[0.147-0.207],KCNU1,Breast size,breast size,GCST003985,8:36989597
rs17625845-<b>?</b>,6 x 10-18,,NR,'-,0.14 unit decrease,[0.171-0.108],"INHBB, RALB",Breast size,breast size,GCST003985,2:120332155
rs3081227-<b>?</b>,3 x 10-15,,NR,'-,0.103 unit decrease,[0.129-0.078],ZNF365,Breast size,breast size,GCST003985,10:62418899
rs7102705-<b>?</b>,1 x 10-9,,NR,'-,0.089 unit decrease,[0.118-0.061],MYEOV,Breast size,breast size,GCST003985,11:69328516
rs2359714-<b>?</b>,4 x 10-9,,NR,'-,0.071 unit increase,[0.047-0.095],"SPAG17, RNA5SP56",Breast size,breast size,GCST003985,1:118227648
rs62105303-<b>?</b>,3 x 10-8,,NR,'-,0.086 unit decrease,[0.117-0.056],"TMEM18, LINC01875",Breast size,breast size,GCST003985,2:632922
rs34091558-<b>?</b>,3 x 10-8,,NR,'-,0.072 unit decrease,[0.098-0.047],LMOD1,Breast size,breast size,GCST003985,1:201917642
rs2645288-<b>?</b>,1 x 10-7,,NR,'-,0.077 unit decrease,[0.105-0.049],TBX15,Breast size,breast size,GCST003985,1:118957860
rs6427508-<b>?</b>,1 x 10-7,,NR,'-,0.067 unit decrease,[0.092-0.042],"RPSAP18, PEX19",Breast size,breast size,GCST003985,1:160269067
rs3205718-<b>?</b>,1 x 10-7,,NR,'-,0.067 unit increase,[0.042-0.092],FAIM2,Breast size,breast size,GCST003985,12:49868026
rs5752793-<b>?</b>,7 x 10-7,,NR,'-,0.065 unit increase,[0.039-0.090],"CCDC117, HSCB",Breast size,breast size,GCST003985,22:28764326
rs200550907-<b>?</b>,8 x 10-7,,NR,'-,0.077 unit decrease,[0.107-0.046],"MARK1, LINC02779",Breast size,breast size,GCST003985,1:220527824
rs17356907-<b>?</b>,1 x 10-13,,NR,'-,0.097 unit increase,[0.071-0.123],PGAM1P5,Breast size,breast size,GCST003985,12:95633983
rs7659874-<b>?</b>,9 x 10-13,,NR,'-,0.105 unit decrease,[0.134-0.076],'-,Breast size,breast size,GCST003985,4:74621799
rs1838564-<b>?</b>,1 x 10-12,,NR,'-,0.136 unit increase,[0.099-0.174],PTHLH,Breast size,breast size,GCST003985,12:28001962
rs5995875-<b>?</b>,3 x 10-12,,NR,'-,0.137 unit decrease,[0.176-0.099],MRTFA,Breast size,breast size,GCST003985,22:40564688
rs9397437-<b>?</b>,1 x 10-11,,NR,'-,0.158 unit decrease,[0.204-0.112],"CCDC170, ESR1",Breast size,breast size,GCST003985,6:151631197
rs148713408-<b>?</b>,2 x 10-7,,NR,'-,0.339 unit increase,[0.212-0.466],VPS13C,Breast size,breast size,GCST003985,15:61928573
rs616402-<b>?</b>,2 x 10-7,,NR,'-,0.067 unit decrease,[0.093-0.042],PEX14,Breast size,breast size,GCST003985,1:10506215
rs62033406-<b>?</b>,4 x 10-7,,NR,'-,0.062 unit increase,[0.038-0.087],FTO,Breast size,breast size,GCST003985,16:53790314
rs28929474-<b>?</b>,5 x 10-7,,NR,'-,0.215 unit decrease,[0.299-0.131],'-,Breast size,breast size,GCST003985,Mapping not available
rs113198678-<b>?</b>,1 x 10-6,,NR,'-,0.12 unit decrease,[0.169-0.072],RBPMS-AS1,Breast size,breast size,GCST003985,8:30384102
rs580384-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,CADPS,Breast size,breast size,GCST003985,3:62747691
rs10771431-<b>A</b>,2 x 10-6,,0.444,'-,0.073 cup size decrease,[0.042-0.104],"A2MP1, PZP",Breast size,breast size,GCST001585,12:9228263
rs12371778-<b>G</b>,1 x 10-8,,0.091,'-,0.162 cup size decrease,[0.11-0.22],PTHLH,Breast size,breast size,GCST001585,12:28003148
rs7816345-<b>T</b>,2 x 10-14,,0.194,'-,0.151 cup size decrease,[0.11-0.19],KCNU1,Breast size,breast size,GCST001585,8:36988591
chr22:45895495-<b>T</b>,7 x 10-6,,0.199,'-,0.115 cup size increase,[0.064-0.166],'-,Breast size,breast size,GCST001585,Mapping not available
chr6:50202617-<b>A</b>,5 x 10-6,,0.053,'-,0.174 cup size decrease,[0.100-0.248],'-,Breast size,breast size,GCST001585,Mapping not available
rs780093-<b>T</b>,5 x 10-6,,0.416,'-,0.072 cup size increase,[0.041-0.103],GCKR,Breast size,breast size,GCST001585,2:27519736
rs34479159-<b>C</b>,6 x 10-6,,0.19,'-,0.089 cup size increase,[0.050-0.128],OSBPL6,Breast size,breast size,GCST001585,2:178239571
chr3:116704634-<b>A</b>,8 x 10-6,,0.054,'-,0.165 cup size decrease,[0.092-0.238],'-,Breast size,breast size,GCST001585,Mapping not available
rs6549915-<b>T</b>,9 x 10-6,,0.444,'-,0.078 cup size decrease,[0.043-0.113],"RBMS3-AS3, RBMS3",Breast size,breast size,GCST001585,3:29167660
rs1529102-<b>A</b>,6 x 10-6,,0.495,'-,0.07 cup size increase,[0.041-0.099],"LINC00309, MIR4433B",Breast size,breast size,GCST001585,2:64268493
rs2716816-<b>C</b>,7 x 10-6,,0.149,'-,0.098 cup size increase,[0.055-0.141],'-,Breast size,breast size,GCST001585,4:179462158
rs10488023-<b>G</b>,8 x 10-6,,0.142,'-,0.099 cup size increase,[0.056-0.142],ELMO1,Breast size,breast size,GCST001585,7:36912416
rs7104745-<b>G</b>,6 x 10-6,,0.458,'-,0.07 cup size increase,[0.039-0.101],CDON,Breast size,breast size,GCST001585,11:126003207
rs34065801-<b>C</b>,6 x 10-6,,0.176,'-,0.096 cup size increase,[0.055-0.137],DCLK1,Breast size,breast size,GCST001585,13:35957411
rs12585963-<b>A</b>,2 x 10-6,,0.312,'-,0.08 cup size increase,[0.047-0.113],'-,Breast size,breast size,GCST001585,13:59379332
rs58263042-<b>C</b>,9 x 10-6,,0.061,'-,0.165 cup size decrease,[0.092-0.238],GAREM1,Breast size,breast size,GCST001585,18:32399612
rs11919041-<b>T</b>,2 x 10-6,,0.287,'-,0.082 cup size decrease,[0.049-0.115],FHIT,Breast size,breast size,GCST001585,3:60777523
rs17356907-<b>G</b>,1 x 10-6,,0.296,'-,0.081 cup size increase,[0.048-0.114],PGAM1P5,Breast size,breast size,GCST001585,12:95633983
rs4849887-<b>T</b>,3 x 10-11,,0.113,'-,0.166 cup size increase,[0.12-0.22],LINC01101,Breast size,breast size,GCST001585,2:120487546
chr3:130947635-<b>A</b>,5 x 10-7,,0.001,'-,2.299 cup size increase,[1.41-3.19],'-,Breast size,breast size,GCST001585,Mapping not available
rs7837045-<b>A</b>,5 x 10-6,,0.22,'-,0.092 cup size decrease,[0.053-0.131],MROH5,Breast size,breast size,GCST001585,8:141530825
rs12173570-<b>T</b>,6 x 10-11,,0.101,'-,0.171 cup size increase,[0.12-0.22],"CCDC170, ESR1",Breast size,breast size,GCST001585,6:151636579
rs17625845-<b>C</b>,5 x 10-10,,0.205,'-,0.125 cup size increase,[.086-.164],"INHBB, RALB",Breast size,breast size,GCST001585,2:120332155
rs4820792-<b>T</b>,4 x 10-7,,0.18,'-,0.105 cup size increase,[0.065-.146],"HSCB, CCDC117",Breast size,breast size,GCST001585,22:28765019
rs61159171-<b>T</b>,6 x 10-6,,0.348,'-,0.075 cup size decrease,[0.042-0.108],DOCK4,Breast size,breast size,GCST001585,7:112002591
rs4665972-<b>T</b>,1 x 10-6,,0.448,'-,0.08 cup size increase,[0.047-0.113],'-,Breast size,breast size,GCST001585,Mapping not available
chr22:40779964-<b>A</b>,5 x 10-7,,0.056,'-,0.187 cup size decrease,[0.11-0.26],'-,Breast size,breast size,GCST001585,Mapping not available
rs580384-<b>C</b>,4 x 10-6,,0.089,'-,0.124 cup size decrease,[0.071-0.177],CADPS,Breast size,breast size,GCST001585,3:62747691
chr6:67596834-<b>A</b>,7 x 10-6,,0.002,'-,1.008 cup size increase,[0.57-1.45],'-,Breast size,breast size,GCST001585,Mapping not available
rs13401620-<b>A</b>,2 x 10-6,,0.224,'-,0.095 cup size decrease,[0.056-0.134],"PTPN4, RPL17P15",Breast size,breast size,GCST001585,2:119755557
rs7089814-<b>C</b>,3 x 10-9,,0.375,'-,0.096 cup size increase,[0.065-0.127],ZNF365,Breast size,breast size,GCST001585,10:62427805
rs7102705-<b>A</b>,5 x 10-6,,0.211,'-,0.086 cup size increase,[0.049-0.123],MYEOV,Breast size,breast size,GCST001585,11:69328516
rs62314947-<b>T</b>,5 x 10-8,,0.281,'-,0.101 cup size decrease,[0.064-0.138],'-,Breast size,breast size,GCST001585,4:74577305
rs10466033-<b>G</b>,6 x 10-6,,0.008,'-,0.437 cup size increase,[0.25-0.63],KAT6B,Breast size,breast size,GCST001585,10:74943248
rs9523848-<b>T</b>,3 x 10-6,,0.293,'-,0.081 cup size decrease,[0.048-0.114],GPC5,Breast size,breast size,GCST001585,13:92929538
rs61280460-<b>T</b>,8 x 10-7,,0.199,'-,0.095 cup size decrease,[0.058-0.132],"SERPINA6, SERPINA2",Breast size,breast size,GCST001585,14:94329847
chr4:187239569-<b>T</b>,6 x 10-6,,0.013,'-,0.406 cup size increase,[0.23-0.58],'-,Breast size,breast size,GCST001585,Mapping not available
rs2819348-<b>C</b>,3 x 10-6,,0.318,'-,0.078 cup size increase,[0.045-0.111],LMOD1,Breast size,breast size,GCST001585,1:201915824
rs10483205-<b>T</b>,2 x 10-7,,0.290889975,'-,0.1527 unit decrease,[0.095-0.21],MRTFA,Breast size,breast size,GCST006655,22:40487595
rs17002036-<b>A</b>,2 x 10-7,,0.288654611,'-,0.1546 unit decrease,[0.097-0.212],MRTFA,Breast size,breast size,GCST006655,22:40601107
rs299109-<b>A</b>,7 x 10-6,,0.245177164,'-,0.1386 unit increase,[0.078-0.199],LINC00499,Breast size,breast size,GCST006655,4:138508889
rs6557160-<b>C</b>,2 x 10-16,,0.251,'-,0.2542 unit increase,[0.19-0.31],"CCDC170, ESR1",Breast size,breast size,GCST006655,6:151628447
rs11446767-<b>AT</b>,5 x 10-8,,0.458,'-,0.1481 unit increase,[0.095-0.201],ESR1,Breast size,breast size,GCST006655,6:151754327
rs10096213-<b>T</b>,6 x 10-9,,0.3805,'-,0.1581 unit decrease,[0.1-0.21],"KCNU1, SMARCE1P4",Breast size,breast size,GCST006655,8:36995695
rs985648-<b>G</b>,8 x 10-6,,0.247866273,'-,0.1384 unit increase,[0.078-0.199],"CARM1P1, LINC01231",Breast size,breast size,GCST006655,9:3128422
rs9397437-<b>?</b>,2 x 10-14,,0.332,'-,'-,'-,"CCDC170, ESR1",Breast size,breast size,GCST006655,6:151631197
rs10110651-<b>?</b>,1 x 10-8,,0.311,'-,'-,'-,KCNU1,Breast size,breast size,GCST006655,8:36989597
rs17001868-<b>?</b>,7 x 10-7,,0.245,'-,'-,'-,"SGSM3, ADSL, SGSM3-AS1",Breast size,breast size,GCST006655,22:40382227
rs146992477-<b>TTCTTTCTTTC</b>,6 x 10-9,,0.381,'-,0.158 unit decrease,[0.11-0.21],KCNU1,Breast size,breast size,GCST006655,8:36984538
rs145023077-<b>?</b>,7 x 10-8,,'-,1.06,'-,[1.04-1.09],HLA-G,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:29829266
rs142979264-<b>?</b>,6 x 10-8,,'-,1.06,'-,[1.04-1.09],RNF39,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:30075223
rs78868683-<b>?</b>,3 x 10-7,,'-,1.05,'-,[1.03-1.08],LINC00243,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:30830500
rs2530710-<b>?</b>,4 x 10-7,,'-,1.0416667,'-,[1.03-1.06],"MUC21, NAPGP2",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:30972610
rs117759870-<b>?</b>,6 x 10-8,,'-,1.06,'-,[1.04-1.09],"HCG27, HLA-C",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:31245753
rs28752857-<b>?</b>,5 x 10-8,,'-,1.06,'-,[1.04-1.08],"LINC02571, HLA-B",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:31330644
rs28399987-<b>?</b>,7 x 10-8,,'-,1.06,'-,[1.04-1.09],MSH5-SAPCD1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:31762974
rs75393409-<b>?</b>,2 x 10-7,,'-,1.06,'-,[1.04-1.09],STK19,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:31972441
rs57079996-<b>?</b>,1 x 10-7,,'-,1.06,'-,[1.04-1.09],TNXB,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:32093562
rs380911-<b>?</b>,9 x 10-6,,'-,1.04,'-,[1.02-1.06],"TSBP1-AS1, NOTCH4",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:32241674
rs36022506-<b>?</b>,2 x 10-6,,'-,1.06,'-,[1.03-1.08],"HLA-DRB1, HLA-DQA1",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:32609610
rs113721192-<b>?</b>,1 x 10-6,,'-,1.06,'-,[1.03-1.08],"HLA-DQB3, MTCO3P1",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:32714813
rs117231810-<b>?</b>,4 x 10-6,,'-,1.06,'-,[1.03-1.08],"HLA-Z, HLA-DMB",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:32920459
rs910320-<b>?</b>,8 x 10-8,,'-,1.05,'-,[1.03-1.07],"HLA-DPB2, COL11A2P1",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:33107666
rs9375182-<b>?</b>,3 x 10-6,,'-,1.0309278,'-,[1.02-1.05],"RN7SL564P, FABP7",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:122773922
rs10272208-<b>?</b>,5 x 10-7,,'-,1.0309278,'-,[1.02-1.05],ATXN7L1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,7:105691372
rs147175877-<b>?</b>,6 x 10-6,,'-,1.1,'-,[1.05-1.14],EXOC4,Cervical cancer (MTAG),cervical carcinoma,GCST009825,7:133504366
rs149996974-<b>?</b>,3 x 10-6,,'-,1.14,'-,[1.08-1.21],"EXOC4, RPS3AP27",Cervical cancer (MTAG),cervical carcinoma,GCST009825,7:133732785
rs2090064-<b>?</b>,3 x 10-7,,'-,1.0416667,'-,[1.02-1.05],"MIR124-1HG, TNKS",Cervical cancer (MTAG),cervical carcinoma,GCST009825,8:9854826
rs4077818-<b>?</b>,2 x 10-6,,'-,1.04,'-,[1.02-1.06],"SDR16C5, CHCHD7",Cervical cancer (MTAG),cervical carcinoma,GCST009825,8:56298047
rs17784899-<b>?</b>,5 x 10-7,,'-,1.05,'-,[1.03-1.07],"PRUNE2, PCA3",Cervical cancer (MTAG),cervical carcinoma,GCST009825,9:76775287
rs140330106-<b>?</b>,8 x 10-6,,'-,1.1,'-,[1.06-1.15],PTBP3,Cervical cancer (MTAG),cervical carcinoma,GCST009825,9:112272205
rs147380957-<b>?</b>,7 x 10-6,,'-,1.07,'-,[1.04-1.10],TRDMT1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,10:17199011
rs150806792-<b>?</b>,8 x 10-8,,'-,1.19,'-,[1.12-1.26],INS-IGF2,Cervical cancer (MTAG),cervical carcinoma,GCST009825,11:2158112
rs377042484-<b>?</b>,3 x 10-6,,'-,1.12,'-,[1.07-1.17],TMTC1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,12:29599423
rs75874947-<b>?</b>,1 x 10-7,,'-,2.84,'-,[1.93-4.19],"NPBWR2, MYT1",Cervical cancer,cervical carcinoma,GCST009826,20:64106159
rs140668832-<b>?</b>,2 x 10-9,,'-,1.07,'-,[1.05-1.09],"LINC02569, HLA-E",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:30512137
rs117670375-<b>?</b>,2 x 10-9,,'-,1.07,'-,[1.05-1.09],TUBB,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:30719695
rs150806792-<b>?</b>,8 x 10-8,,'-,1.19,'-,[1.12-1.26],INS-IGF2,Cervical cancer (MTAG),cervical carcinoma,GCST009825,11:2158112
rs140991990-<b>?</b>,7 x 10-8,,'-,1.16,'-,[1.10-1.23],"SOX9-AS1, LINC02097",Cervical cancer (MTAG),cervical carcinoma,GCST009825,17:72101710
rs1885560-<b>?</b>,6 x 10-6,,'-,1.0526316,'-,[1.03-1.09],FCRL4,Cervical cancer (MTAG),cervical carcinoma,GCST009825,1:157596180
rs75068199-<b>?</b>,4 x 10-7,,'-,1.07,'-,[1.04-1.10],DDR2,Cervical cancer (MTAG),cervical carcinoma,GCST009825,1:162660256
rs76883373-<b>?</b>,5 x 10-6,,'-,1.07,'-,[1.04-1.10],"LINC01249, NPM1P48",Cervical cancer (MTAG),cervical carcinoma,GCST009825,2:4581682
rs62133116-<b>?</b>,2 x 10-6,,'-,1.05,'-,[1.03-1.07],NRXN1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,2:50256810
rs11684858-<b>?</b>,4 x 10-6,,'-,1.06,'-,[1.03-1.09],ALMS1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,2:73416499
rs190074712-<b>?</b>,2 x 10-6,,'-,1.17,'-,[1.10-1.25],"CYP2C56P, PRPS1P1",Cervical cancer (MTAG),cervical carcinoma,GCST009825,2:164262092
rs183319101-<b>?</b>,6 x 10-6,,'-,1.0309278,'-,[1.02-1.05],FSIP2,Cervical cancer (MTAG),cervical carcinoma,GCST009825,2:185844965
rs559021322-<b>?</b>,4 x 10-6,,'-,1.13,'-,[1.07-1.19],MIR5702,Cervical cancer (MTAG),cervical carcinoma,GCST009825,2:226586765
rs59692692-<b>?</b>,6 x 10-6,,'-,1.06,'-,[1.03-1.09],"HDAC11, FBLN2",Cervical cancer (MTAG),cervical carcinoma,GCST009825,3:13530464
chr3:59866982-<b>?</b>,3 x 10-6,,'-,1.16,'-,[1.09-1.24],'-,Cervical cancer (MTAG),cervical carcinoma,GCST009825,Mapping not available
rs117143670-<b>?</b>,7 x 10-6,,'-,1.13,'-,[1.07-1.20],"CLDN1, NMNAT1P3",Cervical cancer (MTAG),cervical carcinoma,GCST009825,3:190245452
rs556607390-<b>?</b>,3 x 10-6,,'-,1.1,'-,[1.05-1.14],ZFYVE28,Cervical cancer (MTAG),cervical carcinoma,GCST009825,4:2279800
rs146513397-<b>?</b>,1 x 10-6,,'-,1.16,'-,[1.09-1.23],CAMK2D,Cervical cancer (MTAG),cervical carcinoma,GCST009825,4:113726137
rs185348880-<b>?</b>,6 x 10-6,,'-,1.13,'-,[1.07-1.19],TTC29,Cervical cancer (MTAG),cervical carcinoma,GCST009825,4:146884350
rs74994185-<b>?</b>,6 x 10-6,,'-,1.06,'-,[1.04-1.09],ZSCAN16-AS1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:28031037
rs79476506-<b>?</b>,7 x 10-6,,'-,1.06,'-,[1.03-1.09],ZSCAN16-AS1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:28137256
rs213237-<b>?</b>,2 x 10-6,,'-,1.03,'-,[1.02-1.05],"ZKSCAN3, ZSCAN31",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:28356161
rs146362527-<b>?</b>,7 x 10-6,,'-,1.06,'-,[1.03-1.09],"OR2E1P, GPX6",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:28499293
rs138803712-<b>?</b>,8 x 10-6,,'-,1.06,'-,[1.03-1.09],"ZBED9, LINC00533",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:28639807
rs3129795-<b>?</b>,8 x 10-6,,'-,1.0526316,'-,[1.03-1.08],"ZNF311, OR2AD1P",Cervical cancer (MTAG),cervical carcinoma,GCST009825,6:29016978
rs147175877-<b>?</b>,3 x 10-6,,'-,2.66,'-,[1.77-4.02],EXOC4,Cervical cancer,cervical carcinoma,GCST009826,7:133504366
rs149996974-<b>?</b>,1 x 10-6,,'-,3.79,'-,[2.21-6.51],"EXOC4, RPS3AP27",Cervical cancer,cervical carcinoma,GCST009826,7:133732785
rs141588684-<b>?</b>,5 x 10-6,,'-,3.6,'-,[2.07-6.23],EXOC4,Cervical cancer,cervical carcinoma,GCST009826,7:133922241
rs2090064-<b>?</b>,5 x 10-7,,'-,1.4492754,'-,[1.25-1.67],"MIR124-1HG, TNKS",Cervical cancer,cervical carcinoma,GCST009826,8:9854826
rs75951998-<b>?</b>,1 x 10-6,,'-,1.86,'-,[1.45-2.38],"SDR16C5, CHCHD7",Cervical cancer,cervical carcinoma,GCST009826,8:56246637
rs58726170-<b>?</b>,7 x 10-6,,'-,2.01,'-,[1.48-2.72],"TOX, GML",Cervical cancer,cervical carcinoma,GCST009826,8:59197008
chr9:22422311-<b>?</b>,5 x 10-6,,'-,4.82,'-,[2.46-9.45],'-,Cervical cancer,cervical carcinoma,GCST009826,Mapping not available
rs17784899-<b>?</b>,6 x 10-7,,'-,1.5,'-,[1.28-1.76],"PRUNE2, PCA3",Cervical cancer,cervical carcinoma,GCST009826,9:76775287
rs147380957-<b>?</b>,4 x 10-6,,'-,1.86,'-,[1.43-2.42],TRDMT1,Cervical cancer,cervical carcinoma,GCST009826,10:17199011
rs150806792-<b>?</b>,5 x 10-8,,'-,4.96,'-,[2.79-8.83],INS-IGF2,Cervical cancer,cervical carcinoma,GCST009826,11:2158112
rs184467454-<b>?</b>,9 x 10-6,,'-,2.47,'-,[1.66-3.67],OR5B1P,Cervical cancer,cervical carcinoma,GCST009826,11:58366737
rs377042484-<b>?</b>,4 x 10-6,,'-,2.65,'-,[1.75-4.01],TMTC1,Cervical cancer,cervical carcinoma,GCST009826,12:29599423
rs142761815-<b>?</b>,2 x 10-6,,'-,2.73,'-,[1.81-4.12],TMEM233,Cervical cancer,cervical carcinoma,GCST009826,12:119604245
rs146343995-<b>?</b>,2 x 10-7,,'-,4.31,'-,[2.49-7.46],LINC00540,Cervical cancer,cervical carcinoma,GCST009826,13:22100187
rs141629209-<b>?</b>,9 x 10-8,,'-,4.67,'-,[2.65-8.22],"RPL35P9, LINC00460",Cervical cancer,cervical carcinoma,GCST009826,13:106422664
rs145233920-<b>?</b>,1 x 10-6,,'-,2.12,'-,[1.57-2.87],TTC5,Cervical cancer,cervical carcinoma,GCST009826,14:20259308
rs149049108-<b>?</b>,4 x 10-6,,'-,2.22,'-,[1.58-3.11],TEP1,Cervical cancer,cervical carcinoma,GCST009826,14:20368118
rs138523818-<b>?</b>,3 x 10-7,,'-,3.57,'-,[2.19-5.83],LRFN5,Cervical cancer,cervical carcinoma,GCST009826,14:41755191
rs41286572-<b>?</b>,4 x 10-6,,'-,2.19,'-,[1.57-3.06],"MIR496, MIR154",Cervical cancer,cervical carcinoma,GCST009826,14:101059844
rs72764914-<b>?</b>,2 x 10-7,,'-,1.87,'-,[1.47-2.37],RBFOX1,Cervical cancer,cervical carcinoma,GCST009826,16:6687493
rs140991990-<b>?</b>,3 x 10-8,,'-,4.94,'-,[2.80-8.71],"SOX9-AS1, LINC02097",Cervical cancer,cervical carcinoma,GCST009826,17:72101710
rs56182403-<b>?</b>,8 x 10-7,,'-,2.72,'-,[1.83-4.04],"RN7SL836P, GIPR",Cervical cancer,cervical carcinoma,GCST009826,19:45666590
rs75724373-<b>?</b>,5 x 10-6,,'-,1.45,'-,[1.24-1.70],"HAS1, FPR1",Cervical cancer,cervical carcinoma,GCST009826,19:51734303
rs201524967-<b>?</b>,2 x 10-6,,'-,3.71,'-,[2.17-6.36],RASSF2,Cervical cancer,cervical carcinoma,GCST009826,20:4817030
rs6513380-<b>?</b>,7 x 10-6,,'-,2.98,'-,[1.85-4.79],"VAPB, RAB22A",Cervical cancer,cervical carcinoma,GCST009826,20:58375898
rs142761815-<b>?</b>,4 x 10-6,,'-,1.1,'-,[1.06-1.14],TMEM233,Cervical cancer (MTAG),cervical carcinoma,GCST009825,12:119604245
rs146343995-<b>?</b>,5 x 10-7,,'-,1.16,'-,[1.09-1.23],LINC00540,Cervical cancer (MTAG),cervical carcinoma,GCST009825,13:22100187
rs141629209-<b>?</b>,4 x 10-7,,'-,1.17,'-,[1.10-1.25],"RPL35P9, LINC00460",Cervical cancer (MTAG),cervical carcinoma,GCST009825,13:106422664
rs145233920-<b>?</b>,2 x 10-6,,'-,1.08,'-,[1.05-1.11],TTC5,Cervical cancer (MTAG),cervical carcinoma,GCST009825,14:20259308
rs149049108-<b>?</b>,4 x 10-6,,'-,1.09,'-,[1.05-1.13],TEP1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,14:20368118
rs138523818-<b>?</b>,2 x 10-6,,'-,1.14,'-,[1.08-1.20],LRFN5,Cervical cancer (MTAG),cervical carcinoma,GCST009825,14:41755191
rs41286572-<b>?</b>,4 x 10-6,,'-,1.09,'-,[1.05-1.13],"MIR496, MIR154",Cervical cancer (MTAG),cervical carcinoma,GCST009825,14:101059844
rs72764914-<b>?</b>,3 x 10-7,,'-,1.07,'-,[1.04-1.10],RBFOX1,Cervical cancer (MTAG),cervical carcinoma,GCST009825,16:6687493
rs140991990-<b>?</b>,7 x 10-8,,'-,1.16,'-,[1.10-1.23],"SOX9-AS1, LINC02097",Cervical cancer (MTAG),cervical carcinoma,GCST009825,17:72101710
rs56182403-<b>?</b>,9 x 10-7,,'-,1.11,'-,[1.06-1.15],"RN7SL836P, GIPR",Cervical cancer (MTAG),cervical carcinoma,GCST009825,19:45666590
rs75724373-<b>?</b>,8 x 10-6,,'-,1.04,'-,[1.02-1.06],"HAS1, FPR1",Cervical cancer (MTAG),cervical carcinoma,GCST009825,19:51734303
rs201524967-<b>?</b>,3 x 10-6,,'-,1.14,'-,[1.08-1.20],RASSF2,Cervical cancer (MTAG),cervical carcinoma,GCST009825,20:4817030
rs75874947-<b>?</b>,2 x 10-7,,'-,1.12,'-,[1.07-1.17],"NPBWR2, MYT1",Cervical cancer (MTAG),cervical carcinoma,GCST009825,20:64106159
rs144335201-<b>?</b>,3 x 10-6,,'-,1.78,'-,[1.40-2.27],"H3C10, H2AC14",Cervical cancer,cervical carcinoma,GCST009826,6:27811880
rs79476506-<b>?</b>,1 x 10-6,,'-,1.79,'-,[1.41-2.26],ZSCAN16-AS1,Cervical cancer,cervical carcinoma,GCST009826,6:28137256
rs213237-<b>?</b>,7 x 10-7,,'-,1.36,'-,[1.21-1.54],"ZKSCAN3, ZSCAN31",Cervical cancer,cervical carcinoma,GCST009826,6:28356161
rs77011267-<b>?</b>,1 x 10-6,,'-,1.79,'-,[1.41-2.26],"OR2E1P, GPX6",Cervical cancer,cervical carcinoma,GCST009826,6:28467717
rs138803712-<b>?</b>,2 x 10-6,,'-,1.82,'-,[1.43-2.33],"ZBED9, LINC00533",Cervical cancer,cervical carcinoma,GCST009826,6:28639807
rs141456208-<b>?</b>,4 x 10-6,,'-,1.75,'-,[1.38-2.23],"NOP56P1, LINC01623",Cervical cancer,cervical carcinoma,GCST009826,6:28800350
rs3129795-<b>?</b>,2 x 10-6,,'-,1.6129031,'-,[1.32-1.96],"ZNF311, OR2AD1P",Cervical cancer,cervical carcinoma,GCST009826,6:29016978
rs149016863-<b>?</b>,3 x 10-6,,'-,1.74,'-,[1.38-2.20],"OR2G1P, OR2U1P",Cervical cancer,cervical carcinoma,GCST009826,6:29256134
rs9257927-<b>?</b>,1 x 10-8,,'-,1.66,'-,[1.39-1.97],"MOG, SUMO2P1",Cervical cancer,cervical carcinoma,GCST009826,6:29641918
rs145023077-<b>?</b>,8 x 10-9,,'-,1.83,'-,[1.49-2.25],HLA-G,Cervical cancer,cervical carcinoma,GCST009826,6:29829266
rs142979264-<b>?</b>,7 x 10-9,,'-,1.84,'-,[1.50-2.26],RNF39,Cervical cancer,cervical carcinoma,GCST009826,6:30075223
rs78868683-<b>?</b>,1 x 10-7,,'-,1.68,'-,[1.39-2.04],LINC00243,Cervical cancer,cervical carcinoma,GCST009826,6:30830500
rs2530710-<b>?</b>,1 x 10-7,,'-,1.5151515,'-,[1.3-1.75],"MUC21, NAPGP2",Cervical cancer,cervical carcinoma,GCST009826,6:30972610
rs28380833-<b>?</b>,8 x 10-9,,'-,1.8,'-,[1.47-2.20],"LINC02571, HLA-B",Cervical cancer,cervical carcinoma,GCST009826,6:31343518
rs138885312-<b>?</b>,2 x 10-8,,'-,1.8,'-,[1.47-2.20],"LTA, NFKBIL1",Cervical cancer,cervical carcinoma,GCST009826,6:31562896
rs143029752-<b>?</b>,3 x 10-8,,'-,1.78,'-,[1.45-2.19],VWA7,Cervical cancer,cervical carcinoma,GCST009826,6:31771721
rs75393409-<b>?</b>,4 x 10-8,,'-,1.78,'-,[1.45-2.18],STK19,Cervical cancer,cervical carcinoma,GCST009826,6:31972441
rs57079996-<b>?</b>,4 x 10-8,,'-,1.77,'-,[1.45-2.18],TNXB,Cervical cancer,cervical carcinoma,GCST009826,6:32093562
rs380911-<b>?</b>,3 x 10-6,,'-,1.51,'-,[1.27-1.80],"TSBP1-AS1, NOTCH4",Cervical cancer,cervical carcinoma,GCST009826,6:32241674
rs367607265-<b>?</b>,2 x 10-7,,'-,1.74,'-,[1.41-2.14],"HLA-DRB9, HLA-DRB5",Cervical cancer,cervical carcinoma,GCST009826,6:32482186
rs113721192-<b>?</b>,3 x 10-7,,'-,1.76,'-,[1.42-2.18],"HLA-DQB3, MTCO3P1",Cervical cancer,cervical carcinoma,GCST009826,6:32714813
rs117231810-<b>?</b>,1 x 10-6,,'-,1.69,'-,[1.37-2.09],"HLA-Z, HLA-DMB",Cervical cancer,cervical carcinoma,GCST009826,6:32920459
rs872956-<b>?</b>,8 x 10-8,,'-,1.58,'-,[1.34-1.86],"HLA-DPB2, COL11A2P1",Cervical cancer,cervical carcinoma,GCST009826,6:33108313
rs9375182-<b>?</b>,3 x 10-6,,'-,1.3513513,'-,[1.19-1.54],"RN7SL564P, FABP7",Cervical cancer,cervical carcinoma,GCST009826,6:122773922
rs10272208-<b>?</b>,2 x 10-6,,'-,1.3333333,'-,[1.19-1.52],ATXN7L1,Cervical cancer,cervical carcinoma,GCST009826,7:105691372
rs140668832-<b>?</b>,3 x 10-10,,'-,1.92,'-,[1.57-2.35],"LINC02569, HLA-E",Cervical cancer,cervical carcinoma,GCST009826,6:30512137
rs117670375-<b>?</b>,3 x 10-10,,'-,1.92,'-,[1.57-2.35],TUBB,Cervical cancer,cervical carcinoma,GCST009826,6:30719695
rs150806792-<b>?</b>,5 x 10-8,,'-,4.96,'-,[2.79-8.83],INS-IGF2,Cervical cancer,cervical carcinoma,GCST009826,11:2158112
rs140991990-<b>?</b>,3 x 10-8,,'-,4.94,'-,[2.80-8.71],"SOX9-AS1, LINC02097",Cervical cancer,cervical carcinoma,GCST009826,17:72101710
rs57561731-<b>?</b>,9 x 10-6,,'-,1.7,'-,[1.34-2.14],UHMK1,Cervical cancer,cervical carcinoma,GCST009826,1:162498796
rs75068199-<b>?</b>,4 x 10-7,,'-,1.82,'-,[1.44-2.30],DDR2,Cervical cancer,cervical carcinoma,GCST009826,1:162660256
rs76883373-<b>?</b>,8 x 10-6,,'-,1.97,'-,[1.46-2.65],"LINC01249, NPM1P48",Cervical cancer,cervical carcinoma,GCST009826,2:4581682
rs62133116-<b>?</b>,2 x 10-6,,'-,1.48,'-,[1.26-1.74],NRXN1,Cervical cancer,cervical carcinoma,GCST009826,2:50256810
rs11684858-<b>?</b>,7 x 10-6,,'-,1.79,'-,[1.39-2.30],ALMS1,Cervical cancer,cervical carcinoma,GCST009826,2:73416499
rs2679850-<b>?</b>,4 x 10-6,,'-,2.2222223,'-,[1.59-3.12],"GPR45, LINC01918",Cervical cancer,cervical carcinoma,GCST009826,2:105183335
rs190074712-<b>?</b>,3 x 10-7,,'-,4.68,'-,[2.60-8.43],"CYP2C56P, PRPS1P1",Cervical cancer,cervical carcinoma,GCST009826,2:164262092
rs183319101-<b>?</b>,8 x 10-6,,'-,1.3333333,'-,[1.18-1.52],FSIP2,Cervical cancer,cervical carcinoma,GCST009826,2:185844965
rs559021322-<b>?</b>,2 x 10-6,,'-,3.63,'-,[2.14-6.17],MIR5702,Cervical cancer,cervical carcinoma,GCST009826,2:226586765
chr3:59760625-<b>?</b>,3 x 10-6,,'-,4.15,'-,[2.28-7.58],'-,Cervical cancer,cervical carcinoma,GCST009826,Mapping not available
chr3:59866982-<b>?</b>,5 x 10-7,,'-,4.98,'-,[2.67-9.30],'-,Cervical cancer,cervical carcinoma,GCST009826,Mapping not available
rs76537691-<b>?</b>,8 x 10-6,,'-,2.81,'-,[1.78-4.43],GBE1,Cervical cancer,cervical carcinoma,GCST009826,3:81782913
rs117143670-<b>?</b>,5 x 10-6,,'-,3.45,'-,[2.03-5.86],"CLDN1, NMNAT1P3",Cervical cancer,cervical carcinoma,GCST009826,3:190245452
rs556607390-<b>?</b>,6 x 10-6,,'-,2.25,'-,[1.58-3.21],ZFYVE28,Cervical cancer,cervical carcinoma,GCST009826,4:2279800
rs146513397-<b>?</b>,7 x 10-7,,'-,3.95,'-,[2.30-6.79],CAMK2D,Cervical cancer,cervical carcinoma,GCST009826,4:113726137
rs185348880-<b>?</b>,8 x 10-7,,'-,3.42,'-,[2.10-5.57],TTC29,Cervical cancer,cervical carcinoma,GCST009826,4:146884350
rs77050118-<b>?</b>,3 x 10-6,,'-,1.79,'-,[1.40-2.28],"RPL8P1, LINC01012",Cervical cancer,cervical carcinoma,GCST009826,6:27685380
rs73730372-<b>?</b>,3 x 10-19,,'-,1.67,'-,[1.49-1.85],"HLA-DRB1, HLA-DQA1",Cervical cancer,cervical carcinoma,GCST003565,6:32616804
rs4782151-<b>C</b>,5 x 10-6,,0.4677,1.91,'-,[1.44-2.52],RPL21P119,Cervical cancer,cervical carcinoma,GCST002405,16:9232128
rs11985951-<b>T</b>,6 x 10-6,,0.871,3.36,'-,[1.94-5.83],'-,Cervical cancer,cervical carcinoma,GCST002405,8:20734998
rs6558578-<b>G</b>,7 x 10-6,,0.7608,2.31,'-,[1.59-3.34],"MYOM2, KBTBD11",Cervical cancer,cervical carcinoma,GCST002405,8:2021565
rs3899697-<b>A</b>,9 x 10-6,,0.2787,1.949,'-,[1.449-2.621],ZNF804B,Cervical cancer,cervical carcinoma,GCST002405,7:88970471
rs997363-<b>C</b>,1 x 10-6,,0.4032,1.986,'-,[1.50-2.62],C2orf83,Cervical cancer,cervical carcinoma,GCST002405,2:227644742
rs7780883-<b>A</b>,2 x 10-6,,0.05376,3.28,'-,[1.956-5.50],"GCNT1P5, GSAP",Cervical cancer,cervical carcinoma,GCST002405,7:77433395
rs6726538-<b>A</b>,3 x 10-6,,0.3871,1.946,'-,[1.471-2.573],"THORLNC, INSIG2",Cervical cancer,cervical carcinoma,GCST002405,2:118131653
rs8088832-<b>C</b>,4 x 10-6,,0.508,1.94,'-,[1.46-2.57],'-,Cervical cancer,cervical carcinoma,GCST002405,18:72259522
rs12068654-<b>T</b>,5 x 10-6,,0.885,3.23,'-,[2.06-6.93],"SLAMF7, LY9",Cervical cancer,cervical carcinoma,GCST002405,1:160773959
DRB1*1301-DQA1*0103-DQB1*0603-<b>?</b>,9 x 10-10,,NR,2.13,'-,[1.67-2.70],'-,Cervical cancer,cervical carcinoma,GCST001900,Mapping not available
DRB1*1501-DQB1*0602-<b>?</b>,4 x 10-7,,0.15,1.39,'-,[1.23-1.58],'-,Cervical cancer,cervical carcinoma,GCST001900,Mapping not available
rs2516448-<b>?</b>,4 x 10-18,,NR,1.42,'-,[1.31-1.54],"LINC01149, MICA",Cervical cancer,cervical carcinoma,GCST001900,6:31422633
rs9272143-<b>?</b>,3 x 10-22,,NR,1.49,'-,[1.37-1.61],HLA-DQA1,Cervical cancer,cervical carcinoma,GCST001900,6:32633026
rs3117027-<b>?</b>,1 x 10-7,,NR,1.25,'-,[1.15-1.36],HLA-DPB2,Cervical cancer,cervical carcinoma,GCST001900,6:33121846
HLA-B*0702-<b>?</b>,8 x 10-8,,0.14,1.42,'-,[1.25-1.61],'-,Cervical cancer,cervical carcinoma,GCST001900,Mapping not available
rs3132461-<b>G</b>,2 x 10-13,,NR,1.358,'-,[NR],"PPIAP9, MICB",Cervical cancer,cervical carcinoma,GCST004833,6:31512891
rs4396968-<b>T</b>,1 x 10-6,,NR,1.26,'-,[NR],GABRB1,Cervical cancer,cervical carcinoma,GCST004833,4:47087167
rs2267681-<b>?</b>,2 x 10-6,,NR,1.1806375,'-,[NR],TBXAS1,Cervical cancer,cervical carcinoma,GCST004833,7:139841136
rs56804039-<b>?</b>,4 x 10-6,,NR,1.2091899,'-,[NR],RN7SL178P,Cervical cancer,cervical carcinoma,GCST004833,8:8523519
rs4738017-<b>G</b>,7 x 10-6,,NR,1.174,'-,[NR],"SULF1, SLCO5A1",Cervical cancer,cervical carcinoma,GCST004833,8:69663895
rs9532669-<b>A</b>,2 x 10-7,,NR,1.216,'-,[NR],"SUGT1P3, ELF1",Cervical cancer,cervical carcinoma,GCST004833,13:40927414
rs11637339-<b>C</b>,6 x 10-6,,NR,1.184,'-,[NR],"RPL7P5, LINC02244",Cervical cancer,cervical carcinoma,GCST004833,15:99451803
rs17087933-<b>?</b>,2 x 10-6,,NR,1.2787724,'-,[NR],'-,Cervical cancer,cervical carcinoma,GCST004833,18:73596115
rs2239704-<b>A</b>,6 x 10-9,,NR,1.23,'-,[NR],LTA,Cervical cancer,cervical carcinoma,GCST004833,6:31572364
rs9272143-<b>?</b>,5 x 10-15,,NR,1.3513513,'-,[NR],HLA-DQA1,Cervical cancer,cervical carcinoma,GCST004833,6:32633026
HLA-DQB1*602-<b>?</b>,4 x 10-12,,0.141,1.44,'-,[NR],'-,Cervical cancer,cervical carcinoma,GCST004833,Mapping not available
HLA-DQA1*0301-<b>?</b>,4 x 10-8,(conditional on HLA-DQB1*0602),0.224,'-,'-,'-,'-,Cervical cancer,cervical carcinoma,GCST004833,Mapping not available
HLA-B*15-<b>?</b>,2 x 10-9,,0.072,0.64,'-,[NR],'-,Cervical cancer,cervical carcinoma,GCST004833,Mapping not available
HAL-DRB1*13-<b>?</b>,1 x 10-9,,0.106,0.69,'-,[NR],'-,Cervical cancer,cervical carcinoma,GCST004833,Mapping not available
rs6547598-<b>A</b>,1 x 10-6,,0.93,1.35,'-,[NR],TCF7L1,Cervical cancer,cervical carcinoma,GCST007119,2:85219363
rs59661306-<b>G</b>,2 x 10-11,,0.15,1.2987013,'-,[NR],"LUCAT1, ADGRV1",Cervical cancer,cervical carcinoma,GCST007119,5:91087644
rs7457728-<b>C</b>,1 x 10-8,,0.39,1.19,'-,[NR],LINC01445,Cervical cancer,cervical carcinoma,GCST007119,7:54380269
rs115137622-<b>C</b>,9 x 10-9,,0.62,1.32,'-,[NR],HLA-DPA3,Cervical cancer,cervical carcinoma,GCST007119,6:33143124
rs8067378-<b>G</b>,3 x 10-6,,0.28,1.22,'-,[NR],"ZPBP2, GSDMB",Cervical cancer,cervical carcinoma,GCST007119,17:39895095
rs183652081-<b>A</b>,4 x 10-7,,NR,2.4900398,'-,NR,ARMH3,Cervical cancer,cervical carcinoma,GCST90011816,10:102040002
rs2856437-<b>A</b>,1 x 10-15,,0.063203,1.3032712,'-,NR,PBX2,Cervical cancer,cervical carcinoma,GCST90011816,6:32189587
rs3130218-<b>A</b>,5 x 10-9,,NR,1.16171,'-,NR,"HLA-DPB2, COL11A2P1",Cervical cancer,cervical carcinoma,GCST90011816,6:33110386
rs2242660-<b>G</b>,2 x 10-7,,NR,1.1015,'-,NR,PRRC2A,Cervical cancer,cervical carcinoma,GCST90011816,6:31629976
rs3131631-<b>G</b>,5 x 10-10,,NR,1.1332,'-,NR,"PPIAP9, MICB",Cervical cancer,cervical carcinoma,GCST90011816,6:31516906
rs10175462-<b>G</b>,8 x 10-14,,0.638323,1.1519,'-,NR,"PAX8-AS1, PAX8",Cervical cancer,cervical carcinoma,GCST90011816,2:113230915
rs9276435-<b>C</b>,2 x 10-10,,NR,1.1631,'-,NR,HLA-DQA2,Cervical cancer,cervical carcinoma,GCST90011816,6:32746090
rs2523496-<b>T</b>,4 x 10-25,,NR,1.2076,'-,NR,MICA,Cervical cancer,cervical carcinoma,GCST90011816,6:31409942
rs9272050-<b>G</b>,1 x 10-39,,NR,1.267,'-,NR,HLA-DQA1,Cervical cancer,cervical carcinoma,GCST90011816,6:32631294
rs114115115-<b>T</b>,6 x 10-13,,NR,1.3463,'-,NR,MUC22,Cervical cancer,cervical carcinoma,GCST90011816,6:31021915
rs116149201-<b>G</b>,3 x 10-9,,NR,3.5068,'-,NR,"HLA-DRB5, HLA-DRB9",Cervical cancer,cervical carcinoma,GCST90011816,6:32480953
rs6812281-<b>T</b>,9 x 10-9,,0.18,2.37,'-,[1.77-3.18],'-,Response to platinum-based neoadjuvant chemotherapy in cervical cancer,"cervical carcinoma, response to platinum-based neoadjuvant chemotherapy",GCST004097,4:179391655
rs1742101-<b>G</b>,7 x 10-6,,0.5,1.92,'-,[1.45-2.56],TTC7B,Response to platinum-based neoadjuvant chemotherapy in cervical cancer,"cervical carcinoma, response to platinum-based neoadjuvant chemotherapy",GCST004097,14:90698719
rs1364121-<b>A</b>,3 x 10-6,,0.25,1.98,'-,[1.49-2.64],CDH13,Response to platinum-based neoadjuvant chemotherapy in cervical cancer,"cervical carcinoma, response to platinum-based neoadjuvant chemotherapy",GCST004097,16:83706502
rs139337062-<b>A</b>,3 x 10-8,,0.488027204,0.7036727,'-,[0.621442066-0.796784242],"RN7SL564P, FABP7",Cervical cancer,cervical carcinoma,GCST90013696,6:122775829
rs13117307-<b>T</b>,3 x 10-10,(Matched),0.1,1.28,'-,[1.19-1.38],EXOC1,Cervical cancer,cervical carcinoma,GCST002082,4:55885574
rs4282438-<b>?</b>,5 x 10-27,(Stringently Matched),0.56,1.35,'-,[1.27-1.41],COL11A2P1,Cervical cancer,cervical carcinoma,GCST002082,6:33104395
rs8067378-<b>G</b>,9 x 10-10,(Matched),0.22,1.19,'-,[1.13-1.26],"ZPBP2, GSDMB",Cervical cancer,cervical carcinoma,GCST002082,17:39895095
rs9277952-<b>?</b>,2 x 10-9,(Matched),0.53,1.18,'-,[1.12-1.23],"ZNF70P1, HTATSF1P1",Cervical cancer,cervical carcinoma,GCST002082,6:33236497
rs1294438-<b>T</b>,1 x 10-6,,0.34,'-,'-,'-,"BTF3P7, LY86",Mammographic density (non-dense area),"non-dense area measurement, mammographic density measurement",GCST002668,6:6751826
rs2190016-<b>T</b>,3 x 10-6,,0.62,'-,'-,'-,'-,Mammographic density (non-dense area),"non-dense area measurement, mammographic density measurement",GCST002668,7:46905209
rs7816345-<b>T</b>,2 x 10-23,,0.18,'-,0.24 unit decrease,[0.18-0.30],KCNU1,Mammographic density (non-dense area),"non-dense area measurement, mammographic density measurement",GCST002668,8:36988591
rs10814275-<b>A</b>,6 x 10-7,,0.95,'-,'-,'-,RGP1,Mammographic density (non-dense area),"non-dense area measurement, mammographic density measurement",GCST002668,9:35758581
rs14168-<b>A</b>,3 x 10-6,,0.94,'-,'-,'-,"PRKG1, CSTF2T",Mammographic density (non-dense area),"non-dense area measurement, mammographic density measurement",GCST002668,10:51695802
rs12220488-<b>A</b>,8 x 10-7,,0.55,'-,'-,'-,ZNF365,Mammographic density (non-dense area),"non-dense area measurement, mammographic density measurement",GCST002668,10:62459241
rs10884482-<b>T</b>,6 x 10-8,,0.07,'-,'-,'-,LINC01435,Mammographic density (non-dense area),"non-dense area measurement, mammographic density measurement",GCST002668,10:107620506
rs1546939-<b>T</b>,9 x 10-6,,0.37,'-,'-,'-,"CYB5AP5, LINC02306",Mammographic density (non-dense area),"non-dense area measurement, mammographic density measurement",GCST002668,14:26201719
rs10034692-<b>A</b>,2 x 10-10,,0.74,'-,0.16 unit decrease,[0.1-0.22],AREG,Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,4:74554070
rs12642133-<b>A</b>,8 x 10-10,,0.3,'-,'-,'-,'-,Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,4:74618075
rs186749-<b>A</b>,3 x 10-7,,0.28,'-,'-,'-,PRDM6,Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,5:123118610
rs12665607-<b>A</b>,2 x 10-8,,0.08,'-,0.17 unit decrease,[0.092-0.248],"CCDC170, ESR1",Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,6:151625494
rs798336-<b>T</b>,2 x 10-6,,0.88,'-,'-,'-,MAGI2,Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,7:78285026
rs10995190-<b>A</b>,1 x 10-16,,0.16,'-,0.24 unit decrease,[0.18-0.30],ZNF365,Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,10:62518923
rs3817198-<b>C</b>,1 x 10-10,,0.66,'-,0.14 unit increase,[0.081-0.199],LSP1,Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,11:1887776
rs11836164-<b>T</b>,1 x 10-7,,0.77,'-,'-,'-,SSPN,Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,12:26293692
rs703556-<b>A</b>,4 x 10-10,,0.98,'-,0.41 unit decrease,[0.25-0.57],'-,Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,12:102618116
rs6104691-<b>A</b>,1 x 10-6,,0.34,'-,'-,'-,LINC02871,Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,20:11016263
rs7289126-<b>A</b>,3 x 10-8,,0.4,'-,0.11 unit decrease,[0.071-0.149],TMEM184B,Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,22:38232300
rs17001868-<b>A</b>,2 x 10-13,,0.92,'-,0.18 unit decrease,[0.12-0.24],"SGSM3, ADSL, SGSM3-AS1",Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,22:40382227
rs186749-<b>A</b>,3 x 10-9,,0.28,'-,0.1 unit increase,[0.061-0.139],PRDM6,Percent mammographic density,"mammographic density percentage, mammographic density measurement",GCST002669,5:123118610
rs7816345-<b>T</b>,5 x 10-8,,0.18,'-,0.08 unit increase,[0.041-0.119],KCNU1,Percent mammographic density,"mammographic density percentage, mammographic density measurement",GCST002669,8:36988591
rs1110403-<b>A</b>,7 x 10-6,,0.58,'-,'-,'-,"RNU6-996P, PPIAP88",Percent mammographic density,"mammographic density percentage, mammographic density measurement",GCST002669,9:107621302
rs10509168-<b>T</b>,1 x 10-9,,0.41,'-,'-,'-,ZNF365,Percent mammographic density,"mammographic density percentage, mammographic density measurement",GCST002669,10:62498069
rs7289126-<b>A</b>,5 x 10-9,,0.4,'-,0.1 unit decrease,[0.061-0.139],TMEM184B,Percent mammographic density,"mammographic density percentage, mammographic density measurement",GCST002669,22:38232300
rs34331777-<b>?</b>,5 x 10-9,,NR,'-,0.042 unit increase,[0.028-0.056],LINC01376,Percent mammographic density,mammographic density percentage,GCST90011733,2:19241491
rs11676272-<b>?</b>,2 x 10-9,,NR,'-,0.043 unit decrease,[0.029-0.057],ADCY3,Percent mammographic density,mammographic density percentage,GCST90011733,2:24918669
rs66470855-<b>?</b>,2 x 10-8,,NR,'-,0.046 unit increase,[0.03-0.062],DIRC3,Percent mammographic density,mammographic density percentage,GCST90011733,2:217401716
rs76643909-<b>?</b>,5 x 10-12,,NR,'-,0.069 unit increase,[0.049-0.089],PPARG,Percent mammographic density,mammographic density percentage,GCST90011733,3:12399868
rs35589286-<b>?</b>,2 x 10-8,,NR,'-,0.045 unit increase,[0.029-0.061],'-,Percent mammographic density,mammographic density percentage,GCST90011733,4:127271525
rs3819405-<b>?</b>,5 x 10-15,,NR,'-,0.059 unit decrease,[0.043-0.075],ATXN1,Percent mammographic density,mammographic density percentage,GCST90011733,6:16399326
rs6558136-<b>?</b>,1 x 10-8,,NR,'-,0.042 unit decrease,[0.026-0.058],"RPL17P33, LINC00589",Percent mammographic density,mammographic density percentage,GCST90011733,8:29665607
rs2138555-<b>?</b>,2 x 10-15,,NR,'-,0.057 unit decrease,[0.043-0.071],ZNF365,Percent mammographic density,mammographic density percentage,GCST90011733,10:62460735
rs6590455-<b>?</b>,5 x 10-8,,NR,'-,0.041 unit decrease,[0.025-0.057],ADAMTS8,Percent mammographic density,mammographic density percentage,GCST90011733,11:130406532
rs10219975-<b>?</b>,1 x 10-8,,NR,'-,0.045 unit decrease,[0.029-0.061],"LINC00445, NBEA",Percent mammographic density,mammographic density percentage,GCST90011733,13:35694988
rs4777948-<b>?</b>,3 x 10-10,,NR,'-,0.046 unit increase,[0.032-0.06],LINC01579,Percent mammographic density,mammographic density percentage,GCST90011733,15:93755010
rs1704773-<b>?</b>,4 x 10-9,,NR,'-,0.044 unit decrease,[0.03-0.058],"FUT2, MAMSTR",Percent mammographic density,mammographic density percentage,GCST90011733,19:48706309
rs1892368-<b>?</b>,3 x 10-6,,NR,'-,0.035 unit decrease,[0.019-0.051],PRKG1,Percent mammographic density,mammographic density percentage,GCST90011733,10:51915035
rs60521023-<b>?</b>,1 x 10-7,,NR,'-,0.041 unit decrease,[0.025-0.057],ARNTL,Percent mammographic density,mammographic density percentage,GCST90011733,11:13292556
rs11040963-<b>?</b>,7 x 10-7,,NR,'-,0.04 unit decrease,[0.024-0.056],"MRPL17, GVINP1",Percent mammographic density,mammographic density percentage,GCST90011733,11:6691983
rs75197674-<b>?</b>,6 x 10-7,,NR,'-,0.046 unit decrease,[0.028-0.064],RAD51B,Percent mammographic density,mammographic density percentage,GCST90011733,14:68504735
rs1779445-<b>?</b>,3 x 10-7,,NR,'-,0.046 unit decrease,[0.028-0.064],TBX15,Percent mammographic density,mammographic density percentage,GCST90011733,1:118965789
rs6703250-<b>?</b>,1 x 10-7,,NR,'-,0.039 unit decrease,[0.025-0.053],FAF1,Percent mammographic density,mammographic density percentage,GCST90011733,1:50952800
rs61777307-<b>?</b>,4 x 10-7,,NR,'-,0.042 unit increase,[0.026-0.058],MDS2,Percent mammographic density,mammographic density percentage,GCST90011733,1:23632829
rs6715731-<b>?</b>,6 x 10-7,,NR,'-,0.037 unit decrease,[0.023-0.051],"FNBP1P1, TET3",Percent mammographic density,mammographic density percentage,GCST90011733,2:74119277
rs4132228-<b>?</b>,1 x 10-7,,NR,'-,0.041 unit increase,[0.025-0.057],ADAMTS9-AS2,Percent mammographic density,mammographic density percentage,GCST90011733,3:64722438
rs6885843-<b>?</b>,1 x 10-6,,NR,'-,0.036 unit increase,[0.022-0.05],"HSPE1P10, BOLA3P3",Percent mammographic density,mammographic density percentage,GCST90011733,5:126732808
rs4132228-<b>?</b>,2 x 10-13,,NR,'-,0.048 unit decrease,[0.034-0.062],ADAMTS9-AS2,Mammographic density (non-dense area),mammographic density measurement,GCST90011732,3:64722438
rs1294419-<b>?</b>,8 x 10-10,,NR,'-,0.038 unit increase,[0.026-0.05],"LY86, BTF3P7",Mammographic density (non-dense area),mammographic density measurement,GCST90011732,6:6742316
rs1949355-<b>?</b>,2 x 10-10,,NR,'-,0.039 unit decrease,[0.027-0.051],ZNF365,Mammographic density (non-dense area),mammographic density measurement,GCST90011732,10:62458664
rs60521023-<b>?</b>,8 x 10-10,,NR,'-,0.041 unit increase,[0.027-0.055],ARNTL,Mammographic density (non-dense area),mammographic density measurement,GCST90011732,11:13292556
rs2875238-<b>?</b>,3 x 10-10,,NR,'-,0.041 unit increase,[0.027-0.055],ADAMTS8,Mammographic density (non-dense area),mammographic density measurement,GCST90011732,11:130412183
rs11836367-<b>?</b>,8 x 10-9,,NR,'-,0.042 unit increase,[0.028-0.056],PGAM1P5,Mammographic density (non-dense area),mammographic density measurement,GCST90011732,12:95633691
rs1812707-<b>?</b>,3 x 10-8,,NR,'-,0.034 unit increase,[0.022-0.046],ADAMTSL3,Mammographic density (non-dense area),mammographic density measurement,GCST90011732,15:83878470
rs10219975-<b>?</b>,6 x 10-6,,NR,'-,0.03 unit increase,[0.016-0.044],"LINC00445, NBEA",Mammographic density (non-dense area),mammographic density measurement,GCST90011732,13:35694988
rs4777948-<b>?</b>,5 x 10-8,,NR,'-,0.034 unit decrease,[0.022-0.046],LINC01579,Mammographic density (non-dense area),mammographic density measurement,GCST90011732,15:93755010
rs6703250-<b>?</b>,5 x 10-10,,NR,'-,0.054 unit decrease,[0.036-0.072],FAF1,Mammographic density (dense area),mammographic density measurement,GCST90011731,1:50952800
rs11684853-<b>?</b>,3 x 10-8,,NR,'-,0.049 unit increase,[0.031-0.067],LINC01376,Mammographic density (dense area),mammographic density measurement,GCST90011731,2:19111157
rs6715731-<b>?</b>,5 x 10-8,,NR,'-,0.048 unit decrease,[0.03-0.066],"FNBP1P1, TET3",Mammographic density (dense area),mammographic density measurement,GCST90011731,2:74119277
rs66470855-<b>?</b>,9 x 10-10,,NR,'-,0.06 unit increase,[0.04-0.08],DIRC3,Mammographic density (dense area),mammographic density measurement,GCST90011731,2:217401716
rs67901221-<b>?</b>,1 x 10-8,,NR,'-,0.069 unit increase,[0.045-0.093],PPARG,Mammographic density (dense area),mammographic density measurement,GCST90011731,3:12375051
rs1503613-<b>?</b>,6 x 10-10,,NR,'-,0.054 unit increase,[0.036-0.072],'-,Mammographic density (dense area),mammographic density measurement,GCST90011731,4:126851213
rs6885843-<b>?</b>,4 x 10-8,,NR,'-,0.048 unit increase,[0.03-0.066],"HSPE1P10, BOLA3P3",Mammographic density (dense area),mammographic density measurement,GCST90011731,5:126732808
rs3819405-<b>?</b>,4 x 10-14,,NR,'-,0.069 unit decrease,[0.051-0.087],ATXN1,Mammographic density (dense area),mammographic density measurement,GCST90011731,6:16399326
rs2642278-<b>?</b>,1 x 10-8,,NR,'-,0.05 unit increase,[0.032-0.068],"MKX, LINC02680",Mammographic density (dense area),mammographic density measurement,GCST90011731,10:27647633
rs1892368-<b>?</b>,2 x 10-8,,NR,'-,0.051 unit decrease,[0.033-0.069],PRKG1,Mammographic density (dense area),mammographic density measurement,GCST90011731,10:51915035
rs11040963-<b>?</b>,2 x 10-8,,NR,'-,0.053 unit decrease,[0.033-0.073],"MRPL17, GVINP1",Mammographic density (dense area),mammographic density measurement,GCST90011731,11:6691983
rs1818476-<b>?</b>,2 x 10-8,,NR,'-,0.055 unit decrease,[0.035-0.075],SSPN,Mammographic density (dense area),mammographic density measurement,GCST90011731,12:26292631
rs75197674-<b>?</b>,6 x 10-9,,NR,'-,0.064 unit decrease,[0.042-0.086],RAD51B,Mammographic density (dense area),mammographic density measurement,GCST90011731,14:68504735
rs11877925-<b>?</b>,7 x 10-9,,NR,'-,0.06 unit decrease,[0.04-0.08],BCL2,Mammographic density (dense area),mammographic density measurement,GCST90011731,18:63229461
rs492602-<b>?</b>,7 x 10-12,,NR,'-,0.06 unit decrease,[0.042-0.078],FUT2,Mammographic density (dense area),mammographic density measurement,GCST90011731,19:48703160
rs17196752-<b>?</b>,9 x 10-9,,NR,'-,0.063 unit increase,[0.041-0.085],PELATON,Mammographic density (dense area),mammographic density measurement,GCST90011731,20:50270731
rs10219975-<b>?</b>,6 x 10-6,,NR,'-,0.043 unit decrease,[0.023-0.063],"LINC00445, NBEA",Mammographic density (dense area),mammographic density measurement,GCST90011731,13:35694988
rs4777948-<b>?</b>,3 x 10-6,,NR,'-,0.041 unit increase,[0.023-0.059],LINC01579,Mammographic density (dense area),mammographic density measurement,GCST90011731,15:93755010
rs6558136-<b>?</b>,4 x 10-7,,NR,'-,0.046 unit decrease,[0.028-0.064],"RPL17P33, LINC00589",Mammographic density (dense area),mammographic density measurement,GCST90011731,8:29665607
rs61777307-<b>?</b>,4 x 10-9,,NR,'-,0.042 unit decrease,[0.028-0.056],MDS2,Mammographic density (non-dense area),mammographic density measurement,GCST90011732,1:23632829
rs10802015-<b>?</b>,2 x 10-10,,NR,'-,0.041 unit decrease,[0.027-0.055],"RNA5SP56, SPAG17",Mammographic density (non-dense area),mammographic density measurement,GCST90011732,1:118240036
rs1779445-<b>?</b>,6 x 10-12,,NR,'-,0.052 unit increase,[0.036-0.068],TBX15,Mammographic density (non-dense area),mammographic density measurement,GCST90011732,1:118965789
rs6718628-<b>?</b>,1 x 10-10,,NR,'-,0.041 unit increase,[0.029-0.053],ADCY3,Mammographic density (non-dense area),mammographic density measurement,GCST90011732,2:24908301
rs11123556-<b>?</b>,9 x 10-15,,NR,'-,0.075 unit decrease,[0.055-0.095],LINC01101,Mammographic density (non-dense area),mammographic density measurement,GCST90011732,2:120488420
rs199689761-<b>?</b>,2 x 10-8,,NR,'-,0.047 unit decrease,[0.031-0.063],PPARG,Mammographic density (non-dense area),mammographic density measurement,GCST90011732,3:12399590
rs4669418-<b>A</b>,9 x 10-6,,0.597,1.86,'-,[1.41-2.47],"RNU4-73P, YWHAQ",Mammographic density,mammographic density measurement,GCST002676,2:9683741
rs6733938-<b>G</b>,5 x 10-6,,0.155,2.38,'-,[1.61-3.45],ADD2,Mammographic density,mammographic density measurement,GCST002676,2:70642341
rs7601137-<b>T</b>,9 x 10-6,,0.848,2.32,'-,[1.58-3.41],AFF3,Mammographic density,mammographic density measurement,GCST002676,2:99743888
rs2904090-<b>C</b>,8 x 10-6,,0.185,2.22,'-,[1.54-3.13],"MAPK10-AS1, MAPK10",Mammographic density,mammographic density measurement,GCST002676,4:86211618
rs4565302-<b>C</b>,5 x 10-6,,0.09,2.94,'-,[1.79-5.00],BTBD9,Mammographic density,mammographic density measurement,GCST002676,6:38432363
rs10995190-<b>A</b>,1 x 10-9,,0.15,'-,0.18 % decrease,[0.12-0.25],ZNF365,Percent mammographic density,mammographic density measurement,GCST000958,10:62518923
